<SEC-DOCUMENT>0001178913-25-002838.txt : 20250813
<SEC-HEADER>0001178913-25-002838.hdr.sgml : 20250813
<ACCEPTANCE-DATETIME>20250813083247
ACCESSION NUMBER:		0001178913-25-002838
CONFORMED SUBMISSION TYPE:	F-3
PUBLIC DOCUMENT COUNT:		25
FILED AS OF DATE:		20250813
DATE AS OF CHANGE:		20250813

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Innoviz Technologies Ltd.
		CENTRAL INDEX KEY:			0001835654
		STANDARD INDUSTRIAL CLASSIFICATION:	MOTOR VEHICLE PARTS & ACCESSORIES [3714]
		ORGANIZATION NAME:           	04 Manufacturing
		EIN:				000000000
		STATE OF INCORPORATION:			L3
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		F-3
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-289554
		FILM NUMBER:		251209094

	BUSINESS ADDRESS:	
		ADDRESS IS A NON US LOCATION: 	YES
		STREET 1:		5 URI ARIAV STREET, BLDG. C, NITZBA 300
		CITY:			ROSH HAAIN
		PROVINCE COUNTRY:   	L3
		BUSINESS PHONE:		972 (54) 7260767

	MAIL ADDRESS:	
		ADDRESS IS A NON US LOCATION: 	YES
		STREET 1:		5 URI ARIAV STREET, BLDG. C, NITZBA 300
		CITY:			ROSH HAAIN
		PROVINCE COUNTRY:   	L3
</SEC-HEADER>
<DOCUMENT>
<TYPE>F-3
<SEQUENCE>1
<FILENAME>zk2533608.htm
<DESCRIPTION>F-3
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: zk-global
         Document created using Broadridge PROfile 25.5.1.5318
         Copyright 1995 - 2025 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left; color: #000000;">
  <div>
    <hr align="center" style="border: none; border-bottom: 1px solid black; border-top: 4px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;">
    <div style="font-family: 'Times New Roman',Times,serif;">
      <div>&#160;</div>
      <div style="text-align: center; font-weight: bold;">As filed with the Securities and Exchange Commission on August 13, 2025</div>
      <div style="text-align: center; font-weight: bold;">&#160;</div>
      <div>
        <div style="text-align: right; font-weight: bold;">Registration No. 333&#8209;</div>
        <hr noshade="noshade" align="center" style="height: 2px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;"></div>
      <div> <font style="font-weight: bold;"><br>
        </font></div>
      <div style="text-align: center; font-weight: bold;">UNITED STATES</div>
      <div style="font-size: 14pt; text-align: center; font-weight: bold;">SECURITIES AND EXCHANGE COMMISSION</div>
      <div style="text-align: center; font-weight: bold;"><u>WASHINGTON, D.C. 20549</u></div>
      <div> <font style="font-weight: bold;"><br>
        </font></div>
      <div style="font-size: 14pt; text-align: center; font-weight: bold;">FORM F&#8209;3</div>
      <div style="text-align: center; font-weight: bold;">REGISTRATION STATEMENT</div>
      <div style="text-align: center; font-weight: bold; font-style: italic;">UNDER</div>
      <div style="text-align: center; font-weight: bold; font-style: italic;"><u>THE SECURITIES ACT OF 1933</u></div>
      <div> <font style="font-weight: bold;"><br>
        </font></div>
      <div style="font-size: 16pt; text-align: center; font-weight: bold;">INNOVIZ TECHNOLOGIES LTD.</div>
      <div style="text-align: center; font-weight: bold; font-style: normal;"><u>(Exact Name of Registrant as Specified in its Charter)</u></div>
      <div>&#160;</div>
      <table cellspacing="0" cellpadding="0" style="width: 100%;" id="z24b15d0d42e542108cdc95c7e3d2aec9">

          <tr>
            <td style="width: 33.33%; font-size: 10pt; text-align: center; vertical-align: top;">
              <div style="font-weight: bold;">State of Israel<br>
              </div>
              <div style="font-weight: bold;">(State or Other Jurisdiction of </div>
              <div style="font-weight: bold;">Incorporation or Organization)</div>
            </td>
            <td style="width: 33.34%; text-align: center; vertical-align: top; font-weight: bold;">
              <div style="font-size: 10pt;">3714<br>
                (Primary Standard Industrial</div>
              <div style="font-size: 10pt;">Classification Code Number)</div>
              <div style="font-size: 10pt;">Innoviz Technologies Ltd.</div>
              <div style="font-size: 10pt;">Innoviz Technologies Campus, </div>
              <div style="font-size: 10pt;">5 Uri Ariav St., Bldg. C, Nitzba 300</div>
              <div style="font-size: 10pt;">Rosh HaAin, Israel</div>
              <div style="font-size: 10pt;">4809202</div>
              <div style="font-size: 10pt;">+972&#8209;74&#8209;700&#8209;3692</div>
            </td>
            <td style="width: 33.34%; font-size: 10pt; text-align: center; vertical-align: top;">
              <div style="font-weight: bold;">Not Applicable<br>
                (I.R.S. Employer<br>
                Identification No.)</div>
            </td>
          </tr>
          <tr>
            <td colspan="3" style="width: 100%; font-size: 10pt; text-align: center; vertical-align: top;">
              <div>(Address, including zip code, and telephone number, including area code, of registrant&#8217;s principal executive offices)</div>
            </td>
          </tr>
          <tr>
            <td style="width: 33.33%; font-size: 10pt; text-align: center; vertical-align: top; font-weight: bold;">&#160;</td>
            <td style="width: 33.34%; text-align: center; vertical-align: top; font-weight: bold;">
              <div> <font style="font-size: 10pt;"><br>
                </font></div>
              <div style="font-size: 10pt;">Cogency Global Inc.</div>
              <div style="font-size: 10pt;">122 East 42nd Street, 18th Floor</div>
              <div style="font-size: 10pt;">New York, NY 10168</div>
              <div style="font-size: 10pt;">(800) 221&#8209;0102</div>
            </td>
            <td style="width: 33.34%; font-size: 10pt; text-align: center; vertical-align: top; font-weight: bold;">&#160;</td>
          </tr>
          <tr>
            <td colspan="3" style="width: 100%; font-size: 10pt; text-align: center; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">
              <div>(Name, address, including zip code, and telephone number, including area code, of agent for service)</div>
            </td>
          </tr>
          <tr>
            <td rowspan="1" style="width: 33.33%; font-size: 10pt; text-align: center; vertical-align: top;">&#160;</td>
            <td rowspan="1" style="width: 33.34%; font-size: 10pt; text-align: center; vertical-align: top;">&#160;</td>
            <td rowspan="1" style="width: 33.34%; font-size: 10pt; text-align: center; vertical-align: top;">&#160;</td>
          </tr>
          <tr>
            <td style="width: 33.33%; font-size: 10pt; text-align: center; vertical-align: top; font-weight: bold;">&#160;</td>
            <td style="width: 33.34%; font-size: 10pt; text-align: center; vertical-align: top;">
              <div style="font-weight: bold; font-style: italic;">Copies to:</div>
            </td>
            <td style="width: 33.34%; font-size: 10pt; text-align: center; vertical-align: top; font-weight: bold;">&#160;</td>
          </tr>
          <tr>
            <td style="width: 33.33%; text-align: center; vertical-align: top; font-weight: bold; padding-bottom: 2px;">
              <div style="font-size: 10pt;">Ryan J. Maierson</div>
              <div style="font-size: 10pt;">Ryan J. Lynch</div>
              <div style="font-size: 10pt;">Latham &amp; Watkins LLP</div>
              <div style="font-size: 10pt;">811 Main Street, Suite 3700</div>
              <div style="font-size: 10pt;">Houston, Texas 77002</div>
              <div style="font-size: 10pt;">Tel: (713) 546&#8209;5400</div>
            </td>
            <td style="width: 33.34%; text-align: center; vertical-align: top; font-weight: bold; border-bottom: 2px solid rgb(0, 0, 0);">
              <div style="font-size: 10pt;">Joshua G. Kiernan</div>
              <div style="font-size: 10pt;">Latham &amp; Watkins LLP</div>
              <div style="font-size: 10pt;">99 Bishopsgate London EC2M 3XF </div>
              <div style="font-size: 10pt;">United Kingdom</div>
              <div style="font-size: 10pt;">Tel: (+44) (20) 7710&#8209;1000</div>
            </td>
            <td style="width: 33.34%; text-align: center; vertical-align: top; font-weight: bold; padding-bottom: 2px;">
              <div style="font-size: 10pt;">Tuvia J. Geffen, Adv.</div>
              <div style="font-size: 10pt;">Mor Kadosh, Adv.</div>
              <div style="font-size: 10pt;">Naschitz, Brandes, Amir &amp; Co.</div>
              <div style="font-size: 10pt;">5 Tuval Street<br>
                Tel-Aviv 6789717, Israel<br>
                Tel: +972 3-623-5000</div>
            </td>
          </tr>
          <tr>
            <td rowspan="1" style="width: 33.33%; font-size: 10pt; text-align: center; vertical-align: top;">&#160;</td>
            <td rowspan="1" style="width: 33.34%; font-size: 10pt; text-align: center; vertical-align: top;">&#160;</td>
            <td rowspan="1" style="width: 33.34%; font-size: 10pt; text-align: center; vertical-align: top;">&#160;</td>
          </tr>

      </table>
      <div> <br>
      </div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">Approximate date of commencement of proposed sale to the public: From time to time after the effectiveness of this registration statement.</div>
      <div> <br>
      </div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">If only securities being registered on this Form are being offered pursuant to dividend or interest reinvestment plans, please check the following box. &#9744;</div>
      <div> <br>
      </div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">If any of the securities being registered on this Form are to be offered on a delayed or continuous basis pursuant to Rule 415 under the Securities Act of 1933, check the
        following box.&#160; &#9746;</div>
      <div> <br>
      </div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">If this Form is filed to register additional securities for an offering pursuant to Rule 462(b) under the Securities Act, please check the following box and list the Securities
        Act registration statement number of the earlier effective registration statement for the same offering. &#9744;</div>
      <div> <br>
      </div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">If this Form is a post&#8209;effective amendment filed pursuant to Rule 462(c) under the Securities Act, check the following box and list the Securities Act registration statement
        number of the earlier effective registration statement for the same offering. &#9744;</div>
      <div> <br>
      </div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">If this Form is a registration statement pursuant to General Instruction I.C. or a post&#8209;effective amendment thereto that shall become effective upon filing with the Commission
        pursuant to Rule 462(e) under the Securities Act, check the following box. &#9744;</div>
      <div> <br>
      </div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">If this Form is a post&#8209;effective amendment to a registration statement filed pursuant to General Instruction I.C. filed to register additional securities or additional classes of
        securities pursuant to Rule 413(b) under the Securities Act, check the following box. &#9744;</div>
      <div> <br>
      </div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933.</div>
      <div style="text-align: right; text-indent: 36pt; line-height: 1.25;"><br>
        Emerging growth company&#160; &#9746;</div>
      <div> <br>
      </div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">If an emerging growth company that prepares its financial statements in accordance with U.S. GAAP, indicate by check mark if the registrant has elected not to use the extended
        transition period for complying with any new or revised financial accounting standards&#8224; provided pursuant to Section 7(a)(2)(B) of the Securities Act. &#9744;</div>
      <div> <br>
      </div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">&#8224; The term &#8220;new or revised financial accounting standard&#8221; refers to any update issued by the Financial Accounting Standards Board to its Accounting Standards Codification after
        April 5, 2012.<br>
      </div>
      <div> <br>
      </div>
      <div>
        <table cellspacing="0" cellpadding="0" border="0" id="z53a07da29efa429c82a55e081bc6c558" style="width: 100%;">

            <tr>
              <td style="width: 33.33%; font-size: 10pt; padding-bottom: 2px;">
                <div>&#160;</div>
              </td>
              <td style="width: 33.33%; font-size: 10pt; border-bottom: 2px solid rgb(0, 0, 0);">
                <div>&#160;</div>
              </td>
              <td style="width: 33.33%; font-size: 10pt; padding-bottom: 2px;">
                <div>&#160;</div>
              </td>
            </tr>

        </table>
      </div>
      <div> <br>
      </div>
      <div style="font-weight: bold;">The registrant hereby amends this registration statement on such date or dates as may be necessary to delay its effective date until the registrant shall file a further amendment which specifically states that this
        registration statement shall thereafter become effective in accordance with Section 8(a) of the Securities Act of 1933 or until this registration statement shall become effective on such date as the Securities and Exchange Commission (the &#8220;SEC&#8221;),
        acting pursuant to said Section 8(a), may determine.</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      </div>
      <div style="font-weight: bold; text-align: center;">EXPLANATORY NOTE</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">This registration statement contains:</div>
      <div>&#160;</div>
      <table cellspacing="0" cellpadding="0" style="width: 100%;" class="DSPFListTable" id="zac7dafe54d9645c180fd69bbdd084a8e">

          <tr>
            <td style="width: 18pt; font-size: 10pt;"><br>
            </td>
            <td style="width: 18pt; font-size: 10pt;">&#8226;</td>
            <td style="width: auto; font-size: 10pt;">
              <div style="text-align: justify;">base prospectus, which covers the offering, issuance and sale by us of up to $200,000,000 in the aggregate of the securities identified herein from time to time in one or more offerings; and</div>
            </td>
          </tr>

      </table>
      <div>&#160;</div>
      <table cellspacing="0" cellpadding="0" style="width: 100%;" class="DSPFListTable" id="zbd3013722da94dabb85a6ff455449c89">

          <tr>
            <td style="width: 18pt; font-size: 10pt;"><br>
            </td>
            <td style="width: 18pt; font-size: 10pt;">&#8226;</td>
            <td style="width: auto; font-size: 10pt;">
              <div style="text-align: justify;">a sales agreement prospectus covering the offering, issuance and sale by us of up to a maximum aggregate offering price of $75,000,000 of our ordinary shares, no par value per share (&#8220;ordinary shares&#8221;) that
                may be issued and sold from time to time under an Open Market Sale Agreement<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">sm</sup>, dated August 13, 2025 (the &#8220;Sales Agreement&#8221;), through or to Jefferies LLC, acting as sales agent and/or principal.</div>
            </td>
          </tr>

      </table>
      <div>&#160;</div>
      <div style="text-align: justify; line-height: 1.25;">The base prospectus immediately follows this explanatory note. The specific terms of any securities to be offered pursuant to the base prospectus will be specified in a prospectus supplement to the
        base prospectus. The sales agreement prospectus immediately follows the base prospectus. The $75,000,000 of ordinary shares that may be offered, issued and sold by us pursuant to the Sales Agreement and under the sales agreement prospectus is
        included in the $200,000,000 of securities that may be offered, issued and sold by us under the base prospectus. Upon termination of the Sales Agreement, any portion of the $75,000,000 included in the sales agreement prospectus that is not sold
        pursuant to the Sales Agreement will be available for sale in other offerings pursuant to the base prospectus and a corresponding prospectus supplement, and if no shares are sold under the Sales Agreement, the full $200,000,000 of securities may be
        sold in other offerings pursuant to the base prospectus and a corresponding prospectus supplement.</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      </div>
      <table cellspacing="0" cellpadding="0" style="width: 100%;" id="z9cab01aec8f74fe890f705ee6744681a">

          <tr>
            <td style="width: 100%; font-size: 10pt; color: rgb(255, 0, 0); font-weight: bold;">
              <div>The information contained in this prospectus is not complete and may be changed. These securities may not be sold until the registration statement filed with the Securities and Exchange Commission is effective. This prospectus is not an
                offer to sell these securities and it is not soliciting an offer to buy these securities in any state where the offer or sale is not permitted.</div>
            </td>
          </tr>

      </table>
      <div> <br>
      </div>
      <div style="font-weight: bold; text-align: center;">SUBJECT TO COMPLETION, DATED AUGUST 13, 2025</div>
      <div style="font-weight: bold;">&#160;</div>
      <div style="font-weight: bold;">PRELIMINARY PROSPECTUS</div>
      <div style="font-weight: bold;">&#160;</div>
      <div style="font-weight: bold; text-align: center;">INNOVIZ TECHNOLOGIES LTD.</div>
      <div>&#160;</div>
      <div style="text-align: center;">
        <div style="line-height: 1.25; font-weight: bold;"><img src="image00001.jpg"> </div>
      </div>
      <div style="font-weight: bold; text-align: center;">$200,000,000</div>
      <div style="font-weight: bold; text-align: center;">Ordinary Shares</div>
      <div style="font-weight: bold; text-align: center;">Warrants<br>
        Debt Securities<br>
        Units</div>
      <table cellspacing="0" cellpadding="0" border="0" style="width: 100%;" id="z9d222faeea2f47c3adc64a3ed4012ae2">

          <tr>
            <td colspan="1" style="width: 40%; font-size: 10pt; padding-bottom: 2px;">&#160;</td>
            <td colspan="1" style="width: 10%; font-size: 10pt; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
            <td style="width: 40%; font-size: 10pt; padding-bottom: 2px;">&#160;</td>
          </tr>

      </table>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">This prospectus relates to the issuance sale from time to time by Innoviz Technologies Ltd., a company organized under the laws of the State of Israel (&#8220;we&#8221;, &#8220;our&#8221;, the &#8220;Company&#8221;
        or &#8220;Innoviz&#8221;) of up to $200,000,000 of ordinary shares, warrants to purchase ordinary shares or debt securities, debt securities or any combination of the above, separately or as units (collectively, the &#8220;securities&#8221;). This prospectus provides you
        with a general description of the securities. Each time we offer and sell securities pursuant to this prospectus, we will provide a supplement to this prospectus that contains specific information about the offering and the amounts, prices and
        terms of the securities offered.</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">We may, from time to time, offer and sell the securities described in this prospectus and any prospectus supplement to or through one or more underwriters, dealers and agents, or
        directly to purchasers, or through a combination of these methods.&#160; If any underwriters, dealers or agents are involved in the sale of any of the securities, their names and any applicable purchase price, fee, commission or discount arrangement
        between or among them will be set forth, or will be calculable from the information set forth, in the applicable prospectus supplement.&#160; See the sections of this prospectus entitled &#8220;<font style="font-style: italic;">About this Prospectus</font>&#8221;
        and &#8220;<font style="font-style: italic;">Plan of Distribution</font>&#8221; for more information.&#160; No securities may be sold without delivery of this prospectus and the applicable prospectus supplement describing the method and terms of the offering of
        such securities.</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">We will receive proceeds from the issuance and sale of our securities.</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">Our ordinary shares and existing warrants are listed on the Nasdaq Stock Market LLC under the trading symbols &#8220;INVZ&#8221; and &#8220;INVZW,&#8221; respectively. On August 11, 2025, the closing
        prices for our ordinary shares and existing warrants on the Nasdaq Stock Market LLC were $1.70 per ordinary share and $0.083 per existing warrant.</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">We may amend or supplement this prospectus from time to time by filing amendments or supplements as required. You should read this entire prospectus and any amendments or
        supplements carefully before you make your investment decision.</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">We are an &#8220;emerging growth company,&#8221; as defined in the Jumpstart Our Business Startups Act of 2012, or JOBS Act, and are subject to reduced public company reporting requirements.</div>
      <div> <br>
      </div>
      <table cellspacing="0" cellpadding="0" border="0" id="d427dea2dd0a4de3b3ca6cd92aff985a" style="width: 100%;">

          <tr>
            <td colspan="1" style="width: 40%; font-size: 10pt; padding-bottom: 2px;">&#160;</td>
            <td colspan="1" style="width: 10%; font-size: 10pt; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
            <td style="width: 40%; font-size: 10pt; padding-bottom: 2px;">&#160;</td>
          </tr>

      </table>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-weight: bold;">Investing in our securities involves a high degree of risk. See &#8220;Risk Factors&#8221; beginning on page 7 of this prospectus and our periodic reports and other
        information filed&#160;with the SEC and incorporated by reference herein, for a discussion of information that should be considered in connection with an investment in our securities.</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-weight: bold;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;"><font style="font-weight: bold;">Neither the Securities and Exchange Commission, the Israel Securities Authority nor any state securities commission has approved or disapproved
          of these securities or determined if this prospectus is truthful or complete. Any representation to the contrary is a criminal offense.</font><br>
        <br>
      </div>
      <table cellspacing="0" cellpadding="0" border="0" id="a51655b5ac3b4c65ad690efaf5571324" style="width: 100%;">

          <tr>
            <td colspan="1" style="width: 40%; font-size: 10pt; padding-bottom: 2px;">&#160;</td>
            <td colspan="1" style="width: 10%; font-size: 10pt; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
            <td style="width: 40%; font-size: 10pt; padding-bottom: 2px;">&#160;</td>
          </tr>

      </table>
      <div>&#160;</div>
      <div style="text-align: center;">The date of this prospectus is&#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160;&#160; , 2025.</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      </div>
      <!--PROfilePageNumberReset%LCR%1%%%-->
      <div style="text-align: center; font-weight: bold;">TABLE OF&#160;CONTENTS</div>
      <div>&#160;</div>
      <div>
        <table cellspacing="0" cellpadding="0" border="0" style="width: 100%;" id="zea67bb9dc2b045ba8fa0b5ac11f16cf7">

            <tr>
              <td style="width: 95%; font-size: 10pt;">
                <div><br>
                </div>
              </td>
              <td style="width: 5%; font-size: 10pt;">
                <div style="font-weight: bold;">Page</div>
              </td>
            </tr>
            <tr>
              <td style="width: 95%; font-size: 10pt;">
                <div><a href="#ABOUT">ABOUT THIS PROSPECTUS</a></div>
              </td>
              <td style="width: 5%; font-size: 10pt; text-align: right; vertical-align: top;">1<br>
              </td>
            </tr>
            <tr>
              <td style="width: 95%; font-size: 10pt;">
                <div><a href="#WHERE">WHERE YOU CAN FIND MORE INFORMATION; INCORPORATION OF INFORMATION BY REFERENCE</a></div>
              </td>
              <td style="width: 5%; font-size: 10pt; text-align: right; vertical-align: top;">2<br>
              </td>
            </tr>
            <tr>
              <td style="width: 95%; font-size: 10pt;">
                <div><a href="#CAUTIONARY">CAUTIONARY STATEMENT REGARDING FORWARD&#8209;LOOKING STATEMENTS</a></div>
              </td>
              <td style="width: 5%; font-size: 10pt; text-align: right; vertical-align: top;">3<br>
              </td>
            </tr>
            <tr>
              <td style="width: 95%; font-size: 10pt;">
                <div><a href="#COMPANY">THE COMPANY</a></div>
              </td>
              <td style="width: 5%; font-size: 10pt; text-align: right; vertical-align: top;">5<br>
              </td>
            </tr>
            <tr>
              <td style="width: 95%; font-size: 10pt;">
                <div><a href="#RISK">RISK FACTORS</a></div>
              </td>
              <td style="width: 5%; font-size: 10pt; text-align: right; vertical-align: top;">7<br>
              </td>
            </tr>
            <tr>
              <td style="width: 95%; font-size: 10pt;">
                <div><a href="#USE">USE OF PROCEEDS</a></div>
              </td>
              <td style="width: 5%; font-size: 10pt; text-align: right; vertical-align: top;">8<br>
              </td>
            </tr>
            <tr>
              <td style="width: 95%; font-size: 10pt;">
                <div><a href="#DIVIDEND">DIVIDEND POLICY</a></div>
              </td>
              <td style="width: 5%; font-size: 10pt; text-align: right; vertical-align: top;">9<br>
              </td>
            </tr>
            <tr>
              <td style="width: 95%; font-size: 10pt; font-weight: bold;">
                <div><a href="#WARRANTS">DESCRIPTION OF ORDINARY SHARES AND EXISTING WARRANTS</a></div>
              </td>
              <td style="width: 5%; font-size: 10pt; text-align: right; vertical-align: top;">10<br>
              </td>
            </tr>
            <tr>
              <td style="width: 95%; font-size: 10pt;">
                <div><a href="#SECURITIES">DESCRIPTION OF DEBT SECURITIES</a></div>
              </td>
              <td style="width: 5%; font-size: 10pt; text-align: right; vertical-align: top;">12<br>
              </td>
            </tr>
            <tr>
              <td style="width: 95%; font-size: 10pt;">
                <div><a href="#WARRANTS2">DESCRIPTION OF WARRANTS</a></div>
              </td>
              <td style="width: 5%; font-size: 10pt; text-align: right; vertical-align: top;">19<br>
              </td>
            </tr>
            <tr>
              <td style="width: 95%; font-size: 10pt;">
                <div><a href="#UNITS">DESCRIPTION OF UNITS</a></div>
              </td>
              <td style="width: 5%; font-size: 10pt; text-align: right; vertical-align: top;">20<br>
              </td>
            </tr>
            <tr>
              <td style="width: 95%; font-size: 10pt;">
                <div><a href="#GLOBAL">GLOBAL SECURITIES</a></div>
              </td>
              <td style="width: 5%; font-size: 10pt; text-align: right; vertical-align: top;">21<br>
              </td>
            </tr>
            <tr>
              <td style="width: 95%; font-size: 10pt;">
                <div><a href="#DISTRIBUTION">PLAN OF DISTRIBUTION</a></div>
              </td>
              <td style="width: 5%; font-size: 10pt; text-align: right; vertical-align: top;">24<br>
              </td>
            </tr>
            <tr>
              <td style="width: 95%; font-size: 10pt;">
                <div><a href="#TAXATION">TAXATION</a></div>
              </td>
              <td style="width: 5%; font-size: 10pt; text-align: right; vertical-align: top;">26<br>
              </td>
            </tr>
            <tr>
              <td style="width: 95%; font-size: 10pt;">
                <div><a href="#EXPENSES">EXPENSES</a></div>
              </td>
              <td style="width: 5%; font-size: 10pt; text-align: right; vertical-align: top;">27<br>
              </td>
            </tr>
            <tr>
              <td style="width: 95%; font-size: 10pt;">
                <div><a href="#LIMITATIONS">FOREIGN EXCHANGE CONTROLS AND OTHER LIMITATIONS</a></div>
              </td>
              <td style="width: 5%; font-size: 10pt; text-align: right; vertical-align: top;">28<br>
              </td>
            </tr>
            <tr>
              <td style="width: 95%; font-size: 10pt;">
                <div><a href="#EXPERTS">EXPERTS</a></div>
              </td>
              <td style="width: 5%; font-size: 10pt; text-align: right; vertical-align: top;">28<br>
              </td>
            </tr>
            <tr>
              <td style="width: 95%; font-size: 10pt;">
                <div><a href="#ENFORCEABILITY">ENFORCEABILITY OF CIVIL LIABILITIES AND AGENT FOR&#160; SERVICE OF PROCESS IN THE UNITED STATES</a></div>
              </td>
              <td style="width: 5%; font-size: 10pt; text-align: right; vertical-align: top;">28<br>
              </td>
            </tr>
            <tr>
              <td style="width: 95%; font-size: 10pt;">
                <div><a href="#AUTHORIZED">AUTHORIZED REPRESENTATIVE</a></div>
              </td>
              <td style="width: 5%; font-size: 10pt; text-align: right; vertical-align: top;">29<br>
              </td>
            </tr>

        </table>
        &#160;</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-weight: bold;">You should rely only on the information contained or incorporated by reference in this prospectus or any supplement. We have not authorized anyone else to
        provide you with different information. The securities offered by this prospectus are being offered only in jurisdictions where the offer is permitted. You should not assume that the information in this prospectus or any supplement is accurate as
        of any date other than the date on the front of each document. Our business, financial condition, results of operations and prospects may have changed since that date.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">Except as otherwise set forth in this prospectus, neither we&#160;nor any underwriters, dealers or agents have taken any action to permit a public offering of these securities outside
        the United States or to permit the possession or distribution of this prospectus outside the United States. Persons outside the United States who come into possession of this prospectus must inform themselves about and observe any restrictions
        relating to the offering of these securities and the distribution of this prospectus outside the United States.</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif;"> <br>
      </div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-weight: normal; font-style: normal;">i</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      </div>
      <div>
        <div style="text-align: center; line-height: 1.25; font-weight: bold;"><a name="ABOUT"><!--Anchor--></a>ABOUT THIS PROSPECTUS</div>
        <div style="line-height: 1.25;">&#160;</div>
        <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">This prospectus is part of a registration statement that we filed with the SEC utilizing a &#8220;shelf&#8221; registration process. By using a shelf registration statement, we may sell
          securities from time to time and in one or more offerings up to a total dollar amount of $200,000,000. Each time that we sell securities, we will provide a prospectus supplement to this prospectus that contains specific information about the
          securities being sold and the specific terms of that offering.&#160; We may also authorize one or more free writing prospectuses to be provided to you that may contain material information relating to these offerings.&#160; The prospectus supplement or
          free writing prospectus may also add, update or change information contained in this prospectus with respect to that offering.&#160; If there is any inconsistency between the information in this prospectus and the applicable prospectus supplement or
          free writing prospectus, you should rely on the prospectus supplement or free writing prospectus, as applicable.&#160; Before purchasing any securities, you should carefully read both this prospectus and the applicable prospectus supplement (and any
          applicable free writing prospectuses), together with the additional information described under the heading &#8220;<font style="font-style: italic;">Where You Can Find More Information; Incorporation by Reference</font>.&#8221;</div>
        <div style="line-height: 1.25;">&#160;</div>
        <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">Neither we nor any underwriters, dealers or agents have authorized anyone to provide you with any information or to make any representations other than those contained in this
          prospectus, any applicable prospectus supplement or any free writing prospectuses prepared by or on behalf of us or to which we have referred you. Neither we nor any underwriters, dealers or agents take responsibility for, and can provide no
          assurance as to, the reliability of, any other information that others may give you. We will not make an offer to sell these securities in any jurisdiction where the offer or sale is not permitted. You should assume that the information appearing
          in this prospectus and the applicable prospectus supplement to this prospectus is accurate only as of the date on its respective cover, that the information appearing in any applicable free writing prospectus is accurate only as of the date of
          that free writing prospectus, and that any information incorporated by reference is accurate only as of the date of the document incorporated by reference, unless we indicate otherwise. Our business, financial condition, results of operations and
          prospects may have changed since those dates. This prospectus incorporates by reference, and any prospectus supplement or free writing prospectus may contain and incorporate by reference, market data and industry statistics and forecasts that are
          based on independent industry publications and other publicly available information.&#160; Although we believe these sources are reliable, we do not guarantee the accuracy or completeness of this information, and we have not independently verified
          this information. In addition, the market and industry data and forecasts that may be included or incorporated by reference in this prospectus, any prospectus supplement or any applicable free writing prospectus may involve estimates, assumptions
          and other risks and uncertainties and are subject to change based on various factors, including those discussed under the heading &#8220;<font style="font-style: italic;">Risk Factors</font>&#8221; contained in this prospectus, the applicable prospectus
          supplement and any applicable free writing prospectus, and under similar headings in other documents that are incorporated by reference into this prospectus.&#160; Accordingly, investors should not place undue reliance on this information.</div>
        <div style="line-height: 1.25;">&#160;</div>
        <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">We may, from time to time, offer and sell the securities described in this prospectus and any prospectus supplement to or through one or more underwriters, dealers and agents,
          or directly to purchasers, or through a combination of these methods.&#160; If any underwriters, dealers or agents are involved in the sale of any of the securities, their names and any applicable purchase price, fee, commission or discount
          arrangement between or among them will be set forth, or will be calculable from the information set forth, in the applicable prospectus supplement.&#160; See the section of this prospectus entitled &#8220;<font style="font-style: italic;">Plan of
            Distribution</font>&#8221; for more information.</div>
        <div style="line-height: 1.25;">&#160;</div>
        <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">Throughout this prospectus, unless otherwise designated, the terms &#8220;we&#8221;, &#8220;us&#8221;, &#8220;our&#8221;, &#8220;Innoviz&#8221;, &#8220;the Company&#8221; and &#8220;our company&#8221; refer to Innoviz Technologies Ltd. The term
          &#8220;ordinary shares&#8221; refers to our ordinary shares, no par value. The term &#8220;existing warrants&#8221; refers to our outstanding warrants to purchase up to 16,231,141 ordinary shares (as of August 11, 2025) at an exercise price equal to $11.50. The term
          &#8220;RDO warrants&#8221; refers to our outstanding warrants to purchase up to 23,021,582 ordinary shares (as of August 11, 2025) at an exercise price equal to $1.69.</div>
        <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
          <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-weight: normal; font-style: normal;">1</font></div>
          <div style="page-break-after: always;" class="BRPFPageBreak">
            <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
        </div>
        <div style="text-align: center; line-height: 1.25; font-weight: bold;"><a name="WHERE"><!--Anchor--></a>WHERE YOU CAN FIND MORE INFORMATION; INCORPORATION OF INFORMATION BY REFERENCE</div>
        <div style="line-height: 1.25; font-weight: bold;">&#160;<br>
          Available Information</div>
        <div style="line-height: 1.25;">&#160;</div>
        <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">We file reports, proxy statements and other information with the SEC.&#160; The SEC maintains a web site that contains reports, proxy and information statements and other
          information about issuers, such as us, who file electronically with the SEC.&#160; The address of that website is <font style="font-style: italic;">http://www.sec.gov</font>.</div>
        <div style="line-height: 1.25;">&#160;</div>
        <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">Our web site address is <font style="font-style: italic;">https://innoviz.tech</font>.&#160; The information on our web site, however, is not, and should not be deemed to be, a
          part of this prospectus.</div>
        <div style="line-height: 1.25;">&#160;</div>
        <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">This prospectus and any prospectus supplement are part of a registration statement that we filed with the SEC and do not contain all of the information in the registration
          statement.&#160; The full registration statement may be obtained from the SEC or us, as provided below. Forms of the indenture and other documents establishing the terms of the offered securities are or may be filed as exhibits to the registration
          statement or documents incorporated by reference in the registration statement.&#160; Statements in this prospectus or any prospectus supplement about these documents are summaries and each statement is qualified in all respects by reference to the
          document to which it refers. You should refer to the actual documents for a more complete description of the relevant matters. You may inspect a copy of the registration statement through the SEC&#8217;s website, as provided above.</div>
        <div style="line-height: 1.25;">&#160;</div>
        <div style="line-height: 1.25; font-weight: bold;">Incorporation by Reference</div>
        <div style="line-height: 1.25;">&#160;</div>
        <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">The SEC&#8217;s rules allow us to &#8220;incorporate by reference&#8221; information into this prospectus, which means that we can disclose important information to you by referring you to
          another document filed separately with the SEC.&#160; The information incorporated by reference is deemed to be part of this prospectus, and the subsequent information that we file with the SEC will automatically update and supersede that
          information.&#160; Any statement contained in this prospectus or a previously filed document incorporated by reference will be deemed to be modified or superseded for purposes of this prospectus to the extent that a statement contained in this
          prospectus or a subsequently filed document incorporated by reference modifies or replaces that statement.</div>
        <div style="line-height: 1.25;">&#160;</div>
        <div style="text-indent: 36pt; line-height: 1.25;">This prospectus and any accompanying prospectus supplement incorporate by reference the documents set forth below that have previously been filed with the SEC:</div>
        <div style="line-height: 1.25;">&#160;</div>
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zfc9f7becc2dd4a4991cf90664afa059c">

            <tr>
              <td style="width: 36pt;"><br>
              </td>
              <td style="width: 18pt; vertical-align: top;">&#8226;</td>
              <td style="width: auto; vertical-align: top;">
                <div>the Company&#8217;s Annual Report on <a href="https://www.sec.gov/Archives/edgar/data/1835654/000117891325000817/0001178913-25-000817-index.htm">Form 20&#8209;F</a> for the year ended December 31, 2024, filed with the SEC on March 12, 2025 (the
                  &#8220;Annual Report&#8221;);</div>
              </td>
            </tr>

        </table>
        <div style="line-height: 1.25;">&#160;</div>
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z0fed0bd9f2154a60bef645fc5effa8fe">

            <tr>
              <td style="width: 36pt;"><br>
              </td>
              <td style="width: 18pt; vertical-align: top;">&#8226;</td>
              <td style="width: auto; vertical-align: top;">
                <div>the Company&#8217;s Reports on Form 6-K furnished to the SEC on <a href="https://www.sec.gov/Archives/edgar/data/1835654/000117891325000012/0001178913-25-000012-index.htm">January 3, 2025</a>, <a href="https://www.sec.gov/Archives/edgar/data/1835654/000117891325000427/0001178913-25-000427-index.htm">February 12, 2025</a>, <a href="https://www.sec.gov/Archives/edgar/data/1835654/000117891325001114/0001178913-25-001114-index.htm">March




                    28, 2025</a>, <a href="https://www.sec.gov/Archives/edgar/data/1835654/000117891325002302/0001178913-25-002302-index.htm">July 3, 2025</a>, and <a href="https://www.sec.gov/Archives/edgar/data/1835654/000117891325002834/0001178913-25-002834-index.htm">August 13, 2025</a>; and</div>
              </td>
            </tr>

        </table>
        <div style="line-height: 1.25;">&#160;</div>
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z8f8a8ebaac0c4ed4be0426b587e3ada6">

            <tr>
              <td style="width: 36pt;"><br>
              </td>
              <td style="width: 18pt; vertical-align: top;">&#8226;</td>
              <td style="width: auto; vertical-align: top;">
                <div>the description of the Company&#8217;s securities contained in the Company&#8217;s registration statement on <a href="https://www.sec.gov/Archives/edgar/data/1835654/000119312521105720/0001193125-21-105720-index.htm">Form 8&#8209;A</a> (File No.
                  001&#8209;40310), filed with the SEC on April 5, 2021, including any amendments or reports filed for the purpose of updating such description.</div>
              </td>
            </tr>

        </table>
        <div style="line-height: 1.25;">&#160;</div>
        <div style="text-indent: 36pt; line-height: 1.25; text-align: justify;">All reports and other documents we subsequently file pursuant to Section 13(a), 13(c), 14 or 15(d) of the Securities Exchange Act of 1934, as amended, which we refer to as the
          &#8220;Exchange Act&#8221; in this prospectus, prior to the termination of this offering, including all such documents we may file with the SEC after the date of the initial registration statement and prior to the effectiveness of the registration statement,
          but excluding any information furnished to, rather than filed with, the SEC, will also be incorporated by reference into this prospectus and deemed to be part of this prospectus from the date of the filing of such reports and documents.</div>
        <div style="line-height: 1.25;">&#160;</div>
        <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">You may request a free copy of any of the documents incorporated by reference in this prospectus by writing to us at the following address:</div>
        <div style="line-height: 1.25;">&#160;</div>
        <div style="text-indent: 36pt; line-height: 1.25;">Innoviz Technologies Ltd.</div>
        <div style="text-indent: 36pt; line-height: 1.25;">Innoviz Technologies Campus</div>
        <div style="text-indent: 36pt; line-height: 1.25;">5 Uri Ariav St.</div>
        <div style="text-indent: 36pt; line-height: 1.25;">Bldg. C, Nitzba 300</div>
        <div style="text-indent: 36pt; line-height: 1.25;">Rosh HaAin</div>
        <div style="text-indent: 36pt; line-height: 1.25;">4809202</div>
        <div style="text-indent: 36pt; line-height: 1.25;">Israel</div>
        <div style="text-indent: 36pt; line-height: 1.25;">Attention: Chief Financial Officer</div>
        <div style="line-height: 1.25;">&#160;</div>
        <div style="text-indent: 36pt; line-height: 1.25;">Exhibits to the filings will not be sent, however, unless those exhibits have specifically been incorporated by reference in this prospectus or any accompanying prospectus supplement.</div>
        <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
          <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-weight: normal; font-style: normal;">2</font></div>
          <div style="page-break-after: always;" class="BRPFPageBreak">
            <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
        </div>
        <div style="text-align: center; line-height: 1.25; font-weight: bold;"><a name="CAUTIONARY"><!--Anchor--></a>CAUTIONARY STATEMENT REGARDING FORWARD&#8209;LOOKING STATEMENTS</div>
        <div style="line-height: 1.25;">&#160;</div>
        <div style="text-indent: 36pt; line-height: 1.25; text-align: justify;">Some of the statements made in this prospectus and the documents incorporated by reference into this prospectus may constitute forward&#8209;looking statements within the meaning of
          the United States federal securities laws. The use of the words or phrases such as &#8220;anticipate&#8221;, &#8220;believe&#8221;, &#8220;continue&#8221;, &#8220;could&#8221;, &#8220;estimate&#8221;, &#8220;expect&#8221;, &#8220;intend&#8221;, &#8220;may&#8221;, &#8220;might&#8221;, &#8220;objective&#8221;, &#8220;ongoing&#8221;, &#8220;plan&#8221;, &#8220;potential&#8221;, &#8220;predict&#8221;, &#8220;project&#8221;,
          &#8220;should&#8221;, &#8220;will&#8221;, &#8220;strategy&#8221;, &#8220;seek&#8221;, &#8220;will be&#8221;, &#8220;will continue&#8221;, &#8220;is likely&#8221;, &#8220;will likely result&#8221;, &#8220;contemplate&#8221;, &#8220;possible&#8221; and &#8220;would&#8221;, or similar words or phrases, or the negatives of those words or phrases, may identify forward&#8209;looking
          statements, but the absence of these words does not necessarily mean that a statement is not forward&#8209;looking. The forward&#8209;looking statements contained herein include, but are not limited to, statements about:</div>
        <div style="line-height: 1.25;">&#160;</div>
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z9d17dd28d4e74831882480a62e781f26">

            <tr>
              <td style="width: 36pt;"><br>
              </td>
              <td style="width: 18pt; vertical-align: top;">&#8226;</td>
              <td style="width: auto; vertical-align: top;">
                <div>our limited operating history and evolving business model makes evaluating our business and future prospects difficult and may increase the risk of your investment;</div>
              </td>
            </tr>

        </table>
        <div style="line-height: 1.25;">&#160;</div>
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z8b0a15b9c1e24e12aeac7c6c33553176">

            <tr>
              <td style="width: 36pt;"><br>
              </td>
              <td style="width: 18pt; vertical-align: top;">&#8226;</td>
              <td style="width: auto; vertical-align: top;">
                <div>continued pricing pressures, automotive original equipment manufacturers (&#8220;OEM&#8221;) cost reduction initiatives and the ability of automotive OEMs to re-source or cancel vehicle or technology programs may result in lower than anticipated
                  margins, or in incremental losses, which may adversely affect our business;</div>
              </td>
            </tr>

        </table>
        <div style="line-height: 1.25;">&#160;</div>
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z6e164a080a414b9dafda5e98f5ab7c2f">

            <tr>
              <td style="width: 36pt;"><br>
              </td>
              <td style="width: 18pt; vertical-align: top;">&#8226;</td>
              <td style="width: auto; vertical-align: top;">
                <div>we are creating innovative technologies by designing and developing unique components. The high price of, or low yield in these components may, affect our ability to sell at competitive prices or may lead to losses;</div>
              </td>
            </tr>

        </table>
        <div style="line-height: 1.25;">&#160;</div>
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zb20e2136cd00400db04d9e62420ef26d">

            <tr>
              <td style="width: 36pt;"><br>
              </td>
              <td style="width: 18pt; vertical-align: top;">&#8226;</td>
              <td style="width: auto; vertical-align: top;">
                <div>there are significant risks to providing our products as a direct supplier to customers, including additional operating costs, increased liabilities, and additional indemnification liabilities;</div>
              </td>
            </tr>

        </table>
        <div style="line-height: 1.25;">&#160;</div>
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="ze3a988e8906e4d328bc66fd86c3d2e15">

            <tr>
              <td style="width: 36pt;"><br>
              </td>
              <td style="width: 18pt; vertical-align: top;">&#8226;</td>
              <td style="width: auto; vertical-align: top;">
                <div>we expect to invest substantially in research and development for the purpose of developing and commercializing new products. These investments could significantly reduce our profitability or increase our losses and may not generate
                  revenue for us;</div>
              </td>
            </tr>

        </table>
        <div style="line-height: 1.25;">&#160;</div>
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zf39f9328d1fc40439661b889b7e2c593">

            <tr>
              <td style="width: 36pt;"><br>
              </td>
              <td style="width: 18pt; vertical-align: top;">&#8226;</td>
              <td style="width: auto; vertical-align: top;">
                <div>we will likely need to obtain additional funds in the future in order to execute our business plan and these funds may not be available to us when we need them, which could negatively affect our business, prospects, financial condition
                  and operating results;</div>
              </td>
            </tr>

        </table>
        <div style="line-height: 1.25;">&#160;</div>
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zbc496a99da624dfa9a79f5cdd3618d3d">

            <tr>
              <td style="width: 36pt;"><br>
              </td>
              <td style="width: 18pt; vertical-align: top;">&#8226;</td>
              <td style="width: auto; vertical-align: top;">
                <div>we may experience significant delays in the design, production and launch of our LiDAR products, which could harm our business, prospects, financial condition and operating results;</div>
              </td>
            </tr>

        </table>
        <div style="line-height: 1.25;">&#160;</div>
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z1114ee994e2a402ab861959512c8b120">

            <tr>
              <td style="width: 36pt;"><br>
              </td>
              <td style="width: 18pt; vertical-align: top;">&#8226;</td>
              <td style="width: auto; vertical-align: top;">
                <div>we are substantially dependent on a limited number of customers. The automotive industry is comprised of a relatively small number of players, which makes each design win material for us, and our business could be materially and
                  adversely affected if any of our customers terminate our programs following such wins;</div>
              </td>
            </tr>

        </table>
        <div style="line-height: 1.25;">&#160;</div>
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z3ed0eec88dfa4d57821fa6aaf30c1f77">

            <tr>
              <td style="width: 36pt;"><br>
              </td>
              <td style="width: 18pt; vertical-align: top;">&#8226;</td>
              <td style="width: auto; vertical-align: top;">
                <div>designing and manufacturing LiDARs on a mass-production scale requires meeting stringent quality requirements and we may face significant challenges and complexities in this process;</div>
              </td>
            </tr>

        </table>
        <div style="line-height: 1.25;">&#160;</div>
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z1723796562ff41e097b85036d98e1acd">

            <tr>
              <td style="width: 36pt;"><br>
              </td>
              <td style="width: 18pt; vertical-align: top;">&#8226;</td>
              <td style="width: auto; vertical-align: top;">
                <div>our transition to production with a contract manufacturer and our ramp-up towards mass production may encounter significant challenges, which could delay commercialization and increase costs;</div>
              </td>
            </tr>

        </table>
        <div style="line-height: 1.25;">&#160;</div>
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z55ef5a3fc56647b49967ed9ed081ddd3">

            <tr>
              <td style="width: 36pt;"><br>
              </td>
              <td style="width: 18pt; vertical-align: top;">&#8226;</td>
              <td style="width: auto; vertical-align: top;">
                <div>the period of time from a design win to implementation is long and we are subject to the risk of cancellations or postponement of contracts or failure to successfully meet customers&#8217; requirements for start of production;</div>
              </td>
            </tr>

        </table>
        <div style="line-height: 1.25;">&#160;</div>
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zd7e259509677485db13627c33ea718f5">

            <tr>
              <td style="width: 36pt;"><br>
              </td>
              <td style="width: 18pt; vertical-align: top;">&#8226;</td>
              <td style="width: auto; vertical-align: top;">
                <div>certain of our strategic, development and supply arrangements could be terminated or may not materialize into long&#8209;term contract partnership arrangements;</div>
              </td>
            </tr>

        </table>
        <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
          <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-weight: normal; font-style: normal;">3</font></div>
          <div style="page-break-after: always;" class="BRPFPageBreak">
            <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
        </div>
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zd8bcf94c3a824a65aa0aaa4e4dd47558">

            <tr>
              <td style="width: 36pt;"><br>
              </td>
              <td style="width: 18pt; vertical-align: top;">&#8226;</td>
              <td style="width: auto; vertical-align: top;">
                <div>we target many customers that are large companies with substantial negotiating power, exacting product standards and potentially competitive internal solutions. If we are unable to sell our products to these customers, our prospects
                  and results of operations will be adversely affected;</div>
              </td>
            </tr>

        </table>
        <div style="line-height: 1.25;">&#160;</div>
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z24f60cf6758a4d77bf8632ae1ec492b9">

            <tr>
              <td style="width: 36pt;"><br>
              </td>
              <td style="width: 18pt; vertical-align: top;">&#8226;</td>
              <td style="width: auto; vertical-align: top;">
                <div>we continue to implement strategic initiatives designed to grow our business.&#160; These initiatives may prove more costly than we currently anticipate and we may not succeed in increasing our revenues by an amount sufficient to offset the
                  costs of these initiatives and to achieve and maintain profitability;</div>
              </td>
            </tr>

        </table>
        <div style="line-height: 1.25;">&#160;</div>
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="za203b80598044c1cb79801550ca84996">

            <tr>
              <td style="width: 36pt;"><br>
              </td>
              <td style="width: 18pt; vertical-align: top;">&#8226;</td>
              <td style="width: auto; vertical-align: top;">
                <div>the first vehicles deploying our LiDAR technology and software became commercially available to end users in 2024. If any vehicles deploying our LiDAR technology and software are involved in traffic accidents or collisions actually or
                  allegedly resulting from undetected defects, errors, or bugs in our products, or if our products actually or allegedly fail to perform as expected, we may be exposed to product liability, warranty and other claims, in addition to a
                  decline in the market adoption of our products, damage to our reputation with current or prospective customers, or increased regulatory scrutiny of our solutions which would adversely affect our operating costs, business and prospects;</div>
              </td>
            </tr>

        </table>
        <div style="line-height: 1.25;">&#160;</div>
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zfe82f86b4fe94084b5d0ea8197a78dfb">

            <tr>
              <td style="width: 36pt;"><br>
              </td>
              <td style="width: 18pt; vertical-align: top;">&#8226;</td>
              <td style="width: auto; vertical-align: top;">
                <div>our failure to maintain compliance with Nasdaq Stock Market LLC (&#8220;Nasdaq&#8221;)&#8217;s continued listing requirements could result in the delisting of our ordinary shares;</div>
              </td>
            </tr>

        </table>
        <div style="line-height: 1.25;">&#160;</div>
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="ze87f94185c0f4dd581ba28e025bdd386">

            <tr>
              <td style="width: 36pt;"><br>
              </td>
              <td style="width: 18pt; vertical-align: top;">&#8226;</td>
              <td style="width: auto; vertical-align: top;">
                <div>we operate in a highly competitive market against a large number of both established competitors and new market entrants, and some market participants have substantially greater resources than we do;</div>
              </td>
            </tr>

        </table>
        <div style="line-height: 1.25;">&#160;</div>
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zb775777e7c9b41e1939c74f2140ded93">

            <tr>
              <td style="width: 36pt;"><br>
              </td>
              <td style="width: 18pt; vertical-align: top;">&#8226;</td>
              <td style="width: auto; vertical-align: top;">
                <div>we may be subject to securities litigation, class action and derivative lawsuits, which could result in substantial costs and could divert management attention away from other business concerns; and</div>
              </td>
            </tr>

        </table>
        <div style="line-height: 1.25;">&#160;</div>
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z63d559b32c20448d89bdb129aaaa90bc">

            <tr>
              <td style="width: 36pt;"><br>
              </td>
              <td style="width: 18pt; vertical-align: top;">&#8226;</td>
              <td style="width: auto; vertical-align: top;">
                <div>the other matters described in the section entitled &#8220;<font style="font-style: italic;">Risk Factors</font>&#8221; beginning on page 7 of this prospectus and other risk factors contained in our Annual Report and our subsequent filings with
                  the SEC incorporated by reference herein.</div>
              </td>
            </tr>

        </table>
        <div style="line-height: 1.25;">&#160;</div>
        <div style="text-indent: 36pt; line-height: 1.25; text-align: justify;">Many important factors, in addition to the factors described above and in other sections of this prospectus and the Annual Report, could adversely impact our business and
          financial performance. Moreover, we operate in an evolving environment. New risks and uncertainties emerge from time to time, and it is not possible for our management to predict all risks and uncertainties, nor can we assess the impact of all
          factors on our business or the extent to which any factor, or combination of factors, may cause actual results to differ materially from estimates or forward&#8209;looking statements. We qualify all of our estimates and forward&#8209;looking statements by
          these cautionary statements. Factors that could cause actual results to differ from our expectations or projections include the risks and uncertainties relating to our business described in this prospectus under &#8220;Risk Factors&#8221; as well as those
          listed under &#8220;<font style="font-style: italic;">Item 3. Key Information &#8211; D. Risk Factors</font>&#8221; in the Annual Report and any risk factors in our subsequent filings with the SEC incorporated by reference herein. We caution you to carefully
          consider these risks and not to place undue reliance on our forward&#8209;looking statements. Forward-looking statements set forth herein speak only as of the date of this prospectus. Except as required by applicable law, including the securities laws
          of the United States, we do not intend to update or revise any forward&#8209;looking statements, whether as a result of new information, future events or otherwise, and we assume no responsibility for updating any forward&#8209;looking statements.</div>
        <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
          <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-weight: normal; font-style: normal;">4</font></div>
          <div style="page-break-after: always;" class="BRPFPageBreak">
            <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
        </div>
        <div style="text-align: center; line-height: 1.25; font-weight: bold;">THE <a name="COMPANY"><!--Anchor--></a>COMPANY</div>
        <div style="line-height: 1.25;">&#160;</div>
        <div style="line-height: 1.25; font-weight: bold;">Company Overview</div>
        <div style="line-height: 1.25;">&#160;</div>
        <div style="text-indent: 36pt; line-height: 1.25; text-align: justify;">We are a leading Tier-1 direct supplier of high-performance, automotive grade LiDAR sensor platforms and complementary software stacks that feature technological breakthroughs
          across core components and bring enhanced vision and superior performance to enable safe autonomous driving at a mass scale. We believe that we provide a comprehensive solution for OEMs and Tier&#8209;1 partners that are developing and marketing
          autonomous driving vehicles to the passenger car and other relevant markets, such as robotaxis, shuttles, delivery vehicles and trucks.</div>
        <div style="line-height: 1.25; text-align: justify;">&#160;</div>
        <div style="text-indent: 36pt; line-height: 1.25; text-align: justify;">We were founded in 2016. From our founding, our culture drew from our core values of solving sophisticated technological problems through creativity and agile thinking. We have
          relied on these values to address the needs of autonomous vehicles in a manner that strikes the desired balance between performance and cost. We created a new type of LiDAR sensor from the chip-level up, including a suite of powerful and
          sophisticated software applications for high-performance computer vision to allow superior perception. In 2018, we achieved a design win to power BMW&#8217;s Level 3 autonomous platform, a program which reached maturity during 2024 and with vehicles
          already being sold with our LiDARs and complementary software stack.</div>
        <div style="line-height: 1.25; text-align: justify;">&#160;</div>
        <div style="text-indent: 36pt; line-height: 1.25; text-align: justify;">Since 2021, we have funded the development of two production path programs: the InnovizOne and InnovizTwo LiDAR sensor platforms and complementary software stacks. With the
          InnovizOne program transitioned from the development phase into full series production in 2024, we eliminated duplicative cost structures and reduced spending on InnovizOne development, while reinvesting a portion of the savings into the
          InnovizTwo sensor platform and complementary software stack. All quoting and bidding activity in our request for information and request for quotation pipeline is now focused on the InnovizTwo platform.</div>
        <div style="line-height: 1.25; text-align: justify;">&#160;</div>
        <div style="text-indent: 36pt; line-height: 1.25; text-align: justify;">During 2022, we made the strategic decision to become a Tier-1 supplier of LiDAR and complementary software stack to the automotive industry. This decision allows us to have
          direct technical discussions with end customers and to improve pricing to automotive OEMs with the goal of continuing to strengthen our position in the automotive market. This strategic decision has played a significant role in our subsequent
          major OEM program wins, as discussed below.</div>
        <div style="line-height: 1.25; text-align: justify;">&#160;</div>
        <div style="text-indent: 36pt; line-height: 1.25; text-align: justify;">In 2022, following more than two years of extensive diligence and qualification, we were selected by Volkswagen as its direct LiDAR supplier for automated vehicles within the
          Volkswagen brands with our InnovizTwo next generation high-performance automotive-grade LiDAR sensor platform, and in 2023, we announced that Volkswagen aims to expand its use of our InnovizTwo LiDAR to its existing light commercial vehicle
          program, the I.D Buzz.</div>
        <div style="line-height: 1.25; text-align: justify;">&#160;</div>
        <div style="text-indent: 36pt; line-height: 1.25; text-align: justify;">In 2024, we announced that Mobileye Vision Technologies Ltd. (&#8220;Mobileye&#8221;) will use the InnovizTwo Long-Range and the new InnovizTwo Short- to Mid-Range LiDARs for the Mobileye
          Drive&#8482; platform. The new InnovizTwo Short- to Mid-Range leverages InnovizTwo Long-Range&#8217;s maturity and is designed to meet the requirements for light commercial vehicles, shuttles, robotaxis, and can be customized to suit a wide array of
          vehicular design and functionality requirements. We believe that the combination of our LiDARs and Mobileye&#8217;s platform is critical to enabling comprehensive sensing capabilities for navigating complex urban environments and enhancing the overall
          safety and reliability of autonomous driving systems, and that this partnership showcases the flexibility of our LiDARs to work across a variety of vehicle platforms to further testing and deployment of autonomous vehicles. Our partners are
          leaders in deploying new technologies into the automotive industry. We believe that our close cooperation with these partners and OEMs positions us well to make Level 3 and Level 4 autonomous driving a commercial reality.</div>
        <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
          <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-weight: normal; font-style: normal;">5</font></div>
          <div style="page-break-after: always;" class="BRPFPageBreak">
            <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
        </div>
        <div style="text-indent: 36pt; line-height: 1.25; text-align: justify;">The sustained cooperation with our customers provides our engineers and other research and development personnel with a valuable competitive edge. These engineers and other
          research and development personnel have been meticulously trained to design, operate and verify our many ground-breaking innovations in accordance and in compliance with the rigorous ISO26262 standard for Functional Safety in the automotive
          industry, and the IATF 16949:2016 certification for Quality Management in the automotive industry. Compliance with these and other standards has been enforced by regular ongoing audits of Innoviz and rigorous testing by our key suppliers,
          existing customers and prospective customers that thoroughly review the performance of various elements of our operations. As a result, our products have been constructed from the bottom up with hardware and software technology that meets the
          most stringent automotive safety, quality, environmental, manufacturing, and other standards.</div>
        <div style="line-height: 1.25; text-align: justify;">&#160;</div>
        <div style="text-indent: 36pt; line-height: 1.25; text-align: justify;">Our innovation has produced LiDAR solutions that deliver market leading performance and that meet the demanding safety requirements for Level 2+ through Level 5 autonomous
          vehicles at price points suitable for mass produced passenger vehicles.</div>
        <div style="line-height: 1.25; text-align: justify;">&#160;</div>
        <div style="text-indent: 36pt; line-height: 1.25; text-align: justify;">Our robust software suite enables our ~905nm wavelength laser-based LiDAR architecture to be easily leveraged to provide compelling solutions for Level 2+ through Level 4 (and
          Level 5 when applicable), using both our long- and short- to medium-range LiDARs. Our integrated custom design of advanced hardware and software components, which leverages the multidisciplinary expertise and experience of our team, enables us to
          provide autonomous solutions that we believe will accelerate widespread adoption across automakers at serial production scale. This means that we are positioned to penetrate the current market, which is focused primarily on Level 2+, Level 3 and
          Level 4 production, and to continue to capture and extend our market share to Level 5, as the market continues to mature.</div>
        <div style="line-height: 1.25; text-align: justify;">&#160;</div>
        <div style="text-indent: 36pt; line-height: 1.25; text-align: justify;">On February 4, 2025, we announced an optimization of our operations to extend our cash runway and accelerate progress towards profitability and free cash flow generation,
          resulting in a reduction in our employee headcount of approximately 9% during the first quarter of 2025.</div>
        <div style="line-height: 1.25; text-align: justify;">&#160;</div>
        <div style="text-indent: 36pt; line-height: 1.25; text-align: justify;">We are currently expanding our third-party manufacturing capacity through contract manufacturers to meet an anticipated&#8209; increase in customer demand for our products. As part
          of this effort, we recently selected Fabrinet (NYSE: FN), a leading provider of advanced optical packaging and precision optical, electro-mechanical, and electronic manufacturing services, as our manufacturing partner for the InnovizTwo LiDAR
          platform. In July 2025, we announced the shipment of the first InnovizTwo LiDAR units from Fabrinet&#8217;s high-volume production line. This collaboration is expected to enable Innoviz to ramp its InnovizTwo LiDARs to volume with a manufacturing
          partner that has automotive-grade facilities around the world, allowing for flexible and cost-effective productions.</div>
        <div style="line-height: 1.25; text-align: justify;">&#160;</div>
        <div style="text-indent: 36pt; line-height: 1.25; text-align: justify;">In response to the growing interest and demand for LiDAR technologies across a range of non-automotive sectors, in June 2025 we announced the launch of InnovizSMART Long-Range,
          a new high-performance LiDAR sensor designed specifically for &#8220;smart&#8221; applications, including security, mobility, aerial, robotics, and intelligent traffic management. With the maturation of our InnovizTwo LiDAR platform and expanding production
          capabilities through third-party capacity, we are expanding our focus to additional markets such as ITS, smart cities and other sectors that are seeking affordable, high-performing LiDAR solutions. Innoviz&#8217;s advanced offerings are well-positioned
          to address the evolving requirements of these industries, supporting a wide variety of new applications.</div>
        <div style="line-height: 1.25; text-align: justify;">&#160;</div>
        <div style="line-height: 1.25; font-weight: bold; text-align: justify;">Recent Developments</div>
        <div style="line-height: 1.25; text-align: justify;">&#160;</div>
        <div style="line-height: 1.25; font-style: italic; font-weight: bold; text-align: justify;">Regained Compliance with Nasdaq&#8217;s Minimum Bid Price Requirement</div>
        <div style="line-height: 1.25; text-align: justify;">&#160;</div>
        <div style="text-indent: 36pt; line-height: 1.25; text-align: justify;">On July 3, 2025, we announced that we received formal written confirmation from Nasdaq confirming that the Company has regained compliance with Nasdaq&#8217;s minimum bid price
          requirement. The closing bid price of the ordinary shares was at $1.00 per share or greater for 10 consecutive business days from June 17 to July 1, 2025. Accordingly, Nasdaq Listing Qualifications Staff notified the Company that it determined
          that the Company regained compliance with Nasdaq Listing Rule 5550(a)(2), and that the matter was closed.</div>
        <div style="line-height: 1.25; text-align: justify;">&#160;</div>
        <div style="line-height: 1.25; font-style: italic; font-weight: bold; text-align: justify;">Events in Israel</div>
        <div style="line-height: 1.25; text-align: justify;">&#160;</div>
        <div style="text-indent: 36pt; line-height: 1.25; text-align: justify;">On June 13, 2025, Israel launched a preemptive attack on Iran, to which Iran responded with ballistic missile and drone attacks in Israel. On June 24, 2025, Israel and Iran
          agreed to a ceasefire, although there is no assurance that this agreement will be upheld, military activity and hostilities continue to exist at varying levels of intensity, and the situation remains volatile, with the potential for escalation
          into a broader regional conflict. At this time, we do not expect the current conflict (or other ongoing conflicts) to have a material impact on our financial and operational results; however, since these are events beyond our control, their
          continuation or cessation may affect our expectations. We continue to monitor political and military developments closely and examine the consequences for our operations, assets and financial and operational results.</div>
        <div style="text-indent: 36pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif;"> <br>
        </div>
        <div style="line-height: 1.25; font-weight: bold; text-align: justify;">Corporate Information</div>
        <div style="line-height: 1.25; text-align: justify;">&#160;</div>
        <div style="text-indent: 36pt; line-height: 1.25; text-align: justify;">We were incorporated in Israel on January 18, 2016 under the Israeli Companies Law, 5759&#8209;1999 (the &#8220;Companies Law&#8221;), and our principal executive office is located at 5 Uri
          Ariav St., Building C, Nitzba 300, Rosh HaAin 4809202, Israel. Our legal and commercial name is Innoviz Technologies Ltd. We are registered with the Israeli Registrar of Companies. Our registration number is 51-538242-2. Our website address is
          https://innoviz.tech, and our telephone number is +972&#8209;74&#8209;700&#8209;3692. Information contained on, or that can be accessed through, our website does not constitute a part of this prospectus and is not incorporated by reference herein. We have included
          our website address in this prospectus solely for informational purposes. The SEC maintains an Internet site that contains reports, proxy and information statements, and other information regarding issuers, such as us, that file electronically,
          with the SEC at www.sec.gov. Our agent for service of process in the United States is Cogency Global Inc., 122 East 42nd Street, 18th Floor, New York, NY 10168.</div>
        <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
          <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-weight: normal; font-style: normal;">6</font></div>
          <div style="page-break-after: always;" class="BRPFPageBreak">
            <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
        </div>
        <div style="text-align: center; line-height: 1.25; font-weight: bold;"><a name="RISK"><!--Anchor--></a>RISK FACTORS</div>
        <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-weight: bold;"> <br>
        </div>
        <div style="text-indent: 36pt; line-height: 1.25; text-align: justify;">Investing in any securities offered pursuant to this prospectus and the applicable prospectus supplement involves risks. You should carefully consider the risk factors set
          forth in our Annual Report incorporated by reference into this prospectus and in our updates, if any, to those risk factors in our reports on Form 6-K incorporated by reference into this prospectus, and all other information contained or
          incorporated by reference into this prospectus, as updated by our subsequent filings under the Exchange Act, and the risk factors and other information contained in the applicable prospectus supplement and any applicable free writing prospectus
          before acquiring any of such securities. The occurrence of any of these risks might cause you to lose all or part of your investment in the offered securities.</div>
        <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
          <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-weight: normal; font-style: normal;">7</font></div>
          <div style="page-break-after: always;" class="BRPFPageBreak">
            <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
        </div>
        <div style="text-align: center; line-height: 1.25; font-weight: bold;"><a name="USE"><!--Anchor--></a>USE OF PROCEEDS</div>
        <div style="line-height: 1.25;">&#160;</div>
        <div style="text-indent: 36pt; line-height: 1.25;">We intend to use the net proceeds from the sale of the securities as set forth in the applicable prospectus supplement.</div>
        <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
          <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-weight: normal; font-style: normal;">8</font></div>
          <div style="page-break-after: always;" class="BRPFPageBreak">
            <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
        </div>
        <div style="text-align: center; line-height: 1.25; font-weight: bold;"><a name="DIVIDEND"><!--Anchor--></a>DIVIDEND POLICY</div>
        <div style="line-height: 1.25;">&#160;</div>
        <div style="text-indent: 36pt; line-height: 1.25; text-align: justify;">We have never declared or paid any cash dividend on our ordinary shares. We currently intend to retain any future earnings and do not expect to pay any dividends in the
          foreseeable future. Any further determination to pay dividends on our ordinary shares would be at the discretion of our board of directors, subject to applicable laws, and would depend on our financial condition, results of operations, capital
          requirements, general business conditions, and other factors that our board of directors may deem relevant.</div>
        <div style="line-height: 1.25;">&#160;</div>
        <div style="text-indent: 36pt; line-height: 1.25; text-align: justify;">Pursuant to the Companies Law, the distribution amount for dividends is limited to the greater of retained earnings or earnings generated over the previous two&#160;years, according
          to the then last reviewed or audited financial statements (less the amount of previously distributed dividends, if not already reduced from the earnings), provided that the end of the period to which the financial statements relate is not more
          than six&#160;months prior to the date of the distribution. As a company listed on an exchange outside of Israel, however, court approval is not required if the proposed distribution is in the form of an equity repurchase, provided that we notify our
          creditors of the proposed equity repurchase and allow such creditors an opportunity to initiate a court proceeding to review the repurchase. If within 30 days such creditors do not file an objection, then we may proceed with the repurchase
          without obtaining court approval. In each case, we are only permitted to distribute a dividend if our board of directors and the court, if applicable, determines that there is no reasonable concern that payment of the dividend will prevent us
          from satisfying our existing and foreseeable obligations as they become due.</div>
        <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
          <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-weight: normal; font-style: normal;">9</font></div>
          <div style="page-break-after: always;" class="BRPFPageBreak">
            <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
        </div>
        <div style="text-align: center; line-height: 1.25; font-weight: bold;">DESCRIPTION OF ORDINARY SHARES, EXISTING WARRANTS AND RDO <a name="WARRANTS"><!--Anchor--></a>WARRANTS</div>
        <div style="line-height: 1.25; text-align: justify;">&#160;</div>
        <div style="text-indent: 36pt; line-height: 1.25; text-align: justify;">Our authorized share capital consists of 500,000,000 ordinary shares, no par value. All of our outstanding ordinary shares are validly issued, fully paid and non-assessable.
          Our ordinary shares are not redeemable and do not have any preemptive rights.</div>
        <div style="line-height: 1.25; text-align: justify;">&#160;</div>
        <div style="text-indent: 36pt; line-height: 1.25; text-align: justify;">In connection with our business combination that closed on April 5, 2021, we issued 16,231,241 existing warrants, each entitling its holder to purchase one ordinary share at an
          initial exercise price equal to $11.50 per share.</div>
        <div style="line-height: 1.25; text-align: justify;">&#160;</div>
        <div style="text-indent: 36pt; line-height: 1.25; text-align: justify;">In connection with our registered direct offering, on February 12, 2025, we issued 23,021,582 RDO warrants, each entitling its holder to purchase one ordinary share at an
          initial exercise price equal to $1.69.</div>
        <div style="line-height: 1.25; text-align: justify;">&#160;</div>
        <div style="text-indent: 36pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">
          <div style="text-indent: 36pt; line-height: 1.25; text-align: justify;">As of August 11, 2025, we had 201,320,184 ordinary shares issued and outstanding, 16,231,141 existing warrants issued and outstanding and 23,021,582 RDO warrants issued and
            outstanding. Our ordinary shares and existing warrants are listed on Nasdaq under the symbols &#8220;INVZ&#8221; and &#8220;INVZW,&#8221; respectively.</div>
        </div>
        <div style="line-height: 1.25; text-align: justify;">&#160;</div>
        <div style="text-indent: 36pt; line-height: 1.25; text-align: justify;">For a description of our ordinary shares and existing warrants, including the rights and obligations attached thereto, please refer to Exhibit 2.1 to our Annual Report, which
          is incorporated by reference herein.</div>
        <div style="line-height: 1.25; text-align: justify;">&#160;</div>
        <div style="line-height: 1.25; font-weight: bold; text-align: justify;">Description of RDO Warrants</div>
        <div style="line-height: 1.25; text-align: justify;">&#160;</div>
        <div style="line-height: 1.25; font-style: italic; text-align: justify;">Duration and Exercise Price</div>
        <div style="line-height: 1.25; text-align: justify;">&#160;</div>
        <div style="text-indent: 36pt; line-height: 1.25; text-align: justify;">Each RDO warrant has an initial exercise price equal to $1.69 per share. The RDO warrants expire on the fifth year anniversary of the original issuance date. The exercise price
          and number of ordinary shares issuable upon exercise is subject to appropriate proportional adjustment in the event of share dividends, share splits, reorganizations or similar events affecting our ordinary shares and the exercise price. The RDO
          warrants are issued in certificated form.</div>
        <div style="line-height: 1.25; text-align: justify;">&#160;</div>
        <div style="line-height: 1.25; font-style: italic; text-align: justify;">Exercisability</div>
        <div style="line-height: 1.25; text-align: justify;">&#160;</div>
        <div style="text-indent: 36pt; line-height: 1.25; text-align: justify;">The RDO warrants are exercisable, at the option of each holder, in whole or in part, by delivering to us a duly executed exercise notice and, within the number of trading days
          comprising the standard settlement period with respect to the ordinary shares as in effect on the date of delivery of the notice of exercise thereafter, payment in full for the number of ordinary shares purchased upon such exercise (except in the
          case of a cashless exercise as discussed below). A holder may not exercise any portion of the RDO warrant to the extent that the holder, together with its affiliates and any other persons acting as a group together with any such persons, would
          own more than 4.99% (or, at the election of the purchaser, 9.99%) of the number of ordinary shares outstanding immediately after exercise (the &#8220;Beneficial Ownership Limitation&#8221;); provided that a holder, upon notice to us, may increase or decrease
          the beneficial ownership limitation, provided, further, that any increase in such beneficial ownership limitation shall be effective 61 days after the date such notice is delivered to us; provided that in no event shall the Beneficial Ownership
          Limit exceed 9.99% of the number of ordinary shares outstanding immediately after exercise.</div>
        <div style="line-height: 1.25; text-align: justify;">&#160;</div>
        <div style="line-height: 1.25; font-style: italic; text-align: justify;">Cashless Exercise</div>
        <div style="text-indent: 36pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif;"> <br>
        </div>
        <div style="text-indent: 36pt; line-height: 1.25; text-align: justify;">If, at the time a holder exercises its RDO warrants, a registration statement registering the issuance of the ordinary shares underlying the RDO warrants under the Securities
          Act is not then effective or available for the issuance of such shares, then in lieu of making the cash payment otherwise contemplated to be made to us upon such exercise in payment of the aggregate exercise price, the holder may elect instead to
          receive upon such exercise (either in whole or in part) the net number of ordinary shares determined according to a formula set forth in the RDO warrants, which generally provides for a number of ordinary shares equal to (A)&#160;(1) the volume
          weighted average price on (x)&#160;the trading day preceding the notice of exercise, if the notice of exercise is executed and delivered on a day that is not a trading day or prior to the opening of &#8220;regular trading hours&#8221; on a trading day or (y)&#160;the
          trading day of the notice of exercise, if the notice of exercise is executed and delivered after the close of &#8220;regular trading hours&#8221; on such trading day, or (2)&#160;the bid price on the day of the notice of exercise, if the notice of exercise is
          executed during &#8220;regular trading hours&#8221; on a trading day and is delivered within two hours thereafter, less (B)&#160;the exercise price, multiplied by (C)&#160;the number of ordinary shares the RDO warrant was exercisable into, with such product then
          divided by the number determined under clause (A)&#160;in this sentence.</div>
        <div style="line-height: 1.25;">&#160;</div>
        <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
          <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-weight: normal; font-style: normal;">10</font></div>
          <div class="BRPFPageBreak" style="page-break-after: always;">
            <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
        </div>
        <div style="line-height: 1.25; font-style: italic;">Fractional Shares</div>
        <div style="line-height: 1.25; text-align: justify;">&#160;</div>
        <div style="text-indent: 36pt; line-height: 1.25; text-align: justify;">No fractional ordinary shares will be issued upon the exercise of the RDO warrants. Rather, we will, at our election, either pay a cash adjustment in respect of such final
          fraction in an amount equal to such fraction multiplied by the exercise price or round up to the next whole share.</div>
        <div style="line-height: 1.25; text-align: justify;">&#160;</div>
        <div style="line-height: 1.25; font-style: italic; text-align: justify;">Transferability</div>
        <div style="line-height: 1.25; text-align: justify;">&#160;</div>
        <div style="text-indent: 36pt; line-height: 1.25; text-align: justify;">Subject to applicable laws, a RDO warrant may be transferred at the option of the holder upon surrender of the RDO warrant to us together with the appropriate instruments of
          transfer and funds sufficient to pay any transfer taxes payable upon such transfer.</div>
        <div style="line-height: 1.25; text-align: justify;">&#160;</div>
        <div style="line-height: 1.25; font-style: italic; text-align: justify;">Trading Market</div>
        <div style="line-height: 1.25; text-align: justify;">&#160;</div>
        <div style="text-indent: 36pt; line-height: 1.25; text-align: justify;">There is no trading market available for the RDO warrants on any securities exchange or nationally recognized trading system and we do not expect a market to develop. We do not
          intend to list the RDO warrants on any securities exchange or nationally recognized trading system. The ordinary shares issuable upon exercise of the RDO warrants are currently listed on Nasdaq under the symbol &#8220;INVZ&#8221;.</div>
        <div style="line-height: 1.25; text-align: justify;">&#160;</div>
        <div style="line-height: 1.25; font-style: italic; text-align: justify;">Rights as a Shareholder</div>
        <div style="line-height: 1.25; text-align: justify;">&#160;</div>
        <div style="text-indent: 36pt; line-height: 1.25; text-align: justify;">Except as otherwise provided in the RDO warrants or by virtue of such holder&#8217;s ownership of the underlying ordinary shares, the holders of the RDO warrants do not have the
          rights or privileges of holders of our ordinary shares, including any voting rights, until they exercise their RDO warrants.</div>
        <div style="line-height: 1.25; text-align: justify;">&#160;</div>
        <div style="line-height: 1.25; font-style: italic; text-align: justify;">Fundamental Transaction</div>
        <div style="line-height: 1.25; text-align: justify;">&#160;</div>
        <div style="text-indent: 36pt; line-height: 1.25; text-align: justify;">In the event of a fundamental transaction, as described in the RDO warrants and generally including any reorganization, recapitalization or reclassification of our ordinary
          shares, the sale, transfer or other disposition of all or substantially all of our properties or assets, our consolidation or merger with or into another person, the acquisition of more than 50% of the share capital of the Company, the holders of
          the RDO warrants will be entitled to receive upon exercise of the RDO warrants the kind and amount of securities, cash or other property that the holders would have received had they exercised the RDO warrants immediately prior to such
          fundamental transaction.&#160; Additionally, as more fully described in the RDO warrants, in the event of certain fundamental transactions, the holders of the RDO warrants will be entitled to receive consideration in an amount equal to the Black
          Scholes value of the RDO warrants on the date of consummation of such transaction.</div>
        <div style="line-height: 1.25; text-align: justify;">&#160;</div>
        <div style="line-height: 1.25; font-style: italic; text-align: justify;">Amendments</div>
        <div style="line-height: 1.25; text-align: justify;">&#160;</div>
        <div style="text-indent: 36pt; line-height: 1.25; text-align: justify;">Amendments of the terms of each RDO warrant require the written consent of us and the holder of the RDO warrant.</div>
        <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
          <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-weight: normal; font-style: normal;">11</font></div>
          <div style="page-break-after: always;" class="BRPFPageBreak">
            <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
        </div>
        <div style="text-align: center; line-height: 1.25; font-weight: bold;">DESCRIPTION OF DEBT <a name="SECURITIES"><!--Anchor--></a>SECURITIES</div>
        <div style="line-height: 1.25;">&#160;</div>
        <div style="text-align: justify; text-indent: 24.5pt; line-height: 1.25;">The following description, together with the additional information we include in any applicable prospectus supplement or free writing prospectus, summarizes certain general
          terms and provisions of the debt securities that we may offer under this prospectus. When we offer to sell a particular series of debt securities, we will describe the specific terms of the series in a supplement to this prospectus.&#160; We will also
          indicate in the supplement to what extent the general terms and provisions described in this prospectus apply to a particular series of debt securities.</div>
        <div style="line-height: 1.25; text-align: justify;">&#160;</div>
        <div style="text-align: justify; text-indent: 24.5pt; line-height: 1.25;">We may issue debt securities either separately, or together with, or upon the conversion or exercise of or in exchange for, other securities described in this prospectus.
          Debt securities may be our senior, senior subordinated or subordinated obligations and, unless otherwise specified in a supplement to this prospectus, the debt securities will be our direct, unsecured obligations and may be issued in one or more
          series.</div>
        <div style="line-height: 1.25; text-align: justify;">&#160;</div>
        <div style="text-align: justify; text-indent: 24.5pt; line-height: 1.25;">The debt securities will be issued under an indenture between us and one or more designated trustees.&#160; We have summarized select portions of the indenture below.&#160; The summary
          is not complete.&#160; The form of the indenture has been filed as an exhibit to the registration statement and you should read the indenture for provisions that may be important to you.&#160; In the summary below, we have included references to the
          section numbers of the indenture so that you can easily locate these provisions.&#160; Capitalized terms used in the summary and not defined herein have the meanings specified in the indenture.</div>
        <div style="line-height: 1.25; text-align: justify;">&#160;</div>
        <div style="text-align: justify; text-indent: 24.5pt; line-height: 1.25;">As used in this section only, &#8220;Innoviz,&#8221; the &#8220;Company,&#8221; &#8220;we,&#8221; &#8220;our&#8221; or &#8220;us&#8221; refer to Innoviz Technologies Ltd. (excluding our subsidiaries, unless expressly stated or the
          context otherwise requires).</div>
        <div style="line-height: 1.25; text-align: justify;">&#160;</div>
        <div style="text-align: justify; line-height: 1.25; font-weight: bold;">General</div>
        <div style="line-height: 1.25; text-align: justify;">&#160;</div>
        <div style="text-align: justify; text-indent: 24.5pt; line-height: 1.25;">The terms of each series of debt securities will be established by or pursuant to a resolution of our board of directors and set forth or determined in the manner provided in
          a resolution of our board of directors, in an officer&#8217;s certificate or by a supplemental indenture.&#160; (Section 2.2)&#160; The particular terms of each series of debt securities will be described in a prospectus supplement relating to such series,
          including any pricing supplement or term sheet.</div>
        <div style="line-height: 1.25; text-align: justify;">&#160;</div>
        <div style="text-align: justify; text-indent: 24.5pt; line-height: 1.25;">We can issue an unlimited amount of debt securities under the indenture that may be in one or more series with the same or various maturities, at par, at a premium, or at a
          discount.&#160; (Section 2.1)&#160; We will set forth in a prospectus supplement, including any pricing supplement or term sheet, relating to any series of debt securities being offered, the aggregate principal amount and the following terms of the debt
          securities, to the extent applicable:</div>
        <div style="line-height: 1.25;">&#160;</div>
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zd6b837c845a3404382258e959c6ebf14">

            <tr>
              <td style="width: 36pt;"><br>
              </td>
              <td style="width: 18pt; vertical-align: top;">&#8226;</td>
              <td style="width: auto; vertical-align: top; text-align: justify;">
                <div>the title and ranking of the debt securities (including the terms of any subordination provisions);</div>
              </td>
            </tr>

        </table>
        <div style="line-height: 1.25;">&#160;</div>
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z66534b5164cf4b7294deb315f8db16d2">

            <tr>
              <td style="width: 36pt;"><br>
              </td>
              <td style="width: 18pt; vertical-align: top;">&#8226;</td>
              <td style="width: auto; vertical-align: top; text-align: justify;">
                <div>the price or prices (expressed as a percentage of the principal amount) at which we will sell the debt securities;</div>
              </td>
            </tr>

        </table>
        <div style="line-height: 1.25;">&#160;</div>
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z105668d65aea4b09b3109843c5393ae1">

            <tr>
              <td style="width: 36pt;"><br>
              </td>
              <td style="width: 18pt; vertical-align: top;">&#8226;</td>
              <td style="width: auto; vertical-align: top; text-align: justify;">
                <div>any limit on the aggregate principal amount of the debt securities;</div>
              </td>
            </tr>

        </table>
        <div style="line-height: 1.25;">&#160;</div>
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zf15246ffee5e4496bac0bf939a013cf3">

            <tr>
              <td style="width: 36pt;"><br>
              </td>
              <td style="width: 18pt; vertical-align: top;">&#8226;</td>
              <td style="width: auto; vertical-align: top; text-align: justify;">
                <div>the date or dates on which the principal of the securities of the series is payable;</div>
              </td>
            </tr>

        </table>
        <div style="line-height: 1.25;">&#160;</div>
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z658cf958ce124db78359ef6082622596">

            <tr>
              <td style="width: 36pt;"><br>
              </td>
              <td style="width: 18pt; vertical-align: top;">&#8226;</td>
              <td style="width: auto; vertical-align: top; text-align: justify;">
                <div>the rate or rates (which may be fixed or variable) per annum or the method used to determine the rate or rates (including any commodity, commodity index, stock exchange index or financial index) at which the debt securities will bear
                  interest, the date or dates from which interest will accrue, the date or dates on which interest will commence and be payable and any regular record date for the interest payable on any interest payment date;</div>
              </td>
            </tr>

        </table>
        <div style="line-height: 1.25;">&#160;</div>
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z4951847a89b2490bbf86fc99cf6b7a88">

            <tr>
              <td style="width: 36pt;"><br>
              </td>
              <td style="width: 18pt; vertical-align: top;">&#8226;</td>
              <td style="width: auto; vertical-align: top; text-align: justify;">
                <div>the place or places where principal of, and interest, if any, on the debt securities will be payable (and the method of such payment), where the securities of such series may be surrendered for registration of transfer or exchange, and
                  where notices and demands to us in respect of the debt securities may be delivered;</div>
              </td>
            </tr>

        </table>
        <div style="line-height: 1.25;">&#160;</div>
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z871ae2853ce74ba2b56860cb12d4dbf7">

            <tr>
              <td style="width: 36pt;"><br>
              </td>
              <td style="width: 18pt; vertical-align: top;">&#8226;</td>
              <td style="width: auto; vertical-align: top; text-align: justify;">
                <div>the applicability of any guarantees;</div>
              </td>
            </tr>

        </table>
        <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
          <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-weight: normal; font-style: normal;">12</font></div>
          <div style="page-break-after: always;" class="BRPFPageBreak">
            <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
        </div>
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z1a510b3d6fdc44b2b1b5ce6f50e00542">

            <tr>
              <td style="width: 36pt;"><br>
              </td>
              <td style="width: 18pt; vertical-align: top;">&#8226;</td>
              <td style="width: auto; vertical-align: top; text-align: justify;">
                <div>the period or periods within which, the price or prices at which and the terms and conditions upon which we may redeem the debt securities;</div>
              </td>
            </tr>

        </table>
        <div style="line-height: 1.25;">&#160;</div>
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z642cb1a84a194ac88a4baff60ec20bd4">

            <tr>
              <td style="width: 36pt;"><br>
              </td>
              <td style="width: 18pt; vertical-align: top;">&#8226;</td>
              <td style="width: auto; vertical-align: top; text-align: justify;">
                <div>any obligation we have to redeem or purchase the debt securities pursuant to any sinking fund or analogous provisions or at the option of a holder of debt securities and the period or periods within which, the price or prices at which
                  and in the terms and conditions upon which securities of the series shall be redeemed or purchased, in whole or in part, pursuant to such obligation;</div>
              </td>
            </tr>

        </table>
        <div style="line-height: 1.25;">&#160;</div>
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="za8a03b85e80d4c6b9d159c7aac707236">

            <tr>
              <td style="width: 36pt;"><br>
              </td>
              <td style="width: 18pt; vertical-align: top;">&#8226;</td>
              <td style="width: auto; vertical-align: top; text-align: justify;">
                <div>the dates on which and the price or prices at which we will repurchase debt securities at the option of the holders of debt securities and other detailed terms and provisions of these repurchase obligations;</div>
              </td>
            </tr>

        </table>
        <div style="line-height: 1.25;">&#160;</div>
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z80f912e305cb4dd3942462db64713ecd">

            <tr>
              <td style="width: 36pt;"><br>
              </td>
              <td style="width: 18pt; vertical-align: top;">&#8226;</td>
              <td style="width: auto; vertical-align: top; text-align: justify;">
                <div>the denominations in which the debt securities will be issued, if other than denominations of $1,000 and any integral multiple thereof;</div>
              </td>
            </tr>

        </table>
        <div style="line-height: 1.25;">&#160;</div>
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z393c11c6c4c541b8b6419926f0a04d2a">

            <tr>
              <td style="width: 36pt;"><br>
              </td>
              <td style="width: 18pt; vertical-align: top;">&#8226;</td>
              <td style="width: auto; vertical-align: top; text-align: justify;">
                <div>whether the debt securities will be issued in the form of certificated debt securities or global debt securities;</div>
              </td>
            </tr>

        </table>
        <div style="line-height: 1.25;">&#160;</div>
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zce267ab01f824c96b19863a1eb9f7b89">

            <tr>
              <td style="width: 36pt;"><br>
              </td>
              <td style="width: 18pt; vertical-align: top;">&#8226;</td>
              <td style="width: auto; vertical-align: top; text-align: justify;">
                <div>the portion of principal amount of the debt securities payable upon declaration of acceleration of the maturity date, if other than the principal amount;</div>
              </td>
            </tr>

        </table>
        <div style="line-height: 1.25;">&#160;</div>
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z82f92dafbdaf458685fef1b2ebb2113c">

            <tr>
              <td style="width: 36pt;"><br>
              </td>
              <td style="width: 18pt; vertical-align: top;">&#8226;</td>
              <td style="width: auto; vertical-align: top; text-align: justify;">
                <div>the currency of denomination of the debt securities, which may be United States Dollars or any foreign currency, and if such currency of denomination is a composite currency, the agency or organization, if any, responsible for
                  overseeing such composite currency;</div>
              </td>
            </tr>

        </table>
        <div style="line-height: 1.25;">&#160;</div>
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z8ec89492ac1b4156af36552f2c8f8198">

            <tr>
              <td style="width: 36pt;"><br>
              </td>
              <td style="width: 18pt; vertical-align: top;">&#8226;</td>
              <td style="width: auto; vertical-align: top; text-align: justify;">
                <div>the designation of the currency, currencies or currency units in which payment of principal of, premium and interest on the debt securities will be made;</div>
              </td>
            </tr>

        </table>
        <div style="line-height: 1.25;">&#160;</div>
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z43d0b41ea7df4e0a9088d33abf680869">

            <tr>
              <td style="width: 36pt;"><br>
              </td>
              <td style="width: 18pt; vertical-align: top;">&#8226;</td>
              <td style="width: auto; vertical-align: top; text-align: justify;">
                <div>if payments of principal of, premium or interest on the debt securities will be made in one or more currencies or currency units other than that or those in which the debt securities are denominated, the manner in which the exchange
                  rate with respect to these payments will be determined;</div>
              </td>
            </tr>

        </table>
        <div style="line-height: 1.25;">&#160;</div>
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z09d08f4c8bc945469ff5ffc41b36a3ff">

            <tr>
              <td style="width: 36pt;"><br>
              </td>
              <td style="width: 18pt; vertical-align: top;">&#8226;</td>
              <td style="width: auto; vertical-align: top; text-align: justify;">
                <div>the manner in which the amounts of payment of principal of, premium, if any, or interest on the debt securities will be determined, if these amounts may be determined by reference to an index based on a currency or currencies or by
                  reference to a commodity, commodity index, stock exchange index or financial index;</div>
              </td>
            </tr>

        </table>
        <div style="line-height: 1.25;">&#160;</div>
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="za8e7915d6a9d4d88b7ec98570dde5b29">

            <tr>
              <td style="width: 36pt;"><br>
              </td>
              <td style="width: 18pt; vertical-align: top;">&#8226;</td>
              <td style="width: auto; vertical-align: top; text-align: justify;">
                <div>any provisions relating to any security provided for the debt securities;</div>
              </td>
            </tr>

        </table>
        <div style="line-height: 1.25;">&#160;</div>
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zbb4d2023a8bb4bb1ba745e924f627fa5">

            <tr>
              <td style="width: 36pt;"><br>
              </td>
              <td style="width: 18pt; vertical-align: top;">&#8226;</td>
              <td style="width: auto; vertical-align: top; text-align: justify;">
                <div>any addition to, deletion of or change in the Events of Default described in this prospectus or in the indenture with respect to the debt securities and any change in the acceleration provisions described in this prospectus or in the
                  indenture with respect to the debt securities;</div>
              </td>
            </tr>

        </table>
        <div style="line-height: 1.25;">&#160;</div>
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zd600242a84fd45dfa24567426f5b28ce">

            <tr>
              <td style="width: 36pt;"><br>
              </td>
              <td style="width: 18pt; vertical-align: top;">&#8226;</td>
              <td style="width: auto; vertical-align: top; text-align: justify;">
                <div>any addition to, deletion of or change in the covenants described in this prospectus or in the indenture with respect to the debt securities;</div>
              </td>
            </tr>

        </table>
        <div style="line-height: 1.25;">&#160;</div>
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z02d022162cfd4f12baf86e4d1786fb7d">

            <tr>
              <td style="width: 36pt;"><br>
              </td>
              <td style="width: 18pt; vertical-align: top;">&#8226;</td>
              <td style="width: auto; vertical-align: top; text-align: justify;">
                <div>any depositaries, interest rate calculation agents, exchange rate calculation agents or other agents with respect to the debt securities;</div>
              </td>
            </tr>

        </table>
        <div style="line-height: 1.25;">&#160;</div>
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="ze49d98a99cda445cb5bf6757c50a09a5">

            <tr>
              <td style="width: 36pt;"><br>
              </td>
              <td style="width: 18pt; vertical-align: top;">&#8226;</td>
              <td style="width: auto; vertical-align: top; text-align: justify;">
                <div>the provisions, if any, relating to conversion or exchange of any debt securities of such series, including if applicable, the conversion or exchange price and period, provisions as to whether conversion or exchange will be mandatory,
                  the events requiring an adjustment of the conversion or exchange price and provisions affecting conversion or exchange;</div>
              </td>
            </tr>

        </table>
        <div style="line-height: 1.25;">&#160;</div>
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="za3109b2b930b4a71b322e44f93bc2c74">

            <tr>
              <td style="width: 36pt;"><br>
              </td>
              <td style="width: 18pt; vertical-align: top;">&#8226;</td>
              <td style="width: auto; vertical-align: top; text-align: justify;">
                <div>any other terms of the debt securities, which may supplement, modify or delete any provision of the indenture as it applies to that series, including any terms that may be required under applicable law or regulations or advisable in
                  connection with the marketing of the securities; and</div>
              </td>
            </tr>

        </table>
        <div> <br>
        </div>
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="za6af296af4654164a1ddbba323b93e17">

            <tr>
              <td style="width: 36pt;"><br>
              </td>
              <td style="width: 18pt; vertical-align: top;">&#8226;</td>
              <td style="width: auto; vertical-align: top; text-align: justify;">
                <div>whether any of our direct or indirect subsidiaries will guarantee the debt securities of that series, including the terms of subordination, if any, of such guarantees.&#160; (Section 2.2)</div>
              </td>
            </tr>

        </table>
        <div style="line-height: 1.25;">&#160;</div>
        <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
          <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-weight: normal; font-style: normal;">13</font></div>
          <div class="BRPFPageBreak" style="page-break-after: always;">
            <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
        </div>
        <div style="text-align: justify; text-indent: 24.5pt; line-height: 1.25;">We may issue debt securities that provide for an amount less than their stated principal amount to be due and payable upon declaration of acceleration of their maturity
          pursuant to the terms of the indenture.&#160; We will provide you with information on the federal income tax considerations and other special considerations applicable to any of these debt securities in the applicable prospectus supplement.</div>
        <div style="line-height: 1.25;">&#160;</div>
        <div style="text-align: justify; text-indent: 24.5pt; line-height: 1.25;">If we denominate the purchase price of any of the debt securities in a foreign currency or currencies or a foreign currency unit or units, or if the principal of and any
          premium and interest on any series of debt securities is payable in a foreign currency or currencies or a foreign currency unit or units, we will provide you with information on the restrictions, elections, general tax considerations, specific
          terms and other information with respect to that issue of debt securities and such foreign currency or currencies or foreign currency unit or units in the applicable prospectus supplement.</div>
        <div style="line-height: 1.25; text-align: justify;">&#160;</div>
        <div style="text-align: justify; line-height: 1.25; font-weight: bold;">Transfer and Exchange</div>
        <div style="line-height: 1.25; text-align: justify;">&#160;</div>
        <div style="text-align: justify; text-indent: 24.5pt; line-height: 1.25;">Each debt security will be represented by either one or more global securities registered in the name of The Depository Trust Company, or the Depositary, or a nominee of the
          Depositary (we will refer to any debt security represented by a global debt security as a &#8220;book-entry debt security&#8221;), or a certificate issued in definitive registered form (we will refer to any debt security represented by a certificated
          security as a &#8220;certificated debt security&#8221;) as set forth in the applicable prospectus supplement.&#160; Except as set forth under the heading &#8220;Global Debt Securities and Book-Entry System&#8221; below, book-entry debt securities will not be issuable in
          certificated form.</div>
        <div style="line-height: 1.25; text-align: justify;">&#160;</div>
        <div style="text-align: justify; text-indent: 24.5pt; line-height: 1.25;"><font style="font-style: italic;">Certificated Debt Securities</font>.&#160; You may transfer or exchange certificated debt securities at any office we maintain for this purpose
          in accordance with the terms of the indenture.&#160; (Section 2.4)&#160; No service charge will be made for any transfer or exchange of certificated debt securities, but we may require payment of a sum sufficient to cover any tax or other governmental
          charge payable in connection with a transfer or exchange.&#160; (Section 2.7)</div>
        <div style="line-height: 1.25; text-align: justify;">&#160;</div>
        <div style="text-align: justify; text-indent: 24.5pt; line-height: 1.25;">You may effect the transfer of certificated debt securities and the right to receive the principal of, premium and interest on certificated debt securities only by
          surrendering the certificate representing those certificated debt securities and either reissuance by us or the trustee of the certificate to the new holder or the issuance by us or the trustee of a new certificate to the new holder.</div>
        <div style="line-height: 1.25; text-align: justify;">&#160;</div>
        <div style="text-align: justify; text-indent: 24.5pt; line-height: 1.25;"><font style="font-style: italic;">Global Debt Securities and Book-Entry System</font>. Each global debt security representing book-entry debt securities will be deposited
          with, or on behalf of, the Depositary, and registered in the name of the Depositary or a nominee of the Depositary.&#160; Please see &#8220;Global Securities.&#8221;</div>
        <div style="line-height: 1.25; text-align: justify;">&#160;</div>
        <div style="text-align: justify; line-height: 1.25; font-weight: bold;">Covenants</div>
        <div style="line-height: 1.25; text-align: justify;">&#160;</div>
        <div style="text-align: justify; text-indent: 24.5pt; line-height: 1.25;">We will set forth in the applicable prospectus supplement any restrictive covenants applicable to any issue of debt securities.&#160; (Article IV)</div>
        <div style="line-height: 1.25; text-align: justify;">&#160;</div>
        <div style="text-align: justify; line-height: 1.25; font-weight: bold;">No Protection in the Event of a Change of Control</div>
        <div style="line-height: 1.25; text-align: justify;">&#160;</div>
        <div style="text-align: justify; text-indent: 24.5pt; line-height: 1.25;">Unless we state otherwise in the applicable prospectus supplement, the debt securities will not contain any provisions which may afford holders of the debt securities
          protection in the event we have a change in control or in the event of a highly leveraged transaction (whether or not such transaction results in a change in control) which could adversely affect holders of debt securities.</div>
        <div style="line-height: 1.25; text-align: justify;">&#160;</div>
        <div style="text-align: justify; line-height: 1.25; font-weight: bold;">Consolidation, Merger and Sale of Assets</div>
        <div style="line-height: 1.25;">&#160;</div>
        <div style="text-align: justify; text-indent: 24.5pt; line-height: 1.25;">We may not consolidate with or merge with or into, or convey, transfer or lease all or substantially all of our properties and assets to any person (a &#8220;successor person&#8221;)
          unless:</div>
        <div style="text-align: justify; text-indent: 24.5pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif;"> <br>
        </div>
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z999378ff8f254a0ab5a5057f33109d8c">

            <tr>
              <td style="width: 36pt;"><br>
              </td>
              <td style="width: 18pt; vertical-align: top;">&#8226;</td>
              <td style="width: auto; vertical-align: top; text-align: justify;">
                <div>we are the surviving entity or the successor person (if other than Innoviz) is a corporation, partnership, trust or other entity organized and validly existing under the laws of any U.S. domestic jurisdiction or the state of Israel and
                  expressly assumes our obligations on the debt securities and under the indenture; and</div>
              </td>
            </tr>

        </table>
        <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
          <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-weight: normal; font-style: normal;">14</font></div>
          <div class="BRPFPageBreak" style="page-break-after: always;">
            <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
        </div>
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zb63b1b5b9fa84cfc8f68318a652d9411">

            <tr>
              <td style="width: 36pt;"><br>
              </td>
              <td style="width: 18pt; vertical-align: top;">&#8226;</td>
              <td style="width: auto; vertical-align: top; text-align: justify;">
                <div>immediately after giving effect to the transaction, no Default or Event of Default, shall have occurred and be continuing.</div>
              </td>
            </tr>

        </table>
        <div style="line-height: 1.25;">&#160;</div>
        <div style="text-align: justify; text-indent: 24.5pt; line-height: 1.25;">Notwithstanding the above, any of our subsidiaries may consolidate with, merge into or transfer all or part of its properties to us.&#160; (Section 5.1)</div>
        <div style="line-height: 1.25;">&#160;</div>
        <div style="text-align: justify; line-height: 1.25; font-weight: bold;">Events of Default</div>
        <div style="line-height: 1.25;">&#160;</div>
        <div style="text-align: justify; text-indent: 24.5pt; line-height: 1.25;">&#8220;Event of Default&#8221; means with respect to any series of debt securities, any of the following:</div>
        <div style="line-height: 1.25;">&#160;</div>
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zd16b1e091d6045fa90dba088fc5aa43d">

            <tr>
              <td style="width: 36pt;"><br>
              </td>
              <td style="width: 18pt; vertical-align: top;">&#8226;</td>
              <td style="width: auto; vertical-align: top; text-align: justify;">
                <div>default in the payment of any interest upon any debt security of that series when it becomes due and payable, and continuance of such default for a period of 30 days (unless the entire amount of the payment is deposited by us with the
                  trustee or with a paying agent prior to the expiration of the 30-day period);</div>
              </td>
            </tr>

        </table>
        <div style="line-height: 1.25;">&#160;</div>
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zbd16e43cb08d4f30b08a23280b1a2bf6">

            <tr>
              <td style="width: 36pt;"><br>
              </td>
              <td style="width: 18pt; vertical-align: top;">&#8226;</td>
              <td style="width: auto; vertical-align: top; text-align: justify;">
                <div>default in the payment of principal of any security of that series at its maturity;</div>
              </td>
            </tr>

        </table>
        <div style="line-height: 1.25;">&#160;</div>
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zc6f0016a3c8348eaa81a567245baaabc">

            <tr>
              <td style="width: 36pt;"><br>
              </td>
              <td style="width: 18pt; vertical-align: top;">&#8226;</td>
              <td style="width: auto; vertical-align: top; text-align: justify;">
                <div>default in the performance or breach of any other covenant or warranty by us in the indenture (other than a covenant or warranty that has been included in the indenture solely for the benefit of a series of debt securities other than
                  that series), which default continues uncured for a period of 60 days after we receive written notice from the trustee or Innoviz and the trustee receive written notice from the holders of not less than 25% in principal amount of the
                  outstanding debt securities of that series as provided in the indenture;</div>
              </td>
            </tr>

        </table>
        <div style="line-height: 1.25;">&#160;</div>
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z88b28d4be3a04394920a8dafd65180c4">

            <tr>
              <td style="width: 36pt;"><br>
              </td>
              <td style="width: 18pt; vertical-align: top;">&#8226;</td>
              <td style="width: auto; vertical-align: top; text-align: justify;">
                <div>certain voluntary or involuntary events of bankruptcy, insolvency or reorganization of Innoviz; and</div>
              </td>
            </tr>

        </table>
        <div style="line-height: 1.25;">&#160;</div>
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zadf3f88f219e4746bcd61bbd63acedcc">

            <tr>
              <td style="width: 36pt;"><br>
              </td>
              <td style="width: 18pt; vertical-align: top;">&#8226;</td>
              <td style="width: auto; vertical-align: top; text-align: justify;">
                <div>any other Event of Default provided with respect to debt securities of that series that is described in the applicable prospectus supplement.&#160; (Section 6.1)</div>
              </td>
            </tr>

        </table>
        <div style="line-height: 1.25;">&#160;</div>
        <div style="text-align: justify; text-indent: 24.5pt; line-height: 1.25;">No Event of Default with respect to a particular series of debt securities (except as to certain events of bankruptcy, insolvency or reorganization) necessarily constitutes
          an Event of Default with respect to any other series of debt securities. (Section 6.1) The occurrence of certain Events of Default or an acceleration under the indenture may constitute an event of default under certain indebtedness of ours or our
          subsidiaries outstanding from time to time.</div>
        <div style="line-height: 1.25;">&#160;</div>
        <div style="text-align: justify; text-indent: 24.5pt; line-height: 1.25;">We will provide the trustee written notice of any Default or Event of Default within 30 days of becoming aware of the occurrence of such Default or Event of Default, which
          notice will describe in reasonable detail the status of such Default or Event of Default and what action we are taking or propose to take in respect thereof.&#160; (Section 6.1)</div>
        <div style="line-height: 1.25;">&#160;</div>
        <div style="text-align: justify; text-indent: 24.5pt; line-height: 1.25;">If an Event of Default with respect to debt securities of any series at the time outstanding occurs and is continuing, then the trustee or the holders of not less than 25% in
          principal amount of the outstanding debt securities of that series may, by a notice in writing to us (and to the trustee if given by the holders), declare to be due and payable immediately the principal of (or, if the debt securities of that
          series are discount securities, that portion of the principal amount as may be specified in the terms of that series) and accrued and unpaid interest, if any, on all debt securities of that series.&#160; In the case of an Event of Default resulting
          from certain events of bankruptcy, insolvency or reorganization, the principal (or such specified amount) of and accrued and unpaid interest, if any, on all outstanding debt securities will become and be immediately due and payable without any
          declaration or other act on the part of the trustee or any holder of outstanding debt securities.&#160; At any time after a declaration of acceleration with respect to debt securities of any series has been made, but before a judgment or decree for
          payment of the money due has been obtained by the trustee, the holders of a majority in principal amount of the outstanding debt securities of that series may rescind and annul the acceleration if all Events of Default, other than the non-payment
          of accelerated principal and interest, if any, with respect to debt securities of that series, have been cured or waived as provided in the indenture.&#160; (Section 6.2) We refer you to the prospectus supplement relating to any series of debt
          securities that are discount securities for the particular provisions relating to acceleration of a portion of the principal amount of such discount securities upon the occurrence of an Event of Default.</div>
        <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
          <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-weight: normal; font-style: normal;">15</font></div>
          <div style="page-break-after: always;" class="BRPFPageBreak">
            <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
        </div>
        <div style="text-align: justify; text-indent: 24.5pt; line-height: 1.25;">The indenture provides that the trustee may refuse to perform any duty or exercise any of its rights or powers under the indenture unless the trustee receives indemnity
          satisfactory to it against any cost, liability or expense which might be incurred by it in performing such duty or exercising such right or power.&#160; (Section 7.1(e))&#160; Subject to certain rights of the trustee, the holders of a majority in principal
          amount of the outstanding debt securities of any series will have the right to direct the time, method and place of conducting any proceeding for any remedy available to the trustee or exercising any trust or power conferred on the trustee with
          respect to the debt securities of that series.&#160; (Section 6.12)</div>
        <div style="line-height: 1.25;">&#160;</div>
        <div style="text-align: justify; text-indent: 24.5pt; line-height: 1.25;">No holder of any debt security of any series will have any right to institute any proceeding, judicial or otherwise, with respect to the indenture or for the appointment of a
          receiver or trustee, or for any remedy under the indenture, unless:</div>
        <div style="line-height: 1.25;">&#160;</div>
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z40ee61be51cf4c50a2f112b8a23a595b">

            <tr>
              <td style="width: 36pt;"><br>
              </td>
              <td style="width: 18pt; vertical-align: top;">&#8226;</td>
              <td style="width: auto; vertical-align: top; text-align: justify;">
                <div>that holder has previously given to the trustee written notice of a continuing Event of Default with respect to debt securities of that series; and</div>
              </td>
            </tr>

        </table>
        <div style="line-height: 1.25;">&#160;</div>
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zbc5d37d6c8d8423dbd65ea3d30b36732">

            <tr>
              <td style="width: 36pt;"><br>
              </td>
              <td style="width: 18pt; vertical-align: top;">&#8226;</td>
              <td style="width: auto; vertical-align: top; text-align: justify;">
                <div>the holders of not less than 25% in principal amount of the outstanding debt securities of that series have made written request, and offered indemnity or security satisfactory to the trustee, to the trustee to institute the proceeding
                  as trustee, and the trustee has not received from the holders of not less than a majority in principal amount of the outstanding debt securities of that series a direction inconsistent with that request and has failed to institute the
                  proceeding within 60 days.&#160; (Section 6.7)</div>
              </td>
            </tr>

        </table>
        <div style="line-height: 1.25;">&#160;</div>
        <div style="text-align: justify; text-indent: 24.5pt; line-height: 1.25;">Notwithstanding any other provision in the indenture, the holder of any debt security will have an absolute and unconditional right to receive payment of the principal of,
          premium and any interest on that debt security on or after the due dates expressed in that debt security and to institute suit for the enforcement of payment.&#160; (Section 6.8)</div>
        <div style="line-height: 1.25;">&#160;</div>
        <div style="text-align: justify; text-indent: 24.5pt; line-height: 1.25;">The indenture requires us, within 120 days after the end of our fiscal year, to furnish to the trustee a statement as to compliance with the indenture.&#160; (Section 4.3)&#160; If a
          Default or Event of Default occurs and is continuing with respect to the securities of any series and if it is known to a responsible officer of the trustee, the trustee shall mail to each holder of the securities of that series notice of a
          Default or Event of Default within 90 days after it occurs or, if later, after a responsible officer of the trustee has knowledge of such Default or Event of Default.&#160; The indenture provides that the trustee may withhold notice to the holders of
          debt securities of any series of any Default or Event of Default (except in payment on any debt securities of that series) with respect to debt securities of that series if the trustee determines in good faith that withholding notice is in the
          interest of the holders of those debt securities.&#160; (Section 7.5)</div>
        <div style="line-height: 1.25;">&#160;</div>
        <div style="text-align: justify; line-height: 1.25; font-weight: bold;">Modification and Waiver</div>
        <div style="line-height: 1.25;">&#160;</div>
        <div style="text-align: justify; text-indent: 24.5pt; line-height: 1.25;">We and the trustee may modify, amend or supplement the indenture or the debt securities of any series without the consent of any holder of any debt security:</div>
        <div style="line-height: 1.25;">&#160;</div>
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zeaf30e79cda7447589c104ca051b3331">

            <tr>
              <td style="width: 36pt;"><br>
              </td>
              <td style="width: 18pt; vertical-align: top;">&#8226;</td>
              <td style="width: auto; vertical-align: top; text-align: justify;">
                <div>to cure any ambiguity, defect or inconsistency;</div>
              </td>
            </tr>

        </table>
        <div style="line-height: 1.25;">&#160;</div>
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z0ce8d79208b24d7cbb952a1608143ef0">

            <tr>
              <td style="width: 36pt;"><br>
              </td>
              <td style="width: 18pt; vertical-align: top;">&#8226;</td>
              <td style="width: auto; vertical-align: top; text-align: justify;">
                <div>to comply with covenants in the indenture described above under the heading &#8220;<font style="font-style: italic;">Consolidation, Merger and Sale of Assets</font>&#8221;;</div>
              </td>
            </tr>

        </table>
        <div style="line-height: 1.25;">&#160;</div>
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="za159a3375a3e4dea8a5316642576cc64">

            <tr>
              <td style="width: 36pt;"><br>
              </td>
              <td style="width: 18pt; vertical-align: top;">&#8226;</td>
              <td style="width: auto; vertical-align: top; text-align: justify;">
                <div>to provide for uncertificated securities in addition to or in place of certificated securities;</div>
              </td>
            </tr>

        </table>
        <div style="line-height: 1.25;">&#160;</div>
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zc42f329aaae8473ca5c121a1146e7727">

            <tr>
              <td style="width: 36pt;"><br>
              </td>
              <td style="width: 18pt; vertical-align: top;">&#8226;</td>
              <td style="width: auto; vertical-align: top; text-align: justify;">
                <div>to add guarantees with respect to debt securities of any series or secure debt securities of any series;</div>
              </td>
            </tr>

        </table>
        <div style="line-height: 1.25;">&#160;</div>
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z7f9aadd47f594b368534aa595ae384c6">

            <tr>
              <td style="width: 36pt;"><br>
              </td>
              <td style="width: 18pt; vertical-align: top;">&#8226;</td>
              <td style="width: auto; vertical-align: top; text-align: justify;">
                <div>to surrender any of our rights or powers under the indenture;</div>
              </td>
            </tr>

        </table>
        <div style="line-height: 1.25;">&#160;</div>
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="ze590d5ce6e004c4a821a1d5aa21b0457">

            <tr>
              <td style="width: 36pt;"><br>
              </td>
              <td style="width: 18pt; vertical-align: top;">&#8226;</td>
              <td style="width: auto; vertical-align: top; text-align: justify;">
                <div>to add covenants or events of default for the benefit of the holders of debt securities of any series;</div>
              </td>
            </tr>

        </table>
        <div style="line-height: 1.25;">&#160;</div>
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z847f440852384fb3bfcc71c38ccd4bc4">

            <tr>
              <td style="width: 36pt;"><br>
              </td>
              <td style="width: 18pt; vertical-align: top;">&#8226;</td>
              <td style="width: auto; vertical-align: top; text-align: justify;">
                <div>to comply with the applicable procedures of the applicable depositary;</div>
              </td>
            </tr>

        </table>
        <div style="line-height: 1.25;">&#160;</div>
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z140407cc76cd49f98309f870c9b54349">

            <tr>
              <td style="width: 36pt;"><br>
              </td>
              <td style="width: 18pt; vertical-align: top;">&#8226;</td>
              <td style="width: auto; vertical-align: top; text-align: justify;">
                <div>to make any change that does not adversely affect the rights of any holder of debt securities;</div>
              </td>
            </tr>

        </table>
        <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
          <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-weight: normal; font-style: normal;">16</font></div>
          <div style="page-break-after: always;" class="BRPFPageBreak">
            <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
        </div>
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z64168d8697b1403fb7e716a955c7ff61">

            <tr>
              <td style="width: 36pt;"><br>
              </td>
              <td style="width: 18pt; vertical-align: top;">&#8226;</td>
              <td style="width: auto; vertical-align: top; text-align: justify;">
                <div>to provide for the issuance of and establish the form and terms and conditions of debt securities of any series as permitted by the indenture;</div>
              </td>
            </tr>

        </table>
        <div style="line-height: 1.25;">&#160;</div>
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z61b581ba80504062b177f9e16d3f5dfa">

            <tr>
              <td style="width: 36pt;"><br>
              </td>
              <td style="width: 18pt; vertical-align: top;">&#8226;</td>
              <td style="width: auto; vertical-align: top; text-align: justify;">
                <div>to effect the appointment of a successor trustee with respect to the debt securities of any series and to add to or change any of the provisions of the indenture to provide for or facilitate administration by more than one trustee; or</div>
              </td>
            </tr>

        </table>
        <div style="line-height: 1.25;">&#160;</div>
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zb224621c91394d1e86431a49b50eb4d7">

            <tr>
              <td style="width: 36pt;"><br>
              </td>
              <td style="width: 18pt; vertical-align: top;">&#8226;</td>
              <td style="width: auto; vertical-align: top; text-align: justify;">
                <div>to comply with requirements of the SEC in order to effect or maintain the qualification of the indenture under the Trust Indenture Act.&#160; (Section 9.1)</div>
              </td>
            </tr>

        </table>
        <div style="line-height: 1.25;">&#160;</div>
        <div style="text-align: justify; text-indent: 24.5pt; line-height: 1.25;">We may also modify and amend the indenture with the consent of the holders of at least a majority in principal amount of the outstanding debt securities of each series
          affected by the modifications or amendments.&#160; We may not make any modification or amendment without the consent of the holders of each affected debt security then outstanding if that amendment will:</div>
        <div style="line-height: 1.25;">&#160;</div>
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z9f491e899a654bc59bde1d50082c9342">

            <tr>
              <td style="width: 36pt;"><br>
              </td>
              <td style="width: 18pt; vertical-align: top;">&#8226;</td>
              <td style="width: auto; vertical-align: top; text-align: justify;">
                <div>reduce the amount of debt securities whose holders must consent to an amendment, supplement or waiver;</div>
              </td>
            </tr>

        </table>
        <div style="line-height: 1.25;">&#160;</div>
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z78b277536dae4ae8a6f7be64e4fcd3b2">

            <tr>
              <td style="width: 36pt;"><br>
              </td>
              <td style="width: 18pt; vertical-align: top;">&#8226;</td>
              <td style="width: auto; vertical-align: top; text-align: justify;">
                <div>reduce the rate of or extend the time for payment of interest (including default interest) on any debt security;</div>
              </td>
            </tr>

        </table>
        <div style="line-height: 1.25;">&#160;</div>
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z54d368a5f0894ab78138c03a779bad09">

            <tr>
              <td style="width: 36pt;"><br>
              </td>
              <td style="width: 18pt; vertical-align: top;">&#8226;</td>
              <td style="width: auto; vertical-align: top; text-align: justify;">
                <div>reduce the principal of or premium on or change the fixed maturity of any debt security or reduce the amount of, or postpone the date fixed for, the payment of any sinking fund or analogous obligation with respect to any series of debt
                  securities;</div>
              </td>
            </tr>

        </table>
        <div style="line-height: 1.25;">&#160;</div>
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="za76985c96d0f4fa9a7bb7c3f02604f40">

            <tr>
              <td style="width: 36pt;"><br>
              </td>
              <td style="width: 18pt; vertical-align: top;">&#8226;</td>
              <td style="width: auto; vertical-align: top; text-align: justify;">
                <div>reduce the principal amount of discount securities payable upon acceleration of maturity;</div>
              </td>
            </tr>

        </table>
        <div style="line-height: 1.25;">&#160;</div>
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z33613086628c490b95ca0c8a81c91b22">

            <tr>
              <td style="width: 36pt;"><br>
              </td>
              <td style="width: 18pt; vertical-align: top;">&#8226;</td>
              <td style="width: auto; vertical-align: top; text-align: justify;">
                <div>waive a default in the payment of the principal of, premium or interest on any debt security (except a rescission of acceleration of the debt securities of any series by the holders of at least a majority in aggregate principal amount
                  of the then outstanding debt securities of that series and a waiver of the payment default that resulted from such acceleration);</div>
              </td>
            </tr>

        </table>
        <div style="line-height: 1.25;">&#160;</div>
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zd1f7e0d715e249e5a1696bd26fe32380">

            <tr>
              <td style="width: 36pt;"><br>
              </td>
              <td style="width: 18pt; vertical-align: top;">&#8226;</td>
              <td style="width: auto; vertical-align: top; text-align: justify;">
                <div>make the principal of or premium or interest on any debt security payable in currency other than that stated in the debt security;</div>
              </td>
            </tr>

        </table>
        <div style="line-height: 1.25;">&#160;</div>
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z9b5d9d73656f4b7b9f8ceb8cb7168a88">

            <tr>
              <td style="width: 36pt;"><br>
              </td>
              <td style="width: 18pt; vertical-align: top;">&#8226;</td>
              <td style="width: auto; vertical-align: top; text-align: justify;">
                <div>make any change to certain provisions of the indenture relating to, among other things, the right of holders of debt securities to receive payment of the principal of, premium and interest on those debt securities and to institute suit
                  for the enforcement of any such payment and to waivers or amendments; or</div>
              </td>
            </tr>

        </table>
        <div style="line-height: 1.25;">&#160;</div>
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z76a90a700ab74698842a6c799d2d82e2">

            <tr>
              <td style="width: 36pt;"><br>
              </td>
              <td style="width: 18pt; vertical-align: top;">&#8226;</td>
              <td style="width: auto; vertical-align: top; text-align: justify;">
                <div>waive a redemption payment with respect to any debt security.&#160; (Section 9.3)</div>
              </td>
            </tr>

        </table>
        <div style="line-height: 1.25;">&#160;</div>
        <div style="text-align: justify; text-indent: 24.5pt; line-height: 1.25;">Except for certain specified provisions, the holders of at least a majority in principal amount of the outstanding debt securities of any series may on behalf of the holders
          of all debt securities of that series waive our compliance with provisions of the indenture.&#160; (Section 9.2) The holders of a majority in principal amount of the outstanding debt securities of any series may on behalf of the holders of all the
          debt securities of such series waive any past default under the indenture with respect to that series and its consequences, except a default in the payment of the principal of, premium or any interest on any debt security of that series;
          provided, however, that the holders of a majority in principal amount of the outstanding debt securities of any series may rescind an acceleration and its consequences, including any related payment default that resulted from the acceleration.&#160;
          (Section 6.13)</div>
        <div style="line-height: 1.25;">&#160;</div>
        <div style="text-align: justify; line-height: 1.25; font-weight: bold;">Defeasance of Debt Securities and Certain Covenants in Certain Circumstances</div>
        <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-weight: bold;"> <br>
        </div>
        <div style="text-align: justify; text-indent: 24.5pt; line-height: 1.25;"><font style="font-style: italic;">Legal Defeasance</font>.&#160; The indenture provides that, unless otherwise provided by the terms of the applicable series of debt securities,
          we may be discharged from any and all obligations in respect of the debt securities of any series (subject to certain exceptions).&#160; We will be so discharged upon the irrevocable deposit with the trustee, in trust, of money and/or U.S. government
          obligations or, in the case of debt securities denominated in a single currency other than U.S. Dollars, government obligations of the government that issued or caused to be issued such currency, that, through the payment of interest and
          principal in accordance with their terms, will provide money or U.S. government obligations in an amount sufficient in the opinion of a nationally recognized firm of independent public accountants or investment bank to pay and discharge each
          installment of principal, premium and interest on and any mandatory sinking fund payments in respect of the debt securities of that series on the stated maturity of those payments in accordance with the terms of the indenture and those debt
          securities.</div>
        <div style="line-height: 1.25;">&#160;</div>
        <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
          <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-weight: normal; font-style: normal;">17</font></div>
          <div class="BRPFPageBreak" style="page-break-after: always;">
            <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
        </div>
        <div style="text-align: justify; text-indent: 24.5pt; line-height: 1.25;">This discharge may occur only if, among other things, we have delivered to the trustee an opinion of counsel stating that we have received from, or there has been published
          by, the United States Internal Revenue Service a ruling or, since the date of execution of the indenture, there has been a change in the applicable United States federal income tax law, in either case to the effect that, and based thereon such
          opinion shall confirm that, the holders of the debt securities of that series will not recognize income, gain or loss for United States federal income tax purposes as a result of the deposit, defeasance and discharge and will be subject to United
          States federal income tax on the same amounts and in the same manner and at the same times as would have been the case if the deposit, defeasance and discharge had not occurred.&#160; (Section 8.3)</div>
        <div style="line-height: 1.25;">&#160;</div>
        <div style="text-align: justify; text-indent: 24.5pt; line-height: 1.25;"><font style="font-style: italic;">Defeasance of Certain Covenants</font>.&#160; The indenture provides that, unless otherwise provided by the terms of the applicable series of
          debt securities, upon compliance with certain conditions:</div>
        <div style="line-height: 1.25;">&#160;</div>
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z24faf2652a3d4b1499a4ffb5ae8984b2">

            <tr>
              <td style="width: 36pt;"><br>
              </td>
              <td style="width: 18pt; vertical-align: top;">&#8226;</td>
              <td style="width: auto; vertical-align: top; text-align: justify;">
                <div>we may omit to comply with the covenant described under the heading &#8220;Consolidation, Merger and Sale of Assets&#8221; and certain other covenants set forth in the indenture, as well as any additional covenants which may be set forth in the
                  applicable prospectus supplement; and</div>
              </td>
            </tr>

        </table>
        <div style="line-height: 1.25;">&#160;</div>
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zc6c2f7e2cea141ebbe36a0cbfa767229">

            <tr>
              <td style="width: 36pt;"><br>
              </td>
              <td style="width: 18pt; vertical-align: top;">&#8226;</td>
              <td style="width: auto; vertical-align: top; text-align: justify;">
                <div>any omission to comply with those covenants will not constitute a Default or an Event of Default with respect to the debt securities of that series (&#8220;covenant defeasance&#8221;).</div>
              </td>
            </tr>

        </table>
        <div style="line-height: 1.25;">&#160;</div>
        <div style="text-align: justify; text-indent: 24.5pt; line-height: 1.25;">The conditions include:</div>
        <div style="line-height: 1.25;">&#160;</div>
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="za2040af307db480bb8b8b1f4c0dba668">

            <tr>
              <td style="width: 36pt;"><br>
              </td>
              <td style="width: 18pt; vertical-align: top;">&#8226;</td>
              <td style="width: auto; vertical-align: top; text-align: justify;">
                <div>depositing with the trustee money and/or U.S. government obligations or, in the case of debt securities denominated in a single currency other than U.S. Dollars, government obligations of the government that issued or caused to be
                  issued such currency, that, through the payment of interest and principal in accordance with their terms, will provide money in an amount sufficient in the opinion of a nationally recognized firm of independent public accountants or
                  investment bank to pay and discharge each installment of principal of, premium and interest on and any mandatory sinking fund payments in respect of the debt securities of that series on the stated maturity of those payments in accordance
                  with the terms of the indenture and those debt securities; and</div>
              </td>
            </tr>

        </table>
        <div style="line-height: 1.25;">&#160;</div>
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z567cc741988446a8af76ad5c9f2cb5e6">

            <tr>
              <td style="width: 36pt;"><br>
              </td>
              <td style="width: 18pt; vertical-align: top;">&#8226;</td>
              <td style="width: auto; vertical-align: top; text-align: justify;">
                <div>delivering to the trustee an opinion of counsel to the effect that the holders of the debt securities of that series will not recognize income, gain or loss for United States federal income tax purposes as a result of the deposit and
                  related covenant defeasance and will be subject to United States federal income tax on the same amounts and in the same manner and at the same times as would have been the case if the deposit and related covenant defeasance had not
                  occurred.&#160; (Section 8.4)</div>
              </td>
            </tr>

        </table>
        <div style="line-height: 1.25;">&#160;</div>
        <div style="text-align: justify; line-height: 1.25; font-weight: bold;">No Personal Liability of Directors, Officers, Employees or Securityholders</div>
        <div style="line-height: 1.25;">&#160;</div>
        <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">None of our past, present or future directors, officers, employees or securityholders, as such, will have any personal liability for any of our obligations under the debt
          securities or the indenture or for any claim based on, or in respect or by reason of, such obligations or their creation.&#160; By accepting a debt security, each holder waives and releases all such liability.&#160; Such waiver and release is part of the
          consideration for the issue of the debt securities.&#160; However, such waiver and release may not be effective to waive liabilities under U.S. federal securities laws, and it is the view of the SEC that such a waiver is against public policy.</div>
        <div style="line-height: 1.25;">&#160;</div>
        <div style="text-align: justify; line-height: 1.25; font-weight: bold;">Governing Law</div>
        <div style="line-height: 1.25;">&#160;</div>
        <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">The indenture and the debt securities, including any claim or controversy arising out of or relating to the indenture or the securities, will be governed by the laws of the
          State of New York.</div>
        <div style="line-height: 1.25;">&#160;</div>
        <div style="text-indent: 36pt; line-height: 1.25;">The indenture will provide that we, the trustee and the holders of the debt securities (by their acceptance of the debt securities) irrevocably waive, to the fullest extent permitted by applicable
          law, any and all right to trial by jury in any legal proceeding arising out of or relating to the indenture, the debt securities or the transactions contemplated thereby.</div>
        <div style="line-height: 1.25;">&#160;</div>
        <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">The indenture will provide that any legal suit, action or proceeding arising out of or based upon the indenture or the transactions contemplated thereby may be instituted in
          the federal courts of the United States of America located in the City of New York or the courts of the State of New York in each case located in the City of New York, and we, the trustee and the holder of the debt securities (by their acceptance
          of the debt securities) irrevocably submit to the non-exclusive jurisdiction of such courts in any such suit, action or proceeding.&#160; The indenture will further provide that service of any process, summons, notice or document by mail (to the
          extent allowed under any applicable statute or rule of court) to such party&#8217;s address set forth in the indenture will be effective service of process for any suit, action or other proceeding brought in any such court.&#160; The indenture will further
          provide that we, the trustee and the holders of the debt securities (by their acceptance of the debt securities) irrevocably and unconditionally waive any objection to the laying of venue of any suit, action or other proceeding in the courts
          specified above and irrevocably and unconditionally waive and agree not to plead or claim any such suit, action or other proceeding has been brought in an inconvenient forum. (Section 10.10).</div>
        <div style="line-height: 1.25;">&#160;</div>
        <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
          <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-weight: normal; font-style: normal;">18</font></div>
          <div style="page-break-after: always;" class="BRPFPageBreak">
            <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
        </div>
        <div style="text-align: center; line-height: 1.25; font-weight: bold;">DESCRIPTION OF <a name="WARRANTS2"><!--Anchor--></a>WARRANTS</div>
        <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-weight: bold;"> <br>
        </div>
        <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">We may issue warrants for the purchase of shares of our ordinary shares or of debt securities.&#160; We may issue warrants independently or together with other securities, and the
          warrants may be attached to or separate from any offered securities.&#160; Each series of warrants will be issued under a separate warrant agreement to be entered into between us and the investors or a warrant agent.&#160; The following summary of material
          provisions of the warrants and warrant agreements are subject to, and qualified in their entirety by reference to, all the provisions of the warrant agreement and warrant certificate applicable to a particular series of warrants. The terms of any
          warrants offered under a prospectus supplement may differ from the terms described below. We urge you to read the applicable prospectus supplement and any related free writing prospectus, as well as the complete warrant agreements and warrant
          certificates that contain the terms of the warrants.</div>
        <div style="line-height: 1.25;">&#160;</div>
        <div style="text-align: justify; text-indent: 18pt; line-height: 1.25;">The particular terms of any issue of warrants will be described in the prospectus supplement relating to such issuance.&#160; Those terms may include:</div>
        <div style="line-height: 1.25;">&#160;</div>
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z7a967723fac14614a49d0f753959e938">

            <tr>
              <td style="width: 36pt;"><br>
              </td>
              <td style="width: 18pt; vertical-align: top;">&#8226;</td>
              <td style="width: auto; vertical-align: top; text-align: justify;">
                <div>the number of ordinary shares purchasable upon the exercise of warrants to purchase such shares and the price at which such number of shares may be purchased upon such exercise;</div>
              </td>
            </tr>

        </table>
        <div style="line-height: 1.25;">&#160;</div>
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zec2438036bb84aa39b1c74e0707aa4de">

            <tr>
              <td style="width: 36pt;"><br>
              </td>
              <td style="width: 18pt; vertical-align: top;">&#8226;</td>
              <td style="width: auto; vertical-align: top; text-align: justify;">
                <div>the principal amount of debt securities that may be purchased upon exercise of a debt warrant and the exercise price for the warrants, which may be payable in cash, securities or other property;</div>
              </td>
            </tr>

        </table>
        <div style="line-height: 1.25;">&#160;</div>
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="ze4668c3056394c7dbee760beba4220fb">

            <tr>
              <td style="width: 36pt;"><br>
              </td>
              <td style="width: 18pt; vertical-align: top;">&#8226;</td>
              <td style="width: auto; vertical-align: top; text-align: justify;">
                <div>the date, if any, on and after which the warrants and the related debt securities or ordinary shares will be separately transferable;</div>
              </td>
            </tr>

        </table>
        <div style="line-height: 1.25;">&#160;</div>
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zf350f6f5cf03454ab82f33dda99a2c63">

            <tr>
              <td style="width: 36pt;"><br>
              </td>
              <td style="width: 18pt; vertical-align: top;">&#8226;</td>
              <td style="width: auto; vertical-align: top; text-align: justify;">
                <div>the terms of any rights to redeem or call the warrants;</div>
              </td>
            </tr>

        </table>
        <div style="line-height: 1.25;">&#160;</div>
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zf897dc15dfea40c6ab91aa217eda68c0">

            <tr>
              <td style="width: 36pt;"><br>
              </td>
              <td style="width: 18pt; vertical-align: top;">&#8226;</td>
              <td style="width: auto; vertical-align: top; text-align: justify;">
                <div>the date on which the right to exercise the warrants will commence and the date on which the right will expire;</div>
              </td>
            </tr>

        </table>
        <div style="line-height: 1.25;">&#160;</div>
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z4b75fb07081943978efdee97c54730aa">

            <tr>
              <td style="width: 36pt;"><br>
              </td>
              <td style="width: 18pt; vertical-align: top;">&#8226;</td>
              <td style="width: auto; vertical-align: top; text-align: justify;">
                <div>material United States federal and Israeli income tax consequences applicable to the warrants; and</div>
              </td>
            </tr>

        </table>
        <div style="line-height: 1.25;">&#160;</div>
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zf57122f3c3e547a18de76395776cc282">

            <tr>
              <td style="width: 36pt;"><br>
              </td>
              <td style="width: 18pt; vertical-align: top;">&#8226;</td>
              <td style="width: auto; vertical-align: top; text-align: justify;">
                <div>any additional terms of the warrants, including terms, procedures, and limitations relating to the exchange, exercise and settlement of the warrants.</div>
              </td>
            </tr>

        </table>
        <div style="line-height: 1.25;">&#160;</div>
        <div style="text-align: justify; text-indent: 18pt; line-height: 1.25;">Holders of warrants will not be entitled:</div>
        <div style="line-height: 1.25;">&#160;</div>
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z3fdefd5fff914a92ab1920edba4bb87a">

            <tr>
              <td style="width: 36pt;"><br>
              </td>
              <td style="width: 18pt; vertical-align: top;">&#8226;</td>
              <td style="width: auto; vertical-align: top; text-align: justify;">
                <div>to vote, consent or receive dividends;</div>
              </td>
            </tr>

        </table>
        <div style="line-height: 1.25;">&#160;</div>
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z7b7494617b88435e9caf5712c150fc4c">

            <tr>
              <td style="width: 36pt;"><br>
              </td>
              <td style="width: 18pt; vertical-align: top;">&#8226;</td>
              <td style="width: auto; vertical-align: top; text-align: justify;">
                <div>receive notice as shareholders with respect to any meeting of shareholders for the election of our directors or any other matter; or</div>
              </td>
            </tr>

        </table>
        <div style="line-height: 1.25;">&#160;</div>
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z12b4c99b1ed642a3be72c07b239e4691">

            <tr>
              <td style="width: 36pt;"><br>
              </td>
              <td style="width: 18pt; vertical-align: top;">&#8226;</td>
              <td style="width: auto; vertical-align: top; text-align: justify;">
                <div>exercise any rights as shareholders of Innoviz.</div>
              </td>
            </tr>

        </table>
        <div style="line-height: 1.25;">&#160;</div>
        <div style="text-align: justify; text-indent: 18pt; line-height: 1.25;">Each warrant will entitle its holder to purchase the principal amount of debt securities or the number of ordinary shares at the exercise price set forth in, or calculable as
          set forth in, the applicable prospectus supplement. Unless we otherwise specify in the applicable prospectus supplement, holders of the warrants may exercise the warrants at any time up to the specified time on the expiration date that we set
          forth in the applicable prospectus supplement. After the close of business on the expiration date, unexercised warrants will become void.</div>
        <div style="text-align: justify; text-indent: 18pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif;"> <br>
        </div>
        <div style="text-align: justify; text-indent: 18pt; line-height: 1.25;">A holder of warrant certificates may exchange them for new warrant certificates of different denominations, present them for registration of transfer and exercise them at the
          corporate trust office of the warrant agent or any other office indicated in the applicable prospectus supplement.&#160; Until any warrants to purchase debt securities are exercised, the holder of the warrants will not have any rights of holders of
          the debt securities that can be purchased upon exercise, including any rights to receive payments of principal, premium or interest on the underlying debt securities or to enforce covenants in the applicable indenture. Until any warrants to
          purchase ordinary shares are exercised, the holders of the warrants will not have any rights of holders of the underlying ordinary shares, including any rights to receive dividends or payments upon any liquidation, dissolution or winding up on
          the ordinary shares, if any.</div>
        <div style="line-height: 1.25;">&#160;</div>
        <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
          <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-weight: normal; font-style: normal;">19</font></div>
          <div style="page-break-after: always;" class="BRPFPageBreak">
            <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
        </div>
        <div style="text-align: center; line-height: 1.25; font-weight: bold;">DESCRIPTION OF <a name="UNITS"><!--Anchor--></a>UNITS</div>
        <div style="line-height: 1.25;">&#160;</div>
        <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">We may issue units consisting of any combination of the other types of securities offered under this prospectus in one or more series.&#160; We may evidence each series of units by
          unit certificates that we will issue under a separate agreement.&#160; We may enter into unit agreements with a unit agent.&#160; Each unit agent will be a bank or trust company that we select.&#160; We will indicate the name and address of the unit agent in
          the applicable prospectus supplement relating to a particular series of units.</div>
        <div style="line-height: 1.25;">&#160;</div>
        <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">The following description, together with the additional information included in any applicable prospectus supplement, summarizes the general features of the units that we may
          offer under this prospectus. You should read any prospectus supplement and any free writing prospectus that we may authorize to be provided to you related to the series of units being offered, as well as the complete unit agreements that contain
          the terms of the units.&#160; Specific unit agreements will contain additional important terms and provisions and we will file as an exhibit to the registration statement of which this prospectus is a part, or will incorporate by reference from
          another report that we file with the SEC, the form of each unit agreement relating to units offered under this prospectus.</div>
        <div style="line-height: 1.25;">&#160;</div>
        <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">If we offer any units, certain terms of that series of units will be described in the applicable prospectus supplement, including, without limitation, the following, as
          applicable:</div>
        <div style="line-height: 1.25;">&#160;</div>
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zcd39bfd41c5d4653ad265db40588798a">

            <tr>
              <td style="width: 36pt;"><br>
              </td>
              <td style="width: 18pt; vertical-align: top;">&#8226;</td>
              <td style="width: auto; vertical-align: top; text-align: justify;">
                <div>the title of the series of units;</div>
              </td>
            </tr>

        </table>
        <div style="line-height: 1.25;">&#160;</div>
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z6292f27b168e4f8cb99b5adf6e89e269">

            <tr>
              <td style="width: 36pt;"><br>
              </td>
              <td style="width: 18pt; vertical-align: top;">&#8226;</td>
              <td style="width: auto; vertical-align: top; text-align: justify;">
                <div>identification and description of the separate constituent securities comprising the units;</div>
              </td>
            </tr>

        </table>
        <div style="line-height: 1.25;">&#160;</div>
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z54fb0ec3173a43b792329f2e74761f9e">

            <tr>
              <td style="width: 36pt;"><br>
              </td>
              <td style="width: 18pt; vertical-align: top;">&#8226;</td>
              <td style="width: auto; vertical-align: top; text-align: justify;">
                <div>the price or prices at which the units will be issued;</div>
              </td>
            </tr>

        </table>
        <div style="line-height: 1.25;">&#160;</div>
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z4351a9dac8db44d1905d25d1b5d0f9ba">

            <tr>
              <td style="width: 36pt;"><br>
              </td>
              <td style="width: 18pt; vertical-align: top;">&#8226;</td>
              <td style="width: auto; vertical-align: top; text-align: justify;">
                <div>the date, if any, on and after which the constituent securities comprising the units will be separately transferable;</div>
              </td>
            </tr>

        </table>
        <div style="line-height: 1.25;">&#160;</div>
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zf5c9a8899354454185087fe02eb70f7f">

            <tr>
              <td style="width: 36pt;"><br>
              </td>
              <td style="width: 18pt; vertical-align: top;">&#8226;</td>
              <td style="width: auto; vertical-align: top; text-align: justify;">
                <div>a discussion of certain United States federal and Israeli income tax considerations applicable to the units; and</div>
              </td>
            </tr>

        </table>
        <div style="line-height: 1.25;">&#160;</div>
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z0ba78aee90f1407d8dedaaacd39361a6">

            <tr>
              <td style="width: 36pt;"><br>
              </td>
              <td style="width: 18pt; vertical-align: top;">&#8226;</td>
              <td style="width: auto; vertical-align: top; text-align: justify;">
                <div>any other terms of the units and their constituent securities.</div>
              </td>
            </tr>

        </table>
        <div style="line-height: 1.25;">&#160;</div>
        <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
          <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-weight: normal; font-style: normal;">20</font></div>
          <div style="page-break-after: always;" class="BRPFPageBreak">
            <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
        </div>
        <div style="text-align: center; line-height: 1.25; font-weight: bold;"><a name="GLOBAL"><!--Anchor--></a>GLOBAL SECURITIES</div>
        <div style="line-height: 1.25;">&#160;</div>
        <div style="line-height: 1.25; font-weight: bold;">Book-Entry, Delivery and Form</div>
        <div style="line-height: 1.25;">&#160;</div>
        <div style="text-align: justify; text-indent: 24.5pt; line-height: 1.25;">Unless we indicate otherwise in any applicable prospectus supplement or free writing prospectus, the securities initially will be issued in book-entry form and represented by
          one or more global notes or global securities, or, collectively, global securities.&#160; The global securities will be deposited with, or on behalf of, The Depository Trust Company, New York, New York, as depositary, or DTC, and registered in the
          name of Cede &amp; Co., the nominee of DTC.&#160; Unless and until it is exchanged for individual certificates evidencing securities under the limited circumstances described below, a global security may not be transferred except as a whole by the
          depositary to its nominee or by the nominee to the depositary, or by the depositary or its nominee to a successor depositary or to a nominee of the successor depositary.</div>
        <div style="line-height: 1.25;">&#160;</div>
        <div style="text-align: justify; text-indent: 24.5pt; line-height: 1.25;">DTC has advised us that it is:</div>
        <div style="line-height: 1.25;">&#160;</div>
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zf83056babcdc4eb292928678b62843fe">

            <tr>
              <td style="width: 36pt;"><br>
              </td>
              <td style="width: 18pt; vertical-align: top;">&#8226;</td>
              <td style="width: auto; vertical-align: top; text-align: justify;">
                <div>a limited-purpose trust company organized under the New York Banking Law;</div>
              </td>
            </tr>

        </table>
        <div style="line-height: 1.25;">&#160;</div>
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zaf63591dbe2a4015a2d3fb39b8a33376">

            <tr>
              <td style="width: 36pt;"><br>
              </td>
              <td style="width: 18pt; vertical-align: top;">&#8226;</td>
              <td style="width: auto; vertical-align: top; text-align: justify;">
                <div>a &#8220;banking organization&#8221; within the meaning of the New York Banking Law;</div>
              </td>
            </tr>

        </table>
        <div style="line-height: 1.25;">&#160;</div>
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z9c6bbdae42f440eb8e27ece1ba197586">

            <tr>
              <td style="width: 36pt;"><br>
              </td>
              <td style="width: 18pt; vertical-align: top;">&#8226;</td>
              <td style="width: auto; vertical-align: top; text-align: justify;">
                <div>a member of the Federal Reserve System;</div>
              </td>
            </tr>

        </table>
        <div style="line-height: 1.25;">&#160;</div>
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="za9b24fe1bd4346afbd4dce31b5635c68">

            <tr>
              <td style="width: 36pt;"><br>
              </td>
              <td style="width: 18pt; vertical-align: top;">&#8226;</td>
              <td style="width: auto; vertical-align: top; text-align: justify;">
                <div>a &#8220;clearing corporation&#8221; within the meaning of the New York Uniform Commercial Code; and</div>
              </td>
            </tr>

        </table>
        <div style="line-height: 1.25;">&#160;</div>
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="ze8d514cbe8e548579ba3157a4f19c465">

            <tr>
              <td style="width: 36pt;"><br>
              </td>
              <td style="width: 18pt; vertical-align: top;">&#8226;</td>
              <td style="width: auto; vertical-align: top; text-align: justify;">
                <div>a &#8220;clearing agency&#8221; registered pursuant to the provisions of Section 17A of the Exchange Act.</div>
              </td>
            </tr>

        </table>
        <div style="line-height: 1.25;">&#160;</div>
        <div style="text-align: justify; text-indent: 24.5pt; line-height: 1.25;">DTC holds securities that its participants deposit with DTC.&#160; DTC also facilitates the settlement among its participants of securities transactions, such as transfers and
          pledges, in deposited securities through electronic computerized book-entry changes in participants&#8217; accounts, thereby eliminating the need for physical movement of securities certificates.&#160; &#8220;Direct participants&#8221; in DTC include securities brokers
          and dealers, including underwriters, banks, trust companies, clearing corporations and other organizations.&#160; DTC is a wholly owned subsidiary of The Depository Trust &amp; Clearing Corporation, or DTCC.&#160; DTCC is the holding company for DTC,
          National Securities Clearing Corporation and Fixed Income Clearing Corporation, all of which are registered clearing agencies.&#160; DTCC is owned by the users of its regulated subsidiaries.&#160; Access to the DTC system is also available to others, which
          we sometimes refer to as indirect participants, that clear through or maintain a custodial relationship with a direct participant, either directly or indirectly.&#160; The rules applicable to DTC and its participants are on file with the SEC.</div>
        <div style="line-height: 1.25;">&#160;</div>
        <div style="text-align: justify; text-indent: 24.5pt; line-height: 1.25;">Purchases of securities under the DTC system must be made by or through direct participants, which will receive a credit for the securities on DTC&#8217;s records.&#160; The ownership
          interest of the actual purchaser of a security, which we sometimes refer to as a beneficial owner, is in turn recorded on the direct and indirect participants&#8217; records.&#160; Beneficial owners of securities will not receive written confirmation from
          DTC of their purchases.&#160; However, beneficial owners are expected to receive written confirmations providing details of their transactions, as well as periodic statements of their holdings, from the direct or indirect participants through which
          they purchased securities.&#160; Transfers of ownership interests in global securities are to be accomplished by entries made on the books of participants acting on behalf of beneficial owners.&#160; Beneficial owners will not receive certificates
          representing their ownership interests in the global securities, except under the limited circumstances described below.</div>
        <div style="line-height: 1.25;">&#160;</div>
        <div style="text-align: justify; text-indent: 24.5pt; line-height: 1.25;">To facilitate subsequent transfers, all global securities deposited by direct participants with DTC will be registered in the name of DTC&#8217;s partnership nominee, Cede &amp;
          Co., or such other name as may be requested by an authorized representative of DTC.&#160; The deposit of securities with DTC and their registration in the name of Cede &amp; Co. or such other nominee will not change the beneficial ownership of the
          securities.&#160; DTC has no knowledge of the actual beneficial owners of the securities.&#160; DTC&#8217;s records reflect only the identity of the direct participants to whose accounts the securities are credited, which may or may not be the beneficial
          owners.&#160; The participants are responsible for keeping account of their holdings on behalf of their customers.</div>
        <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
          <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-weight: normal; font-style: normal;">21</font></div>
          <div style="page-break-after: always;" class="BRPFPageBreak">
            <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
        </div>
        <div style="text-align: justify; text-indent: 24.5pt; line-height: 1.25;">So long as the securities are in book-entry form, you will receive payments and may transfer securities only through the facilities of the depositary and its direct and
          indirect participants.&#160; We will maintain an office or agency in the location specified in the prospectus supplement for the applicable securities, where notices and demands in respect of the securities and the indenture may be delivered to us and
          where certificated securities may be surrendered for payment, registration of transfer or exchange.</div>
        <div style="line-height: 1.25;">&#160;</div>
        <div style="text-align: justify; text-indent: 24.5pt; line-height: 1.25;">Conveyance of notices and other communications by DTC to direct participants, by direct participants to indirect participants and by direct participants and indirect
          participants to beneficial owners will be governed by arrangements among them, subject to any legal requirements in effect from time to time.</div>
        <div style="line-height: 1.25;">&#160;</div>
        <div style="text-align: justify; text-indent: 24.5pt; line-height: 1.25;">Redemption notices will be sent to DTC.&#160; If less than all of the securities of a particular series are being redeemed, DTC&#8217;s practice is to determine by lot the amount of the
          interest of each direct participant in the securities of such series to be redeemed.</div>
        <div style="line-height: 1.25;">&#160;</div>
        <div style="text-align: justify; text-indent: 24.5pt; line-height: 1.25;">Neither DTC nor Cede &amp; Co. (or such other DTC nominee) will consent or vote with respect to the securities.&#160; Under its usual procedures, DTC will mail an omnibus proxy to
          us as soon as possible after the record date.&#160; The omnibus proxy assigns the consenting or voting rights of Cede &amp; Co. to those direct participants to whose accounts the securities of such series are credited on the record date, identified in
          a listing attached to the omnibus proxy.</div>
        <div style="line-height: 1.25;">&#160;</div>
        <div style="text-align: justify; text-indent: 24.5pt; line-height: 1.25;">So long as securities are in book-entry form, we will make payments on those securities to the depositary or its nominee, as the registered owner of such securities, by wire
          transfer of immediately available funds.&#160; If securities are issued in definitive certificated form under the limited circumstances described below and unless if otherwise provided in the description of the applicable securities herein or in the
          applicable prospectus supplement, we will have the option of making payments by check mailed to the addresses of the persons entitled to payment or by wire transfer to bank accounts in the United States designated in writing to the applicable
          trustee or other designated party at least 15 days before the applicable payment date by the persons entitled to payment, unless a shorter period is satisfactory to the applicable trustee or other designated party.</div>
        <div style="line-height: 1.25;">&#160;</div>
        <div style="text-align: justify; text-indent: 24.5pt; line-height: 1.25;">Redemption proceeds, distributions and dividend payments on the securities will be made to Cede &amp; Co., or such other nominee as may be requested by an authorized
          representative of DTC.&#160; DTC&#8217;s practice is to credit direct participants&#8217; accounts upon DTC&#8217;s receipt of funds and corresponding detail information from us on the payment date in accordance with their respective holdings shown on DTC records.&#160;
          Payments by participants to beneficial owners will be governed by standing instructions and customary practices, as is the case with securities held for the account of customers in bearer form or registered in &#8220;street name.&#8221;&#160; Those payments will
          be the responsibility of participants and not of DTC or us, subject to any statutory or regulatory requirements in effect from time to time.&#160; Payment of redemption proceeds, distributions and dividend payments to Cede &amp; Co., or such other
          nominee as may be requested by an authorized representative of DTC, is our responsibility, disbursement of payments to direct participants is the responsibility of DTC, and disbursement of payments to the beneficial owners is the responsibility
          of direct and indirect participants.</div>
        <div style="line-height: 1.25;">&#160;</div>
        <div style="text-align: justify; text-indent: 24.5pt; line-height: 1.25;">Except under the limited circumstances described below, purchasers of securities will not be entitled to have securities registered in their names and will not receive
          physical delivery of securities.&#160; Accordingly, each beneficial owner must rely on the procedures of DTC and its participants to exercise any rights under the securities and the indenture.</div>
        <div style="line-height: 1.25;">&#160;</div>
        <div style="text-align: justify; text-indent: 24.5pt; line-height: 1.25;">The laws of some jurisdictions may require that some purchasers of securities take physical delivery of securities in definitive form.&#160; Those laws may impair the ability to
          transfer or pledge beneficial interests in those securities.</div>
        <div style="line-height: 1.25;">&#160;</div>
        <div style="text-align: justify; text-indent: 24.5pt; line-height: 1.25;">DTC may discontinue providing its services as securities depositary with respect to the securities at any time by giving reasonable notice to us.&#160; Under such circumstances,
          in the event that a successor depositary is not obtained, securities certificates are required to be printed and delivered.</div>
        <div style="line-height: 1.25;">&#160;</div>
        <div style="text-align: justify; text-indent: 24.5pt; line-height: 1.25;">As noted above, beneficial owners of a particular series of securities generally will not receive certificates representing their ownership interests in those securities.&#160;
          However, if:</div>
        <div style="line-height: 1.25;">&#160;</div>
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z162d6ed49d3c44b89f1cdb0427e03b87">

            <tr>
              <td style="width: 36pt;"><br>
              </td>
              <td style="width: 18pt; vertical-align: top;">&#8226;</td>
              <td style="width: auto; vertical-align: top; text-align: justify;">
                <div>DTC notifies us that it is unwilling or unable to continue as a depositary for the global security or securities representing such series of securities or if DTC ceases to be a clearing agency registered under the Exchange Act at a
                  time when it is required to be registered and a successor depositary is not appointed within 90 days of the notification to us or of our becoming aware of DTC&#8217;s ceasing to be so registered, as the case may be;</div>
              </td>
            </tr>

        </table>
        <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
          <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-weight: normal; font-style: normal;">22</font></div>
          <div style="page-break-after: always;" class="BRPFPageBreak">
            <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
        </div>
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z0d082f7687bb4d8eab519d982530a002">

            <tr>
              <td style="width: 36pt;"><br>
              </td>
              <td style="width: 18pt; vertical-align: top;">&#8226;</td>
              <td style="width: auto; vertical-align: top; text-align: justify;">
                <div>we determine, in our sole discretion, not to have such securities represented by one or more global securities; or</div>
              </td>
            </tr>

        </table>
        <div style="line-height: 1.25;">&#160;</div>
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z8254efbf1e8f473d9c4bcf5dedb6206b">

            <tr>
              <td style="width: 36pt;"><br>
              </td>
              <td style="width: 18pt; vertical-align: top;">&#8226;</td>
              <td style="width: auto; vertical-align: top; text-align: justify;">
                <div>an Event of Default has occurred and is continuing with respect to such series of securities,</div>
              </td>
            </tr>

        </table>
        <div style="line-height: 1.25;">&#160;</div>
        <div style="text-align: justify; line-height: 1.25;">we will prepare and deliver certificates for such securities in exchange for beneficial interests in the global securities.&#160; Any beneficial interest in a global security that is exchangeable
          under the circumstances described in the preceding sentence will be exchangeable for securities in definitive certificated form registered in the names that the depositary directs.&#160; It is expected that these directions will be based upon
          directions received by the depositary from its participants with respect to ownership of beneficial interests in the global securities.</div>
        <div style="line-height: 1.25;">&#160;</div>
        <div style="text-align: justify; line-height: 1.25; font-weight: bold;">Euroclear and Clearstream</div>
        <div style="line-height: 1.25;">&#160;</div>
        <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">If so provided in the applicable prospectus supplement, you may hold interests in a global security through Clearstream Banking S.A., which we refer to as &#8220;Clearstream,&#8221; or
          Euroclear Bank S.A./N.V., as operator of the Euroclear System, which we refer to as &#8220;Euroclear,&#8221; either directly if you are a participant in Clearstream or Euroclear or indirectly through organizations which are participants in Clearstream or
          Euroclear.&#160; Clearstream and Euroclear will hold interests on behalf of their respective participants through customers&#8217; securities accounts in the names of Clearstream and Euroclear, respectively, on the books of their respective U.S.
          depositaries, which in turn will hold such interests in customers&#8217; securities accounts in such depositaries&#8217; names on DTC&#8217;s books.</div>
        <div style="line-height: 1.25;">&#160;</div>
        <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">Clearstream and Euroclear are securities clearance systems in Europe. Clearstream and Euroclear hold securities for their respective participating organizations and facilitate
          the clearance and settlement of securities transactions between those participants through electronic book-entry changes in their accounts, thereby eliminating the need for physical movement of certificates.</div>
        <div style="line-height: 1.25;">&#160;</div>
        <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">Payments, deliveries, transfers, exchanges, notices and other matters relating to beneficial interests in global securities owned through Euroclear or Clearstream must comply
          with the rules and procedures of those systems. Transactions between participants in Euroclear or Clearstream, on one hand, and other participants in DTC, on the other hand, are also subject to DTC&#8217;s rules and procedures.</div>
        <div style="line-height: 1.25;">&#160;</div>
        <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">Investors will be able to make and receive through Euroclear and Clearstream payments, deliveries, transfers and other transactions involving any beneficial interests in global
          securities held through those systems only on days when those systems are open for business. Those systems may not be open for business on days when banks, brokers and other institutions are open for business in the United States.</div>
        <div style="line-height: 1.25;">&#160;</div>
        <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">Cross-market transfers between participants in DTC, on the one hand, and participants in Euroclear or Clearstream, on the other hand, will be effected through DTC in accordance
          with the DTC&#8217;s rules on behalf of Euroclear or Clearstream, as the case may be, by their respective U.S. depositaries; however, such cross-market transactions will require delivery of instructions to Euroclear or Clearstream, as the case may be,
          by the counterparty in such system in accordance with the rules and procedures and within the established deadlines (European time) of such system. Euroclear or Clearstream, as the case may be, will, if the transaction meets its settlement
          requirements, deliver instructions to its U.S. depositary to take action to effect final settlement on its behalf by delivering or receiving interests in the global securities through DTC, and making or receiving payment in accordance with normal
          procedures for same-day fund settlement. Participants in Euroclear or Clearstream may not deliver instructions directly to their respective U.S. depositaries.</div>
        <div style="line-height: 1.25;">&#160;</div>
        <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">Due to time zone differences, the securities accounts of a participant in Euroclear or Clearstream purchasing an interest in a global security from a direct participant in DTC
          will be credited, and any such crediting will be reported to the relevant participant in Euroclear or Clearstream, during the securities settlement processing day (which must be a business day for Euroclear or Clearstream) immediately following
          the settlement date of DTC. Cash received in Euroclear or Clearstream as a result of sales of interests in a global security by or through a participant in Euroclear or Clearstream to a direct participant in DTC will be received with value on the
          settlement date of DTC but will be available in the relevant Euroclear or Clearstream cash account only as of the business day for Euroclear or Clearstream following DTC&#8217;s settlement date.</div>
        <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif;"> <br>
        </div>
        <div style="text-align: justify; line-height: 1.25; font-weight: bold;">Other</div>
        <div style="line-height: 1.25;">&#160;</div>
        <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">The information in this section of this prospectus concerning DTC, Clearstream, Euroclear and their respective book-entry systems has been obtained from sources that we believe
          to be reliable, but we do not take responsibility for this information. This information has been provided solely as a matter of convenience. The rules and procedures of DTC, Clearstream and Euroclear are solely within the control of those
          organizations and could change at any time. Neither we nor the trustee nor any agent of ours or of the trustee has any control over those entities and none of us takes any responsibility for their activities. You are urged to contact DTC,
          Clearstream and Euroclear or their respective participants directly to discuss those matters. In addition, although we expect that DTC, Clearstream and Euroclear will perform the foregoing procedures, none of them is under any obligation to
          perform or continue to perform such procedures and such procedures may be discontinued at any time. Neither we nor any agent of ours will have any responsibility for the performance or nonperformance by DTC, Clearstream and Euroclear or their
          respective participants of these or any other rules or procedures governing their respective operations.</div>
        <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
          <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-weight: normal; font-style: normal;">23</font></div>
          <div style="page-break-after: always;" class="BRPFPageBreak">
            <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
        </div>
        <div style="text-align: center; line-height: 1.25; font-weight: bold;">PLAN OF <a name="DISTRIBUTION"><!--Anchor--></a>DISTRIBUTION</div>
        <div style="line-height: 1.25;">&#160;</div>
        <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">We are registering the offer and sale from time to time by us of our securities in one or more offerings of up to $200,000,000 in aggregate offering price.</div>
        <div style="line-height: 1.25;">&#160;</div>
        <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">We will receive proceeds from the issuance and sale of our securities. See &#8220;<font style="font-style: italic;">Use of Proceeds</font>.&#8221; We will bear all costs, expenses and fees
          in connection with the registration of the securities offered by this prospectus.</div>
        <div style="line-height: 1.25;">&#160;</div>
        <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">The securities to be offered and sold by us covered by this prospectus may be offered and sold from time to time.</div>
        <div style="line-height: 1.25;">&#160;</div>
        <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">Sales of the securities offered hereby may be effected by us from time to time in one or more types of transactions (which may include block transactions) on Nasdaq at
          prevailing market prices, in negotiated transactions, through put or call options transactions relating to the securities offered hereby, through short sales of the securities offered hereby, or a combination of such methods of sale. Such
          transactions may or may not involve brokers or dealers. In effecting sales, brokers or dealers engaged by us may arrange for other brokers or dealers to participate. Broker&#8209;dealer transactions may include purchases of the securities by a
          broker&#8209;dealer as principal and resales of the securities by the broker&#8209;dealer for its account pursuant to this prospectus, ordinary brokerage transactions or transactions in which the broker&#8209;dealer solicits purchasers. Such broker&#8209;dealers may
          receive compensation in the form of discounts, concessions or commissions from us and/or the purchasers of the securities offered hereby for whom such broker&#8209;dealers may act as agents or to whom they sell as principal, or both (which compensation
          as to a particular broker&#8209;dealer might be in excess of customary commissions). Any broker&#8209;dealers participating in the distribution of the securities covered by this prospectus may be deemed to be &#8220;underwriters&#8221; within the meaning of the
          Securities Act, and any commissions received by any of those broker&#8209;dealers may be deemed to be underwriting commissions under the Securities Act.</div>
        <div style="line-height: 1.25;">&#160;</div>
        <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">There can be no assurance that we will sell all or any of the securities offered by this prospectus. In addition, we may also sell securities in transactions exempt from
          registration under the Securities Act, rather than under this prospectus. We have the sole and absolute discretion not to accept any purchase offer or make any sale of securities if we deem the purchase price to be unsatisfactory at any
          particular time.</div>
        <div style="line-height: 1.25;">&#160;</div>
        <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">With respect to a particular offering of securities by us, to the extent required, an accompanying prospectus supplement or, if appropriate, a post-effective amendment to the
          registration statement of which this prospectus is part, will be prepared and will set forth the following information:</div>
        <div style="line-height: 1.25;">&#160;</div>
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z6bf428780c344fab9649444d8caea63b">

            <tr>
              <td style="width: 36pt;"><br>
              </td>
              <td style="width: 18pt; vertical-align: top;">&#8226;</td>
              <td style="width: auto; vertical-align: top; text-align: justify;">
                <div>the name of the participating broker&#8209;dealer(s);</div>
              </td>
            </tr>

        </table>
        <div style="line-height: 1.25;">&#160;</div>
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="ze9d4d81281e34eb6a9f10f37bc000003">

            <tr>
              <td style="width: 36pt;"><br>
              </td>
              <td style="width: 18pt; vertical-align: top;">&#8226;</td>
              <td style="width: auto; vertical-align: top; text-align: justify;">
                <div>the specific securities involved;</div>
              </td>
            </tr>

        </table>
        <div style="line-height: 1.25;">&#160;</div>
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z168d43e8177149e1be0ea33c290456ac">

            <tr>
              <td style="width: 36pt;"><br>
              </td>
              <td style="width: 18pt; vertical-align: top;">&#8226;</td>
              <td style="width: auto; vertical-align: top; text-align: justify;">
                <div>the initial price at which such securities are to be sold;</div>
              </td>
            </tr>

        </table>
        <div style="line-height: 1.25;">&#160;</div>
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z009d56608b894d1aa2ab9a472dc597fe">

            <tr>
              <td style="width: 36pt;"><br>
              </td>
              <td style="width: 18pt; vertical-align: top;">&#8226;</td>
              <td style="width: auto; vertical-align: top; text-align: justify;">
                <div>the commissions paid or discounts or concessions allowed to such broker&#8209;dealer(s), where applicable; and</div>
              </td>
            </tr>

        </table>
        <div style="line-height: 1.25;">&#160;</div>
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z988fcba95e9f4b43b3b3d37bbab44582">

            <tr>
              <td style="width: 36pt;"><br>
              </td>
              <td style="width: 18pt; vertical-align: top;">&#8226;</td>
              <td style="width: auto; vertical-align: top; text-align: justify;">
                <div>other facts material to the transaction.</div>
              </td>
            </tr>

        </table>
        <div style="line-height: 1.25;">&#160;</div>
        <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">To the extent required, we will use our best efforts to file one or more supplements to this prospectus to describe any material information with respect to the plan of
          distribution not previously disclosed in this prospectus or any material change to such information.</div>
        <div style="line-height: 1.25;">&#160;</div>
        <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">In compliance with the guidelines of the Financial Industry Regulatory Authority (&#8220;<font style="font-weight: bold;">FINRA</font>&#8221;), the aggregate maximum discount, commission,
          fees or other items constituting underwriting compensation to be received by any FINRA member or independent broker&#8209;dealer will not exceed 8% of the gross proceeds of any offering pursuant to this prospectus and any applicable prospectus
          supplement.</div>
        <div style="line-height: 1.25;">&#160;</div>
        <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">In offering the securities covered by this prospectus, we and any underwriters, broker-dealers or agents who execute sales may be deemed to be &#8220;underwriters&#8221; within the meaning
          of the Securities Act in connection with such sales. Any discounts, commissions, concessions or profit they earn on any resale of those securities may be underwriting discounts and commissions under the Securities Act.</div>
        <div style="line-height: 1.25;">&#160;</div>
        <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
          <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-weight: normal; font-style: normal;">24</font></div>
          <div class="BRPFPageBreak" style="page-break-after: always;">
            <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
        </div>
        <div style="text-align: justify; text-indent: 24.5pt; line-height: 1.25;">Any ordinary shares will be listed on Nasdaq, but any other securities may or may not be listed on a national securities exchange.&#160; To facilitate the offering of securities,
          certain persons participating in the offering may engage in transactions that stabilize, maintain or otherwise affect the price of the securities.&#160; This may include over-allotments or short sales of the securities, which involve the sale by
          persons participating in the offering of more securities than were sold to them.&#160; In these circumstances, these persons would cover such over-allotments or short positions by making purchases in the open market or by exercising their
          over-allotment option, if any.&#160; In addition, these persons may stabilize or maintain the price of the securities by bidding for or purchasing securities in the open market or by imposing penalty bids, whereby selling concessions allowed to
          dealers participating in the offering may be reclaimed if securities sold by them are repurchased in connection with stabilization transactions.&#160; The effect of these transactions may be to stabilize or maintain the market price of the securities
          at a level above that which might otherwise prevail in the open market.&#160; These transactions may be discontinued at any time.</div>
        <div style="line-height: 1.25;">&#160;</div>
        <div style="text-align: justify; text-indent: 24.5pt; line-height: 1.25;">We may engage in at-the-market offerings into an existing trading market in accordance with Rule 415(a)(4) under the Securities Act.&#160; In addition, we may enter into
          derivative transactions with third parties, or sell securities not covered by this prospectus to third parties in privately negotiated transactions.&#160; If the applicable prospectus supplement so indicates, in connection with those derivatives, the
          third parties may sell securities covered by this prospectus and the applicable prospectus supplement, including in short sale transactions.&#160; If so, the third party may use securities pledged by us or borrowed from us or others to settle those
          sales or to close out any related open borrowings of shares, and may use securities received from us in settlement of those derivatives to close out any related open borrowings of shares.&#160; The third party in such sale transactions will be an
          underwriter and, if not identified in this prospectus, will be named in the applicable prospectus supplement (or a post-effective amendment).&#160; In addition, we may otherwise loan or pledge securities to a financial institution or other third party
          that in turn may sell the securities short using this prospectus and an applicable prospectus supplement. Such financial institution or other third party may transfer its economic short position to investors in our securities or in connection
          with a concurrent offering of other securities.</div>
        <div style="line-height: 1.25;">&#160;</div>
        <div style="text-align: justify; text-indent: 24.5pt; line-height: 1.25;">The specific terms of any lock-up provisions in respect of any given offering will be described in the applicable prospectus supplement.</div>
        <div style="line-height: 1.25;">&#160;</div>
        <div style="text-align: justify; text-indent: 24.5pt; line-height: 1.25;">The underwriters, dealers and agents may engage in transactions with us, or perform services for us, in the ordinary course of business for which they receive compensation.</div>
        <div style="line-height: 1.25;">&#160;</div>
        <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">The underwriters, broker-dealers and agents may engage in transactions with us, or perform services for us, in the ordinary course of business. In order to comply with the
          securities laws of certain states, if applicable, the securities must be sold in such jurisdictions only through registered or licensed brokers or dealers. In addition, in certain states the securities may not be sold unless they have been
          registered or qualified for sale in the applicable state or an exemption from the registration or qualification requirement is available and is complied with.</div>
        <div style="line-height: 1.25;">&#160;</div>
        <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
          <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-weight: normal; font-style: normal;">25</font></div>
          <div style="page-break-after: always;" class="BRPFPageBreak">
            <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
        </div>
        <div style="text-align: center; line-height: 1.25; font-weight: bold;"><a name="TAXATION"><!--Anchor--></a>TAXATION</div>
        <div style="line-height: 1.25;">&#160;</div>
        <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">Material tax consequences relating to the purchase, ownership and disposition of any of the securities registered by this prospectus will be set forth in the applicable
          prospectus supplement(s) relating to the offering of such securities.</div>
        <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
          <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-weight: normal; font-style: normal;">26</font></div>
          <div style="page-break-after: always;" class="BRPFPageBreak">
            <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
        </div>
        <div style="text-align: center; line-height: 1.25; font-weight: bold;"><a name="EXPENSES"><!--Anchor--></a>EXPENSES</div>
        <div style="line-height: 1.25;">&#160;</div>
        <div style="text-indent: 36pt; line-height: 1.25;">The following table sets forth the expenses (other than underwriting discounts and commissions or agency fees and other items constituting underwriters&#8217; or agents&#8217; compensation, if any) expected to
          be incurred by us in connection with a possible offering of the securities registered under the registration statement of which this prospectus forms a part.</div>
        <div style="line-height: 1.25;">&#160;</div>
        <table cellspacing="0" cellpadding="0" border="0" align="center" class="cfttable" id="z375d1a5517ef47a5b09757c9b151940d" style="width: 60%; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">

            <tr>
              <td valign="bottom" style="vertical-align: top; width: 86%; background-color: rgb(204, 238, 255);">
                <div style="text-align: justify; line-height: 1.25;">SEC Registration Fee&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</div>
              </td>
              <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
              <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">
                <div style="line-height: 1.25;">$</div>
              </td>
              <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 11%; background-color: rgb(204, 238, 255);">
                <div style="line-height: 1.25;">22,167.15</div>
              </td>
              <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
            </tr>
            <tr>
              <td valign="bottom" style="vertical-align: top; width: 86%;">
                <div style="text-align: justify; line-height: 1.25;">FINRA filing fee&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</div>
              </td>
              <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
              <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
              <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 11%;">
                <div style="line-height: 1.25;">22,218.30</div>
              </td>
              <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
            </tr>
            <tr>
              <td valign="bottom" style="vertical-align: top; width: 86%; background-color: rgb(204, 238, 255);">
                <div style="text-align: justify; line-height: 1.25;">Legal fees and&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</div>
              </td>
              <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
              <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
              <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 11%; background-color: rgb(204, 238, 255);">&#160;</td>
              <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">
                <div style="line-height: 1.25;">**</div>
              </td>
            </tr>
            <tr>
              <td valign="bottom" style="vertical-align: top; width: 86%;">
                <div style="text-align: justify; line-height: 1.25;">Accountants&#8217; fees and expenses&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</div>
              </td>
              <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
              <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
              <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 11%;">&#160;</td>
              <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%;">
                <div style="line-height: 1.25;">**</div>
              </td>
            </tr>
            <tr>
              <td valign="bottom" style="vertical-align: top; width: 86%; background-color: rgb(204, 238, 255);">
                <div style="text-align: justify; line-height: 1.25;">Printing expenses&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</div>
              </td>
              <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
              <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
              <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 11%; background-color: rgb(204, 238, 255);">&#160;</td>
              <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">
                <div style="line-height: 1.25;">**</div>
              </td>
            </tr>
            <tr>
              <td valign="bottom" style="vertical-align: top; width: 86%;">
                <div style="text-align: justify; line-height: 1.25;">Transfer agent fees and expenses&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</div>
              </td>
              <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
              <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
              <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 11%;">&#160;</td>
              <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%;">
                <div style="line-height: 1.25;">**</div>
              </td>
            </tr>
            <tr>
              <td valign="bottom" style="vertical-align: top; width: 86%; background-color: rgb(204, 238, 255);">
                <div style="text-align: justify; line-height: 1.25;">Miscellaneous&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</div>
              </td>
              <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
              <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
              <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 11%; background-color: rgb(204, 238, 255);">&#160;</td>
              <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">
                <div style="line-height: 1.25;">**</div>
              </td>
            </tr>
            <tr>
              <td valign="bottom" style="vertical-align: top; width: 86%;">
                <div style="text-align: justify; line-height: 1.25;"><font style="font-weight: bold;">Total</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</div>
              </td>
              <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
              <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
              <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 11%;">&#160;</td>
              <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%;">
                <div style="line-height: 1.25;">**</div>
              </td>
            </tr>

        </table>
        <div style="line-height: 1.25;">&#160;</div>
        <div style="text-align: justify; line-height: 1.25;">* Estimated fees and expenses are not presently known. If required, to be provided by a prospectus supplement or as an exhibit to a Current Report on Form 6-K that is incorporated by reference
          into this prospectus.</div>
        <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
          <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-weight: normal; font-style: normal;">27</font></div>
          <div style="page-break-after: always;" class="BRPFPageBreak">
            <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
        </div>
        <div style="text-align: center; line-height: 1.25; font-weight: bold;">FOREIGN EXCHANGE CONTROLS AND OTHER <a name="LIMITATIONS"><!--Anchor--></a>LIMITATIONS</div>
        <div style="line-height: 1.25;">&#160;</div>
        <div style="text-indent: 36pt; line-height: 1.25; text-align: justify;">Israeli law and regulations do not impose any material foreign exchange restrictions on non&#8209;Israeli holders of our ordinary shares and warrants.</div>
        <div style="line-height: 1.25;">&#160;</div>
        <div style="text-indent: 36pt; line-height: 1.25; text-align: justify;">Non&#8209;residents of Israel who purchase our ordinary shares will be able to convert dividends, if any, thereon, and any amounts payable upon our dissolution, liquidation or
          winding up, as well as the proceeds of any sale in Israel of our ordinary shares to an Israeli resident, into freely repairable dollars, at the exchange rate prevailing at the time of conversion, provided that the Israeli income tax has been
          withheld (or paid) with respect to such amounts or an exemption has been obtained.</div>
        <div style="line-height: 1.25;">&#160;</div>
        <div style="text-align: center; line-height: 1.25; font-weight: bold;">LEGAL
          <!--Anchor-->MATTERS</div>
        <div style="line-height: 1.25;">&#160;</div>
        <div style="text-indent: 36pt; line-height: 1.25; text-align: justify;">The validity of our ordinary shares and certain other matters of Israeli law will be passed upon for us by Naschitz, Brandes, Amir &amp; Co., Tel-Aviv, Israel. The validity of
          the debt securities, warrants and units offered hereby will be passed upon for us by Latham &amp; Watkins LLP, Houston, Texas. Additional legal matters may be passed upon for us, any underwriters, dealers or agents by counsel that we will name in
          the applicable prospectus supplement.</div>
        <div style="line-height: 1.25;">&#160;</div>
        <div style="text-align: center; line-height: 1.25; font-weight: bold;"><a name="EXPERTS"><!--Anchor--></a>EXPERTS</div>
        <div style="line-height: 1.25; text-align: justify;">&#160;</div>
        <div style="text-indent: 36pt; line-height: 1.25; text-align: justify;">The consolidated financial statements as of December 31, 2024 and 2023 and for each of the two years in the period ended December 31, 2024 incorporated in this prospectus by
          reference to the Annual Report on Form 20-F for the year ended December 31, 2024 have been so incorporated in reliance on the report of Kesselman &amp; Kesselman, a member firm of PricewaterhouseCoopers International Limited, an independent
          registered public accounting firm, given on the authority of said firm as experts in auditing and accounting.</div>
        <div style="line-height: 1.25; text-align: justify;">&#160;</div>
        <div style="text-indent: 36pt; line-height: 1.25; text-align: justify;">The consolidated financial statements of Innoviz Technologies Ltd. for the year ended December 31, 2022 appearing in Innoviz Technologies Ltd.&#8217;s Annual Report (Form 20&#8209;F) for
          the year ended December 31, 2024 have been audited by Kost Forer Gabbay &amp; Kasierer, a member of Ernst &amp; Young Global, independent registered public accounting firm, as set forth in their report thereon, included therein, and incorporated
          herein by reference. Such consolidated financial statements are incorporated herein by reference in reliance upon such reports given on the authority of such firm as experts in accounting and auditing.</div>
        <div style="line-height: 1.25;">&#160;</div>
        <div style="text-align: center; line-height: 1.25; font-weight: bold;"><a name="ENFORCEABILITY"><!--Anchor--></a>ENFORCEABILITY OF CIVIL LIABILITIES AND AGENT FOR<br>
          SERVICE OF PROCESS IN THE UNITED STATES</div>
        <div style="line-height: 1.25;">&#160;</div>
        <div style="text-indent: 36pt; line-height: 1.25; text-align: justify;">We are incorporated under the laws of the State of Israel. Service of process upon us and upon our directors and officers and the Israeli experts named in this prospectus, most
          of whom reside outside the United States, may be difficult to obtain within the United States.&#160; Furthermore, because substantially all of our assets and substantially all of our directors and officers are located outside the United States, any
          judgment obtained in the United States against us or any of our directors and officers may not be collectible within the United States.</div>
        <div style="line-height: 1.25; text-align: justify;">&#160;</div>
        <div style="text-indent: 36pt; line-height: 1.25; text-align: justify;">We have been informed by our legal counsel in Israel, Naschitz, Brandes, Amir &amp; Co., Advocates, our legal counsel in Israel that it may be difficult to assert U.S.
          securities laws claims in original actions instituted in Israel. Israeli courts may refuse to hear a claim based on an alleged violation of U.S. securities laws because Israel is not the most appropriate forum in which to bring such a claim. In
          addition, even if an Israeli court agrees to hear a claim, it may determine that Israeli law and not U.S. law is applicable to the claim. If U.S. law is found to be applicable, the content of applicable U.S. law must be proven as a fact which can
          be a time-consuming and costly process. Matters of procedure will also be governed by Israeli law.</div>
        <div style="line-height: 1.25; text-align: justify;">&#160;</div>
        <div style="text-indent: 36pt; line-height: 1.25; text-align: justify;">We have irrevocably appointed Cogency Global Inc., as our agent to receive service of process in any action against us in any U.S. federal or state court arising out of this
          offering or any purchase or sale of securities in connection with this offering. Subject to specified time limitations and legal procedures, Israeli courts may enforce a U.S. judgment in a civil matter which, subject to certain exceptions, is
          non-appealable, including a judgment based upon the civil liability provisions of the Securities Act or the Exchange Act and including a monetary or compensatory judgment in a non-civil matter, provided that, among other things:</div>
        <div style="text-indent: 36pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif;"> <br>
        </div>
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="ze2f633c4f8454091bc2331ae43e3bb22">

            <tr>
              <td style="width: 36pt;"><br>
              </td>
              <td style="width: 18pt; vertical-align: top;">&#8226;</td>
              <td style="width: auto; vertical-align: top;">
                <div>the judgment was rendered by a court of competent jurisdiction, according to the laws of the state in which the judgment is given;</div>
              </td>
            </tr>

        </table>
        <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
          <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-weight: normal; font-style: normal;">28</font></div>
          <div class="BRPFPageBreak" style="page-break-after: always;">
            <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
        </div>
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z9c3d20cfb56a4572989afed76b1de585">

            <tr>
              <td style="width: 36pt;"><br>
              </td>
              <td style="width: 18pt; vertical-align: top;">&#8226;</td>
              <td style="width: auto; vertical-align: top;">
                <div>the judgment is enforceable according to the laws of Israel and according to the law of the foreign state in which the relief was granted; and</div>
              </td>
            </tr>

        </table>
        <div style="line-height: 1.25;">&#160;</div>
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z760597b0f2974fe59a2226cb9c45ebaa">

            <tr>
              <td style="width: 36pt;"><br>
              </td>
              <td style="width: 18pt; vertical-align: top;">&#8226;</td>
              <td style="width: auto; vertical-align: top;">
                <div>the judgment is not contrary to public policy of Israel.</div>
              </td>
            </tr>

        </table>
        <div style="line-height: 1.25;">&#160;</div>
        <div style="text-indent: 36pt; line-height: 1.25;">Even if such conditions are met, an Israeli court may not declare a foreign civil judgment enforceable if:</div>
        <div style="line-height: 1.25;">&#160;</div>
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zca0da35da8e04fd5988a366d769aae1d">

            <tr>
              <td style="width: 36pt;"><br>
              </td>
              <td style="width: 18pt; vertical-align: top;">&#8226;</td>
              <td style="width: auto; vertical-align: top;">
                <div>the prevailing law of the foreign state in which the judgment is rendered does not allow for the enforcement of judgments of Israeli courts (subject to exceptional cases);</div>
              </td>
            </tr>

        </table>
        <div style="line-height: 1.25;">&#160;</div>
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="ze512f1049b924567941b3324e792955d">

            <tr>
              <td style="width: 36pt;"><br>
              </td>
              <td style="width: 18pt; vertical-align: top;">&#8226;</td>
              <td style="width: auto; vertical-align: top;">
                <div>the defendant did not have a reasonable opportunity to be heard and to present his or her evidence, in the opinion of the Israeli court;</div>
              </td>
            </tr>

        </table>
        <div style="line-height: 1.25;">&#160;</div>
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z43ebee19c85e4dec83129ff9563a7fa7">

            <tr>
              <td style="width: 36pt;"><br>
              </td>
              <td style="width: 18pt; vertical-align: top;">&#8226;</td>
              <td style="width: auto; vertical-align: top;">
                <div>the enforcement of the civil liabilities set forth in the judgment is likely to impair the security or sovereignty of Israel;</div>
              </td>
            </tr>

        </table>
        <div style="line-height: 1.25;">&#160;</div>
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zc8a666ae900544e18c07cf4393c7a675">

            <tr>
              <td style="width: 36pt;"><br>
              </td>
              <td style="width: 18pt; vertical-align: top;">&#8226;</td>
              <td style="width: auto; vertical-align: top;">
                <div>the judgment was obtained by fraud;</div>
              </td>
            </tr>

        </table>
        <div style="line-height: 1.25;">&#160;</div>
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zbb938692b6014f0cad225ba2ea3ce300">

            <tr>
              <td style="width: 36pt;"><br>
              </td>
              <td style="width: 18pt; vertical-align: top;">&#8226;</td>
              <td style="width: auto; vertical-align: top;">
                <div>the judgment was rendered by a court not competent to render it according to the rules of private international law as they apply in Israel;</div>
              </td>
            </tr>

        </table>
        <div style="line-height: 1.25;">&#160;</div>
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z18ed72c48f824d048ff628722723e162">

            <tr>
              <td style="width: 36pt;"><br>
              </td>
              <td style="width: 18pt; vertical-align: top;">&#8226;</td>
              <td style="width: auto; vertical-align: top;">
                <div>the judgment conflicts with any other valid judgment in the same matter between the same parties; or</div>
              </td>
            </tr>

        </table>
        <div style="line-height: 1.25;">&#160;</div>
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z215205874f444512b4131f915c6568fc">

            <tr>
              <td style="width: 36pt;"><br>
              </td>
              <td style="width: 18pt; vertical-align: top;">&#8226;</td>
              <td style="width: auto; vertical-align: top;">
                <div>an action between the same parties in the same matter was pending in any Israeli court or tribunal at the time at which the lawsuit was instituted in the foreign court.</div>
              </td>
            </tr>

        </table>
        <div style="line-height: 1.25;">&#160;</div>
        <div style="text-indent: 36pt; line-height: 1.25; text-align: justify;">If a foreign judgment is enforced by an Israeli court, it generally will be payable in Israeli currency, which can then be converted into non-Israeli currency and transferred
          out of Israel. The usual practice in an action before an Israeli court to recover an amount in a non-Israeli currency is for the Israeli court to issue a judgment for the equivalent amount in Israeli currency at the rate of exchange in force on
          the date of the judgment, but the judgment debtor may make payment in foreign currency. Pending collection, the amount of the judgment of an Israeli court stated in Israeli currency ordinarily will be linked to the Israeli consumer price index
          plus interest at the annual statutory rate set by Israeli regulations prevailing at the time. Judgment creditors must bear the risk of unfavorable exchange rates.</div>
        <div style="line-height: 1.25;">&#160;</div>
        <div style="text-align: center; line-height: 1.25; font-weight: bold;"><a name="AUTHORIZED"><!--Anchor--></a>AUTHORIZED REPRESENTATIVE</div>
        <div style="line-height: 1.25;">&#160;</div>
        <div style="text-indent: 36pt; line-height: 1.25;">Our authorized representative in the United States for this offering as required pursuant to Section 6(a) of the Securities Act is Cogency Global Inc., 22 East 42nd Street, 18th Floor New York, NY
          10168.</div>
        <div style="line-height: 1.25;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<br style="line-height: 1.25;">
        </div>
        <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
          <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-weight: normal; font-style: normal;">29</font></div>
          <div style="page-break-after: always;" class="BRPFPageBreak">
            <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
        </div>
        <div style="text-align: center; line-height: 1.25; font-weight: bold;">INNOVIZ TECHNOLOGIES LTD.</div>
        <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-weight: bold;"> <br>
        </div>
        <div style="text-align: center; line-height: 1.25;">
          <div style="line-height: 1.25; font-weight: bold;"><img src="image00001.jpg"> </div>
        </div>
        <div style="line-height: 1.25;">&#160;</div>
        <div style="text-align: center; line-height: 1.25;"><font style="font-weight: bold;">PROSPECTUS DATED</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-weight: bold;">, 2025</font></div>
        <div><br>
        </div>
        <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
          <div class="BRPFPageBreak" style="page-break-after: always;">
            <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
        </div>
        <div>
          <div><br>
          </div>
          <div style="text-align: justify; margin-right: 0.85pt; line-height: 1.25; font-weight: bold; color: rgb(255, 0, 0);">The information in this preliminary prospectus is not complete and may be changed. These securities may not be sold until the
            registration statement filed with the Securities and Exchange Commission is effective. This preliminary prospectus is not an offer to sell nor does it seek an offer to buy these securities in any jurisdiction where the offer or sale is not
            permitted.</div>
          <div style="line-height: 1.25;">&#160;</div>
          <div style="text-align: justify; line-height: 1.25; color: rgb(255, 0, 0);">SUBJECT TO COMPLETION, DATED AUGUST 13, 2025.</div>
          <div style="line-height: 1.25;">&#160;</div>
          <div style="line-height: 1.25; font-weight: bold;">PROSPECTUS SUPPLEMENT</div>
          <div style="line-height: 1.25; font-weight: bold;"> <br>
          </div>
          <div style="line-height: 1.25; font-weight: bold; text-align: center;"><img src="image00001.jpg"> </div>
          <div style="text-align: center; line-height: 1.25; font-weight: bold;">Up to $75,000,000</div>
          <div style="line-height: 1.25;">&#160;</div>
          <div style="text-align: center; line-height: 1.25; font-weight: bold;">Innoviz Technologies Ltd.</div>
          <div style="line-height: 1.25;">&#160;</div>
          <div style="text-align: center; line-height: 1.25; font-weight: bold;">Ordinary Shares</div>
          <div style="line-height: 1.25;">&#160;</div>
          <div style="text-indent: 36pt; line-height: 1.25; text-align: justify;">We have entered into an Open Market Sale Agreement<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">SM</sup> (the &#8220;sales agreement&#8221;) with Jefferies
            LLC (&#8220;Jefferies&#8221;), dated August 13, 2025, relating to the sale of our ordinary shares, no par value per share, from time to time offered by this prospectus supplement and the base prospectus. In accordance with the terms of the sales agreement,
            we may offer and sell our ordinary shares, no par value per share, having an aggregate offering price of up to $75,000,000 from time to time through Jefferies acting as our sales agent.</div>
          <div style="line-height: 1.25; text-align: justify;">&#160;</div>
          <div style="text-indent: 36pt; line-height: 1.25; text-align: justify;">Our ordinary shares are listed on The Nasdaq Stock Market LLC (&#8220;Nasdaq&#8221;) under the symbol &#8220;INVZ.&#8221; On August 11, 2025, the last reported sale price of our ordinary shares on
            Nasdaq was $1.70 per ordinary share. We are both an &#8220;emerging growth company&#8221; and a &#8220;foreign private issuer&#8221; under applicable U.S. Securities and Exchange Commission rules and are eligible for reduced public company disclosure requirements.</div>
          <div style="line-height: 1.25; text-align: justify;">&#160;</div>
          <div style="text-indent: 36pt; line-height: 1.25; text-align: justify;">Sales of our ordinary shares, if any, under this prospectus supplement and the base prospectus will be made in sales deemed to be &#8220;at the market offerings&#8221; as defined in Rule
            415(a)(4) promulgated under the Securities Act of 1933, as amended, or the Securities Act. Jefferies is not required to sell any specific amount of ordinary shares, but will act as our sales agent using commercially reasonable efforts
            consistent with its normal trading and sales practices, on mutually agreed terms between Jefferies and us. There is no arrangement for funds to be received in any escrow, trust or similar arrangement.</div>
          <div style="line-height: 1.25; text-align: justify;">&#160;</div>
          <div style="text-indent: 36pt; line-height: 1.25; text-align: justify;">The compensation to Jefferies for sales of ordinary shares pursuant to the sales agreement will be an amount equal to 3% of the gross proceeds of any ordinary shares sold
            under the sales agreement. In connection with the sale of the ordinary shares on our behalf, Jefferies will be deemed to be an &#8220;underwriter&#8221; within the meaning of the Securities Act and the compensation of Jefferies will be deemed to be
            underwriting commissions or discounts. We have also agreed to provide indemnification and contribution to Jefferies with respect to certain liabilities, including liabilities under the Securities Act or the Securities Exchange Act of 1934, as
            amended.</div>
          <div style="line-height: 1.25; text-align: justify;">&#160;</div>
          <div style="text-indent: 36pt; line-height: 1.25; font-style: italic; text-align: justify;">See "Risk Factors" beginning on page S-9 of this prospectus supplement, in the base prospectus and under similar headings in the documents incorporated by
            reference into this prospectus supplement, including our periodic reports and other information filed with the SEC, to read about factors you should consider before buying our ordinary shares.</div>
          <div style="text-indent: 36pt; line-height: 1.25; font-style: italic;"> <br>
          </div>
          <div style="text-indent: 36pt; line-height: 1.25; font-style: italic;">
            <hr align="center" style="height: 1px; width: 20%; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;"> </div>
          <!--PROfilePageNumberReset%LCR%2%%%-->
          <div style="text-align: center; margin-right: 194.4pt; margin-left: 194.4pt; line-height: 1.25; font-weight: bold;"> &#160;&#160;&#160;&#160; <br>
          </div>
          <div style="text-indent: 36pt; line-height: 1.25; font-weight: bold;">Neither the Securities and Exchange Commission, the Israel Securities Authority nor any state securities commission or other regulatory body has approved or disapproved of
            these securities or passed upon the accuracy or adequacy of this prospectus supplement or the base prospectus.&#160; Any representation to the contrary is a criminal offense.</div>
          <div style="line-height: 1.25;">&#160;</div>
          <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" id="z7f71915edb6b499f9bfc29062ac7b081">

              <tr>
                <td style="width: 100%; vertical-align: top; font-size: 12pt;">
                  <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman',Times,serif; font-weight: bold;">Jefferies</div>
                </td>
              </tr>

          </table>
          <div style="line-height: 1.25;"><br style="line-height: 1.25;">
          </div>
          <div style="text-align: center; line-height: 1.25; font-weight: bold;">Prospectus supplement dated&#160; &#160; &#160; &#160; &#160;&#160; , 2025</div>
          <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
            <div class="BRPFPageBreak" style="page-break-after: always;">
              <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
          </div>
          <div class="BRPFPageFooter">&#160;</div>
          <div style="text-align: center; line-height: 1.25; font-weight: bold;">TABLE OF CONTENTS</div>
          <div style="line-height: 1.25;">&#160;</div>
          <div style="line-height: 1.25; font-weight: bold;">
            <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman',Times,serif; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);" id="z93163a8d070e479885a4273bccb87e07">

                <tr>
                  <td rowspan="1" style="width: 91.7%; vertical-align: top;">
                    <div style="line-height: 1.25; font-weight: bold;">PROSPECTUS SUPPLEMENT</div>
                  </td>
                  <td rowspan="1" style="width: 8.3%; vertical-align: top;">&#160;</td>
                </tr>
                <tr>
                  <td rowspan="1" style="width: 91.7%; vertical-align: top;">&#160;</td>
                  <td rowspan="1" style="width: 8.3%; vertical-align: top;">
                    <div style="text-align: right; line-height: 1.25; font-weight: bold;">Page</div>
                  </td>
                </tr>
                <tr>
                  <td style="width: 91.7%; vertical-align: top;">
                    <div style="line-height: 1.25;"><a href="#SUMMARY_PS">PROSPECTUS SUPPLEMENT SUMMARY</a></div>
                  </td>
                  <td style="width: 8.3%; vertical-align: top;">
                    <div style="text-align: right; line-height: 1.25;">S-4</div>
                  </td>
                </tr>
                <tr>
                  <td style="width: 91.7%; vertical-align: top;">
                    <div style="line-height: 1.25;"><a href="#OFFERING_PS">THE OFFERING</a></div>
                  </td>
                  <td style="width: 8.3%; vertical-align: top;">
                    <div style="text-align: right; line-height: 1.25;">S-7</div>
                  </td>
                </tr>
                <tr>
                  <td style="width: 91.7%; vertical-align: top;">
                    <div style="line-height: 1.25;"><a href="#RISK_PS">RISK FACTORS</a></div>
                  </td>
                  <td style="width: 8.3%; vertical-align: top;">
                    <div style="text-align: right; line-height: 1.25;">S-9</div>
                  </td>
                </tr>
                <tr>
                  <td style="width: 91.7%; vertical-align: top;">
                    <div style="line-height: 1.25;"><a href="#CAUTIONARY_PS">CAUTIONARY STATEMENT REGARDING FORWARD LOOKING STATEMENTS</a></div>
                  </td>
                  <td style="width: 8.3%; vertical-align: top;">
                    <div style="text-align: right; line-height: 1.25;">S-14</div>
                  </td>
                </tr>
                <tr>
                  <td style="width: 91.7%; vertical-align: top;">
                    <div style="line-height: 1.25;"><a href="#USE_PS">USE OF PROCEEDS</a></div>
                  </td>
                  <td style="width: 8.3%; vertical-align: top;">
                    <div style="text-align: right; line-height: 1.25;">S-16</div>
                  </td>
                </tr>
                <tr>
                  <td style="width: 91.7%; vertical-align: top;">
                    <div style="line-height: 1.25;"><a href="#DILUTION_PS">DILUTION</a></div>
                  </td>
                  <td style="width: 8.3%; vertical-align: top;">
                    <div style="text-align: right; line-height: 1.25;">S-18</div>
                  </td>
                </tr>
                <tr>
                  <td style="width: 91.7%; vertical-align: top;">
                    <div style="line-height: 1.25;"><a href="#TAXATION_PS">TAXATION</a></div>
                  </td>
                  <td style="width: 8.3%; vertical-align: top;">
                    <div style="text-align: right; line-height: 1.25;">S-19</div>
                  </td>
                </tr>
                <tr>
                  <td style="width: 91.7%; vertical-align: top;">
                    <div style="line-height: 1.25;"><a href="#DISTRIBUTION_PS">PLAN OF DISTRIBUTION</a></div>
                  </td>
                  <td style="width: 8.3%; vertical-align: top;">
                    <div style="text-align: right; line-height: 1.25;">S-30</div>
                  </td>
                </tr>
                <tr>
                  <td style="width: 91.7%; vertical-align: top;">
                    <div style="line-height: 1.25;"><a href="#MATTERS_PS">LEGAL MATTERS</a></div>
                  </td>
                  <td style="width: 8.3%; vertical-align: top;">
                    <div style="text-align: right; line-height: 1.25;">S-31</div>
                  </td>
                </tr>
                <tr>
                  <td style="width: 91.7%; vertical-align: top;">
                    <div style="line-height: 1.25;"><a href="#EXPERTS_PS">EXPERTS</a></div>
                  </td>
                  <td style="width: 8.3%; vertical-align: top;">
                    <div style="text-align: right; line-height: 1.25;">S-31</div>
                  </td>
                </tr>
                <tr>
                  <td style="width: 91.7%; vertical-align: top;">
                    <div style="line-height: 1.25;"><a href="#LIABILITIES_PS">ENFORCEABILITY OF CIVIL LIABILITIES</a></div>
                  </td>
                  <td style="width: 8.3%; vertical-align: top;">
                    <div style="text-align: right; line-height: 1.25;">S-32</div>
                  </td>
                </tr>
                <tr>
                  <td style="width: 91.7%; vertical-align: top;">
                    <div style="line-height: 1.25;"><a href="#INFORMATION_PS">WHERE YOU CAN FIND MORE INFORMATION</a></div>
                  </td>
                  <td style="width: 8.3%; vertical-align: top;">
                    <div style="text-align: right; line-height: 1.25;">S-33</div>
                  </td>
                </tr>
                <tr>
                  <td style="width: 91.7%; vertical-align: top;">
                    <div style="line-height: 1.25;"><a href="#REFERENCE_PS">INCORPORATION BY REFERENCE</a></div>
                  </td>
                  <td style="width: 8.3%; vertical-align: top;">
                    <div style="text-align: right; line-height: 1.25;">S-34</div>
                  </td>
                </tr>

            </table>
          </div>
          <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
            <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-weight: normal; font-style: normal;">S - 1</font></div>
            <div class="BRPFPageBreak" style="page-break-after: always;">
              <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
          </div>
          <br>
          <div style="text-align: center; line-height: 1.25; font-weight: bold;"><!--Anchor-->ABOUT THIS PROSPECTUS SUPPLEMENT</div>
          <div style="line-height: 1.25;">&#160;</div>
          <div style="text-indent: 36pt; line-height: 1.25; text-align: justify;">This document is in two parts. The first part is this prospectus supplement, which describes the specific terms of this offering of ordinary shares and also adds to and
            updates information contained in the base prospectus and the documents incorporated by reference into this prospectus supplement and the base prospectus. The second part is the base prospectus, along with the documents incorporated by reference
            therein, which provides more general information, some of which may not apply to this offering. Generally, when we refer to this prospectus, we are referring to both parts of this document combined. To the extent there is a conflict between the
            information contained in this prospectus supplement, on the one hand, and the information contained in the base prospectus or in any document incorporated by reference that was filed with the Securities and Exchange Commission (the &#8220;SEC&#8221;),
            before the date of this prospectus supplement, on the other hand, you should rely on the information contained in this prospectus supplement. If any statement in one of these documents is inconsistent with a statement in another document having
            a later date - for example, a document incorporated by reference in the base prospectus - the statement in the document having the later date modifies or supersedes the earlier statement.</div>
          <div style="line-height: 1.25; text-align: justify;">&#160;</div>
          <div style="text-indent: 36pt; line-height: 1.25; text-align: justify;">This prospectus supplement and the base prospectus are part of a &#8220;shelf&#8221; registration statement that we filed with the SEC. Under this shelf registration process, we may
            offer from time to time various securities, of which this offering of ordinary shares is a part. Such registration statement also includes exhibits that provide more detail on the matters discussed in this prospectus supplement and the base
            prospectus. You should read this prospectus supplement and the base prospectus, as well as the documents incorporated by reference herein and therein, the additional information described under the section titled &#8220;<font style="font-style: italic;">Where You Can Find More Information</font>&#8221; and &#8220;<font style="font-style: italic;">Incorporation by Reference</font>&#8221; in this prospectus supplement, and any free writing prospectus that we have authorized for use in connection with
            this offering, before investing in our ordinary shares.</div>
          <div style="line-height: 1.25; text-align: justify;">&#160;</div>
          <div style="text-indent: 36pt; line-height: 1.25; text-align: justify;">We have not, and Jefferies has not, authorized anyone to provide you with information, or to make any representation, different from that contained or incorporated by
            reference in this prospectus supplement and the base prospectus, along with the information contained in any free writing prospectus that we have authorized for use in connection with this offering. We and Jefferies take no responsibility for,
            and can provide no assurance as to the reliability of, any other information that others may give you. You should assume that the information appearing in this prospectus supplement, the base prospectus, the documents incorporated by reference
            in this prospectus supplement and the base prospectus,&#160;and in any free writing prospectus that we have authorized for use in connection with this offering is accurate only as of the respective dates of those documents, unless we indicate
            otherwise. Our business, financial condition, results of operations and prospects may have changed since those dates.</div>
          <div style="line-height: 1.25; text-align: justify;">&#160;</div>
          <div style="text-indent: 36pt; line-height: 1.25; text-align: justify;">The information contained in this prospectus supplement, the base prospectus, the documents incorporated by reference herein or therein and any free writing prospectus we may
            authorize for use in connection with this offering, is accurate only as of their respective dates, regardless of the time of delivery of any such document or the time of any sale of our ordinary shares. Our business, financial condition,
            results of operations and prospects may have changed since those dates. It is important for you to read and consider all information contained in this prospectus supplement, the base prospectus, the documents incorporated by reference herein
            and therein and any free writing prospectus that we have authorized for use in connection with this offering, in making your investment decision. </div>
          <div style="line-height: 1.25; text-align: justify;">&#160;</div>
          <div style="text-indent: 36pt; line-height: 1.25; text-align: justify;">We further note that the representations, warranties and covenants made by us in any agreement that is filed as an exhibit to any document that is incorporated by reference
            in this prospectus supplement or the base prospectus were made solely for the benefit of the parties to such agreement, including, in some cases, for the purpose of allocating risk among the parties to such agreements, and should not be deemed
            to be a representation, warranty or covenant to you. Moreover, such representations, warranties and covenants were accurate only as of the date when made; therefore, such representations, warranties and covenants should not be relied on as
            accurate representations of the current state of our affairs.</div>
          <div style="line-height: 1.25; text-align: justify;">&#160;</div>
          <div style="text-indent: 36pt; line-height: 1.25; text-align: justify;">We are not, and Jefferies is not, making an offer to sell our ordinary shares in any jurisdiction where the offer or sale is not permitted. Neither this prospectus supplement
            nor the base prospectus constitute, and may not be used in connection with, an offer to sell, or a solicitation of an offer to buy, any securities offered by this prospectus supplement by any person in any jurisdiction in which it is unlawful
            for such person to make such an offer or solicitation. You must comply with all applicable laws and regulations in force in any applicable jurisdiction and you must obtain any consent, approval or permission required by you for the purchase,
            offer or sale of the ordinary shares under the laws and regulations in force in the jurisdiction to which you are subject or in which you make your purchase, offer or sale, and neither we nor Jefferies will have any responsibility therefor.</div>
          <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
            <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-weight: normal; font-style: normal;">S - 2</font></div>
            <div class="BRPFPageBreak" style="page-break-after: always;">
              <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
          </div>
          <div style="line-height: 1.25;">&#160;</div>
          <div style="text-indent: 36pt; line-height: 1.25; text-align: justify;">This prospectus supplement contains references to trademarks, trade names and service marks belonging to other entities. Solely for convenience, trademarks, trade names and
            service marks referred to in this prospectus supplement may appear without the &#174; or TM symbols, but such references are not intended to indicate, in any way, that the applicable licensor will not assert, to the fullest extent under applicable
            law, its rights to these trademarks and trade names. We do not intend our use or display of other companies&#8217; trade names, trademarks or service marks to imply a relationship with, or endorsement or sponsorship of us by, any other companies.</div>
          <div style="line-height: 1.25; text-align: justify;">&#160;</div>
          <div style="text-indent: 36pt; line-height: 1.25; text-align: justify;">Unless otherwise indicated, information contained in this prospectus supplement, the base prospectus or the documents incorporated by reference into this prospectus
            supplement concerning Innoviz&#8217;s industry and the regions in which it operates, including Innoviz&#8217;s general expectations and market position, market opportunity, market share and other management estimates, is based on information obtained from
            various independent publicly available sources and other industry publications, surveys and forecasts. Innoviz has not independently verified the accuracy or completeness of any third-party information. Similarly, internal surveys, industry
            forecasts and market research, which Innoviz believes to be reliable based upon its management&#8217;s knowledge of the industry, have not been independently verified.</div>
          <div style="line-height: 1.25; text-align: justify;">&#160;</div>
          <div style="text-indent: 36pt; line-height: 1.25; text-align: justify;">We are both an &#8220;emerging growth company&#8221; and a &#8220;foreign private issuer&#8221; under applicable U.S. Securities and Exchange Commission rules and are eligible for reduced public
            company disclosure requirements for this prospectus supplement and future filings.</div>
          <div style="line-height: 1.25; text-align: justify;">&#160;</div>
          <div style="text-indent: 36pt; line-height: 1.25; text-align: justify;">Except where the context otherwise requires or where otherwise indicated in this prospectus supplement, the terms &#8220;Innoviz,&#8221; the &#8220;Company,&#8221; &#8220;we,&#8221; &#8220;us,&#8221; &#8220;our,&#8221; &#8220;our company&#8221;
            and &#8220;our business&#8221; refer to Innoviz Technologies Ltd., together with its consolidated subsidiaries as a consolidated entity. The term &#8220;ordinary shares&#8221; refers to our ordinary shares, no par value per share.</div>
          <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
            <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-weight: normal; font-style: normal;">S - 3</font></div>
            <div class="BRPFPageBreak" style="page-break-after: always;">
              <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
          </div>
          <div style="line-height: 1.25;">&#160;</div>
          <div style="line-height: 1.25">
            <div style="border: #000000 2px solid; padding: 5px; width: 99%;">
              <div>&#160;</div>
              <div>
                <div style="text-align: center; line-height: 1.25; font-weight: bold;">PROSPECTUS SUPPLEMENT <a name="SUMMARY_PS"><!--Anchor--></a>SUMMARY</div>
                <div style="line-height: 1.25;">&#160;</div>
                <div style="text-indent: 36pt; line-height: 1.25; font-style: italic; text-align: justify;">This summary highlights information contained elsewhere in this prospectus supplement or the base prospectus or incorporated by reference herein or
                  therein. This summary does not contain all the information that you should consider before deciding to invest in our ordinary shares. You should carefully read this entire prospectus supplement, the base prospectus and any related free
                  writing prospectus, including each of the documents incorporated herein and therein by reference, before making an investment decision. You should carefully consider the information set forth under &#8220;Risk Factors&#8221; in this prospectus
                  supplement, in the base prospectus and in any related free writing prospectus, and under similar headings in the documents that are incorporated by reference into this prospectus supplement or the base prospectus, including our Annual
                  Report on Form 20&#8209;F for the year ended December 31, 2024 filed with the SEC on March 12, 2025 (our &#8220;Annual Report&#8221;) and in our updates, if any, to those risk factors in our reports on Form 6-K incorporated by reference into this
                  prospectus supplement. You should also carefully read the information incorporated by reference into the base prospectus, including our financial statements (and accompanying notes), and the other information in the exhibits to the
                  registration statement of which the base prospectus is a part.</div>
                <div style="line-height: 1.25; text-align: justify;">&#160;</div>
                <div style="line-height: 1.25; font-weight: bold; text-align: justify;">Company Overview</div>
                <div style="line-height: 1.25; text-align: justify;">&#160;</div>
                <div style="text-indent: 36pt; line-height: 1.25; text-align: justify;">We are a leading Tier-1 direct supplier of high-performance, automotive grade LiDAR sensor platforms and complementary software stacks that feature technological
                  breakthroughs across core components and bring enhanced vision and superior performance to enable safe autonomous driving at a mass scale. We believe that we provide a comprehensive solution for OEMs and Tier&#8209;1 partners that are
                  developing and marketing autonomous driving vehicles to the passenger car and other relevant markets, such as robotaxis, shuttles, delivery vehicles and trucks. </div>
                <div style="line-height: 1.25; text-align: justify;">&#160;</div>
                <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">We were founded in 2016. From our founding, our culture drew from our core values of solving sophisticated technological problems through creativity and agile thinking.
                  We have relied on these values to address the needs of autonomous vehicles in a manner that strikes the desired balance between performance and cost. We created a new type of LiDAR sensor from the chip-level up, including a suite of
                  powerful and sophisticated software applications for high-performance computer vision to allow superior perception. In 2018, we achieved a design win to power BMW&#8217;s Level 3 autonomous platform, a program which reached maturity during 2024
                  and with vehicles already being sold with our LiDARs and complementary software stack. </div>
                <div style="line-height: 1.25; text-align: justify;">&#160;</div>
                <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">Since 2021, we have funded the development of two production path programs: the InnovizOne and InnovizTwo LiDAR sensor platforms and complementary software stacks. With
                  the InnovizOne program transitioned from the development phase into full series production in 2024, we eliminated duplicative cost structures and reduced spending on InnovizOne development, while reinvesting a portion of the savings into
                  the InnovizTwo sensor platform and complementary software stack. All quoting and bidding activity in our request for information and request for quotation pipeline is now focused on the InnovizTwo platform.</div>
                <div style="line-height: 1.25; text-align: justify;">&#160;</div>
                <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">During 2022, we made the strategic decision to become a Tier-1 supplier of LiDAR and complementary software stack to the automotive industry. This decision allows us to
                  have direct technical discussions with end customers and to improve pricing to automotive OEMs with the goal of continuing to strengthen our position in the automotive market. This strategic decision has played a significant role in our
                  subsequent major OEM program wins, as discussed below.</div>
                <div style="line-height: 1.25; text-align: justify;">&#160;</div>
                <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">In 2022, following more than two years of extensive diligence and qualification, we were selected by Volkswagen as its direct LiDAR supplier for automated vehicles
                  within the Volkswagen brands with our InnovizTwo next generation high-performance automotive-grade LiDAR sensor platform, and in 2023, we announced that Volkswagen aims to expand its use of our InnovizTwo LiDAR to its existing light
                  commercial vehicle program, the I.D Buzz. </div>
                <div style="line-height: 1.25; text-align: justify;">&#160;</div>
                <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">In 2024, we announced that Mobileye Vision Technologies Ltd. (&#8220;Mobileye&#8221;) will use the InnovizTwo Long-Range and the new InnovizTwo Short- to Mid-Range LiDARs for the
                  Mobileye Drive&#8482; platform. The new InnovizTwo Short- to Mid-Range leverages InnovizTwo Long-Range&#8217;s maturity and is designed to meet the requirements for light commercial vehicles, shuttles, robotaxis, and can be customized to suit a wide
                  array of vehicular design and functionality requirements. We believe that the combination of our LiDARs and Mobileye&#8217;s platform is critical to enabling comprehensive sensing capabilities for navigating complex urban environments and
                  enhancing the overall safety and reliability of autonomous driving systems, and that this partnership showcases the flexibility of our LiDARs to work across a variety of vehicle platforms to further testing and deployment of autonomous
                  vehicles. Our partners are leaders in deploying new technologies into the automotive industry. We believe that our close cooperation with these partners and OEMs positions us well to make Level 3 and Level 4 autonomous driving a
                  commercial reality.</div>
              </div>
              <div>&#160;</div>
            </div>
          </div>
          <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
            <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-weight: normal; font-style: normal;">S - 4</font></div>
            <div class="BRPFPageBreak" style="page-break-after: always;">
              <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
          </div>
          <br>
          <div style="border: #000000 2px solid; padding: 5px; width: 99%;">
            <div>&#160;
              <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">The sustained cooperation with our customers provides our engineers and other research and development personnel with a valuable competitive edge. These engineers and
                other research and development personnel have been meticulously trained to design, operate and verify our many ground-breaking innovations in accordance and in compliance with the rigorous ISO26262 standard for Functional Safety in the
                automotive industry, and the IATF 16949:2016 certification for Quality Management in the automotive industry. Compliance with these and other standards has been enforced by regular ongoing audits of Innoviz and rigorous testing by our key
                suppliers, existing customers and prospective customers that thoroughly review the performance of various elements of our operations. As a result, our products have been constructed from the bottom up with hardware and software technology
                that meets the most stringent automotive safety, quality, environmental, manufacturing, and other standards.</div>
              <div style="line-height: 1.25; text-align: justify;">&#160;</div>
              <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">Our innovation has produced LiDAR solutions that deliver market leading performance and that meet the demanding safety requirements for Level 2+ through Level 5
                autonomous vehicles at price points suitable for mass produced passenger vehicles. </div>
              <div style="line-height: 1.25; text-align: justify;">&#160;</div>
              <div style="text-indent: 36pt; line-height: 1.25; text-align: justify;">Our robust software suite enables our ~905nm wavelength laser-based LiDAR architecture to be easily leveraged to provide compelling solutions for Level 2+ through Level 4
                (and Level 5 when applicable), using both our long- and short- to medium-range LiDARs. Our integrated custom design of advanced hardware and software components, which leverages the multidisciplinary expertise and experience of our team,
                enables us to provide autonomous solutions that we believe will accelerate widespread adoption across automakers at serial production scale. This means that we are positioned to penetrate the current market, which is focused primarily on
                Level 2+, Level 3 and Level 4 production, and to continue to capture and extend our market share to Level 5, as the market continues to mature.</div>
              <div style="line-height: 1.25; text-align: justify;">&#160;</div>
              <div style="text-indent: 36pt; line-height: 1.25; text-align: justify;">On February 4, 2025, we announced an optimization of our operations to extend our cash runway and accelerate progress towards profitability and free cash flow generation,
                resulting in a reduction in our employee headcount of approximately 9% during the first quarter of 2025.</div>
              <div style="line-height: 1.25; text-align: justify;">&#160;</div>
              <div style="text-indent: 36pt; line-height: 1.25; text-align: justify;">We are currently expanding our third-party manufacturing capacity through contract manufacturers to meet an anticipated&#8209; increase in customer demand for our products. As
                part of this effort, we recently selected Fabrinet (NYSE: FN), a leading provider of advanced optical packaging and precision optical, electro-mechanical, and electronic manufacturing services, as our manufacturing partner for the
                InnovizTwo LiDAR platform. In July 2025, we announced the shipment of the first InnovizTwo LiDAR units from Fabrinet&#8217;s high-volume production line. This collaboration is expected to enable Innoviz to ramp its InnovizTwo LiDARs to volume
                with a manufacturing partner that has automotive-grade facilities around the world, allowing for flexible and cost-effective productions.</div>
              <div style="line-height: 1.25; text-align: justify;">&#160;</div>
              <div style="text-indent: 36pt; line-height: 1.25; text-align: justify;">In response to the growing interest and demand for LiDAR technologies across a range of non-automotive sectors, in June 2025 we announced the launch of InnovizSMART
                Long-Range, a new high-performance LiDAR sensor designed specifically for &#8220;smart&#8221; applications, including security, mobility, aerial, robotics, and intelligent traffic management. With the maturation of our InnovizTwo LiDAR platform and
                expanding production capabilities through third-party capacity, we are expanding our focus to additional markets such as ITS, smart cities and other sectors that are seeking affordable, high-performing LiDAR solutions. Innoviz&#8217;s advanced
                offerings are well-positioned to address the evolving requirements of these industries, supporting a wide variety of new applications.</div>
            </div>
            <div>&#160;</div>
          </div>
          <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
            <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-weight: normal; font-style: normal;">S - 5</font></div>
            <div class="BRPFPageBreak" style="page-break-after: always;">
              <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
          </div>
          <div><br>
            <div>
              <div style="border: #000000 2px solid; padding: 5px; width: 99%;">
                <div>&#160;<br>
                  <div style="line-height: 1.25; font-weight: bold;">Recent Developments</div>
                  <div style="line-height: 1.25;">&#160;</div>
                  <div style="line-height: 1.25; font-style: italic; font-weight: bold;">Regained Compliance with Nasdaq&#8217;s Minimum Bid Price Requirement</div>
                  <div style="line-height: 1.25; text-align: justify;">&#160;</div>
                  <div style="text-indent: 36pt; line-height: 1.25; text-align: justify;">On July 3, 2025, we announced that we received formal written confirmation from Nasdaq confirming that the Company has regained compliance with Nasdaq&#8217;s minimum bid
                    price requirement. The closing bid price of the ordinary shares was at $1.00 per share or greater for 10 consecutive business days from June 17 to July 1, 2025. Accordingly, Nasdaq Listing Qualifications Staff notified the Company that
                    it determined that the Company regained compliance with Nasdaq Listing Rule 5550(a)(2), and that the matter was closed.</div>
                  <div style="line-height: 1.25; text-align: justify;">&#160;</div>
                  <div style="line-height: 1.25; font-style: italic; font-weight: bold; text-align: justify;">Events in Israel</div>
                  <div style="line-height: 1.25; text-align: justify;">&#160;</div>
                  <div style="text-indent: 36pt; line-height: 1.25; text-align: justify;">On June 13, 2025, Israel launched a preemptive attack on Iran, to which Iran responded with ballistic missile and drone attacks in Israel. On June 24, 2025, Israel
                    and Iran agreed to a ceasefire, although there is no assurance that this agreement will be upheld, military activity and hostilities continue to exist at varying levels of intensity, and the situation remains volatile, with the
                    potential for escalation into a broader regional conflict. At this time, we do not expect the current conflict (or other ongoing conflicts) to have a material impact on our financial and operational results; however, since these are
                    events beyond our control, their continuation or cessation may affect our expectations. We continue to monitor political and military developments closely and examine the consequences for our operations, assets and financial and
                    operational results.</div>
                  <div style="line-height: 1.25; text-align: justify;">&#160;</div>
                  <div style="line-height: 1.25; font-weight: bold; text-align: justify;">Corporate Information</div>
                  <div style="line-height: 1.25; text-align: justify;">&#160;</div>
                  <div style="text-indent: 36pt; line-height: 1.25; text-align: justify;">We were incorporated in Israel on January 18, 2016 under the Israeli Companies Law, 5759&#8209;1999 (the &#8220;Companies Law&#8221;), and our principal executive office is located at
                    5 Uri Ariav St., Building C, Nitzba 300, Rosh HaAin 4809202, Israel. Our legal and commercial name is Innoviz Technologies Ltd. We are registered with the Israeli Registrar of Companies. Our registration number is 51-538242-2. Our
                    website address is https://innoviz.tech, and our telephone number is +972&#8209;74&#8209;700&#8209;3692. Information contained on, or that can be accessed through, our website does not constitute a part of this prospectus supplement and is not
                    incorporated by reference herein. We have included our website address in this prospectus supplement solely for informational purposes. The SEC maintains an Internet site that contains reports, proxy and information statements, and
                    other information regarding issuers, such as us, that file electronically, with the SEC at www.sec.gov. Our agent for service of process in the United States is Cogency Global Inc., 122 East 42nd Street, 18th Floor, New York, NY 10168.</div>
                </div>
                <div>&#160;</div>
              </div>
            </div>
          </div>
          <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
            <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-weight: normal; font-style: normal;">S - 6</font></div>
            <div class="BRPFPageBreak" style="page-break-after: always;">
              <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
          </div>
          <div><br>
          </div>
          <div>
            <div style="border: #000000 2px solid; padding: 5px; width: 99%;">
              <div>&#160;<br>
                <div style="text-align: center; line-height: 1.25; font-weight: bold;">THE <a name="OFFERING_PS"><!--Anchor--></a>OFFERING</div>
                <div style="line-height: 1.25;">&#160;</div>
                <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" id="z2d58151c74bd4d9a88ac0102bd0509d3">

                    <tr>
                      <td style="width: 47.98%; vertical-align: top;">
                        <div style="text-align: justify; line-height: 1.25;">Ordinary shares offered by us</div>
                      </td>
                      <td style="width: 52.02%; vertical-align: top;">
                        <div style="line-height: 1.25;">Ordinary shares, no par value, having an aggregate offering price of up to $75,000,000.</div>
                      </td>
                    </tr>
                    <tr>
                      <td rowspan="1" style="width: 47.98%; vertical-align: top;">&#160;</td>
                      <td rowspan="1" style="width: 52.02%; vertical-align: top;">&#160;</td>
                    </tr>
                    <tr>
                      <td style="width: 47.98%; vertical-align: top;">
                        <div style="text-align: justify; text-indent: -162pt; margin-left: 162pt; line-height: 1.25;">Ordinary shares to be outstanding after </div>
                        <div style="text-align: justify; line-height: 1.25;">this offering</div>
                      </td>
                      <td style="width: 52.02%; vertical-align: top;">
                        <div style="line-height: 1.25;">Up to 244,892,487 ordinary shares, assuming sales at a price of $1.70 per share, which was the closing price of our ordinary shares on Nasdaq on August 11, 2025. The actual number of ordinary shares
                          issued will vary depending on the sales price under this offering.</div>
                      </td>
                    </tr>
                    <tr>
                      <td rowspan="1" style="width: 47.98%; vertical-align: top;">&#160;</td>
                      <td rowspan="1" style="width: 52.02%; vertical-align: top;">&#160;</td>
                    </tr>
                    <tr>
                      <td style="width: 47.98%; vertical-align: top;">
                        <div style="text-align: justify; line-height: 1.25;">Manner of offering</div>
                      </td>
                      <td style="width: 52.02%; vertical-align: top;">
                        <div style="line-height: 1.25;">&#8220;At the market&#8221; offering that may be made from time to time through Jefferies as our sales agent. See &#8220;<font style="font-style: italic;">Plan of Distribution</font>&#8221; on&#160;page&#160;S-30.</div>
                      </td>
                    </tr>
                    <tr>
                      <td rowspan="1" style="width: 47.98%; vertical-align: top;">&#160;</td>
                      <td rowspan="1" style="width: 52.02%; vertical-align: top;">&#160;</td>
                    </tr>
                    <tr>
                      <td style="width: 47.98%; vertical-align: top;">
                        <div style="text-align: justify; line-height: 1.25;">Use of proceeds</div>
                      </td>
                      <td style="width: 52.02%; vertical-align: top;">
                        <div style="line-height: 1.25;">We intend to use the net proceeds from this offering for general business purposes. See &#8220;<font style="font-style: italic;">Use of Proceeds</font>&#8221; on&#160;page&#160;S-16.</div>
                      </td>
                    </tr>
                    <tr>
                      <td rowspan="1" style="width: 47.98%; vertical-align: top;">&#160;</td>
                      <td rowspan="1" style="width: 52.02%; vertical-align: top;">&#160;</td>
                    </tr>
                    <tr>
                      <td style="width: 47.98%; vertical-align: top;">
                        <div style="text-align: justify; line-height: 1.25;">Dividend policy</div>
                      </td>
                      <td style="width: 52.02%; vertical-align: top;">
                        <div style="line-height: 1.25;">We have never declared or paid any cash dividend on our ordinary shares. We currently intend to retain any future earnings and do not expect to pay any dividends in the foreseeable future. Any further
                          determination to pay dividends on our ordinary shares would be at the discretion of our board of directors, subject to applicable laws, and would depend on our financial condition, results of operations, capital requirements,
                          general business conditions, and other factors that our board of directors may deem relevant.</div>
                      </td>
                    </tr>
                    <tr>
                      <td rowspan="1" style="width: 47.98%; vertical-align: top;">&#160;</td>
                      <td rowspan="1" style="width: 52.02%; vertical-align: top;">&#160;</td>
                    </tr>
                    <tr>
                      <td style="width: 47.98%; vertical-align: top;">
                        <div style="text-align: justify; line-height: 1.25;">Risk factors</div>
                      </td>
                      <td style="width: 52.02%; vertical-align: top;">
                        <div style="line-height: 1.25;">See &#8220;<font style="font-style: italic;">Risk Factors</font>&#8221; and the other information included in this prospectus supplement, the base prospectus and under similar headings in the documents that are
                          incorporated by reference into this prospectus supplement or the base prospectus for a discussion of factors you should consider before deciding to invest in our ordinary shares.</div>
                      </td>
                    </tr>
                    <tr>
                      <td rowspan="1" style="width: 47.98%; vertical-align: top;">&#160;</td>
                      <td rowspan="1" style="width: 52.02%; vertical-align: top;">&#160;</td>
                    </tr>
                    <tr>
                      <td style="width: 47.98%; vertical-align: top;">
                        <div style="text-align: justify; line-height: 1.25;">Nasdaq trading symbol</div>
                      </td>
                      <td style="width: 52.02%; vertical-align: top;">
                        <div style="text-align: justify; line-height: 1.25;">&#8220;INVZ.&#8221; </div>
                      </td>
                    </tr>

                </table>
                <div style="line-height: 1.25;">&#160;</div>
                <div style="text-indent: 36pt; line-height: 1.25;">The number of our ordinary shares to be issued and outstanding after this offering is based on 200,774,840 ordinary shares outstanding as of June 30, 2025. The number of ordinary shares to
                  be issued and outstanding after this offering excludes:</div>
                <div style="line-height: 1.25;">&#160;</div>
                <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z19b2f21d33a34510b3a40d52625c1e94">

                    <tr>
                      <td style="width: 36pt;"><br>
                      </td>
                      <td style="width: 18pt; vertical-align: top;">&#8226;</td>
                      <td style="width: auto; vertical-align: top;">
                        <div>16,231,141 warrants (Nasdaq: INVZW) outstanding as of June 30, 2025, each entitling its holder to purchase one ordinary share at an initial exercise price equal to $11.50 per share; </div>
                      </td>
                    </tr>

                </table>
                <div style="line-height: 1.25;">&#160;</div>
                <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zd7b8e24460314e90a905f834cfe55980">

                    <tr>
                      <td style="width: 36pt;"><br>
                      </td>
                      <td style="width: 18pt; vertical-align: top;">&#8226;</td>
                      <td style="width: auto; vertical-align: top;">
                        <div>23,021,582 warrants outstanding as of June 30, 2025, each entitling its holder to purchase one ordinary share at an initial exercise price equal to $1.69 per share;&#160;</div>
                      </td>
                    </tr>

                </table>
                <div style="line-height: 1.25;">&#160;</div>
              </div>
              <div>&#160;</div>
            </div>
          </div>
          <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
            <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-weight: normal; font-style: normal;">S - 7</font></div>
            <div class="BRPFPageBreak" style="page-break-after: always;">
              <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
          </div>
          <div><br>
          </div>
          <div>
            <div style="border: #000000 2px solid; padding: 5px; width: 99%;">
              <div>&#160;<br>
                <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z3fa73161e43d4f39943f79b12b925e26">

                    <tr>
                      <td style="width: 36pt;"><br>
                      </td>
                      <td style="width: 18pt; vertical-align: top;">&#8226;</td>
                      <td style="width: auto; vertical-align: top;">
                        <div> 9,702,210 ordinary shares issuable upon the exercise of options outstanding under our equity incentive plans as of June 30, 2025, at a weighted average exercise price of $5.04 per share;</div>
                      </td>
                    </tr>

                </table>
                <div style="line-height: 1.25;">&#160;</div>
                <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z6b2d9c56042f4cce899fce6b9b1d2f5b">

                    <tr>
                      <td style="width: 36pt;"><br>
                      </td>
                      <td style="width: 18pt; vertical-align: top;">&#8226;</td>
                      <td style="width: auto; vertical-align: top;">
                        <div>15,071,937 ordinary shares issuable upon the vesting of restricted share units (&#8220;RSUs&#8221;) outstanding under our equity incentive plans as of June 30, 2025; and</div>
                      </td>
                    </tr>

                </table>
                <div style="line-height: 1.25;">&#160;</div>
                <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zd76710a4f1e2492ea7095f6d1dc3730b">

                    <tr>
                      <td style="width: 36pt;"><br>
                      </td>
                      <td style="width: 18pt; vertical-align: top;">&#8226;</td>
                      <td style="width: auto; vertical-align: top;">
                        <div>8,582,398 ordinary shares reserved for future issuance under our equity incentive plan, which number is prior to the reduction of the ordinary shares subject to any outstanding options or RSUs granted subsequent to June 30,
                          2025, as well as any future increases in the number of ordinary shares for future issuances under our equity incentive plan. </div>
                      </td>
                    </tr>

                </table>
                <div style="line-height: 1.25;">&#160;</div>
                <div style="text-indent: 36pt; line-height: 1.25;">In addition, unless otherwise indicated, all information contained in this prospectus supplement assumes:</div>
                <div style="line-height: 1.25;">&#160;</div>
                <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zdfd460565182425e990ee58e559be05a">

                    <tr>
                      <td style="width: 36pt;"><br>
                      </td>
                      <td style="width: 18pt; vertical-align: top;">&#8226;</td>
                      <td style="width: auto; vertical-align: top;">
                        <div>no exercise of the outstanding warrants described above after June 30, 2025; </div>
                      </td>
                    </tr>

                </table>
                <div style="line-height: 1.25;">&#160;</div>
                <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="ze1d8b68aa33e4934be833592fe6e41d3">

                    <tr>
                      <td style="width: 36pt;"><br>
                      </td>
                      <td style="width: 18pt; vertical-align: top;">&#8226;</td>
                      <td style="width: auto; vertical-align: top;">
                        <div>no exercise of the outstanding options described above after June 30, 2025; and</div>
                      </td>
                    </tr>

                </table>
                <div style="line-height: 1.25;">&#160;</div>
                <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z56ff898e001b4140844762b38b441592">

                    <tr>
                      <td style="width: 36pt;"><br>
                      </td>
                      <td style="width: 18pt; vertical-align: top;">&#8226;</td>
                      <td style="width: auto; vertical-align: top;">
                        <div>no vesting of the outstanding RSUs described above after June 30, 2025.</div>
                      </td>
                    </tr>

                </table>
                <div style="line-height: 1.25;">&#160;</div>
                <div class="BRPFPageHeader"> </div>
              </div>
            </div>
          </div>
          <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
            <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-weight: normal; font-style: normal;">S - 8</font></div>
            <div class="BRPFPageBreak" style="page-break-after: always;">
              <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
          </div>
          <div style="text-align: center; line-height: 1.25; font-weight: bold;"><br>
            <a name="RISK_PS"><!--Anchor--></a>RISK FACTORS</div>
          <div style="line-height: 1.25;">&#160;</div>
          <div style="text-indent: 36pt; line-height: 1.25; font-style: italic; text-align: justify;">Investing in our ordinary shares involves a high degree of risk. Our business, prospects, financial condition or operating results could be materially
            adversely affected by the risks identified below, as well as other risks not currently known to us or that we currently consider immaterial. The trading price of our ordinary shares could decline due to any of these risks, and you may lose all
            or part of your investment. Before deciding whether to invest in our ordinary shares, you should consider carefully the risk factors discussed below and those contained in the section entitled &#8220;Risk Factors&#8221; contained in our Annual Report, as
            filed with the SEC, which is incorporated herein by reference in its entirety, as well as any amendment or update to our risk factors reflected in subsequent filings with the SEC.</div>
          <div style="line-height: 1.25;">&#160;</div>
          <div style="line-height: 1.25; font-weight: bold;">Risks Related to this Offering</div>
          <div style="line-height: 1.25;">&#160;</div>
          <div style="line-height: 1.25; font-style: italic; font-weight: bold;">We will have broad discretion over the use of proceeds we receive in this offering and may not apply the proceeds in ways that increase the value of your investment.</div>
          <div style="line-height: 1.25;">&#160;</div>
          <div style="text-indent: 36pt; line-height: 1.25; text-align: justify;">Our management will have broad discretion in the application of the net proceeds from this offering and, as a result, you will have to rely upon the judgment of our
            management with respect to the use of these proceeds. Our management may spend a portion or all of the net proceeds in ways that not all shareholders approve of or that may not yield a favorable return. The failure by our management to apply
            these funds effectively could harm our business.</div>
          <div style="line-height: 1.25;">&#160;</div>
          <div style="line-height: 1.25; font-style: italic; font-weight: bold;">The market price and trading volume of our ordinary shares may be volatile and could decline significantly.</div>
          <div style="line-height: 1.25;">&#160;</div>
          <div style="text-indent: 36pt; line-height: 1.25; text-align: justify;">Nasdaq, the stock market on which our ordinary shares are listed under the symbol &#8220;INVZ,&#8221; has from time to time experienced significant price and volume fluctuations. Even if
            an active, liquid and orderly trading market is sustained for our ordinary shares, the market price of our ordinary shares may be volatile and could decline significantly. From January 1, 2024 through August 11, 2025, our ordinary shares traded
            as high as $2.58 per share and as low as $0.4870 per share. In addition, the trading volume in our ordinary shares may fluctuate and cause significant price variations to occur. We cannot assure you that the market price of our ordinary shares
            will not fluctuate widely or decline significantly in the future in response to a number of factors, including, among others, the following:</div>
          <div style="line-height: 1.25;">&#160;</div>
          <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z08edb19db03a4d2585ba8f8755ea9fc7">

              <tr>
                <td style="width: 36pt;"><br>
                </td>
                <td style="width: 18pt; vertical-align: top;">&#8226;</td>
                <td style="width: auto; vertical-align: top;">
                  <div>the realization of any of the risk factors presented in this prospectus supplement, the base prospectus and in any related free writing prospectus, and under similar headings in the documents that are incorporated by reference into
                    this prospectus supplement or the base prospectus;</div>
                </td>
              </tr>

          </table>
          <div style="line-height: 1.25;">&#160;</div>
          <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z168c6d3611a34ef5ae65e1d290ab8115">

              <tr>
                <td style="width: 36pt;"><br>
                </td>
                <td style="width: 18pt; vertical-align: top;">&#8226;</td>
                <td style="width: auto; vertical-align: top;">
                  <div>actual or anticipated differences in our estimates, or in the estimates of analysts, for our revenues, results of operations, level of indebtedness, liquidity or financial condition;</div>
                </td>
              </tr>

          </table>
          <div style="line-height: 1.25;">&#160;</div>
          <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z562e740285f54c0f97eb7bed34d2bdea">

              <tr>
                <td style="width: 36pt;"><br>
                </td>
                <td style="width: 18pt; vertical-align: top;">&#8226;</td>
                <td style="width: auto; vertical-align: top;">
                  <div>availability of capital to fund our contracts and our growth; </div>
                </td>
              </tr>

          </table>
          <div style="line-height: 1.25;">&#160;</div>
          <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zf254c629cc6843ff8025dd6a8d872780">

              <tr>
                <td style="width: 36pt;"><br>
                </td>
                <td style="width: 18pt; vertical-align: top;">&#8226;</td>
                <td style="width: auto; vertical-align: top;">
                  <div>additions and departures of key personnel;</div>
                </td>
              </tr>

          </table>
          <div style="line-height: 1.25;">&#160;</div>
          <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z27d5afb7cbf5429ab719cca9c4b3fb9e">

              <tr>
                <td style="width: 36pt;"><br>
                </td>
                <td style="width: 18pt; vertical-align: top;">&#8226;</td>
                <td style="width: auto; vertical-align: top;">
                  <div>failure to comply with the requirements of Nasdaq (including the continued listing requirements);</div>
                </td>
              </tr>

          </table>
          <div style="line-height: 1.25;">&#160;</div>
          <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z41260c4b09b24eb1b739df148c048b59">

              <tr>
                <td style="width: 36pt;"><br>
                </td>
                <td style="width: 18pt; vertical-align: top;">&#8226;</td>
                <td style="width: auto; vertical-align: top;">
                  <div>failure to comply with the Sarbanes-Oxley Act or other laws or regulations;</div>
                </td>
              </tr>

          </table>
          <div style="line-height: 1.25;">&#160;</div>
          <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z0918302e4d8846fa986b2a934c12d92e">

              <tr>
                <td style="width: 36pt;"><br>
                </td>
                <td style="width: 18pt; vertical-align: top;">&#8226;</td>
                <td style="width: auto; vertical-align: top;">
                  <div>future issuances, sales, resales or repurchases or anticipated issuances, sales, resales or repurchases, of our securities including due to the expiration of contractual lock-up agreements or the exercise of warrants;</div>
                </td>
              </tr>

          </table>
          <div style="line-height: 1.25;">&#160;</div>
          <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z45722591d0d0417ea909d8d48fea4d5b">

              <tr>
                <td style="width: 36pt;"><br>
                </td>
                <td style="width: 18pt; vertical-align: top;">&#8226;</td>
                <td style="width: auto; vertical-align: top;">
                  <div>publication of research reports about us;</div>
                </td>
              </tr>

          </table>
          <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
            <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-weight: normal; font-style: normal;">S - 9</font></div>
            <div class="BRPFPageBreak" style="page-break-after: always;">
              <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
          </div>
          <div style="line-height: 1.25;">&#160;</div>
          <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z1c16c843f9e74189a632e9381361fd2f">

              <tr>
                <td style="width: 36pt;"><br>
                </td>
                <td style="width: 18pt; vertical-align: top;">&#8226;</td>
                <td style="width: auto; vertical-align: top;">
                  <div>the performance and market valuations of other similar companies;</div>
                </td>
              </tr>

          </table>
          <div style="line-height: 1.25;">&#160;</div>
          <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zce990db8df0c40abba0e55b667bd2001">

              <tr>
                <td style="width: 36pt;"><br>
                </td>
                <td style="width: 18pt; vertical-align: top;">&#8226;</td>
                <td style="width: auto; vertical-align: top;">
                  <div>failure of securities analysts to initiate or maintain coverage of our company, changes in financial estimates by any securities analysts who follow us or our failure to meet these estimates or the expectations of investors;</div>
                </td>
              </tr>

          </table>
          <div style="line-height: 1.25;">&#160;</div>
          <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z54662b6694ea4512b2ebe84bf5f427ed">

              <tr>
                <td style="width: 36pt;"><br>
                </td>
                <td style="width: 18pt; vertical-align: top;">&#8226;</td>
                <td style="width: auto; vertical-align: top;">
                  <div>new laws, regulations, subsidies, or credits or new interpretations of existing laws applicable to us;</div>
                </td>
              </tr>

          </table>
          <div style="line-height: 1.25;">&#160;</div>
          <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z8874f5ccbef645c085a55fd61b99cfb0">

              <tr>
                <td style="width: 36pt;"><br>
                </td>
                <td style="width: 18pt; vertical-align: top;">&#8226;</td>
                <td style="width: auto; vertical-align: top;">
                  <div>commencement of, or involvement in, litigation involving us;</div>
                </td>
              </tr>

          </table>
          <div style="line-height: 1.25;">&#160;</div>
          <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z0b52a353171748a298c0d16abd6a292e">

              <tr>
                <td style="width: 36pt;"><br>
                </td>
                <td style="width: 18pt; vertical-align: top;">&#8226;</td>
                <td style="width: auto; vertical-align: top;">
                  <div>broad disruptions in the financial markets, including sudden disruptions in the credit markets;</div>
                </td>
              </tr>

          </table>
          <div style="line-height: 1.25;">&#160;</div>
          <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z4f7ceb52a3dd45d9ac9672750d484b4b">

              <tr>
                <td style="width: 36pt;"><br>
                </td>
                <td style="width: 18pt; vertical-align: top;">&#8226;</td>
                <td style="width: auto; vertical-align: top;">
                  <div>speculation in the press or investment community;</div>
                </td>
              </tr>

          </table>
          <div style="line-height: 1.25;">&#160;</div>
          <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z6be746b55f5e4407857aee432e382683">

              <tr>
                <td style="width: 36pt;"><br>
                </td>
                <td style="width: 18pt; vertical-align: top;">&#8226;</td>
                <td style="width: auto; vertical-align: top;">
                  <div>actual, potential or perceived control, accounting or reporting problems;</div>
                </td>
              </tr>

          </table>
          <div style="line-height: 1.25;">&#160;</div>
          <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z80a840dd329d443d832975c1b34a9749">

              <tr>
                <td style="width: 36pt;"><br>
                </td>
                <td style="width: 18pt; vertical-align: top;">&#8226;</td>
                <td style="width: auto; vertical-align: top;">
                  <div>changes in accounting principles, policies and guidelines; and</div>
                </td>
              </tr>

          </table>
          <div style="line-height: 1.25;">&#160;</div>
          <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z19baae1b824a4f47906edbb38b53f875">

              <tr>
                <td style="width: 36pt;"><br>
                </td>
                <td style="width: 18pt; vertical-align: top;">&#8226;</td>
                <td style="width: auto; vertical-align: top;">
                  <div>other events or factors, including those resulting from infectious diseases, health epidemics and pandemics, natural disasters, war, acts of terrorism (such as the war and hostilities between Israel and Hamas, Hezbollah, the Houthi
                    movement and Iran) or responses to these events.</div>
                </td>
              </tr>

          </table>
          <div style="line-height: 1.25;">&#160;</div>
          <div style="text-indent: 36pt; line-height: 1.25; text-align: justify;">In the past, securities class-action litigation has often been instituted against companies following periods of volatility in the market price of their shares. This type of
            litigation could result in substantial costs and divert our management&#8217;s attention and resources, which could have a material adverse effect on us.</div>
          <div style="line-height: 1.25;">&#160;</div>
          <div style="line-height: 1.25; font-style: italic; font-weight: bold;">If securities or industry analysts cease publishing research or reports about us, our business, or our market, or if they change their recommendations regarding our ordinary
            shares adversely, or if we fail to meet, or significantly exceed, the financial guidance we publicly announced on a periodic basis, then the price and trading volume of our ordinary shares could decline.</div>
          <div style="line-height: 1.25;">&#160;</div>
          <div style="text-indent: 36pt; line-height: 1.25; text-align: justify;">The trading market for our ordinary shares is influenced by the research and reports that industry or financial analysts publish about us or our business. We do not control
            these analysts, or the content and opinions included in their reports. As a relatively new public company, analysts who publish information about our ordinary shares will have had relatively little experience with us, which could affect their
            ability to accurately forecast our results and could make it more likely that we fail to meet our estimates. If any of the analysts who cover us issues an inaccurate or unfavorable opinion regarding us, the price of our ordinary shares would
            likely decline. In addition, the share prices of many companies in the technology industry have declined significantly after those companies have failed to meet, or significantly exceed, the financial guidance publicly announced by the
            companies or the expectations of analysts. If our financial results fail to meet, or significantly exceed, our announced guidance or the expectations of analysts or public investors, analysts could downgrade our ordinary shares or publish
            unfavorable research about us and our securities. If one or more of these analysts cease coverage of us or fail to publish reports on it regularly, our visibility in the financial markets could decrease, which in turn could cause the price of
            our ordinary shares or trading volume to decline.</div>
          <div style="line-height: 1.25;">&#160;</div>
          <div style="line-height: 1.25; font-style: italic; font-weight: bold;">Sales of a substantial number of our ordinary shares in the public market, or the perception that they may occur, could cause the price of our ordinary shares to fall.</div>
          <div style="line-height: 1.25;">&#160;</div>
          <div style="text-indent: 36pt; line-height: 1.25; text-align: justify;">The market price of our ordinary shares could decline as a result of sales of a large number of our ordinary shares in the public market following this offering.
            Substantially all of our outstanding ordinary shares are, and the ordinary shares offered in this offering will be, freely tradeable without restriction or further registration under the Securities Act. The perception that these sales might
            occur may also cause the market price of our ordinary shares to decline.</div>
          <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
            <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-weight: normal; font-style: normal;">S - 10</font></div>
            <div class="BRPFPageBreak" style="page-break-after: always;">
              <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
          </div>
          <div style="line-height: 1.25;">&#160;</div>
          <div style="line-height: 1.25; font-style: italic; font-weight: bold;">We do not intend to pay dividends in the foreseeable future.</div>
          <div style="line-height: 1.25;">&#160;</div>
          <div style="text-indent: 36pt; line-height: 1.25; text-align: justify;">We have never declared or paid any cash dividends on our ordinary shares, and we currently intend to retain all available funds and any future earnings for use in the
            operation of our business and do not anticipate paying any dividends on our ordinary shares in the foreseeable future. Any future determination to pay dividends on our ordinary shares will be at the discretion of our board of directors, subject
            to applicable laws, and would depend on our financial condition, results of operations, capital requirements, general business conditions, and other factors that our board of directors may deem relevant. Consequently, you may be unable to
            realize a gain on your investment except by selling our ordinary shares after price appreciation, which may never occur.</div>
          <div style="line-height: 1.25; text-align: justify;">&#160;</div>
          <div style="text-indent: 36pt; line-height: 1.25; text-align: justify;">Our board of directors has sole discretion whether to pay dividends. If our board of directors decides to pay dividends, the form, frequency, and amount will depend upon our
            future, operations and earnings, capital requirements and surplus, general financial condition, contractual restrictions and other factors that our directors may deem relevant. The Companies Law imposes restrictions on our ability to declare
            and pay dividends. See the sections titled &#8220;<font style="font-style: italic;">Description of Ordinary Shares</font>, <font style="font-style: italic;">Existing Warrants and Existing RDO Warrants</font>&#8221; in the base prospectus and &#8220;<font style="font-style: italic;">Description of Registrant&#8217;s Securities&#8212;Ordinary Shares&#8212;Dividend and Liquidation Rights</font>&#8221; in Exhibit 2.1 to our Annual Report incorporated herein by reference for additional information. Payment of dividends
            may also be subject to Israeli withholding taxes. See the section titled &#8220;<font style="font-style: italic;">Taxation&#8212;Material Israeli Tax Considerations</font>&#8221; for additional information.</div>
          <div style="line-height: 1.25; text-align: justify;">&#160;</div>
          <div style="line-height: 1.25; text-align: justify;"><font style="font-weight: bold; font-style: italic;">Purchasers of ordinary shares in this offering will experience immediate and substantial dilution in the book value of their investment.</font>&#160;</div>
          <div style="line-height: 1.25; text-align: justify;">&#160;</div>
          <div style="text-indent: 36pt; line-height: 1.25;">
            <div style="text-indent: 36pt; line-height: 1.25; text-align: justify;">The price per ordinary share being offered may be higher than the net tangible book value per ordinary share outstanding prior to this offering. Therefore, if you purchase
              our ordinary shares in this offering, you may pay a price per share that substantially exceeds the as adjusted net tangible book value per share after the completion of this offering. After giving effect to the sale of ordinary shares in the
              aggregate amount of $75.0 million in this offering at an assumed public offering price of $1.70, the last reported sale price of our ordinary shares on Nasdaq on August 11, 2025, after deducting Jefferies&#8217; commissions and offering expenses
              payable by us, our net tangible book value on an adjusted basis as of June 30, 2025 would have been $0.67 per ordinary share. This amount represents an immediate increase in net tangible book value of $0.21 per ordinary share to our existing
              shareholders and an immediate dilution of $1.03 per ordinary share to new investors purchasing ordinary shares in this offering. Furthermore, if outstanding warrants or options are exercised, or additional RSUs vest and settle, you could
              experience further dilution. See the section titled &#8220;<font style="font-style: italic;">Dilution</font>&#8221; for a more detailed description of the dilution to new investors in the offering.</div>
          </div>
          <div style="line-height: 1.25; text-align: justify;">&#160;</div>
          <div style="line-height: 1.25; font-style: italic; font-weight: bold; text-align: justify;">You may experience future dilution as a result of future equity offerings. </div>
          <div style="line-height: 1.25; text-align: justify;">&#160;</div>
          <div style="text-indent: 36pt; line-height: 1.25; text-align: justify;">In order to raise additional capital, we may in the future offer additional ordinary shares or other securities convertible into or exchangeable for our ordinary shares at
            prices that may not be the same as the price per share in this offering. We may sell shares or other securities in any other offering at a price per share that is less than the price per share paid by any investors in this offering, and
            investors purchasing shares or other securities in the future could have rights superior to existing shareholders. These amounts assume all shares are sold under this program. We cannot assure you as to the number of shares or price at which
            any shares will be sold hereunder. The price per share at which we sell additional ordinary shares, or securities convertible or exchangeable into ordinary shares, in future transactions may be higher or lower than the price per share paid by
            any investors in this offering. See the section titled &#8220;<font style="font-style: italic;">Dilution</font>&#8221; for a more detailed discussion of the dilution you may incur if you purchase ordinary shares in this offering.</div>
          <div style="line-height: 1.25; text-align: justify;">&#160;</div>
          <div style="line-height: 1.25; font-style: italic; font-weight: bold; text-align: justify;">The actual number of shares we will issue under the sales agreement in this offering and gross proceeds resulting from those sales, at any one time or in
            total, is uncertain.</div>
          <div style="line-height: 1.25; text-align: justify;">&#160;</div>
          <div style="text-indent: 36pt; line-height: 1.25; text-align: justify;">Subject to certain limitations in the sales agreement and compliance with applicable law, we have the discretion to deliver a placement notice to Jefferies at any time
            throughout the term of the sales agreement. The number of shares that are sold by Jefferies after delivering a placement notice will fluctuate based on the market price of our ordinary shares during the sales period and limits we set with
            Jefferies in any instruction to sell shares, and the demand for our ordinary shares during the sales period. Because the price per share of each share sold will fluctuate based on the market price of our ordinary shares during the sales period,
            it is not possible at this stage to predict the number of shares that will be ultimately issued or the gross proceeds to be raised in connection with those sales, if any.</div>
          <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
            <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-weight: normal; font-style: normal;">S - 11</font></div>
            <div class="BRPFPageBreak" style="page-break-after: always;">
              <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
          </div>
          <div style="line-height: 1.25;">&#160;</div>
          <div style="line-height: 1.25; font-style: italic; font-weight: bold;">The ordinary shares offered in this offering will be sold in &#8220;at the market offerings,&#8221; and investors who buy shares at different times will likely pay different prices.</div>
          <div style="line-height: 1.25;">&#160;</div>
          <div style="text-indent: 36pt; line-height: 1.25; text-align: justify;">Investors who purchase shares in this offering at different times will likely pay different prices, and so may experience different outcomes in their investment results. We
            will have discretion, subject to market demand and the terms of the sales agreement, to vary the timing, prices and numbers of shares sold, and there is no minimum or maximum sales price for shares to be sold in this offering. Investors may
            experience a decline in the value of their shares as a result of share sales made at prices lower than the prices they paid.</div>
          <div style="line-height: 1.25; text-align: justify;">&#160;</div>
          <div style="line-height: 1.25; font-style: italic; font-weight: bold; text-align: justify;">U.S. holders of our ordinary shares may suffer adverse tax consequences if we are treated as a passive foreign investment company.</div>
          <div style="line-height: 1.25; text-align: justify;">&#160;</div>
          <div style="text-indent: 36pt; line-height: 1.25; text-align: justify;">&#160;A non-U.S. corporation generally will be treated as a &#8220;passive foreign investment company&#8221; (&#8220;PFIC&#8221;) for U.S. federal income tax purposes, in any taxable year if either (1)
            at least 75% of its gross income for such year is passive income (such as interest income) or (2) at least 50% of the value of its assets (based on an average of the quarterly values of the assets) during such year is attributable to assets
            that produce or are held for the production of passive income. We believe we were a PFIC for our taxable year ending December 31, 2024. However, as discussed below, whether we were a PFIC for any given taxable year is based on a complex and
            factual determination and there is no assurance that the Internal Revenue Service (&#8220;IRS&#8221;) will agree with our determination. Based on the current and anticipated composition of the income, assets and operations of our company and our
            subsidiaries, we cannot be sure as to whether we will be a PFIC for U.S. federal income tax purposes for our taxable year ending December 31, 2025 or in future taxable years. Moreover, because PFIC status is based on our income, assets and
            activities for the entire taxable year, it is not possible to determine whether we will be characterized as a PFIC for our current taxable year or future taxable years until after the close of the applicable taxable year. This is an annual
            factual determination that depends on, among other things, the composition of our income (including the relative size of our gross operating loss and our passive income) and assets, and the market value of our shares and assets (including
            unbooked goodwill), including the composition of income and assets of our subsidiaries, from time to time, and thus a determination can only be made annually after the close of each taxable year. Moreover, the value of our assets (including
            unbooked goodwill) for purposes of the PFIC determination may be determined by reference to the trading value of our ordinary shares, which could fluctuate significantly.If we are a PFIC for any taxable year, a U.S. Holder (as defined below
            under &#8220;Taxation &#8211; United States Federal Income Tax Considerations&#8221;) of our ordinary shares may be subject to adverse tax consequences and may incur certain information reporting obligations, even if we cease to be a PFIC in the subsequent
            years. Under the generally applicable PFIC rules, a U.S. Holder generally would be subject to U.S. federal income tax at the then prevailing maximum rates on ordinary income and possibly an &#8220;interest&#8221; charge, in respect of &#8220;excess
            distributions&#8221; and upon any gain from the disposition of our ordinary shares, as if the excess distribution or gain had been recognized ratably over such U.S. Holder&#8217;s holding period of our ordinary shares. Additionally, if we are a PFIC for
            any taxable year during which U.S. Holders hold our ordinary shares, we would generally continue to be treated as a PFIC with respect to such U.S. Holders even if we do not satisfy either of the above tests to be classified as a PFIC in any
            subsequent year. Certain elections (including a qualified electing fund or a mark-to-market election) may be available to U.S. Holders of our ordinary shares to mitigate some of the adverse tax consequences resulting from PFIC treatment. For a
            further discussion, see &#8220;Taxation&#8212;United States Federal Income Tax Considerations&#8212;Passive Foreign Investment Company Considerations.&#8221; </div>
          <div style="line-height: 1.25; text-align: justify;">&#160;</div>
          <div style="text-indent: 36pt; line-height: 1.25; text-align: justify;">U.S. Holders of our ordinary shares are strongly encouraged to consult their own tax advisors regarding the potential application of these rules to us and the ownership of
            our ordinary shares.</div>
          <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
            <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-weight: normal; font-style: normal;">S - 12</font></div>
            <div class="BRPFPageBreak" style="page-break-after: always;">
              <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
          </div>
          <div style="line-height: 1.25;">&#160;</div>
          <div style="line-height: 1.25; font-style: italic; font-weight: bold;">If a United States person is treated as owning at least 10% of our shares, such person may be subject to adverse U.S. federal income tax consequences.</div>
          <div style="line-height: 1.25;">&#160;</div>
          <div style="text-indent: 36pt; line-height: 1.25; text-align: justify;">A United States person that owns (directly, indirectly or constructively) at least 10% of the total combined voting power or value of all classes of stock of a non-U.S.
            corporation that is a controlled foreign corporation for U.S. federal income tax purposes (a &#8220;United States shareholder&#8221;) may be required to report annually and include in its U.S. taxable income its pro rata share of the controlled foreign
            corporation&#8217;s &#8220;Subpart F income,&#8221; &#8220;global intangible low-taxed income (renamed &#8220;net CFC tested income&#8221; for taxable years beginning after December 31, 2025, pursuant to the One Big Beautiful Bill Act of 2025 (the &#8220;OBBBA&#8221;)),&#8221; and investments in
            U.S. property by the controlled foreign corporation regardless of whether such controlled foreign corporation makes any distributions. A foreign corporation for U.S. federal income tax purposes generally is considered a controlled foreign
            corporation if United States shareholders own (directly, indirectly or constructively), in the aggregate, more than 50% of the total combined voting power of all classes of voting stock of that foreign corporation or more than 50% of the total
            value of all stock of that foreign corporation. Regardless of whether we are treated as a controlled foreign corporation, for taxable years beginning before January 1, 2026, certain of our non-U.S. subsidiaries may be treated as controlled
            foreign corporations because our U.S. subsidiaries are treated as constructively owning the stock of our non-U.S. subsidiaries (so-called &#8220;downward attribution&#8221;), and a U.S. Holder owning (directly, indirectly or constructively) at least 10% of
            the value or voting power of our shares may be treated as a United States shareholder with respect to such non-U.S. subsidiaries that are treated as controlled foreign corporations. However, for taxable years beginning after December 31, 2025,
            as a result of the restoration of Section 958(b)(4) of the Internal Revenue Code by the OBBBA, restoring a limitation on downward attribution, our non-U.S. subsidiaries generally will not be treated as controlled foreign corporations and no
            U.S. Holder will be treated as a United States shareholder with respect to such non-U.S. subsidiaries solely by reason of the inclusion of one or more U.S. subsidiaries within our group. </div>
          <div style="line-height: 1.25;">&#160;</div>
          <div style="text-indent: 36pt; line-height: 1.25; text-align: justify;">U.S. Holders of our ordinary shares are strongly encouraged to consult their own tax advisors regarding the potential application of these rules to us and the ownership of
            our ordinary shares for taxable years beginning before January 1, 2026 and with respect to the potential effect of any changes pursuant to the OBBBA for the taxable years beginning after December 31, 2025.</div>
          <div style="line-height: 1.25; text-align: justify;">&#160;</div>
          <div style="line-height: 1.25; font-weight: bold; text-align: justify;">Risks Related to Our Ordinary Shares</div>
          <div style="line-height: 1.25; text-align: justify;">&#160;</div>
          <div style="line-height: 1.25;">
            <div style="text-align: justify; line-height: 1.25; font-style: italic; font-weight: bold;">Our failure to maintain compliance with Nasdaq&#8217;s continued listing requirements could result in the delisting of our ordinary shares.</div>
          </div>
          <div style="line-height: 1.25;">
            <div style="line-height: 1.25;"><br style="line-height: 1.25;">
            </div>
          </div>
          <div style="line-height: 1.25;">
            <div style="text-indent: 36pt; line-height: 1.25; text-align: justify;">Our ordinary shares are currently listed for trading on Nasdaq. We must satisfy Nasdaq&#8217;s continued listing requirements, including, among other things, a minimum bid price
              requirement of $1.00 per ordinary share or risk delisting.</div>
          </div>
          <div style="line-height: 1.25;">
            <div style="line-height: 1.25;"><br style="line-height: 1.25;">
            </div>
          </div>
          <div style="line-height: 1.25;">
            <div style="text-indent: 36pt; line-height: 1.25; text-align: justify;">On March 28, 2025, we received a letter from the Listing Qualifications Department indicating that for the thirty consecutive business days prior, the bid price for the
              ordinary shares had closed below the minimum $1.00 per ordinary share requirement for continued listing on Nasdaq under Nasdaq Listing Rule 5450(a)(1). In accordance with Nasdaq Listing Rule 5810(c)(3)(A), we were provided an initial period
              of 180 calendar days, or until September 22, 2025, to regain compliance. The letter stated that the Listing Qualifications Department staff will provide written notification that we have achieved compliance with Rule 5450(a)(1) if at any time
              before September 22, 2025, the bid price of the ordinary shares closed at $1.00 per ordinary share or more for a minimum of ten consecutive business days.</div>
            <div style="line-height: 1.25;"><br style="line-height: 1.25;">
            </div>
            <div style="text-indent: 36pt; line-height: 1.25; text-align: justify;">On July 3, 2025, we announced that we received formal written confirmation from Nasdaq confirming that the Company regained compliance with Nasdaq&#8217;s minimum bid price
              requirement. The closing bid price of the ordinary shares was at $1.00 per share or greater for 10 consecutive business days from June 17, 2025 to July 1, 2025. Accordingly, Nasdaq Listing Qualifications Staff notified the Company that it
              determined that the Company regained compliance with Nasdaq Listing Rule 5550(a)(2), and that the matter was closed.</div>
            <div style="line-height: 1.25;"><br style="line-height: 1.25;">
            </div>
            <div style="text-indent: 36pt; line-height: 1.25; text-align: justify;">No assurance can be given that the price of the ordinary shares will not again be in violation of Nasdaq&#8217;s minimum bid price requirement in the future. Our failure to meet
              this or other requirements may result in our securities being delisted from Nasdaq. A delisting could substantially decrease trading in the ordinary shares, adversely affect the market liquidity of the ordinary shares as a result of the loss
              of market efficiencies associated with Nasdaq and the loss of federal preemption of state securities laws, adversely affect our ability to obtain financing on acceptable terms, if at all, and may result in the potential loss of confidence by
              investors, suppliers, customers and employees and fewer business development opportunities. Additionally, the market price of the ordinary shares may decline further and shareholders may lose some or all of their investment.</div>
          </div>
          <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
            <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-weight: normal; font-style: normal;">S - 13</font></div>
            <div class="BRPFPageBreak" style="page-break-after: always;">
              <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
          </div>
          <div style="text-align: center; line-height: 1.25; font-weight: bold;"> <br>
          </div>
          <div style="text-align: center; line-height: 1.25; font-weight: bold;"><a name="CAUTIONARY_PS"><!--Anchor--></a>CAUTIONARY STATEMENT REGARDING FORWARD&#8209;LOOKING STATEMENTS</div>
          <div style="line-height: 1.25;">&#160;</div>
          <div style="text-indent: 36pt; line-height: 1.25; text-align: justify;">This prospectus supplement, the base prospectus and the documents incorporated by reference herein contain forward looking statements within the meaning of Section 27A of the
            Securities Act. All statements other than statements of historical facts contained in this prospectus, including statements regarding our future results of operations and financial position, business strategy and plans and our objectives for
            future operations, are forward looking statements. In some cases, these forward&#8209;looking statements can be identified by words or phrases such as &#8220;may,&#8221; &#8220;might,&#8221; &#8220;will,&#8221; &#8220;could,&#8221; &#8220;would,&#8221; &#8220;should,&#8221; &#8220;expect,&#8221; &#8220;plan,&#8221; &#8220;anticipate,&#8221; &#8220;intend,&#8221;
            &#8220;seek,&#8221; &#8220;believe,&#8221; &#8220;estimate,&#8221; &#8220;predict,&#8221; &#8220;potential,&#8221; &#8220;continue,&#8221; &#8220;contemplate,&#8221; &#8220;possible&#8221; or similar words or phrases, or the negatives of those words or phrases. Statements regarding our future results of operations and financial position,
            growth strategy and plans and objectives of management for future operations, including, among others, expansion in new and existing markets, are forward&#8209;looking statements.</div>
          <div style="line-height: 1.25;">&#160;</div>
          <div style="text-indent: 36pt; line-height: 1.25; text-align: justify;">Our estimates and forward&#8209;looking statements are mainly based on our current expectations and estimates of future events and trends which affect or may affect our business,
            operations and industry. Although we believe that these estimates and forward&#8209;looking statements are based upon reasonable assumptions, they are subject to numerous risks and uncertainties.</div>
          <div style="line-height: 1.25;">&#160;</div>
          <div style="text-indent: 36pt; line-height: 1.25;">Forward&#8209;looking statements contained or incorporated in this prospectus supplement and the base prospectus include, but are not limited to, statements about:</div>
          <div style="line-height: 1.25;">&#160;</div>
          <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z4eca8c8980ad4b1089348a559f1384a5">

              <tr>
                <td style="width: 36pt;"><br>
                </td>
                <td style="width: 18pt; vertical-align: top;">&#8226;</td>
                <td style="width: auto; vertical-align: top;">
                  <div>our limited operating history and evolving business model makes evaluating our business and future prospects difficult and may increase the risk of your investment;</div>
                </td>
              </tr>

          </table>
          <div style="line-height: 1.25;">&#160;</div>
          <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zbc824780212f4151829d0461a3076db2">

              <tr>
                <td style="width: 36pt;"><br>
                </td>
                <td style="width: 18pt; vertical-align: top;">&#8226;</td>
                <td style="width: auto; vertical-align: top;">
                  <div>continued pricing pressures, automotive original equipment manufacturers (&#8220;OEM&#8221;) cost reduction initiatives and the ability of automotive OEMs to re-source or cancel vehicle or technology programs may result in lower than anticipated
                    margins, or in incremental losses, which may adversely affect our business;</div>
                </td>
              </tr>

          </table>
          <div style="line-height: 1.25;">&#160;</div>
          <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zfe97e40b9cdc4b54b4532866d34a5bd6">

              <tr>
                <td style="width: 36pt;"><br>
                </td>
                <td style="width: 18pt; vertical-align: top;">&#8226;</td>
                <td style="width: auto; vertical-align: top;">
                  <div>we are creating innovative technologies by designing and developing unique components. The high price of, or low yield in, these components may affect our ability to sell at competitive prices, or may lead to losses;</div>
                </td>
              </tr>

          </table>
          <div style="line-height: 1.25;">&#160;</div>
          <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z63bf6549a4124c4989c6a8abeb589155">

              <tr>
                <td style="width: 36pt;"><br>
                </td>
                <td style="width: 18pt; vertical-align: top;">&#8226;</td>
                <td style="width: auto; vertical-align: top;">
                  <div>there are significant risks to providing our products as a direct supplier to customers, including additional operating costs, increased liabilities, and additional indemnification liabilities;</div>
                </td>
              </tr>

          </table>
          <div style="line-height: 1.25;">&#160;</div>
          <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zd378dd56101f4b0d81ae9cae120c0738">

              <tr>
                <td style="width: 36pt;"><br>
                </td>
                <td style="width: 18pt; vertical-align: top;">&#8226;</td>
                <td style="width: auto; vertical-align: top;">
                  <div>we expect to invest substantially in research and development for the purpose of developing and commercializing new products. These investments could significantly reduce our profitability or increase our losses and may not generate
                    revenue for us;</div>
                </td>
              </tr>

          </table>
          <div style="line-height: 1.25;">&#160;</div>
          <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zf8f64867dcde4911b87e78281c073bae">

              <tr>
                <td style="width: 36pt;"><br>
                </td>
                <td style="width: 18pt; vertical-align: top;">&#8226;</td>
                <td style="width: auto; vertical-align: top;">
                  <div>we will likely need to obtain additional funds in the future in order to execute our business plan and these funds may not be available to us when we need them, which could negatively affect our business, prospects, financial
                    condition and operating results&#894; </div>
                </td>
              </tr>

          </table>
          <div style="line-height: 1.25;">&#160;</div>
          <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="za74c5a701a014483a03ec219b2bfe32b">

              <tr>
                <td style="width: 36pt;"><br>
                </td>
                <td style="width: 18pt; vertical-align: top;">&#8226;</td>
                <td style="width: auto; vertical-align: top;">
                  <div>we may experience significant delays in the design, production and launch of our LiDAR products, which could harm our business, prospects, financial condition and operating results;</div>
                </td>
              </tr>

          </table>
          <div style="line-height: 1.25;">&#160;</div>
          <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zf07fec28fdb84d988eee9eb289ae65cd">

              <tr>
                <td style="width: 36pt;"><br>
                </td>
                <td style="width: 18pt; vertical-align: top;">&#8226;</td>
                <td style="width: auto; vertical-align: top;">
                  <div>we are substantially dependent on a limited number of customers. The automotive industry is comprised of a relatively small number of players, which makes each design win material for us, and our business could be materially and
                    adversely affected if any of our customers terminate our programs following such wins&#894;</div>
                </td>
              </tr>

          </table>
          <div style="line-height: 1.25;">&#160;</div>
          <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z10f7bcd9202d4a7fb3f052b70f225314">

              <tr>
                <td style="width: 36pt;"><br>
                </td>
                <td style="width: 18pt; vertical-align: top;">&#8226;</td>
                <td style="width: auto; vertical-align: top;">
                  <div>designing and manufacturing LiDARs on a mass-production scale requires meeting stringent quality requirements and we may face significant challenges and complexities in this process&#894;</div>
                </td>
              </tr>

          </table>
          <div style="line-height: 1.25;">&#160;</div>
          <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
            <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-weight: normal; font-style: normal;">S - 14</font></div>
            <div class="BRPFPageBreak" style="page-break-after: always;">
              <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
          </div>
          <div style="line-height: 1.25;">&#160;</div>
          <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z72aad830c5f3473bb3e41d588a0209cc">

              <tr>
                <td style="width: 36pt;"><br>
                </td>
                <td style="width: 18pt; vertical-align: top;">&#8226;</td>
                <td style="width: auto; vertical-align: top;">
                  <div>our transition to production with a contract manufacturer and our ramp-up towards mass production may encounter significant challenges, which could delay commercialization and increase costs;</div>
                </td>
              </tr>

          </table>
          <div style="line-height: 1.25;">&#160;</div>
          <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zdbabe90b82484ce0b5fef8c8d9c2d828">

              <tr>
                <td style="width: 36pt;"><br>
                </td>
                <td style="width: 18pt; vertical-align: top;">&#8226;</td>
                <td style="width: auto; vertical-align: top;">
                  <div>the period of time from a design win to implementation is long and we are subject to the risk of cancellations or postponement of contracts or failure to successfully meet customers&#8217; requirements for start of production&#894;</div>
                </td>
              </tr>

          </table>
          <div style="line-height: 1.25;">&#160;</div>
          <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zf7b223160c19427baefbf4d05045727d">

              <tr>
                <td style="width: 36pt;"><br>
                </td>
                <td style="width: 18pt; vertical-align: top;">&#8226;</td>
                <td style="width: auto; vertical-align: top;">
                  <div>certain of our strategic, development and supply arrangements could be terminated or may not materialize into long-term contract partnership arrangements&#894;</div>
                </td>
              </tr>

          </table>
          <div style="line-height: 1.25;">&#160;</div>
          <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z4f1b4cddd6664891a76f516b59eccfda">

              <tr>
                <td style="width: 36pt;"><br>
                </td>
                <td style="width: 18pt; vertical-align: top;">&#8226;</td>
                <td style="width: auto; vertical-align: top;">
                  <div>we target many customers that are large companies with substantial negotiating power, exacting product standards and potentially competitive internal solutions. If we are unable to sell our products to these customers, our prospects
                    and results of operations will be adversely affected&#894;</div>
                </td>
              </tr>

          </table>
          <div style="line-height: 1.25;">&#160;</div>
          <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z9eabd5a8ac6045d58c33af7a0edda388">

              <tr>
                <td style="width: 36pt;"><br>
                </td>
                <td style="width: 18pt; vertical-align: top;">&#8226;</td>
                <td style="width: auto; vertical-align: top;">
                  <div>we continue to implement strategic initiatives designed to grow our business. These initiatives may prove more costly than we currently anticipate and we may not succeed in increasing our revenues by an amount sufficient to offset
                    the costs of these initiatives and to achieve and maintain profitability&#894;</div>
                </td>
              </tr>

          </table>
          <div style="line-height: 1.25;">&#160;</div>
          <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="ze963c35e18df47f3973ba34112f7c042">

              <tr>
                <td style="width: 36pt;"><br>
                </td>
                <td style="width: 18pt; vertical-align: top;">&#8226;</td>
                <td style="width: auto; vertical-align: top;">
                  <div>the first vehicles deploying our LiDAR technology and software became commercially available to end users in 2024. If any vehicles deploying our LiDAR technology and software are involved in traffic accidents or collisions actually
                    or allegedly resulting from undetected defects, errors, or bugs in our products, or if our products actually or allegedly fail to perform as expected, we may be exposed to product liability, warranty and other claims, in addition to a
                    decline in the market adoption of our products, damage to our reputation with current or prospective customers, or increased regulatory scrutiny of our solutions which would adversely affect our operating costs, business and prospects;</div>
                </td>
              </tr>

          </table>
          <div style="line-height: 1.25;">&#160;</div>
          <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z9bf2268ac617459ba9e67a1703dbc444">

              <tr>
                <td style="width: 36pt;"><br>
                </td>
                <td style="width: 18pt; vertical-align: top;">&#8226;</td>
                <td style="width: auto; vertical-align: top;">
                  <div>our failure to maintain compliance with Nasdaq&#8217;s continued listing requirements could result in the delisting of our ordinary shares;</div>
                </td>
              </tr>

          </table>
          <div style="line-height: 1.25;">&#160;</div>
          <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zf56dd97b98934161925ef7fb0601b4fc">

              <tr>
                <td style="width: 36pt;"><br>
                </td>
                <td style="width: 18pt; vertical-align: top;">&#8226;</td>
                <td style="width: auto; vertical-align: top;">
                  <div>we operate in a highly competitive market against a large number of both established competitors and new market entrants, and some market participants have substantially greater resources than we do; </div>
                </td>
              </tr>

          </table>
          <div style="line-height: 1.25;">&#160;</div>
          <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zcba3636ba8cc43a89c5672774f647d49">

              <tr>
                <td style="width: 36pt;"><br>
                </td>
                <td style="width: 18pt; vertical-align: top;">&#8226;</td>
                <td style="width: auto; vertical-align: top;">
                  <div>we may be subject to securities litigation, class action and derivative lawsuits, which could result in substantial costs and could divert management attention away from other business concerns; and</div>
                </td>
              </tr>

          </table>
          <div style="line-height: 1.25;">&#160;</div>
          <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z98fd8ca4fc234edda2a9030c749db090">

              <tr>
                <td style="width: 36pt;"><br>
                </td>
                <td style="width: 18pt; vertical-align: top;">&#8226;</td>
                <td style="width: auto; vertical-align: top;">
                  <div>the other matters described in the section entitled &#8220;<font style="font-style: italic;">Risk Factors</font>&#8221; beginning on page S-9 of this prospectus supplement and other risk factors contained in our Annual Report and our subsequent
                    filings with the SEC that we incorporated by reference herein.</div>
                </td>
              </tr>

          </table>
          <div style="line-height: 1.25;">&#160;</div>
          <div style="text-indent: 36pt; line-height: 1.25; text-align: justify;">Many important factors, in addition to the factors described above and in other sections of this prospectus supplement, the base prospectus and the documents incorporated by
            reference herein, could adversely impact our business and financial performance. Moreover, we operate in an evolving environment. New risks and uncertainties emerge from time to time, and it is not possible for our management to predict all
            risks and uncertainties, nor can we assess the impact of all factors on our business or the extent to which any factor, or combination of factors, may cause actual results and, in the case of our forward-looking order book, actual orders to
            differ materially from estimates or forward&#8209;looking statements. We qualify all of our estimates and forward&#8209;looking statements by these cautionary statements. Factors that could cause actual results to differ from our expectations or
            projections include the risks and uncertainties relating to our business described in this prospectus supplement under &#8220;Risk Factors&#8221; as well as those listed under &#8220;Item 3. Key Information &#8211; D. Risk Factors&#8221; in our Annual Report, and any risk
            factors in our subsequent filings with the SEC incorporated by reference herein. We caution you to carefully consider these risks and not to place undue reliance on our forward&#8209;looking statements. Forward-looking statements set forth herein
            speak only as of the date of this prospectus. Except as required by applicable law, including the securities laws of the United States, we do not intend to update or revise any forward&#8209;looking statements, whether as a result of new information,
            future events or otherwise, and we assume no responsibility for updating any forward&#8209;looking statements.</div>
          <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
            <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-weight: normal; font-style: normal;">S - 15</font></div>
            <div class="BRPFPageBreak" style="page-break-after: always;">
              <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
          </div>
          <div style="line-height: 1.25;">&#160;</div>
          <div style="text-align: center; line-height: 1.25; font-weight: bold;"><a name="USE_PS"><!--Anchor--></a>USE OF PROCEEDS</div>
          <div style="line-height: 1.25;">&#160;</div>
          <div style="text-indent: 36pt; line-height: 1.25; text-align: justify;">We may issue and sell ordinary shares having aggregate sales proceeds of up to $75,000,000 from time to time. The amount of proceeds from this offering will depend upon the
            number of ordinary shares sold and the market price at which they are sold. There can be no assurance that we will be able to sell any shares under or fully utilize the sales agreement with Jefferies as a source of financing.</div>
          <div style="line-height: 1.25;">&#160;</div>
          <div style="text-indent: 36pt; line-height: 1.25; text-align: justify;">We intend to use the net proceeds from this offering for general business purposes, including, but not limited to:</div>
          <div style="line-height: 1.25;">&#160;</div>
          <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zf27732dbdfbb4461af36b0a7e4afa8ad">

              <tr>
                <td style="width: 54pt;"><br>
                </td>
                <td style="width: 18pt; vertical-align: top;">&#8226;</td>
                <td style="width: auto; vertical-align: top;">
                  <div>research and development activities;</div>
                </td>
              </tr>

          </table>
          <div style="line-height: 1.25;">&#160;</div>
          <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z2725a6cbd24b48acba2ee99902f693af">

              <tr>
                <td style="width: 54pt;"><br>
                </td>
                <td style="width: 18pt; vertical-align: top;">&#8226;</td>
                <td style="width: auto; vertical-align: top;">
                  <div>commercializing our product sales;</div>
                </td>
              </tr>

          </table>
          <div style="line-height: 1.25;">&#160;</div>
          <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z30b00d9e24ba44b0a5983352de8bd9b7">

              <tr>
                <td style="width: 54pt;"><br>
                </td>
                <td style="width: 18pt; vertical-align: top;">&#8226;</td>
                <td style="width: auto; vertical-align: top;">
                  <div>funding our continuing operations;</div>
                </td>
              </tr>

          </table>
          <div style="line-height: 1.25;">&#160;</div>
          <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z094473d8573d47c190ba5d5d538cda98">

              <tr>
                <td style="width: 54pt;"><br>
                </td>
                <td style="width: 18pt; vertical-align: top;">&#8226;</td>
                <td style="width: auto; vertical-align: top;">
                  <div>expanding our production capabilities to produce LiDAR solutions;</div>
                </td>
              </tr>

          </table>
          <div style="line-height: 1.25;">&#160;</div>
          <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zebbff012ad794fa59d2d10fceb901002">

              <tr>
                <td style="width: 54pt;"><br>
                </td>
                <td style="width: 18pt; vertical-align: top;">&#8226;</td>
                <td style="width: auto; vertical-align: top;">
                  <div>outsourcing the production of our LiDAR solutions; and</div>
                </td>
              </tr>

          </table>
          <div style="line-height: 1.25;">&#160;</div>
          <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z2f879d4d2fc348e684a576c6b96c62b1">

              <tr>
                <td style="width: 54pt;"><br>
                </td>
                <td style="width: 18pt; vertical-align: top;">&#8226;</td>
                <td style="width: auto; vertical-align: top;">
                  <div>producing inventory of our LiDAR solutions.</div>
                </td>
              </tr>

          </table>
          <div style="line-height: 1.25;">&#160;</div>
          <div style="text-indent: 36pt; line-height: 1.25; text-align: justify;">We will have broad discretion in the way that we use the net proceeds of this offering. We expect that the proceeds from this offering will support our liquidity position in
            response to variability in the timing of the Company&#8217;s receipt of payments from customers. Our use of the net proceeds from this offering will depend on a number of factors, including our future revenue and cash generated by operations and the
            other factors described in &#8220;<font style="font-style: italic;">Risk Factors</font>.&#8221;</div>
          <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
            <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-weight: normal; font-style: normal;">S - 16</font></div>
            <div class="BRPFPageBreak" style="page-break-after: always;">
              <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
          </div>
          <div style="line-height: 1.25;">&#160;</div>
          <div style="text-align: center; line-height: 1.25; font-weight: bold;">CAPITALIZATION</div>
          <div style="line-height: 1.25;">&#160;</div>
          <div style="text-indent: 36pt; line-height: 1.25; text-align: justify;">The table below sets forth our cash and cash equivalents and capitalization as of June 30, 2025:</div>
          <div style="line-height: 1.25;">&#160;</div>
          <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zf142f32b0ff34c42babaf9e49c774525">

              <tr>
                <td style="width: 36pt;"><br>
                </td>
                <td style="width: 18pt; vertical-align: top;">&#8226;</td>
                <td style="width: auto; vertical-align: top;">
                  <div>on an actual basis; and</div>
                </td>
              </tr>

          </table>
          <div style="line-height: 1.25;">&#160;</div>
          <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z14f9ab1a12f24eac8ef73b317c39a150">

              <tr>
                <td style="width: 36pt;"><br>
                </td>
                <td style="width: 18pt; vertical-align: top;">&#8226;</td>
                <td style="width: auto; vertical-align: top;">
                  <div>on an as adjusted basis to reflect the issuance and sale of an aggregate of 44,117,647 ordinary shares in this offering at an assumed offering price of $1.70 per share (the last reported sale price of our ordinary shares on The
                    Nasdaq Stock Market LLC on August 11, 2025) for aggregate gross proceeds of approximately $75,000,000, after deducting commissions and estimated offering expenses payable by us.</div>
                </td>
              </tr>

          </table>
          <div style="line-height: 1.25;">&#160;</div>
          <div style="text-indent: 36pt; line-height: 1.25; text-align: justify;">Investors should read this table in conjunction with our audited financial statements and notes thereto incorporated by reference herein as well as &#8220;<font style="font-style: italic;">Use of Proceeds</font>&#8221; included elsewhere in this prospectus supplement, Item 5. &#8220;<font style="font-style: italic;">Operating and Financial Review and Prospects</font>&#8221; in our Annual Report and Exhibit 99.1 to our Report on Form 6&#8209;K
            filed with the SEC on August 13, 2025, each of which is incorporated by reference herein.</div>
          <div style="line-height: 1.25;">&#160;</div>
          <div style="line-height: 1.25">
            <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left; color: #000000; width: 100%;" id="z676110005f2140b3a1e018ae2e5467f2" class="cfttable">

                <tr>
                  <td valign="bottom" style="vertical-align: top; padding-bottom: 2px;">
                    <div style="line-height: 1.25;">&#160;</div>
                  </td>
                  <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;" colspan="1" class="cftguttercell">&#160;</td>
                  <td valign="bottom" style="vertical-align: top; border-bottom: #000000 solid 2px;" colspan="6">
                    <div style="text-align: center; line-height: 1.25; font-weight: bold;">As of June 30, 2025</div>
                  </td>
                  <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px;" colspan="1" class="cftfncell">&#160;</td>
                </tr>
                <tr>
                  <td valign="bottom" style="vertical-align: top; padding-bottom: 2px;">
                    <div style="line-height: 1.25;">&#160;</div>
                  </td>
                  <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;" colspan="1" class="cftguttercell">&#160;</td>
                  <td valign="bottom" style="vertical-align: top; border-bottom: #000000 solid 2px;" colspan="2">
                    <div style="text-align: center; line-height: 1.25; font-weight: bold;">Actual</div>
                  </td>
                  <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px;" colspan="1" class="cftfncell">&#160;</td>
                  <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;" colspan="1" class="cftguttercell">&#160;</td>
                  <td valign="bottom" style="vertical-align: top; border-bottom: #000000 solid 2px;" colspan="2">
                    <div style="text-align: center; line-height: 1.25; font-weight: bold;">As adjusted<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(1)</sup></div>
                  </td>
                  <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px;" colspan="1" class="cftfncell">&#160;</td>
                </tr>
                <tr>
                  <td valign="bottom" style="vertical-align: top;">
                    <div style="line-height: 1.25;">&#160;</div>
                  </td>
                  <td valign="bottom" style="vertical-align: bottom;" colspan="1" class="cftguttercell">&#160;</td>
                  <td valign="bottom" style="vertical-align: top;" colspan="6">
                    <div style="text-align: center; line-height: 1.25; font-weight: bold;">(in thousands, except share and per share data)</div>
                  </td>
                  <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom;" colspan="1" class="cftfncell">&#160;</td>
                </tr>
                <tr>
                  <td valign="bottom" style="vertical-align: top; width: 76%; background-color: rgb(204, 238, 255); padding-bottom: 2px;">
                    <div style="text-indent: -7.7pt; margin-left: 7.7pt; line-height: 1.25;">Cash and cash equivalents, bank deposits, short&#8209;term restricted cash and marketable securities</div>
                  </td>
                  <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px;" colspan="1" class="cftguttercell">&#160;</td>
                  <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0);" colspan="1" class="cftcurrcell">
                    <div style="line-height: 1.25;">$</div>
                  </td>
                  <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0);" colspan="1" class="cftnumcell">
                    <div style="line-height: 1.25;">79,395</div>
                  </td>
                  <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px;" colspan="1" class="cftfncell">&#160;</td>
                  <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px;" colspan="1" class="cftguttercell">&#160;</td>
                  <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0);" colspan="1" class="cftcurrcell">
                    <div style="line-height: 1.25;">$</div>
                  </td>
                  <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0);" colspan="1" class="cftnumcell">
                    <div style="line-height: 1.25;">151,018</div>
                  </td>
                  <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px;" colspan="1" class="cftfncell">&#160;</td>
                </tr>
                <tr>
                  <td valign="bottom" style="vertical-align: top; width: 76%;">
                    <div style="text-indent: -7.7pt; margin-left: 7.7pt; line-height: 1.25;">Total debt&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</div>
                  </td>
                  <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
                  <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">
                    <div style="line-height: 1.25;">$</div>
                  </td>
                  <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">
                    <div style="line-height: 1.25;">&#8212;</div>
                  </td>
                  <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">&#160;</td>
                  <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
                  <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">
                    <div style="line-height: 1.25;">$</div>
                  </td>
                  <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">
                    <div style="line-height: 1.25;">&#8212;</div>
                  </td>
                  <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">&#160;</td>
                </tr>
                <tr>
                  <td valign="bottom" style="vertical-align: top; width: 76%; background-color: rgb(204, 238, 255);">
                    <div style="text-indent: -7.7pt; margin-left: 7.7pt; line-height: 1.25;">Ordinary Shares of no par value: 500,000,000 shares authorized, 200,774,840 shares issued and outstanding, actual; 500,000,000 shares authorized, 244,892,487
                      shares issued and outstanding, as adjusted</div>
                  </td>
                  <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
                  <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell">&#160;</td>
                  <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
                    <div style="line-height: 1.25;">&#8212;</div>
                  </td>
                  <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">&#160;</td>
                  <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
                  <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell">&#160;</td>
                  <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
                    <div style="line-height: 1.25;">&#8212;</div>
                  </td>
                  <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">&#160;</td>
                </tr>
                <tr>
                  <td valign="bottom" style="vertical-align: top; width: 76%;">
                    <div style="text-indent: -7.7pt; margin-left: 7.7pt; line-height: 1.25;">Additional paid&#8209;in capital&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</div>
                  </td>
                  <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
                  <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">&#160;</td>
                  <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">
                    <div style="line-height: 1.25;">854,286</div>
                  </td>
                  <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">&#160;</td>
                  <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
                  <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">&#160;</td>
                  <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">
                    <div style="line-height: 1.25;">925,909</div>
                  </td>
                  <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">&#160;</td>
                </tr>
                <tr>
                  <td valign="bottom" style="vertical-align: top; width: 76%; background-color: rgb(204, 238, 255); padding-bottom: 2px;">
                    <div style="text-indent: -7.7pt; margin-left: 7.7pt; line-height: 1.25;">Accumulated deficit&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</div>
                  </td>
                  <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px;" colspan="1" class="cftguttercell">&#160;</td>
                  <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0);" colspan="1" class="cftcurrcell">&#160;</td>
                  <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0);" colspan="1" class="cftnumcell">
                    <div style="line-height: 1.25;">(761,166</div>
                  </td>
                  <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px;" colspan="1" class="cftfncell">
                    <div style="line-height: 1.25;">)</div>
                  </td>
                  <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px;" colspan="1" class="cftguttercell">&#160;</td>
                  <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0);" colspan="1" class="cftcurrcell">&#160;</td>
                  <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0);" colspan="1" class="cftnumcell">
                    <div style="line-height: 1.25;">(761,166</div>
                  </td>
                  <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px;" colspan="1" class="cftfncell">
                    <div style="line-height: 1.25;">)</div>
                  </td>
                </tr>
                <tr>
                  <td valign="bottom" style="vertical-align: top; width: 76%; padding-bottom: 2px;">
                    <div style="text-indent: -7.7pt; margin-left: 7.7pt; line-height: 1.25;">Total shareholders&#8217; equity&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</div>
                  </td>
                  <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" colspan="1" class="cftguttercell">&#160;</td>
                  <td valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);" colspan="1" class="cftcurrcell">
                    <div style="line-height: 1.25;">$</div>
                  </td>
                  <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);" colspan="1" class="cftnumcell">
                    <div style="line-height: 1.25;">93,120</div>
                  </td>
                  <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" colspan="1" class="cftfncell">&#160;</td>
                  <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" colspan="1" class="cftguttercell">&#160;</td>
                  <td valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);" colspan="1" class="cftcurrcell">
                    <div style="line-height: 1.25;">$</div>
                  </td>
                  <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);" colspan="1" class="cftnumcell">
                    <div style="line-height: 1.25;">164,743</div>
                  </td>
                  <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" colspan="1" class="cftfncell">&#160;</td>
                </tr>
                <tr>
                  <td valign="bottom" style="vertical-align: top; width: 76%; background-color: rgb(204, 238, 255); padding-bottom: 4px;">
                    <div style="text-indent: -7.7pt; margin-left: 7.7pt; line-height: 1.25; font-weight: bold;">Total capitalization&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</div>
                  </td>
                  <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 4px;" colspan="1" class="cftguttercell">&#160;</td>
                  <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 4px double rgb(0, 0, 0);" colspan="1" class="cftcurrcell">
                    <div style="line-height: 1.25;">$</div>
                  </td>
                  <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); border-bottom: 4px double rgb(0, 0, 0);" colspan="1" class="cftnumcell">
                    <div style="line-height: 1.25;">93,120</div>
                  </td>
                  <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 4px;" colspan="1" class="cftfncell">&#160;</td>
                  <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 4px;" colspan="1" class="cftguttercell">&#160;</td>
                  <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 4px double rgb(0, 0, 0);" colspan="1" class="cftcurrcell">
                    <div style="line-height: 1.25;">$</div>
                  </td>
                  <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); border-bottom: 4px double rgb(0, 0, 0);" colspan="1" class="cftnumcell">
                    <div style="line-height: 1.25;">164,743</div>
                  </td>
                  <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 4px;" colspan="1" class="cftfncell">&#160;</td>
                </tr>

            </table>
          </div>
          <div style="line-height: 1.25"> <br>
          </div>
          <div style="text-indent: 36pt; line-height: 1.25;"> (1) These amounts assume all shares are sold under this program. We cannot assure you as to the number of shares or price at which any shares will be sold hereunder.<br>
          </div>
          <div style="text-indent: 36pt; line-height: 1.25;"> <br>
          </div>
          <div style="text-indent: 36pt; line-height: 1.25;">As adjusted shareholders&#8217; equity amounts shown in the table above exclude the impact of:</div>
          <div style="line-height: 1.25;">&#160;</div>
          <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z636c7640ff434dc99b1f478713045326">

              <tr>
                <td style="width: 36pt;"><br>
                </td>
                <td style="width: 18pt; vertical-align: top;">&#8226;</td>
                <td style="width: auto; vertical-align: top;">
                  <div>16,231,141 warrants (Nasdaq: INVZW) outstanding as of June 30, 2025, each entitling its holder to purchase one ordinary share at an initial exercise price equal to $11.50 per share;</div>
                </td>
              </tr>

          </table>
          <div style="line-height: 1.25;">&#160;</div>
          <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z4c84cd0cca9447efac349a99cad0087f">

              <tr>
                <td style="width: 36pt;"><br>
                </td>
                <td style="width: 18pt; vertical-align: top;">&#8226;</td>
                <td style="width: auto; vertical-align: top;">
                  <div>23,021,582 warrants outstanding as of June 30, 2025, each entitling its holder to purchase one ordinary share at an initial exercise price equal to $1.69 per share;&#160;</div>
                </td>
              </tr>

          </table>
          <div style="line-height: 1.25;">&#160;</div>
          <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z1072c170381c496ebaf28bdbd8655114">

              <tr>
                <td style="width: 36pt;"><br>
                </td>
                <td style="width: 18pt; vertical-align: top;">&#8226;</td>
                <td style="width: auto; vertical-align: top;">
                  <div>9,702,210 ordinary shares issuable upon the exercise of options outstanding under our equity incentive plans as of June 30, 2025, at a weighted average exercise price of $5.04 per share;</div>
                </td>
              </tr>

          </table>
          <div style="line-height: 1.25;">&#160;</div>
          <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zd08320c4f59e440a9161658fe1dced40">

              <tr>
                <td style="width: 36pt;"><br>
                </td>
                <td style="width: 18pt; vertical-align: top;">&#8226;</td>
                <td style="width: auto; vertical-align: top;">
                  <div>15,071,937 ordinary shares issuable upon the vesting of restricted share units (&#8220;RSUs&#8221;) outstanding under our equity incentive plans as of June 30, 2025; and</div>
                </td>
              </tr>

          </table>
          <div style="line-height: 1.25;">&#160;</div>
          <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z56f9c8d953464b25b17afbdcba39a97d">

              <tr>
                <td style="width: 36pt;"><br>
                </td>
                <td style="width: 18pt; vertical-align: top;">&#8226;</td>
                <td style="width: auto; vertical-align: top;">
                  <div>8,582,398 ordinary shares reserved for future issuance under our equity incentive plan, which number is prior to the reduction of the ordinary shares subject to any outstanding options or RSUs granted subsequent to June 30, 2025, as
                    well as any future increases in the number of ordinary shares for future issuances under our equity incentive plan.</div>
                </td>
              </tr>

          </table>
          <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
            <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-weight: normal; font-style: normal;">S - 17</font></div>
            <div class="BRPFPageBreak" style="page-break-after: always;">
              <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
          </div>
          <div style="line-height: 1.25;"><br style="line-height: 1.25;">
          </div>
          <div style="text-align: center; line-height: 1.25; font-weight: bold;"><a name="DILUTION_PS"><!--Anchor--></a>DILUTION</div>
          <div style="line-height: 1.25;">&#160;</div>
          <div style="text-indent: 36pt; line-height: 1.25; text-align: justify;">If you invest in our ordinary shares in this offering, your ownership interest will be immediately diluted to the extent of the difference between the public offering price
            per share and the net tangible book value per ordinary share after this offering. Our net tangible book value as of June 30, 2025 was $0.46 per ordinary share. Net tangible book value per ordinary share represents the amount of our total
            consolidated tangible assets, less the amount of our total consolidated liabilities, divided by the number of ordinary shares outstanding as of June 30, 2025. Dilution in net tangible book value per ordinary share represents the difference
            between the amount per ordinary share paid by purchasers of ordinary shares in this offering and the as adjusted net tangible book value per ordinary share of our ordinary shares immediately after giving effect to this offering.</div>
          <div style="line-height: 1.25;">&#160;</div>
          <div style="text-indent: 36pt; line-height: 1.25;">
            <div style="text-indent: 36pt; line-height: 1.25; text-align: justify;">After giving effect to the sale of ordinary shares in the aggregate amount of $75.0 million in this offering at an assumed public offering price of $1.70 per ordinary
              share, the last reported sale price of our ordinary shares on Nasdaq on August 11, 2025, after deducting Jefferies&#8217; commissions and offering expenses payable by us, our net tangible book value on an adjusted basis as of June 30, 2025 would
              have been $0.67 per ordinary share. This amount represents an immediate increase in net tangible book value of $0.21 per ordinary share to our existing shareholders and an immediate dilution of $1.03 per ordinary share to new investors
              purchasing ordinary shares in this offering. We determine dilution by subtracting the as adjusted net tangible book value per ordinary share after this offering from the amount of cash that a new investor paid for an ordinary share.</div>
          </div>
          <div style="line-height: 1.25;">&#160;</div>
          <div style="text-indent: 36pt; line-height: 1.25; text-align: justify;">The following table illustrates this dilution on a per ordinary share basis.&#160;The as adjusted information is illustrative only and will adjust based on the actual price to the
            public, the actual number of ordinary shares sold and other terms of the offering determined at the time ordinary shares are sold pursuant to this prospectus. The ordinary shares sold in this offering, if any, will be sold from time to time at
            various prices:</div>
          <div style="line-height: 1.25;">&#160;</div>
          <table cellspacing="0" cellpadding="0" class="cfttable" id="ze6abd7fa5b914c9a93a6488e358840be" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left; color: #000000; width: 100%;">

              <tr>
                <td valign="bottom" style="vertical-align: top; width: 76%; background-color: rgb(204, 238, 255);">
                  <div style="text-indent: -11.05pt; margin-left: 11.05pt; line-height: 1.25;">Assumed public offering price per share&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</div>
                </td>
                <td valign="bottom" style="vertical-align: top; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
                <td valign="bottom" style="vertical-align: top; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
                <td valign="bottom" style="vertical-align: top; width: 9%; background-color: rgb(204, 238, 255);">&#160;</td>
                <td valign="bottom" style="vertical-align: top; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
                <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
                <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">
                  <div style="line-height: 1.25;">$</div>
                </td>
                <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
                  <div style="line-height: 1.25;">1.70</div>
                </td>
                <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
              </tr>
              <tr>
                <td valign="bottom" style="vertical-align: top; width: 76%;">
                  <div style="line-height: 1.25;">Net tangible book value per share as of June 30, 2025&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</div>
                </td>
                <td valign="bottom" style="vertical-align: top; width: 1%;">&#160;</td>
                <td valign="bottom" style="vertical-align: top; width: 1%;">$</td>
                <td valign="bottom" style="vertical-align: top; width: 9%;">
                  <div style="line-height: 1.25; text-align: right;">0.46</div>
                </td>
                <td valign="bottom" style="vertical-align: top; width: 1%;">&#160;</td>
                <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
                <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%;">
                  <div style="line-height: 1.25;"><br>
                  </div>
                </td>
                <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;"><br>
                </td>
                <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
              </tr>
              <tr>
                <td valign="bottom" style="vertical-align: top; width: 76%; background-color: rgb(204, 238, 255); padding-bottom: 2px;">
                  <div style="line-height: 1.25;">Increase in net tangible book value per share attributable to this offering</div>
                </td>
                <td valign="bottom" style="vertical-align: top; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px;">&#160;</td>
                <td valign="bottom" style="vertical-align: top; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
                <td valign="bottom" style="vertical-align: top; width: 9%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0);">
                  <div style="line-height: 1.25; text-align: right;">0.21</div>
                </td>
                <td valign="bottom" style="vertical-align: top; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px;">&#160;</td>
                <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px;">&#160;</td>
                <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px;">&#160;</td>
                <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); padding-bottom: 2px;">
                  <div style="line-height: 1.25;"><br>
                  </div>
                </td>
                <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px;">&#160;</td>
              </tr>
              <tr>
                <td valign="bottom" style="vertical-align: top; width: 76%; padding-bottom: 2px;">
                  <div style="text-indent: -11.05pt; margin-left: 11.05pt; line-height: 1.25;">As adjusted net tangible book value per share after this offering&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</div>
                </td>
                <td valign="bottom" style="vertical-align: top; width: 1%; padding-bottom: 2px;">&#160;</td>
                <td valign="bottom" style="vertical-align: top; width: 1%; padding-bottom: 2px;">&#160;</td>
                <td valign="bottom" style="vertical-align: top; width: 9%; padding-bottom: 2px;">&#160;</td>
                <td valign="bottom" style="vertical-align: top; width: 1%; padding-bottom: 2px;">&#160;</td>
                <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
                <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
                <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);">
                  <div style="line-height: 1.25;">0.67</div>
                </td>
                <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
              </tr>
              <tr>
                <td valign="bottom" style="vertical-align: top; width: 76%; background-color: rgb(204, 238, 255);">
                  <div style="text-indent: -11.05pt; margin-left: 11.05pt; line-height: 1.25;">Dilution per share to new investors in this offering&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</div>
                </td>
                <td valign="bottom" style="vertical-align: top; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
                <td valign="bottom" style="vertical-align: top; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
                <td valign="bottom" style="vertical-align: top; width: 9%; background-color: rgb(204, 238, 255);">&#160;</td>
                <td valign="bottom" style="vertical-align: top; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
                <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
                <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">
                  <div style="line-height: 1.25;">$</div>
                </td>
                <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
                  <div style="line-height: 1.25;">1.03</div>
                </td>
                <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
              </tr>

          </table>
          <div style="line-height: 1.25;">&#160;</div>
          <div style="text-indent: 36pt; line-height: 1.25;">
            <div style="text-indent: 36pt; line-height: 1.25; text-align: justify;">The ordinary shares sold in this offering, if any, will be sold from time to time at various prices. An increase of $0.25 per ordinary share in the price at which the
              ordinary shares are sold from the assumed public offering price of $1.70 per ordinary share shown in the table above, assuming all of our ordinary shares in the aggregate amount of $75.0 million are sold at that price, would cause our as
              adjusted net tangible book value per ordinary share after the offering to be $0.69 per ordinary share and would increase the dilution in net tangible book value per share to new investors to $1.26 per ordinary share, after deducting
              Jefferies&#8217; commissions and estimated aggregate offering expenses payable by us. A decrease of $0.25 per ordinary share in the price at which the ordinary shares are sold from the assumed public offering price of $1.70 per ordinary share shown
              in the table above, assuming all of our ordinary shares in the aggregate amount of $75.0 million are sold at that price, would cause our as adjusted net tangible book value per ordinary share after the offering to be $0.65 per ordinary share
              and would decrease the dilution in net tangible book value per ordinary share to new investors to $0.80 per ordinary share, after deducting Jefferies&#8217; commissions and offering expenses payable by us. This information is supplied for
              illustrative purposes only&#160;and may differ based on the actual offering price and the actual number of shares offered.</div>
          </div>
          <div style="line-height: 1.25;">&#160;</div>
          <div style="text-indent: 36pt; line-height: 1.25;">To the extent any of our outstanding warrants or options are exercised, or RSUs vest, there will be further dilution to new investors.</div>
          <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
            <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-weight: normal; font-style: normal;">S - 18</font></div>
            <div class="BRPFPageBreak" style="page-break-after: always;">
              <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
          </div>
          <div style="line-height: 1.25;">&#160;</div>
          <div style="text-align: center; line-height: 1.25; font-weight: bold;"><a name="TAXATION_PS"><!--Anchor--></a>TAXATION</div>
          <div style="line-height: 1.25;">&#160;</div>
          <div style="text-indent: 36pt; line-height: 1.25; font-style: italic; text-align: justify;">The following description is not intended to constitute a complete analysis of all tax consequences relating to the acquisition, ownership and disposition
            of our ordinary shares. You should consult your own tax advisor concerning the tax consequences of your particular situation, as well as any tax consequences that may arise under the laws of any state, local, foreign or other taxing
            jurisdiction.</div>
          <div style="line-height: 1.25;">&#160;</div>
          <div style="line-height: 1.25; font-weight: bold;">Material Israeli Tax Considerations</div>
          <div style="line-height: 1.25;">&#160;</div>
          <div style="text-indent: 36pt; line-height: 1.25; text-align: justify;">The following is a brief summary of the material Israeli tax laws applicable to us, and certain Israeli Government programs that benefit us. This section also contains a
            discussion of material Israeli tax consequences concerning the purchase, ownership and disposition of our ordinary shares. This summary does not discuss all the aspects of Israeli tax law that may be relevant to a particular investor in light
            of his or her personal investment circumstances or to some types of investors subject to special treatment under Israeli law. Examples of such investors include residents of Israel or traders in securities who are subject to special tax regimes
            not covered in this discussion. To the extent that the discussion is based on tax legislation that has not yet been subject to judicial or administrative interpretation, we cannot assure you that the appropriate tax authorities or the courts
            will accept the views expressed in this discussion. The discussion below is subject to change, including due to amendments under Israeli law or changes to the applicable judicial or administrative interpretations of Israeli law, which change
            could affect the tax consequences described below.</div>
          <div style="line-height: 1.25;">&#160;</div>
          <div style="text-indent: 36pt; line-height: 1.25; text-align: justify;"><font style="font-style: italic;">General corporate tax structure in Israel</font>.&#160;Israeli companies are generally subject to corporate income tax. In December 2016, the
            Israeli Parliament approved the Economic Efficiency Law (Legislative Amendments for Applying the Economic Policy for the 2017 and 2018 Budget Years) which reduces the corporate income tax rate from 25% to 24% effective from January&#160;1, 2017, and
            to 23% effective from January&#160;1, 2018 onwards. However, the effective tax rate payable by a company that derives income from an Approved Enterprise, a Preferred Enterprise, a Special Preferred Enterprise, a Benefited Enterprise, a Preferred
            Technological Enterprise or Special Preferred Technological Enterprise (as discussed below) may be considerably less. Capital gains derived by an Israeli company are generally subject to the corporate income tax rate.</div>
          <div style="line-height: 1.25;">&#160;</div>
          <div style="text-indent: 36pt; line-height: 1.25;"><font style="font-style: italic;">Law for the Encouragement of Industry (Taxes), 5729-1969.</font> The Law for the Encouragement of Industry (Taxes), 5729-1969, generally referred to as the
            Industry Encouragement Law, provides several tax benefits for &#8220;Industrial Companies.&#8221; We believe that we currently qualify as an Industrial Company within the meaning of the Industry Encouragement Law.</div>
          <div style="line-height: 1.25;">&#160;</div>
          <div style="text-indent: 36pt; line-height: 1.25; text-align: justify;">The Industry Encouragement Law and the regulations promulgated thereunder provide that an &#8220;Industrial Company&#8221; is an Israeli resident-company, of which 90% or more of its
            income in any tax year, other than income from certain government loans, capital gains, dividends, interest and linkage differentials, is derived from an &#8220;Industrial Enterprise&#8221; owned by it and located in Israel or in the &#8220;Area,&#8221; in accordance
            with the definition under section&#160;3A of the Israeli Tax Ordinance (the &#8220;Ordinance&#8221;). An &#8220;Industrial Enterprise&#8221; is defined as an enterprise whose principal activity in a given tax year is industrial production.</div>
          <div style="line-height: 1.25;">&#160;</div>
          <div style="text-indent: 36pt; line-height: 1.25;">Following are the main tax benefits available to Industrial Companies:</div>
          <div style="line-height: 1.25;">&#160;</div>
          <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z4c049621d263463fb21ad4f49fd957b3">

              <tr>
                <td style="width: 54pt;"><br>
                </td>
                <td style="width: 18pt; vertical-align: top;">&#8226;</td>
                <td style="width: auto; vertical-align: top;">
                  <div>Amortization of the cost of purchased patents, rights to use a patent, and&#160;know-how,&#160;which are used for the development or advancement of the Industrial Enterprise, over an eight-year period, commencing on the year in which the
                    Industrial Company began to use them;</div>
                </td>
              </tr>

          </table>
          <div style="line-height: 1.25;">&#160;</div>
          <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z0c04e351f9d843609ef83c902d7f91c5">

              <tr>
                <td style="width: 54pt;"><br>
                </td>
                <td style="width: 18pt; vertical-align: top;">&#8226;</td>
                <td style="width: auto; vertical-align: top;">
                  <div>Under limited conditions, an election to file consolidated tax returns with controlled Israeli Industrial Companies; and</div>
                </td>
              </tr>

          </table>
          <div style="line-height: 1.25;">&#160;</div>
          <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z187ead3e8a92404b800ae1f1b135eaf0">

              <tr>
                <td style="width: 54pt;"><br>
                </td>
                <td style="width: 18pt; vertical-align: top;">&#8226;</td>
                <td style="width: auto; vertical-align: top;">
                  <div>Expenses related to a public offering are deductible in equal amounts over three years commencing on the year of the offering.</div>
                </td>
              </tr>

          </table>
          <div style="line-height: 1.25;">&#160;</div>
          <div style="text-indent: 36pt; line-height: 1.25;">Eligibility for benefits under the Industry Encouragement Law is not contingent upon approval of any governmental authority.</div>
          <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
            <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-weight: normal; font-style: normal;">S - 19</font></div>
            <div class="BRPFPageBreak" style="page-break-after: always;">
              <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
          </div>
          <div style="line-height: 1.25;">&#160;</div>
          <div style="line-height: 1.25;">&#160;</div>
          <div style="text-indent: 36pt; line-height: 1.25; text-align: justify;"><font style="font-style: italic;">Tax benefits and grants for research and development</font>.&#160;Israeli tax law allows, under certain conditions, a tax deduction for
            expenditures related to scientific research and development projects, including capital expenditures, for the year in which they are incurred. Expenditures are deemed related to scientific research and development projects, if:</div>
          <div style="line-height: 1.25;">&#160;</div>
          <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z969c42c7bed84708bb878a8b92cfba92">

              <tr>
                <td style="width: 54pt;"><br>
                </td>
                <td style="width: 18pt; vertical-align: top;">&#8226;</td>
                <td style="width: auto; vertical-align: top;">
                  <div>The expenditures are approved by the relevant Israeli government ministry, determined by the field of research;</div>
                </td>
              </tr>

          </table>
          <div style="line-height: 1.25;">&#160;</div>
          <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zed94fadb1a60436481cfca8023e0a381">

              <tr>
                <td style="width: 54pt;"><br>
                </td>
                <td style="width: 18pt; vertical-align: top;">&#8226;</td>
                <td style="width: auto; vertical-align: top;">
                  <div>The research and development must be for the promotion of the company; and</div>
                </td>
              </tr>

          </table>
          <div style="line-height: 1.25;">&#160;</div>
          <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z21d56fcfc0af4e418ff49840ab445e93">

              <tr>
                <td style="width: 54pt;"><br>
                </td>
                <td style="width: 18pt; vertical-align: top;">&#8226;</td>
                <td style="width: auto; vertical-align: top;">
                  <div>The research and development is carried out by or on behalf of the company seeking such tax deduction.</div>
                </td>
              </tr>

          </table>
          <div style="line-height: 1.25;">&#160;</div>
          <div style="text-indent: 36pt; line-height: 1.25; text-align: justify;">The amount of such deductible expenses is reduced by the sum of any funds received through government grants for the finance of such scientific research and development
            projects. No deduction under these research and development deduction rules is allowed if such deduction is related to an expense invested in an asset depreciable under the general depreciation rules of the Ordinance. Expenditures that are
            unqualified under the conditions above are deductible in equal amounts over three years commencing in the year of the payment of such expenses.</div>
          <div style="line-height: 1.25;">&#160;</div>
          <div style="text-indent: 36pt; line-height: 1.25; text-align: justify;">From time to time, we may apply to the Israel Innovation Authority (the &#8220;IIA&#8221;) for approval to allow a tax deduction for all or most of research and development expenses
            during the year incurred. There can be no assurance that such application will be accepted. If we will not be able to deduct research and development expenses during the year of the payment, we will be able to deduct research and development
            expenses during a period of three years commencing in the year of the payment of such expenses.</div>
          <div style="line-height: 1.25;">&#160;</div>
          <div style="text-indent: 36pt; line-height: 1.25; text-align: justify;"><font style="font-style: italic;">Law for the Encouragement of Capital Investments, 5719-1959.</font> The Law for the Encouragement of Capital Investments, 5719-1959,
            generally referred to as the Investment Law, provides certain incentives for capital investments in production facilities (or other eligible assets).</div>
          <div style="line-height: 1.25;">&#160;</div>
          <div style="text-indent: 36pt; line-height: 1.25; text-align: justify;">The Investment Law was significantly amended effective as of April&#160;1, 2005 (the &#8220;2005 Amendment&#8221;), as of January&#160;1, 2011 (the &#8220;2011 Amendment&#8221;) and as of January&#160;1, 2017 (the
            &#8220;2017 Amendment&#8221;). Pursuant to the 2005 Amendment, tax benefits granted in accordance with the provisions of the Investment Law prior to its revision by the 2005 Amendment remain in force, but any benefits granted subsequently are subject to
            the provisions of the amended Investment Law. Similarly, the 2011 Amendment introduced new benefits to replace those granted in accordance with the provisions of the Investment Law in effect prior to the 2011 Amendment. However, companies
            entitled to benefits under the Investment Law as in effect prior to January&#160;1, 2011 were entitled to choose to continue to enjoy such benefits, provided that certain conditions are met, or elect instead, irrevocably, to forego such benefits and
            have the benefits of the 2011 Amendment apply. The 2017 Amendment introduces new benefits for Technological Enterprises, alongside the existing tax benefits.</div>
          <div style="line-height: 1.25;">&#160;</div>
          <div style="text-indent: 36pt; line-height: 1.25; text-align: justify;"><font style="font-style: italic;">Tax benefits under the 2011 amendment.</font> The 2011 Amendment canceled the availability of the benefits granted to Industrial Companies
            under the Investment Law prior to 2011 and, instead, introduced new benefits for income generated by a &#8220;Preferred Company&#8221; through its &#8220;Preferred Enterprise&#8221; (as such terms are defined in the Investment Law) as of January&#160;1, 2011. The
            definition of a Preferred Company includes a company incorporated in Israel that is not fully owned by a governmental entity, and that has, among other things, Preferred Enterprise status and is controlled and managed from Israel. Pursuant to
            the 2011 Amendment, a Preferred Company is entitled to a reduced corporate tax rate of 15% with respect to its income derived by its Preferred Enterprise in 2011 and 2012, unless the Preferred Enterprise is located in a specified development
            zone, in which case the rate will be 10%. Under the 2011 Amendment, such corporate tax rate was reduced from 15% and 10%, respectively, to 12.5% and 7%, respectively, in 2013, 16% and 9% respectively, in 2014, 2015 and 2016, and 16% and 7.5%,
            respectively, in 2017 and thereafter. Income derived by a Preferred Company from a &#8220;Special Preferred Enterprise&#8221; (as such term is defined in the Investment Law) would be entitled, during a benefits period of 10&#160;years, to further reduced tax
            rates of 8%, or 5% if the Special Preferred Enterprise is located in a certain development zone.</div>
          <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
            <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-weight: normal; font-style: normal;">S - 20</font></div>
            <div class="BRPFPageBreak" style="page-break-after: always;">
              <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
          </div>
          <div style="line-height: 1.25;">&#160;</div>
          <div style="text-indent: 36pt; line-height: 1.25; text-align: justify;">Dividends distributed from income which is attributed to a &#8220;Preferred Enterprise&#8221; will be subject to withholding tax at source at the following rates: (i)&#160;Israeli resident
            corporations &#8211; 0%, (although, if such dividends are subsequently distributed to individuals or a&#160;non-Israeli&#160;company the below rates detailed in sub sections&#160;(ii) and (iii)&#160;shall apply), (ii)&#160;Israeli resident individuals &#8211; 20%,
            and&#160;(iii)&#160;non-Israeli&#160;residents (individuals and corporations) &#8211; if a valid certificate is obtained in advance from the Israel Tax Authority (&#8220;ITA&#8221;) &#8211; 20% under the Investment Law or a reduced tax rate under the provisions of any applicable
            double tax treaty; if such a valid certificate is not obtained then the applicable withholding tax rate shall be 25% or 30% if distributed to a &#8220;substantial shareholder&#8221; (as explained below) at the time of the distribution or at any time during
            the preceding 12-month period.</div>
          <div style="line-height: 1.25; text-align: justify;">&#160;</div>
          <div style="text-indent: 36pt; line-height: 1.25; text-align: justify;"><font style="font-style: italic;">New tax benefits under the 2017 Amendment that became effective on January&#160;1, 2017.</font> The 2017 Amendment was enacted as part of the
            Economic Efficiency Law that was published on December&#160;29, 2016, and is effective as of January&#160;1, 2017. The 2017 Amendment provides new tax benefits for two types of &#8220;Technological Enterprises,&#8221; as described below, and is in addition to the
            other existing tax beneficial programs under the Investment Law. In addition, the 2017 Amendment also changed the definition of the term &#8220;Preferred Income&#8221;, which is the income eligible for benefits according to 2011 Amendment. </div>
          <div style="line-height: 1.25; text-align: justify;">&#160;</div>
          <div style="text-indent: 36pt; line-height: 1.25; text-align: justify;">The 2017 Amendment provides that a technological company satisfying certain conditions will qualify as a &#8220;Preferred Technological Enterprise&#8221; and will thereby enjoy a reduced
            corporate tax rate of 12% on income that qualifies as &#8220;Preferred Technological Income,&#8221; as defined in the Investment Law. The tax rate is further reduced to 7.5% for a Preferred Technological Enterprise located in development zone &#8220;A.&#8221; In
            addition, a Preferred Technological Company will enjoy a reduced corporate tax rate of 12% on capital gain derived from the sale of certain &#8220;Benefitted Intangible Assets&#8221; (as such term is defined in the Investment Law) to a related foreign
            company if the Benefitted Intangible Assets were acquired from a foreign company on or after January&#160;1, 2017 for at least NIS 200&#160;million, and the sale receives prior approval from the IIA.</div>
          <div style="line-height: 1.25; text-align: justify;">&#160;</div>
          <div style="text-indent: 36pt; line-height: 1.25; text-align: justify;">The 2017 Amendment further provides that a technology company satisfying certain conditions (including, <font style="font-style: italic;">inter </font>alia, having group
            consolidated revenues of at least NIS 10&#160;billion) will qualify as a &#8220;Special Preferred Technological Enterprise&#8221; and will thereby enjoy a reduced corporate tax rate of 6% on &#8220;Preferred Technological Income&#8221; regardless of the company&#8217;s
            geographic location within Israel. In addition, a Special Preferred Technological Enterprise will enjoy a reduced corporate tax rate of 6% on capital gain derived from the sale of certain &#8220;Benefitted Intangible Assets&#8221; to a related foreign
            company if the Benefitted Intangible Assets were either developed by the Special Preferred Technological Enterprise or acquired from a foreign company on or after January&#160;1, 2017, and the sale received prior approval from the IIA. A Special
            Preferred Technological Enterprise that acquires Benefitted Intangible Assets from a foreign company for more than NIS 500&#160;million will be eligible for these benefits for at least 10 years, subject to certain approvals as specified in the
            Investment Law.</div>
          <div style="line-height: 1.25; text-align: justify;">&#160;</div>
          <div style="text-indent: 36pt; line-height: 1.25; text-align: justify;">Dividends distributed to Israeli shareholders by a Preferred Technological Enterprise or a Special Preferred Technological Enterprise, paid out of Preferred Technological
            Income or capital gain derived from the sale of certain Benefitted Intangible Assets, are generally subject to withholding tax at source at the rate of 20% (in the case of non-Israeli shareholders&#8212;subject to the receipt in advance of a valid
            certificate from the ITA allowing for such reduced tax rate, or such lower rate as may be provided in an applicable tax treaty). However, if such dividends are paid to an Israeli company, no tax is required to be withheld (although, if such
            dividends are subsequently distributed to individuals or a non-Israeli company, withholding tax at a rate of 20% or such lower rate as may be provided in an applicable tax treaty, will apply). If such dividends are distributed to a foreign
            company that holds solely or together with other foreign companies 90% or more in the Israeli company and other conditions are met, the withholding tax rate will be 4% (in either case, subject to the receipt in advance of a valid certificate
            from the ITA allowing for such 4% rate or lower treaty tax rate).</div>
          <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
            <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-weight: normal; font-style: normal;">S - 21</font></div>
            <div class="BRPFPageBreak" style="page-break-after: always;">
              <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
          </div>
          <div style="line-height: 1.25;">&#160;</div>
          <div style="text-indent: 36pt; line-height: 1.25; text-align: justify;">Currently, we believe that we may be eligible to receive the tax benefits under the 2017 Amendment as a Preferred Technological Enterprise but there is no assurance that we
            will meet all the terms and conditions required under the Investment Law that will allow us to enjoy any tax benefits under the Investment Law. It should be noted that the proportion of income that may be considered Preferred Technological
            Income and enjoy the tax benefits described above should be calculated according to a nexus formula, which is based on the proportion as that of qualifying expenditures incurred in the development of the Benefitted Intangible Assets compared to
            overall expenditures.</div>
          <div style="line-height: 1.25; text-align: justify;">&#160;</div>
          <div style="line-height: 1.25; font-style: italic; font-weight: bold; text-align: justify;">Taxation of Our Shareholders</div>
          <div style="line-height: 1.25; text-align: justify;">&#160;</div>
          <div style="text-indent: 36pt; line-height: 1.25; text-align: justify;"><font style="font-style: italic;">Capital gains taxes applicable to non-Israeli resident shareholders.</font> A non-Israeli resident who derives capital gains from the sale
            of ordinary shares in an Israeli resident company that were purchased after December 31, 2008 should be exempt from Israeli tax unless, among other requirements, the ordinary shares were held through a permanent establishment that the
            non-resident maintains in Israel. If not exempt, a non-Israeli resident shareholder would generally be subject to tax on capital gain at the ordinary corporate income tax rate (23% in 2025), if generated by a company, or at the rate of 25%, if
            generated by an individual, or 30%, if generated by an individual who is a &#8220;substantial shareholder&#8221; (as defined under the Ordinance), at the time of sale or at any time during the preceding 12-month period (or if the shareholder claims a
            deduction for interest and linkage differences expenses in connection with the purchase and holding of such shares). A &#8220;substantial shareholder&#8221; is generally a person who, alone or together with such person&#8217;s relatives or another person who
            collaborates with such person on a permanent basis, holds, directly or indirectly, at least 10% of any of the &#8220;means of control&#8221; of the corporation. &#8220;Means of control&#8221; generally include, among others, the right to vote, receive profits,
            nominate a director or an executive officer, receive assets upon liquidation, or order someone who holds any of the aforesaid rights how to act, regardless of the source of such right. Individual and corporate shareholders dealing in securities
            in Israel are taxed at the tax rates applicable to business income (corporate income tax rate for a corporation (23% in 2025) and a marginal tax rate of up to 47% for an individual in 2025 (excluding surtax, as discussed below)) unless contrary
            provisions in a relevant tax treaty apply. Non-Israeli entities will not be entitled to the foregoing exemption if Israeli residents: (i)&#160;have a controlling interest of more than 25% in such non-Israeli entity or (ii)&#160;are the beneficiaries of,
            or are entitled to, 25% or more of the revenues or profits of such non-Israeli entity, whether directly or indirectly. In addition, such exemption is not applicable to a person whose gains from selling or otherwise disposing of the ordinary
            shares are deemed to be business income.</div>
          <div style="line-height: 1.25; text-align: justify;">&#160;</div>
          <div style="text-indent: 36pt; line-height: 1.25; text-align: justify;">Additionally, a sale of ordinary shares by a non-Israeli resident may be exempt from Israeli capital gains tax under the provisions of an applicable tax treaty. For example,
            under The Convention Between the Government of the United States of America and the Government of the State of Israel with respect to Taxes on Income, as amended (the &#8220;United States-Israel Tax Treaty&#8221;), the sale, exchange or other disposition
            of ordinary shares by a shareholder who is a United States resident (for purposes of the treaty) holding the ordinary shares as a capital asset and who is entitled to claim the benefits afforded to such a resident by the United States-Israel
            Tax Treaty (a &#8220;Treaty U.S. Resident&#8221;) is generally exempt from Israeli capital gains tax, unless: (i)&#160;the capital gain arising from such sale, exchange or disposition is attributed to real estate located in Israel; (ii)&#160;the capital gain arising
            from such sale, exchange or disposition is attributed to royalties; (iii)&#160;the capital gain arising from the such sale, exchange or disposition is attributed to a permanent establishment in Israel, under certain terms; (iv)&#160;such Treaty U.S.
            Resident holds, directly or indirectly, shares representing 10% or more of the voting capital of such company during any part of the 12-month period preceding the sale, exchange or disposition, subject to certain conditions; or (v)&#160;such Treaty
            U.S. Resident is an individual and was present in Israel for a period or periods aggregating 183 days or more during the relevant taxable year. In any such case, the sale, exchange or disposition of our ordinary shares would be subject to
            Israeli tax (unless exempt under the Israeli domestic law as described above). Under the United States-Israel Tax Treaty, a Treaty U.S. Resident may be permitted to claim a credit for such taxes against the U.S. federal income tax imposed with
            respect to such sale, exchange or disposition, subject to the limitations under U.S. law applicable to foreign tax credits. The United States-Israel Tax Treaty does not provide such credit against any U.S. state or local taxes.</div>
          <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
            <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-weight: normal; font-style: normal;">S - 22</font></div>
            <div class="BRPFPageBreak" style="page-break-after: always;">
              <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
          </div>
          <div style="line-height: 1.25;">&#160;</div>
          <div style="text-indent: 36pt; line-height: 1.25; text-align: justify;">Regardless of whether non-Israeli shareholders may be liable for Israeli capital gains tax on the sale of their ordinary shares, the payment of the consideration for such
            sale may be subject to the withholding of Israeli tax at source and shareholders may be required to demonstrate that they are exempt from tax on their capital gains in order to avoid withholding at source at the time of sale. Specifically, the
            ITA may require shareholders who are not liable for Israeli capital gains tax on such a sale to sign declarations on forms specified by the ITA, provide documents&#160; (including, for example, a certificate of residency) or obtain a specific
            exemption from the Israel Tax Authority to confirm their status as non-Israeli residents (and, in the absence of such declarations or exemptions, the ITA may require the purchaser of the shares to withhold tax at source).</div>
          <div style="line-height: 1.25; text-align: justify;">&#160;</div>
          <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">A tax return must be filed, and an advance payment must be paid, by January 31 of each year for sales of securities traded on a stock exchange made within the last six months
            of the preceding year, and by July 31 of each year for the sales made in the first six months of that year. Capital gains must also be reported on the annual income tax return. If all taxes are duly withheld, a non-Israeli resident is generally
            exempt from the obligation to file such tax returns in Israel with respect to such income, provided that (i) such income was not generated from business conducted in Israel by the non-Israeli&#160;resident, (ii) the non-Israeli&#160;resident has no other
            taxable sources of income in Israel with respect to which a tax return is required to be filed, and (iii) the non-Israeli&#160;resident is not obligated to pay surtax (as described below).</div>
          <div style="line-height: 1.25; text-align: justify;">&#160;</div>
          <div style="text-indent: 36pt; line-height: 1.25; text-align: justify;"><font style="font-style: italic;">Taxation of non-Israeli shareholders on receipt of dividends.</font> Non-Israeli residents (either individuals or corporations) are
            generally subject to Israeli income tax on the receipt of dividends paid on our ordinary shares at the rate of 25%, which tax will be withheld at source, unless relief is provided in a treaty between Israel and the shareholder&#8217;s country of
            residence (subject to the receipt in advance of a valid withholding tax certificate from the ITA allowing for a reduced tax rate). With respect to a person who is a &#8220;substantial shareholder&#8221; at the time of receiving the dividend or on any time
            during the preceding 12 months, the applicable tax rate is 30%. Such dividends are generally subject to Israeli withholding tax at a rate of 25% so long as the ordinary shares are registered with a nominee company (whether the recipient is a
            substantial shareholder or not) or, subject to the receipt in advance of a valid withholding tax certificate from the ITA allowing for a reduced tax rate, 15% if the dividend is distributed from income attributed to an Approved Enterprise or a
            Benefited Enterprise and 20% if the dividend is distributed from income attributed to a Preferred Enterprise, a Special Preferred Enterprise, Preferred Technological Enterprise or Special Preferred Technological Enterprise or such lower rate as
            may be provided in an applicable tax treaty. For example, under the United States-Israel Tax Treaty, the maximum rate of tax withheld at source in Israel on dividends paid to a holder of our ordinary shares who is a Treaty U.S. Resident is 25%.
            However, generally, the maximum rate of withholding tax on dividends, not generated by an Approved Enterprise, Benefited Enterprise, Preferred Enterprise, Special Preferred Enterprise, Preferred Technological Enterprise or Special Preferred
            Technological Enterprise, that are paid to a U.S. corporation holding 10% or more of the outstanding voting capital throughout the tax year in which the dividend is distributed as well as during the previous tax year, is 12.5%, provided that
            not more than 25% of the gross income of the paying corporation for such preceding year consists of certain types of dividends and interest. Notwithstanding the foregoing, dividends distributed from income attributed to an Approved Enterprise,
            Benefited Enterprise, Preferred Enterprise, Special Preferred Enterprise, Preferred Technological Enterprise or Special Preferred Technological Enterprise are not entitled to such reduction under the United States-Israel Tax Treaty but are
            subject to a withholding tax rate of 15% for a shareholder that is a U.S. corporation, provided that the conditions related to 10% or more holdings and to our gross income for the previous year (as set forth in the previous sentence) are met.
            The aforementioned rates under the United States-Israel Tax Treaty would not apply if the dividend income is derived through a permanent establishment of the U.S. resident in Israel. If the dividend is attributable partly to income derived from
            an Approved Enterprise, Benefited Enterprise, Preferred Enterprise, Special Preferred Enterprise, Preferred Technological Enterprise or Special Preferred Technological Enterprise and partly to other sources of income, the withholding rate will
            be a blended rate reflecting the relative portions of the two types of income. We cannot assure you that we will designate the profits that we may distribute in a way that will reduce shareholders&#8217; tax liability.</div>
          <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
            <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-weight: normal; font-style: normal;">S - 23</font></div>
            <div class="BRPFPageBreak" style="page-break-after: always;">
              <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
          </div>
          <div style="line-height: 1.25;">&#160;</div>
          <div style="text-indent: 36pt; line-height: 1.25; text-align: justify;">A non-Israeli resident who receives dividends from which all tax due was withheld at source according to applicable provisions of the Ordinance and the regulations
            promulgated thereunder is generally exempt from the obligation to file tax returns in Israel with respect to such income, provided that (i)&#160;such income was not generated from business conducted in Israel by the non-Israeli&#160;resident, (ii)&#160;the
            non-Israeli&#160;resident has no other taxable sources of income in Israel with respect to which a tax return is required to be filed, and (iii)&#160;the non-Israeli&#160;resident is not obligated to pay surtax (as described below).</div>
          <div style="line-height: 1.25; text-align: justify;">&#160;</div>
          <div style="text-indent: 36pt; line-height: 1.25; text-align: justify;"><font style="font-style: italic;">Surtax</font>. Subject to the provisions of an applicable tax treaty, individuals who are subject to tax in Israel (whether any such
            individual is an Israeli resident or non-Israeli resident) are also subject to an additional tax at a rate of 3% on annual income (including, but not limited to, dividends, interest and capital gain) exceeding NIS 721,560 for 2025, which amount
            is generally linked to the annual change in the Israeli consumer price index. In addition, the portion of an individual&#8217;s annual income from capital sources (e.g., capital gains, real estate appreciation, dividends, interest, CPI linkage
            differentials, rental income, passive royalties, etc.) exceeding a certain threshold (NIS 721,560 in 2025) is subject to an additional surtax of 2%. It should be emphasized that with respect to non-Israeli residents, these surtaxes apply to
            Israeli source income (unless such income is exempt under Israeli domestic law or an applicable tax treaty).</div>
          <div style="line-height: 1.25; text-align: justify;">&#160;</div>
          <div style="text-indent: 36pt; line-height: 1.25; text-align: justify;"><font style="font-style: italic;">Estate and Gift Tax</font>.&#160;Israeli law presently does not impose estate or gift taxes.</div>
          <div style="line-height: 1.25; text-align: justify;">&#160;</div>
          <div style="line-height: 1.25; font-weight: bold; text-align: justify;">United States Federal Income Tax Considerations</div>
          <div style="line-height: 1.25; text-align: justify;">&#160;</div>
          <div style="text-indent: 36pt; line-height: 1.25; text-align: justify;">The following is a description of certain material U.S. federal income tax consequences of the acquisition, ownership and disposition of our ordinary shares offered pursuant
            to this prospectus supplement. This description addresses only the U.S. federal income tax consequences to U.S. Holders (as defined below) that hold our ordinary shares as capital assets within the meaning of Section 1221 of the Internal
            Revenue Code of 1986, as amended (the &#8220;Code&#8221;), and that have the U.S. dollar as their functional currency.</div>
          <div style="line-height: 1.25; text-align: justify;">&#160;</div>
          <div style="text-indent: 36pt; line-height: 1.25; text-align: justify;">This discussion is based upon the Code, applicable U.S. Treasury regulations, administrative pronouncements and judicial decisions, in each case as in effect on the date
            hereof, all of which are subject to change (possibly with retroactive effect). No ruling has been or will be requested from the Internal Revenue Service (the &#8220;IRS&#8221;) regarding the tax consequences of the acquisition, ownership or disposition of
            the ordinary shares, and there can be no assurance that the IRS will agree with the discussion set out below. This summary does not address any U.S. tax consequences other than U.S. federal income tax consequences (e.g., the estate and gift tax
            or the Medicare tax on net investment income) and does not address any state, local or non&#8209;U.S. tax consequences.</div>
          <div style="line-height: 1.25;">&#160;</div>
          <div style="text-indent: 36pt; line-height: 1.25; text-align: justify;">This description does not address tax considerations applicable to holders that may be subject to special tax rules, including, without limitation:</div>
          <div style="line-height: 1.25;">&#160;</div>
          <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z8d9235c7e1c84466a6841f60533f32d6">

              <tr>
                <td style="width: 36pt;"><br>
                </td>
                <td style="width: 18pt; vertical-align: top;">&#8226;</td>
                <td style="width: auto; vertical-align: top;">
                  <div>banks, financial institutions or insurance companies;</div>
                </td>
              </tr>

          </table>
          <div style="line-height: 1.25;">&#160;</div>
          <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zfd92985325c34a2e83cb7ca2064083d8">

              <tr>
                <td style="width: 36pt;"><br>
                </td>
                <td style="width: 18pt; vertical-align: top;">&#8226;</td>
                <td style="width: auto; vertical-align: top;">
                  <div>real estate investment trusts or regulated investment companies;</div>
                </td>
              </tr>

          </table>
          <div style="line-height: 1.25;">&#160;</div>
          <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z2d5579c5ece64dc5b385337e5153da4b">

              <tr>
                <td style="width: 36pt;"><br>
                </td>
                <td style="width: 18pt; vertical-align: top;">&#8226;</td>
                <td style="width: auto; vertical-align: top;">
                  <div>dealers or brokers;</div>
                </td>
              </tr>

          </table>
          <div style="line-height: 1.25;">&#160;</div>
          <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zb76ef0e559044b2eba2f67662f2053b8">

              <tr>
                <td style="width: 36pt;"><br>
                </td>
                <td style="width: 18pt; vertical-align: top;">&#8226;</td>
                <td style="width: auto; vertical-align: top;">
                  <div>traders that elect to mark to market;</div>
                </td>
              </tr>

          </table>
          <div style="line-height: 1.25;">&#160;</div>
          <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z2f19070ed7854af08234f875b71a2d12">

              <tr>
                <td style="width: 36pt;"><br>
                </td>
                <td style="width: 18pt; vertical-align: top;">&#8226;</td>
                <td style="width: auto; vertical-align: top;">
                  <div>tax exempt entities or organizations;</div>
                </td>
              </tr>

          </table>
          <div style="line-height: 1.25;">&#160;</div>
          <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z758831d1db8041ad9165be11c14438fb">

              <tr>
                <td style="width: 36pt;"><br>
                </td>
                <td style="width: 18pt; vertical-align: top;">&#8226;</td>
                <td style="width: auto; vertical-align: top;">
                  <div> &#8220;individual retirement accounts&#8221; and other tax deferred accounts;</div>
                </td>
              </tr>

          </table>
          <div style="line-height: 1.25;">&#160;</div>
          <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zd3885d12f40e490ab8a712b9a3fa009f">

              <tr>
                <td style="width: 36pt;"><br>
                </td>
                <td style="width: 18pt; vertical-align: top;">&#8226;</td>
                <td style="width: auto; vertical-align: top;">
                  <div>certain former citizens or long term residents of the United States;</div>
                </td>
              </tr>

          </table>
          <div style="line-height: 1.25;">&#160;</div>
          <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z99b5940ea4424e96a9d84c2bea5d117e">

              <tr>
                <td style="width: 36pt;"><br>
                </td>
                <td style="width: 18pt; vertical-align: top;">&#8226;</td>
                <td style="width: auto; vertical-align: top;">
                  <div>persons that are resident or ordinarily resident in or have a permanent establishment in a jurisdiction outside the United States;</div>
                </td>
              </tr>

          </table>
          &#160;
          <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z6f801cb6fece46ac96b6af4bcb54b9b9">

              <tr>
                <td style="width: 36pt;"><br>
                </td>
                <td style="width: 18pt; vertical-align: top;">&#8226;</td>
                <td style="width: auto; vertical-align: top;">
                  <div>persons subject to any alternative minimum tax;</div>
                </td>
              </tr>

          </table>
          <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
            <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-weight: normal; font-style: normal;">S - 24</font></div>
            <div class="BRPFPageBreak" style="page-break-after: always;">
              <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
          </div>
          <div style="line-height: 1.25"> <br>
          </div>
          <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z05d92beadeb0421a929e594f9faa8b73">

              <tr>
                <td style="width: 36pt;"><br>
                </td>
                <td style="width: 18pt; vertical-align: top;">&#8226;</td>
                <td style="width: auto; vertical-align: top;">
                  <div>persons that acquired our ordinary shares pursuant to the exercise of any employee share option or otherwise as compensation for the performance of services;</div>
                </td>
              </tr>

          </table>
          <div style="line-height: 1.25;">&#160;</div>
          <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zba066028e2de4c8ebe58a91fb6dc626a">

              <tr>
                <td style="width: 36pt;"><br>
                </td>
                <td style="width: 18pt; vertical-align: top;">&#8226;</td>
                <td style="width: auto; vertical-align: top;">
                  <div>persons holding our ordinary shares as part of a &#8220;hedging,&#8221; &#8220;integrated&#8221; or &#8220;conversion&#8221; transaction or as a position in a &#8220;straddle&#8221; for U.S. federal income tax purposes;</div>
                </td>
              </tr>

          </table>
          <div style="line-height: 1.25;">&#160;</div>
          <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z11f9fac87a6b477f9478b804613fe908">

              <tr>
                <td style="width: 36pt;"><br>
                </td>
                <td style="width: 18pt; vertical-align: top;">&#8226;</td>
                <td style="width: auto; vertical-align: top;">
                  <div>persons subject to special tax accounting rules as a result of any item of gross income with respect to the ordinary shares being taken into account in an applicable financial statement;</div>
                </td>
              </tr>

          </table>
          <div style="line-height: 1.25;">&#160;</div>
          <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z3d9f71cf77944fbf9d0d88b957f9f7ad">

              <tr>
                <td style="width: 36pt;"><br>
                </td>
                <td style="width: 18pt; vertical-align: top;">&#8226;</td>
                <td style="width: auto; vertical-align: top;">
                  <div>partnerships or other pass-through entities or arrangements and persons holding ordinary shares through partnerships or other pass-through entities or arrangements; or</div>
                </td>
              </tr>

          </table>
          <div style="line-height: 1.25;">&#160;</div>
          <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z00203c1536a84cb2b41d0280ae16271f">

              <tr>
                <td style="width: 36pt;"><br>
                </td>
                <td style="width: 18pt; vertical-align: top;">&#8226;</td>
                <td style="width: auto; vertical-align: top;">
                  <div>holders that directly, indirectly or through attribution own 10% or more of the total voting power or value of all of our outstanding shares.</div>
                </td>
              </tr>

          </table>
          <div style="line-height: 1.25;">&#160;</div>
          <div style="text-indent: 36pt; line-height: 1.25;">For purposes of this description, a &#8220;U.S. Holder&#8221; is a beneficial owner of our ordinary shares that, for U.S. federal income tax purposes, is:</div>
          <div style="line-height: 1.25;">&#160;</div>
          <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z8d5a3bf221b846dbac5fb5f27239fc0b">

              <tr>
                <td style="width: 36pt;"><br>
                </td>
                <td style="width: 18pt; vertical-align: top;">&#8226;</td>
                <td style="width: auto; vertical-align: top;">
                  <div>an individual who is a citizen or resident of the United States;</div>
                </td>
              </tr>

          </table>
          <div style="line-height: 1.25;">&#160;</div>
          <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z0548c07f03e94738b3f8b292c275aa53">

              <tr>
                <td style="width: 36pt;"><br>
                </td>
                <td style="width: 18pt; vertical-align: top;">&#8226;</td>
                <td style="width: auto; vertical-align: top;">
                  <div>a corporation (or other entity treated as a corporation for U.S. federal income tax purposes) created or organized in or under the laws of the United States or any state thereof, including the District of Columbia;</div>
                </td>
              </tr>

          </table>
          <div style="line-height: 1.25;">&#160;</div>
          <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zbf854a699fbf4eca9da70425eed87cff">

              <tr>
                <td style="width: 36pt;"><br>
                </td>
                <td style="width: 18pt; vertical-align: top;">&#8226;</td>
                <td style="width: auto; vertical-align: top;">
                  <div>an estate the income of which is subject to U.S. federal income taxation regardless of its source; or</div>
                </td>
              </tr>

          </table>
          <div style="line-height: 1.25;">&#160;</div>
          <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z7f9f092972cd49d4b60f27830bb69f95">

              <tr>
                <td style="width: 36pt;"><br>
                </td>
                <td style="width: 18pt; vertical-align: top;">&#8226;</td>
                <td style="width: auto; vertical-align: top;">
                  <div>a trust if such trust has validly elected to be treated as a United States person for U.S. federal income tax purposes or if (1) a court within the United States is able to exercise primary supervision over its administration and (2)
                    one or more United States persons have the authority to control all of the substantial decisions of such trust.</div>
                </td>
              </tr>

          </table>
          <div style="line-height: 1.25;">&#160;</div>
          <div style="text-indent: 36pt; line-height: 1.25; text-align: justify;">If an entity or arrangement treated as a partnership for U.S. federal income tax purposes holds our ordinary shares, the tax treatment of a partner in such partnership will
            generally depend on the status of the partner and the activities of the partnership. Such a partner or partnership should consult its tax advisor as to the particular U.S. federal income tax consequences of acquiring, owning and disposing of
            our ordinary shares in its particular circumstance.</div>
          <div style="line-height: 1.25;">&#160;</div>
          <div style="text-indent: 36pt; line-height: 1.25; text-align: justify;">You should consult your tax advisor with respect to the U.S. federal, state, local and foreign tax consequences of acquiring, owning and disposing of our ordinary shares.</div>
          <div style="line-height: 1.25;">&#160;</div>
          <div style="line-height: 1.25; font-style: italic;">Distributions on Ordinary Shares</div>
          <div style="line-height: 1.25;">&#160;</div>
          <div style="text-indent: 36pt; line-height: 1.25; text-align: justify;">As noted below in &#8220;&#8212;Passive Foreign Investment Company Considerations,&#8221; we believe we were a PFIC for our most recent taxable year ended December 31, 2024, and we cannot be
            sure as to whether we will be a PFIC for our current taxable year ending December 31, 2025. Accordingly, the treatment most likely to apply to a U.S. Holder with respect to distributions on ordinary shares is as set forth below under &#8220;&#8212;Passive
            Foreign Investment Company Considerations.&#8221;&#160; Subject to the discussion below in &#8220;&#8212;Passive Foreign Investment Company Considerations,&#8221;&#160; the gross amount of any distribution made to you with respect to our ordinary shares, before reduction for
            any Israeli taxes withheld therefrom, generally will be includible in your income as dividend income on the date on which the dividends are actually or constructively received, to the extent such distribution is paid out of our current or
            accumulated earnings and profits as determined under U.S. federal income tax principles. To the extent that the amount of any distribution by us exceeds our current and accumulated earnings and profits as determined under U.S. federal income
            tax principles, it will be treated first as a tax free return of your adjusted tax basis in our ordinary shares and thereafter as capital gain. However, we do not expect to maintain calculations of our earnings and profits under U.S. federal
            income tax principles and, therefore, you should expect that the entire amount of any distribution generally will be reported as dividend income to you. If you are a non&#8209;corporate U.S. Holder, you may qualify for the lower rates of taxation
            with respect to dividends on ordinary shares applicable to long term capital gains (i.e., gains from the sale of capital assets held for more than one year), provided that we are not a PFIC (as discussed below under &#8220;&#8212;Passive Foreign Investment
            Company Considerations&#8221;) with respect to you in our taxable year in which the dividend was paid or in the prior taxable year and certain other conditions are met, including certain holding period requirements and the absence of certain risk
            reduction transactions. However, such dividends will not be eligible for the dividends received deduction generally allowed to corporate U.S. Holders.</div>
          <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
            <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-weight: normal; font-style: normal;">S - 25</font></div>
            <div class="BRPFPageBreak" style="page-break-after: always;">
              <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
          </div>
          <div style="line-height: 1.25;">&#160;</div>
          <div style="text-indent: 36pt; line-height: 1.25; text-align: justify;">Dividends paid to you with respect to our ordinary shares generally will be treated as foreign source income, which may be relevant in calculating your foreign tax credit
            limitation. Subject to certain conditions and limitations, Israeli tax withheld on dividends may be credited against your U.S. federal income tax liability or, at your election, be deducted from your U.S. federal taxable income. Dividends that
            we distribute generally should constitute &#8220;passive category income&#8221; for purposes of the foreign tax credit. A foreign tax credit for foreign taxes imposed on distributions may be subject to significant limitations. The rules relating to the
            determination of the foreign tax credit are complex, and you should consult your tax advisor to determine whether and to what extent you would be entitled to this credit.</div>
          <div style="line-height: 1.25; text-align: justify;">&#160;</div>
          <div style="line-height: 1.25; font-style: italic; text-align: justify;">Sale, Exchange or Other Disposition of Ordinary Shares </div>
          <div style="line-height: 1.25; text-align: justify;">&#160;</div>
          <div style="text-indent: 36pt; line-height: 1.25; text-align: justify;">&#160;As noted below in &#8220;&#8212;Passive Foreign Investment Company Considerations,&#8221; we believe we were a PFIC for our most recent taxable year ended December 31, 2024, and we cannot be
            sure as to whether we will be a PFIC for our current taxable year ending December 31, 2025. Accordingly, the treatment most likely to apply to a U.S. Holder upon the sale, exchange or other disposition of ordinary shares is as set forth below
            in &#8220;&#8212;Passive Foreign Investment Company Considerations.&#8221; </div>
          <div style="line-height: 1.25; text-align: justify;">&#160;</div>
          <div style="text-indent: 36pt; line-height: 1.25; text-align: justify;">Subject to the discussion below under &#8220;&#8212;Passive Foreign Investment Considerations,&#8221; you generally will recognize gain or loss on the sale, exchange or other disposition of
            our ordinary shares equal to the difference between the amount realized on such sale, exchange or other disposition and your adjusted tax basis in our ordinary shares, and such gain or loss will be capital gain or loss. If you are a
            non&#8209;corporate U.S. Holder, capital gain from the sale, exchange or other disposition of ordinary shares is currently generally eligible for a preferential rate of taxation applicable to capital gains, if your holding period for such ordinary
            shares exceeds one year (i.e., such gain is long term capital gain). The deductibility of capital losses for U.S. federal income tax purposes is subject to limitations. Any such gain or loss that a U.S. Holder recognizes generally will be
            treated as U.S. source income or loss for foreign tax credit limitation purposes. The rules governing the treatment of foreign taxes imposed on a U.S. Holder and foreign tax credits are complex, and U.S. Holders should consult their tax
            advisors as to whether the Israeli tax on gains may be creditable or deductible in light of their particular circumstances, including their eligibility for benefits under an applicable income tax treaty and the potential impact of applicable
            United States Treasury regulations.</div>
          <div style="line-height: 1.25; text-align: justify;">&#160;</div>
          <div style="line-height: 1.25; font-style: italic; text-align: justify;">Passive Foreign Investment Company Considerations</div>
          <div style="line-height: 1.25; text-align: justify;">&#160;</div>
          <div style="text-indent: 36pt; line-height: 1.25; text-align: justify;">In general, a non&#8209;U.S. corporation will be classified as a &#8220;passive foreign investment company&#8221; or &#8220;PFIC&#8221; for any taxable year if at least (i) 75% of its gross income is
            classified as &#8220;passive income&#8221; or (ii) 50% of its gross assets (generally determined on the basis of a quarterly average) produce or are held for the production of passive income. Passive income for this purpose generally includes dividends,
            interest, royalties, rents, gains from commodities and securities transactions and the excess of gains over losses from the disposition of assets which produce passive income. For these purposes, cash and other assets readily convertible into
            cash are considered passive assets, and goodwill and other unbooked intangibles are generally taken into account. In making this determination, the non&#8209;U.S. corporation is treated as earning its proportionate share of any income and owning its
            proportionate share of any assets of any corporation in which it directly or indirectly holds 25% or more (by value) of the stock.</div>
          <div style="line-height: 1.25; text-align: justify;">&#160;</div>
          <div style="text-indent: 36pt; line-height: 1.25; text-align: justify;">We believe we were a PFIC for our taxable year ending December 31, 2024. However, as discussed below, whether we were a PFIC for any given taxable year is based on a complex
            and factual determination and there is no assurance that the IRS will agree with our determination. Based on the current and anticipated composition of our income, assets and operations, and those of our subsidiaries, we cannot be sure as to
            whether we will be a PFIC for U.S. federal income tax purposes for our taxable year ending December 31, 2025 or in future taxable years. Moreover, because PFIC status is based on our income, assets and activities for the entire taxable year, it
            is not possible to determine whether we will be characterized as a PFIC for our current taxable year or future taxable years until after the close of the applicable taxable year. Moreover, we must determine our PFIC status annually based on
            tests that are factual in nature, and our status in future years will depend on our income, assets and activities in each of those years and, as a result, cannot be predicted with certainty as of the date hereof. The value of our assets
            (including unbooked goodwill) for purposes of the PFIC determination may be determined by reference to the trading value of our ordinary shares, which could fluctuate significantly.</div>
          <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
            <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-weight: normal; font-style: normal;">S - 26</font></div>
            <div class="BRPFPageBreak" style="page-break-after: always;">
              <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
          </div>
          <div style="line-height: 1.25;">&#160;</div>
          <div style="text-indent: 36pt; line-height: 1.25; text-align: justify;">If we are determined to be a PFIC for any taxable year (or portion thereof) that is included in the holding period of a U.S. Holder of our ordinary shares, and the U.S.
            Holder did not make either a timely qualified electing fund (&#8220;QEF&#8221;) election or a mark&#8209;to&#8209;market election for our first taxable year as a PFIC in which the U.S. Holder held ordinary shares, as described below, such holder generally will be
            subject to special rules with respect to:</div>
          <div style="line-height: 1.25;">&#160;</div>
          <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z03279f2d89c74bff9096c0b03d0dd885">

              <tr>
                <td style="width: 36pt;"><br>
                </td>
                <td style="width: 18pt; vertical-align: top;">&#8226;</td>
                <td style="width: auto; vertical-align: top;">
                  <div>any gain recognized by the U.S. Holder on the sale or other disposition of its ordinary shares (or shares of any of our subsidiaries that are Lower-Tier PFICs, as defined and discussed below); and</div>
                </td>
              </tr>

          </table>
          <div style="line-height: 1.25;">&#160;</div>
          <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zf7c6b00430314b27b7fd47822e5e2e53">

              <tr>
                <td style="width: 36pt;"><br>
                </td>
                <td style="width: 18pt; vertical-align: top;">&#8226;</td>
                <td style="width: auto; vertical-align: top;">
                  <div>any &#8220;excess distribution&#8221; made to the U.S. Holder (generally, any distributions to such U.S. Holder during a taxable year of the U.S. Holder that are greater than 125% of the average annual distributions received by such U.S. Holder
                    in respect of the ordinary shares during the three preceding taxable years of such U.S. Holder or, if shorter, such U.S. Holder&#8217;s holding period for the ordinary shares) and certain distributions received on shares of any of our
                    subsidiaries that are Lower-Tier PFICs, as defined and discussed below.</div>
                </td>
              </tr>

          </table>
          <div style="line-height: 1.25;">&#160;</div>
          <div style="text-indent: 36pt; line-height: 1.25;">Under these rules,</div>
          <div style="line-height: 1.25;">&#160;</div>
          <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z9d60a61bc58f495fab5971133fce6355">

              <tr>
                <td style="width: 36pt;"><br>
                </td>
                <td style="width: 18pt; vertical-align: top;">&#8226;</td>
                <td style="width: auto; vertical-align: top;">
                  <div>the U.S. Holder&#8217;s gain or excess distribution will be allocated ratably over the U.S. Holder&#8217;s holding period for the ordinary shares;</div>
                </td>
              </tr>

          </table>
          <div style="line-height: 1.25;">&#160;</div>
          <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z214a1906d8e94a0b916acd1de3df222a">

              <tr>
                <td style="width: 36pt;"><br>
                </td>
                <td style="width: 18pt; vertical-align: top;">&#8226;</td>
                <td style="width: auto; vertical-align: top;">
                  <div>the amount allocated to the U.S. Holder&#8217;s taxable year in which the U.S. Holder recognized the gain or received the excess distribution, or to the period in the U.S. Holder&#8217;s holding period before the first day of our first taxable
                    year in which we are a PFIC, will be taxed as ordinary income;</div>
                </td>
              </tr>

          </table>
          <div style="line-height: 1.25;">&#160;</div>
          <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zcf8567c70d2245759065b63430259a48">

              <tr>
                <td style="width: 36pt;"><br>
                </td>
                <td style="width: 18pt; vertical-align: top;">&#8226;</td>
                <td style="width: auto; vertical-align: top;">
                  <div>the amount allocated to other taxable years (or portions thereof) of the U.S. Holder and included in its holding period will be taxed at the highest tax rate in effect for that year and applicable to the U.S. Holder; and</div>
                </td>
              </tr>

          </table>
          <div style="line-height: 1.25;">&#160;</div>
          <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z0bc692f6da8648b8a8e12a94519e109e">

              <tr>
                <td style="width: 36pt;"><br>
                </td>
                <td style="width: 18pt; vertical-align: top;">&#8226;</td>
                <td style="width: auto; vertical-align: top;">
                  <div>the interest charge generally applicable to underpayments of tax will be imposed in respect of the tax attributable to each such other taxable year of the U.S. Holder.</div>
                </td>
              </tr>

          </table>
          <div style="line-height: 1.25;">&#160;</div>
          <div style="text-indent: 36pt; line-height: 1.25; text-align: justify;">In general, if we are determined to be a PFIC, a U.S. Holder may avoid the PFIC tax consequences described above with respect to our ordinary shares by making a timely QEF
            election to include in income its pro rata share of our net capital gains (as long&#8209;term capital gain) and other earnings and profits (as ordinary income), on a current basis, in each case whether or not distributed, in the taxable year of the
            U.S. Holder in which or with which our taxable year ends. A U.S. Holder generally may make a separate election to defer the payment of taxes on undistributed income inclusions under the QEF rules, but if deferred, any such taxes will be subject
            to an interest charge. </div>
          <div style="line-height: 1.25;">&#160;</div>
          <div style="text-indent: 36pt; line-height: 1.25; text-align: justify;">The QEF election is made on a shareholder&#8209;by&#8209;shareholder basis and, once made, can be revoked only with the consent of the IRS. A U.S. Holder generally makes a QEF election
            by attaching a completed IRS Form 8621 (Information Return by a Shareholder of a Passive Foreign Investment Company or Qualified Electing Fund), including the information provided in a PFIC Annual Information Statement, to a timely filed U.S.
            federal income tax return for the tax year to which the election relates. Retroactive QEF elections generally may be made only by filing a protective statement with such return and if certain other conditions are met or with the consent of the
            IRS. U.S. Holders should consult their tax advisors regarding the availability and tax consequences of a retroactive QEF election under their particular circumstances.</div>
          <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
            <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-weight: normal; font-style: normal;">S - 27</font></div>
            <div class="BRPFPageBreak" style="page-break-after: always;">
              <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
          </div>
          <div style="line-height: 1.25;">&#160;</div>
          <div style="text-indent: 36pt; line-height: 1.25; text-align: justify;">In order to comply with the requirements of a QEF election, a U.S. Holder must receive a PFIC Annual Information Statement from us. There can be no assurance, however, that
            we will timely provide such information for the current taxable year or subsequent taxable years. The failure to provide such information on an annual basis could prevent a U.S. Holder from making a QEF election or result in the invalidation or
            termination of a U.S. Holder&#8217;s prior QEF election.</div>
          <div style="line-height: 1.25; text-align: justify;">&#160;</div>
          <div style="text-indent: 36pt; line-height: 1.25; text-align: justify;">If we are determined to be a PFIC and a U.S. Holder does not make a QEF election as described above, we would continue to be treated as a PFIC with respect to such U.S.
            Holder unless (i) we cease to be a PFIC and (ii) the U.S. Holder made a purging election under the PFIC rules. One type of purging election creates a deemed sale of such shares at their fair market value. Any gain recognized in this deemed sale
            will be subject to the special tax and interest charge rules treating the gain as an excess distribution, as described above. As a result of this election, the U.S. Holder will have additional tax basis and, solely for purposes of the PFIC
            rules, a new holding period in the ordinary shares. U.S. Holders should consult their tax advisors as to the application of the rules governing purging elections to their particular circumstances (including a potential separate &#8220;deemed
            dividend&#8221; purging election that may be available if we are a &#8220;controlled foreign corporation&#8221; for U.S. federal income tax purposes).</div>
          <div style="line-height: 1.25; text-align: justify;">&#160;</div>
          <div style="text-indent: 36pt; line-height: 1.25; text-align: justify;">If a U.S. Holder has made a QEF election with respect to our ordinary shares, and the special tax and interest charge rules do not apply to such shares (because of a timely
            QEF election for our first taxable year as a PFIC in which the U.S. Holder holds such shares or a purge of the PFIC taint pursuant to a purging election), any gain recognized on the sale of our ordinary shares generally will be taxable as
            capital gain and no interest charge will be imposed under the PFIC rules. As discussed above, U.S. Holders of a QEF are currently taxed on their pro rata shares of our earnings and profits, whether or not distributed. In such case, a subsequent
            distribution of such earnings and profits that were previously included in income generally should not be taxable as a dividend to such U.S. Holders. The tax basis of a U.S. Holder&#8217;s shares in a QEF will be increased by amounts that are
            included in income, and decreased by amounts distributed but not taxed as dividends, under the above rules.</div>
          <div style="line-height: 1.25; text-align: justify;">&#160;</div>
          <div style="text-indent: 36pt; line-height: 1.25; text-align: justify;">Although a determination as to our PFIC status will be made annually, an initial determination that our company is a PFIC will generally apply for subsequent years to a U.S.
            Holder who held ordinary shares while we were a PFIC, whether or not we meet the test for PFIC status in those subsequent years. A U.S. Holder who makes the QEF election discussed above for our first taxable year as a PFIC in which the U.S.
            Holder holds ordinary shares, however, will not be subject to the PFIC tax and interest charge rules discussed above in respect to such shares. In addition, such U.S. Holder will not be subject to the QEF inclusion regime with respect to such
            ordinary shares for any taxable year of us that ends within or with a taxable year of the U.S. Holder and in which we are not a PFIC. On the other hand, if the QEF election is not effective for each of our taxable years in which we are a PFIC
            and the U.S. Holder holds ordinary shares, the PFIC rules discussed above will continue to apply to such ordinary shares unless the U.S. Holder makes a purging election, as described above, and pays the tax and interest charge with respect to
            the gain inherent in such shares attributable to the pre&#8209;QEF election period. </div>
          <div style="line-height: 1.25; text-align: justify;">&#160;</div>
          <div style="text-indent: 36pt; line-height: 1.25; text-align: justify;">Alternatively, if a U.S. Holder, at the close of its taxable year, owns shares in a PFIC that are treated as marketable stock, the U.S. Holder may make a mark&#8209;to&#8209;market
            election with respect to such shares for such taxable year. If the U.S. Holder makes a valid mark&#8209;to&#8209;market election for the first taxable year of the U.S. Holder in which the U.S. Holder holds ordinary shares and for which we are determined to
            be a PFIC, such U.S. Holder generally will not be subject to the PFIC rules described above in respect to its ordinary shares. Instead, in general, the U.S. Holder will include as ordinary income each year the excess, if any, of the fair market
            value of its ordinary shares at the end of its taxable year over the adjusted basis in its ordinary shares. Such a U.S. Holder also will be allowed to take an ordinary loss in respect of the excess, if any, of the adjusted basis of its ordinary
            shares over the fair market value of its ordinary shares at the end of its taxable year (but only to the extent of the net amount of previously included income as a result of the mark&#8209;to&#8209;market election). Such U.S. Holder&#8217;s basis in its
            ordinary shares will be adjusted to reflect any such income or loss amounts, and any further gain recognized on a sale or other taxable disposition of the ordinary shares will be treated as ordinary income. </div>
          <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
            <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-weight: normal; font-style: normal;">S - 28</font></div>
            <div class="BRPFPageBreak" style="page-break-after: always;">
              <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
          </div>
          <div style="line-height: 1.25;">&#160;</div>
          <div style="text-indent: 36pt; line-height: 1.25; text-align: justify;">The mark&#8209;to&#8209;market election is available only for stock that is regularly traded on a national securities exchange that is registered with the SEC, including Nasdaq, or on a
            foreign exchange or market that the IRS determines has rules sufficient to ensure that the market price represents a legitimate and sound fair market value. U.S. Holders should consult their tax advisors regarding the availability and tax
            consequences of a mark&#8209;to&#8209;market election in respect to our ordinary shares under their particular circumstances.</div>
          <div style="line-height: 1.25; text-align: justify;">&#160;</div>
          <div style="text-indent: 36pt; line-height: 1.25; text-align: justify;">Certain of the PFIC rules may impact U.S. Holders with respect to equity interests in subsidiaries and other entities which we may hold, directly or indirectly, that are
            PFICs (collectively, &#8220;Lower&#8209;Tier PFICs&#8221;). There can be no assurance that we do not own, or will not in the future own or acquire, an interest in a subsidiary or other entity that is or would be treated as a Lower&#8209;Tier PFIC. If we are a PFIC and
            own any interests in a Lower&#8209;Tier PFIC, a U.S. Holder generally must make a separate QEF election for each Lower&#8209;Tier PFIC, subject to our providing the relevant tax information for each Lower&#8209;Tier PFIC on an annual basis. Because a
            mark-to-market election cannot be made for any Lower-Tier PFICs that we may own, you will generally continue to be subject to the adverse U.S.&#160;federal income tax consequences discussed above with respect to your indirect interest in any such
            Lower-Tier PFIC even if you make a mark-to-market election with respect to our ordinary shares. U.S. Holders should consult their tax advisors regarding the application of the PFIC rules to any of our subsidiaries. </div>
          <div style="line-height: 1.25; text-align: justify;">&#160;</div>
          <div style="text-indent: 36pt; line-height: 1.25; text-align: justify;">A U.S. Holder of a PFIC may be required to file an IRS Form 8621 on an annual basis in certain circumstances which include, but are not limited to, if a U.S. Holder
            recognizes gain on a disposition of such ordinary shares or receives distributions with respect to such ordinary shares. U.S. Holders should consult their tax advisors regarding any reporting requirements that may apply to them if we are a
            PFIC. </div>
          <div style="line-height: 1.25; text-align: justify;">&#160;</div>
          <div style="text-indent: 36pt; line-height: 1.25; text-align: justify;">The rules dealing with PFICs and with the QEF and mark&#8209;to&#8209;market elections are complex, are unclear in certain respects, and are affected by various factors in addition to
            those described above. Accordingly, U.S. Holders of ordinary shares should consult their tax advisors concerning the application of the PFIC rules to our ordinary shares under their particular circumstances.</div>
          <div style="line-height: 1.25; text-align: justify;">&#160;</div>
          <div style="line-height: 1.25; font-style: italic; text-align: justify;">Backup Withholding Tax and Certain Information Reporting Requirements</div>
          <div style="line-height: 1.25; text-align: justify;">&#160;</div>
          <div style="text-indent: 36pt; line-height: 1.25; text-align: justify;">Distributions on, and proceeds paid from the sale or other taxable disposition of, the ordinary shares may be subject to information reporting to the IRS. In addition, a U.S.
            Holder may be subject to backup withholding on payments received in connection with distributions and proceeds from the sale or other taxable disposition of ordinary shares made within the United States or through certain U.S. related financial
            intermediaries.</div>
          <div style="line-height: 1.25; text-align: justify;">&#160;</div>
          <div style="text-indent: 36pt; line-height: 1.25; text-align: justify;">Backup withholding will not apply, however, to a U.S. Holder that furnishes a correct taxpayer identification number, provides other required certification and otherwise
            complies with the applicable requirements of the backup withholding rules or that is otherwise exempt from backup withholding (and, when required, demonstrates such exemption). Backup withholding is not an additional tax. Rather, any amount
            withheld under the backup withholding rules will be creditable or refundable against the U.S. Holder&#8217;s U.S. federal income tax liability, provided the required information is timely furnished to the IRS.</div>
          <div style="line-height: 1.25; text-align: justify;">&#160;</div>
          <div style="line-height: 1.25; font-style: italic; text-align: justify;">Foreign Asset Reporting</div>
          <div style="line-height: 1.25; text-align: justify;">&#160;</div>
          <div style="text-indent: 36pt; line-height: 1.25; text-align: justify;">Certain U.S. Holders are required to report their holdings of certain foreign financial assets, including equity of foreign entities, if the aggregate value of all of these
            assets exceeds certain threshold amounts, by filing IRS Form 8938 with their federal income tax return. Our ordinary shares are expected to constitute foreign financial assets subject to these requirements unless the ordinary shares are held in
            an account at certain financial institutions. U.S. Holders should consult their tax advisors regarding their information reporting obligations, if any, with respect to their ownership and disposition of our ordinary shares and the significant
            penalties for non&#8209;compliance.</div>
          <div style="line-height: 1.25; text-align: justify;">&#160;</div>
          <div style="text-indent: 36pt; line-height: 1.25; text-align: justify;">The above description is not intended to constitute a complete analysis of all U.S. federal income tax consequences relating to acquisition, ownership and disposition of our
            ordinary shares. You should consult your tax advisor concerning the tax consequences of your particular situation.</div>
          <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
            <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-weight: normal; font-style: normal;">S - 29</font></div>
            <div class="BRPFPageBreak" style="page-break-after: always;">
              <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
          </div>
          <div style="line-height: 1.25;">&#160;</div>
          <div style="text-align: center; line-height: 1.25; font-weight: bold;">PLAN OF <a name="DISTRIBUTION_PS"><!--Anchor--></a>DISTRIBUTION</div>
          <div style="line-height: 1.25;">
            <div style="line-height: 1.25;"><br style="line-height: 1.25;">
            </div>
            <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">We have entered into a sales agreement with Jefferies, under which we may offer and sell up to $75,000,000 of our ordinary shares from time to time through Jefferies acting
              as agent. Sales of our ordinary shares, if any, under this prospectus supplement and the base prospectus will be made by any method that is deemed to be an &#8220;at the market offering&#8221; as defined in Rule&#160;415(a)(4) under the Securities Act.</div>
          </div>
          <div style="line-height: 1.25;">
            <div style="line-height: 1.25;"><br style="line-height: 1.25;">
            </div>
            <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">Each time we wish to issue and sell our ordinary shares under the sales agreement, we will notify Jefferies of the number of shares to be issued, the dates on which such
              sales are anticipated to be made, any limitation on the number of shares to be sold in any one day and any minimum price below which sales may not be made. Once we have so instructed Jefferies, unless Jefferies declines to accept the terms of
              such notice, Jefferies has agreed to use its commercially reasonable efforts consistent with its normal trading and sales practices to sell such shares up to the amount specified on such terms. The obligations of Jefferies under the sales
              agreement to sell our ordinary shares are subject to a number of conditions that we must meet.</div>
            <div style="line-height: 1.25;">&#160;</div>
            <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">The settlement of sales of shares between us and Jefferies is generally anticipated to occur on the first trading day following the date on which the sale was made. Sales
              of our ordinary shares as contemplated in this prospectus supplement will be settled through the facilities of The Depository Trust Company or by such other means as we and Jefferies may agree upon. There is no arrangement for funds to be
              received in an escrow, trust or similar arrangement.</div>
            <div style="line-height: 1.25;">&#160;</div>
            <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">We will pay Jefferies a commission equal to 3% of the aggregate gross proceeds we receive from each sale of our ordinary shares. Because there is no minimum offering amount
              required as a condition to close this offering, the actual total public offering amount, commissions and proceeds to us, if any, are not determinable at this time. In addition, we have agreed to reimburse Jefferies for the fees and
              disbursements of its counsel, payable upon execution of the sales agreement, in an amount not to exceed $75,000 for Jefferies&#8217; U.S. counsel and $25,000 for Jefferies&#8217; Israeli counsel, in addition to certain ongoing disbursements of its legal
              counsel. We estimate that the total expenses for the offering, excluding any commissions or expense reimbursement payable to Jefferies under the terms of the sales agreement, will be approximately $0.8 million. The remaining sale proceeds,
              after deducting any other transaction fees, will equal our net proceeds from the sale of such shares.</div>
            <div style="line-height: 1.25;">&#160;</div>
            <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">Jefferies will provide written confirmation to us before the open on Nasdaq on the day following each day on which our ordinary shares are sold under the sales agreement.
              Each confirmation will include the number of shares sold on that day, the aggregate gross proceeds of such sales and the proceeds to us.</div>
            <div style="line-height: 1.25;">&#160;</div>
            <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">In connection with the sale of our ordinary shares on our behalf, Jefferies will be deemed to be an &#8220;underwriter&#8221; within the meaning of the Securities Act, and the
              compensation of Jefferies will be deemed to be underwriting commissions or discounts. We have agreed to indemnify Jefferies against certain civil liabilities, including liabilities under the Securities Act. We have also agreed to contribute
              to payments Jefferies may be required to make in respect of such liabilities.</div>
            <div style="line-height: 1.25;">&#160;</div>
            <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">The offering of our ordinary shares pursuant to the sales agreement will terminate upon the earlier of (i)&#160;the sale of all ordinary shares subject to the sales agreement
              and (ii)&#160;the termination of the sales agreement as permitted therein. We and Jefferies may each terminate the sales agreement at any time upon ten trading days&#8217; prior notice.</div>
            <div style="line-height: 1.25;">&#160;</div>
            <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">This summary of the material provisions of the sales agreement does not purport to be a complete statement of its terms and conditions. A copy of the sales agreement will
              be filed as an exhibit to a Report on&#160;Form&#160;6-K&#160;filed under the Exchange Act and is incorporated by reference in this prospectus supplement.</div>
            <div style="line-height: 1.25;">&#160;</div>
            <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">Jefferies and its affiliates may in the future provide various investment banking, commercial banking, financial advisory and other financial services for us and our
              affiliates, for which services they may in the future receive customary fees. In the course of its business, Jefferies may actively trade our securities for its own account or for the accounts of customers, and, accordingly, Jefferies may at
              any time hold long or short positions in such securities.</div>
          </div>
          <div style="line-height: 1.25;">
            <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">&#160;</div>
            <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">A prospectus supplement and the base prospectus in electronic format may be made available on a website maintained by Jefferies, and Jefferies may distribute the prospectus
              supplement and the base prospectus electronically.</div>
          </div>
          <br>
          <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
            <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-weight: normal; font-style: normal;">S - 30</font></div>
            <div class="BRPFPageBreak" style="page-break-after: always;">
              <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
          </div>
          <div style="text-align: center; line-height: 1.25;"><br style="line-height: 1.25;">
          </div>
          <div style="text-align: center; line-height: 1.25; font-weight: bold;">LEGAL <a name="MATTERS_PS"><!--Anchor--></a>MATTERS</div>
          <div style="line-height: 1.25;">&#160;</div>
          <div style="text-indent: 36pt; line-height: 1.25; text-align: justify;">The validity of the ordinary shares offered hereby and certain other matters of Israeli law will be passed upon for us by Naschitz, Brandes, Amir &amp; Co., Advocates.
            Certain matters of U.S. federal law will be passed upon for us by Latham &amp; Watkins LLP. Certain matters of Israeli law will be passed upon for Jefferies by Gornitzky &amp; Co. Certain matters of U.S. federal law will be passed upon for
            Jefferies by Skadden, Arps, Slate, Meagher &amp; Flom LLP, New York, New York.</div>
          <div style="line-height: 1.25;">&#160;</div>
          <div style="text-align: center; line-height: 1.25; font-weight: bold;"><a name="EXPERTS_PS"><!--Anchor--></a>EXPERTS</div>
          <div style="line-height: 1.25;">&#160;</div>
          <div style="text-indent: 36pt; line-height: 1.25; text-align: justify;">The consolidated financial statements as of December 31, 2024 and 2023 and for each of the two years in the period ended December 31, 2024 incorporated in this prospectus
            supplement by reference to the Annual Report on Form 20-F for the year ended December 31, 2024 have been so incorporated in reliance on the report of Kesselman &amp; Kesselman, a member firm of PricewaterhouseCoopers International Limited, an
            independent registered public accounting firm, given on the authority of said firm as experts in auditing and accounting<font style="font-weight: bold;">.</font></div>
          <div style="line-height: 1.25;">&#160;</div>
          <div style="text-indent: 36pt; line-height: 1.25; text-align: justify;">The consolidated financial statements of Innoviz Technologies Ltd. for the year ended December 31, 2022 appearing in Innoviz Technologies Ltd.&#8217;s Annual Report (Form 20&#8209;F) for
            the year ended December 31, 2024 have been audited by Kost Forer Gabbay &amp; Kasierer, a member of Ernst &amp; Young Global, independent registered public accounting firm, as set forth in their report thereon, included therein, and
            incorporated herein by reference. Such consolidated financial statements are incorporated herein by reference in reliance upon such reports given on the authority of such firm as experts in accounting and auditing.</div>
          <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
            <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-weight: normal; font-style: normal;">S - 31</font></div>
            <div class="BRPFPageBreak" style="page-break-after: always;">
              <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
          </div>
          <div style="line-height: 1.25;">&#160;</div>
          <div style="text-align: center; line-height: 1.25; font-weight: bold;">ENFORCEABILITY OF CIVIL <a name="LIABILITIES_PS"><!--Anchor--></a>LIABILITIES</div>
          <div style="line-height: 1.25;">&#160;</div>
          <div style="text-indent: 36pt; line-height: 1.25; text-align: justify;">We are incorporated under the laws of the State of Israel. Service of process upon us and upon our directors and officers and the Israeli experts named in this prospectus
            supplement, most of whom reside outside the United States, may be difficult to obtain within the United States. Furthermore, because substantially all of our assets and substantially all of our directors and officers are located outside the
            United States, any judgment obtained in the United States against us or any of our directors and officers may not be collectible within the United States.</div>
          <div style="line-height: 1.25;">&#160;</div>
          <div style="text-indent: 36pt; line-height: 1.25; text-align: justify;">We have been informed by our legal counsel in Israel, Naschitz, Brandes, Amir &amp; Co., Advocates, our legal counsel in Israel, that it may be difficult to assert U.S.
            securities laws claims in original actions instituted in Israel. Israeli courts may refuse to hear a claim based on an alleged violation of U.S. securities laws because Israel is not the most appropriate forum in which to bring such a claim. In
            addition, even if an Israeli court agrees to hear a claim, it may determine that Israeli law and not U.S. law is applicable to the claim. If U.S. law is found to be applicable, the content of applicable U.S. law must be proven as a fact, which
            can be a time-consuming and costly process. Matters of procedure will also be governed by Israeli law.</div>
          <div style="line-height: 1.25;">&#160;</div>
          <div style="text-indent: 36pt; line-height: 1.25; text-align: justify;">We have irrevocably appointed Cogency Global Inc. as our agent to receive service of process in any action against us in any U.S. federal or state court arising out of this
            offering or any purchase or sale of securities in connection with this offering. Subject to specified time limitations and legal procedures, Israeli courts may enforce a U.S. judgment in a civil matter which, subject to certain exceptions, is
            non-appealable, including a judgment based upon the civil liability provisions of the Securities Act or the Exchange Act and including a monetary or compensatory judgment in a non-civil matter, provided that, among other things:</div>
          <div style="line-height: 1.25;">&#160;</div>
          <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z14b18ba91b444859a2145f28b7d1caf6">

              <tr>
                <td style="width: 36pt;"><br>
                </td>
                <td style="width: 18pt; vertical-align: top;">&#8226;</td>
                <td style="width: auto; vertical-align: top;">
                  <div>the judgment was rendered by a court of competent jurisdiction, according to the laws of the state in which the judgment is given;</div>
                </td>
              </tr>

          </table>
          <div style="line-height: 1.25;">&#160;</div>
          <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z65bf97dc7f8b4a1ba39ee573dcddeb18">

              <tr>
                <td style="width: 36pt;"><br>
                </td>
                <td style="width: 18pt; vertical-align: top;">&#8226;</td>
                <td style="width: auto; vertical-align: top;">
                  <div>the judgment is enforceable according to the laws of Israel and according to the law of the foreign state in which the relief was granted; and</div>
                </td>
              </tr>

          </table>
          <div style="line-height: 1.25;">&#160;</div>
          <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zda48c178fbf24e89862dcc8a973580fe">

              <tr>
                <td style="width: 36pt;"><br>
                </td>
                <td style="width: 18pt; vertical-align: top;">&#8226;</td>
                <td style="width: auto; vertical-align: top;">
                  <div>the judgment is not contrary to public policy of Israel.</div>
                </td>
              </tr>

          </table>
          <div style="line-height: 1.25;">&#160;</div>
          <div style="text-indent: 36pt; line-height: 1.25;">Even if such conditions are met, an Israeli court may not declare a foreign civil judgment enforceable if:</div>
          <div style="line-height: 1.25;">&#160;</div>
          <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z87189708ce094167b55ecdda4e8f7a51">

              <tr>
                <td style="width: 36pt;"><br>
                </td>
                <td style="width: 18pt; vertical-align: top;">&#8226;</td>
                <td style="width: auto; vertical-align: top;">
                  <div>the prevailing law of the foreign state in which the judgment is rendered does not allow for the enforcement of judgments of Israeli courts (subject to exceptional cases);</div>
                </td>
              </tr>

          </table>
          <div style="line-height: 1.25;">&#160;</div>
          <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z8da7019bb93f45bc9e17ec1ebadbab30">

              <tr>
                <td style="width: 36pt;"><br>
                </td>
                <td style="width: 18pt; vertical-align: top;">&#8226;</td>
                <td style="width: auto; vertical-align: top;">
                  <div>the defendant did not have a reasonable opportunity to be heard and to present his or her evidence, in the opinion of the Israeli court;</div>
                </td>
              </tr>

          </table>
          <div style="line-height: 1.25;">&#160;</div>
          <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zaa48961f40604ed5a3da04301c17991b">

              <tr>
                <td style="width: 36pt;"><br>
                </td>
                <td style="width: 18pt; vertical-align: top;">&#8226;</td>
                <td style="width: auto; vertical-align: top;">
                  <div>the enforcement of the civil liabilities set forth in the judgment is likely to impair the security or sovereignty of Israel;</div>
                </td>
              </tr>

          </table>
          <div style="line-height: 1.25;">&#160;</div>
          <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z77a968df1a7c4885b0c1c9c2b9a8871c">

              <tr>
                <td style="width: 36pt;"><br>
                </td>
                <td style="width: 18pt; vertical-align: top;">&#8226;</td>
                <td style="width: auto; vertical-align: top;">
                  <div>the judgment was obtained by fraud;</div>
                </td>
              </tr>

          </table>
          <div style="line-height: 1.25;">&#160;</div>
          <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z3adcedbf98964872b0433bd410e844ee">

              <tr>
                <td style="width: 36pt;"><br>
                </td>
                <td style="width: 18pt; vertical-align: top;">&#8226;</td>
                <td style="width: auto; vertical-align: top;">
                  <div>the judgment was rendered by a court not competent to render it according to the rules of private international law as they apply in Israel;</div>
                </td>
              </tr>

          </table>
          <div style="line-height: 1.25;">&#160;</div>
          <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z32def8db79af4d4695fd2c020c728fd7">

              <tr>
                <td style="width: 36pt;"><br>
                </td>
                <td style="width: 18pt; vertical-align: top;">&#8226;</td>
                <td style="width: auto; vertical-align: top;">
                  <div>the judgment conflicts with any other valid judgment in the same matter between the same parties; or</div>
                </td>
              </tr>

          </table>
          <div style="line-height: 1.25;">&#160;</div>
          <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z774606833bb2493ca3d89ac763bd6758">

              <tr>
                <td style="width: 36pt;"><br>
                </td>
                <td style="width: 18pt; vertical-align: top;">&#8226;</td>
                <td style="width: auto; vertical-align: top;">
                  <div>an action between the same parties in the same matter was pending in any Israeli court or tribunal at the time at which the lawsuit was instituted in the foreign court.</div>
                </td>
              </tr>

          </table>
          <br>
          <div style="text-indent: 36pt; line-height: 1.25; text-align: justify;">If a foreign judgment is enforced by an Israeli court, it generally will be payable in Israeli currency, which can then be converted into non-Israeli currency and transferred
            out of Israel. The usual practice in an action before an Israeli court to recover an amount in a non-Israeli currency is for the Israeli court to issue a judgment for the equivalent amount in Israeli currency at the rate of exchange in force on
            the date of the judgment, but the judgment debtor may make payment in foreign currency. Pending collection, the amount of the judgment of an Israeli court stated in Israeli currency ordinarily will be linked to the Israeli consumer price index
            plus interest at the annual statutory rate set by Israeli regulations prevailing at the time. Judgment creditors must bear the risk of unfavorable exchange rates.</div>
          <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
            <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-weight: normal; font-style: normal;">S - 32</font></div>
            <div class="BRPFPageBreak" style="page-break-after: always;">
              <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
          </div>
          <div style="line-height: 1.25;">&#160;</div>
          <div style="text-align: center; line-height: 1.25; font-weight: bold;">WHERE YOU CAN FIND MORE <a name="INFORMATION_PS"><!--Anchor--></a>INFORMATION</div>
          <div style="line-height: 1.25; text-align: justify;">&#160;</div>
          <div style="text-indent: 36pt; line-height: 1.25; text-align: justify;">We have filed with the SEC a registration statement (including exhibits to the registration statement) on Form F&#8209;3 under the Securities Act. This prospectus supplement and
            the base prospectus do not contain all of the information set forth in the registration statement. For further information, we refer you to the registration statement and the exhibits and schedules filed as part of the registration statement.</div>
          <div style="line-height: 1.25; text-align: justify;">&#160;</div>
          <div style="text-indent: 36pt; line-height: 1.25; text-align: justify;">Information and statements contained in this prospectus supplement or any annex to this prospectus supplement are qualified in all respects by reference to the copy of the
            relevant contract or other annex filed as an exhibit to the registration statement.</div>
          <div style="line-height: 1.25; text-align: justify;">&#160;</div>
          <div style="text-indent: 36pt; line-height: 1.25; text-align: justify;">Statements made in this prospectus supplement concerning the contents of any contract, agreement or other document are not complete descriptions of all terms of these
            documents. If a document has been filed as an exhibit to the registration statement, we refer you to the copy of the document that has been filed for a complete description of its terms. Each statement in this prospectus supplement relating to
            a document filed as an exhibit is qualified in all respects by the filed exhibit. You should read this prospectus supplement and the documents that we have filed as exhibits to the registration statement completely.</div>
          <div style="line-height: 1.25; text-align: justify;">&#160;</div>
          <div style="text-indent: 36pt; line-height: 1.25; text-align: justify;">We are subject to the informational requirements of the Exchange Act. Accordingly, we are required to file reports and other information with the SEC, including annual
            reports on Form 20&#8209;F and reports on Form 6&#8209;K. The SEC maintains an internet website that contains reports and other information about issuers, like us, that file electronically with the SEC. The address of that website is www.sec.gov.</div>
          <div style="line-height: 1.25; text-align: justify;">&#160;</div>
          <div style="text-indent: 36pt; line-height: 1.25; text-align: justify;">As a foreign private issuer, we are exempt under the Exchange Act from, among other things, the rules prescribing the furnishing and content of proxy statements, and our
            officers, directors and principal shareholders are exempt from the reporting and short&#8209;swing profit recovery provisions contained in Section 16 of the Exchange Act. In addition, we are not required under the Exchange Act to file periodic
            reports and financial statements with the SEC as frequently or as promptly as U.S. companies whose securities are registered under the Exchange Act.</div>
          <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
            <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-weight: normal; font-style: normal;">S - 33</font></div>
            <div class="BRPFPageBreak" style="page-break-after: always;">
              <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
          </div>
          <div style="line-height: 1.25;">&#160;</div>
          <div style="text-align: center; line-height: 1.25; font-weight: bold;">INCORPORATION BY <a name="REFERENCE_PS"><!--Anchor--></a>REFERENCE</div>
          <div style="line-height: 1.25;">&#160;</div>
          <div style="text-indent: 36pt; line-height: 1.25; text-align: justify;">The SEC&#8217;s rules allow us to &#8220;incorporate by reference&#8221; information into this prospectus supplement, which means that we can disclose important information to you by referring
            you to another document filed separately with the SEC. The information incorporated by reference is deemed to be part of this prospectus supplement, and subsequent information that we file with the SEC will automatically update and supersede
            that information. Any statement contained in this prospectus supplement or a previously filed document incorporated by reference will be deemed to be modified or superseded for purposes of this prospectus supplement to the extent that a
            statement contained in this prospectus supplement or a subsequently filed document incorporated by reference modifies or replaces that statement. </div>
          <div style="line-height: 1.25;">&#160;</div>
          <div style="text-indent: 36pt; line-height: 1.25; text-align: justify;">We incorporate by reference into this prospectus supplement the documents listed below and any future filings made by us with the SEC under Section 13(a), 13(c) 15(d) of the
            Exchange Act including (i) any future annual reports on Form 20-F and (ii) any future reports on Form 6-K that are identified in such reports as being incorporated by reference in this prospectus supplement (but only to the extent identified in
            such report), except for information &#8220;furnished&#8221; to the SEC which is not deemed filed and not incorporated in this prospectus supplement, until the termination of the offering of securities described in this prospectus supplement. This
            prospectus supplement incorporates by reference the documents set forth below that have previously been filed with the SEC:</div>
          <div style="line-height: 1.25;">&#160;</div>
          <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z278fa25a0de442f7abddee4c9641dde8">

              <tr>
                <td style="width: 54pt;"><br>
                </td>
                <td style="width: 18pt; vertical-align: top;">&#8226;</td>
                <td style="width: auto; vertical-align: top;">
                  <div>the Company&#8217;s Annual Report on <a href="https://www.sec.gov/Archives/edgar/data/1835654/000117891325000817/0001178913-25-000817-index.htm">Form 20&#8209;F</a> for the fiscal year ended December 31, 2024 filed with the SEC on March 12,
                    2025.</div>
                </td>
              </tr>

          </table>
          <div style="line-height: 1.25;">&#160;</div>
          <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zcea531498899496c9c1a924216d46536">

              <tr>
                <td style="width: 54pt;"><br>
                </td>
                <td style="width: 18pt; vertical-align: top;">&#8226;</td>
                <td style="width: auto; vertical-align: top;">
                  <div>the Company&#8217;s Reports on Form 6-K furnished to the SEC on <a href="https://www.sec.gov/Archives/edgar/data/1835654/000117891325000012/0001178913-25-000012-index.htm">January 3, 2025</a>, <a href="https://www.sec.gov/Archives/edgar/data/1835654/000117891325000427/0001178913-25-000427-index.htm">February 12, 2025</a>, <a href="https://www.sec.gov/Archives/edgar/data/1835654/000117891325001114/0001178913-25-001114-index.htm">March 28, 2025</a>, <a href="https://www.sec.gov/Archives/edgar/data/1835654/000117891325002302/0001178913-25-002302-index.htm">July




                      3, 2025</a> and <a href="https://www.sec.gov/Archives/edgar/data/1835654/000117891325002834/0001178913-25-002834-index.htm">August 13, 2025</a>; and</div>
                </td>
              </tr>

          </table>
          <div style="line-height: 1.25;">&#160;</div>
          <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="za62f797c0ba3428e8ab4184857dff004">

              <tr>
                <td style="width: 54pt;"><br>
                </td>
                <td style="width: 18pt; vertical-align: top;">&#8226;</td>
                <td style="width: auto; vertical-align: top;">
                  <div>the description of the Company&#8217;s securities contained in the Company&#8217;s registration statement on <a href="https://www.sec.gov/Archives/edgar/data/1835654/000119312521105720/0001193125-21-105720-index.htm">Form 8&#8209;A</a> (File No.
                    001&#8209;40310), filed with the SEC on April 5, 2021, including any amendments or reports filed for the purpose of updating such description.</div>
                </td>
              </tr>

          </table>
          <div style="line-height: 1.25;">&#160;</div>
          <div style="text-indent: 36pt; line-height: 1.25; text-align: justify;">We undertake to provide without charge to each person (including any beneficial owner) who receives a copy of this prospectus supplement and the base prospectus, upon written
            or oral request, a copy of all of the preceding documents that are incorporated by reference (other than exhibits, unless the exhibits are specifically incorporated by reference into these documents). You may request a copy of these filings, at
            no cost, by writing to us at: c/o Innoviz Technologies Ltd., 5 Uri Ariav St., Building C, Rosh HaAin, Israel 4809202 or by telephone to: +972&#8209;74&#8209;700&#8209;3692.</div>
          <div style="line-height: 1.25;">&#160;</div>
          <div style="text-indent: 36pt; line-height: 1.25; text-align: justify;">Exhibits to the filings will not be sent, however, unless those exhibits have specifically been incorporated by reference in this prospectus supplement or the base
            prospectus.</div>
          <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
            <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-weight: normal; font-style: normal;">S - 34</font></div>
            <div class="BRPFPageBreak" style="page-break-after: always;">
              <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
          </div>
          <div style="line-height: 1.25;">&#160;</div>
          <div style="text-align: center; line-height: 1.25; font-size: 12pt;">Up to $75,000,000</div>
          <div style="line-height: 1.25;">&#160;</div>
          <div style="text-align: center; line-height: 1.25; font-size: 12pt; font-weight: bold;">Innoviz Technologies Ltd.</div>
          <div style="line-height: 1.25;">&#160;</div>
          <div style="text-align: center; line-height: 1.25; font-size: 12pt;">Ordinary Shares</div>
          <div style="text-align: center; line-height: 1.25;"> <br>
          </div>
          <div style="text-align: center; line-height: 1.25;">
            <hr align="center" style="height: 1px; width: 20%; color: #000000; background-color: #000000; margin-left: auto; margin-right: auto; border: none;"> </div>
          <div style="line-height: 1.25;">
            <div style="text-align: center; margin-right: 144pt; margin-left: 144pt; line-height: 1.25;"><img src="image00002.jpg"></div>
            <div style="line-height: 1.25;">
              <hr align="center" style="height: 1px; width: 20%; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;"></div>
          </div>
          <div style="line-height: 1.25;"><br style="line-height: 1.25;">
          </div>
          <div style="line-height: 1.25;">
            <div style="text-align: center; line-height: 1.25; font-weight: bold; font-size: 12pt;">Jefferies</div>
            <div style="line-height: 1.25;">&#160;</div>
          </div>
        </div>
        <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
          <div style="page-break-after: always;" class="BRPFPageBreak">
            <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
        </div>
        <!--PROfilePageNumberReset%Num%1%II - %%-->
        <div style="text-align: center; line-height: 1.25; font-weight: bold;">PART II</div>
        <div style="line-height: 1.25;">&#160;</div>
        <div style="text-align: center; line-height: 1.25; font-weight: bold;">INFORMATION NOT REQUIRED IN PROSPECTUS</div>
        <div style="line-height: 1.25;">&#160;</div>
        <div style="line-height: 1.25; font-weight: bold;">Item 8. Indemnification of Directors, Officers and Employees</div>
        <div style="line-height: 1.25;">&#160;</div>
        <div style="text-indent: 36pt; line-height: 1.25; text-align: justify;">Under the Israeli Companies Law, 5759&#8209;1999 (the &#8220;Companies Law&#8221;), an Israeli company may not exculpate an office holder from liability for a breach of the duty of loyalty. An
          Israeli company may exculpate in advance an office holder from liability to the company, in whole or in part, for damages caused to the company as a result of a breach of duty of care but only if a provision authorizing such exculpation is
          included in its articles of association. Our amended and restated articles of association (the &#8220;Innoviz Articles&#8221;) include such a provision. An Israeli company may not exculpate a director from liability arising out of a prohibited dividend or
          distribution to shareholders.</div>
        <div style="line-height: 1.25;">&#160;</div>
        <div style="text-indent: 36pt; line-height: 1.25; text-align: justify;">Under the Companies Law, an Israeli company may indemnify an office holder in respect of the following liabilities and expenses incurred for acts performed as an office holder,
          either in advance of an event or following an event, provided a provision authorizing such indemnification is contained in its articles of association:</div>
        <div style="line-height: 1.25;">&#160;</div>
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z6b71824fde314296a73ff4e9be7943ba">

            <tr>
              <td style="width: 36pt;"><br>
              </td>
              <td style="width: 18pt; vertical-align: top;">&#8226;</td>
              <td style="width: auto; vertical-align: top;">
                <div>a financial liability imposed on him or her in favor of another person pursuant to a judgment, including a settlement or arbitrator&#8217;s award approved by a court. However, if an undertaking to indemnify an office holder with respect to
                  such liability is provided in advance, then such an undertaking must be limited to events which, in the opinion of the board of directors, can be foreseen based on the company&#8217;s activities when the undertaking to indemnify is given, and
                  to an amount or according to criteria determined by the board of directors as reasonable under the circumstances, and such undertaking shall detail the abovementioned events and amount or criteria;</div>
              </td>
            </tr>

        </table>
        <div style="line-height: 1.25;">&#160;</div>
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zb491d0247584410bae9872777f8a1832">

            <tr>
              <td style="width: 36pt;"><br>
              </td>
              <td style="width: 18pt; vertical-align: top;">&#8226;</td>
              <td style="width: auto; vertical-align: top;">
                <div>reasonable litigation expenses, including attorneys&#8217; fees, incurred by the office holder as (1) a result of an investigation or proceeding instituted against him or her by an authority authorized to conduct such investigation or
                  proceeding, <font style="font-style: italic;">provided </font>that (i) no indictment was filed against such office holder as a result of such investigation or proceeding; and (ii) no financial liability, such as a criminal penalty, was
                  imposed upon him or her as a substitute for the criminal proceeding as a result of such investigation or proceeding or, if such financial liability was imposed, it was imposed with respect to an offense that does not require proof of
                  criminal intent; and (2) in connection with a monetary sanction;</div>
              </td>
            </tr>

        </table>
        <div style="line-height: 1.25;">&#160;</div>
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z1d8217c4962945349a4c188bde848180">

            <tr>
              <td style="width: 36pt;"><br>
              </td>
              <td style="width: 18pt; vertical-align: top;">&#8226;</td>
              <td style="width: auto; vertical-align: top;">
                <div>reasonable litigation expenses, including attorneys&#8217; fees, incurred by the office holder or imposed by a court in proceedings instituted against him or her by the company, on its behalf or by a third&#8209;party or in connection with
                  criminal proceedings in which the office holder was acquitted or as a result of a conviction for an offense that does not require proof of criminal intent; and</div>
              </td>
            </tr>

        </table>
        <div style="line-height: 1.25;">&#160;</div>
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z6c518fd20dff4082b76962e4c2ef4ebe">

            <tr>
              <td style="width: 36pt;"><br>
              </td>
              <td style="width: 18pt; vertical-align: top;">&#8226;</td>
              <td style="width: auto; vertical-align: top;">
                <div>expenses, including reasonable litigation expenses and legal fees, incurred by an office holder in relation to an administrative proceeding instituted against such office holder, or certain compensation payments made to an injured
                  party imposed on an office holder by an administrative proceeding, pursuant to certain provisions of the Israeli Securities Law 5728-1968 (the &#8220;Israeli Securities Law&#8221;).</div>
              </td>
            </tr>

        </table>
        <div style="line-height: 1.25;">&#160;</div>
        <div style="text-indent: 36pt; line-height: 1.25;">Under the Companies Law, an Israeli company may insure an office holder against the following liabilities incurred for acts performed as an office holder if and to the extent provided in the
          company&#8217;s articles of association:</div>
        <div style="line-height: 1.25;">&#160;</div>
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z848560cf9b8c40e3ae23fb5174b659d7">

            <tr>
              <td style="width: 36pt;"><br>
              </td>
              <td style="width: 18pt; vertical-align: top;">&#8226;</td>
              <td style="width: auto; vertical-align: top;">
                <div>a breach of the duty of loyalty to the company, to the extent that the office holder acted in good faith and had a reasonable basis to believe that the act would not prejudice the company;</div>
              </td>
            </tr>

        </table>
        <div style="line-height: 1.25;">&#160;</div>
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z63ec11205d9b46f2a537de764c3a0b50">

            <tr>
              <td style="width: 36pt;"><br>
              </td>
              <td style="width: 18pt; vertical-align: top;">&#8226;</td>
              <td style="width: auto; vertical-align: top;">
                <div>a breach of the duty of care to the company or to a third&#8209;party, including a breach arising out of the negligent conduct of the office holder;</div>
              </td>
            </tr>

        </table>
        <div style="line-height: 1.25;">&#160;</div>
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z9c17893b3664454083f39086f0d40acf">

            <tr>
              <td style="width: 36pt;"><br>
              </td>
              <td style="width: 18pt; vertical-align: top;">&#8226;</td>
              <td style="width: auto; vertical-align: top;">
                <div>a financial liability imposed on the office holder in favor of a third&#8209;party;</div>
              </td>
            </tr>

        </table>
        <div style="line-height: 1.25;">&#160;</div>
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z2de4702441b7438ea03cf840d35ff466">

            <tr>
              <td style="width: 36pt;"><br>
              </td>
              <td style="width: 18pt; vertical-align: top;">&#8226;</td>
              <td style="width: auto; vertical-align: top;">
                <div>a financial liability imposed on the office holder in favor of a third&#8209;party harmed by a breach in an administrative proceeding,&#160;pursuant to certain provisions of the Israeli Securities Law; and</div>
              </td>
            </tr>

        </table>
        <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
          <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-weight: normal; font-style: normal;">II - 1</font></div>
          <div style="page-break-after: always;" class="BRPFPageBreak">
            <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
        </div>
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z737a4cee57df4cf3ac3c81367f95679c">

            <tr>
              <td style="width: 36pt;"><br>
              </td>
              <td style="width: 18pt; vertical-align: top;">&#8226;</td>
              <td style="width: auto; vertical-align: top;">
                <div>expenses, including reasonable litigation expenses, including attorneys&#8217; fees, incurred by the office holder as a result of an administrative proceeding instituted against him or her, pursuant to certain provisions of the Israeli
                  Securities Law.</div>
              </td>
            </tr>

        </table>
        <div style="line-height: 1.25;">&#160;</div>
        <div style="text-indent: 36pt; line-height: 1.25;">Under the Companies Law, an Israeli company may not indemnify, exculpate or insure an office holder against any of the following:</div>
        <div style="line-height: 1.25;">&#160;</div>
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zb2c07ce2a4ac4cff99714109a293fd66">

            <tr>
              <td style="width: 36pt;"><br>
              </td>
              <td style="width: 18pt; vertical-align: top;">&#8226;</td>
              <td style="width: auto; vertical-align: top;">
                <div>a breach of the duty of loyalty, except to the extent that the office holder acted in good faith and had a reasonable basis to believe that the act would not prejudice the company;</div>
              </td>
            </tr>

        </table>
        <div style="line-height: 1.25;">&#160;</div>
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="za554d80e38d54f7d8ebb0d3745895565">

            <tr>
              <td style="width: 36pt;"><br>
              </td>
              <td style="width: 18pt; vertical-align: top;">&#8226;</td>
              <td style="width: auto; vertical-align: top;">
                <div>a breach of the duty of care committed intentionally or recklessly, excluding a breach arising out of the negligent conduct of the office holder;</div>
              </td>
            </tr>

        </table>
        <div style="line-height: 1.25;">&#160;</div>
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z2d8bf27c331f48a081d80dcdc2f983c1">

            <tr>
              <td style="width: 36pt;"><br>
              </td>
              <td style="width: 18pt; vertical-align: top;">&#8226;</td>
              <td style="width: auto; vertical-align: top;">
                <div>an act or omission committed with intent to derive illegal personal benefit; or</div>
              </td>
            </tr>

        </table>
        <div style="line-height: 1.25;">&#160;</div>
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zfe14e342108b4710811dc6fcf57b049a">

            <tr>
              <td style="width: 36pt;"><br>
              </td>
              <td style="width: 18pt; vertical-align: top;">&#8226;</td>
              <td style="width: auto; vertical-align: top;">
                <div>a fine or forfeit levied against the office holder.</div>
              </td>
            </tr>

        </table>
        <div style="line-height: 1.25;">&#160;</div>
        <div style="text-indent: 36pt; line-height: 1.25; text-align: justify;">Under the Companies Law, exculpation, indemnification and insurance of office holders must be approved by the compensation committee and the board of directors and, with
          respect to directors and the chief executive officer, also by shareholders. However, under regulations promulgated under the Companies Law, the insurance of office holders does not require shareholder approval and may be approved by only the
          compensation committee, if the engagement terms are determined in accordance with the company&#8217;s compensation policy, which was approved by the shareholders by the same special majority required to approve a compensation policy, provided that the
          insurance policy is on market terms and the insurance policy is not likely to materially impact the company&#8217;s profitability, assets or obligations</div>
        <div style="line-height: 1.25;">&#160;</div>
        <div style="text-indent: 36pt; line-height: 1.25; text-align: justify;">The Innoviz Articles permit us to exculpate, indemnify and insure our office holders for any liability imposed on them as a consequence of an act (including any omission) which
          was performed by virtue of being an office holder. Our office holders are currently covered by a directors and officers&#8217; liability insurance policy.</div>
        <div style="line-height: 1.25; text-align: justify;">&#160;</div>
        <div style="text-indent: 36pt; line-height: 1.25; text-align: justify;">We have entered into agreements with each of our directors and executive officers exculpating them to the fullest extent permitted by law, from liability towards us for damages
          caused to us as a result of a breach of duty of care, and undertaking to indemnify them to the fullest extent permitted by law. This indemnification is limited to events determined as foreseeable by the board of directors based on our activities,
          and to an amount or according to criteria determined by the board of directors as reasonable under the circumstances.</div>
        <div style="line-height: 1.25; text-align: justify;">&#160;</div>
        <div style="text-indent: 36pt; line-height: 1.25; text-align: justify;">The maximum indemnification amount set forth in such agreements is limited to an amount equal to the higher of $40,000,000 and 25% of our shareholder&#8217;s equity as reflected in
          our most recent consolidated financial statements made publicly available prior to the date on which the indemnity payment is made (other than indemnification for an offering of securities to the public, including by a shareholder in a secondary
          offering, in which case the maximum indemnification amount is limited to the gross proceeds raised by us and/or any selling shareholder in such public offering). The maximum amount set forth in such agreements is in addition to any amount paid
          (if paid) under insurance and/or by a third&#8209;party pursuant to an indemnification arrangement.</div>
        <div style="line-height: 1.25; text-align: justify;">&#160;</div>
        <div style="text-indent: 36pt; line-height: 1.25; text-align: justify;">We have purchased and currently intend to maintain insurance on behalf of each and every person who is or was a director or officer of the Company against any loss arising from
          any claim asserted against him or her and incurred by him or her in any such capacity, subject to certain exclusions.</div>
        <div style="line-height: 1.25; text-align: justify;">&#160;</div>
        <div style="text-indent: 36pt; line-height: 1.25; text-align: justify;">There is no pending litigation or proceeding against any of our directors or officers as to which indemnification is being sought, nor are we aware of any pending or threatened
          litigation that may result in claims for indemnification by any director or officer.</div>
        <div style="line-height: 1.25; text-align: justify;">&#160;</div>
        <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
          <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-weight: normal; font-style: normal;">II - 2</font></div>
          <div class="BRPFPageBreak" style="page-break-after: always;">
            <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
        </div>
        <div style="line-height: 1.25; font-weight: bold;">Item 9. Exhibits and Financial Statement Schedules</div>
        <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-weight: bold;"> <br>
        </div>
        <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="z1feda60daa3340fe9b9defd16330170c">

            <tr>
              <td rowspan="1" style="width: 9%; vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
              <td rowspan="1" colspan="1" style="width: 1%; vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
              <td rowspan="1" style="width: 38%; vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
              <td rowspan="1" colspan="1" style="width: 1%; vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
              <td colspan="9" rowspan="1" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
                <div style="line-height: 1.25;">
                  <div style="text-align: center; line-height: 1.25; font-weight: bold;">Incorporation by Reference</div>
                </div>
              </td>
            </tr>
            <tr>
              <td style="width: 9%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
                <div style="line-height: 1.25;">
                  <div style="text-align: center; line-height: 1.25; font-weight: bold;">Exhibit No.</div>
                </div>
              </td>
              <td colspan="1" style="width: 1%; vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
              <td style="width: 38%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
                <div style="line-height: 1.25;">
                  <div style="text-align: center; line-height: 1.25; font-weight: bold;">Description</div>
                </div>
              </td>
              <td colspan="1" style="width: 1%; vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
              <td style="width: 8%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
                <div style="line-height: 1.25;">
                  <div style="text-align: center; line-height: 1.25; font-weight: bold;">Form</div>
                </div>
              </td>
              <td colspan="1" style="width: 1%; vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
              <td style="width: 10%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
                <div style="line-height: 1.25;">
                  <div style="text-align: center; line-height: 1.25; font-weight: bold;">File No.</div>
                </div>
              </td>
              <td colspan="1" style="width: 1%; vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
              <td style="width: 9%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
                <div style="line-height: 1.25;">
                  <div style="text-align: center; line-height: 1.25; font-weight: bold;">Exhibit No.</div>
                </div>
              </td>
              <td colspan="1" style="width: 1%; vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
              <td style="width: 10%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
                <div style="line-height: 1.25;">
                  <div style="text-align: center; line-height: 1.25; font-weight: bold;">Filing Date</div>
                </div>
              </td>
              <td colspan="1" style="width: 1%; vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
              <td style="width: 10%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
                <div style="line-height: 1.25;">
                  <div style="text-align: center; line-height: 1.25; font-weight: bold;">Filed /Furnished</div>
                </div>
              </td>
            </tr>
            <tr>
              <td style="width: 9%; vertical-align: top;">
                <div style="text-align: justify; line-height: 1.25;">1.1</div>
              </td>
              <td colspan="1" style="width: 1%; vertical-align: top;"><br>
              </td>
              <td style="width: 38%; vertical-align: top;">
                <div style="text-align: justify; line-height: 1.25;">Form of Underwriting Agreement.</div>
              </td>
              <td colspan="1" style="width: 1%; vertical-align: top;">&#160;</td>
              <td style="width: 8%; vertical-align: top;">&#160;</td>
              <td colspan="1" style="width: 1%; vertical-align: top;">&#160;</td>
              <td style="width: 10%; vertical-align: top;">&#160;</td>
              <td colspan="1" style="width: 1%; vertical-align: top;">&#160;</td>
              <td style="width: 9%; vertical-align: top;">&#160;</td>
              <td colspan="1" style="width: 1%; vertical-align: top;">&#160;</td>
              <td style="width: 10%; vertical-align: top;">&#160;</td>
              <td colspan="1" style="width: 1%; vertical-align: top;">&#160;</td>
              <td style="width: 10%; vertical-align: top;">
                <div style="text-align: justify; line-height: 1.25; font-weight: bold;">*</div>
              </td>
            </tr>
            <tr>
              <td style="width: 9%; vertical-align: top;">
                <div style="text-align: justify; line-height: 1.25;"><a href="exhibit_1-2.htm">1.2</a></div>
              </td>
              <td colspan="1" style="width: 1%; vertical-align: top;"><a href="exhibit_1-2.htm"><br>
                </a> </td>
              <td style="width: 38%; vertical-align: top;">
                <div style="text-align: justify; line-height: 1.25;"><a href="exhibit_1-2.htm">Open Market Sale Agreement<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">SM</sup>, dated as of August 13, 2025, by and
                    between Innoviz Technologies Ltd. And Jefferies LLC.</a></div>
              </td>
              <td colspan="1" style="width: 1%; vertical-align: top;">&#160;</td>
              <td style="width: 8%; vertical-align: top;">&#160;</td>
              <td colspan="1" style="width: 1%; vertical-align: top;">&#160;</td>
              <td style="width: 10%; vertical-align: top;">&#160;</td>
              <td colspan="1" style="width: 1%; vertical-align: top;">&#160;</td>
              <td style="width: 9%; vertical-align: top;">&#160;</td>
              <td colspan="1" style="width: 1%; vertical-align: top;">&#160;</td>
              <td style="width: 10%; vertical-align: top;">&#160;</td>
              <td colspan="1" style="width: 1%; vertical-align: top;">&#160;</td>
              <td style="width: 10%; vertical-align: top;">&#160;</td>
            </tr>
            <tr>
              <td style="width: 9%; vertical-align: top;">
                <div style="text-align: justify; line-height: 1.25;"><a href="https://www.sec.gov/Archives/edgar/data/1835654/000117891322002154/exhibit_3-1.htm">3.1</a></div>
              </td>
              <td colspan="1" style="width: 1%; vertical-align: top;"><br>
              </td>
              <td style="width: 38%; vertical-align: top;">
                <div style="line-height: 1.25;"><a href="https://www.sec.gov/Archives/edgar/data/1835654/000117891322002154/exhibit_3-1.htm">Amended and Restated Articles of Association of Innoviz Technologies Ltd.</a></div>
              </td>
              <td colspan="1" style="width: 1%; vertical-align: top;">&#160;</td>
              <td style="width: 8%; vertical-align: top;">
                <div style="text-align: justify; line-height: 1.25;">F&#8209;3</div>
              </td>
              <td colspan="1" style="width: 1%; vertical-align: top;">&#160;</td>
              <td style="width: 10%; vertical-align: top;">
                <div style="text-align: justify; line-height: 1.25;">333&#8209;265170</div>
              </td>
              <td colspan="1" style="width: 1%; vertical-align: top;">&#160;</td>
              <td style="width: 9%; vertical-align: top;">
                <div style="text-align: justify; line-height: 1.25;">3.1</div>
              </td>
              <td colspan="1" style="width: 1%; vertical-align: top;">&#160;</td>
              <td style="width: 10%; vertical-align: top;">
                <div style="text-align: justify; line-height: 1.25;">May 24, 2022</div>
              </td>
              <td colspan="1" style="width: 1%; vertical-align: top;">&#160;</td>
              <td style="width: 10%; vertical-align: top;">&#160;</td>
            </tr>
            <tr>
              <td style="width: 9%; vertical-align: top;">
                <div style="text-align: justify; line-height: 1.25;"><a href="exhibit_4-1.htm">4.1</a></div>
              </td>
              <td colspan="1" style="width: 1%; vertical-align: top;"><a href="exhibit_4-1.htm"><br>
                </a> </td>
              <td style="width: 38%; vertical-align: top;">
                <div style="line-height: 1.25;"><a href="exhibit_4-1.htm">Form of Indenture.</a></div>
              </td>
              <td colspan="1" style="width: 1%; vertical-align: top;">&#160;</td>
              <td style="width: 8%; vertical-align: top;">&#160;</td>
              <td colspan="1" style="width: 1%; vertical-align: top;">&#160;</td>
              <td style="width: 10%; vertical-align: top;">&#160;</td>
              <td colspan="1" style="width: 1%; vertical-align: top;">&#160;</td>
              <td style="width: 9%; vertical-align: top;">&#160;</td>
              <td colspan="1" style="width: 1%; vertical-align: top;">&#160;</td>
              <td style="width: 10%; vertical-align: top;">&#160;</td>
              <td colspan="1" style="width: 1%; vertical-align: top;">&#160;</td>
              <td style="width: 10%; vertical-align: top;">&#160;</td>
            </tr>
            <tr>
              <td style="width: 9%; vertical-align: top;">
                <div style="text-align: justify; line-height: 1.25;">4.2</div>
              </td>
              <td colspan="1" style="width: 1%; vertical-align: bottom;"><br>
              </td>
              <td style="width: 38%; vertical-align: bottom;">
                <div style="text-align: justify; line-height: 1.25;">Form of Note.</div>
              </td>
              <td colspan="1" style="width: 1%; vertical-align: top;">&#160;</td>
              <td style="width: 8%; vertical-align: top;">&#160;</td>
              <td colspan="1" style="width: 1%; vertical-align: top;">&#160;</td>
              <td style="width: 10%; vertical-align: top;">&#160;</td>
              <td colspan="1" style="width: 1%; vertical-align: top;">&#160;</td>
              <td style="width: 9%; vertical-align: top;">&#160;</td>
              <td colspan="1" style="width: 1%; vertical-align: top;">&#160;</td>
              <td style="width: 10%; vertical-align: top;">&#160;</td>
              <td colspan="1" style="width: 1%; vertical-align: top;">&#160;</td>
              <td style="width: 10%; vertical-align: top;">
                <div style="text-align: justify; line-height: 1.25;">*</div>
              </td>
            </tr>
            <tr>
              <td style="width: 9%; vertical-align: top;">
                <div style="text-align: justify; line-height: 1.25;">4.3</div>
              </td>
              <td colspan="1" style="width: 1%; vertical-align: bottom;"><br>
              </td>
              <td style="width: 38%; vertical-align: bottom;">
                <div style="text-align: justify; line-height: 1.25;">Form of Warrant.</div>
              </td>
              <td colspan="1" style="width: 1%; vertical-align: top;">&#160;</td>
              <td style="width: 8%; vertical-align: top;">&#160;</td>
              <td colspan="1" style="width: 1%; vertical-align: top;">&#160;</td>
              <td style="width: 10%; vertical-align: top;">&#160;</td>
              <td colspan="1" style="width: 1%; vertical-align: top;">&#160;</td>
              <td style="width: 9%; vertical-align: top;">&#160;</td>
              <td colspan="1" style="width: 1%; vertical-align: top;">&#160;</td>
              <td style="width: 10%; vertical-align: top;">&#160;</td>
              <td colspan="1" style="width: 1%; vertical-align: top;">&#160;</td>
              <td style="width: 10%; vertical-align: top;">
                <div style="text-align: justify; line-height: 1.25;">*</div>
              </td>
            </tr>
            <tr>
              <td style="width: 9%; vertical-align: top;">
                <div style="text-align: justify; line-height: 1.25;">4.4</div>
              </td>
              <td colspan="1" style="width: 1%; vertical-align: bottom;"><br>
              </td>
              <td style="width: 38%; vertical-align: bottom;">
                <div style="text-align: justify; line-height: 1.25;">Form of Warrant Agreement.</div>
              </td>
              <td colspan="1" style="width: 1%; vertical-align: top;">&#160;</td>
              <td style="width: 8%; vertical-align: top;">&#160;</td>
              <td colspan="1" style="width: 1%; vertical-align: top;">&#160;</td>
              <td style="width: 10%; vertical-align: top;">&#160;</td>
              <td colspan="1" style="width: 1%; vertical-align: top;">&#160;</td>
              <td style="width: 9%; vertical-align: top;">&#160;</td>
              <td colspan="1" style="width: 1%; vertical-align: top;">&#160;</td>
              <td style="width: 10%; vertical-align: top;">&#160;</td>
              <td colspan="1" style="width: 1%; vertical-align: top;">&#160;</td>
              <td style="width: 10%; vertical-align: top;">
                <div style="text-align: justify; line-height: 1.25;">*</div>
              </td>
            </tr>
            <tr>
              <td style="width: 9%; vertical-align: top;">
                <div style="text-align: justify; line-height: 1.25;">4.5</div>
              </td>
              <td colspan="1" style="width: 1%; vertical-align: bottom;"><br>
              </td>
              <td style="width: 38%; vertical-align: bottom;">
                <div style="text-align: justify; line-height: 1.25;">Form of Unit Agreement.</div>
              </td>
              <td colspan="1" style="width: 1%; vertical-align: top;">&#160;</td>
              <td style="width: 8%; vertical-align: top;">&#160;</td>
              <td colspan="1" style="width: 1%; vertical-align: top;">&#160;</td>
              <td style="width: 10%; vertical-align: top;">&#160;</td>
              <td colspan="1" style="width: 1%; vertical-align: top;">&#160;</td>
              <td style="width: 9%; vertical-align: top;">&#160;</td>
              <td colspan="1" style="width: 1%; vertical-align: top;">&#160;</td>
              <td style="width: 10%; vertical-align: top;">&#160;</td>
              <td colspan="1" style="width: 1%; vertical-align: top;">&#160;</td>
              <td style="width: 10%; vertical-align: top;">
                <div style="text-align: justify; line-height: 1.25;">*</div>
              </td>
            </tr>
            <tr>
              <td style="width: 9%; vertical-align: top;">
                <div style="text-align: justify; line-height: 1.25;"><a href="exhibit_5-1.htm">5.1</a></div>
              </td>
              <td colspan="1" style="width: 1%; vertical-align: bottom;"><a href="exhibit_5-1.htm"><br>
                </a> </td>
              <td style="width: 38%; vertical-align: bottom;">
                <div style="line-height: 1.25;"><a href="exhibit_5-1.htm">Opinion of Naschitz, Brandes, Amir &amp; Co., Advocates.</a></div>
              </td>
              <td colspan="1" style="width: 1%; vertical-align: top;">&#160;</td>
              <td style="width: 8%; vertical-align: top;">&#160;</td>
              <td colspan="1" style="width: 1%; vertical-align: top;">&#160;</td>
              <td style="width: 10%; vertical-align: top;">&#160;</td>
              <td colspan="1" style="width: 1%; vertical-align: top;">&#160;</td>
              <td style="width: 9%; vertical-align: top;">&#160;</td>
              <td colspan="1" style="width: 1%; vertical-align: top;">&#160;</td>
              <td style="width: 10%; vertical-align: top;">&#160;</td>
              <td colspan="1" style="width: 1%; vertical-align: top;">&#160;</td>
              <td style="width: 10%; vertical-align: top;">&#160;</td>
            </tr>
            <tr>
              <td style="width: 9%; vertical-align: top;">
                <div style="text-align: justify; line-height: 1.25;"><a href="exhibit_5-2.htm">5.2</a></div>
              </td>
              <td colspan="1" style="width: 1%; vertical-align: bottom;"><a href="exhibit_5-2.htm"><br>
                </a> </td>
              <td style="width: 38%; vertical-align: bottom;">
                <div style="line-height: 1.25;"><a href="exhibit_5-2.htm">Opinion of Latham &amp; Watkins LLP.</a></div>
              </td>
              <td colspan="1" style="width: 1%; vertical-align: top;">&#160;</td>
              <td style="width: 8%; vertical-align: top;">&#160;</td>
              <td colspan="1" style="width: 1%; vertical-align: top;">&#160;</td>
              <td style="width: 10%; vertical-align: top;">&#160;</td>
              <td colspan="1" style="width: 1%; vertical-align: top;">&#160;</td>
              <td style="width: 9%; vertical-align: top;">&#160;</td>
              <td colspan="1" style="width: 1%; vertical-align: top;">&#160;</td>
              <td style="width: 10%; vertical-align: top;">&#160;</td>
              <td colspan="1" style="width: 1%; vertical-align: top;">&#160;</td>
              <td style="width: 10%; vertical-align: top;">&#160;</td>
            </tr>
            <tr>
              <td style="width: 9%; vertical-align: top;">
                <div style="text-align: justify; line-height: 1.25;"><a href="exhibit_5-3.htm">5.3</a></div>
              </td>
              <td colspan="1" style="width: 1%; vertical-align: bottom;"><a href="exhibit_5-3.htm"><br>
                </a> </td>
              <td style="width: 38%; vertical-align: bottom;">
                <div style="text-align: justify; line-height: 1.25;"><a href="exhibit_5-3.htm">Opinion of Naschitz, Brandes, Amir &amp; Co., Advocates.</a></div>
              </td>
              <td colspan="1" style="width: 1%; vertical-align: top;">&#160;</td>
              <td style="width: 8%; vertical-align: top;">&#160;</td>
              <td colspan="1" style="width: 1%; vertical-align: top;">&#160;</td>
              <td style="width: 10%; vertical-align: top;">&#160;</td>
              <td colspan="1" style="width: 1%; vertical-align: top;">&#160;</td>
              <td style="width: 9%; vertical-align: top;">&#160;</td>
              <td colspan="1" style="width: 1%; vertical-align: top;">&#160;</td>
              <td style="width: 10%; vertical-align: top;">&#160;</td>
              <td colspan="1" style="width: 1%; vertical-align: top;">&#160;</td>
              <td style="width: 10%; vertical-align: top;">&#160;</td>
            </tr>
            <tr>
              <td style="width: 9%; vertical-align: top;">
                <div style="text-align: justify; line-height: 1.25;"><a href="exhibit_23-1.htm">23.1</a></div>
              </td>
              <td colspan="1" style="width: 1%; vertical-align: top;"><a href="exhibit_23-1.htm"><br>
                </a> </td>
              <td style="width: 38%; vertical-align: top;">
                <div style="line-height: 1.25;"><a href="exhibit_23-1.htm">Consent of Kesselman &amp; Kesselman, a member firm of PricewaterhouseCoopers International Limited ,
                    an independent registered public accounting firm.</a></div>
              </td>
              <td colspan="1" style="width: 1%; vertical-align: top;">&#160;</td>
              <td style="width: 8%; vertical-align: top;">&#160;</td>
              <td colspan="1" style="width: 1%; vertical-align: top;">&#160;</td>
              <td style="width: 10%; vertical-align: top;">&#160;</td>
              <td colspan="1" style="width: 1%; vertical-align: top;">&#160;</td>
              <td style="width: 9%; vertical-align: top;">&#160;</td>
              <td colspan="1" style="width: 1%; vertical-align: top;">&#160;</td>
              <td style="width: 10%; vertical-align: top;">&#160;</td>
              <td colspan="1" style="width: 1%; vertical-align: top;">&#160;</td>
              <td style="width: 10%; vertical-align: top;">&#160;</td>
            </tr>
            <tr>
              <td style="width: 9%; vertical-align: top;">
                <div style="text-align: justify; line-height: 1.25;"><a href="exhibit_23-2.htm">23.2</a></div>
              </td>
              <td colspan="1" style="width: 1%; vertical-align: top;"><a href="exhibit_23-2.htm"><br>
                </a> </td>
              <td style="width: 38%; vertical-align: top;">
                <div style="text-align: justify; line-height: 1.25;"><a href="exhibit_23-2.htm">Consent of Kost Forer Gabbay &amp; Kasierer, a member of Ernst &amp; Young
                    Global, an independent registered public accounting firm.</a></div>
              </td>
              <td colspan="1" style="width: 1%; vertical-align: top;">&#160;</td>
              <td style="width: 8%; vertical-align: top;">&#160;</td>
              <td colspan="1" style="width: 1%; vertical-align: top;">&#160;</td>
              <td style="width: 10%; vertical-align: top;">&#160;</td>
              <td colspan="1" style="width: 1%; vertical-align: top;">&#160;</td>
              <td style="width: 9%; vertical-align: top;">&#160;</td>
              <td colspan="1" style="width: 1%; vertical-align: top;">&#160;</td>
              <td style="width: 10%; vertical-align: top;">&#160;</td>
              <td colspan="1" style="width: 1%; vertical-align: top;">&#160;</td>
              <td style="width: 10%; vertical-align: top;">&#160;</td>
            </tr>
            <tr>
              <td style="width: 9%; vertical-align: top;">
                <div style="text-align: justify; line-height: 1.25;"><a href="exhibit_5-1.htm">23.3</a></div>
              </td>
              <td colspan="1" style="width: 1%; vertical-align: top;"><a href="exhibit_5-1.htm"><br>
                </a> </td>
              <td style="width: 38%; vertical-align: top;">
                <div style="line-height: 1.25;"><a href="exhibit_5-1.htm">Consent of Naschitz, Brandes, Amir &amp; Co., Advocates (included in Exhibits 5.1 and 5.3).</a></div>
              </td>
              <td colspan="1" style="width: 1%; vertical-align: top;">&#160;</td>
              <td style="width: 8%; vertical-align: top;">&#160;</td>
              <td colspan="1" style="width: 1%; vertical-align: top;">&#160;</td>
              <td style="width: 10%; vertical-align: top;">&#160;</td>
              <td colspan="1" style="width: 1%; vertical-align: top;">&#160;</td>
              <td style="width: 9%; vertical-align: top;">&#160;</td>
              <td colspan="1" style="width: 1%; vertical-align: top;">&#160;</td>
              <td style="width: 10%; vertical-align: top;">&#160;</td>
              <td colspan="1" style="width: 1%; vertical-align: top;">&#160;</td>
              <td style="width: 10%; vertical-align: top;">&#160;</td>
            </tr>
            <tr>
              <td style="width: 9%; vertical-align: top;">
                <div style="text-align: justify; line-height: 1.25;"><a href="exhibit_5-2.htm">23.4</a></div>
              </td>
              <td colspan="1" style="width: 1%; vertical-align: top;"><a href="exhibit_5-2.htm"><br>
                </a> </td>
              <td style="width: 38%; vertical-align: top;">
                <div style="line-height: 1.25;"><a href="exhibit_5-2.htm">Consent of Latham &amp; Watkins LLP (included in Exhibit 5.2).</a></div>
              </td>
              <td colspan="1" style="width: 1%; vertical-align: top;">&#160;</td>
              <td style="width: 8%; vertical-align: top;">&#160;</td>
              <td colspan="1" style="width: 1%; vertical-align: top;">&#160;</td>
              <td style="width: 10%; vertical-align: top;">&#160;</td>
              <td colspan="1" style="width: 1%; vertical-align: top;">&#160;</td>
              <td style="width: 9%; vertical-align: top;">&#160;</td>
              <td colspan="1" style="width: 1%; vertical-align: top;">&#160;</td>
              <td style="width: 10%; vertical-align: top;">&#160;</td>
              <td colspan="1" style="width: 1%; vertical-align: top;">&#160;</td>
              <td style="width: 10%; vertical-align: top;">&#160;</td>
            </tr>
            <tr>
              <td style="width: 9%; vertical-align: top;">
                <div style="text-align: justify; line-height: 1.25;"><a href="#POWER">24.1</a></div>
              </td>
              <td colspan="1" style="width: 1%; vertical-align: top;"><a href="#POWER"><br>
                </a> </td>
              <td style="width: 38%; vertical-align: top;">
                <div style="line-height: 1.25;"><a href="#POWER">Power of Attorney (included on the signature page hereto).</a></div>
              </td>
              <td colspan="1" style="width: 1%; vertical-align: top;">&#160;</td>
              <td style="width: 8%; vertical-align: top;">&#160;</td>
              <td colspan="1" style="width: 1%; vertical-align: top;">&#160;</td>
              <td style="width: 10%; vertical-align: top;">&#160;</td>
              <td colspan="1" style="width: 1%; vertical-align: top;">&#160;</td>
              <td style="width: 9%; vertical-align: top;">&#160;</td>
              <td colspan="1" style="width: 1%; vertical-align: top;">&#160;</td>
              <td style="width: 10%; vertical-align: top;">&#160;</td>
              <td colspan="1" style="width: 1%; vertical-align: top;">&#160;</td>
              <td style="width: 10%; vertical-align: top;">&#160;</td>
            </tr>
            <tr>
              <td style="width: 9%; vertical-align: top;">
                <div style="text-align: justify; line-height: 1.25;"><a href="exfilingfees.htm">107</a></div>
              </td>
              <td colspan="1" style="width: 1%; vertical-align: top;"><a href="exfilingfees.htm"><br>
                </a> </td>
              <td style="width: 38%; vertical-align: top;">
                <div style="text-align: justify; line-height: 1.25;"><a href="exfilingfees.htm">Calculation of Registration Fee.</a></div>
              </td>
              <td colspan="1" style="width: 1%; vertical-align: top;">&#160;</td>
              <td style="width: 8%; vertical-align: top;">&#160;</td>
              <td colspan="1" style="width: 1%; vertical-align: top;">&#160;</td>
              <td style="width: 10%; vertical-align: top;">&#160;</td>
              <td colspan="1" style="width: 1%; vertical-align: top;">&#160;</td>
              <td style="width: 9%; vertical-align: top;">&#160;</td>
              <td colspan="1" style="width: 1%; vertical-align: top;">&#160;</td>
              <td style="width: 10%; vertical-align: top;">&#160;</td>
              <td colspan="1" style="width: 1%; vertical-align: top;">&#160;</td>
              <td style="width: 10%; vertical-align: top;">&#160;</td>
            </tr>

        </table>
        <div style="line-height: 1.25">&#160;<br>
          <hr noshade="noshade" align="left" style="background-color: #000000; border: 0px; height: 1px; width: 2in; margin-left: 0pt; margin-right: auto; color: #000000;"> </div>
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z768881014ce441eeb5f7619821274505">

            <tr>
              <td style="width: 28.35pt; vertical-align: top;">*</td>
              <td style="width: auto; vertical-align: top; text-align: justify;">
                <div>To be filed by amendment or incorporated by reference in connection with the offering of the securities.</div>
              </td>
            </tr>

        </table>
        <div style="line-height: 1.25;">&#160;</div>
        <div style="line-height: 1.25; font-weight: bold;">Item 10. Undertakings</div>
        <div style="line-height: 1.25;">&#160;</div>
        <div style="text-indent: 36pt; line-height: 1.25;">(1) The undersigned registrant hereby undertakes:</div>
        <div style="line-height: 1.25;">&#160;</div>
        <div style="text-align: justify; text-indent: 24.5pt; margin-left: 24.45pt; line-height: 1.25;">(a) To file, during any period in which offers or sales are being made, a post-effective amendment to this registration statement:</div>
        <div style="line-height: 1.25;">&#160;</div>
        <div style="text-align: justify; text-indent: 24.5pt; margin-left: 48.95pt; line-height: 1.25;">(i) to include any prospectus required by Section 10(a)(3) of the Securities Act of 1933;</div>
        <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
          <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-weight: normal; font-style: normal;">II - 3</font></div>
          <div style="page-break-after: always;" class="BRPFPageBreak">
            <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
        </div>
        <div style="text-align: justify; text-indent: 24.5pt; margin-left: 48.95pt; line-height: 1.25;">(ii) to reflect in the prospectus any facts or events arising after the effective date of the registration statement (or the most recent post-effective
          amendment thereof) which, individually or in the aggregate, represent a fundamental change in the information set forth in the registration statement.&#160; Notwithstanding the foregoing, any increase or decrease in volume of securities offered (if
          the total dollar value of securities offered would not exceed that which was registered) and any deviation from the low or high end of the estimated maximum offering range may be reflected in the form of prospectus filed with the SEC pursuant to
          Rule 424(b) if, in the aggregate, the changes in volume and price represent no more than 20 percent change in the maximum aggregate offering price set forth in the "Calculation of Registration Fee" table in the effective registration statement;
          and</div>
        <div style="line-height: 1.25; text-align: justify;">&#160;</div>
        <div style="text-align: justify; text-indent: 24.5pt; margin-left: 48.95pt; line-height: 1.25;">(iii) to include any material information with respect to the plan of distribution not previously disclosed in the registration statement or any
          material change to such information in the registration statement;</div>
        <div style="line-height: 1.25; text-align: justify;">&#160;</div>
        <div style="text-align: justify; margin-left: 24.45pt; line-height: 1.25;"><font style="font-style: italic;">provided</font>, <font style="font-style: italic;">however</font>, that paragraphs (a)(1)(i), (a)(1)(ii), and (a)(1)(iii) above do not
          apply if the information required to be included in a post-effective amendment by those paragraphs is contained in reports filed with or furnished to the SEC by the registrant pursuant to section 13 or section 15(d) of the Securities Exchange Act
          of 1934 that are incorporated by reference in the registration statement, or is contained in a form of prospectus filed pursuant to Rule 424(b) that is a part of the registration statement.</div>
        <div style="line-height: 1.25; text-align: justify;">&#160;</div>
        <div style="text-align: justify; text-indent: 24.5pt; margin-left: 24.45pt; line-height: 1.25;">(b) That, for the purpose of determining any liability under the Securities Act of 1933, each such post-effective amendment shall be deemed to be a new
          registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof.</div>
        <div style="line-height: 1.25; text-align: justify;">&#160;</div>
        <div style="text-align: justify; text-indent: 24.5pt; margin-left: 24.45pt; line-height: 1.25;">(c) To remove from registration by means of a post-effective amendment any of the securities being registered which remain unsold at the termination of
          the offering.</div>
        <div style="line-height: 1.25; text-align: justify;">&#160;</div>
        <div style="text-align: justify; text-indent: 24.5pt; margin-left: 24.45pt; line-height: 1.25;">(d) To file a post-effective amendment to the registration statement to include any financial statements required by Item 8.A of Form 20-F (&#167; 249.220f
          of this chapter) at the start of any delayed offering or throughout a continuous offering. Financial statements and information otherwise required by Section 10(a)(3) of the Act (15 U.S.C. 77j(a)(3)) need not be furnished, provided that the
          registrant includes in the prospectus, by means of a post-effective amendment, financial statements required pursuant to this paragraph (a)(4) and other information necessary to ensure that all other information in the prospectus is at least as
          current as the date of those financial statements. Notwithstanding the foregoing, a post-effective amendment need not be filed to include financial statements and information required by Section 10(a)(3) of the Act or Item 8.A of Form 20-F if
          such financial statements and information are contained in periodic reports filed with or furnished to the SEC by the registrant pursuant to section 13 or section 15(d) of the Securities Exchange Act of 1934 that are incorporated by reference in
          the Form F-3.</div>
        <div style="line-height: 1.25; text-align: justify;">&#160;</div>
        <div style="text-align: justify; text-indent: 24.5pt; margin-left: 24.45pt; line-height: 1.25;">(e) That, for the purpose of determining liability under the Securities Act of 1933 to any purchaser:</div>
        <div style="line-height: 1.25; text-align: justify;">&#160;</div>
        <div style="text-align: justify; text-indent: 24.5pt; margin-left: 48.95pt; line-height: 1.25;">(i) Each prospectus filed by the registrant pursuant to Rule 424(b)(3) shall be deemed to be part of the registration statement as of the date the filed
          prospectus was deemed part of and included in the registration statement; and</div>
        <div style="text-align: justify; text-indent: 24.5pt; margin-left: 48.95pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif;"> <br>
        </div>
        <div style="text-align: justify; text-indent: 24.5pt; margin-left: 48.95pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">
          <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">(ii) Each prospectus required to be filed pursuant to Rule 424(b)(2), (b)(5), or (b)(7) as part of a registration statement in reliance on Rule 430B relating to an
            offering made pursuant to Rule 415(a)(1)(i), (vii), or (x) for the purpose of providing the information required by section 10(a) of the Securities Act of 1933 shall be deemed to be part of and included in the registration statement as of the
            earlier of the date such form of prospectus is first used after effectiveness or the date of the first contract of sale of securities in the offering described in the prospectus.&#160; As provided in Rule 430B, for liability purposes of the issuer
            and any person that is at that date an underwriter, such date shall be deemed to be a new effective date of the registration statement relating to the securities in the registration statement to which that prospectus relates, and the offering
            of such securities at that time shall be deemed to be the initial bona fide offering thereof.&#160; <font style="font-style: italic;">Provided</font>, <font style="font-style: italic;">however</font>, that no statement made in a registration
            statement or prospectus that is part of the registration statement or made in a document incorporated or deemed incorporated by reference into the registration statement or prospectus that is part of the registration statement will, as to a
            purchaser with a time of contract of sale prior to such effective date, supersede or modify any statement that was made in the registration statement or prospectus that was part of the registration statement or made in any such document
            immediately prior to such effective date.</div>
        </div>
        <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
          <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-weight: normal; font-style: normal;">II - 4</font></div>
          <div style="page-break-after: always;" class="BRPFPageBreak">
            <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
        </div>
        <div style="text-align: justify; text-indent: 24.5pt; margin-left: 24.45pt; line-height: 1.25;">(f) That, for the purpose of determining liability of the registrant under the Securities Act of 1933 to any purchaser in the initial distribution of
          the securities, the undersigned registrant undertakes that in a primary offering of securities of the undersigned registrant pursuant to this registration statement, regardless of the underwriting method used to sell the securities to the
          purchaser, if the securities are offered or sold to such purchaser by means of any of the following communications, the undersigned registrant will be a seller to the purchaser and will be considered to offer or sell such securities to such
          purchaser:</div>
        <div style="line-height: 1.25;">&#160;</div>
        <div style="text-align: justify; text-indent: 24.5pt; margin-left: 48.95pt; line-height: 1.25;">(i) any preliminary prospectus or prospectus of the undersigned registrant relating to the offering required to be filed pursuant to Rule 424;</div>
        <div style="line-height: 1.25;">&#160;</div>
        <div style="text-align: justify; text-indent: 24.5pt; margin-left: 48.95pt; line-height: 1.25;">(ii) any free writing prospectus relating to the offering prepared by or on behalf of the undersigned registrant or used or referred to by the
          undersigned registrant;</div>
        <div style="line-height: 1.25; text-align: justify;">&#160;</div>
        <div style="text-align: justify; text-indent: 24.5pt; margin-left: 48.95pt; line-height: 1.25;">(iii) the portion of any other free writing prospectus relating to the offering containing material information about the undersigned registrant or its
          securities provided by or on behalf of the undersigned registrant; and</div>
        <div style="line-height: 1.25; text-align: justify;">&#160;</div>
        <div style="text-align: justify; text-indent: 24.5pt; margin-left: 48.95pt; line-height: 1.25;">(iv) any other communications that is an offer in the offering made by the undersigned registrant to the purchaser.</div>
        <div style="line-height: 1.25; text-align: justify;">&#160;</div>
        <div style="text-align: justify; text-indent: 24.5pt; line-height: 1.25;">(2) The undersigned registrant hereby undertakes that, for purposes of determining any liability under the Securities Act of 1933, each filing of the registrant&#8217;s annual
          report pursuant to Section 13(a) or Section 15(d) of the Securities Exchange Act of 1934 (and, where applicable, each filing of an employee benefit plan&#8217;s annual report pursuant to section 15(d) of the Securities Exchange Act of 1934) that is
          incorporated by reference in the registration statement shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial <font style="font-style: italic;">bona fide</font> offering thereof.</div>
        <div style="line-height: 1.25; text-align: justify;">&#160;</div>
        <div style="text-align: justify; text-indent: 24.5pt; line-height: 1.25;">(3) Insofar as indemnification for liabilities arising under the Securities Act of 1933 may be permitted to directors, officers and controlling persons of the registrant
          pursuant to the foregoing provisions, or otherwise, the registrant has been advised that in the opinion of the SEC such indemnification is against public policy as expressed in the Securities Act and is, therefore, unenforceable.&#160; In the event
          that a claim for indemnification against such liabilities (other than the payment by the registrant of expenses incurred or paid by a director, officer or controlling person of the registrant in the successful defense of any action, suit or
          proceeding) is asserted by such director, officer or controlling person in connection with the securities being registered, the registrant will, unless in the opinion of its counsel the matter has been settled by controlling precedent, submit to
          a court of appropriate jurisdiction the question whether such indemnification by it is against public policy as expressed in the Securities Act and will be governed by the final adjudication of such issue.</div>
        <div style="line-height: 1.25; text-align: justify;">&#160;</div>
        <div style="text-indent: 22.5pt; line-height: 1.25; text-align: justify;">(4) The undersigned registrant hereby undertakes that, for purposes of determining any liability under the Securities Act, the information omitted from the form of prospectus
          filed as part of this registration statement in reliance upon Rule&#160;430A and contained in a form of prospectus filed by the registrant pursuant to Rule&#160;424(b)(1) or (4)&#160;or 497(h) under the Securities Act shall be deemed to be part of this
          registration statement as of the time it was declared effective.</div>
        <div style="line-height: 1.25; text-align: justify;">&#160;</div>
        <div style="text-indent: 22.5pt; line-height: 1.25; text-align: justify;">(5) The undersigned registrant hereby undertakes that, for the purpose of determining any liability under the Securities Act, each post-effective amendment that contains a
          form of prospectus shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof.</div>
        <div style="text-indent: 22.5pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif;"> <br>
        </div>
        <div style="text-indent: 22.5pt; line-height: 1.25; text-align: justify;">(6) The undersigned registrant hereby undertakes to file an application for the purpose of determining the eligibility of the trustee to act under subsection (a) of Section
          310 of the Trust Indenture Act (the &#8220;Act&#8221;) in accordance with the rules and regulations prescribed by the SEC under section 305(b)(2) of the Act.</div>
        <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
          <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-weight: normal; font-style: normal;">II - 5</font></div>
          <div style="page-break-after: always;" class="BRPFPageBreak">
            <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
        </div>
        <div style="text-align: center; line-height: 1.25; font-weight: bold;">SIGNATURES</div>
        <div style="line-height: 1.25;">&#160;</div>
        <div style="text-indent: 36pt; line-height: 1.25; text-align: justify;">Pursuant to the requirements of the Securities Act of 1933, the registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing
          on Form F-3 and has duly caused this registration statement to be signed on its behalf by the undersigned, thereunto duly authorized, in Rosh HaAin, Israel, on this 13th day of August, 2025.</div>
        <div style="line-height: 1.25;">&#160;</div>
        <div style="line-height: 1.25">
          <table cellspacing="0" cellpadding="0" border="0" style="width: 100%; border-collapse: separate; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">

              <tr>
                <td valign="top" style="width: 50%;">&#160;</td>
                <td valign="top" colspan="2" style="font-weight: bold;">INNOVIZ TECHNOLOGIES LTD.</td>
                <td valign="top" style="width: 10%;">&#160;</td>
              </tr>
              <tr>
                <td valign="top" style="width: 50%;">&#160;</td>
                <td valign="top" style="width: 5%;">&#160;</td>
                <td valign="top" style="width: 35%;">&#160;</td>
                <td valign="top" style="width: 10%;">&#160;</td>
              </tr>
              <tr>
                <td valign="top" align="left" style="width: 50%; padding-bottom: 2px;"><br>
                </td>
                <td valign="top" style="width: 5%; padding-bottom: 2px;">
                  <div align="left" style="margin-left: 0pt; text-indent: 0pt; margin-right: 0pt;">By: </div>
                </td>
                <td valign="top" nowrap="nowrap" align="left" style="width: 35%; border-bottom: 2px solid rgb(0, 0, 0);"><font style="font-family: 'Times New Roman',Times,serif;">/s/ Eldar Cegla</font></td>
                <td valign="top" style="width: 10%; padding-bottom: 2px;">&#160;</td>
              </tr>
              <tr>
                <td valign="top" style="width: 50%;">&#160;</td>
                <td valign="top" style="width: 5%;">Name:</td>
                <td valign="bottom" nowrap="nowrap" align="left" style="width: 35%;">Eldar Cegla</td>
                <td valign="top" style="width: 10%;">&#160;</td>
              </tr>
              <tr>
                <td valign="top" style="width: 50%;">&#160;</td>
                <td valign="top" style="width: 5%;"><font style="font-family: 'Times New Roman',Times,serif;">Title:</font></td>
                <td valign="top" style="width: 35%;"><font style="font-family: 'Times New Roman',Times,serif;">Chief Financial Officer</font></td>
                <td valign="top" style="width: 10%;">&#160;</td>
              </tr>

          </table>
        </div>
        <div style="line-height: 1.25"> <br>
        </div>
        <div style="text-align: center; line-height: 1.25; font-weight: bold;"><a name="POWER"><!--Anchor--></a>POWER OF ATTORNEY</div>
        <div style="line-height: 1.25;">&#160;</div>
        <div style="text-indent: 36pt; line-height: 1.25; text-align: justify;">KNOW ALL PERSONS BY THESE PRESENTS, that each person whose signature appears below does hereby constitute and appoint each of Omer David Keilaf and Eldar Cegla, with full power
          of substitution and full power to act without the other, as his or her true and lawful attorney&#8209;in&#8209;fact and agent to act for him or her in his or her name, place and stead, in any and all capacities, to sign any and all amendments (including
          post&#8209;effective amendments) to this registration statement, and to file this registration statement, with all exhibits thereto, and other documents in connection therewith, with the SEC, granting unto said attorneys&#8209;in&#8209;fact and agents, and each of
          them, full power and authority to do and perform each and every act and thing requisite and necessary to be done in order to effectuate the same as fully, to all intents and purposes, as they or he or she might or could do in person, hereby
          ratifying and confirming all that said attorneys&#8209;in&#8209;fact and agents, or any of them, may lawfully do or cause to be done by virtue hereof.</div>
        <div style="line-height: 1.25;">&#160;</div>
        <div style="text-indent: 36pt; line-height: 1.25; text-align: justify;">Pursuant to the requirements of the Securities Act of 1933, as amended, this registration statement has been signed by the following persons in the capacities and on the date
          indicated.</div>
        <div style="line-height: 1.25;">&#160;</div>
        <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="ze58a8c57a136436aaaa6ae41ee392093">

            <tr>
              <td style="width: 33.33%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">
                <div style="line-height: 1.25;">
                  <div style="text-align: justify; line-height: 1.25; font-weight: bold;">NAME</div>
                </div>
              </td>
              <td colspan="1" style="width: 1%; vertical-align: top; padding-bottom: 2px;">&#160;</td>
              <td style="width: 32%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">
                <div style="line-height: 1.25;">
                  <div style="text-align: justify; line-height: 1.25; font-weight: bold;">POSITION</div>
                </div>
              </td>
              <td colspan="1" style="width: 1%; vertical-align: top; padding-bottom: 2px;">&#160;</td>
              <td style="width: 33%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">
                <div style="line-height: 1.25;">
                  <div style="text-align: justify; line-height: 1.25; font-weight: bold;">DATE</div>
                </div>
              </td>
            </tr>
            <tr>
              <td style="width: 33.33%; vertical-align: top;">
                <div style="text-align: justify; line-height: 1.25;"><u>/s/ Omer David Keilaf</u>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<br>
                  Omer David Keilaf</div>
              </td>
              <td colspan="1" style="width: 1%; vertical-align: top;">&#160;</td>
              <td style="width: 32%; vertical-align: top;">
                <div style="text-align: justify; line-height: 1.25;">Chief Executive Officer and Director (<font style="font-style: italic;">Principal Executive Officer</font>)</div>
              </td>
              <td colspan="1" style="width: 1%; vertical-align: top;">&#160;</td>
              <td style="width: 33%; vertical-align: top;">
                <div style="text-align: justify; line-height: 1.25;">August 13, 2025</div>
              </td>
            </tr>
            <tr>
              <td rowspan="1" style="width: 33.33%; vertical-align: top;">&#160;</td>
              <td rowspan="1" colspan="1" style="width: 1%; vertical-align: top;">&#160;</td>
              <td rowspan="1" style="width: 32%; vertical-align: top;">&#160;</td>
              <td rowspan="1" colspan="1" style="width: 1%; vertical-align: top;">&#160;</td>
              <td rowspan="1" style="width: 33%; vertical-align: top;">&#160;</td>
            </tr>
            <tr>
              <td style="width: 33.33%; vertical-align: top;">
                <div style="text-align: justify; line-height: 1.25;"><u>/s/ Eldar Cegla</u>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<br>
                  Eldar Cegla</div>
              </td>
              <td colspan="1" style="width: 1%; vertical-align: top;">&#160;</td>
              <td style="width: 32%; vertical-align: top;">
                <div style="text-align: justify; line-height: 1.25;">Chief Financial Officer (<font style="font-style: italic;">Principal Financial Officer and Principal Accounting Officer</font>)</div>
              </td>
              <td colspan="1" style="width: 1%; vertical-align: top;">&#160;</td>
              <td style="width: 33%; vertical-align: top;">
                <div style="text-align: justify; line-height: 1.25;">August 13, 2025</div>
              </td>
            </tr>
            <tr>
              <td rowspan="1" style="width: 33.33%; vertical-align: top;">&#160;</td>
              <td rowspan="1" colspan="1" style="width: 1%; vertical-align: top;">&#160;</td>
              <td rowspan="1" style="width: 32%; vertical-align: top;">&#160;</td>
              <td rowspan="1" colspan="1" style="width: 1%; vertical-align: top;">&#160;</td>
              <td rowspan="1" style="width: 33%; vertical-align: top;">&#160;</td>
            </tr>
            <tr>
              <td style="width: 33.33%; vertical-align: top;">
                <div style="text-align: justify; line-height: 1.25;"><u>/s/ Amichai Steimberg</u>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<br>
                  Amichai Steimberg</div>
              </td>
              <td colspan="1" style="width: 1%; vertical-align: top;">&#160;</td>
              <td style="width: 32%; vertical-align: top;">
                <div style="text-align: justify; line-height: 1.25;">Director</div>
              </td>
              <td colspan="1" style="width: 1%; vertical-align: top;">&#160;</td>
              <td style="width: 33%; vertical-align: top;">
                <div style="text-align: justify; line-height: 1.25;">August 13, 2025</div>
              </td>
            </tr>
            <tr>
              <td rowspan="1" style="width: 33.33%; vertical-align: top;">&#160;</td>
              <td rowspan="1" colspan="1" style="width: 1%; vertical-align: top;">&#160;</td>
              <td rowspan="1" style="width: 32%; vertical-align: top;">&#160;</td>
              <td rowspan="1" colspan="1" style="width: 1%; vertical-align: top;">&#160;</td>
              <td rowspan="1" style="width: 33%; vertical-align: top;">&#160;</td>
            </tr>
            <tr>
              <td style="width: 33.33%; vertical-align: top;">
                <div style="text-align: justify; line-height: 1.25;"><u>/s/ Aharon Aharon</u>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<br>
                  Aharon Aharon</div>
              </td>
              <td colspan="1" style="width: 1%; vertical-align: top;">&#160;</td>
              <td style="width: 32%; vertical-align: top;">
                <div style="text-align: justify; line-height: 1.25;">Director</div>
              </td>
              <td colspan="1" style="width: 1%; vertical-align: top;">&#160;</td>
              <td style="width: 33%; vertical-align: top;">
                <div style="text-align: justify; line-height: 1.25;">August 13, 2025</div>
              </td>
            </tr>
            <tr>
              <td rowspan="1" style="width: 33.33%; vertical-align: top;">&#160;</td>
              <td rowspan="1" colspan="1" style="width: 1%; vertical-align: top;">&#160;</td>
              <td rowspan="1" style="width: 32%; vertical-align: top;">&#160;</td>
              <td rowspan="1" colspan="1" style="width: 1%; vertical-align: top;">&#160;</td>
              <td rowspan="1" style="width: 33%; vertical-align: top;">&#160;</td>
            </tr>
            <tr>
              <td style="width: 33.33%; vertical-align: top;">
                <div style="text-align: justify; line-height: 1.25;"><u>/s/ Dan Falk</u>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<br>
                  Dan Falk</div>
              </td>
              <td colspan="1" style="width: 1%; vertical-align: top;">&#160;</td>
              <td style="width: 32%; vertical-align: top;">
                <div style="text-align: justify; line-height: 1.25;">Director</div>
              </td>
              <td colspan="1" style="width: 1%; vertical-align: top;">&#160;</td>
              <td style="width: 33%; vertical-align: top;">
                <div style="text-align: justify; line-height: 1.25;">August 13, 2025</div>
              </td>
            </tr>
            <tr>
              <td rowspan="1" style="width: 33.33%; vertical-align: top;">&#160;</td>
              <td rowspan="1" colspan="1" style="width: 1%; vertical-align: top;">&#160;</td>
              <td rowspan="1" style="width: 32%; vertical-align: top;">&#160;</td>
              <td rowspan="1" colspan="1" style="width: 1%; vertical-align: top;">&#160;</td>
              <td rowspan="1" style="width: 33%; vertical-align: top;">&#160;</td>
            </tr>
            <tr>
              <td style="width: 33.33%; vertical-align: top;">
                <div style="text-align: justify; line-height: 1.25;"><u>/s/ Stefan Jacoby</u>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<br>
                  Stefan Jacoby</div>
              </td>
              <td colspan="1" style="width: 1%; vertical-align: top;">&#160;</td>
              <td style="width: 32%; vertical-align: top;">
                <div style="text-align: justify; line-height: 1.25;">Director</div>
              </td>
              <td colspan="1" style="width: 1%; vertical-align: top;">&#160;</td>
              <td style="width: 33%; vertical-align: top;">
                <div style="text-align: justify; line-height: 1.25;">August 13, 2025</div>
              </td>
            </tr>
            <tr>
              <td rowspan="1" style="width: 33.33%; vertical-align: top;">&#160;</td>
              <td rowspan="1" colspan="1" style="width: 1%; vertical-align: top;">&#160;</td>
              <td rowspan="1" style="width: 32%; vertical-align: top;">&#160;</td>
              <td rowspan="1" colspan="1" style="width: 1%; vertical-align: top;">&#160;</td>
              <td rowspan="1" style="width: 33%; vertical-align: top;">&#160;</td>
            </tr>
            <tr>
              <td style="width: 33.33%; vertical-align: top;">
                <div style="text-align: justify; line-height: 1.25;"><u>/s/ Ronit Maor</u>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<br>
                  Ronit Maor</div>
              </td>
              <td colspan="1" style="width: 1%; vertical-align: top;">&#160;</td>
              <td style="width: 32%; vertical-align: top;">
                <div style="text-align: justify; line-height: 1.25;">Director</div>
              </td>
              <td colspan="1" style="width: 1%; vertical-align: top;">&#160;</td>
              <td style="width: 33%; vertical-align: top;">
                <div style="text-align: justify; line-height: 1.25;">August 13, 2025</div>
              </td>
            </tr>
            <tr>
              <td rowspan="1" style="width: 33.33%; vertical-align: top;">&#160;</td>
              <td rowspan="1" colspan="1" style="width: 1%; vertical-align: top;">&#160;</td>
              <td rowspan="1" style="width: 32%; vertical-align: top;">&#160;</td>
              <td rowspan="1" colspan="1" style="width: 1%; vertical-align: top;">&#160;</td>
              <td rowspan="1" style="width: 33%; vertical-align: top;">&#160;</td>
            </tr>
            <tr>
              <td style="width: 33.33%; vertical-align: top;">
                <div style="text-align: justify; line-height: 1.25;"><u>/s/ James Sheridan</u>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<br>
                  James Sheridan</div>
              </td>
              <td colspan="1" style="width: 1%; vertical-align: top;">&#160;</td>
              <td style="width: 32%; vertical-align: top;">
                <div style="text-align: justify; line-height: 1.25;">Director</div>
              </td>
              <td colspan="1" style="width: 1%; vertical-align: top;">&#160;</td>
              <td style="width: 33%; vertical-align: top;">
                <div style="text-align: justify; line-height: 1.25;">August 13, 2025</div>
              </td>
            </tr>
            <tr>
              <td rowspan="1" style="width: 33.33%; vertical-align: top;">&#160;</td>
              <td rowspan="1" colspan="1" style="width: 1%; vertical-align: top;">&#160;</td>
              <td rowspan="1" style="width: 32%; vertical-align: top;">&#160;</td>
              <td rowspan="1" colspan="1" style="width: 1%; vertical-align: top;">&#160;</td>
              <td rowspan="1" style="width: 33%; vertical-align: top;">&#160;</td>
            </tr>
            <tr>
              <td style="width: 33.33%; vertical-align: top;">
                <div style="text-align: justify; line-height: 1.25;"><u>/s/ Orit Stav</u>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<br>
                  Orit Stav</div>
              </td>
              <td colspan="1" style="width: 1%; vertical-align: top;">&#160;</td>
              <td style="width: 32%; vertical-align: top;">
                <div style="text-align: justify; line-height: 1.25;">Director</div>
              </td>
              <td colspan="1" style="width: 1%; vertical-align: top;">&#160;</td>
              <td style="width: 33%; vertical-align: top;">
                <div style="text-align: justify; line-height: 1.25;">August 13, 2025</div>
              </td>
            </tr>
            <tr>
              <td rowspan="1" style="width: 33.33%; vertical-align: top;">&#160;</td>
              <td rowspan="1" colspan="1" style="width: 1%; vertical-align: top;">&#160;</td>
              <td rowspan="1" style="width: 32%; vertical-align: top;">&#160;</td>
              <td rowspan="1" colspan="1" style="width: 1%; vertical-align: top;">&#160;</td>
              <td rowspan="1" style="width: 33%; vertical-align: top;">&#160;</td>
            </tr>
            <tr>
              <td style="width: 33.33%; vertical-align: top;">
                <div style="text-align: justify; line-height: 1.25;"><u>/s/ Alexander von Witzleben</u>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<br>
                  Alexander von Witzleben</div>
              </td>
              <td colspan="1" style="width: 1%; vertical-align: top;">&#160;</td>
              <td style="width: 32%; vertical-align: top;">
                <div style="text-align: justify; line-height: 1.25;">Director</div>
              </td>
              <td colspan="1" style="width: 1%; vertical-align: top;">&#160;</td>
              <td style="width: 33%; vertical-align: top;">
                <div style="text-align: justify; line-height: 1.25;">August 13, 2025</div>
              </td>
            </tr>

        </table>
        <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
          <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-weight: normal; font-style: normal;">II - 6</font></div>
          <div style="page-break-after: always;" class="BRPFPageBreak">
            <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
        </div>
        <div style="text-align: center; line-height: 1.25; font-weight: bold;">AUTHORIZED REPRESENTATIVE</div>
        <div style="line-height: 1.25;">&#160;</div>
        <div style="text-indent: 36pt; line-height: 1.25; text-align: justify;">Pursuant to the requirements of the Securities Act of 1933, as amended, the undersigned, the duly authorized representative in the United States of Innoviz Technologies Ltd.
          has signed this registration statement on August 13, 2025.</div>
        <div style="line-height: 1.25">&#160;
          <div style="line-height: 1.25">
            <table cellspacing="0" cellpadding="0" border="0" style="width: 100%; border-collapse: separate; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">

                <tr>
                  <td valign="top" align="left" style="width: 50%; padding-bottom: 2px;"><br>
                  </td>
                  <td valign="top" style="width: 5%; padding-bottom: 2px;">
                    <div align="left" style="margin-left: 0pt; text-indent: 0pt; margin-right: 0pt;">By: </div>
                  </td>
                  <td valign="top" nowrap="nowrap" align="left" style="width: 35%; border-bottom: 2px solid rgb(0, 0, 0);">/s/ Colleen De Vries</td>
                  <td valign="top" style="width: 10%; padding-bottom: 2px;">&#160;</td>
                </tr>
                <tr>
                  <td valign="top" style="width: 50%;">&#160;</td>
                  <td valign="top" style="width: 5%;">Name:</td>
                  <td valign="bottom" nowrap="nowrap" align="left" style="width: 35%;">Colleen De Vries</td>
                  <td valign="top" style="width: 10%;">&#160;</td>
                </tr>
                <tr>
                  <td valign="top" style="width: 50%;">&#160;</td>
                  <td valign="top" style="width: 5%;"><font style="font-family: 'Times New Roman',Times,serif;">Title:</font></td>
                  <td valign="top" style="width: 35%;">SVP on behalf of Cogency Global Inc.</td>
                  <td valign="top" style="width: 10%;">&#160;</td>
                </tr>

            </table>
          </div>
        </div>
        <br>
      </div>
    </div>
  </div>
  <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-weight: normal; font-style: normal;">II - 7</font>
    <hr align="center" style="border: none; border-bottom: 4px solid black; border-top: 1px solid black; height: 10px; color: #ffffff; background-color: #ffffff; margin-left: auto; margin-right: auto;"></div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-1.2
<SEQUENCE>2
<FILENAME>exhibit_1-2.htm
<DESCRIPTION>EXHIBIT 1.2
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: zk-global
         Document created using Broadridge PROfile 25.5.1.5318
         Copyright 1995 - 2025 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left; color: #000000;">
  <div>
    <hr align="center" style="border: none; border-bottom: 1px solid black; border-top: 4px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;">
    <div style="text-align: right;"><font style="font-weight: bold;"><u>Exhibit 1.2</u></font><br>
    </div>
    <div> </div>
    <div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: center; line-height: 1.25; font-weight: bold;"><u>OPEN MARKET SALE AGREEMENT</u><sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">S</sup><sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">M</sup></div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: right; line-height: 1.25;">August 13, 2025</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="margin-right: 72pt; line-height: 1.25;">JEFFERIES LLC<br>
        520 Madison Avenue</div>
      <div style="text-align: justify; line-height: 1.25;">New York, New York 10022</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; line-height: 1.25;">Ladies and Gentlemen:</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">Innoviz Technologies Ltd., a company organized under the laws of the State of Israel (the &#8220;<font style="font-weight: bold;">Company</font>&#8221;), proposes, subject to the terms and
        conditions stated herein, to issue and sell from time to time through Jefferies LLC, as sales agent and/or principal (the &#8220;<font style="font-weight: bold;">Agent</font>&#8221;), ordinary shares, no par value per share, of the Company (the &#8220;<font style="font-weight: bold;">Ordinary Shares</font>&#8221;), having an aggregate offering price of up to $75 million, on the terms set forth in this agreement (this &#8220;<font style="font-weight: bold;">Agreement</font>&#8221;).</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="line-height: 1.25;"><font style="font-weight: bold;">Section 1.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-weight: bold;">&#160; DEFINITIONS</font></div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">(a)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Certain Definitions</u>.&#160; For purposes of this Agreement, capitalized terms used herein and not otherwise defined shall have the following respective meanings:</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">&#8220;<font style="font-weight: bold;">Agency Period</font>&#8221; means the period commencing on the date of this Agreement and expiring on the earliest to occur of (x)&#160;the date on which
        the Agent shall have placed the Maximum Program Amount pursuant to this Agreement and (y)&#160;the date this Agreement is terminated pursuant to <u>Section 7</u>.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">&#8220;<font style="font-weight: bold;">Commission</font>&#8221; means the U.S. Securities and Exchange Commission.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">&#8220;<font style="font-weight: bold;">Exchange Act</font>&#8221; means the Securities Exchange Act of 1934, as amended, and the rules and regulations of the Commission thereunder.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">&#8220;<font style="font-weight: bold;">Floor Price</font>&#8221; means the minimum price set by the Company in the Issuance Notice below which the Agent shall not sell Shares during the
        applicable period set forth in the Issuance Notice, which may be adjusted by the Company at any time during the period set forth in the Issuance Notice by delivering written notice of such change to the Agent and which in no event shall be less
        than $0.50 without the prior written consent of the Agent, which may be withheld in the Agent&#8217;s sole discretion.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">&#8220;<font style="font-weight: bold;">Issuance Amount</font>&#8221; means the aggregate Sales Price of the Shares to be sold by the Agent pursuant to any Issuance Notice.</div>
      <br>
      <hr noshade="noshade" align="left" style="background-color: #000000; border: 0px; height: 1px; width: 2in; margin-left: 0pt; margin-right: auto; color: #000000;">
      <div style="line-height: 1.25;"><sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">SM</sup> &#8220;Open Market Sale Agreement&#8221; is a service mark of Jefferies LLC</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      </div>
      <!--PROfilePageNumberReset%Num%2%%%-->
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">&#8220;<font style="font-weight: bold;">Issuance Notice</font>&#8221; means a written notice delivered to the Agent by the Company in accordance with this Agreement in the form attached
        hereto as <u>Exhibit A</u> that is executed by its Chief Executive Officer or Chief Financial Officer.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">&#8220;<font style="font-weight: bold;">Issuance Notice Date</font>&#8221; means any Trading Day during the Agency Period that an Issuance Notice is delivered pursuant to <u>Section 3(b)(i)</u>.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">&#160;&#8220;<font style="font-weight: bold;">Issuance Price</font>&#8221; means the Sales Price less the Selling Commission.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">&#8220;<font style="font-weight: bold;">Maximum Program Amount</font>&#8221; means Ordinary Shares with an aggregate Sales Price of the lesser of (a) the number or dollar amount of Ordinary
        Shares registered under the effective Registration Statement (defined below) pursuant to which the offering is being made, (b) the number of authorized but unissued Ordinary Shares (less Ordinary Shares issuable upon exercise, conversion or
        exchange of any outstanding securities of the Company or otherwise reserved from the Company&#8217;s authorized share capital), (c) the number or dollar amount of Ordinary Shares permitted to be sold under Form F-3 (including General Instruction I.B.6
        thereof, if applicable), or (d) the number or dollar amount of Ordinary Shares for which the Company has filed a Prospectus (defined below).</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">&#8220;<font style="font-weight: bold;">Person</font>&#8221; means an individual or a corporation, partnership, limited liability company, trust, incorporated or unincorporated association,
        joint venture, joint stock company, governmental authority or other entity of any kind.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">&#8220;<font style="font-weight: bold;">Principal Market</font>&#8221; means the Nasdaq Stock Market LLC or such other national securities exchange on which the Ordinary Shares, including
        any Shares, are then listed.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">&#8220;<font style="font-weight: bold;">Sales Price</font>&#8221; means the actual sale execution price of each Share placed by the Agent pursuant to this Agreement.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">&#8220;<font style="font-weight: bold;">Securities Act</font>&#8221; means the Securities Act of 1933, as amended, and the rules and regulations of the Commission thereunder.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">&#8220;<font style="font-weight: bold;">Selling Commission</font>&#8221; means three percent (3%) of the gross proceeds of Shares sold pursuant to this Agreement, or as otherwise agreed
        between the Company and the Agent with respect to any Shares sold pursuant to this Agreement.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">&#160;&#8220;<font style="font-weight: bold;">Settlement Date</font>&#8221; means the first business day following each Trading Day during the period set forth in the Issuance Notice on which
        Shares are sold pursuant to this Agreement, when the Company shall deliver to the Agent the amount of Shares sold on such Trading Day and the Agent shall deliver to the Company the Issuance Price received on such sales.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">&#8220;<font style="font-weight: bold;">Shares</font>&#8221; means the Company&#8217;s Ordinary Shares issued or issuable pursuant to this Agreement.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">&#8220;<font style="font-weight: bold;">Trading Day</font>&#8221; means any day on which the Principal Market is open for trading.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-weight: normal; font-style: normal;">2</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      </div>
      <div style="line-height: 1.25;"><font style="font-weight: bold;">Section 2.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-weight: bold;">&#160; REPRESENTATIONS AND WARRANTIES OF THE COMPANY</font></div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">The Company represents and warrants to, and agrees with, the Agent that as of (1) the date of this Agreement, (2) each Issuance Notice Date, (3) each Settlement Date, (4) each
        Triggering Event Date and (5) as of each Time of Sale (each of the times referenced above is referred to herein as a &#8220;<font style="font-weight: bold;">Representation Date</font>&#8221;), except as may be disclosed in the Prospectus (including any
        documents incorporated by reference therein and any supplements thereto) on or before a Representation Date:</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">(a)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Registration Statement</u>.&#160; The Company has prepared and filed or will file with the Commission a shelf registration statement on Form&#160;F-3&#160;that contains a base
        prospectus.&#160; Such registration statement registers the issuance and sale by the Company of the Shares under the Securities Act.&#160; The Company may file one or more additional registration statements from time to time that will contain a base
        prospectus and related prospectus or prospectus supplement, if applicable, with respect to the Shares. Except where the context otherwise requires, such registration statement(s), including any information deemed to be a part thereof pursuant to
        Rule 430B under the Securities Act, including all financial statements, exhibits and schedules thereto and all documents incorporated or deemed to be incorporated therein by reference, as from time to time amended or supplemented pursuant to Item 6
        of Form F-3 under the Securities Act as from time to time amended or supplemented, is herein referred to as the &#8220;<font style="font-weight: bold;">Registration Statement</font>,&#8221; and the base prospectus constituting a part of such registration
        statement(s), together with any prospectus supplement filed with the Commission pursuant to Rule 424(b) under the Securities Act relating to a particular issuance of the Shares, including all documents incorporated or deemed to be incorporated
        therein by reference pursuant to Item 6 of Form F-3 under the Securities Act, in each case, as from time to time amended or supplemented, is referred to herein as the &#8220;<font style="font-weight: bold;">Prospectus</font>,&#8221; except that if any revised
        prospectus is provided to the Agent by the Company for use in connection with the offering of the Shares that is not required to be filed by the Company pursuant to Rule 424(b) under the Securities Act, the term &#8220;<font style="font-weight: bold;">Prospectus</font>&#8221;
        shall refer to such revised prospectus from and after the time it is first provided to the Agent for such use.&#160; The Registration Statement at the time it originally became effective is herein called the &#8220;<font style="font-weight: bold;">Original
          Registration Statement</font>.&#8221;&#160; As used in this Agreement, the terms &#8220;amendment&#8221; or &#8220;supplement&#8221; when applied to the Registration Statement or the Prospectus shall be deemed to include the filing by the Company with the Commission of any
        document under the Exchange Act after the date hereof that is or is deemed to be incorporated therein by reference.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">All references in this Agreement to financial statements and schedules and other information which is &#8220;contained,&#8221; &#8220;included&#8221; or &#8220;stated&#8221; in the Registration Statement or the
        Prospectus (and all other references of like import) shall be deemed to mean and include all such financial statements and schedules and other information which is or is deemed to be incorporated by reference in or otherwise deemed under the
        Securities Act to be a part of or included in the Registration Statement or the Prospectus, as the case may be, as of any specified date; and all references in this Agreement to amendments or supplements to the Registration Statement or the
        Prospectus shall be deemed to mean and include, without limitation, the filing of any document under the Exchange Act which is or is deemed to be incorporated by reference in or otherwise deemed under the Securities Act to be a part of or included
        in the Registration Statement or the Prospectus, as the case may be, as of any specified date.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-weight: normal; font-style: normal;">3</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      </div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">At the time the Registration Statement was or will be originally declared effective and at the time the Company&#8217;s most recent annual report on Form&#160;20-F was filed with the
        Commission, if later, the Company met the then-applicable requirements for use of Form&#160;F-3 under the Securities Act.&#160; During the Agency Period, each time the Company files an annual report on Form 20-F the Company will meet the then-applicable
        requirements for use of Form F-3 under the Securities Act.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">(b)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Compliance with Registration Requirements</u>.&#160; The Original Registration Statement and any Rule&#160;462(b) Registration Statement will be declared effective by the
        Commission under the Securities Act prior to the date of their first use.&#160; The Company has complied to the Commission&#8217;s satisfaction with all requests of the Commission for additional or supplemental information.&#160; No stop order suspending the
        effectiveness of the Registration Statement or any Rule&#160;462(b) Registration Statement is in effect and no proceedings for such purpose have been instituted or are pending or, to the best knowledge of the Company, are contemplated or threatened by
        the Commission.<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#160;</sup>The Company meets the requirements for use of Form F-3 under the Securities Act.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; line-height: 1.25;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The Prospectus when filed complied or will comply in all material respects with the Securities Act and, if filed with the Commission through its Electronic Data Gathering, Analysis and
        Retrieval system (except as may be permitted by Regulation&#160;S&#8209;T under the Securities Act), was identical to the copy thereof delivered to the Agent for use in connection with the issuance and sale of the Shares.&#160; Each of the Registration Statement,
        any Rule&#160;462(b) Registration Statement and any post-effective amendment thereto, at the time it became or becomes effective and at all subsequent times, complied and will comply in all material respects with the Securities Act and did not and will
        not contain any untrue statement of a material fact or omit to state a material fact required to be stated therein or necessary to make the statements therein not misleading.&#160; As of the date of this Agreement, the Prospectus and any Free Writing
        Prospectus (as defined below) considered together (collectively, the &#8220;<font style="font-weight: bold;">Time of Sale Information</font>&#8221;) did not contain any untrue statement of a material fact or omit to state a material fact necessary to make the
        statements therein, in the light of the circumstances under which they were made, not misleading.&#160; The Prospectus, as amended or supplemented, as of its date and at all subsequent times, did not and will not contain any untrue statement of a
        material fact or omit to state a material fact necessary in order to make the statements therein, in the light of the circumstances under which they were made, not misleading.&#160; The representations and warranties set forth in the three immediately
        preceding sentences do not apply to statements in or omissions from the Registration Statement, any Rule&#160;462(b) Registration Statement, or any post-effective amendment thereto, or the Prospectus, or any amendments or supplements thereto, made in
        reliance upon and in conformity with information relating to the Agent furnished to the Company in writing by the Agent expressly for use therein, it being understood and agreed that the only such information furnished by the Agent to the Company
        consists of the information described in <u>Section 6</u> below.&#160; There are no contracts or other documents required to be described in the Prospectus or to be filed as exhibits to the Registration Statement which have not been described or filed
        as required. The Registration Statement and the offer and sale of the Shares as contemplated hereby meet the requirements of Rule 415 under the Securities Act and comply in all material respects with said rule.</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-weight: normal; font-style: normal;">4</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      </div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">(c)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Ineligible Issuer Status</u>. The Company is not an &#8220;ineligible issuer&#8221; in connection with the offering of the Shares pursuant to Rules 164, 405 and 433 under the
        Securities Act.&#160; Any Free Writing Prospectus that the Company is required to file pursuant to Rule 433(d) under the Securities Act has been, or will be, filed with the Commission in accordance with the requirements of the Securities Act.&#160; Each Free
        Writing Prospectus that the Company has filed, or is required to file, pursuant to Rule 433(d) under the Securities Act or that was prepared by or on behalf of or used or referred to by the Company complies or will comply in all material respects
        with the requirements of Rule 433 under the Securities Act including timely filing with the Commission or retention where required and legending, and each such Free Writing Prospectus, as of its issue date and at all subsequent times through the
        completion of the issuance and sale of the Shares did not, does not and will not include any information that conflicted, conflicts with or will conflict with the information contained in the Registration Statement or the Prospectus, including any
        document incorporated by reference therein.&#160; Except for the Free Writing Prospectuses, if any, and electronic road shows, if any, furnished to you before first use, the Company has not prepared, used or referred to, and will not, without your prior
        consent, prepare, use or refer to, any Free Writing Prospectus.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">(d)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Incorporated Documents</u>. The documents incorporated or deemed to be incorporated by reference in the Registration Statement and the Prospectus, at the time
        they were filed with the Commission, complied in all material respects with the requirements of the Exchange Act, as applicable, and, when read together with the other information in the Prospectus, do not contain an untrue statement of a material
        fact or omit to state a material fact required to be stated therein or necessary to make the statements therein, in light of the circumstances under which they were made, not misleading.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">(e)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Exchange Act Compliance</u>.&#160; The documents incorporated or deemed to be incorporated by reference in the Prospectus, at the time they were or hereafter are filed
        with the Commission, and any Free Writing Prospectus or amendment or supplement thereto complied and will comply in all material respects with the requirements of the Exchange Act, and, when read together with the other information in the
        Prospectus, at the time the Registration Statement and any amendments thereto become effective and at each Time of Sale (as defined below), as the case may be, will not contain an untrue statement of a material fact or omit to state a material fact
        required to be stated therein or necessary to make the statements therein, in the light of the circumstances under which they were made, not misleading;</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">(f)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>No Material Adverse Effect</u>.&#160; Neither the Company nor any of its subsidiaries has, since the date of the latest audited financial statements included or
        incorporated by reference in the Prospectus, (i) sustained any material loss or interference with its business from fire, explosion, flood or other calamity, whether or not covered by insurance, or from any labor dispute or court or governmental
        action, order or decree or (ii) entered into any transaction or agreement (whether or not in the ordinary course of business) that is material to the Company and its subsidiaries taken as a whole or incurred any liability or obligation, direct or
        contingent, that is material to the Company and its subsidiaries taken as a whole, in each case otherwise than as set forth or contemplated in the Prospectus; and, since the respective dates as of which information is given in the Registration
        Statement and the Prospectus, there has not been (x) any material change in the share capital or outstanding long-term indebtedness of the Company or any of its subsidiaries, (y) any dividends or distribution of any kind declared, paid or made by
        the Company or, except for dividends paid to the Company or other subsidiaries, by any of the Company&#8217;s subsidiaries on any class of share capital, or any repurchase or redemption by the Company or any of its subsidiaries of any class of share
        capital, or (z) any Material Adverse Effect (as defined below); as used in this Agreement, &#8220;<font style="font-weight: bold;">Material Adverse Effect</font>&#8221; shall mean any material adverse change or effect, or any development involving a
        prospective material adverse change or effect, in or affecting (i) the business, properties, general affairs, management, financial position, shareholders&#8217; equity or results of operations of the Company and its subsidiaries, taken as a whole,
        except as set forth or contemplated in the Prospectus, or (ii) the ability of the Company to perform its obligations under this Agreement, including the issuance and sale of the Shares, or to consummate the transactions contemplated by this
        Agreement;</div>
      <div style="line-height: 1.25">&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-weight: normal; font-style: normal;">5</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      </div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">(g)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Title to Properties</u>.&#160; The Company and its subsidiaries do not own any real property. The Company and its subsidiaries have good and marketable title to all
        personal property (other than with respect to Intellectual Property, title to which is addressed exclusively in Section 1(z) below) owned by them, in each case free and clear of all security interests, liens, encumbrances and defects except such as
        are described in the Prospectus or such as do not materially affect the value of such property and do not interfere with the use made and proposed to be made of such property by the Company and its subsidiaries; and any real property and buildings
        held under lease by the Company and its subsidiaries are held by them under valid, subsisting and enforceable leases with such exceptions as are not material and do not materially interfere with the use made and proposed to be made of such property
        and buildings by the Company and its subsidiaries;</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">(h)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Incorporation and Good Standing of the Company</u>.&#160; Each of the Company and each of its subsidiaries has been (i) duly organized and is validly existing and in
        good standing (where such concept exists) under the laws of its jurisdiction of organization, with power and authority (corporate and other) to own its properties and conduct its business as described in the Registration Statement and Prospectus,
        and (ii) duly qualified as a foreign corporation for the transaction of business and is in good standing (where such concept exists) under the laws of each other jurisdiction in which it owns or leases properties or conducts any business so as to
        require such qualification, except, in the case of this clause (ii), where the failure to be so qualified or in good standing would not, individually or in the aggregate, have a Material Adverse Effect; and each subsidiary of the Company has been
        listed in the Registration Statement. The Company is not currently designated as a &#8220;breaching company&#8221; (within the meaning of the Israeli Companies Law, 5759-1999, as amended (the &#8220;<font style="font-weight: bold;">Companies Law</font>&#8221;)) by the
        Registrar of the Companies of the State of Israel and there is no basis for such designation. The articles of association, certificate of incorporation and by-laws (and other applicable organizational documents) of the Company and each of its
        subsidiaries comply with the requirements of applicable law in its jurisdiction of incorporation and are in full force and effect;</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">(i)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Authorization</u>.&#160; This Agreement has been duly authorized, executed and delivered by the Company; the Company has all requisite corporate power and authority,
        including under Chapter 5 of Part VI of the Companies Law, to execute, deliver and perform its obligations under this Agreement;</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">(j)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Capitalization and Other Share Capital Matters</u>.&#160; The Company has an authorized capitalization as set forth in the Prospectus and all of the issued and
        outstanding shares of the Company have been duly and validly authorized and issued and are fully paid and non-assessable, have been issued in compliance with the Companies Law and the Israeli Securities Law, 5728-1968, as amended, and the
        regulations promulgated thereunder (collectively, the &#8220;<font style="font-weight: bold;">Israeli Securities Law</font>&#8221;), and conform to the description of the ordinary shares contained in the Registration Statement and the Prospectus; and all of
        the issued shares of each subsidiary of the Company have been duly and validly authorized and issued, are fully paid and non-assessable and (except, in the case of any non-U.S. subsidiary, for directors&#8217; qualifying shares) are owned directly or
        indirectly by the Company, free and clear of all liens, encumbrances, equities or claims, except for such liens or encumbrances described in the Registration Statement and the Prospectus, there are no options, warrants, agreements, contracts or
        other rights in existence to purchase or acquire from the Company, or equity or debt securities convertible into or exchangeable or exercisable for, any shares of the share capital of the Company; the Shares to be issued and sold by the Company to
        the Agent hereunder have been duly and validly authorized and, when issued and delivered against payment therefor as provided herein, will be duly and validly issued and fully paid and non-assessable and will conform to the description of the
        ordinary shares contained in the Registration Statement and the Prospectus; the issuance of the Shares is not subject to any preemptive or similar rights; the description of the Company&#8217;s share option, share bonus and other share plans or
        arrangements (the &#8220;<font style="font-weight: bold;">Company Share Plans</font>&#8221;), and the options and other equity incentive awards or other rights granted thereunder (collectively, the &#8220;<font style="font-weight: bold;">Options</font>&#8221;), set forth
        in the Registration Statement and the Prospectus accurately and fairly presents the information required to be shown with respect to such plans, arrangements, options and rights; each grant of an Option (A) was duly authorized no later than the
        date on which the grant of such Option was by its terms to be effective by all necessary corporate action, including, as applicable, approval by the board of directors of the Company (or a duly constituted and authorized committee thereof) and any
        required shareholder approval by the necessary number of votes or written consents, and the award agreement governing such grant (if any) was duly executed and delivered by each party thereto, (B) that was intended to qualify for either the
        &#8220;capital gains track&#8221; or the &#8220;employment income track&#8221; of Section 102 of the Israeli Income Tax Ordinance (New Version), 5721-1961, and the rules and regulations promulgated thereunder, so qualifies as was indicated with respect to each such Option
        at the date that such Option was granted, and (C) was made in accordance with the terms of the applicable Company Share Plan and applicable laws and regulatory rules or requirements, including all applicable federal and Israeli securities laws;</div>
      <div style="line-height: 1.25">&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-weight: normal; font-style: normal;">6</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      </div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">(k)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Non-Contravention of Existing Instruments</u>.&#160; The issue and sale of the Shares and the compliance by the Company with this Agreement and the consummation of the
        transactions contemplated in this Agreement, the Registration Statement and the Prospectus will not conflict with or result in a breach or violation of any of the terms or provisions of, or constitute a default under, (A) any indenture, mortgage,
        deed of trust, loan agreement, lease or other agreement or instrument to which the Company or any of its subsidiaries is a party or by which the Company or any of its subsidiaries is bound or to which any of the property or assets of the Company or
        any of its subsidiaries is subject, (B) the articles of association, certificate of incorporation or by-laws (or other applicable organizational documents) of the Company or any of its subsidiaries, or (C) any law or statute or any judgment, order,
        rule or regulation of any court or governmental agency or body having jurisdiction over the Company or any of its subsidiaries or any of their properties, except, in the case of clauses (A) or (C) for such defaults, breaches, or violations that
        would not, individually or in the aggregate, have a Material Adverse Effect; and no consent, approval, authorization, order, registration or qualification of or with any such court or governmental agency or body is required for the issue and sale
        of the Shares or the consummation by the Company of the transactions contemplated by this Agreement, except such as have been obtained under the Securities Act, the approval by the Financial Industry Regulatory Authority, Inc. (&#8220;<font style="font-weight: bold;">FINRA</font>&#8221;) of the underwriting terms and arrangements, the approval of the Shares for listing on the Principal Market, such consents, approvals, authorizations, registrations or qualifications as may be required
        under state securities or Blue Sky laws in connection with the purchase and distribution of the Shares by the Agent and the obligation to file certain information with the Registrar of Companies in Israel after the Settlement Date;</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">(l)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>No Material Actions or Proceedings</u>.&#160; Other than as set forth in the Prospectus, there are no legal, governmental or regulatory investigations, actions,
        demands, claims, suits, arbitrations, inquiries or proceedings (&#8220;<font style="font-weight: bold;">Actions</font>&#8221;) pending to which the Company or any of its subsidiaries or, to the Company&#8217;s knowledge, any officer or director of the Company or any
        of its subsidiaries is a party or of which any property or assets of the Company or any of its subsidiaries or, to the Company&#8217;s knowledge, any officer or director of the Company or any of its subsidiaries is the subject which, if determined
        adversely to the Company or any of its subsidiaries (or such officer or director), would individually or in the aggregate have a Material Adverse Effect; and, to the Company&#8217;s knowledge, no such Actions are threatened or contemplated by
        governmental authorities or others. No material labor dispute with the employees of the Company or any of its subsidiaries, or with the employees of any principal supplier, manufacturer, customer or contractor of the Company, exists or, to the
        knowledge of the Company, is threatened or imminent;</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">(m)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Stock Exchange Listing</u>. The Ordinary Shares are registered pursuant to Section 12(b) or 12(g) of the Exchange Act and are listed on the Principal Market. The
        Company has taken no action designed to, or likely to have the effect of, terminating the registration of the Ordinary Shares under the Exchange Act or delisting the Ordinary Shares from the Principal Market, nor has the Company received any
        notification that the Commission or the Principal Market is contemplating terminating such registration or listing.&#160; To the Company&#8217;s knowledge, it is in compliance with all applicable listing requirements of the Principal Market;</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">(n)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Summaries.</u>&#160; The statements set forth in the Registration Statement and the Prospectus under the caption &#8220;Description of Ordinary Shares and Existing
        Warrants&#8221;, insofar as they purport to constitute a summary of the terms of the ordinary shares of the Company, constitute accurate summaries of the matters described therein in all material respects;</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">(o)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Investment Company Act</u>.&#160; The Company is not and, after giving effect to the offering and sale of the Shares and the application of the proceeds thereof, will
        not be an &#8220;investment company&#8221;, as such term is defined in the Investment Company Act of 1940, as amended (the &#8220;<font style="font-weight: bold;">Investment Company Act</font>&#8221;);</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">(p)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>FPI Status.</u>&#160; The Company is a &#8220;foreign private issuer&#8221; within the meaning of Rule 405 under the Securities Act;</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">(q)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Independent Accountants</u>.&#160; (i) Kost, Forer, Gabbay &amp; Kasierer, a member firm of Ernst &amp; Young Global, which has certified certain financial statements
        of the Company for the year ended December 31, 2022, and its subsidiaries, is (X) an independent registered public accounting firm as required by the Securities Act and the rules and regulations of the Commission thereunder, (Y) in compliance with
        the applicable requirements relating to the qualification of accountants under Rule 2-01 of Regulation S-X under the Securities Act, and (Z) a registered public accounting firm as defined by the Public Company Accounting Oversight Board (&#8220;PCAOB&#8221;)
        whose registration has not been suspended or revoked and who has not requested such registration to be withdrawn, and (ii) Kesselman &amp; Kesselman, a member firm of PricewaterhouseCoopers International Limited, which has certified certain
        financial statements of the Company and its subsidiaries for the years ended December 31, 2023 and 2024, that were filed with the Commission as a part of the Registration Statement and the Prospectus, is (X) an independent registered public
        accounting firm as required by the Securities Act and the rules and regulations of the Commission thereunder, (Y) in compliance with the applicable requirements relating to the qualification of accountants under Rule 2-01 of Regulation S-X under
        the Securities Act, and (Z) a registered public accounting firm as defined by the PCAOB whose registration has not been suspended or revoked and who has not requested such registration to be withdrawn;</div>
      <div style="line-height: 1.25">&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-weight: normal; font-style: normal;">7</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      </div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">(r)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Internal Controls</u>.&#160; The Company maintains a system of internal control over financial reporting (as such term is defined in Rule 13a-15(f) under the Exchange
        Act) that (i) complies with the requirements of the Exchange Act applicable to the Company, (ii) has been designed by the Company&#8217;s principal executive officer and principal financial officer, or under their supervision, to provide reasonable
        assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles applied in the United States (&#8220;<font style="font-weight: bold;">GAAP</font>&#8221;)


        and (iii) is sufficient to provide reasonable assurance that (A) transactions are executed in accordance with management&#8217;s general or specific authorization, (B) transactions are recorded as necessary to permit preparation of financial statements
        in conformity with GAAP and to maintain accountability for assets, (C) access to assets is permitted only in accordance with management&#8217;s general or specific authorization, (D) the recorded accountability for assets is compared with the existing
        assets at reasonable intervals and appropriate action is taken with respect to any differences and (E) the interactive data in eXtensible Business Reporting Language included or incorporated by reference in the Registration Statement and the
        Prospectus fairly presents the information called for in all material respects and is prepared in accordance with the Commission&#8217;s rules and guidelines applicable thereto; and the Company&#8217;s internal control over financial reporting is effective and
        the Company is not aware of any material weaknesses in its internal control over financial reporting (it being understood that this subsection shall not require the Company to comply with Section 404 of the Sarbanes Oxley Act of 2002, as amended (&#8220;<font style="font-weight: bold;">Sarbanes Oxley</font>&#8221;), as of an earlier date than it would otherwise be required to so comply under applicable law). Since the date of the latest audited annual financial statements included or incorporated by
        reference in the Prospectus, there have been no significant deficiencies or material weaknesses in the Company&#8217;s internal control over financial reporting (whether or not remediated), and there has been no change in the Company&#8217;s internal control
        over financial reporting that has materially affected, or is reasonably likely to materially affect, the Company&#8217;s internal control over financial reporting;</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">(s)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Disclosure Controls and Procedures</u>.&#160; The Company maintains disclosure controls and procedures (as such term is defined in Rule 13a-15(e) under the Exchange
        Act) that comply with the requirements of the Exchange Act applicable to the Company; such disclosure controls and procedures have been designed to ensure that material information relating to the Company and its subsidiaries is made known to the
        Company&#8217;s principal executive officer and principal financial officer by others within those entities; and such disclosure controls and procedures are effective;</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">(t)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Related Party Transactions</u>.&#160; There are no business relationships or related-party transactions involving the Company or any of its subsidiaries or any other
        person required to be described in the Registration Statement or the Prospectus which have not been described as required;</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">(u)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Foreign Corrupt Practices</u>.&#160; None of the Company or any of its subsidiaries nor, to the knowledge of the Company, any director, officer, agent, employee,
        affiliate or other person associated with or acting on behalf of the Company or any of its subsidiaries has (i) made, offered, promised or authorized any unlawful contribution, gift, entertainment or other unlawful expense (or taken any act in
        furtherance thereof); (ii) made, offered, promised or authorized any direct or indirect unlawful payment; or (iii) violated or is in violation of any provision of the U.S. Foreign Corrupt Practices Act of 1977, as amended, or the rules and
        regulations thereunder, the Bribery Act 2010 of the United Kingdom, Sections 291 and 291A of the Israeli Penal Law, 5737-1977, and the rules and regulations promulgated thereunder, or any other applicable anti-corruption, anti-bribery or related
        law, statute or regulation (collectively, &#8220;<font style="font-weight: bold;">Anti-Corruption Laws</font>&#8221;); the Company and its subsidiaries have conducted their businesses in compliance with Anti-Corruption Laws and have instituted and maintained
        and will continue to maintain policies and procedures reasonably designed to promote and achieve compliance with such laws and with the representations and warranties contained herein; neither the Company nor any of its subsidiaries will use,
        directly or indirectly, the proceeds of the offering in furtherance of an offer, payment, promise to pay, or authorization of the payment or giving of money, or anything else of value, to any person in violation of Anti-Corruption Laws;</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">(v)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Money Laundering Laws</u>.&#160; The operations of the Company and its subsidiaries are and have been conducted at all times in compliance with the requirements of
        applicable anti-money laundering laws, including, but not limited to, the Bank Secrecy Act of 1970, as amended by the USA PATRIOT ACT of 2001, and the rules and regulations promulgated thereunder, the Israeli Prohibition on Money Laundering Law,
        5760-2000, the Israeli Prohibition on Money Laundering (The Banking Corporations&#8217; Requirements regarding Identification, Reporting and Record-Keeping for the Prevention of Money Laundering and the Financing of Terrorism) Order, 5761-2001, the
        Israeli Counter-Terrorism Law, 5776-2016, the Israeli Prohibition of Financing Terrorism Law, 5765-2005, Prohibition of Money Laundering (The Business Service Providers Requirements regarding Identification, Recordkeeping for the Prevention of
        Money Laundering and the Financing of Terrorism) Order, 5775-2014, financial recordkeeping and reporting requirements of the Currency and Foreign Transactions Reporting Act of 1970, as amended, and the anti-money laundering laws of the various
        jurisdictions in which the Company and its subsidiaries conduct business, the rules and regulations thereunder and any related or similar rules, regulation or guidelines issued, administered or enforced by any governmental agency (collectively, the
        &#8220;<font style="font-weight: bold;">Money Laundering Laws</font>&#8221;), and no action, suit or proceeding by or before any court or governmental agency, authority or body or any arbitrator involving the Company or any of its subsidiaries with respect to
        the Money Laundering Laws is pending or, to the knowledge of the Company, threatened;</div>
      <div style="line-height: 1.25">&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-weight: normal; font-style: normal;">8</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      </div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">(w)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Sanctions</u>.&#160; None of the Company or any of its subsidiaries, nor, to the knowledge of the Company, after due inquiry, any directors, officers, employees,
        agent, affiliate, employee or other person associated with or acting on behalf of the Company or any of its subsidiaries is currently the subject or the target of any sanctions administered or enforced by the U.S. Government, including, without
        limitation, the Office of Foreign Assets Control of the U.S. Department of the Treasury, or the U.S. Department of State and including, without limitation, the designation as a &#8220;specially designated national&#8221; or &#8220;blocked person,&#8221; the European
        Union, His Majesty&#8217;s Treasury, the United Nations Security Council, or other relevant sanctions authority, or a resident or incorporated or engaged in a business in an &#8220;<font style="font-weight: bold;">Enemy State</font>&#8221; pursuant to the Israeli
        Trade with the Enemy Ordinance, 1939 (collectively, &#8220;<font style="font-weight: bold;">Sanctions</font>&#8221;), nor is the Company or any of its material subsidiaries located, organized, or resident in a country or territory that is the subject or target
        of comprehensive country-wide or territory-wide Sanctions (as of the date of this Agreement, Cuba, Iran, Syria, Russia, North Korea, the Crimea region of Ukraine the so-called Donetsk People&#8217;s Republic, or the so-called Luhansk People&#8217;s Republic,
        and the non-government controlled oblasts of Zaporizhzhia and Kherson) (each a &#8220;<font style="font-weight: bold;">Sanctioned Jurisdiction</font>&#8221;), and the Company will not directly or indirectly use the proceeds of the offering of the Shares
        hereunder, or lend, contribute or otherwise make available such proceeds to any subsidiary, joint venture partner or other person or entity (i) to fund or facilitate any activities of or business with any person, or in any country or territory,
        that, at the time of such funding, is the subject or the target of comprehensive Sanctions, in violation of applicable Sanctions or (ii) in any other manner that will result in a violation by any person (including any person participating in the
        transactions contemplated herein, whether as underwriter, advisor, investor or otherwise) of Sanctions; neither the Company nor any of its subsidiaries is engaged in, or has, at any time in the past five years, engaged in, any dealings or
        transactions with or involving any individual or entity that was or is, as applicable, at the time of such dealing or transaction, the subject or target of Sanctions or with any Sanctioned Jurisdiction in violation of applicable Sanctions; the
        Company and its subsidiaries have instituted, and maintain, policies and procedures designed to promote and achieve continued compliance with Sanctions;</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">(x)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Financial Statements</u>.&#160; The financial statements included or incorporated by reference in the Registration Statement and the Prospectus, together with the
        related schedules and notes, present fairly in all material respects,&#160;the financial position of the Company and its subsidiaries at the dates indicated and the statement of operations, shareholders&#8217; equity and cash flows of the Company and its
        subsidiaries for the periods specified; said financial statements have been prepared in conformity with GAAP applied on a consistent basis throughout the periods involved. The supporting schedules, if any, present fairly in all material respects in
        accordance with GAAP the information required to be stated therein. Except as included therein, no historical or pro forma financial statements or supporting schedules are required to be included in the Registration Statement or the Prospectus
        under the Securities Act or the rules and regulations promulgated thereunder. All disclosures contained in the Registration Statement and the Prospectus regarding &#8220;non-GAAP financial measures&#8221; (as such term is defined by the rules and regulations
        of the Commission) comply with Regulation G of the Exchange Act and Item 10 of Regulation S-K of the Securities Act, to the extent applicable;</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">(y)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Intellectual Property</u>.&#160; Except as would not, individually or in the aggregate, reasonably be expected to have a Material Adverse Effect, the Company and each
        of its subsidiaries (i) own or otherwise possess adequate and valid rights to use all patents, trademarks, service marks, trade names, domain names, copyrights, and registrations and applications thereof, licenses, know-how, software, algorithms,
        data and databases, systems and technology (including trade secrets and other unpatented and/or unpatentable proprietary or confidential information, processes, models, methodologies, systems or procedures and other intellectual property)
        (together, &#8220;<font style="font-weight: bold;">Intellectual Property</font>&#8221;) necessary for the conduct of their respective businesses as currently conducted; (ii) do not, through the conduct of their respective businesses, infringe, misappropriate
        or otherwise violate, and, to the Company&#8217;s knowledge, have not infringed, misappropriated or otherwise violated, any Intellectual Property rights of any third party; (iii) have not received any written notice of any claim alleging infringement,
        misappropriation or other violation of any Intellectual Property rights of any third party; (iv) have taken reasonable efforts in accordance with standard industry practice to maintain the confidentiality of all trade secrets and other confidential
        information owned by the Company or any of its subsidiaries; and (v) have used all software and other materials distributed under a &#8220;free,&#8221; &#8220;open source,&#8221; or similar licensing model (including but not limited to the GNU General Public License, GNU
        Lesser General Public License and GNU Affero General Public License) (&#8220;Open Source Materials&#8221;) in compliance with all license terms applicable to such Open Source Materials, and none of the proprietary software or other proprietary technology of
        the Company or any of its subsidiaries (such software and technology, &#8220;<font style="font-weight: bold;">Company Proprietary Software</font>&#8221;) incorporates or uses Open Source Materials in a manner that requires or has required any Company
        Proprietary Software to be disclosed or distributed in source code form, or licensed for the purpose of making derivative works (or otherwise requires the Company or any of its subsidiaries to permit reverse engineering thereof), or imposes
        restrictions on the consideration to be charged for the distribution thereof (including requiring any Company Proprietary Software to be redistributed at no charge or minimal charge). There is no pending or, to the Company&#8217;s knowledge, threatened
        action, suit, proceeding or claim by any third party challenging the validity, scope, enforceability or ownership of any material Intellectual Property owned or purported to be owned by the Company or its subsidiaries. The Company and its
        subsidiaries have taken commercially reasonable steps to secure interests in material Intellectual Property owned or purported to be owned by the Company from their employees and contractors, including requiring their employees to execute invention
        assignment agreements in favor of the Company or one of its subsidiaries in respect thereof;</div>
      <div style="line-height: 1.25">&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-weight: normal; font-style: normal;">9</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      </div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">(z)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Cybersecurity</u>.&#160; Except as would not, individually or in the aggregate reasonably be expected to have a Material Adverse Effect, (i) the Company&#8217;s and its
        subsidiaries&#8217; information technology assets and equipment, computers, systems, networks, hardware, software, websites, applications, and databases (collectively, &#8220;<font style="font-weight: bold;">IT Systems</font>&#8221;) are adequate for, and operate
        and perform in all material respects as required in connection with the operation of the business of the Company and its subsidiaries as currently conducted, and to the knowledge of the Company,&#160; are free and clear of all material bugs, errors,
        defects, Trojan horses, time bombs, malware and other corruptants; and (ii) the Company and its subsidiaries have implemented and maintained commercially reasonable controls, policies, procedures, and safeguards, consistent with applicable law,
        that are intended to maintain and protect their material confidential information and trade secrets and the integrity, continuous operation, redundancy and security of their IT Systems and data (including personal or personally identifiable data
        (such data, &#8220;<font style="font-weight: bold;">Personal Data</font>&#8221;)) used or held for use in connection with their businesses; and (iii) to the knowledge of the Company, there have been no security breaches, violations, outages or unauthorized
        uses of or accesses to (or other security incident, including any ransomware attack, compromising) such IT Systems or Personal Data, except for those that have been remedied without material cost or liability or the duty to notify any other Person
        under applicable Privacy Laws, nor any incidents under internal review or investigations by any governmental authority relating to the same. Except as would not, individually or in the aggregate reasonably be expected to have a Material Adverse
        Effect, the Company and its subsidiaries are presently (and, for the past three years, have been) in compliance with all applicable laws or statutes&#160; and all applicable judgments, orders, rules and regulations of any court or arbitrator or
        governmental or regulatory authority, and contractual obligations to which the Company is bound relating to the privacy and security of IT Systems and Personal Data and to the protection of such IT Systems and Personal Data from unauthorized use,
        access, misappropriation or modification;</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">(aa)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Compliance with Data Privacy Laws</u>. Except as would not, individually or in the aggregate reasonably be expected to have a Material Adverse Effect, (i) the
        Company and its subsidiaries are presently (and, for the past three years, have been) in compliance with all applicable national, state and federal data privacy and security laws and regulations relating to the processing, collection, disposal,
        storage, protection, use, sharing, transfer, disclosure, handling, and analysis of Personal Data, including without limitation, to the extent applicable to the Company and its subsidiaries, the Health Insurance Portability and Accountability Act of
        1996 (42 U.S.C. Section 1320d et seq.), as amended by the Health Information Technology for Economic and Clinical Health Act (42 U.S.C. Section 17921 et seq.); the Israeli Protection of Privacy Law, 5741-1981, the Israeli Privacy Protection
        Regulations (Information Security), 5777-2017, the Israeli Patient&#8217;s Rights Law, 5756-1996; the European Union General Data Protection Regulation (EU 2016/679); the California Consumer Protection Act of 2018; the California Privacy Rights Act 2020
        (collectively, the &#8220;<font style="font-weight: bold;">Privacy Laws</font>&#8221;), as well as its Policies and any contractual obligations to third parties to which the Company is bound in respect of the processing, collection, disposal, storage, use,
        sharing, transfer, disclosure, handling, and analysis of Personal Data; (ii) the Company and its subsidiaries have in place, comply with, and take commercially reasonable steps designed to ensure compliance with their policies and procedures
        relating to data privacy and security and the processing, collection, disposal, storage, use, sharing, transfer, disclosure, handling, and analysis of Personal Data (the &#8220;<font style="font-weight: bold;">Policies</font>&#8221;); and (iii) the Company and
        its subsidiaries presently make disclosures to users or customers required by applicable Privacy Laws, and none of such disclosures made or contained in any Policy have, to the knowledge of the Company, been inaccurate or in violation of any
        applicable Privacy Laws. Except as would not, individually or in the aggregate, reasonably be expected to have a Material Adverse Effect, neither the Company nor any subsidiary: (x) has received written notice of any actual or potential violation
        of, or inquiry, enforcement action or investigation of a governmental or regulatory authority regarding compliance with any of the Privacy Laws; (y) is currently conducting or paying for, in whole or in part, any investigation, remediation, or
        other corrective action pursuant to any Privacy Law; or (z) is a party to any order, decree, or agreement that imposes any obligation or liability under any Privacy Law;</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">(bb)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Forward-Looking Statements.</u>&#160; No forward-looking statement (within the meaning of Section 27A of the Securities Act and Section 21E of the Exchange Act)
        included or incorporated by reference in any of the Registration Statement or the Prospectus has been made or reaffirmed without a reasonable basis or has been disclosed other than in good faith;</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">(cc)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Statistical and Market-Related Data</u>.&#160; Nothing has come to the attention of the Company that has caused the Company to believe that the statistical and
        market-related data included in each of the Registration Statement and the Prospectus is not based on or derived from sources that are reliable and accurate in all material respects;</div>
      <div style="line-height: 1.25">&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-weight: normal; font-style: normal;">10</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      </div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">(dd)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Sarbanes-Oxley</u>.&#160; There is and has been no failure on the part of the Company or any of the Company&#8217;s directors or officers, in their capacities as such, to
        comply with any applicable provision of Sarbanes-Oxley and the rules and regulations promulgated in connection therewith, including Section 402 related to loans and Sections 302 and 906 related to certifications;</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">(ee)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>No Price Stabilization or Manipulation; Compliance with Regulation M</u>.&#160; Neither the Company nor any of its affiliates has taken or will take, directly or
        indirectly, any action designed to or that could reasonably be expected to cause or result in the stabilization or manipulation of the price of any security of the Company, any of its subsidiaries or of any &#8220;reference security&#8221; (as defined in Rule
        100 of Regulation M under the Exchange Act (&#8220;<font style="font-weight: bold;">Regulation M</font>&#8221;)) with respect to the Ordinary Shares, whether to facilitate the sale or resale of the Shares or otherwise, and has taken no action which would
        directly or indirectly violate Regulation M;</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">(ff)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>No Solicitation.</u>&#160; Neither the Company nor any of its subsidiaries has engaged nor will engage in any form of solicitation, advertising or other action
        constituting an offer or a sale under the Israeli Securities Law in connection with the transactions contemplated hereby, which would require the publication of a prospectus in the State of Israel under the laws of the State of Israel (assuming the
        Agent did not engage in any form of solicitation, advertising or other action constituting an offer or a sale of the Shares in the State of Israel, other than to Israeli investors listed in the First Addendum to the Israeli Securities Law (the &#8220;<font style="font-weight: bold;">Addendum</font>&#8221;) who submitted written confirmation to the Agent and the Company that such investor falls within the scope of the Addendum, is aware of the meaning of same and agrees to it);</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">(gg)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>All Necessary Permits, etc</u>.&#160; The Company and each of its subsidiaries have such permits, licenses, approvals, consents, franchises, certificates and other
        approvals or authorizations of governmental or regulatory authorities (&#8220;<font style="font-weight: bold;">Permits</font>&#8221;) as are necessary under applicable law to own their respective properties and conduct their respective businesses in the manner
        described in the Registration Statement and the Prospectus, except for any of the foregoing that would not, individually or in the aggregate, have a Material Adverse Effect. Neither the Company nor any of its subsidiaries has received notice of any
        proceedings related to the revocation or modification of any such Permits that, individually or in the aggregate, if the subject of an unfavorable decision, ruling or finding, would have a Material Adverse Effect;</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">(hh)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Insurance</u>.&#160; The Company and its subsidiaries, taken as a whole, are insured against such losses and risks and in such amounts as are prudent and customary in
        the businesses in which they are engaged and as required by law;</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">(ii)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Emerging Growth Company</u>.&#160; From the time of filing of the Registration Statement through the date hereof, the Company has been and is an &#8220;emerging growth
        company&#8221; as defined in Section 2(a)(19) of the Securities Act (an &#8220;<font style="font-weight: bold;">Emerging Growth Company</font>&#8221;);</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">(jj)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Environmental Laws</u>.&#160; Each of the Company and its subsidiaries (i) is in compliance with all, and has not violated any, laws, regulations, ordinances, rules,
        orders, judgments, decrees, permits or other legal requirements of any governmental authority, including, without limitation, any international, national, state, provincial, regional, or local authority, relating to the protection of human health
        or safety, the environment, or natural resources, or to hazardous or toxic substances or wastes, pollutants or contaminants (&#8220;<font style="font-weight: bold;">Environmental Laws</font>&#8221;) applicable to the Company or its subsidiaries (as the case
        may be), which compliance includes, without limitation, obtaining, maintaining and complying with all permits and authorizations and approvals required by Environmental Laws to conduct its business, and (ii) has not received written notice of any
        actual or alleged violation of Environmental Laws, or of any potential liability for or other obligation concerning the presence, disposal or release of hazardous or toxic substances or wastes, pollutants or contaminants, except in the case of (i)
        and (ii) where the failure to comply or the potential liability or obligation would not, individually or in the aggregate, reasonably be expected to have a Material Adverse Effect. Except as described in the Registration Statement, and the
        Prospectus, (A) there are no proceedings that are pending against the Company or any of its subsidiaries under Environmental Laws in which a governmental authority is also a party and (B) the Company is not aware of any non-compliance with
        Environmental Laws, or liabilities under Environmental Laws, which would reasonably be expected to have a Material Adverse Effect;</div>
      <div style="line-height: 1.25">&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-weight: normal; font-style: normal;">11</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      </div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">(kk)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Tax Law Compliance</u>. Each of the Company and its subsidiaries has timely filed all federal, state, local and foreign, including Israeli, income, value added
        and franchise tax returns required to be filed through the date hereof, which returns are true and correct in all material respects, and have timely paid all taxes required to be paid by it with regard to the period up to and including the date of
        this Agreement, in each case, subject to permitted extensions (except where the failure to file or pay would not, individually or in the aggregate, reasonably be expected to have a Material Adverse Effect). No tax deficiency has been determined
        adversely to the Company in writing which would reasonably be expected to have a Material Adverse Effect. Neither the Company nor any of its subsidiaries is subject to any pending tax audits or investigations or has received any notice in writing
        or has knowledge of any tax deficiency, which, if adversely determined, would have a Material Adverse Effect; the Company and its subsidiaries are and have at all times been resident for tax purposes in their place of incorporation and are not and
        have not been treated as resident in any other jurisdiction for any tax purpose (including any double taxation arrangement) and no unresolved written claim has been made by any governmental authority that the Company or its subsidiaries are or may
        be subject to tax of a particular type or required to file a tax return of a particular type in a jurisdiction where it does not file a tax return of such type;</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">(ll)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>ERISA Compliance</u>.&#160; Except as otherwise disclosed in the Prospectus, the Company and its subsidiaries and any &#8220;employee benefit plan&#8221; (as defined under the
        Employee Retirement Income Security Act of 1974, as amended, and the regulations and published interpretations thereunder (collectively, &#8220;<font style="font-weight: bold;">ERISA</font>&#8221;)), whether or not subject to ERISA, established or maintained
        by the Company, its subsidiaries or their &#8220;ERISA Affiliates&#8221; (as defined below) are in compliance in all material respects with ERISA.&#160; &#8220;<font style="font-weight: bold;">ERISA Affiliate</font>&#8221; means, with respect to the Company or any of its
        subsidiaries, any member of any group of organizations described in Sections&#160;414(b), (c), (m) or (o) of the Internal Revenue Code of 1986, as amended, and the regulations and published interpretations thereunder (the &#8220;<font style="font-weight: bold;">Code</font>&#8221;) of which the Company or such subsidiary is a member.&#160; No &#8220;reportable event&#8221; (as defined under ERISA) has occurred or is reasonably expected to occur with respect to any &#8220;employee benefit plan&#8221; established or maintained by the
        Company, its subsidiaries or any of their ERISA Affiliates.&#160; No &#8220;employee benefit plan&#8221; established or maintained by the Company, its subsidiaries or any of their ERISA Affiliates, if such &#8220;employee benefit plan&#8221; were terminated, would have any
        &#8220;amount of unfunded benefit liabilities&#8221; (as defined under ERISA).&#160; Neither the Company, its subsidiaries nor any of their ERISA Affiliates has incurred or reasonably expects to incur any liability under (i)&#160;Title&#160;IV of ERISA with respect to
        termination of, or withdrawal from, any &#8220;employee benefit plan&#8221; or (ii)&#160;Sections&#160;412, 4971, 4975 or 4980B of the Code.&#160; Each &#8220;employee benefit plan&#8221; established or maintained by the Company, its subsidiaries or any of their ERISA Affiliates that is
        intended to be qualified under Section&#160;401(a) of the Code is so qualified and nothing has occurred, whether by action or failure to act, which would cause the loss of such qualification.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">(mm)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Other Agreements</u>. The Company is not a party to any agreement with an agent or underwriter for any other &#8220;at the market&#8221; or continuous equity transaction;</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">(nn)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Governing Law</u>.&#160; The choice of laws of the State of New York as the governing law of this Agreement is a valid choice of law under the laws of the State of
        Israel and will be honored by the courts of the State of Israel; the Company has the power to submit, and pursuant to Section 8(g) of this Agreement, has legally, validly, effectively and irrevocably submitted, to the personal jurisdiction of each
        of the Specified Courts (as defined in Section 8(g)) and has validly and irrevocably waived any objection to the laying of venue of any suit, action or proceeding brought in such court; and the Company has the power to designate, appoint and
        authorize, and pursuant to Section 8(g) of this Agreement, has legally, validly, effectively and irrevocably designated, appointed and authorized an agent for service of process in any action arising out of or relating to this Agreement or the
        Shares, and service of process effected on such authorized agent will be effective to confer valid personal jurisdiction over the Company;</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">(oo)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Funding</u>.&#160; The Company has not received any funding, grants or subsidies from or on behalf of or under the authority of the Israel Innovation Authority of the
        Israeli Ministry of Economy and Industry, the Authority for Investment and Development of Industry and the Economy of the State of Israel, or any other governmental or regulatory agency or authority or any bi- or multi-national grant program,
        framework or foundation;</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">(pp)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Immunity</u>.&#160; Except as provided by laws or statutes generally applicable to transactions of the type described in this Agreement, neither the Company nor any
        of its subsidiaries or their properties or assets has immunity under the laws of Israel, New York or United States law from any legal action, suit or proceeding, from the giving of any relief in any such legal action, suit or proceeding, from
        set-off or counterclaim, from the jurisdiction of Israeli, New York or United States federal court, from service of process, attachment upon or prior to judgment, or attachment in aid of execution of judgment, or from execution of a judgment, or
        other legal process or proceeding for the giving of any relief or for the enforcement of a judgment, in any such court with respect to their respective obligations, liabilities or any other matter under or arising out of or in connection herewith;
        and, to the extent that the Company or any of its subsidiaries or any of its properties, assets or revenues may have or may hereafter become entitled to any such right of immunity in any such court in which proceedings arising out of, or relating
        to the transactions contemplated by this Agreement, may at any time be commenced, the Company has, pursuant to Section 8(h) of this Agreement, waived, and it will waive, or will cause its subsidiaries to waive, such right to the extent permitted by
        law; neither the Company nor any of its properties or assets has any immunity from any legal action, suit or proceeding, from the giving of any relief in any such legal action, suit or proceeding, from set-off or counterclaim, from the jurisdiction
        of any court or from any legal process (whether through service of process or notice, attachment upon or prior to judgment, attachment in aid of execution or from execution of a judgment, or otherwise) under the laws of the State of Israel. The
        irrevocable and unconditional waiver and agreement of the Company contained in Section 8(h) not to plead or claim any such immunity in any legal action, suit or proceeding based on this Agreement is valid and binding under the laws of the State of
        Israel;</div>
      <div style="line-height: 1.25">&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-weight: normal; font-style: normal;">12</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      </div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">(qq)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Taxes</u>. Except for any net income, capital gains or franchise taxes imposed on the Agent by the government of the State of Israel or any political subdivision
        or taxing authority thereof or therein as a result of any present or former connection (other than any connection resulting from the transactions contemplated by this Agreement) between the Agent and the State of Israel, no net income, withholding,
        capital gains, franchise, transaction, documentary, or registration taxes, stamp duties or other issuance or transfer taxes are payable by or on behalf of the Agent in the State of Israel, the United States or any political subdivision or taxing
        authority thereof solely in connection with (i) the execution, delivery and performance of this Agreement, (ii) the issuance and delivery of the Shares in the manner contemplated by this Agreement and the Prospectus or (iii) the sale and delivery
        by the Agent of the Shares as contemplated herein and in the Prospectus;</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">(rr)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Tax Incentive Programs</u>. The Company is in compliance with all conditions and requirements stipulated under any applicable law, regulation, instruments of
        approval and tax rulings granted to it (the &#8220;<font style="font-weight: bold;">Rulings</font>&#8221;) with respect to any &#8220;Approved Enterprise,&#8221; &#8220;Benefited Enterprise,&#8221; or &#8220;Industrial Company&#8221; status of the Company or any of its facilities as well as with
        respect to any other tax benefits claimed or received by it, including any &#8220;Approved Enterprise,&#8221; &#8220;Benefited Enterprise,&#8221; &#8220;Preferred Enterprise,&#8221; &#8220;Preferred Technological Enterprise&#8221; or &#8220;Special Preferred Technological Enterprise&#8221; status or
        benefits (collectively, &#8220;<font style="font-weight: bold;">Tax Incentive Program</font>s&#8221;) and by Israeli laws and regulations relating to any Tax Incentive Program; (ii) all information supplied by the Company to the appropriate authorities with
        respect to applications or notifications relating to any Tax Incentive Program (including in connection with any Ruling) was true, correct and complete in all material respects when supplied to the appropriate authorities; and (iii) the Company has
        not received&#160; any notice in writing, nor does it have knowledge, of any proceeding or investigation relating to revocation or modification or denial of any current or past Tax Incentive Programs granted with respect to the Company or any of its
        facilities or any such status or benefits, in each case, except for any failure to comply, inaccuracy or notice (as appropriate) that would not, individually or in the aggregate, have a Material Adverse Effect;</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">(ss)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>No Dissolution</u>.&#160; No proceedings have been instituted in the State of Israel for the dissolution of the Company;</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">(tt)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Employees</u>.&#160; All obligations of the Company to provide statutory severance pay to all its currently engaged employees in Israel (&#8220;<font style="font-weight: bold;">Israeli Employees</font>&#8221;) are, in accordance with Section 14 of the Israeli Severance Pay Law, 5723-1963 (the &#8220;<font style="font-weight: bold;">Severance Pay Law</font>&#8221;), and are fully funded or, if not required to be funded, are accrued
        on the Company&#8217;s financial statements, and all such employees have been subject to the provisions of Section 14 of the Severance Pay Law with respect to their entire salary, as defined under the Severance Pay Law, from the date of commencement of
        their employment with the Company, and the Company has been, with such exceptions as are not material, in full compliance with the technical and substantive requirements for a Section 14 Arrangement with respect to severance pay with respect to
        100% of such salary for which severance pay is due under the Severance Pay Law; and all amounts that the Company is required by contract or applicable law either (A) to deduct from Israeli Employees&#8217; salaries or to transfer to such Israeli
        Employees&#8217; pension or provident, life insurance, incapacity insurance, advance study fund or other similar funds or (B) to withhold from their Israeli Employees&#8217; salaries and benefits (including any other income in cash or in kind) and to pay to
        any Israeli governmental authority as required by applicable Israeli tax law and regulations, have, in each case, been duly deducted, transferred, withheld and paid, and the Company has no outstanding obligation to make any such deduction,
        transfer, withholding or payment other than in ordinary course payment timelines;</div>
      <div style="line-height: 1.25">&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-weight: normal; font-style: normal;">13</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      </div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">(uu)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Approvals</u>.&#160; Except as set forth or contemplated in the Prospectus, no approvals are currently required in the State of Israel in order for the Company to pay
        dividends or other distributions declared by the Company to the holders of Shares. Under current laws and regulations of the State of Israel and any political subdivision thereof, any amount payable with respect to the Shares upon liquidation of
        the Company or upon redemption thereof and dividends and other distributions declared and payable on the share capital of the Company may be paid by the Company in United States dollars and freely transferred out of the State of Israel;</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">(vv)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Judgments</u>.&#160; Any final judgment for a fixed or determined sum of money rendered by any U.S. federal or New York state court located in the State of New York
        having jurisdiction under its own laws in respect of any suit, action or proceeding against the Company based upon this Agreement would be declared enforceable against the Company by the courts of the State of Israel, without reconsideration or
        reexamination of the merits, subject to the conditions, qualifications, restrictions and limitations described under the caption &#8220;Enforceability of Civil Liabilities&#8221; in the Registration Statement and the Prospectus;</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">(ww)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Indemnification</u>.&#160; The indemnification and contribution provisions set forth in Section 6 hereof do not contravene Israeli law or public policy; and</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">The legality, validity, enforceability or admissibility into evidence of the Registration Statement and the Prospectus, this Agreement or the Shares in any jurisdiction in which
        the Company is organized or does business is not dependent upon such document being submitted into, filed or recorded with any court or other authority in any such jurisdiction on or before the date hereof or that any tax, imposition or charge be
        paid in any such jurisdiction on or in respect of any such document.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">Any certificate signed by any officer or representative of the Company or any of its subsidiaries and delivered to the Agent or counsel for the Agent in connection with an
        issuance of Shares shall be deemed a representation and warranty by the Company to the Agent as to the matters covered thereby on the date of such certificate.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">The Company acknowledges that the Agent and, for purposes of the opinions to be delivered pursuant to <u>Section 4(p)</u> hereof, counsel to the Company and counsel to the
        Agent, will rely upon the accuracy and truthfulness of the foregoing representations and hereby consents to such reliance.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-weight: normal; font-style: normal;">14</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      </div>
      <div style="line-height: 1.25;"><font style="font-weight: bold;">Section 3.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-weight: bold;">&#160; ISSUANCE AND SALE OF ORDINARY SHARES</font></div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">(a)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Sale of Securities</u>.&#160; On the basis of the representations, warranties and agreements herein contained, but subject to the terms and conditions herein set
        forth, the Company and the Agent agree that the Company may from time to time seek to sell Shares through the Agent, acting as sales agent, or directly to the Agent, acting as principal, as follows, with an aggregate Sales Price of up to the
        Maximum Program Amount, based on and in accordance with Issuance Notices as the Company may deliver, during the Agency Period.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">(b)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Mechanics of Issuances</u>.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">(i)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Issuance Notice</u>.&#160; Upon the terms and subject to the conditions set forth herein, on any Trading Day during the Agency Period on which the conditions set forth
        in <u>Section 5(a)</u> and <u>Section 5(b)</u> shall have been satisfied, the Company may exercise its right to request an issuance of Shares by delivering to the Agent an Issuance Notice; <font style="font-style: italic;">provided, however</font>,
        that (A) in no event may the Company deliver an Issuance Notice to the extent that (I) the sum of (x) the aggregate Sales Price of the requested Issuance Amount, plus (y) the aggregate Sales Price of all Shares issued under all previous Issuance
        Notices effected pursuant to this Agreement, would exceed the Maximum Program Amount; and (B) prior to delivery of any Issuance Notice, the period set forth for any previous Issuance Notice shall have expired or been terminated. An Issuance Notice
        shall be considered delivered on the Trading Day that it is received by e&#8209;mail to the persons set forth in Schedule A hereto and confirmed by the Company by telephone (including a voicemail message to the persons so identified), with the
        understanding that, with adequate prior written notice, the Agent may modify the list of such persons from time to time.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">(ii)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Agent Efforts</u>.&#160; Upon the terms and subject to the conditions set forth in this Agreement, upon the receipt of an Issuance Notice, the Agent will use its
        commercially reasonable efforts consistent with its normal sales and trading practices to place the Shares with respect to which the Agent has agreed to act as sales agent, subject to, and in accordance with the information specified in, the
        Issuance Notice, unless the sale of the Shares described therein has been suspended, cancelled or otherwise terminated in accordance with the terms of this Agreement.&#160; For the avoidance of doubt, the parties to this Agreement may modify an Issuance
        Notice at any time provided they both agree in writing to any such modification.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">(iii)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Method of Offer and Sale</u>.&#160; The Shares may be offered and sold (A) in privately negotiated transactions with the consent of the Company; (B) as block
        transactions; or (C) by any other method permitted by law deemed to be an &#8220;at the market offering&#8221; as defined in Rule 415(a)(4) under the Securities Act, including sales made directly on the Principal Market or sales made into any other existing
        trading market of the Ordinary Shares.&#160; Nothing in this Agreement shall be deemed to require either party to agree to the method of offer and sale specified in the preceding sentence, and (except as specified in clauses (A) and (B) above) the
        method of placement of any Shares by the Agent shall be at the Agent&#8217;s discretion.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">(iv)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Confirmation to the Company</u>.&#160; If acting as sales agent hereunder, the Agent will provide written confirmation to the Company no later than the opening of the
        Trading Day following the Trading Day on which it has placed Shares hereunder setting forth the number of Shares sold on such Trading Day, the corresponding Sales Price and the Issuance Price payable to the Company in respect thereof.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-weight: normal; font-style: normal;">15</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      </div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">(v)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Settlement</u>.&#160; Each issuance of Shares will be settled on the applicable Settlement Date for such issuance of Shares and, subject to the provisions of <u>Section


          5</u>, on or before each Settlement Date, the Company will, or will cause its transfer agent to, electronically transfer the Shares being sold by crediting the Agent or its designee&#8217;s account at The Depository Trust Company through its
        Deposit/Withdrawal At Custodian (DWAC) System, or by such other means of delivery as may be mutually agreed upon by the parties hereto and, upon receipt of such Shares, which in all cases shall be freely tradable, transferable, registered shares in
        good deliverable form, the Agent will deliver, by wire transfer of immediately available funds, the related Issuance Price in same day funds delivered to an account designated by the Company prior to the Settlement Date.&#160; The Company may sell
        Shares to the Agent as principal at a price agreed upon at each relevant time Shares are sold pursuant to this Agreement (each, a &#8220;<font style="font-weight: bold;">Time of Sale</font>&#8221;).</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">(vi)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Suspension or Termination of Sales</u>.&#160; Consistent with standard market settlement practices, the Company or the Agent may, upon notice to the other party
        hereto in writing or by telephone (confirmed immediately by verifiable email), suspend any sale of Shares, and the period set forth in an Issuance Notice shall immediately terminate; <font style="font-style: italic;">provided, however</font>, that
        (A) such suspension and termination shall not affect or impair either party&#8217;s obligations with respect to any Shares placed or sold hereunder prior to the receipt of such notice; (B) if the Company suspends or terminates any sale of Shares after
        the Agent confirms such sale to the Company, the Company shall still be obligated to comply with <u>Section 3(b)(v)</u> with respect to such Shares; and (C) if the Company defaults in its obligation to deliver Shares on a Settlement Date (other
        than as a result of a failure by the Agent of its obligations under this Agreement), the Company agrees that it will hold the Agent harmless against any loss, claim, damage or expense (including, without limitation, penalties, interest and
        reasonable legal fees and expenses), as incurred, arising out of or in connection with such default by the Company. The parties hereto acknowledge and agree that, in performing its obligations under this Agreement, the Agent may borrow Ordinary
        Shares from stock lenders in the event that the Company has not delivered Shares to settle sales as required by subsection (v) above, and may use the Shares to settle or close out such borrowings.&#160; The Company agrees that no such notice shall be
        effective against the Agent unless it is made to the persons identified in writing by the Agent pursuant to <u>Section 3(b)(i)</u>.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">(vii)&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>No Guarantee of Placement, Etc.</u>&#160; The Company acknowledges and agrees that (A) there can be no assurance that the Agent will be successful in placing Shares;
        (B) the Agent will incur no liability or obligation to the Company or any other Person if it does not sell Shares; and (C)&#160;the Agent shall be under no obligation to purchase Shares on a principal basis pursuant to this Agreement, except as
        otherwise specifically agreed by the Agent and the Company.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">(viii)&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>Material Non-Public Information.</u>&#160; Notwithstanding any other provision of this Agreement, the Company and the Agent agree that the Company shall not deliver
        any Issuance Notice to the Agent, and the Agent shall not be obligated to place any Shares, during any period in which the Company is in possession of material non-public information.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">(c)&#160;&#160;&#160;&#160; &#160;&#160; &#160;&#160;&#160; <u>Fees</u>.&#160; As compensation for services rendered, the Company shall pay to the Agent, on the applicable Settlement Date, the Selling Commission for the
        applicable Issuance Amount (including with respect to any suspended or terminated sale pursuant to <u>Section 3(b)(vi))</u> by the Agent deducting the Selling Commission from the applicable Issuance Amount.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">(d)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Expenses</u>.&#160; The Company agrees to pay all costs, fees and expenses incurred in connection with the performance of its obligations hereunder and in connection
        with the transactions contemplated hereby, including without limitation (i)&#160;all expenses incident to the issuance and delivery of the Shares (including all printing and engraving costs); (ii)&#160;all fees and expenses of the registrar and transfer
        agent of the Shares; (iii)&#160;all necessary issue, transfer and other stamp taxes in connection with the issuance and sale of the Shares to the Agent in the manner contemplated herein; (iv)&#160;all fees and expenses of the Company&#8217;s counsel, independent
        public or certified public accountants and other advisors; (v)&#160;all costs and expenses incurred in connection with the preparation, printing, filing, shipping and distribution of the Registration Statement (including financial statements, exhibits,
        schedules, consents and certificates of experts), the Prospectus, any Free Writing Prospectus (as defined below) prepared by or on behalf of, used by, or referred to by the Company, and all amendments and supplements thereto, and this Agreement;
        (vi)&#160;all filing fees, attorneys&#8217; fees and expenses incurred by the Company or the Agent in connection with qualifying or registering (or obtaining exemptions from the qualification or registration of) all or any part of the Shares for offer and
        sale under the state securities or blue sky laws or the provincial securities laws of Canada, and, if requested by the Agent, preparing and printing a &#8220;<font style="font-weight: bold;">Blue Sky Survey</font>&#8221; or memorandum and a &#8220;Canadian wrapper,
        and any supplements thereto, advising the Agent of such qualifications, registrations, determinations and exemptions; (vii) the reasonable fees and disbursements of the Agent&#8217;s counsel, including&#160;the reasonable fees and expenses of counsel for the
        Agent in connection with, FINRA review, if any, and approval of the Agent&#8217;s participation in the offering and distribution of the Shares; (viii)&#160;the filing fees incident to FINRA review, if any; (ix) the costs and expenses of the Company relating
        to investor presentations on any &#8220;road show&#8221; undertaken in connection with the marketing of the offering of the Shares, including, without limitation, expenses associated with the preparation or dissemination of any electronic road show, expenses
        associated with the production of road show slides and graphics, fees and expenses of any consultants engaged in connection with the road show presentations with the prior approval of the Company, travel and lodging expenses of the representatives,
        employees and officers of the Company and of the Agent and any such consultants, and the cost of any aircraft chartered in connection with the road show; and (x)&#160;the fees and expenses associated with listing the Shares on the Principal Market. The
        fees and disbursements of Agent&#8217;s counsel pursuant to subsections (vi) and (vii) above shall not exceed (A) $75,000 for Agent&#8217;s U.S. counsel and $25,000 for Agent&#8217;s Israeli counsel in connection with the execution of this Agreement, (B) $25,000 for
        Agent&#8217;s U.S. counsel and $10,000 for Agent&#8217;s Israeli counsel in connection with each Triggering Event Date (as defined below) involving the filing of a Form 20-F on which the Company is required to provide a certificate pursuant to <u>Section 4(o</u>),


        and (C) $15,000 for Agent&#8217;s U.S. counsel and $10,000 for Agent&#8217;s Israeli counsel in connection with each other Triggering Event Date (as defined below) for periods in which no out of the ordinary diligence or comfort letter event is triggered on
        which the Company is required to provide a certificate pursuant to <u>Section 4(o</u>).</div>
      <div style="line-height: 1.25">&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-weight: normal; font-style: normal;">16</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      </div>
      <div style="line-height: 1.25;"><font style="font-weight: bold;">Section 4.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-weight: bold;">&#160; ADDITIONAL COVENANTS</font></div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">The Company covenants and agrees with the Agent as follows, in addition to any other covenants and agreements made elsewhere in this Agreement:</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">(a)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Exchange Act Compliance</u>.&#160; During the Agency Period, the Company shall (i) file, on a timely basis, with the Commission all reports and documents required to
        be filed under Section 13, 14 or 15 of the Exchange Act in the manner and within the time periods required by the Exchange Act; and (ii) if sales are made pursuant to this Agreement, either (A) include in its interim financial reports on Form 6-K
        and its annual reports filed on Form 20-F, a summary detailing, for the relevant reporting period, (1) the number of Shares sold through the Agent pursuant to this Agreement and (2) the net proceeds received by the Company from such sales or (B)
        prepare a prospectus supplement containing, or include in such other filing permitted by the Securities Act or Exchange Act (each an &#8220;<font style="font-weight: bold;">Interim Prospectus Supplement&#8221;)</font>, such summary information and, at least
        once a quarter and subject to this Section 4, file such Interim Prospectus Supplement pursuant to Rule 424(b) under the Securities Act (and within the time periods required by Rule 424(b) and Rule 430B under the Securities Act).</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">(b)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Securities Act Compliance</u>.&#160; After the date of this Agreement, the Company shall promptly advise the Agent in writing (i) of the receipt of any comments of, or
        requests for additional or supplemental information from, the Commission; (ii) of the time and date of any filing of any post-effective amendment to the Registration Statement, any Rule 462(b) Registration Statement or any amendment or supplement
        to the Prospectus, any Free Writing Prospectus; (iii) of the time and date that any post-effective amendment to the Registration Statement or any Rule 462(b) Registration Statement becomes effective; and (iv) of the issuance by the Commission of
        any stop order suspending the effectiveness of the Registration Statement or any post-effective amendment thereto, any Rule 462(b) Registration Statement or any amendment or supplement to the Prospectus or of any order preventing or suspending the
        use of any Free Writing Prospectus or the Prospectus, or of any proceedings to remove, suspend or terminate from listing or quotation the Ordinary Shares from any securities exchange upon which they are listed for trading or included or designated
        for quotation, or of the threatening or initiation of any proceedings for any of such purposes.&#160; If the Commission shall enter any such stop order at any time, the Company will use its best efforts to obtain the lifting of such order as soon as
        practicable.&#160; Additionally, the Company agrees that it shall comply with the provisions of Rule 424(b) and Rule 433, as applicable, under the Securities Act and will use its reasonable efforts to confirm that any filings made by the Company under
        such Rule 424(b) or Rule 433 were received in a timely manner by the Commission.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">(c)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Amendments and Supplements to the Prospectus and Other Securities Act Matters</u>.&#160; If any event shall occur or condition exist as a result of which it is
        necessary to amend or supplement the Prospectus so that the Prospectus does not include an untrue statement of a material fact or omit to state a material fact necessary in order to make the statements therein, in the light of the circumstances
        when the Prospectus is delivered to a purchaser, not misleading, or if in the opinion of the Agent or counsel for the Agent it is otherwise necessary to amend or supplement the Prospectus to comply with applicable law, including the Securities Act,
        the Company agrees (subject to Sections&#160;4(d) and 4(f)) to promptly prepare, file with the Commission and furnish at its own expense to the Agent, amendments or supplements to the Prospectus so that the statements in the Prospectus as so amended or
        supplemented will not include an untrue statement of a material fact or omit to state a material fact necessary in order to make the statements therein, in the light of the circumstances when the Prospectus is delivered to a purchaser, be
        misleading or so that the Prospectus, as amended or supplemented, will comply with applicable law including the Securities Act.&#160; Neither the Agent&#8217;s consent to, or delivery of, any such amendment or supplement shall constitute a waiver of any of
        the Company&#8217;s obligations under Sections 4(d) and 4(f).</div>
      <div style="line-height: 1.25">&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-weight: normal; font-style: normal;">17</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      </div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">(d)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Agent&#8217;s Review of Proposed Amendments and Supplements</u>.<font style="font-style: italic;">&#160; </font>Prior to amending or supplementing the Registration
        Statement (including any registration statement filed under Rule&#160;462(b) under the Securities Act) or the Prospectus (excluding any amendment or supplement through incorporation of any report filed under the Exchange Act), the Company shall furnish
        to the Agent for review, a reasonable amount of time prior to the proposed time of filing or use thereof, a copy of each such proposed amendment or supplement, and the Company shall not file or use any such proposed amendment or supplement without
        the Agent&#8217;s prior consent, and to file with the Commission within the applicable period specified in Rule 424(b) under the Securities Act any prospectus required to be filed pursuant to such Rule.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">(e)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Use of Free Writing Prospectus</u>. Neither the Company nor the Agent has prepared, used, referred to or distributed, or will prepare, use, refer to or
        distribute, without the other party&#8217;s prior written consent, any &#8220;written communication&#8221; that constitutes a &#8220;free writing prospectus&#8221; as such terms are defined in Rule 405 under the Securities Act with respect to the offering contemplated by this
        Agreement (any such free writing prospectus being referred to herein as a &#8220;<font style="font-weight: bold;">Free Writing Prospectus</font>&#8221;).</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">(f)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Free Writing Prospectuses</u>.&#160; The Company shall furnish to the Agent for review, a reasonable amount of time prior to the proposed time of filing or use
        thereof, a copy of each proposed free writing prospectus or any amendment or supplement thereto to be prepared by or on behalf of, used by, or referred to by the Company and the Company shall not file, use or refer to any proposed free writing
        prospectus or any amendment or supplement thereto without the Agent&#8217;s consent.&#160; The Company shall furnish to the Agent, without charge, as many copies of any free writing prospectus prepared by or on behalf of, or used by the Company, as the Agent
        may reasonably request.&#160; If at any time when a prospectus is required by the Securities Act (including, without limitation, pursuant to Rule&#160;173(d)) to be delivered in connection with sales of the Shares (but in any event if at any time through and
        including the date of this Agreement) there occurred or occurs an event or development as a result of which any free writing prospectus prepared by or on behalf of, used by, or referred to by the Company conflicted or would conflict with the
        information contained in the Registration Statement or included or would include an untrue statement of a material fact or omitted or would omit to state a material fact necessary in order to make the statements therein, in the light of the
        circumstances prevailing at that subsequent time, not misleading, the Company shall promptly amend or supplement such free writing prospectus to eliminate or correct such conflict or so that the statements in such free writing prospectus as so
        amended or supplemented will not include an untrue statement of a material fact or omit to state a material fact necessary in order to make the statements therein, in the light of the circumstances prevailing at such subsequent time, not
        misleading, as the case may be; <font style="font-style: italic;">provided, however</font>, that prior to amending or supplementing any such free writing prospectus, the Company shall furnish to the Agent for review, a reasonable amount of time
        prior to the proposed time of filing or use thereof, a copy of such proposed amended or supplemented free writing prospectus and the Company shall not file, use or refer to any such amended or supplemented free writing prospectus without the
        Agent&#8217;s consent.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-weight: normal; font-style: normal;">18</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      </div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">(g)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Filing of Agent Free Writing Prospectuses</u>.&#160; The Company shall not take any action that would result in the Agent or the Company being required to file with
        the Commission pursuant to Rule 433(d) under the Securities Act a free writing prospectus prepared by or on behalf of the Agent that the Agent otherwise would not have been required to file thereunder.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">(h)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Copies of Registration Statement and Prospectus</u>.&#160; After the date of this Agreement through the last time that a prospectus is required by the Securities Act
        (including, without limitation, pursuant to Rule&#160;173(d)) to be delivered in connection with sales of the Shares, the Company agrees to furnish the Agent with copies (which may be electronic copies) of the Registration Statement and each amendment
        thereto, and with copies (which may be electronic copies) of the Prospectus and each amendment or supplement thereto in the form in which it is filed with the Commission pursuant to the Securities Act or Rule&#160;424(b) under the Securities Act, both
        in such quantities as the Agent may reasonably request from time to time; and, if the delivery of a prospectus is required under the Securities Act or under the blue sky or securities laws of any jurisdiction at any time on or prior to the
        applicable Settlement Date for any period set forth in an Issuance Notice in connection with the offering or sale of the Shares and if at such time any event has occurred as a result of which the Prospectus as then amended or supplemented would
        include an untrue statement of a material fact or omit to state any material fact necessary in order to make the statements therein, in the light of the circumstances under which they were made when such Prospectus is delivered, not misleading, or,
        if for any other reason it is necessary during such same period to amend or supplement the Prospectus or to file under the Exchange Act any document incorporated by reference in the Prospectus in order to comply with the Securities Act or the
        Exchange Act, to notify the Agent and to request that the Agent suspend offers to sell Shares (and, if so notified, the Agent shall cease such offers as soon as practicable); and if the Company decides to amend or supplement the Registration
        Statement or the Prospectus as then amended or supplemented, to advise the Agent promptly by telephone (with confirmation in writing) and to prepare and cause to be filed promptly with the Commission an amendment or supplement to the Registration
        Statement or the Prospectus as then amended or supplemented that will correct such statement or omission or effect such compliance; provided, however, that if during such same period the Agent is required to deliver a prospectus in respect of
        transactions in the Shares, the Company shall promptly prepare and file with the Commission such an amendment or supplement.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">(i)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Blue Sky Compliance</u>.&#160; The Company shall cooperate with the Agent and counsel for the Agent to qualify or register the Shares for sale under (or obtain
        exemptions from the application of) the state securities or blue sky laws or Canadian provincial securities laws of those jurisdictions designated by the Agent, shall comply with such laws and shall continue such qualifications, registrations and
        exemptions in effect so long as required for the distribution of the Shares.&#160; The Company shall not be required to qualify as a foreign corporation or to take any action that would subject it to general service of process in any such jurisdiction
        where it is not presently qualified or where it would be subject to taxation as a foreign corporation.&#160; The Company will advise the Agent promptly of the suspension of the qualification or registration of (or any such exemption relating to) the
        Shares for offering, sale or trading in any jurisdiction or any initiation or threat of any proceeding for any such purpose, and in the event of the issuance of any order suspending such qualification, registration or exemption, the Company shall
        use its best efforts to obtain the withdrawal thereof as soon as practicable.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-weight: normal; font-style: normal;">19</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      </div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">(j)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Earnings Statement</u>.&#160; As soon as practicable, the Company will make generally available to its security holders and to the Agent an earnings statement (which
        need not be audited) covering a period of at least twelve months beginning with the first fiscal quarter of the Company occurring after the date of this Agreement which shall satisfy the provisions of Section 11(a) of the Securities Act and Rule
        158 under the Securities Act.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">(k)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Listing; Reservation of Shares</u>.&#160; (a) The Company will maintain the listing of the Shares on the Principal Market; and (b) the Company will reserve and keep
        available at all times, free of preemptive rights, Shares for the purpose of enabling the Company to satisfy its obligations under this Agreement.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">(l)&#160;&#160;&#160;&#160; &#160;&#160; &#160;&#160;&#160; <u>Transfer Agent</u>.&#160; The Company shall engage and maintain, at its expense, a registrar and transfer agent for the Shares.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">(m)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Due Diligence</u>.&#160; During the term of this Agreement, the Company will reasonably cooperate with any reasonable due diligence review conducted by the Agent in
        connection with the transactions contemplated hereby, including, without limitation, providing information and making available documents and senior corporate officers, during normal business hours and at the Company&#8217;s principal offices or
        virtually, as the Agent may reasonably request from time to time.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">(n)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Representations and Warranties</u>.&#160; The Company acknowledges that each delivery of an Issuance Notice and each delivery of Shares on a Settlement Date shall be
        deemed to be (i) an affirmation to the Agent that the representations and warranties of the Company contained in or made pursuant to this Agreement are true and correct as of the date of such Issuance Notice or of such Settlement Date, as the case
        may be, as though made at and as of each such date, except as may be disclosed in the Prospectus (including any documents incorporated by reference therein and any supplements thereto); and (ii)&#160;an undertaking that the Company will advise the Agent
        if any of such representations and warranties will not be true and correct as of the Settlement Date for the Shares relating to such Issuance Notice, as though made at and as of each such date (except that such representations and warranties shall
        be deemed to relate to the Registration Statement and the Prospectus as amended and supplemented relating to such Shares).</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">(o)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Deliverables at Triggering Event Dates; Certificates.</u> The Company agrees that on or prior to the date of the first Issuance Notice and, during the term of
        this Agreement after the date of the first Issuance Notice, upon:</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt; line-height: 1.25;">(A)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;the filing with the Commission of an amendment or supplement of any Registration Statement or Prospectus (other than a prospectus supplement relating solely to an
        offering of securities other than the Shares or a prospectus filed pursuant to Section 4(a)(ii)(B)), by means of a post-effective amendment, sticker or supplement, but not by means of incorporation of documents by reference into the Registration
        Statement or Prospectus;</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: justify; text-indent: 72pt; line-height: 1.25;">(B)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;the filing with the Commission of an annual report on Form 20-F or quarterly unaudited financial statements furnished on Form 6-K under the Exchange Act (including
        any Form 20-F/A or Form 6-K/A containing amended financial statements or a material amendment to the previously filed or furnished report on Form 6-K or Form 20-F, as applicable), in each case, of the Company; or</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-weight: normal; font-style: normal;">20</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      </div>
      <div style="text-align: justify; text-indent: 72pt; line-height: 1.25;">(C)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;the filing with the Commission of a Form 6-K of the Company containing amended financial statements under the Exchange Act that is incorporated by reference into the
        Registration Statement;</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; line-height: 1.25;">(any such event, a &#8220;<font style="font-weight: bold;">Triggering Event Date</font>&#8221;), the Company shall furnish the Agent (but in the case of clause (C) above only if the Agent reasonably determines
        that the information contained in such Form 6-K of the Company is material) with a certificate as of the Triggering Event Date, in the form and substance satisfactory to the Agent and its counsel, substantially similar to the form previously
        provided to the Agent and its counsel, modified, as necessary, to relate to the Registration Statement and the Prospectus as amended or supplemented, (A) confirming that the representations and warranties of the Company contained in this Agreement
        are true and correct, (B) confirming that the Company has performed all of its obligations hereunder to be performed on or prior to the date of such certificate and as to the matters set forth in <u>Section 5(a)(iii)</u> hereof, and (C) containing
        any other certification that the Agent shall reasonably request. The requirement to provide a certificate under this <u>Section 4(o)</u> shall be waived for any Triggering Event Date occurring at a time when no Issuance Notice is pending or a
        suspension is in effect, which waiver shall continue until the earlier to occur of the date the Company delivers instructions for the sale of Shares hereunder (which for such calendar quarter shall be considered a Triggering Event Date) and the
        next occurring Triggering Event Date. Notwithstanding the foregoing, if the Company subsequently decides to sell Shares following a Triggering Event Date when a suspension was in effect and did not provide the Agent with a certificate under this
        Section 4(o), then before the Company delivers the instructions for the sale of Shares or the Agent sells any Shares pursuant to such instructions, the Company shall provide the Agent with a certificate in conformity with this Section 4(o) dated as
        of the date that the instructions for the sale of Shares are issued.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">(p)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Legal Opinions.</u>&#160; On or prior to the date of the first Issuance Notice and on or prior to each Triggering Event Date with respect to which the Company is
        obligated to deliver a certificate pursuant to Section 4(o) for which no waiver is applicable and excluding the date of this Agreement, a negative assurances letter and the written legal opinion of Latham &amp; Watkins LLP, U.S. counsel to the
        Company, Naschitz, Brandes, Amir &amp; Co., Advocates, Israeli counsel to the Company, and Skadden, Arps, Slate, Meagher &amp; Flom LLP, U.S. counsel to the Agent, each dated the date of delivery, in form and substance reasonably satisfactory to
        Agent and its counsel, substantially similar to the form previously provided to the Agent and its counsel, modified, as necessary, to relate to the Registration Statement and the Prospectus as then amended or supplemented. In lieu of such opinions
        for subsequent periodic filings, in the discretion of the Agent, the Company may furnish a reliance letter from such counsel to the Agent, permitting the Agent to rely on a previously delivered opinion letter, modified as appropriate for any
        passage of time or Triggering Event Date (except that statements in such prior opinion shall be deemed to relate to the Registration Statement and the Prospectus as amended or supplemented as of such Triggering Event Date).</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">(q)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Comfort Letter</u>. On or prior to the date of the first Issuance Notice and on or prior to each Triggering Event Date with respect to which the Company is
        obligated to deliver a certificate pursuant to Section 4(o) for which no waiver is applicable and excluding the date of this Agreement, the Company shall cause Kesselman &amp; Kesselman, a member firm of PricewaterhouseCoopers International
        Limited, the independent registered public accounting firm who has audited the financial statements of the Company included or incorporated by reference in the Registration Statement (other than financial statements for the year ended December 31,
        2022), to furnish the Agent a comfort letter dated the date of delivery, in form and substance reasonably satisfactory to the Agent and its counsel, substantially similar to the form previously provided to the Agent and its counsel (if applicable);
        provided, however, that such comfort letter will only be required on the Triggering Event Date specified to the extent that it contains financial statements filed with the Commission under the Exchange Act and incorporated or deemed to be
        incorporated by reference into a Prospectus.&#160; If requested by the Agent, the Company shall also cause a comfort letter to be furnished to the Agent within five (5) Trading Days of the date of occurrence of any material transaction or event
        requiring the filing of a report on Form 6-K containing material amended financial information of the Company, including the restatement of the Company&#8217;s financial statements. The Company shall be required to furnish no more than one comfort letter
        hereunder per calendar quarter.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-weight: normal; font-style: normal;">21</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      </div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">(r)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Secretary&#8217;s Certificate</u>. On or prior to the date of the first Issuance Notice and on or prior to each Triggering Event Date, the Company shall furnish the
        Agent a certificate executed by the Secretary of the Company, signing in such capacity, dated the date of delivery (i) certifying that attached thereto are true and complete copies of the resolutions duly adopted by the Board of Directors of the
        Company authorizing the execution and delivery of this Agreement and the consummation of the transactions contemplated hereby (including, without limitation, the issuance of the Shares pursuant to this Agreement), which authorization shall be in
        full force and effect on and as of the date of such certificate, (ii) certifying and attesting to the office, incumbency, due authority and specimen signatures of each Person who executed this Agreement for or on behalf of the Company, and (iii)
        containing any other certification that the Agent shall reasonably request; provided, however, that if the Secretary of the Company is unavailable to execute such certificate, the General Counsel or an executive officer of the Company may deliver
        this certificate in such person&#8217;s capacity as General Counsel or executive officer of the Company.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">(s)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Agent&#8217;s Own Account; Clients&#8217; Account</u>.&#160; The Company consents to the Agent trading, in compliance with applicable law, in the Ordinary Shares for the Agent&#8217;s
        own account and for the account of its clients at the same time as sales of the Shares occur pursuant to this Agreement.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">(t)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Investment Limitation</u>.&#160; The Company shall not invest, or otherwise use the proceeds received by the Company from its sale of the Shares in such a manner as
        would require the Company or any of its subsidiaries to register as an investment company under the Investment Company Act.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">(u)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Market Activities</u>.&#160; Neither the Company nor any of its subsidiaries has taken or will take, directly or indirectly, any action designed to or that might be
        reasonably expected to cause or result in stabilization or manipulation of the price of the Ordinary Shares or any other reference security, whether to facilitate the sale or resale of the Shares or otherwise, and the Company will, and shall cause
        each of its affiliates to, comply with all applicable provisions of Regulation M.&#160; If the limitations of Rule 102 of Regulation M (&#8220;<font style="font-weight: bold;">Rule 102</font>&#8221;) do not apply with respect to the Ordinary Shares or any other
        reference security pursuant to any exception set forth in Section (d) of Rule 102, then promptly upon notice from the Agent (or, if later, at the time stated in the notice), the Company will, and shall cause each of its affiliates to, comply with
        Rule 102 as though such exception were not available but the other provisions of Rule 102 (as interpreted by the Commission) did apply. The Company shall promptly notify the Agent if it no longer meets the requirements set forth in Section (d) of
        Rule 102. </div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">(v)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Notice of Other Sale</u>.&#160; Without the written consent of the Agent, the Company will not, directly or indirectly, offer to sell, sell, contract to sell, grant
        any option to sell or otherwise dispose of any Ordinary Shares or securities convertible into or exchangeable for Ordinary Shares (other than Shares hereunder), warrants or any rights to purchase or acquire Ordinary Shares, during the period
        beginning on the third Trading Day immediately prior to the date on which any Issuance Notice is delivered to the Agent hereunder and ending on the third Trading Day immediately following the Settlement Date with respect to Shares sold pursuant to
        such Issuance Notice; and will not directly or indirectly enter into any other &#8220;at the market&#8221; or continuous equity transaction offer to sell, sell, contract to sell, grant any option to sell or otherwise dispose of any Ordinary Shares (other than
        the Shares offered pursuant to this Agreement) or securities convertible into or exchangeable for Ordinary Shares, warrants or any rights to purchase or acquire, Ordinary Shares prior to the termination of this Agreement; provided, however, that
        such restrictions will not be required in connection with the Company&#8217;s (i) issuance or sale of Ordinary Shares, options or other equity awards to purchase or acquire Ordinary Shares or Ordinary Shares issuable upon the exercise of options or other
        equity awards pursuant to any employee or director share option, incentive or benefit plan, share purchase or ownership plan, long-term incentive plan, dividend reinvestment plan, inducement award under Nasdaq rules or other compensation plan of
        the Company or its subsidiaries, (ii) issuance or sale of Ordinary Shares issuable upon exchange, conversion or redemption of securities or the exercise or vesting of warrants, options or other equity awards, (iii) issuance or sale of Ordinary
        Shares or securities convertible or exchangeable for Ordinary Shares as consideration for mergers, acquisitions, other business combinations, joint ventures or strategic alliances occurring after the date of this agreement which are not used for
        capital raising purposes, provided that such issuance or sale shall not exceed 5% of the Ordinary Shares of the Company then outstanding and (iv) modification of any outstanding options, warrants of any rights to purchase or acquire Ordinary
        Shares.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-weight: normal; font-style: normal;">22</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      </div>
      <div style="line-height: 1.25;"><font style="font-weight: bold;">Section 5.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-weight: bold;">&#160; CONDITIONS TO DELIVERY OF ISSUANCE NOTICES AND TO SETTLEMENT</font></div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">(a)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Conditions Precedent to the Right of the Company to Deliver an Issuance Notice and the Obligation of the Agent to Sell Shares</u>.&#160; The right of the Company to
        deliver an Issuance Notice hereunder is subject to the satisfaction, on the date of delivery of such Issuance Notice, and the obligation of the Agent to use its commercially reasonable efforts to place Shares during the applicable period set forth
        in the Issuance Notice is subject to the satisfaction, on each Trading Day during the applicable period set forth in the Issuance Notice, of each of the following conditions:</div>
      <div style="line-height: 1.25">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z893b802e72d94b19a7d79d78fe412609">

          <tr>
            <td style="width: 36pt;"><br>
            </td>
            <td style="width: 36pt; vertical-align: top;">(i)</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div><u>Accuracy of the Company&#8217;s Representations and Warranties; Performance by the Company</u>.&#160; The representations and warranties of the Company contained in this Agreement are true and correct as of the date of the Issuance Notice (other
                than representations and warranties made as of a specific date that shall be true and correct as of such date), and the Company shall have delivered the certificate required to be delivered pursuant to <u>Section 4(o)</u> on or before the
                date on which delivery of such certificate is required pursuant to <u>Section 4(o)</u>. The Company shall have performed, satisfied and complied with all covenants, agreements and conditions required by this Agreement to be performed,
                satisfied or complied with by the Company at or prior to such date, including, but not limited to, the covenants contained in <u>Section 4(p)</u>, <u>Section 4(q)</u> and <u>Section 4(r)</u>.</div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z5993d0b389df4103b6b0a5224069d512">

          <tr>
            <td style="width: 36pt;"><br>
            </td>
            <td style="width: 36pt; vertical-align: top;">(ii)</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div><u>No Injunction</u>.&#160; No statute, rule, regulation, executive order, decree, ruling or injunction shall have been enacted, entered, promulgated or endorsed by any court or governmental authority of competent jurisdiction or any
                self-regulatory organization having authority over the matters contemplated hereby that prohibits or directly and materially adversely affects any of the transactions contemplated by this Agreement, and no proceeding shall have been
                commenced that may have the effect of prohibiting or materially adversely affecting any of the transactions contemplated by this Agreement.</div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zc6776221142a4926ad578b029e3356a5">

          <tr>
            <td style="width: 36pt;"><br>
            </td>
            <td style="width: 36pt; vertical-align: top;">(iii)</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div><u>Material Adverse Effects</u>. Except as disclosed in the Prospectus and the Time of Sale Information, (a) in the judgment of the Agent there shall not have occurred any Material Adverse Effect; and (b) there shall not have occurred
                any downgrading, nor shall any notice have been given of any intended or potential downgrading or of any review for a possible change that does not indicate the direction of the possible change, in the rating accorded any securities of the
                Company or any of its subsidiaries by any &#8220;nationally recognized statistical rating organization&#8221; as such term is defined for purposes of Section 3(a)(62) of the Exchange Act.</div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z4145bf2cc7d5455ba7cb4401c07461f6">

          <tr>
            <td style="width: 36pt;"><br>
            </td>
            <td style="width: 36pt; vertical-align: top;">(iv)</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div><u>No Suspension of Trading in or Delisting of Ordinary Shares; Other Events</u>.&#160; The trading of the Ordinary Shares (including without limitation the Shares) shall not have been suspended by the Commission, the Principal Market or
                FINRA and the Ordinary Shares (including without limitation the Shares) shall have been approved for listing or quotation on and shall not have been delisted from the Nasdaq Stock Market, the New York Stock Exchange or any of their
                constituent markets.&#160; There shall not have occurred (and be continuing in the case of occurrences under clauses&#160;(i) and (ii)&#160;below) any of the following:&#160; (i)&#160;trading or quotation in any of the Company&#8217;s securities shall have been suspended
                or limited by the Commission or by the Principal Market or trading in securities generally on either the Principal Market shall have been suspended or limited, or minimum or maximum prices shall have been generally established on any of
                such stock exchanges by the Commission or the FINRA; (ii)&#160;a general banking moratorium shall have been declared by any of federal, New York or Israeli, authorities or a material disruption in commercial banking or securities settlement or
                there shall have occurred clearance services in the United States or the State of Israel; or (iii) there shall have occurred any outbreak or escalation of national or international hostilities or any crisis or calamity, or any change in the
                United States or international financial markets, or any substantial change or development involving a prospective substantial change in United States&#8217;, Israeli or international political, financial or economic conditions, as in the
                judgment of the Agent is material and adverse and, in the case of both clauses (ii) and (iii), makes it impracticable to market the Shares in the manner and on the terms described in the Prospectus or to enforce contracts for the sale of
                securities.</div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">(b)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Documents Required to be Delivered on each Issuance Notice Date</u>.&#160; The Agent&#8217;s obligation to use its commercially reasonable efforts to place Shares hereunder
        shall additionally be conditioned upon the delivery to the Agent on or before the Issuance Notice Date of a certificate in form and substance reasonably satisfactory to the Agent, executed by the Chief Executive Officer or Chief Financial Officer
        of the Company, to the effect that all conditions to the delivery of such Issuance Notice shall have been satisfied as at the date of such certificate (which certificate shall not be required if the foregoing representations shall be set forth in
        the Issuance Notice).</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">(c)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>No Misstatement or Material Omission</u>. The Agent shall not have advised the Company that the Registration Statement, the Prospectus or the Times of Sales
        Information, or any amendment or supplement thereto, contains an untrue statement of fact that in the Agent&#8217;s reasonable opinion is material, or omits to state a fact that in the Agent&#8217;s reasonable opinion is material and is required to be stated
        therein or is necessary to make the statements therein not misleading.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-weight: normal; font-style: normal;">23</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      </div>
      <div style="line-height: 1.25;"><font style="font-weight: bold;">Section 6.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-weight: bold;">&#160; INDEMNIFICATION AND CONTRIBUTION</font></div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">
        <div style="text-indent: 36pt; line-height: 1.25;">(a)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Indemnification of the Agent</u>.&#160; The Company agrees to indemnify and hold harmless the Agent, its officers and employees, and each person, if any, who controls the Agent within
          the meaning of the Securities Act or the Exchange Act against any loss, claim, damage, liability or expense, as incurred, to which the Agent or such officer, employee or controlling person may become subject, under the Securities Act, the
          Exchange Act, other federal or state statutory law or regulation, or the laws or regulations of foreign jurisdictions where Shares have been offered or sold or at common law or otherwise (including in settlement of any litigation), insofar as
          such loss, claim, damage, liability or expense (or actions in respect thereof as contemplated below) arises out of or is based upon (i)&#160;any untrue statement or alleged untrue statement of a material fact contained in the Registration Statement,
          or any amendment thereto, including any information deemed to be a part thereof pursuant to Rule&#160;430B under the Securities Act, or the omission or alleged omission therefrom of a material fact required to be stated therein or necessary to make
          the statements therein not misleading; or (ii)&#160;any untrue statement or alleged untrue statement of a material fact contained in any Free Writing Prospectus that the Company has used, referred to or filed, or is required to file, pursuant to Rule
          433(d) of the Securities Act or the Prospectus (or any amendment or supplement thereto), or the omission or alleged omission therefrom of a material fact necessary in order to make the statements therein, in the light of the circumstances under
          which they were made, not misleading, and to reimburse the Agent and each such officer, employee and controlling person for any and all expenses (including the fees and disbursements of counsel chosen by the Agent) as such expenses are reasonably
          incurred by the Agent or such officer, employee or controlling person in connection with investigating, defending, settling, compromising or paying any such loss, claim, damage, liability, expense or action; provided, however, that the foregoing
          indemnity agreement shall not apply to any loss, claim, damage, liability or expense to the extent, but only to the extent, arising out of or based upon any untrue statement or alleged untrue statement or omission or alleged omission made in
          reliance upon and in conformity with written information furnished to the Company by the Agent expressly for use in the Registration Statement, any such Free Writing Prospectus or the Prospectus (or any amendment or supplement thereto), it being
          understood and agreed that the only such information furnished by the Agent to the Company consists solely of the ninth paragraph under the caption &#8220;Plan of Distribution&#8221; in the Prospectus.&#160; The indemnity agreement set forth in this <u>Section
            6(a)</u> shall be in addition to any liabilities that the Company may otherwise have.</div>
      </div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">
        <div style="text-indent: 36pt; line-height: 1.25;">(b)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Indemnification of the Company, its Directors and Officers</u>.&#160; The Agent agrees to indemnify and hold harmless the Company, each of its directors, each of its officers who signed
          the Registration Statement and each person, if any, who controls the Company within the meaning of the Securities Act or the Exchange Act against any loss, claim, damage, liability or expense, as incurred, to which the Company or any such
          director, officer or controlling person may become subject, under the Securities Act, the Exchange Act, or other federal or state statutory law or regulation, or the laws or regulations of foreign jurisdictions where Shares have been offered or
          sold or at common law or otherwise (including in settlement of any litigation), arises out of or is based upon (i) any untrue statement or alleged untrue statement of a material fact contained in the Registration Statement, or any amendment
          thereto, including any information deemed to be a part thereof pursuant to Rule 430B under the Securities Act, or the omission or alleged omission therefrom of a material fact required to be stated therein or necessary to make the statements
          therein not misleading; or (ii) any untrue statement or alleged untrue statement of a material fact contained in any Free Writing Prospectus that the Company has used, referred to or filed, or is required to file, pursuant to Rule 433(d) of the
          Securities Act or the Prospectus (or any amendment or supplement thereto), or the omission or alleged omission therefrom of a material fact necessary in order to make the statements therein, in the light of the circumstances under which they were
          made, not misleading; but, for each of (i) and (ii) above, only to the extent arising out of or based upon any untrue statement or alleged untrue statement or omission or alleged omission made in reliance upon and in conformity with written
          information furnished to the Company by the Agent expressly for use in the Registration Statement, any such Free Writing Prospectus or the Prospectus (or any amendment or supplement thereto), it being understood and agreed that the only such
          information furnished by the Agent to the Company consists of the information set forth in the ninth paragraph under the caption &#8220;Plan of Distribution&#8221; in the Prospectus, and to reimburse the Company and each such director, officer and
          controlling person for any and all documented expenses (including the reasonable and documented fees and disbursements of one counsel chosen by the Company) as such expenses are reasonably incurred by the Company or such officer, director or
          controlling person in connection with investigating, defending, settling, compromising or paying any such loss, claim, damage, liability, expense or action. The indemnity agreement set forth in this Section 6(b) shall be in addition to any
          liabilities that the Agent or the Company may otherwise have.</div>
      </div>
      <div style="line-height: 1.25">&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-weight: normal; font-style: normal;">24</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      </div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">(c)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Notifications and Other Indemnification Procedures</u>.&#160; Promptly after receipt by an indemnified party under this <u>Section 6</u> of notice of the commencement
        of any action, such indemnified party will, if a claim in respect thereof is to be made against an indemnifying party under this <u>Section 6</u>, notify the indemnifying party in writing of the commencement thereof, but the omission so to notify
        the indemnifying party will not relieve it from any liability which it may have to any indemnified party for contribution or otherwise than under the indemnity agreement contained in this <u>Section 6</u> or to the extent it is not prejudiced as a
        proximate result of such failure.&#160; In case any such action is brought against any indemnified party and such indemnified party seeks or intends to seek indemnity from an indemnifying party, the indemnifying party will be entitled to participate in,
        and, to the extent that it shall elect, jointly with all other indemnifying parties similarly notified, by written notice delivered to the indemnified party promptly after receiving the aforesaid notice from such indemnified party, to assume the
        defense thereof with counsel reasonably satisfactory to such indemnified party; provided, however, if the defendants in any such action include both the indemnified party and the indemnifying party and the indemnified party shall have reasonably
        concluded that a conflict may arise between the positions of the indemnifying party and the indemnified party in conducting the defense of any such action or that there may be legal defenses available to it and/or other indemnified parties which
        are different from or additional to those available to the indemnifying party, the indemnified party or parties shall have the right to select separate counsel to assume such legal defenses and to otherwise participate in the defense of such action
        on behalf of such indemnified party or parties.&#160; Upon receipt of notice from the indemnifying party to such indemnified party of such indemnifying party&#8217;s election so to assume the defense of such action and approval by the indemnified party of
        counsel, the indemnifying party will not be liable to such indemnified party under this <u>Section 6</u> for any legal or other expenses subsequently incurred by such indemnified party in connection with the defense thereof unless (i)&#160;the
        indemnified party shall have employed separate counsel in accordance with the proviso to the preceding sentence (it being understood, however, that the indemnifying party shall not be liable for the fees and expenses of more than one separate
        counsel (together with local counsel), representing the indemnified parties who are parties to such action), which counsel (together with any local counsel) for the indemnified parties shall be selected by the Agent (in the case of counsel for the
        indemnified parties referred to in <u>Section 6(a)</u><font style="font-weight: bold;">&#160;</font>and <u>Section 6(b)</u><font style="font-weight: bold;">&#160;</font>above), (ii)&#160;the indemnifying party shall not have employed counsel satisfactory to the
        indemnified party to represent the indemnified party within a reasonable time after notice of commencement of the action or (iii) the indemnifying party has authorized in writing the employment of counsel for the indemnified party at the expense of
        the indemnifying party, in each of which cases the fees and expenses of counsel shall be at the expense of the indemnifying party and shall be paid as they are incurred.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">(d)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Settlements</u>.&#160; The indemnifying party under this <u>Section 6</u> shall not be liable for any settlement of any proceeding effected without its written
        consent, but if settled with such consent or if there be a final judgment for the plaintiff, the indemnifying party agrees to indemnify the indemnified party against any loss, claim, damage, liability or expense by reason of such settlement or
        judgment.&#160; Notwithstanding the foregoing sentence, if at any time an indemnified party shall have requested an indemnifying party to reimburse the indemnified party for fees and expenses of counsel as contemplated by Section 6(c) hereof, the
        indemnifying party agrees that it shall be liable for any settlement of any proceeding effected without its written consent if (i) such settlement is entered into more than 30 days after receipt by such indemnifying party of the aforesaid request;
        and (ii) such indemnifying party shall not have reimbursed the indemnified party in accordance with such request prior to the date of such settlement.&#160; No indemnifying party shall, without the prior written consent of the indemnified party, effect
        any settlement, compromise or consent to the entry of judgment in any pending or threatened action, suit or proceeding in respect of which any indemnified party is or could have been a party and indemnity was or could have been sought hereunder by
        such indemnified party, unless such settlement, compromise or consent includes an unconditional release of such indemnified party from all liability on claims that are the subject matter of such action, suit or proceeding.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-weight: normal; font-style: normal;">25</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      </div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">(e)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Contribution</u>.&#160; If the indemnification provided for in this <u>Section 6</u> is for any reason held to be unavailable to or otherwise insufficient to hold
        harmless an indemnified party in respect of any losses, claims, damages, liabilities or expenses referred to therein, then each indemnifying party shall contribute to the aggregate amount paid or payable by such indemnified party, as incurred, as a
        result of any losses, claims, damages, liabilities or expenses referred to therein (i)&#160;in such proportion as is appropriate to reflect the relative benefits received by the Company, on the one hand, and the Agent, on the other hand, from the
        offering of the Shares pursuant to this Agreement; or (ii)&#160;if the allocation provided by clause&#160;(i) above is not permitted by applicable law, in such proportion as is appropriate to reflect not only the relative benefits referred to in clause&#160;(i)
        above but also the relative fault of the Company, on the one hand, and the Agent, on the other hand, in connection with the statements or omissions which resulted in such losses, claims, damages, liabilities or expenses, as well as any other
        relevant equitable considerations.&#160; The relative benefits received by the Company, on the one hand, and the Agent, on the other hand, in connection with the offering of the Shares pursuant to this Agreement shall be deemed to be in the same
        respective proportions as the total gross proceeds from the offering of the Shares (before deducting expenses) received by the Company bear to the total commissions received by the Agent.&#160; The relative fault of the Company, on the one hand, and the
        Agent, on the other hand, shall be determined by reference to, among other things, whether any such untrue or alleged untrue statement of a material fact or omission or alleged omission to state a material fact relates to information supplied by
        the Company, on the one hand, or the Agent, on the other hand, and the parties&#8217; relative intent, knowledge, access to information and opportunity to correct or prevent such statement or omission.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">The amount paid or payable by a party as a result of the losses, claims, damages, liabilities and expenses referred to above shall be deemed to include, subject to the
        limitations set forth in <u>Section 6(c)</u>, any legal or other fees or expenses reasonably incurred by such party in connection with investigating or defending any action or claim.&#160; The provisions set forth in <u>Section 6(c)</u> with respect
        to notice of commencement of any action shall apply if a claim for contribution is to be made under this <u>Section 6(e)</u>; <font style="font-style: italic;">provided, however,</font> that no additional notice shall be required with respect to
        any action for which notice has been given under <u>Section 6(c)</u> for purposes of indemnification.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">The Company and the Agent agree that it would not be just and equitable if contribution pursuant to this <u>Section 6(e)</u> were determined by pro rata allocation or by any
        other method of allocation which does not take account of the equitable considerations referred to in this <u>Section 6(e)</u>.</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">Notwithstanding the provisions of this <u>Section 6(e)</u>, the Agent shall not be required to contribute any amount in excess of the agent fees received by the Agent in
        connection with the offering contemplated hereby.&#160; No person guilty of fraudulent misrepresentation (within the meaning of Section&#160;11(f) of the Securities Act) shall be entitled to contribution from any person who was not guilty of such fraudulent
        misrepresentation.&#160; For purposes of this <u>Section 6(e)</u>, each officer and employee of the Agent and each person, if any, who controls the Agent within the meaning of the Securities Act or the Exchange Act shall have the same rights to
        contribution as the Agent, and each director of the Company, each officer of the Company who signed the Registration Statement, and each person, if any, who controls the Company within the meaning of the Securities Act and the Exchange Act shall
        have the same rights to contribution as the Company.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-weight: normal; font-style: normal;">26</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      </div>
      <div style="line-height: 1.25;"><font style="font-weight: bold;">Section 7.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-weight: bold;">&#160; TERMINATION &amp; SURVIVAL</font></div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">(a)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Term</u>.&#160; Subject to the provisions of this <u>Section 7</u>, the term of this Agreement shall continue from the date of this Agreement until the end of the
        Agency Period, unless earlier terminated by the parties to this Agreement pursuant to this <u>Section 7</u>.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">(b)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Termination; Survival Following Termination</u>.</div>
      <div style="line-height: 1.25">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z5c1a1b092b324803bc92e1434c1ff818">

          <tr>
            <td style="width: 54pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top;">(i)</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>Either party may terminate this Agreement prior to the end of the Agency Period, by giving written notice as required by this Agreement, upon ten (10) Trading Days&#8217; notice to the other party; provided that, (A) if the Company terminates
                this Agreement after the Agent confirms to the Company any sale of Shares, the Company shall remain obligated to comply with <u>Section 3(b)(v)</u> with respect to such Shares and (B) <u>Section 2</u>, <u>Section 6</u>, <u>Section 7</u>
                and <u>Section 8</u> shall survive termination of this Agreement.&#160; If termination shall occur prior to the Settlement Date for any sale of Shares, such sale shall nevertheless settle in accordance with the terms of this Agreement.</div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25">&#160;</div>
      <div>
        <table cellspacing="0" cellpadding="0" class="DSPFListTable" id="z18e1c11573ab4d51a43c0c9c7e847ef5" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%;">

            <tr style="vertical-align: top;">
              <td style="width: 54pt;">&#160;</td>
              <td style="text-align: right; vertical-align: top; width: 18pt;">
                <div style="text-align: justify; line-height: 1.25;">(ii)</div>
              </td>
              <td style="text-align: left; vertical-align: top; width: auto;">
                <div style="text-align: justify; line-height: 1.25;">In addition to the survival provision of <u>Section 7(b)(i)</u>, the respective indemnities, agreements, representations, warranties and other statements of the Company, of its officers
                  and of the Agent set forth in or made pursuant to this Agreement will remain in full force and effect, regardless of any investigation made by or on behalf of the Agent or the Company or any of its or their partners, officers or directors
                  or any controlling person, as the case may be, and, anything herein to the contrary notwithstanding, will survive delivery of and payment for the Shares sold hereunder and any termination of this Agreement.</div>
              </td>
            </tr>

        </table>
      </div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="line-height: 1.25;"><font style="font-weight: bold;">Section 8.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-weight: bold;">&#160; MISCELLANEOUS</font></div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">(a)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Press Releases and Disclosure</u>.&#160; The Company may issue a press release describing the material terms of the transactions contemplated hereby as soon as
        practicable following the date of this Agreement, and will file with the Commission a report on Form&#160;6&#8209;K, with this Agreement attached as an exhibit thereto, describing the material terms of the transactions contemplated hereby, and the Company
        shall consult with the Agent prior to making such disclosures, and the parties hereto shall use all commercially reasonable efforts, acting in good faith, to agree upon a text for such disclosures that is reasonably satisfactory to all parties
        hereto. No party hereto shall issue thereafter any press release or like public statement (including, without limitation, any disclosure required in reports filed with the Commission pursuant to the Exchange Act) related to this Agreement or any of
        the transactions contemplated hereby without the prior written approval of the other party hereto, except as may be necessary or appropriate in the reasonable opinion of the party seeking to make disclosure to comply with the requirements of
        applicable law or stock exchange rules. If any such press release or like public statement is required, the party making such disclosure shall consult with the other party prior to making such disclosure, and the parties shall use all commercially
        reasonable efforts, acting in good faith, to agree upon a text for such disclosure that is reasonably satisfactory to all parties hereto.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-weight: normal; font-style: normal;">27</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      </div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">(b)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>No Advisory or Fiduciary Relationship</u>.<font style="font-weight: bold;">&#160; </font>The Company acknowledges and agrees that (i) the transactions contemplated by
        this Agreement, including the determination of any fees, are arm&#8217;s-length commercial transactions between the Company and the Agent, (ii) when acting as a principal under this Agreement, the Agent is and has been acting solely as a principal is not
        the agent or fiduciary of the Company, or its shareholders, creditors, employees or any other party, (iii) the Agent has not assumed nor will assume an advisory or fiduciary responsibility in favor of the Company with respect to the transactions
        contemplated hereby or the process leading thereto (irrespective of whether the Agent has advised or is currently advising the Company on other matters) and the Agent does not have any obligation to the Company with respect to the transactions
        contemplated hereby except the obligations expressly set forth in this Agreement, (iv) the Agent and its respective affiliates may be engaged in a broad range of transactions that involve interests that differ from those of the Company, and (v) the
        Agent has not provided any legal, accounting, regulatory or tax advice with respect to the transactions contemplated hereby and the Company has consulted its own legal, accounting, regulatory and tax advisors to the extent it deemed appropriate.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">(c)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Research Analyst Independence</u>.&#160; The Company acknowledges that the Agent&#8217;s research analysts and research departments are required to and should be independent
        from their respective investment banking divisions and are subject to certain regulations and internal policies, and as such the Agent&#8217;s research analysts may hold views and make statements or investment recommendations and/or publish research
        reports with respect to the Company or the offering that differ from the views of their respective investment banking divisions.&#160; The Company understands that the Agent is a full service securities firm and as such from time to time, subject to
        applicable securities laws, may effect transactions for its own account or the account of its customers and hold long or short positions in debt or equity securities of the companies that may be the subject of the transactions contemplated by this
        Agreement.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">(d)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Notices</u>.&#160; All communications hereunder shall be in writing and shall be mailed, emailed, hand delivered or telecopied and confirmed to the parties hereto as
        follows:</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-indent: -36pt; margin-left: 54pt; line-height: 1.25;">If to the Agent:</div>
      <div style="text-indent: -36pt; margin-left: 54pt; line-height: 1.25;"><br>
        Jefferies LLC<br>
        520 Madison Avenue<br>
        New&#160;York, NY 10022<br>
        Attention:&#160; General Counsel</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-indent: -36pt; margin-left: 54pt; line-height: 1.25;">with a copy (which shall not constitute notice) to:</div>
      <div style="text-indent: -36pt; margin-left: 54pt; line-height: 1.25;"><br>
        Skadden, Arps, Slate, Meagher &amp; Flom LLP</div>
      <div style="margin-left: 54pt; line-height: 1.25;">One Manhattan West</div>
      <div style="margin-left: 54pt; line-height: 1.25;">New York, New York 10001</div>
      <div style="margin-left: 54pt; line-height: 1.25;">Attention: David Goldschmidt</div>
      <div style="margin-left: 54pt; line-height: 1.25;">Email: david.goldschmidt@skadden.com<br>
        <br style="line-height: 1.25;">
      </div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-weight: normal; font-style: normal;">28</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      </div>
      <div style="text-indent: -36pt; margin-left: 54pt; line-height: 1.25;">If to the Company:<br>
        <br style="line-height: 1.25;">
      </div>
      <div style="text-indent: 0pt; margin-left: 54pt; line-height: 1.25;">Innoviz Technologies Ltd.</div>
      <div style="margin-left: 54pt; line-height: 1.25;">5 Uri Ariav Street, Building C</div>
      <div style="margin-left: 54pt; line-height: 1.25;">Rosh HaAin, Israel</div>
      <div style="margin-left: 54pt; line-height: 1.25;">Attention: Eldar Cegla, CFO<br>
        Email: <u>eldarc@innoviz-tech.com</u></div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-indent: -36pt; margin-left: 54pt; line-height: 1.25;">with a copy (which shall not constitute notice) to:</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="margin-left: 54pt; line-height: 1.25;">Latham &amp; Watkins LLP<br>
        811 Main Street, Suite 3700</div>
      <div style="text-indent: 0pt; margin-left: 54pt; line-height: 1.25;">Houston, Texas 77009</div>
      <div style="margin-left: 54pt; line-height: 1.25;">Attention: Ryan Lynch</div>
      <div style="margin-left: 54pt; line-height: 1.25;">Email: ryan.lynch@lw.com</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="margin-left: 54pt; line-height: 1.25;">Latham &amp; Watkins LLP</div>
      <div style="margin-left: 54pt; line-height: 1.25;">99 Bishopsgate</div>
      <div style="margin-left: 54pt; line-height: 1.25;">London EC2M 3XF</div>
      <div style="margin-left: 54pt; line-height: 1.25;">United Kingdom</div>
      <div style="margin-left: 54pt; line-height: 1.25;">Attention: Joshua Kiernan</div>
      <div style="margin-left: 54pt; line-height: 1.25;">E-mail: joshua.kiernan@lw.com</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="margin-left: 54pt; line-height: 1.25;">and</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="margin-left: 54pt; line-height: 1.25;">Naschitz, Brandes, Amir &amp; Co.</div>
      <div style="margin-left: 54pt; line-height: 1.25;">5 Tuval Street</div>
      <div style="margin-left: 54pt; line-height: 1.25;">Tel Aviv, Israel 6789717</div>
      <div style="margin-left: 54pt; line-height: 1.25;">Email: tgeffen@nblaw.com</div>
      <div style="margin-left: 54pt; line-height: 1.25;">Attention: Tuvia Geffen<br>
        <br style="line-height: 1.25;">
      </div>
      <div style="text-align: justify; line-height: 1.25;">Any party hereto may change the address for receipt of communications by giving written notice to the others in accordance with this <u>Section 8(d)</u>.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">(e)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Successors</u>.&#160; This Agreement will inure to the benefit of and be binding upon the parties hereto, and to the benefit of the employees, officers and directors
        and controlling persons referred to in <u>Section 6</u>, and in each case their respective successors, and no other person will have any right or obligation hereunder.&#160; The term &#8220;successors&#8221; shall not include any purchaser of the Shares as such
        from the Agent merely by reason of such purchase.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">(f)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Partial Unenforceability</u>.&#160; The invalidity or unenforceability of any Article, Section, paragraph or provision of this Agreement shall not affect the validity
        or enforceability of any other Article, Section, paragraph or provision hereof.&#160; If any Article, Section, paragraph or provision of this Agreement is for any reason determined to be invalid or unenforceable, there shall be deemed to be made such
        minor changes (and only such minor changes) as are necessary to make it valid and enforceable.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-weight: normal; font-style: normal;">29</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      </div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">(g)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Governing Law Provisions</u>.&#160; This Agreement shall be governed by and construed in accordance with the internal laws of the State of New York applicable to
        agreements made and to be performed in such state.&#160; Any legal suit, action or proceeding arising out of or based upon this Agreement or the transactions contemplated hereby (&#8220;<font style="font-weight: bold;">Related Proceedings</font>&#8221;) may be
        instituted in the federal courts of the United States of America located in the Borough of Manhattan in the City of New York or the courts of the State of New York in each case located in the Borough of Manhattan in the City of New York
        (collectively, the &#8220;<font style="font-weight: bold;">Specified Courts</font>&#8221;), and each party irrevocably submits to the exclusive jurisdiction (except for proceedings instituted in regard to the enforcement of a judgment of any such court (a &#8220;<font style="font-weight: bold;">Related Judgment</font>&#8221;), as to which such jurisdiction is non-exclusive) of such courts in any such suit, action or proceeding.&#160; The Company irrevocably appoints Cogency Global Inc. as its authorized agent upon which
        process may be served in any such suit or proceeding, and agrees that service of process upon such agent shall be deemed in every respect effective service of process upon the Company in any such suit or proceeding. The Company further agrees to
        take any and all actions as may be necessary to maintain such designation and appointment of such agent in full force and effect for a period of no less than seven years from the date of this Agreement. The parties irrevocably and unconditionally
        waive any objection to the laying of venue of any suit, action or other proceeding in the Specified Courts and irrevocably and unconditionally waive and agree not to plead or claim in any such court that any such suit, action or other proceeding
        brought in any such court has been brought in an inconvenient forum.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">(h)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Immunity</u>.&#160; To the extent that the Company has or hereafter may acquire any immunity (sovereign or otherwise) from jurisdiction of any court of (i) the State
        of Israel, or any political subdivision thereof, (ii) the United States or the State of New York, (iii) any jurisdiction in which it owns or leases property or assets or from any legal process (whether through service of notice, attachment prior to
        judgment, attachment in aid of execution, execution, set-off or otherwise) with respect to it or its respective property and assets or this Agreement, the Company hereby irrevocably waives such immunity in respect of its obligations under this
        Agreement to the fullest extent permitted by applicable law.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">(i)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Electronic Signature</u>.&#160; This Agreement may be executed by any one or more of the parties hereto in any number of counterparts, each of which shall be deemed to
        be an original, but all such counterparts shall together constitute one and the same instrument. Counterparts may be delivered via electronic mail (including any electronic signature covered by the U.S. federal ESIGN Act of 2000, Uniform Electronic
        Transactions Act, the Electronic Signatures and Records Act or other applicable law, e.g., www.docusign.com) or other transmission method and any counterpart so delivered shall be deemed to have been duly and validly delivered and be valid and
        effective for all purposes.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">(j)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Judgment Currency</u>. The obligations of the Company pursuant to this Agreement in respect of any sum due to the Agent shall, notwithstanding any judgment in a
        currency other than U.S. dollars, not be discharged until the first business day, following receipt by the Agent of any sum adjudged to be so due in such other currency, on which (and only to the extent that) the Agent may in accordance with normal
        banking procedures purchase U.S. dollars with such other currency; if the U.S. dollars so purchased are less than the sum originally due to the Agent hereunder, the Company agrees, as a separate obligation and notwithstanding any such judgment, to
        indemnify the Agent against such loss.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-weight: normal; font-style: normal;">30</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      </div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">(k)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Payments</u>. All payments made or deemed to be made by or on behalf of the Company to the Agent under this Agreement shall be made without withholding or
        deduction for or on account of any present or future taxes, duties, assessments or governmental charges of whatsoever nature imposed or levied by or on behalf of the State of Israel or any political subdivision or any taxing authority thereof or
        therein or of any other jurisdiction in which the Company is organized or incorporated, engaged in business for tax purposes or is otherwise resident for tax purposes or has a permanent establishment, any jurisdiction from or through which a
        payment is made by or on behalf of the Company, or any political subdivision, authority or agency in or of any of the foregoing having power to tax, unless the Company is or becomes required by law to withhold or deduct such taxes, duties,
        assessments or governmental charges. In such event, the Company will pay such additional amounts which will result, after such withholding or deduction, in the receipt by the Agent, of the amounts that would otherwise have been received had such
        deduction or withholding not been required; provided, that the Company shall not be required to pay such additional amounts to the extent that such tax, duty, assessment, government charge, deduction or other withholding was imposed due to the
        Agent having any present or former connection with the jurisdiction imposing such tax, duty, deduction or other withholding, other than solely as a result of the execution and delivery of, or performance of, its obligations under this Agreement or
        receipt of any payments or enforcement of rights hereunder. If requested by the Company, the Agent shall reasonably cooperate with the Company, by providing reasonably required information for the Company to obtain an exemption certificate from
        withholding or deduction in connection with the payments under this Agreement, if any. All sums payable, paid or deemed payable under this Agreement shall be considered exclusive of value added tax, sales tax or other similar taxes which, to the
        extent payable, shall be borne by, paid, collected and remitted by the Company in accordance with applicable law.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">(l)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>General Provisions</u>.&#160; This Agreement constitutes the entire agreement of the parties to this Agreement and supersedes all prior written or oral and all
        contemporaneous oral agreements, understandings and negotiations with respect to the subject matter hereof.&#160; This Agreement may be executed in two or more counterparts, each one of which shall be an original, with the same effect as if the
        signatures thereto and hereto were upon the same instrument, and may be delivered by facsimile transmission or by electronic delivery of a portable document format (PDF) file.&#160; This Agreement may not be amended or modified unless in writing by all
        of the parties hereto, and no condition herein (express or implied) may be waived unless waived in writing by each party whom the condition is meant to benefit.&#160; The Article and Section headings herein are for the convenience of the parties only
        and shall not affect the construction or interpretation of this Agreement.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: center; line-height: 1.25; font-style: italic;">[Signature Page Immediately Follows]</div>
      <div class="BRPFPageHeader">
        <div style="line-height: 1.25">&#160;</div>
        <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
          <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-weight: normal; font-style: normal;">31</font></div>
          <div class="BRPFPageBreak" style="page-break-after: always;">
            <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
        </div>
      </div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">If the foregoing is in accordance with your understanding of our agreement, kindly sign and return to the Company the enclosed copies hereof, whereupon this instrument, along
        with all counterparts hereof, shall become a binding agreement in accordance with its terms</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="line-height: 1.25;">
        <table cellspacing="0" cellpadding="0" border="0" style="width: 100%; border-collapse: separate; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">

            <tr>
              <td valign="top" rowspan="1" style="width: 50%;">&#160;</td>
              <td valign="top" rowspan="1" colspan="2" style="width: 38%; font-weight: normal;">
                <div>Very truly yours,</div>
                <div> <br>
                </div>
              </td>
              <td valign="top" rowspan="1" style="width: 12%;">&#160;</td>
            </tr>
            <tr>
              <td valign="top" style="width: 50%;">&#160;</td>
              <td valign="top" colspan="2" style="width: 38%; font-weight: bold;">INNOVIZ TECHNOLOGIES LTD.</td>
              <td valign="top" style="width: 12%;">&#160;</td>
            </tr>
            <tr>
              <td valign="top" style="width: 50%;"><br>
              </td>
              <td valign="top" style="width: 3%;">&#160;</td>
              <td valign="top" style="width: 35%;">&#160;</td>
              <td valign="top" style="width: 12%;">&#160;</td>
            </tr>
            <tr>
              <td valign="top" align="left" style="width: 50%; padding-bottom: 2px;"><br>
              </td>
              <td valign="top" style="width: 3%; padding-bottom: 2px;">
                <div align="left" style="margin-left: 0pt; text-indent: 0pt; margin-right: 0pt">By: </div>
              </td>
              <td valign="top" nowrap="nowrap" align="left" style="width: 35%; border-bottom: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">/s/ Eldar Cegla</div>
              </td>
              <td valign="top" style="width: 12%; padding-bottom: 2px;">&#160;</td>
            </tr>
            <tr>
              <td valign="top" style="width: 50%;"><br>
              </td>
              <td valign="top" style="width: 3%;">&#160;</td>
              <td valign="bottom" nowrap="nowrap" align="left" style="width: 35%;">Name: Eldar Cegla</td>
              <td valign="top" style="width: 12%;">&#160;</td>
            </tr>
            <tr>
              <td valign="top" style="width: 50%;">&#160;</td>
              <td valign="top" style="width: 3%;">&#160;</td>
              <td valign="top" style="width: 35%;">Title:&#160;&#160; CFO<br>
              </td>
              <td valign="top" style="width: 12%;">&#160;</td>
            </tr>

        </table>
      </div>
      <div style="line-height: 1.25; font-weight: 400; font-family: 'Times New Roman',Times,serif;"><br>
      </div>
      <div style="line-height: 1.25; font-weight: 400; font-family: 'Times New Roman',Times,serif;">
        <table cellspacing="0" cellpadding="0" border="0" style="width: 100%; border-collapse: separate; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">

            <tr>
              <td valign="top" align="left" style="width: 50%; padding-bottom: 2px;"><br>
              </td>
              <td valign="top" style="width: 3%; padding-bottom: 2px;">
                <div align="left" style="margin-left: 0pt; text-indent: 0pt; margin-right: 0pt">By: </div>
              </td>
              <td valign="top" nowrap="nowrap" align="left" style="width: 35%; border-bottom: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">
                  <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">/s/ Omer Kelif</div>
                </div>
              </td>
              <td valign="top" style="width: 12%; padding-bottom: 2px;">&#160;</td>
            </tr>
            <tr>
              <td valign="top" style="width: 50%;"><br>
              </td>
              <td valign="top" style="width: 3%;">&#160;</td>
              <td valign="bottom" nowrap="nowrap" align="left" style="width: 35%;">Name: Omer Kelif</td>
              <td valign="top" style="width: 12%;">&#160;</td>
            </tr>
            <tr>
              <td valign="top" style="width: 50%;">&#160;</td>
              <td valign="top" style="width: 3%;">&#160;</td>
              <td valign="top" style="width: 35%;">Title:&#160;&#160; CEO<br>
              </td>
              <td valign="top" style="width: 12%;">&#160;</td>
            </tr>

        </table>
      </div>
      <div style="line-height: 1.25; font-weight: 400; font-family: 'Times New Roman',Times,serif;"><br>
      </div>
      <div style="text-indent: 36pt; line-height: 1.25;">The foregoing Agreement is hereby confirmed and accepted by the Agent in New York, New York as of the date first above written.</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="line-height: 1.25; font-weight: bold;">JEFFERIES LLC</div>
      <div style="line-height: 1.25;">
        <table cellspacing="0" cellpadding="0" border="0" style="width: 100%; border-collapse: separate; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">

            <tr>
              <td valign="top" style="width: 3%;">&#160;</td>
              <td valign="top" style="width: 35%;">&#160;</td>
              <td valign="top" style="width: 62%;">&#160;</td>
            </tr>
            <tr>
              <td valign="top" style="width: 3%; padding-bottom: 2px;">
                <div align="left" style="margin-left: 0pt; text-indent: 0pt; margin-right: 0pt">By: </div>
              </td>
              <td valign="top" nowrap="nowrap" align="left" style="width: 35%; border-bottom: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left; line-height: 1.25;">/s/ Michael Magarro</div>
              </td>
              <td valign="top" style="width: 62%; padding-bottom: 2px;">&#160;</td>
            </tr>
            <tr>
              <td valign="top" style="width: 3%;">&#160;</td>
              <td valign="bottom" nowrap="nowrap" align="left" style="width: 35%;">Name: Michael Magarro</td>
              <td valign="top" style="width: 62%;">&#160;</td>
            </tr>
            <tr>
              <td valign="top" style="width: 3%;">&#160;</td>
              <td valign="top" style="width: 35%;">Title:&#160;&#160; Managing Director</td>
              <td valign="top" style="width: 62%;">&#160;</td>
            </tr>

        </table>
      </div>
    </div>
    <br>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <!--PROfilePageNumberReset%Num%1%A - %%-->
    <div>
      <div style="text-align: center; line-height: 1.25; font-weight: bold;">EXHIBIT A</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: center; line-height: 1.25;">ISSUANCE NOTICE</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="line-height: 1.25;">[Date]</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="line-height: 1.25;">Jefferies LLC</div>
      <div style="line-height: 1.25;">520 Madison Avenue</div>
      <div style="line-height: 1.25;">New York, New York 10022</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="line-height: 1.25;">Attn: [__________]</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: justify; line-height: 1.25;">Reference is made to the Open Market Sale Agreement between Innoviz Technologies Ltd. (the &#8220;<font style="font-weight: bold;">Company</font>&#8221;) and Jefferies LLC (the &#8220;<font style="font-weight: bold;">Agent</font>&#8221;) dated as of August 13, 2025.&#160; The Company confirms that all conditions to the delivery of this Issuance Notice are satisfied as of the date hereof.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="line-height: 1.25;">Date of Delivery of Issuance Notice (determined pursuant to <u>Section 3(b)(i)</u>): _______________________</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="line-height: 1.25;">Issuance Amount (equal to the total Sales Price for such Shares):</div>
      <div style="line-height: 1.25"><br>
      </div>
      <div style="line-height: 1.25">
        <table cellspacing="0" cellpadding="0" border="0" id="za8f646259356449fa96538a3418ded17" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; color: #000000; width: 100%;">

            <tr>
              <td rowspan="1" style="width: 25%; padding-bottom: 2px; text-align: right;">&#160;$</td>
              <td rowspan="1" style="width: 20%; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
              <td rowspan="1" style="width: 55%; padding-bottom: 2px;">&#160;</td>
            </tr>
            <tr>
              <td rowspan="1" style="width: 25%;">&#160;</td>
              <td rowspan="1" style="width: 20%;">&#160;</td>
              <td rowspan="1" style="width: 55%;">&#160;</td>
            </tr>
            <tr>
              <td style="width: 25%; padding-bottom: 2px;">Number of days in selling period:&#160; <br>
              </td>
              <td style="width: 20%; border-bottom: 2px solid rgb(0, 0, 0);"><br>
              </td>
              <td style="width: 55%; padding-bottom: 2px;"><br>
              </td>
            </tr>
            <tr>
              <td style="width: 25%;"><br>
              </td>
              <td style="width: 20%;"><br>
              </td>
              <td style="width: 55%;"><br>
              </td>
            </tr>
            <tr>
              <td style="width: 25%; padding-bottom: 2px;">First date of selling period:&#160;&#160;&#160;&#160; <br>
              </td>
              <td style="width: 20%; border-bottom: 2px solid rgb(0, 0, 0);"><br>
              </td>
              <td style="width: 55%; padding-bottom: 2px;"><br>
              </td>
            </tr>
            <tr>
              <td style="width: 25%;"><br>
              </td>
              <td style="width: 20%;"><br>
              </td>
              <td style="width: 55%;"><br>
              </td>
            </tr>
            <tr>
              <td style="width: 25%; padding-bottom: 2px;">Last date of selling period: <br>
              </td>
              <td style="width: 20%; border-bottom: 2px solid rgb(0, 0, 0);"><br>
              </td>
              <td style="width: 55%; padding-bottom: 2px;"><br>
              </td>
            </tr>
            <tr>
              <td style="width: 25%;"><br>
              </td>
              <td style="width: 20%;"><br>
              </td>
              <td style="width: 55%;"><br>
              </td>
            </tr>
            <tr>
              <td style="width: 25%; padding-bottom: 2px;">Settlement Date(s) if other than standard T+1 settlement:</td>
              <td style="width: 20%; border-bottom: 2px solid rgb(0, 0, 0);"><br>
              </td>
              <td style="width: 55%; padding-bottom: 2px;"><br>
              </td>
            </tr>

        </table>
      </div>
      <br>
      <div style="text-align: justify; line-height: 1.25;">Floor Price Limitation (in no event less than $0.50 without the prior written consent of the Agent, which consent may be withheld in the Agent&#8217;s sole discretion): $ ____ per share</div>
      <div style="line-height: 1.25">&#160;
        <table cellspacing="0" cellpadding="0" border="0" id="zba735b5349a54347b270f7cddc79c448" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; color: #000000; width: 100%;">

            <tr>
              <td style="width: 7%; padding-bottom: 2px;">Comments: </td>
              <td style="width: 93%; border-bottom: 2px solid rgb(0, 0, 0);"><br>
              </td>
            </tr>

        </table>
      </div>
      <div style="line-height: 1.25">&#160;
        <table cellspacing="0" cellpadding="0" border="0" style="width: 100%; border-collapse: separate; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">

            <tr>
              <td valign="top" align="left" style="width: 50%; padding-bottom: 2px;"><br>
              </td>
              <td valign="top" style="width: 3%; padding-bottom: 2px;">
                <div align="left" style="margin-left: 0pt; text-indent: 0pt; margin-right: 0pt">By: </div>
              </td>
              <td valign="top" nowrap="nowrap" align="left" style="width: 35%; border-bottom: #000000 2px solid"><br>
              </td>
              <td valign="top" style="width: 12%; padding-bottom: 2px;">&#160;</td>
            </tr>
            <tr>
              <td valign="top" style="width: 50%;"><br>
              </td>
              <td valign="top" style="width: 3%;">&#160;</td>
              <td valign="bottom" nowrap="nowrap" align="left" style="width: 35%;">Name:</td>
              <td valign="top" style="width: 12%;">&#160;</td>
            </tr>
            <tr>
              <td valign="top" style="width: 50%;">&#160;</td>
              <td valign="top" style="width: 3%;">&#160;</td>
              <td valign="top" style="width: 35%;">Title:</td>
              <td valign="top" style="width: 12%;">&#160;</td>
            </tr>

        </table>
      </div>
    </div>
    <br>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-weight: normal; font-style: normal;">A - 1</font></div>
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div>
      <div style="text-align: center; line-height: 1.25; font-weight: bold;">Schedule A</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: center; line-height: 1.25; font-weight: bold;">Notice Parties</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="line-height: 1.25;"><u>The Company</u></div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="line-height: 1.25;">Omer David Keilaf<br>
        Eldar Cegla<br>
        Dana Nutkevitch</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="line-height: 1.25;"><u>The Agent</u></div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="line-height: 1.25;">Becky Steinthal<br>
        Michael Magarro</div>
      <div style="line-height: 1.25">&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      </div>
      <div style="text-align: center; line-height: 1.25; font-weight: bold;">ENDNOTES</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="line-height: 1.25; text-align: center;">B-2<br style="line-height: 1.25;">
      </div>
      <div style="line-height: 1.25;">
        <hr align="center" style="border: none; border-bottom: 4px solid black; border-top: 1px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;"> </div>
    </div>
  </div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.1
<SEQUENCE>3
<FILENAME>exhibit_4-1.htm
<DESCRIPTION>EXHIBIT 4.1
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: zk-global
         Document created using Broadridge PROfile 25.5.1.5318
         Copyright 1995 - 2025 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left; color: #000000;">
  <div>
    <hr align="center" style="border: none; border-bottom: 1px solid black; border-top: 4px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;">
    <div style="text-align: right;"><u><font style="font-weight: bold;">Exhibit 4.1</font></u><br>
    </div>
    <div> <br>
    </div>
    <div>
      <div style="text-align: center; line-height: 1.25; font-weight: bold;">INNOVIZ TECHNOLOGIES LTD.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: center; line-height: 1.25; font-weight: bold;"><u>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</u></div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: center; line-height: 1.25; font-weight: bold;">INDENTURE</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: center; line-height: 1.25;">Dated as of ___________, 20___</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: center; line-height: 1.25; font-weight: bold;"><u>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</u></div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: center; line-height: 1.25; font-weight: bold;">[_________]</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: center; line-height: 1.25;">Trustee</div>
      <div style="line-height: 1.25;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <br style="line-height: 1.25;">
      </div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: center; line-height: 1.25; font-variant: small-caps; font-weight: bold;">TABLE OF CONTENTS</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: right; line-height: 1.25;"><u>Page</u></div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="line-height: 1.25">
        <table cellspacing="0" cellpadding="0" border="0" id="z9709c53b21154a83996a9783b2b7b32e" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

            <tr>
              <td style="vertical-align: top;" rowspan="1" colspan="2">
                <div style="line-height: 1.25;"><a href="#ARTICLEI.">ARTICLE I. DEFINITIONS AND INCORPORATION BY REFERENCE</a></div>
              </td>
              <td style="width: 5%; vertical-align: top;">
                <div style="text-align: right; line-height: 1.25;">1</div>
              </td>
            </tr>
            <tr>
              <td style="width: 13%; vertical-align: top;">
                <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif; margin-left: 27pt;">Section 1.1.&#160;</div>
              </td>
              <td style="width: 82%; vertical-align: top;">
                <div style="line-height: 1.25;">Definitions.</div>
              </td>
              <td style="width: 5%; vertical-align: top;">
                <div style="text-align: right; line-height: 1.25;">1</div>
              </td>
            </tr>
            <tr>
              <td style="width: 13%; vertical-align: top;">
                <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif; margin-left: 27pt;">Section 1.2.&#160;</div>
              </td>
              <td style="width: 82%; vertical-align: top;">
                <div style="line-height: 1.25;">Other Definitions.</div>
              </td>
              <td style="width: 5%; vertical-align: top;">
                <div style="text-align: right; line-height: 1.25;">4</div>
              </td>
            </tr>
            <tr>
              <td style="width: 13%; vertical-align: top;">
                <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif; margin-left: 27pt;">Section 1.3.&#160;</div>
              </td>
              <td style="width: 82%; vertical-align: top;">
                <div style="line-height: 1.25;">Incorporation by Reference of Trust Indenture Act.<br>
                </div>
              </td>
              <td style="width: 5%; vertical-align: bottom; text-align: right;">4</td>
            </tr>
            <tr>
              <td style="width: 13%; vertical-align: top;">
                <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif; margin-left: 27pt;">Section 1.4.&#160;</div>
              </td>
              <td style="width: 82%; vertical-align: top;">
                <div style="line-height: 1.25;">Rules of Construction.</div>
              </td>
              <td style="width: 5%; vertical-align: top;">
                <div style="text-align: right; line-height: 1.25;">5</div>
              </td>
            </tr>
            <tr>
              <td style="width: 13%; vertical-align: top;" rowspan="1">&#160;</td>
              <td style="width: 82%; vertical-align: top;" rowspan="1">&#160;</td>
              <td style="width: 5%; vertical-align: top;" rowspan="1">&#160;</td>
            </tr>
            <tr>
              <td style="vertical-align: top;" rowspan="1" colspan="2">
                <div style="line-height: 1.25;"><a href="#ARTICLEII.">ARTICLE II. THE SECURITIES</a></div>
              </td>
              <td style="width: 5%; vertical-align: top;">
                <div style="text-align: right; line-height: 1.25;">5<br>
                </div>
              </td>
            </tr>
            <tr>
              <td style="width: 13%; vertical-align: top;">
                <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif; margin-left: 27pt;">Section 2.1.&#160;</div>
              </td>
              <td style="width: 82%; vertical-align: top;">
                <div style="line-height: 1.25;">Issuable in Series.</div>
              </td>
              <td style="width: 5%; vertical-align: top;">
                <div style="text-align: right; line-height: 1.25;">5<br>
                </div>
              </td>
            </tr>
            <tr>
              <td style="width: 13%; vertical-align: top;">
                <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif; margin-left: 27pt;">Section 2.2.&#160;</div>
              </td>
              <td style="width: 82%; vertical-align: top;">
                <div style="line-height: 1.25;">Establishment of Terms of Series of Securities.</div>
              </td>
              <td style="width: 5%; vertical-align: top;">
                <div style="text-align: right; line-height: 1.25;">6</div>
              </td>
            </tr>
            <tr>
              <td style="width: 13%; vertical-align: top;">
                <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif; margin-left: 27pt;">Section 2.3.&#160;</div>
              </td>
              <td style="width: 82%; vertical-align: top;">
                <div style="line-height: 1.25;">Execution and Authentication.</div>
              </td>
              <td style="width: 5%; vertical-align: top;">
                <div style="text-align: right; line-height: 1.25;">8</div>
              </td>
            </tr>
            <tr>
              <td style="width: 13%; vertical-align: top;">
                <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif; margin-left: 27pt;">Section 2.4.&#160;</div>
              </td>
              <td style="width: 82%; vertical-align: top;">
                <div style="line-height: 1.25;">Registrar and Paying Agent.</div>
              </td>
              <td style="width: 5%; vertical-align: top;">
                <div style="text-align: right; line-height: 1.25;">9</div>
              </td>
            </tr>
            <tr>
              <td style="width: 13%; vertical-align: top;">
                <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif; margin-left: 27pt;">Section 2.5.&#160;</div>
              </td>
              <td style="width: 82%; vertical-align: top;">
                <div style="line-height: 1.25;">Paying Agent to Hold Money in Trust.</div>
              </td>
              <td style="width: 5%; vertical-align: top;">
                <div style="text-align: right; line-height: 1.25;">10</div>
              </td>
            </tr>
            <tr>
              <td style="width: 13%; vertical-align: top;">
                <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif; margin-left: 27pt;">Section 2.6.&#160;</div>
              </td>
              <td style="width: 82%; vertical-align: top;">
                <div style="line-height: 1.25;">Securityholder Lists.</div>
              </td>
              <td style="width: 5%; vertical-align: top;">
                <div style="text-align: right; line-height: 1.25;">10</div>
              </td>
            </tr>
            <tr>
              <td style="width: 13%; vertical-align: top;">
                <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif; margin-left: 27pt;">Section 2.7.&#160;</div>
              </td>
              <td style="width: 82%; vertical-align: top;">
                <div style="line-height: 1.25;">Transfer and Exchange.</div>
              </td>
              <td style="width: 5%; vertical-align: top;">
                <div style="text-align: right; line-height: 1.25;">10</div>
              </td>
            </tr>
            <tr>
              <td style="width: 13%; vertical-align: top;">
                <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif; margin-left: 27pt;">Section 2.8.&#160;</div>
              </td>
              <td style="width: 82%; vertical-align: top;">
                <div style="line-height: 1.25;">Mutilated, Destroyed, Lost and Stolen Securities.</div>
              </td>
              <td style="width: 5%; vertical-align: top;">
                <div style="text-align: right; line-height: 1.25;">10</div>
              </td>
            </tr>
            <tr>
              <td style="width: 13%; vertical-align: top;">
                <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif; margin-left: 27pt;">Section 2.9.&#160;</div>
              </td>
              <td style="width: 82%; vertical-align: top;">
                <div style="line-height: 1.25;">Outstanding Securities.</div>
              </td>
              <td style="width: 5%; vertical-align: top;">
                <div style="text-align: right; line-height: 1.25;">11</div>
              </td>
            </tr>
            <tr>
              <td style="width: 13%; vertical-align: top;">
                <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif; margin-left: 27pt;">Section 2.10.&#160;</div>
              </td>
              <td style="width: 82%; vertical-align: top;">
                <div style="line-height: 1.25;">Treasury Securities.</div>
              </td>
              <td style="width: 5%; vertical-align: top;">
                <div style="text-align: right; line-height: 1.25;">12</div>
              </td>
            </tr>
            <tr>
              <td style="width: 13%; vertical-align: top;">
                <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif; margin-left: 27pt;">Section 2.11.&#160;</div>
              </td>
              <td style="width: 82%; vertical-align: top;">
                <div style="line-height: 1.25;">Temporary Securities.</div>
              </td>
              <td style="width: 5%; vertical-align: top;">
                <div style="text-align: right; line-height: 1.25;">12</div>
              </td>
            </tr>
            <tr>
              <td style="width: 13%; vertical-align: top;">
                <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif; margin-left: 27pt;">Section 2.12.&#160;</div>
              </td>
              <td style="width: 82%; vertical-align: top;">
                <div style="line-height: 1.25;">Cancellation.</div>
              </td>
              <td style="width: 5%; vertical-align: top;">
                <div style="text-align: right; line-height: 1.25;">12</div>
              </td>
            </tr>
            <tr>
              <td style="width: 13%; vertical-align: top;">
                <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif; margin-left: 27pt;">Section 2.13.&#160;</div>
              </td>
              <td style="width: 82%; vertical-align: top;">
                <div style="line-height: 1.25;">Defaulted Interest.</div>
              </td>
              <td style="width: 5%; vertical-align: top;">
                <div style="text-align: right; line-height: 1.25;">12</div>
              </td>
            </tr>
            <tr>
              <td style="width: 13%; vertical-align: top;">
                <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif; margin-left: 27pt;">Section 2.14.&#160;</div>
              </td>
              <td style="width: 82%; vertical-align: top;">
                <div style="line-height: 1.25;">Global Securities.</div>
              </td>
              <td style="width: 5%; vertical-align: top;">
                <div style="text-align: right; line-height: 1.25;">13</div>
              </td>
            </tr>
            <tr>
              <td style="width: 13%; vertical-align: top;">
                <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif; margin-left: 27pt;">Section 2.15.&#160;</div>
              </td>
              <td style="width: 82%; vertical-align: top;">
                <div style="line-height: 1.25;">CUSIP Numbers.</div>
              </td>
              <td style="width: 5%; vertical-align: top;">
                <div style="text-align: right; line-height: 1.25;">14</div>
              </td>
            </tr>
            <tr>
              <td style="width: 13%; vertical-align: top;" rowspan="1">&#160;</td>
              <td style="width: 82%; vertical-align: top;" rowspan="1">&#160;</td>
              <td style="width: 5%; vertical-align: top;" rowspan="1">&#160;</td>
            </tr>
            <tr>
              <td style="vertical-align: top;" rowspan="1" colspan="2">
                <div style="line-height: 1.25;"><a href="#ARTICLEIII.">ARTICLE III. REDEMPTION</a></div>
              </td>
              <td style="width: 5%; vertical-align: top;">
                <div style="text-align: right; line-height: 1.25;">15</div>
              </td>
            </tr>
            <tr>
              <td style="width: 13%; vertical-align: top;">
                <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif; margin-left: 27pt;">Section 3.1.&#160;</div>
              </td>
              <td style="width: 82%; vertical-align: top;">
                <div style="line-height: 1.25;">Notice to Trustee.</div>
              </td>
              <td style="width: 5%; vertical-align: top;">
                <div style="text-align: right; line-height: 1.25;">15</div>
              </td>
            </tr>
            <tr>
              <td style="width: 13%; vertical-align: top;">
                <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif; margin-left: 27pt;">Section 3.2.&#160;</div>
              </td>
              <td style="width: 82%; vertical-align: top;">
                <div style="line-height: 1.25;">Selection of Securities to be Redeemed.</div>
              </td>
              <td style="width: 5%; vertical-align: top;">
                <div style="text-align: right; line-height: 1.25;">15</div>
              </td>
            </tr>
            <tr>
              <td style="width: 13%; vertical-align: top;">
                <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif; margin-left: 27pt;">Section 3.3.&#160;</div>
              </td>
              <td style="width: 82%; vertical-align: top;">
                <div style="line-height: 1.25;">Notice of Redemption.</div>
              </td>
              <td style="width: 5%; vertical-align: top;">
                <div style="text-align: right; line-height: 1.25;">15</div>
              </td>
            </tr>
            <tr>
              <td style="width: 13%; vertical-align: top;">
                <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif; margin-left: 27pt;">Section 3.4.&#160;</div>
              </td>
              <td style="width: 82%; vertical-align: top;">
                <div style="line-height: 1.25;">Effect of Notice of Redemption.</div>
              </td>
              <td style="width: 5%; vertical-align: bottom; text-align: right;">16<br>
              </td>
            </tr>
            <tr>
              <td style="width: 13%; vertical-align: top;">
                <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif; margin-left: 27pt;">Section 3.5.&#160;</div>
              </td>
              <td style="width: 82%; vertical-align: top;">
                <div style="line-height: 1.25;">Deposit of Redemption Price.</div>
              </td>
              <td style="width: 5%; vertical-align: bottom; text-align: right;">16<br>
              </td>
            </tr>
            <tr>
              <td style="width: 13%; vertical-align: top;">
                <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif; margin-left: 27pt;">Section 3.6.&#160;</div>
              </td>
              <td style="width: 82%; vertical-align: top;">
                <div style="line-height: 1.25;">Securities Redeemed in Part.</div>
              </td>
              <td style="width: 5%; vertical-align: bottom; text-align: right;">16<br>
              </td>
            </tr>
            <tr>
              <td style="width: 13%; vertical-align: top;" rowspan="1">&#160;</td>
              <td style="width: 82%; vertical-align: top;" rowspan="1">&#160;</td>
              <td style="width: 5%; vertical-align: top;" rowspan="1">&#160;</td>
            </tr>
            <tr>
              <td style="vertical-align: top;" rowspan="1" colspan="2">
                <div style="line-height: 1.25;"><a href="#ARTICLEIV.">ARTICLE IV. COVENANTS</a></div>
              </td>
              <td style="width: 5%; vertical-align: top;">
                <div style="text-align: right; line-height: 1.25;">17</div>
              </td>
            </tr>
            <tr>
              <td style="width: 13%; vertical-align: top;">
                <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif; margin-left: 27pt;">Section 4.1.&#160;</div>
              </td>
              <td style="width: 82%; vertical-align: top;">
                <div style="line-height: 1.25;">Payment of Principal and Interest.</div>
              </td>
              <td style="width: 5%; vertical-align: top;">
                <div style="text-align: right; line-height: 1.25;">17</div>
              </td>
            </tr>
            <tr>
              <td style="width: 13%; vertical-align: top;">
                <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif; margin-left: 27pt;">Section 4.2.&#160;</div>
              </td>
              <td style="width: 82%; vertical-align: top;">
                <div style="line-height: 1.25;">SEC Reports.</div>
              </td>
              <td style="width: 5%; vertical-align: top;">
                <div style="text-align: right; line-height: 1.25;">17</div>
              </td>
            </tr>
            <tr>
              <td style="width: 13%; vertical-align: top;">
                <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif; margin-left: 27pt;">Section 4.3.&#160;</div>
              </td>
              <td style="width: 82%; vertical-align: top;">
                <div style="line-height: 1.25;">Compliance Certificate.</div>
              </td>
              <td style="width: 5%; vertical-align: top;">
                <div style="text-align: right; line-height: 1.25;">17</div>
              </td>
            </tr>
            <tr>
              <td style="width: 13%; vertical-align: top;">
                <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif; margin-left: 27pt;">Section 4.4.&#160;</div>
              </td>
              <td style="width: 82%; vertical-align: top;">
                <div style="line-height: 1.25;">Stay, Extension and Usury Laws.</div>
              </td>
              <td style="width: 5%; vertical-align: top;">
                <div style="text-align: right; line-height: 1.25;">18</div>
              </td>
            </tr>
            <tr>
              <td style="width: 13%; vertical-align: top;" rowspan="1">&#160;</td>
              <td style="width: 82%; vertical-align: top;" rowspan="1">&#160;</td>
              <td style="width: 5%; vertical-align: top;" rowspan="1">&#160;</td>
            </tr>
            <tr>
              <td style="vertical-align: top;" rowspan="1" colspan="2">
                <div style="line-height: 1.25;"><a href="#ARTICLEV.">ARTICLE V. SUCCESSORS</a></div>
              </td>
              <td style="width: 5%; vertical-align: top;">
                <div style="text-align: right; line-height: 1.25;">18</div>
              </td>
            </tr>
            <tr>
              <td style="width: 13%; vertical-align: top;">
                <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif; margin-left: 27pt;">Section 5.1.&#160;</div>
              </td>
              <td style="width: 82%; vertical-align: top;">
                <div style="line-height: 1.25;">When Company May Merge, Etc.</div>
              </td>
              <td style="width: 5%; vertical-align: top;">
                <div style="text-align: right; line-height: 1.25;">18</div>
              </td>
            </tr>
            <tr>
              <td style="width: 13%; vertical-align: top;">
                <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif; margin-left: 27pt;">Section 5.2.&#160;</div>
              </td>
              <td style="width: 82%; vertical-align: top;">
                <div style="line-height: 1.25;">Successor Corporation Substituted.</div>
              </td>
              <td style="width: 5%; vertical-align: top;">
                <div style="text-align: right; line-height: 1.25;">18</div>
              </td>
            </tr>

        </table>
        <div><br>
        </div>
        <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
          <div style="page-break-after: always;" class="BRPFPageBreak">
            <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
        </div>
        <!--PROfilePageNumberReset%LCR%2%%%-->
        <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

            <tr>
              <td style="vertical-align: top;" rowspan="1" colspan="2">
                <div style="line-height: 1.25;"><a href="#ARTICLEVI.">ARTICLE VI. DEFAULTS AND REMEDIES</a></div>
              </td>
              <td style="width: 5%; vertical-align: top;">
                <div style="text-align: right; line-height: 1.25;">19</div>
              </td>
            </tr>
            <tr>
              <td style="width: 13%; vertical-align: top;">
                <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif; margin-left: 27pt;">Section 6.1.&#160;</div>
              </td>
              <td style="width: 82%; vertical-align: top;">
                <div style="line-height: 1.25;">Events of Default.</div>
              </td>
              <td style="width: 5%; vertical-align: top;">
                <div style="text-align: right; line-height: 1.25;">19</div>
              </td>
            </tr>
            <tr>
              <td style="width: 13%; vertical-align: top;">
                <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif; margin-left: 27pt;">Section 6.2.&#160;</div>
              </td>
              <td style="width: 82%; vertical-align: top;">
                <div style="line-height: 1.25;">Acceleration of Maturity; Rescission and Annulment.</div>
              </td>
              <td style="width: 5%; vertical-align: top;">
                <div style="text-align: right; line-height: 1.25;">20</div>
              </td>
            </tr>
            <tr>
              <td style="width: 13%; vertical-align: top;">
                <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif; margin-left: 27pt;">Section 6.3.&#160;</div>
              </td>
              <td style="width: 82%; vertical-align: top;">
                <div style="line-height: 1.25;">Collection of Indebtedness and Suits for Enforcement by Trustee.</div>
              </td>
              <td style="width: 5%; vertical-align: top;">
                <div style="text-align: right; line-height: 1.25;">21</div>
              </td>
            </tr>
            <tr>
              <td style="width: 13%; vertical-align: top;">
                <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif; margin-left: 27pt;">Section 6.4.&#160;</div>
              </td>
              <td style="width: 82%; vertical-align: top;">
                <div style="line-height: 1.25;">Trustee May File Proofs of Claim.</div>
              </td>
              <td style="width: 5%; vertical-align: top;">
                <div style="text-align: right; line-height: 1.25;">22</div>
              </td>
            </tr>
            <tr>
              <td style="width: 13%; vertical-align: top;">
                <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif; margin-left: 27pt;">Section 6.5.&#160;</div>
              </td>
              <td style="width: 82%; vertical-align: top;">
                <div style="line-height: 1.25;">Trustee May Enforce Claims Without Possession of Securities.</div>
              </td>
              <td style="width: 5%; vertical-align: top;">
                <div style="text-align: right; line-height: 1.25;">22</div>
              </td>
            </tr>
            <tr>
              <td style="width: 13%; vertical-align: top;">
                <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif; margin-left: 27pt;">Section 6.6.&#160;</div>
              </td>
              <td style="width: 82%; vertical-align: top;">
                <div style="line-height: 1.25;">Application of Money Collected.</div>
              </td>
              <td style="width: 5%; vertical-align: top;">
                <div style="text-align: right; line-height: 1.25;">22</div>
              </td>
            </tr>
            <tr>
              <td style="width: 13%; vertical-align: top;">
                <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif; margin-left: 27pt;">Section 6.7.&#160;</div>
              </td>
              <td style="width: 82%; vertical-align: top;">
                <div style="line-height: 1.25;">Limitation on Suits.</div>
              </td>
              <td style="width: 5%; vertical-align: top;">
                <div style="text-align: right; line-height: 1.25;">23</div>
              </td>
            </tr>
            <tr>
              <td style="width: 13%; vertical-align: top;">
                <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif; margin-left: 27pt;">Section 6.8.&#160;</div>
              </td>
              <td style="width: 82%; vertical-align: top;">
                <div style="line-height: 1.25;">Unconditional Right of Holders to Receive Principal and Interest.</div>
              </td>
              <td style="width: 5%; vertical-align: top;">
                <div style="text-align: right; line-height: 1.25;">24</div>
              </td>
            </tr>
            <tr>
              <td style="width: 13%; vertical-align: top;">
                <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif; margin-left: 27pt;">Section 6.9.&#160;</div>
              </td>
              <td style="width: 82%; vertical-align: top;">
                <div style="line-height: 1.25;">Restoration of Rights and Remedies.</div>
              </td>
              <td style="width: 5%; vertical-align: top;">
                <div style="text-align: right; line-height: 1.25;">24</div>
              </td>
            </tr>
            <tr>
              <td style="width: 13%; vertical-align: top;">
                <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif; margin-left: 27pt;">Section 6.10.&#160;</div>
              </td>
              <td style="width: 82%; vertical-align: top;">
                <div style="line-height: 1.25;">Rights and Remedies Cumulative.</div>
              </td>
              <td style="width: 5%; vertical-align: top;">
                <div style="text-align: right; line-height: 1.25;">24</div>
              </td>
            </tr>
            <tr>
              <td style="width: 13%; vertical-align: top;">
                <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif; margin-left: 27pt;">Section 6.11.&#160;</div>
              </td>
              <td style="width: 82%; vertical-align: top;">
                <div style="line-height: 1.25;">Delay or Omission Not Waiver.</div>
              </td>
              <td style="width: 5%; vertical-align: top;">
                <div style="text-align: right; line-height: 1.25;">24</div>
              </td>
            </tr>
            <tr>
              <td style="width: 13%; vertical-align: top;">
                <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif; margin-left: 27pt;">Section 6.12.&#160;</div>
              </td>
              <td style="width: 82%; vertical-align: top;">
                <div style="line-height: 1.25;">Control by Holders.</div>
              </td>
              <td style="width: 5%; vertical-align: top;">
                <div style="text-align: right; line-height: 1.25;">24</div>
              </td>
            </tr>
            <tr>
              <td style="width: 13%; vertical-align: top;">
                <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif; margin-left: 27pt;">Section 6.13.&#160;</div>
              </td>
              <td style="width: 82%; vertical-align: top;">
                <div style="line-height: 1.25;">Waiver of Past Defaults.</div>
              </td>
              <td style="width: 5%; vertical-align: top;">
                <div style="text-align: right; line-height: 1.25;">25</div>
              </td>
            </tr>
            <tr>
              <td style="width: 13%; vertical-align: top;">
                <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif; margin-left: 27pt;">Section 6.14.&#160;</div>
              </td>
              <td style="width: 82%; vertical-align: top;">
                <div style="line-height: 1.25;">Undertaking for Costs.</div>
              </td>
              <td style="width: 5%; vertical-align: top;">
                <div style="text-align: right; line-height: 1.25;">25</div>
              </td>
            </tr>
            <tr>
              <td style="width: 13%; vertical-align: top;" rowspan="1">&#160;</td>
              <td style="width: 82%; vertical-align: top;" rowspan="1">&#160;</td>
              <td style="width: 5%; vertical-align: top;" rowspan="1">&#160;</td>
            </tr>
            <tr>
              <td style="vertical-align: top;" rowspan="1" colspan="2">
                <div style="line-height: 1.25;"><a href="#ARTICLEVII.">ARTICLE VII. TRUSTEE</a></div>
              </td>
              <td style="width: 5%; vertical-align: top;">
                <div style="text-align: right; line-height: 1.25;">25</div>
              </td>
            </tr>
            <tr>
              <td style="width: 13%; vertical-align: top;">
                <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif; margin-left: 27pt;">Section 7.1.&#160;</div>
              </td>
              <td style="width: 82%; vertical-align: top;">
                <div style="line-height: 1.25;">Duties of Trustee.</div>
              </td>
              <td style="width: 5%; vertical-align: top;">
                <div style="text-align: right; line-height: 1.25;">25</div>
              </td>
            </tr>
            <tr>
              <td style="width: 13%; vertical-align: top;">
                <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif; margin-left: 27pt;">Section 7.2.&#160;</div>
              </td>
              <td style="width: 82%; vertical-align: top;">
                <div style="line-height: 1.25;">Rights of Trustee.</div>
              </td>
              <td style="width: 5%; vertical-align: top;">
                <div style="text-align: right; line-height: 1.25;">27</div>
              </td>
            </tr>
            <tr>
              <td style="width: 13%; vertical-align: top;">
                <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif; margin-left: 27pt;">Section 7.3.&#160;</div>
              </td>
              <td style="width: 82%; vertical-align: top;">
                <div style="line-height: 1.25;">Individual Rights of Trustee.</div>
              </td>
              <td style="width: 5%; vertical-align: top;">
                <div style="text-align: right; line-height: 1.25;">28</div>
              </td>
            </tr>
            <tr>
              <td style="width: 13%; vertical-align: top;">
                <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif; margin-left: 27pt;">Section 7.4.&#160;</div>
              </td>
              <td style="width: 82%; vertical-align: top;">
                <div style="line-height: 1.25;">Trustee&#8217;s Disclaimer.</div>
              </td>
              <td style="width: 5%; vertical-align: top;">
                <div style="text-align: right; line-height: 1.25;">28</div>
              </td>
            </tr>
            <tr>
              <td style="width: 13%; vertical-align: top;">
                <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif; margin-left: 27pt;">Section 7.5.&#160;</div>
              </td>
              <td style="width: 82%; vertical-align: top;">
                <div style="line-height: 1.25;">Notice of Defaults.</div>
              </td>
              <td style="width: 5%; vertical-align: top;">
                <div style="text-align: right; line-height: 1.25;">28</div>
              </td>
            </tr>
            <tr>
              <td style="width: 13%; vertical-align: top;">
                <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif; margin-left: 27pt;">Section 7.6.&#160;</div>
              </td>
              <td style="width: 82%; vertical-align: top;">
                <div style="line-height: 1.25;">Reports by Trustee to Holders.</div>
              </td>
              <td style="width: 5%; vertical-align: top;">
                <div style="text-align: right; line-height: 1.25;">28</div>
              </td>
            </tr>
            <tr>
              <td style="width: 13%; vertical-align: top;">
                <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif; margin-left: 27pt;">Section 7.7.&#160;</div>
              </td>
              <td style="width: 82%; vertical-align: top;">
                <div style="line-height: 1.25;">Compensation and Indemnity.</div>
              </td>
              <td style="width: 5%; vertical-align: top;">
                <div style="text-align: right; line-height: 1.25;">29</div>
              </td>
            </tr>
            <tr>
              <td style="width: 13%; vertical-align: top;">
                <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif; margin-left: 27pt;">Section 7.8.&#160;</div>
              </td>
              <td style="width: 82%; vertical-align: top;">
                <div style="line-height: 1.25;">Replacement of Trustee.</div>
              </td>
              <td style="width: 5%; vertical-align: top;">
                <div style="text-align: right; line-height: 1.25;">29<br>
                </div>
              </td>
            </tr>
            <tr>
              <td style="width: 13%; vertical-align: top;">
                <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif; margin-left: 27pt;">Section 7.9.&#160;</div>
              </td>
              <td style="width: 82%; vertical-align: top;">
                <div style="line-height: 1.25;">Successor Trustee by Merger, Etc.</div>
              </td>
              <td style="width: 5%; vertical-align: top;">
                <div style="text-align: right; line-height: 1.25;">30</div>
              </td>
            </tr>
            <tr>
              <td style="width: 13%; vertical-align: top;">
                <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif; margin-left: 27pt;">Section 7.10.&#160;</div>
              </td>
              <td style="width: 82%; vertical-align: top;">
                <div style="line-height: 1.25;">Eligibility; Disqualification.</div>
              </td>
              <td style="width: 5%; vertical-align: top;">
                <div style="text-align: right; line-height: 1.25;">30</div>
              </td>
            </tr>
            <tr>
              <td style="width: 13%; vertical-align: top;">
                <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif; margin-left: 27pt;">Section 7.11.&#160;</div>
              </td>
              <td style="width: 82%; vertical-align: top;">
                <div style="line-height: 1.25;">Preferential Collection of Claims Against Company.</div>
              </td>
              <td style="width: 5%; vertical-align: top;">
                <div style="text-align: right; line-height: 1.25;">31</div>
              </td>
            </tr>
            <tr>
              <td style="width: 13%; vertical-align: top;" rowspan="1">&#160;</td>
              <td style="width: 82%; vertical-align: top;" rowspan="1">&#160;</td>
              <td style="width: 5%; vertical-align: top;" rowspan="1">&#160;</td>
            </tr>
            <tr>
              <td style="vertical-align: top;" rowspan="1" colspan="2">
                <div style="line-height: 1.25;"><a href="#ARTICLEVIII.">ARTICLE VIII. SATISFACTION AND DISCHARGE; DEFEASANCE</a></div>
              </td>
              <td style="width: 5%; vertical-align: top;">
                <div style="text-align: right; line-height: 1.25;">31</div>
              </td>
            </tr>
            <tr>
              <td style="width: 13%; vertical-align: top;">
                <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif; margin-left: 27pt;">Section 8.1.&#160;</div>
              </td>
              <td style="width: 82%; vertical-align: top;">
                <div style="line-height: 1.25;">Satisfaction and Discharge of Indenture.</div>
              </td>
              <td style="width: 5%; vertical-align: top;">
                <div style="text-align: right; line-height: 1.25;">31</div>
              </td>
            </tr>
            <tr>
              <td style="width: 13%; vertical-align: top;">
                <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif; margin-left: 27pt;">Section 8.2.&#160;</div>
              </td>
              <td style="width: 82%; vertical-align: top;">
                <div style="line-height: 1.25;">Application of Trust Funds; Indemnification.</div>
              </td>
              <td style="width: 5%; vertical-align: top;">
                <div style="text-align: right; line-height: 1.25;">32</div>
              </td>
            </tr>
            <tr>
              <td style="width: 13%; vertical-align: top;">
                <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif; margin-left: 27pt;">Section 8.3.&#160;</div>
              </td>
              <td style="width: 82%; vertical-align: top;">
                <div style="line-height: 1.25;">Legal Defeasance of Securities of any Series.</div>
              </td>
              <td style="width: 5%; vertical-align: top;">
                <div style="text-align: right; line-height: 1.25;">33</div>
              </td>
            </tr>
            <tr>
              <td style="width: 13%; vertical-align: top;">
                <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif; margin-left: 27pt;">Section 8.4.&#160;</div>
              </td>
              <td style="width: 82%; vertical-align: top;">
                <div style="line-height: 1.25;">Covenant Defeasance.</div>
              </td>
              <td style="width: 5%; vertical-align: top;">
                <div style="text-align: right; line-height: 1.25;">34</div>
              </td>
            </tr>
            <tr>
              <td style="width: 13%; vertical-align: top;">
                <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif; margin-left: 27pt;">Section 8.5.&#160;</div>
              </td>
              <td style="width: 82%; vertical-align: top;">
                <div style="line-height: 1.25;">Repayment to Company.</div>
              </td>
              <td style="width: 5%; vertical-align: top;">
                <div style="text-align: right; line-height: 1.25;">35</div>
              </td>
            </tr>
            <tr>
              <td style="width: 13%; vertical-align: top;">
                <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif; margin-left: 27pt;">Section 8.6.&#160;</div>
              </td>
              <td style="width: 82%; vertical-align: top;">
                <div style="line-height: 1.25;">Reinstatement.</div>
              </td>
              <td style="width: 5%; vertical-align: top;">
                <div style="text-align: right; line-height: 1.25;">35</div>
              </td>
            </tr>
            <tr>
              <td style="width: 13%; vertical-align: top;" rowspan="1">&#160;</td>
              <td style="width: 82%; vertical-align: top;" rowspan="1">&#160;</td>
              <td style="width: 5%; vertical-align: top;" rowspan="1">&#160;</td>
            </tr>
            <tr>
              <td style="vertical-align: top;" rowspan="1" colspan="2">
                <div style="line-height: 1.25;"><a href="#ARTICLEIX.">ARTICLE IX. AMENDMENTS AND WAIVERS</a></div>
              </td>
              <td style="width: 5%; vertical-align: top;">
                <div style="text-align: right; line-height: 1.25;">36</div>
              </td>
            </tr>
            <tr>
              <td style="width: 13%; vertical-align: top;">
                <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif; margin-left: 27pt;">Section 9.1.&#160;</div>
              </td>
              <td style="width: 82%; vertical-align: top;">
                <div style="line-height: 1.25;">Without Consent of Holders.</div>
              </td>
              <td style="width: 5%; vertical-align: top;">
                <div style="text-align: right; line-height: 1.25;">36</div>
              </td>
            </tr>
            <tr>
              <td style="width: 13%; vertical-align: top;">
                <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif; margin-left: 27pt;">Section 9.2.&#160;</div>
              </td>
              <td style="width: 82%; vertical-align: top;">
                <div style="line-height: 1.25;">With Consent of Holders.</div>
              </td>
              <td style="width: 5%; vertical-align: top;">
                <div style="text-align: right; line-height: 1.25;">36</div>
              </td>
            </tr>
            <tr>
              <td style="width: 13%; vertical-align: top;">
                <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif; margin-left: 27pt;">Section 9.3.&#160;</div>
              </td>
              <td style="width: 82%; vertical-align: top;">
                <div style="line-height: 1.25;">Limitations.</div>
              </td>
              <td style="width: 5%; vertical-align: top;">
                <div style="text-align: right; line-height: 1.25;">37</div>
              </td>
            </tr>
            <tr>
              <td style="width: 13%; vertical-align: top;">
                <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif; margin-left: 27pt;">Section 9.4.&#160;</div>
              </td>
              <td style="width: 82%; vertical-align: top;">
                <div style="line-height: 1.25;">Compliance with Trust Indenture Act.</div>
              </td>
              <td style="width: 5%; vertical-align: top;">
                <div style="text-align: right; line-height: 1.25;">37</div>
              </td>
            </tr>
            <tr>
              <td style="width: 13%; vertical-align: top;">
                <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif; margin-left: 27pt;">Section 9.5.&#160;</div>
              </td>
              <td style="width: 82%; vertical-align: top;">
                <div style="line-height: 1.25;">Revocation and Effect of Consents.</div>
              </td>
              <td style="width: 5%; vertical-align: top;">
                <div style="text-align: right; line-height: 1.25;">38</div>
              </td>
            </tr>
            <tr>
              <td style="width: 13%; vertical-align: top;">
                <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif; margin-left: 27pt;">Section 9.6.&#160;</div>
              </td>
              <td style="width: 82%; vertical-align: top;">
                <div style="line-height: 1.25;">Notation on or Exchange of Securities.</div>
              </td>
              <td style="width: 5%; vertical-align: top;">
                <div style="text-align: right; line-height: 1.25;">38</div>
              </td>
            </tr>
            <tr>
              <td style="width: 13%; vertical-align: top;">
                <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif; margin-left: 27pt;">Section 9.7.&#160;</div>
              </td>
              <td style="width: 82%; vertical-align: top;">
                <div style="line-height: 1.25;">Trustee Protected.</div>
              </td>
              <td style="width: 5%; vertical-align: top;">
                <div style="text-align: right; line-height: 1.25;">38</div>
              </td>
            </tr>

        </table>
        <div><br>
        </div>
        <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
          <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-weight: normal; font-style: normal;" class="BRPFPageNumber">ii</font></div>
          <div style="page-break-after: always;" class="BRPFPageBreak">
            <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
        </div>
        <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

            <tr>
              <td style="vertical-align: top;" rowspan="1" colspan="2">
                <div style="line-height: 1.25;"><a href="#ARTICLEX.">ARTICLE X. MISCELLANEOUS</a></div>
              </td>
              <td style="width: 5%; vertical-align: top;">
                <div style="text-align: right; line-height: 1.25;">39</div>
              </td>
            </tr>
            <tr>
              <td style="width: 13%; vertical-align: top;">
                <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif; margin-left: 27pt;">Section 10.1.&#160;</div>
              </td>
              <td style="width: 82%; vertical-align: top;">
                <div style="line-height: 1.25;">Trust Indenture Act Controls.</div>
              </td>
              <td style="width: 5%; vertical-align: top;">
                <div style="text-align: right; line-height: 1.25;">39</div>
              </td>
            </tr>
            <tr>
              <td style="width: 13%; vertical-align: top;">
                <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif; margin-left: 27pt;">Section 10.2.&#160;</div>
              </td>
              <td style="width: 82%; vertical-align: top;">
                <div style="line-height: 1.25;">Notices.</div>
              </td>
              <td style="width: 5%; vertical-align: top;">
                <div style="text-align: right; line-height: 1.25;">39</div>
              </td>
            </tr>
            <tr>
              <td style="width: 13%; vertical-align: top;">
                <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif; margin-left: 27pt;">Section 10.3.&#160;</div>
              </td>
              <td style="width: 82%; vertical-align: top;">
                <div style="line-height: 1.25;">Communication by Holders with Other Holders.</div>
              </td>
              <td style="width: 5%; vertical-align: top;">
                <div style="text-align: right; line-height: 1.25;">40</div>
              </td>
            </tr>
            <tr>
              <td style="width: 13%; vertical-align: top;">
                <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif; margin-left: 27pt;">Section 10.4.&#160;</div>
              </td>
              <td style="width: 82%; vertical-align: top;">
                <div style="line-height: 1.25;">Certificate and Opinion as to Conditions Precedent.</div>
              </td>
              <td style="width: 5%; vertical-align: top;">
                <div style="text-align: right; line-height: 1.25;">40</div>
              </td>
            </tr>
            <tr>
              <td style="width: 13%; vertical-align: top;">
                <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif; margin-left: 27pt;">Section 10.5.&#160;</div>
              </td>
              <td style="width: 82%; vertical-align: top;">
                <div style="line-height: 1.25;">Statements Required in Certificate or Opinion.</div>
              </td>
              <td style="width: 5%; vertical-align: top;">
                <div style="text-align: right; line-height: 1.25;">41</div>
              </td>
            </tr>
            <tr>
              <td style="width: 13%; vertical-align: top;">
                <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif; margin-left: 27pt;">Section 10.6.&#160;</div>
              </td>
              <td style="width: 82%; vertical-align: top;">
                <div style="line-height: 1.25;">Rules by Trustee and Agents.</div>
              </td>
              <td style="width: 5%; vertical-align: top;">
                <div style="text-align: right; line-height: 1.25;">41</div>
              </td>
            </tr>
            <tr>
              <td style="width: 13%; vertical-align: top;">
                <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif; margin-left: 27pt;">Section 10.7.&#160;</div>
              </td>
              <td style="width: 82%; vertical-align: top;">
                <div style="line-height: 1.25;">Legal Holidays.</div>
              </td>
              <td style="width: 5%; vertical-align: top;">
                <div style="text-align: right; line-height: 1.25;">41</div>
              </td>
            </tr>
            <tr>
              <td style="width: 13%; vertical-align: top;">
                <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif; margin-left: 27pt;">Section 10.8.&#160;</div>
              </td>
              <td style="width: 82%; vertical-align: top;">
                <div style="line-height: 1.25;">No Recourse Against Others.</div>
              </td>
              <td style="width: 5%; vertical-align: top;">
                <div style="text-align: right; line-height: 1.25;">41</div>
              </td>
            </tr>
            <tr>
              <td style="width: 13%; vertical-align: top;">
                <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif; margin-left: 27pt;">Section 10.9.&#160;</div>
              </td>
              <td style="width: 82%; vertical-align: top;">
                <div style="line-height: 1.25;">Counterparts.</div>
              </td>
              <td style="width: 5%; vertical-align: top;">
                <div style="text-align: right; line-height: 1.25;">41</div>
              </td>
            </tr>
            <tr>
              <td style="width: 13%; vertical-align: top;">
                <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif; margin-left: 27pt;">Section 10.10.&#160;</div>
              </td>
              <td style="width: 82%; vertical-align: top;">
                <div style="line-height: 1.25;">Governing Law; Waiver of Jury Trial; Consent to Jurisdiction.</div>
              </td>
              <td style="width: 5%; vertical-align: top;">
                <div style="text-align: right; line-height: 1.25;">42</div>
              </td>
            </tr>
            <tr>
              <td style="width: 13%; vertical-align: top;">
                <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif; margin-left: 27pt;">Section 10.11.&#160;</div>
              </td>
              <td style="width: 82%; vertical-align: top;">
                <div style="line-height: 1.25;">No Adverse Interpretation of Other Agreements.</div>
              </td>
              <td style="width: 5%; vertical-align: top;">
                <div style="text-align: right; line-height: 1.25;">43</div>
              </td>
            </tr>
            <tr>
              <td style="width: 13%; vertical-align: top;">
                <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif; margin-left: 27pt;">Section 10.12.&#160;</div>
              </td>
              <td style="width: 82%; vertical-align: top;">
                <div style="line-height: 1.25;">Successors.</div>
              </td>
              <td style="width: 5%; vertical-align: top;">
                <div style="text-align: right; line-height: 1.25;">43</div>
              </td>
            </tr>
            <tr>
              <td style="width: 13%; vertical-align: top;">
                <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif; margin-left: 27pt;">Section 10.13.&#160;</div>
              </td>
              <td style="width: 82%; vertical-align: top;">
                <div style="line-height: 1.25;">Severability.</div>
              </td>
              <td style="width: 5%; vertical-align: top;">
                <div style="text-align: right; line-height: 1.25;">43</div>
              </td>
            </tr>
            <tr>
              <td style="width: 13%; vertical-align: top;">
                <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif; margin-left: 27pt;">Section 10.14.&#160;</div>
              </td>
              <td style="width: 82%; vertical-align: top;">
                <div style="line-height: 1.25;">Table of Contents, Headings, Etc.</div>
              </td>
              <td style="width: 5%; vertical-align: top;">
                <div style="text-align: right; line-height: 1.25;">43</div>
              </td>
            </tr>
            <tr>
              <td style="width: 13%; vertical-align: top;">
                <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif; margin-left: 27pt;">Section 10.15.&#160;</div>
              </td>
              <td style="width: 82%; vertical-align: top;">
                <div style="line-height: 1.25;">Securities in a Foreign Currency.</div>
              </td>
              <td style="width: 5%; vertical-align: top;">
                <div style="text-align: right; line-height: 1.25;">43</div>
              </td>
            </tr>
            <tr>
              <td style="width: 13%; vertical-align: top;">
                <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif; margin-left: 27pt;">Section 10.16.&#160;</div>
              </td>
              <td style="width: 82%; vertical-align: top;">
                <div style="line-height: 1.25;">Judgment Currency.</div>
              </td>
              <td style="width: 5%; vertical-align: top;">
                <div style="text-align: right; line-height: 1.25;">44</div>
              </td>
            </tr>
            <tr>
              <td style="width: 13%; vertical-align: top;">
                <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif; margin-left: 27pt;">Section 10.17.&#160;</div>
              </td>
              <td style="width: 82%; vertical-align: top;">
                <div style="line-height: 1.25;">Force Majeure.</div>
              </td>
              <td style="width: 5%; vertical-align: top;">
                <div style="text-align: right; line-height: 1.25;">44</div>
              </td>
            </tr>
            <tr>
              <td style="width: 13%; vertical-align: top;">
                <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif; margin-left: 27pt;">Section 10.18.&#160;</div>
              </td>
              <td style="width: 82%; vertical-align: top;">
                <div style="line-height: 1.25;">U.S.A. Patriot Act.</div>
              </td>
              <td style="width: 5%; vertical-align: top;">
                <div style="text-align: right; line-height: 1.25;">44</div>
              </td>
            </tr>
            <tr>
              <td style="width: 13%; vertical-align: top;" rowspan="1">&#160;</td>
              <td style="width: 82%; vertical-align: top;" rowspan="1">&#160;</td>
              <td style="width: 5%; vertical-align: top;" rowspan="1">&#160;</td>
            </tr>
            <tr>
              <td style="vertical-align: top;" rowspan="1" colspan="2">
                <div style="line-height: 1.25;"><a href="#ARTICLEXI.">ARTICLE XI. SINKING FUNDS</a></div>
              </td>
              <td style="width: 5%; vertical-align: top;">
                <div style="text-align: right; line-height: 1.25;">45</div>
              </td>
            </tr>
            <tr>
              <td style="width: 13%; vertical-align: top;">
                <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif; margin-left: 27pt;">Section 11.1.&#160;</div>
              </td>
              <td style="width: 82%; vertical-align: top;">
                <div style="line-height: 1.25;">Applicability of Article.</div>
              </td>
              <td style="width: 5%; vertical-align: top;">
                <div style="text-align: right; line-height: 1.25;">45</div>
              </td>
            </tr>
            <tr>
              <td style="width: 13%; vertical-align: top;">
                <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif; margin-left: 27pt;">Section 11.2.&#160;</div>
              </td>
              <td style="width: 82%; vertical-align: top;">
                <div style="line-height: 1.25;">Satisfaction of Sinking Fund Payments with Securities.</div>
              </td>
              <td style="width: 5%; vertical-align: top;">
                <div style="text-align: right; line-height: 1.25;">45</div>
              </td>
            </tr>
            <tr>
              <td style="width: 13%; vertical-align: top;">
                <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif; margin-left: 27pt;">Section 11.3.&#160;</div>
              </td>
              <td style="width: 82%; vertical-align: top;">
                <div style="line-height: 1.25;">Redemption of Securities for Sinking Fund.</div>
              </td>
              <td style="width: 5%; vertical-align: top;">
                <div style="text-align: right; line-height: 1.25;">46</div>
              </td>
            </tr>

        </table>
      </div>
      <div style="line-height: 1.25"> <br>
      </div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-weight: normal; font-style: normal;" class="BRPFPageNumber">iii</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <!--PROfilePageNumberReset%LCR%4%%%-->
      <div style="text-align: center; line-height: 1.25; font-weight: bold;">INNOVIZ TECHNOLOGIES LTD.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: center; line-height: 1.25;">Reconciliation and tie between Trust Indenture Act of 1939 and<br>
        Indenture, dated as of ____________, 20__</div>
      <div style="line-height: 1.25">&#160;
        <table cellspacing="0" cellpadding="0" border="0" id="z12ef257fbc2140c4b8ac2350b08bf43c" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

            <tr>
              <td style="width: 7%; vertical-align: top; text-align: right;">
                <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#167; 310(a)(1)</div>
              </td>
              <td style="width: 83%; vertical-align: top;"><br>
              </td>
              <td style="width: 10%; vertical-align: top;">
                <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">7.1</div>
              </td>
            </tr>
            <tr>
              <td style="width: 7%; vertical-align: top; text-align: right;">
                <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">(a)(2)</div>
              </td>
              <td style="width: 83%; vertical-align: top;"><br>
              </td>
              <td style="width: 10%; vertical-align: top;">
                <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">7.1</div>
              </td>
            </tr>
            <tr>
              <td style="width: 7%; vertical-align: top; text-align: right;">
                <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">(a)(3)</div>
              </td>
              <td style="width: 83%; vertical-align: top;"><br>
              </td>
              <td style="width: 10%; vertical-align: top;">
                <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">Not Applicable</div>
              </td>
            </tr>
            <tr>
              <td style="width: 7%; vertical-align: top; text-align: right;">
                <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">(a)(4)</div>
              </td>
              <td style="width: 83%; vertical-align: top;"><br>
              </td>
              <td style="width: 10%; vertical-align: top;">
                <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">Not Applicable</div>
              </td>
            </tr>
            <tr>
              <td style="width: 7%; vertical-align: top; text-align: right;">
                <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">(a)(5)</div>
              </td>
              <td style="width: 83%; vertical-align: top;"><br>
              </td>
              <td style="width: 10%; vertical-align: top;">
                <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">7.1</div>
              </td>
            </tr>
            <tr>
              <td style="width: 7%; vertical-align: top; text-align: right;">
                <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">(b)</div>
              </td>
              <td style="width: 83%; vertical-align: top;"><br>
              </td>
              <td style="width: 10%; vertical-align: top;">
                <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">7.1</div>
              </td>
            </tr>
            <tr>
              <td style="width: 7%; vertical-align: top; text-align: right;">
                <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#167; 311(a)</div>
              </td>
              <td style="width: 83%; vertical-align: top;"><br>
              </td>
              <td style="width: 10%; vertical-align: top;">
                <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">7.11</div>
              </td>
            </tr>
            <tr>
              <td style="width: 7%; vertical-align: top; text-align: right;">
                <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">(b)</div>
              </td>
              <td style="width: 83%; vertical-align: top;"><br>
              </td>
              <td style="width: 10%; vertical-align: top;">
                <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">7.11</div>
              </td>
            </tr>
            <tr>
              <td style="width: 7%; vertical-align: top; text-align: right;">
                <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">(c)</div>
              </td>
              <td style="width: 83%; vertical-align: top;"><br>
              </td>
              <td style="width: 10%; vertical-align: top;">
                <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">Not Applicable</div>
              </td>
            </tr>
            <tr>
              <td style="width: 7%; vertical-align: top; text-align: right;">
                <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#167; 312(a)</div>
              </td>
              <td style="width: 83%; vertical-align: top;"><br>
              </td>
              <td style="width: 10%; vertical-align: top;">
                <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">2.6</div>
              </td>
            </tr>
            <tr>
              <td style="width: 7%; vertical-align: top; text-align: right;">
                <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">(b)</div>
              </td>
              <td style="width: 83%; vertical-align: top;"><br>
              </td>
              <td style="width: 10%; vertical-align: top;">
                <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">10.3</div>
              </td>
            </tr>
            <tr>
              <td style="width: 7%; vertical-align: top; text-align: right;">
                <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">(c)</div>
              </td>
              <td style="width: 83%; vertical-align: top;"><br>
              </td>
              <td style="width: 10%; vertical-align: top;">
                <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">10.3</div>
              </td>
            </tr>
            <tr>
              <td style="width: 7%; vertical-align: top; text-align: right;">
                <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#167; 313(a)</div>
              </td>
              <td style="width: 83%; vertical-align: top;"><br>
              </td>
              <td style="width: 10%; vertical-align: top;">
                <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">7.6</div>
              </td>
            </tr>
            <tr>
              <td style="width: 7%; vertical-align: top; text-align: right;">
                <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">(b)(1)</div>
              </td>
              <td style="width: 83%; vertical-align: top;"><br>
              </td>
              <td style="width: 10%; vertical-align: top;">
                <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">7.6</div>
              </td>
            </tr>
            <tr>
              <td style="width: 7%; vertical-align: top; text-align: right;">
                <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">(b)(2)</div>
              </td>
              <td style="width: 83%; vertical-align: top;"><br>
              </td>
              <td style="width: 10%; vertical-align: top;">
                <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">7.6</div>
              </td>
            </tr>
            <tr>
              <td style="width: 7%; vertical-align: top; text-align: right;">
                <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">(c)(1)</div>
              </td>
              <td style="width: 83%; vertical-align: top;"><br>
              </td>
              <td style="width: 10%; vertical-align: top;">
                <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">7.6</div>
              </td>
            </tr>
            <tr>
              <td style="width: 7%; vertical-align: top; text-align: right;">
                <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">(d)</div>
              </td>
              <td style="width: 83%; vertical-align: top;"><br>
              </td>
              <td style="width: 10%; vertical-align: top;">
                <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">7.6</div>
              </td>
            </tr>
            <tr>
              <td style="width: 7%; vertical-align: top; text-align: right;">
                <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#167; 314(a)</div>
              </td>
              <td style="width: 83%; vertical-align: top;"><br>
              </td>
              <td style="width: 10%; vertical-align: top;">
                <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">4.2, 10.5</div>
              </td>
            </tr>
            <tr>
              <td style="width: 7%; vertical-align: top; text-align: right;">
                <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">(b)</div>
              </td>
              <td style="width: 83%; vertical-align: top;"><br>
              </td>
              <td style="width: 10%; vertical-align: top;">
                <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">Not Applicable</div>
              </td>
            </tr>
            <tr>
              <td style="width: 7%; vertical-align: top; text-align: right;">
                <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">(c)(1)</div>
              </td>
              <td style="width: 83%; vertical-align: top;"><br>
              </td>
              <td style="width: 10%; vertical-align: top;">
                <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">10.4</div>
              </td>
            </tr>
            <tr>
              <td style="width: 7%; vertical-align: top; text-align: right;">
                <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">(c)(2)</div>
              </td>
              <td style="width: 83%; vertical-align: top;"><br>
              </td>
              <td style="width: 10%; vertical-align: top;">
                <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">10.4</div>
              </td>
            </tr>
            <tr>
              <td style="width: 7%; vertical-align: top; text-align: right;">
                <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">(c)(3)</div>
              </td>
              <td style="width: 83%; vertical-align: top;"><br>
              </td>
              <td style="width: 10%; vertical-align: top;">
                <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">Not Applicable</div>
              </td>
            </tr>
            <tr>
              <td style="width: 7%; vertical-align: top; text-align: right;">
                <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">(d)</div>
              </td>
              <td style="width: 83%; vertical-align: top;"><br>
              </td>
              <td style="width: 10%; vertical-align: top;">
                <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">Not Applicable</div>
              </td>
            </tr>
            <tr>
              <td style="width: 7%; vertical-align: top; text-align: right;">
                <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">(e)</div>
              </td>
              <td style="width: 83%; vertical-align: top;"><br>
              </td>
              <td style="width: 10%; vertical-align: top;">
                <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">10.5</div>
              </td>
            </tr>
            <tr>
              <td style="width: 7%; vertical-align: top; text-align: right;">
                <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">(f)</div>
              </td>
              <td style="width: 83%; vertical-align: top;"><br>
              </td>
              <td style="width: 10%; vertical-align: top;">
                <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">Not Applicable</div>
              </td>
            </tr>
            <tr>
              <td style="width: 7%; vertical-align: top; text-align: right;">
                <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#167; 315(a)</div>
              </td>
              <td style="width: 83%; vertical-align: top;"><br>
              </td>
              <td style="width: 10%; vertical-align: top;">
                <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">7.1</div>
              </td>
            </tr>
            <tr>
              <td style="width: 7%; vertical-align: top; text-align: right;">
                <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">(b)</div>
              </td>
              <td style="width: 83%; vertical-align: top;"><br>
              </td>
              <td style="width: 10%; vertical-align: top;">
                <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">7.5</div>
              </td>
            </tr>
            <tr>
              <td style="width: 7%; vertical-align: top; text-align: right;">
                <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">(c)</div>
              </td>
              <td style="width: 83%; vertical-align: top;"><br>
              </td>
              <td style="width: 10%; vertical-align: top;">
                <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">7.1</div>
              </td>
            </tr>
            <tr>
              <td style="width: 7%; vertical-align: top; text-align: right;">
                <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">(d)</div>
              </td>
              <td style="width: 83%; vertical-align: top;"><br>
              </td>
              <td style="width: 10%; vertical-align: top;">
                <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">7.1</div>
              </td>
            </tr>
            <tr>
              <td style="width: 7%; vertical-align: top; text-align: right;">
                <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">(e)</div>
              </td>
              <td style="width: 83%; vertical-align: top;"><br>
              </td>
              <td style="width: 10%; vertical-align: top;">
                <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">6.14</div>
              </td>
            </tr>
            <tr>
              <td style="width: 7%; vertical-align: top; text-align: right;">
                <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#167; 316(a)</div>
              </td>
              <td style="width: 83%; vertical-align: top;"><br>
              </td>
              <td style="width: 10%; vertical-align: top;">
                <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">2.1</div>
              </td>
            </tr>
            <tr>
              <td style="width: 7%; vertical-align: top; text-align: right;">
                <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">(a)(1)(A)</div>
              </td>
              <td style="width: 83%; vertical-align: top;"><br>
              </td>
              <td style="width: 10%; vertical-align: top;">
                <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">6.12</div>
              </td>
            </tr>
            <tr>
              <td style="width: 7%; vertical-align: top; text-align: right;">
                <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">(a)(1)(B)</div>
              </td>
              <td style="width: 83%; vertical-align: top;"><br>
              </td>
              <td style="width: 10%; vertical-align: top;">
                <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">6.13</div>
              </td>
            </tr>
            <tr>
              <td style="width: 7%; vertical-align: top; text-align: right;">
                <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">(b)</div>
              </td>
              <td style="width: 83%; vertical-align: top;"><br>
              </td>
              <td style="width: 10%; vertical-align: top;">
                <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">6.8</div>
              </td>
            </tr>
            <tr>
              <td style="width: 7%; vertical-align: top; text-align: right;">
                <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#167; 317(a)(1)</div>
              </td>
              <td style="width: 83%; vertical-align: top;"><br>
              </td>
              <td style="width: 10%; vertical-align: top;">
                <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">6.3</div>
              </td>
            </tr>
            <tr>
              <td style="width: 7%; vertical-align: top; text-align: right;">
                <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">(a)(2)</div>
              </td>
              <td style="width: 83%; vertical-align: top;"><br>
              </td>
              <td style="width: 10%; vertical-align: top;">
                <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">6.4</div>
              </td>
            </tr>
            <tr>
              <td style="width: 7%; vertical-align: top; text-align: right;">
                <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">(b)</div>
              </td>
              <td style="width: 83%; vertical-align: top;"><br>
              </td>
              <td style="width: 10%; vertical-align: top;">
                <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">2.5</div>
              </td>
            </tr>
            <tr>
              <td style="width: 7%; vertical-align: top; text-align: right;">
                <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#167; 318(a)</div>
              </td>
              <td style="width: 83%; vertical-align: top;"><br>
              </td>
              <td style="width: 10%; vertical-align: top;">
                <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">10.1</div>
              </td>
            </tr>

        </table>
      </div>
      <div style="line-height: 1.25"> <br>
      </div>
      <div style="text-align: justify; line-height: 1.25;">Note:&#160; This reconciliation and tie shall not, for any purpose, be deemed to be part of the Indenture.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-weight: normal; font-style: normal;" class="BRPFPageNumber">iv</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; text-indent: 72pt; line-height: 1.25;">Indenture dated as of __________, 20__ between Innoviz Technologies Ltd., a company incorporated under the laws of
        Israel (&#8220;<font style="font-style: italic;">Company</font>&#8221;), and [______] (&#8220;<font style="font-style: italic;">Trustee</font>&#8221;).</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt; line-height: 1.25;">Each party agrees as follows for the benefit of the other party and for the equal and ratable benefit of the
        Holders of the Securities issued under this Indenture.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: center; line-height: 1.25;">ARTICLE I.<a name="ARTICLEI."><!--Anchor--></a><br>
        DEFINITIONS AND INCORPORATION BY REFERENCE</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-indent: 36pt; line-height: 1.25;">Section 1.1.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Definitions.</u></div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt; line-height: 1.25;">&#8220;<font style="font-style: italic;">Additional
          Amounts</font>&#8221; means any additional amounts which are required hereby or by any Security, under circumstances specified herein or therein, to be paid by the Company in respect of certain taxes imposed on Holders specified herein or therein and
        which are owing to such Holders.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt; line-height: 1.25;">&#8220;<font style="font-style: italic;">Affiliate</font>&#8221;
        of any specified person means any other person directly or indirectly controlling or controlled by or under common control with such specified person.&#160;&#160; For the purposes of this definition, &#8220;control&#8221; (including, with correlative meanings, the terms
        &#8220;controlled by&#8221; and &#8220;under common control with&#8221;), as used with respect to any person, shall mean the possession, directly or indirectly, of the power to direct or cause the direction of the management or policies of such person, whether through the
        ownership of voting securities or by agreement or otherwise.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt; line-height: 1.25;">&#8220;<font style="font-style: italic;">Agent</font>&#8221;
        means any Registrar, Paying Agent or Notice Agent.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt; line-height: 1.25;">&#8220;<font style="font-style: italic;">Board of
          Directors</font>&#8221; means the board of directors of the Company or any duly authorized committee thereof.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt; line-height: 1.25;">&#8220;<font style="font-style: italic;">Board Resolution</font>&#8221;
        means a copy of a resolution certified by the Secretary or an Assistant Secretary of the Company to have been adopted by the Board of Directors or pursuant to authorization by the Board of Directors and to be in full force and effect on the date of
        the certificate and delivered to the Trustee.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt; line-height: 1.25;">&#8220;<font style="font-style: italic;">Business Day</font>&#8221;
        means any day except a Saturday, Sunday or a legal holiday in The City of New York, New York (or in connection with any payment, the place of payment) on which banking institutions are authorized or required by law, regulation or executive order to
        close.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt; line-height: 1.25;">&#8220;<font style="font-style: italic;">Capital Stock</font>&#8221;
        means any and all shares, interests, participations, rights or other equivalents (however designated) of corporate stock.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt; line-height: 1.25;">&#8220;<font style="font-style: italic;">Company</font>&#8221;
        means the party named as such above until a successor replaces it and thereafter means the successor.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt; line-height: 1.25;">&#8220;<font style="font-style: italic;">Company Order</font>&#8221;
        means a written order signed in the name of the Company by an Officer.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <!--PROfilePageNumberReset%Num%2%%%-->
      <div style="text-align: justify; text-indent: 72pt; line-height: 1.25;">&#8220;<font style="font-style: italic;">Corporate Trust
          Office</font>&#8221; means the office of the Trustee at which at any particular time its corporate trust business related to this Indenture shall be principally administered.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt; line-height: 1.25;">&#8220;<font style="font-style: italic;">Default</font>&#8221;
        means any event which is, or after notice or passage of time or both would be, an Event of Default.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt; line-height: 1.25;">&#8220;<font style="font-style: italic;">Depositary</font>&#8221;
        means, with respect to the Securities of any Series issuable or issued in whole or in part in the form of one or more Global Securities, the person designated as Depositary for such Series by the Company, which Depositary shall be a clearing agency
        registered under the Exchange Act; and if at any time there is more than one such person, &#8220;Depositary&#8221; as used with respect to the Securities of any Series shall mean the Depositary with respect to the Securities of such Series.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt; line-height: 1.25;">&#8220;<font style="font-style: italic;">Discount Security</font>&#8221;
        means any Security that provides for an amount less than the stated principal amount thereof to be due and payable upon declaration of acceleration of the maturity thereof pursuant to Section 6.2.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt; line-height: 1.25;">&#8220;<font style="font-style: italic;">Dollars</font>&#8221;
        and &#8220;<font style="font-style: italic;">$</font>&#8221; means the currency of The United States of America.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt; line-height: 1.25;">&#8220;<font style="font-style: italic;">Exchange Act</font>&#8221;
        means the Securities Exchange Act of 1934, as amended.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt; line-height: 1.25;">&#8220;<font style="font-style: italic;">Foreign Currency</font>&#8221;
        means any currency or currency unit issued by a government other than the government of The United States of America.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt; line-height: 1.25;">&#8220;<font style="font-style: italic;">Foreign
          Government Obligations</font>&#8221; means, with respect to Securities of any Series that are denominated in a Foreign Currency, direct obligations of, or obligations guaranteed by, the government that issued or caused to be issued such currency for
        the payment of which obligations its full faith and credit is pledged and which are not callable or redeemable at the option of the issuer thereof.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt; line-height: 1.25;"><font style="font-style: italic;">&#8220;GAAP&#8221;</font>
        means generally accepted accounting principles in the United States of America set forth in the opinions and pronouncements of the Accounting Principles Board of the American Institute of Certified Public Accountants and statements and
        pronouncements of the Financial Accounting Standards Board or in such other statements by such other entity as have been approved by a significant segment of the accounting profession, which are in effect as of the date of determination.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt; line-height: 1.25;">&#8220;<font style="font-style: italic;">Global Security</font>&#8221;
        or &#8220;<font style="font-style: italic;">Global Securities</font>&#8221; means a Security or Securities, as the case may be, in the form established pursuant to Section 2.2 evidencing all or
        part of a Series of Securities, issued to the Depositary for such Series or its nominee, and registered in the name of such Depositary or nominee.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt; line-height: 1.25;">&#8220;<font style="font-style: italic;">Holder</font>&#8221; or
        &#8220;<font style="font-style: italic;">Securityholder</font>&#8221; means a person in whose name a Security is registered.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt; line-height: 1.25;">&#8220;<font style="font-style: italic;">Indenture</font>&#8221;
        means this Indenture as amended or supplemented from time to time and shall include the form and terms of particular Series of Securities established as contemplated hereunder.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-weight: normal; font-style: normal;" class="BRPFPageNumber">2</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; text-indent: 72pt; line-height: 1.25;">&#8220;<font style="font-style: italic;">interest</font>&#8221;
        with respect to any Discount Security which by its terms bears interest only after Maturity, means interest payable after Maturity.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt; line-height: 1.25;">&#8220;<font style="font-style: italic;">Maturity</font>,&#8221;
        when used with respect to any Security, means the date on which the principal of such Security becomes due and payable as therein or herein provided, whether at the Stated Maturity or by declaration of acceleration, call for redemption or
        otherwise.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt; line-height: 1.25;">&#8220;<font style="font-style: italic;">Officer</font>&#8221;
        means the Chief Executive Officer, the Chief Financial Officer, the General Counsel, the Treasurer or any Assistant Treasurer, the Secretary or any Assistant Secretary, and any Vice President of the Company.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt; line-height: 1.25;">&#8220;<font style="font-style: italic;">Officer&#8217;s
          Certificate</font>&#8221; means a certificate signed by any Officer.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt; line-height: 1.25;">&#8220;<font style="font-style: italic;">Opinion of
          Counsel</font>&#8221; means a written opinion of legal counsel who is acceptable to the Trustee.&#160; The counsel may be an employee of or counsel to the Company. The opinion may contain customary limitations, conditions and exceptions.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt; line-height: 1.25;">&#8220;<font style="font-style: italic;">person</font>&#8221;
        means any individual, corporation, partnership, joint venture, association, limited liability company, joint-stock company, trust, unincorporated organization or government or any agency or political subdivision thereof.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt; line-height: 1.25;">&#8220;<font style="font-style: italic;">principal</font>&#8221;
        of a Security means the principal of the Security plus, when appropriate, the premium, if any, on, and any Additional Amounts in respect of, the Security.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt; line-height: 1.25;">&#8220;<font style="font-style: italic;">Responsible
          Officer</font>&#8221; means any officer of the Trustee in its Corporate Trust Office having responsibility for administration of this Indenture and also means, with respect to a particular corporate trust matter, any other officer to whom any corporate
        trust matter is referred because of his or her knowledge of and familiarity with a particular subject.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt; line-height: 1.25;">&#8220;<font style="font-style: italic;">SEC</font>&#8221; means
        the Securities and Exchange Commission.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt; line-height: 1.25;">&#8220;<font style="font-style: italic;">Securities</font>&#8221;
        means the debentures, notes or other debt instruments of the Company of any Series authenticated and delivered under this Indenture.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt; line-height: 1.25;">&#8220;<font style="font-style: italic;">Series</font>&#8221; or
        &#8220;<font style="font-style: italic;">Series of Securities</font>&#8221; means each series of debentures, notes or other debt instruments of the Company created pursuant to Sections 2.1 and 2.2
        hereof.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt; line-height: 1.25;">&#8220;<font style="font-style: italic;">Stated Maturity</font>&#8221;
        when used with respect to any Security, means the date specified in such Security as the fixed date on which the principal of such Security or interest is due and payable.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt; line-height: 1.25;">&#8220;<font style="font-style: italic;">Subsidiary</font>&#8221;
        of any specified person means any corporation, association or other business entity of which more than 50% of the total voting power of shares of Capital Stock entitled (without regard to the occurrence of any contingency) to vote in the election
        of directors, managers or trustees thereof is at the time owned or controlled, directly or indirectly, by such person or one or more of the other Subsidiaries of that person or a combination thereof.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-weight: normal; font-style: normal;" class="BRPFPageNumber">3</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; text-indent: 72pt; line-height: 1.25;">&#8220;<font style="font-style: italic;">TIA</font>&#8221; means
        the Trust Indenture Act of 1939 (15 U.S. Code &#167;&#167; 77aaa-77bbbb) as in effect on the date of this Indenture; <u>provided</u>, <u>however</u>, that in the event the Trust Indenture Act of 1939 is amended after such date, &#8220;TIA&#8221; means, to the extent required by any such amendment, the Trust Indenture Act as so amended.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt; line-height: 1.25;">&#8220;<font style="font-style: italic;">Trustee</font>&#8221;
        means the person named as the &#8220;Trustee&#8221; in the first paragraph of this instrument until a successor Trustee shall have become such pursuant to the applicable provisions of this Indenture, and thereafter &#8220;Trustee&#8221; shall mean or include each person
        who is then a Trustee hereunder, and if at any time there is more than one such person, &#8220;Trustee&#8221; as used with respect to the Securities of any Series shall mean the Trustee with respect to Securities of that Series.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt; line-height: 1.25;">&#8220;<font style="font-style: italic;">U.S. Government
          Obligations</font>&#8221; means securities which are direct obligations of, or guaranteed by, The United States of America for the payment of which its full faith and credit is pledged and which are not callable or redeemable at the option of the
        issuer thereof, and shall also include a depositary receipt issued by a bank or trust company as custodian with respect to any such U.S. Government Obligation or a specific payment of interest on or principal of any such U.S. Government Obligation
        held by such custodian for the account of the holder of a depositary receipt, <font style="font-style: italic;">provided</font> that (except as required by law) such custodian is not
        authorized to make any deduction from the amount payable to the holder of such depositary receipt from any amount received by the custodian in respect of the U.S. Government Obligation evidenced by such depositary receipt.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-indent: 36pt; line-height: 1.25;">Section 1.2.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Other Definitions</u>.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="line-height: 1.25">
        <table cellspacing="0" cellpadding="0" border="0" id="z2bdad11d253d4cbf8f976ba47ca22d73" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

            <tr>
              <td style="width: 90%; vertical-align: top;">
                <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif; margin-left: 36pt;"><u>TERM</u></div>
              </td>
              <td style="width: 10%; vertical-align: bottom; text-align: center;">
                <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">DEFINED IN</div>
              </td>
            </tr>
            <tr>
              <td style="width: 90%; vertical-align: top;">
                <div style="line-height: 1.25;"><br>
                </div>
              </td>
              <td style="width: 10%; vertical-align: bottom; text-align: center;">
                <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;"><u>SECTION</u></div>
              </td>
            </tr>
            <tr>
              <td style="width: 90%; vertical-align: top;">
                <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif; margin-left: 36pt;">&#8220;Bankruptcy Law&#8221;</div>
              </td>
              <td style="width: 10%; vertical-align: bottom; text-align: center;">
                <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">6.1</div>
              </td>
            </tr>
            <tr>
              <td style="width: 90%; vertical-align: top;">
                <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif; margin-left: 36pt;">&#8220;Custodian&#8221;</div>
              </td>
              <td style="width: 10%; vertical-align: bottom; text-align: center;">
                <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">6.1</div>
              </td>
            </tr>
            <tr>
              <td style="width: 90%; vertical-align: top;">
                <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif; margin-left: 36pt;">&#8220;Event of Default&#8221;</div>
              </td>
              <td style="width: 10%; vertical-align: bottom; text-align: center;">
                <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">6.1</div>
              </td>
            </tr>
            <tr>
              <td style="width: 90%; vertical-align: top;">
                <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif; margin-left: 36pt;">&#8220;Judgment Currency&#8221;</div>
              </td>
              <td style="width: 10%; vertical-align: bottom; text-align: center;">
                <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">10.16</div>
              </td>
            </tr>
            <tr>
              <td style="width: 90%; vertical-align: top;">
                <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif; margin-left: 36pt;">&#8220;Legal Holiday&#8221;</div>
              </td>
              <td style="width: 10%; vertical-align: bottom; text-align: center;">
                <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">10.7</div>
              </td>
            </tr>
            <tr>
              <td style="width: 90%; vertical-align: top;">
                <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif; margin-left: 36pt;">&#8220;mandatory sinking fund payment&#8221;</div>
              </td>
              <td style="width: 10%; vertical-align: bottom; text-align: center;">
                <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">11.1</div>
              </td>
            </tr>
            <tr>
              <td style="width: 90%; vertical-align: top;">
                <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif; margin-left: 36pt;">&#8220;New York Banking Day&#8221;</div>
              </td>
              <td style="width: 10%; vertical-align: bottom; text-align: center;">
                <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">10.16</div>
              </td>
            </tr>
            <tr>
              <td style="width: 90%; vertical-align: top;">
                <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif; margin-left: 36pt;">&#8220;Notice Agent&#8221;</div>
              </td>
              <td style="width: 10%; vertical-align: bottom; text-align: center;">
                <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">2.4</div>
              </td>
            </tr>
            <tr>
              <td style="width: 90%; vertical-align: top;">
                <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif; margin-left: 36pt;">&#8220;optional sinking fund payment&#8221;</div>
              </td>
              <td style="width: 10%; vertical-align: bottom; text-align: center;">
                <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">11.1</div>
              </td>
            </tr>
            <tr>
              <td style="width: 90%; vertical-align: top;">
                <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif; margin-left: 36pt;">&#8220;Paying Agent&#8221;</div>
              </td>
              <td style="width: 10%; vertical-align: bottom; text-align: center;">
                <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">2.4</div>
              </td>
            </tr>
            <tr>
              <td style="width: 90%; vertical-align: top;">
                <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif; margin-left: 36pt;">&#8220;Registrar&#8221;</div>
              </td>
              <td style="width: 10%; vertical-align: bottom; text-align: center;">
                <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">2.4</div>
              </td>
            </tr>
            <tr>
              <td style="width: 90%; vertical-align: top;">
                <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif; margin-left: 36pt;">&#8220;Required Currency&#8221;</div>
              </td>
              <td style="width: 10%; vertical-align: bottom; text-align: center;">
                <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">10.16</div>
              </td>
            </tr>
            <tr>
              <td style="width: 90%; vertical-align: top;">
                <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif; margin-left: 36pt;">&#8220;Specified Courts&#8221;</div>
              </td>
              <td style="width: 10%; vertical-align: bottom; text-align: center;">
                <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">10.1</div>
              </td>
            </tr>
            <tr>
              <td style="width: 90%; vertical-align: top;">
                <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif; margin-left: 36pt;">&#8220;successor person&#8221;</div>
              </td>
              <td style="width: 10%; vertical-align: bottom; text-align: center;">
                <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">5.1</div>
              </td>
            </tr>

        </table>
      </div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-indent: 36pt; line-height: 1.25;">Section 1.3.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Incorporation by Reference of Trust Indenture Act</u>.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt; line-height: 1.25;">Whenever this Indenture refers to a provision of the TIA, the provision is incorporated by reference in and made a
        part of this Indenture.&#160; The following TIA terms used in this Indenture have the following meanings:</div>
      <div style="line-height: 1.25">
        <div style="text-align: justify; text-indent: 72pt; margin-right: 36pt; line-height: 1.25;"> <br>
        </div>
        <div style="text-align: justify; text-indent: 72pt; margin-right: 36pt; line-height: 1.25;">&#8220;<font style="font-style: italic;">Commission</font>&#8221; means the SEC.</div>
      </div>
      <div style="line-height: 1.25"> <br>
      </div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-weight: normal; font-style: normal;" class="BRPFPageNumber">4</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; text-indent: 72pt; margin-right: 36pt; line-height: 1.25;"><br>
      </div>
      <div style="text-align: justify; text-indent: 72pt; margin-right: 36pt; line-height: 1.25;">&#8220;<font style="font-style: italic;">indenture securities</font>&#8221; means the Securities.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt; margin-right: 36pt; line-height: 1.25;">&#8220;<font style="font-style: italic;">indenture security holder</font>&#8221; means a Securityholder.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt; margin-right: 36pt; line-height: 1.25;">&#8220;<font style="font-style: italic;">indenture to be qualified</font>&#8221; means this Indenture.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt; margin-right: 36pt; line-height: 1.25;">&#8220;<font style="font-style: italic;">indenture trustee</font>&#8221; or &#8220;<font style="font-style: italic;">institutional trustee</font>&#8221; means the Trustee.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; margin-right: 36pt; margin-left: 72pt; line-height: 1.25;">&#8220;<font style="font-style: italic;">obligor</font>&#8221; on the indenture securities means the Company and any successor obligor upon the Securities.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt; line-height: 1.25;">All other terms used in this Indenture that are defined by the TIA, defined by TIA reference to another statute or
        defined by SEC rule under the TIA and not otherwise defined herein are used herein as so defined.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-indent: 36pt; line-height: 1.25;">Section 1.4.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Rules of Construction</u>.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt; line-height: 1.25;">Unless the context otherwise requires:</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; line-height: 1.25;">(a)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;a term has the meaning assigned to it;</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; line-height: 1.25;">(b)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;an accounting term not otherwise defined has the meaning assigned to it in accordance with GAAP;</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; line-height: 1.25;">(c)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#8220;<font style="font-style: italic;">or</font>&#8221; is not exclusive;</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; line-height: 1.25;">(d)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;words in the singular include the plural, and in the plural include the singular; and</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; line-height: 1.25;">(e)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;provisions apply to successive events and transactions.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: center; line-height: 1.25;">ARTICLE II.<a name="ARTICLEII."><!--Anchor--></a><br>
        THE SECURITIES</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-indent: 36pt; line-height: 1.25;">Section 2.1.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Issuable in Series</u>.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt; line-height: 1.25;">The aggregate principal amount of Securities that may be authenticated and delivered under this Indenture is
        unlimited.&#160; The Securities may be issued in one or more Series. All Securities of a Series shall be identical except as may be set forth or determined in the manner provided in a Board Resolution, a supplemental indenture or an Officer&#8217;s
        Certificate detailing the adoption of the terms thereof pursuant to authority granted under a Board Resolution. In the case of Securities of a Series to be issued from time to time, the Board Resolution, Officer&#8217;s Certificate or supplemental
        indenture detailing the adoption of the terms thereof pursuant to authority granted under a Board Resolution may provide for the method by which specified terms (such as interest rate, maturity date, record date or date from which interest shall
        accrue) are to be determined.&#160; Securities may differ between Series in respect of any matters, provided that all Series of Securities shall be equally and ratably entitled to the benefits of the Indenture.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-weight: normal; font-style: normal;" class="BRPFPageNumber">5</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-indent: 36pt; line-height: 1.25;">Section 2.2.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Establishment of Terms of Series of Securities</u>.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt; line-height: 1.25;">At or prior to the issuance of any Securities within a Series, the following shall be established (as to the Series
        generally, in the case of Subsection 2.2.1 and either as to such Securities within the Series or as to the Series generally in the case of Subsections 2.2.2 through 2.2.23) by or pursuant to a Board Resolution, and set forth or determined in the
        manner provided in a Board Resolution, supplemental indenture hereto or Officer&#8217;s Certificate:</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt; line-height: 1.25;">2.2.1.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;the title (which shall distinguish the Securities of that particular Series from the Securities of any other Series) and ranking (including the terms of any subordination provisions) of the Series;</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt; line-height: 1.25;">2.2.2.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;the price or prices (expressed as a percentage of the principal amount thereof) at which the Securities of the Series will be issued;</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt; line-height: 1.25;">2.2.3.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;any limit upon the aggregate principal amount of the Securities of the Series which may be authenticated and delivered under this Indenture (except for Securities authenticated and delivered upon registration of transfer of, or in
          exchange for, or in lieu of, other Securities of the Series pursuant to Section 2.7, 2.8, 2.11, 3.6 or 9.6);</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt; line-height: 1.25;">2.2.4.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;the date or dates on which the principal of the Securities of the Series is payable;</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt; line-height: 1.25;">2.2.5.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;the rate or rates (which may be fixed or variable) per annum or, if applicable, the method used to determine such rate or rates (including, but not limited to, any commodity, commodity index, stock exchange index or financial index) at
          which the Securities of the Series shall bear interest, if any, the date or dates from which such interest, if any, shall accrue, the date or dates on which such interest, if any, shall commence and be payable and any regular record date for the
          interest payable on any interest payment date;</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt; line-height: 1.25;">2.2.6.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;the place or places where the principal of and interest, if any, on the Securities of the Series shall be payable, where the Securities of such Series may be surrendered for registration of transfer or exchange and where notices and
          demands to or upon the Company in respect of the Securities of such Series and this Indenture may be delivered, and the method of such payment, if by wire transfer, mail or other means;</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt; line-height: 1.25;">2.2.7.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;if applicable, the period or periods within which, the price or prices at which and the terms and conditions upon which the Securities of the Series may be redeemed, in whole or in part, at the option of the Company;</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt; line-height: 1.25;">2.2.8.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;the obligation, if any, of the Company to redeem or purchase the Securities of the Series pursuant to any sinking fund or analogous provisions or at the option of a Holder thereof and the period or periods within which, the price or
          prices at which and the terms and conditions upon which Securities of the Series shall be redeemed or purchased, in whole or in part, pursuant to such obligation;</div>
      <div style="line-height: 1.25">&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-weight: normal; font-style: normal;" class="BRPFPageNumber">6</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; text-indent: 72pt; line-height: 1.25;">2.2.9.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;the dates, if any, on which and the price or prices at which the Securities of the Series will be repurchased by the Company at the option of the Holders thereof and other detailed terms and provisions of such repurchase obligations;</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt; line-height: 1.25;">2.2.10.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;if other than denominations of $1,000 and any integral multiple thereof, the denominations in which the Securities of the Series shall be issuable;</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt; line-height: 1.25;">2.2.11.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;the forms of the Securities of the Series and whether the Securities will be issuable as Global Securities;</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt; line-height: 1.25;">2.2.12.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;if other than the principal amount thereof, the portion of the principal amount of the Securities of the Series that shall be payable upon declaration of acceleration of the maturity thereof pursuant to Section 6.2;</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt; line-height: 1.25;">2.2.13.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;the currency of denomination of the Securities of the Series, which may be Dollars or any Foreign Currency, and if such currency of denomination is a composite currency, the agency or organization, if any, responsible for overseeing such
          composite currency;</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt; line-height: 1.25;">2.2.14.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;the designation of the currency, currencies or currency units in which payment of the principal of and interest, if any, on the Securities of the Series will be made;</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt; line-height: 1.25;">2.2.15.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;if payments of principal of or interest, if any, on the Securities of the Series are to be made in one or more currencies or currency units other than that or those in which such Securities are denominated, the manner in which the
          exchange rate with respect to such payments will be determined;</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt; line-height: 1.25;">2.2.16.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;the manner in which the amounts of payment of principal of or interest, if any, on the Securities of the Series will be determined, if such amounts may be determined by reference to an index based on a currency or currencies or by
          reference to a commodity, commodity index, stock exchange index or financial index;</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt; line-height: 1.25;">2.2.17.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;the provisions, if any, relating to any security provided for the Securities of the Series;</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt; line-height: 1.25;">2.2.18.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;any addition to, deletion of or change in the Events of Default which applies to any Securities of the Series and any change in the right of the Trustee or the requisite Holders of such Securities to declare the principal amount thereof
          due and payable pursuant to Section 6.2;</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt; line-height: 1.25;">2.2.19.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;any addition to, deletion of or change in the covenants set forth in Articles IV or V which applies to Securities of the Series;</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt; line-height: 1.25;">2.2.20.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;any Depositaries, interest rate calculation agents, exchange rate calculation agents or other agents with respect to Securities of such Series if other than those appointed herein;</div>
      <div style="line-height: 1.25">&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-weight: normal; font-style: normal;" class="BRPFPageNumber">7</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; text-indent: 72pt; line-height: 1.25;">2.2.21.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;the provisions, if any, relating to conversion or exchange of any Securities of such Series, including if applicable, the conversion or exchange price, the conversion or exchange period, provisions as to whether conversion or exchange
          will be mandatory, at the option of the Holders thereof or at the option of the Company, the events requiring an adjustment of the conversion price or exchange price and provisions affecting conversion or exchange if such Series of Securities are
          redeemed;</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt; line-height: 1.25;">2.2.22.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;any other terms of the Series (which may supplement, modify or delete any provision of this Indenture insofar as it applies to such Series), including any terms that may be required under applicable law or regulations or advisable in
          connection with the marketing of Securities of that Series; and</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt; line-height: 1.25;">2.2.23.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;whether any of the Company&#8217;s direct or indirect Subsidiaries will guarantee the Securities of that Series, including the terms of subordination, if any, of such guarantees.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt; line-height: 1.25;">All Securities of any one Series need not be issued at the same time and may be issued from time to time,
        consistent with the terms of this Indenture, if so provided by or pursuant to the Board Resolution, supplemental indenture hereto or Officer&#8217;s Certificate referred to above.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-indent: 36pt; line-height: 1.25;">Section 2.3.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Execution and Authentication</u>.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt; line-height: 1.25;">An Officer shall sign the Securities for the Company by manual, facsimile or electronic signature.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt; line-height: 1.25;">If an Officer whose signature is on a Security no longer holds that office at the time the Security is
        authenticated, the Security shall nevertheless be valid.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt; line-height: 1.25;">A Security shall not be valid until authenticated by the manual signature of the Trustee or an authenticating
        agent.&#160; The signature shall be conclusive evidence that the Security has been authenticated under this Indenture.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt; line-height: 1.25;">The Trustee shall at any time, and from time to time, authenticate Securities for original issue in the principal
        amount provided in the Board Resolution, supplemental indenture hereto or Officer&#8217;s Certificate, upon receipt by the Trustee of a Company Order.&#160; Each Security shall be dated the date of its authentication.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt; line-height: 1.25;">The aggregate principal amount of Securities of any Series outstanding at any time may not exceed any limit upon
        the maximum principal amount for such Series set forth in the Board Resolution, supplemental indenture hereto or Officer&#8217;s Certificate delivered pursuant to Section 2.2, except as provided in Section 2.8.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt; line-height: 1.25;">Prior to the issuance of Securities of any Series, the Trustee shall have received and (subject to Section 7.2)
        shall be fully protected in relying on:&#160; (a) the Board Resolution, supplemental indenture hereto or Officer&#8217;s Certificate establishing the form of the Securities of that Series or of Securities within that Series and the terms of the Securities of
        that Series or of Securities within that Series, (b) an Officer&#8217;s Certificate complying with Section 10.4, and (c) an Opinion of Counsel complying with Section 10.4.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-weight: normal; font-style: normal;" class="BRPFPageNumber">8</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; text-indent: 72pt; line-height: 1.25;">The Trustee shall have the right to decline to authenticate and deliver any Securities of such Series: (a) if the
        Trustee, being advised by counsel, determines that such action may not be taken lawfully; or (b) if the Trustee in good faith by its board of directors or trustees, executive committee or a trust committee of directors and/or vice-presidents or a
        committee of Responsible Officers shall determine that such action would expose the Trustee to personal liability to Holders of any then outstanding Series of Securities.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt; line-height: 1.25;">The Trustee may appoint an authenticating agent acceptable to the Company to authenticate Securities.&#160; An
        authenticating agent may authenticate Securities whenever the Trustee may do so.&#160; Each reference in this Indenture to authentication by the Trustee includes authentication by such agent.&#160; An authenticating agent has the same rights as an Agent to
        deal with the Company or an Affiliate of the Company.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-indent: 36pt; line-height: 1.25;">Section 2.4.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Registrar and Paying Agent</u>.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt; line-height: 1.25;">The Company shall maintain, with respect to each Series of Securities, at the place or places specified with
        respect to such Series pursuant to Section 2.2, an office or agency where Securities of such Series may be presented or surrendered for payment (&#8220;<font style="font-style: italic;">Paying
          Agent</font>&#8221;), where Securities of such Series may be surrendered for registration of transfer or exchange (&#8220;<font style="font-style: italic;">Registrar</font>&#8221;) and where notices
        and demands to or upon the Company in respect of the Securities of such Series and this Indenture may be delivered (&#8220;<font style="font-style: italic;">Notice Agent</font>&#8221;).&#160; The
        Registrar shall keep a register with respect to each Series of Securities and to their transfer and exchange.&#160; The Company will give prompt written notice to the Trustee of the name and address, and any change in the name or address, of each
        Registrar, Paying Agent or Notice Agent.&#160; If at any time the Company shall fail to maintain any such required Registrar, Paying Agent or Notice Agent or shall fail to furnish the Trustee with the name and address thereof, such presentations,
        surrenders, notices and demands may be made or served at the Corporate Trust Office of the Trustee, and the Company hereby appoints the Trustee as its agent to receive all such presentations, surrenders, notices and demands; <u>provided</u>, <u>however</u>, that any appointment of the Trustee as the Notice
        Agent shall exclude the appointment of the Trustee or any office of the Trustee as an agent to receive the service of legal process on the Company.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt; line-height: 1.25;">The Company may also from time to time designate one or more co-registrars, additional paying agents or additional
        notice agents and may from time to time rescind such designations; <u>provided</u>, <u>however</u>,
        that no such designation or rescission shall in any manner relieve the Company of its obligations to maintain a Registrar, Paying Agent and Notice Agent in each place so specified pursuant to Section 2.2 for Securities of any Series for such
        purposes.&#160; The Company will give prompt written notice to the Trustee of any such designation or rescission and of any change in the name or address of any such co-registrar, additional paying agent or additional notice agent.&#160; The term &#8220;<font style="font-style: italic;">Registrar</font>&#8221; includes any co-registrar; the term &#8220;<font style="font-style: italic;">Paying
          Agent</font>&#8221; includes any additional paying agent; and the term &#8220;<font style="font-style: italic;">Notice Agent</font>&#8221; includes any additional notice agent.&#160; The Company or any of
        its Affiliates may serve as Registrar or Paying Agent.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt; line-height: 1.25;">The Company hereby appoints the Trustee the initial Registrar, Paying Agent and Notice Agent for each Series unless
        another Registrar, Paying Agent or Notice Agent, as the case may be, is appointed prior to the time Securities of that Series are first issued.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-weight: normal; font-style: normal;" class="BRPFPageNumber">9</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-indent: 36pt; line-height: 1.25;">Section 2.5.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Paying Agent to Hold Money in Trust</u>.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt; line-height: 1.25;">The Company shall require each Paying Agent other than the Trustee to agree in writing that the Paying Agent will
        hold in trust, for the benefit of Securityholders of any Series of Securities, or the Trustee, all money held by the Paying Agent for the payment of principal of or interest on the Series of Securities, and will notify the Trustee in writing of any
        default by the Company in making any such payment.&#160; While any such default continues, the Trustee may require a Paying Agent to pay all money held by it to the Trustee.&#160; The Company at any time may require a Paying Agent to pay all money held by it
        to the Trustee.&#160; Upon payment over to the Trustee, the Paying Agent (if other than the Company or a Subsidiary of the Company) shall have no further liability for the money.&#160; If the Company or a Subsidiary of the Company acts as Paying Agent, it
        shall segregate and hold in a separate trust fund for the benefit of Securityholders of any Series of Securities all money held by it as Paying Agent.&#160; Upon any bankruptcy, reorganization or similar proceeding with respect to the Company, the
        Trustee shall serve as Paying Agent for the Securities.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-indent: 36pt; line-height: 1.25;">Section 2.6.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Securityholder Lists</u>.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt; line-height: 1.25;">The Trustee shall preserve in as current a form as is reasonably practicable the most recent list available to it
        of the names and addresses of Securityholders of each Series of Securities and shall otherwise comply with TIA&#160; &#167; 312(a).&#160; If the Trustee is not the Registrar, the Company shall furnish to the Trustee at least ten days before each interest payment
        date and at such other times as the Trustee may request in writing a list, in such form and as of such date as the Trustee may reasonably require, of the names and addresses of Securityholders of each Series of Securities.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-indent: 36pt; line-height: 1.25;">Section 2.7.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Transfer and Exchange</u>.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt; line-height: 1.25;">Where Securities of a Series are presented to the Registrar or a co-registrar with a request to register a transfer
        or to exchange them for an equal principal amount of Securities of the same Series, the Registrar shall register the transfer or make the exchange if its requirements for such transactions are met.&#160; To permit registrations of transfers and
        exchanges, the Trustee shall authenticate Securities at the Registrar&#8217;s request.&#160; No service charge shall be made for any registration of transfer or exchange (except as otherwise expressly permitted herein), but the Company may require payment of
        a sum sufficient to cover any transfer tax or similar governmental charge payable in connection therewith (other than any such transfer tax or similar governmental charge payable upon exchanges pursuant to Sections 2.11, 3.6 or 9.6).</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt; line-height: 1.25;">Neither the Company nor the Registrar shall be required (a) to issue, register the transfer of, or exchange
        Securities of any Series for the period beginning at the opening of business 15 days immediately preceding the sending of a notice of redemption of Securities of that Series selected for redemption and ending at the close of business on the day
        such notice is sent, or (b) to register the transfer of or exchange Securities of any Series selected, called or being called for redemption as a whole or the portion being redeemed of any such Securities selected, called or being called for
        redemption in part.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-indent: 36pt; line-height: 1.25;">Section 2.8.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Mutilated, Destroyed, Lost and Stolen Securities</u>.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt; line-height: 1.25;">If any mutilated Security is surrendered to the Trustee, the Company shall execute and the Trustee shall
        authenticate and deliver in exchange therefor a new Security of the same Series and of like tenor and principal amount and bearing a number not contemporaneously outstanding.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-weight: normal; font-style: normal;" class="BRPFPageNumber">10</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      </div>
      <div style="text-align: justify; text-indent: 72pt; line-height: 1.25;">If there shall be delivered to the Company and the Trustee (i) evidence to their satisfaction of the destruction,
        loss or theft of any Security and (ii) such security or indemnity bond as may be required by each of them to hold itself and any of its agents harmless, then, in the absence of notice to the Company or the Trustee that such Security has been
        acquired by a bona fide purchaser, the Company shall execute and upon receipt of a Company Order the Trustee shall authenticate and make available for delivery, in lieu of any such destroyed, lost or stolen Security, a new Security of the same
        Series and of like tenor and principal amount and bearing a number not contemporaneously outstanding.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt; line-height: 1.25;">In case any such mutilated, destroyed, lost or stolen Security has become or is about to become due and payable,
        the Company in its discretion may, instead of issuing a new Security, pay such Security.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt; line-height: 1.25;">Upon the issuance of any new Security under this Section, the Company may require the payment of a sum sufficient
        to cover any tax or other governmental charge that may be imposed in relation thereto and any other expenses (including the fees and expenses of the Trustee) connected therewith.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt; line-height: 1.25;">Every new Security of any Series issued pursuant to this Section in lieu of any destroyed, lost or stolen Security
        shall constitute an original additional contractual obligation of the Company, whether or not the destroyed, lost or stolen Security shall be at any time enforceable by anyone, and shall be entitled to all the benefits of this Indenture equally and
        proportionately with any and all other Securities of that Series duly issued hereunder.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt; line-height: 1.25;">The provisions of this Section are exclusive and shall preclude (to the extent lawful) all other rights and
        remedies with respect to the replacement or payment of mutilated, destroyed, lost or stolen Securities.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-indent: 36pt; line-height: 1.25;">Section 2.9.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Outstanding Securities</u>.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt; line-height: 1.25;">The Securities outstanding at any time are all the Securities authenticated by the Trustee except for those
        canceled by it, those delivered to it for cancellation, those reductions in the interest on a Global Security effected by the Trustee in accordance with the provisions hereof and those described in this Section as not outstanding.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt; line-height: 1.25;">If a Security is replaced pursuant to Section 2.8, it ceases to be outstanding until the Trustee receives proof
        satisfactory to it that the replaced Security is held by a bona fide purchaser.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt; line-height: 1.25;">If the Paying Agent (other than the Company, a Subsidiary of the Company or an Affiliate of the Company) holds on
        the Maturity of Securities of a Series money sufficient to pay such Securities payable on that date, then on and after that date such Securities of the Series cease to be outstanding and interest on them ceases to accrue.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-weight: normal; font-style: normal;" class="BRPFPageNumber">11</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; text-indent: 72pt; line-height: 1.25;">The Company may purchase or otherwise acquire the Securities, whether by open market purchases, negotiated
        transactions or otherwise.&#160; A Security does not cease to be outstanding because the Company or an Affiliate of the Company holds the Security (but see Section 2.10 below).</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt; line-height: 1.25;">In determining whether the Holders of the requisite principal amount of outstanding Securities have given any
        request, demand, authorization, direction, notice, consent or waiver hereunder, the principal amount of a Discount Security that shall be deemed to be outstanding for such purposes shall be the amount of the principal thereof that would be due and
        payable as of the date of such determination upon a declaration of acceleration of the Maturity thereof pursuant to Section 6.2.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-indent: 36pt; line-height: 1.25;">Section 2.10.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Treasury Securities</u>.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt; line-height: 1.25;">In determining whether the Holders of the required principal amount of Securities of a Series have concurred in any
        request, demand, authorization, direction, notice, consent or waiver, Securities of a Series owned by the Company or any Affiliate of the Company shall be disregarded, except that for the purposes of determining whether the Trustee shall be
        protected in relying on any such request, demand, authorization, direction, notice, consent or waiver only Securities of a Series that a Responsible Officer of the Trustee knows are so owned shall be so disregarded.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-indent: 36pt; line-height: 1.25;">Section 2.11.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Temporary Securities</u>.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt; line-height: 1.25;">Until definitive Securities are ready for delivery, the Company may prepare and the Trustee shall authenticate
        temporary Securities upon a Company Order.&#160; Temporary Securities shall be substantially in the form of definitive Securities but may have variations that the Company considers appropriate for temporary Securities.&#160; Without unreasonable delay, the
        Company shall prepare and the Trustee upon receipt of a Company Order shall authenticate definitive Securities of the same Series and date of maturity in exchange for temporary Securities.&#160; Until so exchanged, temporary securities shall have the
        same rights under this Indenture as the definitive Securities.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-indent: 36pt; line-height: 1.25;">Section 2.12.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Cancellation</u>.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt; line-height: 1.25;">The Company at any time may deliver Securities to the Trustee for cancellation.&#160; The Registrar and the Paying Agent
        shall forward to the Trustee any Securities surrendered to them for registration of transfer, exchange or payment.&#160; The Trustee shall cancel all Securities surrendered for transfer, exchange, payment, replacement or cancellation and shall destroy
        such canceled Securities (subject to the record retention requirement of the Exchange Act and the Trustee) and deliver a certificate of such cancellation to the Company upon written request of the Company.&#160; The Company may not issue new Securities
        to replace Securities that it has paid or delivered to the Trustee for cancellation.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-indent: 36pt; line-height: 1.25;">Section 2.13.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Defaulted Interest</u>.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt; line-height: 1.25;">If the Company defaults in a payment of interest on a Series of Securities, it shall pay the defaulted interest,
        plus, to the extent permitted by law, any interest payable on the defaulted interest, to the persons who are Securityholders of the Series on a subsequent special record date.&#160; The Company shall fix the record date and payment date.&#160; At least ten
        days before the special record date, the Company shall send to the Trustee and to each Securityholder of the Series a notice that states the special record date, the payment date and the amount of interest to be paid.&#160; The Company may pay defaulted
        interest in any other lawful manner.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-weight: normal; font-style: normal;" class="BRPFPageNumber">12</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      </div>
      <div style="text-indent: 36pt; line-height: 1.25;">Section 2.14.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Global Securities</u>.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt; line-height: 1.25;">2.14.1.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Terms of Securities</u>.&#160; A Board Resolution, a supplemental indenture hereto or an Officer&#8217;s Certificate shall establish whether the Securities of a
          Series shall be issued in whole or in part in the form of one or more Global Securities and the Depositary for such Global Security or Securities.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt; line-height: 1.25;">2.14.2.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Transfer and Exchange</u>.&#160; Notwithstanding any provisions to the contrary contained in Section 2.7 of the Indenture and in addition thereto, any
          Global Security shall be exchangeable pursuant to Section 2.7 of the Indenture for Securities registered in the names of Holders other than the Depositary for such Security or its nominee only if (i) such Depositary notifies the Company that it
          is unwilling or unable to continue as Depositary for such Global Security or if at any time such Depositary ceases to be a clearing agency registered under the Exchange Act, and, in either case, the Company fails to appoint a successor Depositary
          registered as a clearing agency under the Exchange Act within 90 days of such event or (ii) the Company executes and delivers to the Trustee an Officer&#8217;s Certificate to the effect that such Global Security shall be so exchangeable.&#160; Any Global
          Security that is exchangeable pursuant to the preceding sentence shall be exchangeable for Securities registered in such names as the Depositary shall direct in writing in an aggregate principal amount equal to the principal amount of the Global
          Security with like tenor and terms.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt; line-height: 1.25;">Except as provided in this Section 2.14.2, a Global Security may not be transferred except as a whole by the
        Depositary with respect to such Global Security to a nominee of such Depositary, by a nominee of such Depositary to such Depositary or another nominee of such Depositary or by the Depositary or any such nominee to a successor Depositary or a
        nominee of such a successor Depositary.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt; line-height: 1.25;">2.14.3.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Legends</u>.&#160; Any Global Security issued hereunder shall bear a legend in substantially the following form:</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt; line-height: 1.25;">&#8220;THIS SECURITY IS A GLOBAL SECURITY WITHIN THE MEANING OF THE INDENTURE HEREINAFTER REFERRED TO AND IS REGISTERED
        IN THE NAME OF THE DEPOSITARY OR A NOMINEE OF THE DEPOSITARY.&#160; THIS SECURITY IS EXCHANGEABLE FOR SECURITIES REGISTERED IN THE NAME OF A PERSON OTHER THAN THE DEPOSITARY OR ITS NOMINEE ONLY IN THE LIMITED CIRCUMSTANCES DESCRIBED IN THE INDENTURE,
        AND MAY NOT BE TRANSFERRED EXCEPT AS A WHOLE BY THE DEPOSITARY TO A NOMINEE OF THE DEPOSITARY, BY A NOMINEE OF THE DEPOSITARY TO THE DEPOSITARY OR ANOTHER NOMINEE OF THE DEPOSITARY OR BY THE DEPOSITARY OR ANY SUCH NOMINEE TO A SUCCESSOR DEPOSITARY
        OR A NOMINEE OF SUCH A SUCCESSOR DEPOSITARY.&#8221;</div>
      <div style="line-height: 1.25">&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-weight: normal; font-style: normal;" class="BRPFPageNumber">13</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; text-indent: 72pt; line-height: 1.25;">In addition, so long as the Depository Trust Company (&#8220;DTC&#8221;) is the Depositary, each Global Note registered in the
        name of DTC or its nominee shall bear a legend in substantially the following form:</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt; line-height: 1.25;">&#8220;UNLESS THIS GLOBAL NOTE IS PRESENTED BY AN AUTHORIZED REPRESENTATIVE OF THE DEPOSITORY TRUST COMPANY, A NEW YORK
        CORPORATION (&#8220;DTC&#8221;), TO THE COMPANY OR ITS AGENT FOR REGISTRATION OF TRANSFER, EXCHANGE OR PAYMENT, AND ANY GLOBAL NOTE ISSUED IS REGISTERED IN THE NAME OF CEDE &amp; CO. OR IN SUCH OTHER NAME AS IS REQUESTED BY AN AUTHORIZED REPRESENTATIVE OF DTC
        (AND ANY PAYMENT IS MADE TO CEDE &amp; CO. OR TO SUCH OTHER ENTITY AS IS REQUESTED BY AN AUTHORIZED REPRESENTATIVE OF DTC), ANY TRANSFER, PLEDGE OR OTHER USE HEREOF FOR VALUE OR OTHERWISE BY OR TO ANY PERSON IS WRONGFUL INASMUCH AS THE REGISTERED
        OWNER HEREOF, CEDE &amp; CO., HAS AN INTEREST HEREIN.&#8221;</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt; line-height: 1.25;">2.14.4.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Acts of Holders</u>.&#160; The Depositary, as a Holder, may appoint agents and otherwise authorize participants to give or take any request, demand,
          authorization, direction, notice, consent, waiver or other action which a Holder is entitled to give or take under the Indenture.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt; line-height: 1.25;">2.14.5.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Payments</u>.&#160; Notwithstanding the other provisions of this Indenture, unless otherwise specified as contemplated by Section 2.2, payment of the
          principal of and interest, if any, on any Global Security shall be made to the Holder thereof.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt; line-height: 1.25;">2.14.6.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Consents, Declaration and Directions</u>.&#160; The Company, the Trustee and any Agent shall treat a person as the Holder of such principal amount of
          outstanding Securities of such Series represented by a Global Security as shall be specified in a written statement of the Depositary or by the applicable procedures of the Depositary with respect to such Global Security, for purposes of
          obtaining any consents, declarations, waivers or directions required to be given by the Holders pursuant to this Indenture.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-indent: 36pt; line-height: 1.25;">Section 2.15.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>CUSIP Numbers</u>.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt; line-height: 1.25;">The Company in issuing the Securities may use &#8220;CUSIP&#8221; numbers (if then generally in use), and, if so, the Trustee
        shall use &#8220;CUSIP&#8221; numbers in notices of redemption as a convenience to Holders; <u>provided</u> that any such notice may state that no representation is made as to
        the correctness of such numbers either as printed on the Securities or as contained in any notice of a redemption and that reliance may be placed only on the other elements of identification printed on the Securities, and any such redemption shall
        not be affected by any defect in or omission of such numbers.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-weight: normal; font-style: normal;" class="BRPFPageNumber">14</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: center; line-height: 1.25;">ARTICLE III.<a name="ARTICLEIII."><!--Anchor--></a><br>
        REDEMPTION</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-indent: 36pt; line-height: 1.25;">Section 3.1.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Notice to Trustee</u>.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt; line-height: 1.25;">The Company may, with respect to any Series of Securities, reserve the right to redeem and pay the Series of
        Securities or may covenant to redeem and pay the Series of Securities or any part thereof prior to the Stated Maturity thereof at such time and on such terms as provided for in such Securities.&#160; If a Series of Securities is redeemable and the
        Company wants or is obligated to redeem prior to the Stated Maturity thereof all or part of the Series of Securities pursuant to the terms of such Securities, it shall notify the Trustee in writing of the redemption date and the principal amount of
        the Series of Securities to be redeemed.&#160; The Company shall give the notice at least 15 days before the redemption date, unless a shorter period is satisfactory to the Trustee.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-indent: 36pt; line-height: 1.25;">Section 3.2.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Selection of Securities to be Redeemed</u>.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt; line-height: 1.25;">Unless otherwise indicated for a particular Series by a Board Resolution, a supplemental indenture hereto or an
        Officer&#8217;s Certificate, if less than all the Securities of a Series are to be redeemed, the Securities of the Series to be redeemed will be selected as follows:&#160; (a) if the Securities are in the form of Global Securities, in accordance with the
        procedures of the Depositary, (b) if the Securities are listed on any national securities exchange, in compliance with the requirements of the principal national securities exchange, if any, on which the Securities are listed, or (c) if not
        otherwise provided for under clause (a) or (b) in the manner that the Trustee deems fair and appropriate, including by lot or other method, unless otherwise required by law or applicable stock exchange requirements, subject, in the case of Global
        Securities, to the applicable rules and procedures of the Depositary.&#160; The Securities to be redeemed shall be selected from Securities of the Series outstanding not previously called for redemption.&#160; Portions of the principal of Securities of the
        Series that have denominations larger than $1,000 may be selected for redemption.&#160; Securities of the Series and portions of them it selected for redemption shall be in amounts of $1,000 or whole multiples of $1,000 or, with respect to Securities of
        any Series issuable in other denominations pursuant to Section 2.2.10, the minimum principal denomination for each Series and the authorized integral multiples thereof.&#160; Provisions of this Indenture that apply to Securities of a Series called for
        redemption also apply to portions of Securities of that Series called for redemption.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-indent: 36pt; line-height: 1.25;">Section 3.3.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Notice of Redemption</u>.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt; line-height: 1.25;">Unless otherwise indicated for a particular Series by Board Resolution, a supplemental indenture hereto or an
        Officer&#8217;s Certificate, at least 15 days but not more than 60 days before a redemption date, the Company shall send or cause to be sent by first-class mail or electronically, in accordance with the procedures of the Depositary, a notice of
        redemption to each Holder whose Securities are to be redeemed.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt; line-height: 1.25;">The notice shall identify the Securities of the Series to be redeemed and shall state:</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; line-height: 1.25;">(a)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;the redemption date;</div>
      <div style="line-height: 1.25">&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-weight: normal; font-style: normal;" class="BRPFPageNumber">15</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; line-height: 1.25;">(b)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;the redemption price;</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; line-height: 1.25;">(c)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;the name and address of the Paying Agent;</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; line-height: 1.25;">(d)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;if any Securities are being redeemed in part, the portion of the principal amount of such Securities to be redeemed and that, after the redemption date and upon surrender of such Security, a new Security or Securities in
          principal amount equal to the unredeemed portion of the original Security shall be issued in the name of the Holder thereof upon cancellation of the original Security;</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; line-height: 1.25;">(e)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;that Securities of the Series called for redemption must be surrendered to the Paying Agent to collect the redemption price;</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; line-height: 1.25;">(f)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;that interest on Securities of the Series called for redemption ceases to accrue on and after the redemption date unless the Company defaults in the deposit of the redemption price;</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; line-height: 1.25;">(g)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;the CUSIP number, if any; and</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; line-height: 1.25;">(h)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;any other information as may be required by the terms of the particular Series or the Securities of a Series being redeemed.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt; line-height: 1.25;">At the Company&#8217;s request, the Trustee shall give the notice of redemption in the Company&#8217;s name and at its expense,
        provided, however, that the Company has delivered to the Trustee, at least 10 days (unless a shorter time shall be acceptable to the Trustee) prior to the notice date, an Officer&#8217;s Certificate requesting that the Trustee give such notice and
        setting forth the information to be stated in such notice.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-indent: 36pt; line-height: 1.25;">Section 3.4.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Effect of Notice of Redemption</u>.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt; line-height: 1.25;">Once notice of redemption is sent as provided in Section 3.3, Securities of a Series called for redemption become
        due and payable on the redemption date and at the redemption price.&#160; Except as otherwise provided in the supplemental indenture, Board Resolution or Officer&#8217;s Certificate for a Series, a notice of redemption may not be conditional.&#160; Upon surrender
        to the Paying Agent, such Securities shall be paid at the redemption price plus accrued interest to the redemption date.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-indent: 36pt; line-height: 1.25;">Section 3.5.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Deposit of Redemption Price</u>.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt; line-height: 1.25;">On or before 11:00 a.m., New York City time, on the redemption date, the Company shall deposit with the Paying
        Agent money sufficient to pay the redemption price of and accrued interest, if any, on all Securities to be redeemed on that date.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-indent: 36pt; line-height: 1.25;">Section 3.6.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Securities Redeemed in Part</u>.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt; line-height: 1.25;">Upon surrender of a Security that is redeemed in part, the Trustee shall authenticate for the Holder a new Security
        of the same Series and the same maturity equal in principal amount to the unredeemed portion of the Security surrendered.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-weight: normal; font-style: normal;" class="BRPFPageNumber">16</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: center; line-height: 1.25;">ARTICLE IV.<a name="ARTICLEIV."><!--Anchor--></a><br>
        COVENANTS</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-indent: 36pt; line-height: 1.25;">Section 4.1.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Payment of Principal and Interest</u>.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt; line-height: 1.25;">The Company covenants and agrees for the benefit of the Holders of each Series of Securities that it will duly and
        punctually pay the principal of and interest, if any, on the Securities of that Series in accordance with the terms of such Securities and this Indenture.&#160; On or before 11:00 a.m., New York City time, on the applicable payment date, the Company
        shall deposit with the Paying Agent money sufficient to pay the principal of and interest, if any, on the Securities of each Series in accordance with the terms of such Securities and this Indenture.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-indent: 36pt; line-height: 1.25;">Section 4.2.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>SEC Reports</u>.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt; line-height: 1.25;">To the extent any Securities of a Series are outstanding, the Company shall deliver to the Trustee within 15 days
        after it files them with the SEC copies of the annual reports and of the information, documents, and other reports (or copies of such portions of any of the foregoing as the SEC may by rules and regulations prescribe) which the Company is required
        to file with the SEC pursuant to Section 13 or 15(d) of the Exchange Act.&#160; The Company also shall comply with the other provisions of TIA &#167; 314(a). Reports, information and documents filed with the SEC via the EDGAR system will be deemed to be
        delivered to the Trustee as of the time of such filing via EDGAR for purposes of this Section 4.2.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt; line-height: 1.25;">Delivery of reports, information and documents to the Trustee under this Section 4.2 is for informational purposes
        only and the Trustee&#8217;s receipt of the foregoing shall not constitute constructive or actual notice of any information contained therein or determinable from information contained therein, including the Company&#8217;s compliance with any of the covenants
        hereunder (as to which the Trustee is entitled to rely exclusively on Officer&#8217;s Certificates).&#160; All such reports, information or documents referred to in this Section 4.2 that the Company files with the SEC via the SEC&#8217;s EDGAR system shall be
        deemed to be filed with the Trustee and transmitted to Holders at the time such reports, information or documents are filed via the EDGAR system (or any successor system).</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-indent: 36pt; line-height: 1.25;">Section 4.3.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Compliance Certificate</u>.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt; line-height: 1.25;">To the extent any Securities of a Series are outstanding, the Company shall deliver to the Trustee, within 120 days
        after the end of each fiscal year of the Company, an Officer&#8217;s Certificate stating that a review of the activities of the Company and its Subsidiaries during the preceding fiscal year has been made under the supervision of the signing Officers with
        a view to determining whether the Company has kept, observed, performed and fulfilled its obligations under this Indenture, and further stating, as to each such Officer signing such certificate, that to the best of his/her knowledge the Company has
        kept, observed, performed and fulfilled each and every covenant contained in this Indenture and is not in default in the performance or observance of any of the terms, provisions and conditions hereof (or, if a Default or Event of Default shall
        have occurred, describing all such Defaults or Events of Default of which the Officer may have knowledge).</div>
      <div style="line-height: 1.25">&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-weight: normal; font-style: normal;" class="BRPFPageNumber">17</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-indent: 36pt; line-height: 1.25;">Section 4.4.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Stay, Extension and Usury Laws</u>.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt; line-height: 1.25;">The Company covenants (to the extent that it may lawfully do so) that it will not at any time insist upon, plead,
        or in any manner whatsoever claim or take the benefit or advantage of, any stay, extension or usury law wherever enacted, now or at any time hereafter in force, which may affect the covenants or the performance of this Indenture or the Securities;
        and the Company (to the extent it may lawfully do so) hereby expressly waives all benefit or advantage of any such law and covenants that it will not, by resort to any such law, hinder, delay or impede the execution of any power herein granted to
        the Trustee, but will suffer and permit the execution of every such power as though no such law has been enacted.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: center; line-height: 1.25;">ARTICLE V.<a name="ARTICLEV."><!--Anchor--></a><br>
        SUCCESSORS</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-indent: 36pt; line-height: 1.25;">Section 5.1.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>When Company May Merge, Etc</u>.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt; line-height: 1.25;">The Company shall not consolidate with or merge with or into, or convey, transfer or lease all or substantially all
        of its properties and assets to, any person (a &#8220;<font style="font-style: italic;">successor person</font>&#8221;) unless:</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; line-height: 1.25;">(a)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;the Company is the surviving entity or the successor person (if other than the Company) is a corporation, partnership, trust or other entity organized and validly existing under the laws of any U.S. domestic jurisdiction or
          the state of Israel and expressly assumes the Company&#8217;s obligations on the Securities and under this Indenture; and</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; line-height: 1.25;">(b)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;immediately after giving effect to the transaction, no Default or Event of Default, shall have occurred and be continuing.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt; line-height: 1.25;">The Company shall deliver to the Trustee prior to the consummation of the proposed transaction an Officer&#8217;s
        Certificate to the foregoing effect and an Opinion of Counsel stating that the proposed transaction and any supplemental indenture comply with this Indenture.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt; line-height: 1.25;">Notwithstanding the above, any Subsidiary of the Company may consolidate with, merge into or transfer all or part
        of its properties to the Company. Neither an Officer&#8217;s Certificate nor an Opinion of Counsel shall be required to be delivered in connection therewith.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-indent: 36pt; line-height: 1.25;">Section 5.2.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Successor Corporation Substituted</u>.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt; line-height: 1.25;">Upon any consolidation or merger, or any sale, lease, conveyance or other disposition of all or substantially all
        of the assets of the Company in accordance with Section 5.1, the successor corporation formed by such consolidation or into or with which the Company is merged or to which such sale, lease, conveyance or other disposition is made shall succeed to,
        and be substituted for, and may exercise every right and power of, the Company under this Indenture with the same effect as if such successor person has been named as the Company herein; <u>provided</u>, <u>however</u>, that the predecessor Company in the case of a sale, conveyance or other disposition (other than a
        lease) shall be released from all obligations and covenants under this Indenture and the Securities.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-weight: normal; font-style: normal;" class="BRPFPageNumber">18</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: center; line-height: 1.25;">ARTICLE VI.<a name="ARTICLEVI."><!--Anchor--></a><br>
        DEFAULTS AND REMEDIES</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-indent: 36pt; line-height: 1.25;">Section 6.1.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Events of Default</u>.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt; line-height: 1.25;">&#8220;<font style="font-style: italic;">Event of Default</font>,&#8221;
        wherever used herein with respect to Securities of any Series, means any one of the following events, unless in the establishing Board Resolution, supplemental indenture or Officer&#8217;s Certificate, it is provided that such Series shall not have the
        benefit of said Event of Default:</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; line-height: 1.25;">(a)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;default in the payment of any interest on any Security of that Series when it becomes due and payable, and continuance of such default for a period of 30 days (unless the entire amount of such payment is deposited by the
          Company with the Trustee or with a Paying Agent prior to 11:00 a.m., New&#160; York City time, on the 30<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">th</sup> day of such period); or</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; line-height: 1.25;">(b)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;default in the payment of principal of any Security of that Series at its Maturity; or</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; line-height: 1.25;">(c)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;default in the performance or breach of any covenant or warranty of the Company in this Indenture (other than defaults pursuant to paragraph (a) or (b) above or pursuant to a covenant or warranty that has been included in
          this Indenture solely for the benefit of a Series of Securities other than that Series), which default continues uncured for a period of 60 days after there has been given, by registered or certified mail, to the Company by the Trustee or to the
          Company and the Trustee by the Holders of at least 25% in principal amount of the outstanding Securities of that Series a written notice specifying such default or breach and requiring it to be remedied and stating that such notice is a &#8220;Notice
          of Default&#8221; hereunder; or</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; line-height: 1.25;">(d)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;the Company pursuant to or within the meaning of any Bankruptcy Law:</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 72pt; line-height: 1.25;">(i)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;commences a voluntary case,</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 72pt; line-height: 1.25;">(ii)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;consents to the entry of an order for relief against it in an involuntary case,</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 72pt; line-height: 1.25;">(iii)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;consents to the appointment of a Custodian of it or for all or substantially all of its property,</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 72pt; line-height: 1.25;">(iv)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;makes a general assignment for the benefit of its creditors,</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 72pt; line-height: 1.25;">(v)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;applies for the granting of a freeze order (<font style="font-style: italic;">hakpaat halichim</font>) under the Israeli Companies Law, 5759-1999, or under the Israeli
          Insolvency and Economic Rehabilitation Law, 5778-2018; or</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 72pt; line-height: 1.25;">(vi)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;generally is unable to pay its debts as the same become due; or</div>
      <div style="line-height: 1.25">&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-weight: normal; font-style: normal;" class="BRPFPageNumber">19</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; line-height: 1.25;">(e)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;a court of competent jurisdiction enters an order or decree under any Bankruptcy Law that:</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 72pt; line-height: 1.25;">(i)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;is for relief against the Company in an involuntary case,</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 72pt; line-height: 1.25;">(ii)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;appoints a Custodian of the Company or for all or substantially all of its property,</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 72pt; line-height: 1.25;">(iii)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;orders the liquidation of the Company, or</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 72pt; line-height: 1.25;">(iv)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;grants a freeze order (<font style="font-style: italic;">hakpaat halichim</font>) under the Israeli Companies Law, 5759-1999 or under the Israeli Insolvency and
          Economic Rehabilitation Law, 5778-2018;</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; margin-left: 36pt; line-height: 1.25;">and the order or decree remains unstayed and in effect for 60 days; or</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; line-height: 1.25;">(f)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;any other Event of Default provided with respect to Securities of that Series, which is specified in a Board Resolution, a supplemental indenture hereto or an Officer&#8217;s Certificate, in accordance with Section 2.2.18.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt; line-height: 1.25;">The term &#8220;<font style="font-style: italic;">Bankruptcy
          Law</font>&#8221; means title 11, U.S. Code or any similar Federal or State law or foreign law for the relief of debtors, including, without limitation, the Israeli Companies Law, 5759-1999 and the Israeli Insolvency and Economic Rehabilitation Law,
        5778-2018.&#160; The term &#8220;<font style="font-style: italic;">Custodian</font>&#8221; means any receiver, trustee, assignee, liquidator or similar official under any Bankruptcy Law.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt; line-height: 1.25;">The Company will provide the Trustee written notice of any Default or Event of Default within 30 days of becoming
        aware of the occurrence of such Default or Event of Default, which notice will describe in reasonable detail the status of such Default or Event of Default and what action the Company is taking or proposes to take in respect thereof.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-indent: 36pt; line-height: 1.25;">Section 6.2.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Acceleration of Maturity; Rescission and Annulment</u>.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt; line-height: 1.25;">If an Event of Default with respect to Securities of any Series at the time outstanding occurs and is continuing
        (other than an Event of Default referred to in Section 6.1(d) or (e)) then in every such case the Trustee or the Holders of not less than 25% in principal amount of the outstanding Securities of that Series may declare the principal amount (or, if
        any Securities of that Series are Discount Securities, such portion of the principal amount as may be specified in the terms of such Securities) of and accrued and unpaid interest, if any, on all of the Securities of that Series to be due and
        payable immediately, by a notice in writing to the Company (and to the Trustee if given by Holders), and upon any such declaration such principal amount (or specified amount) and accrued and unpaid interest, if any, shall become immediately due and
        payable.&#160; If an Event of Default specified in Section 6.1(d) or (e) shall occur, the principal amount (or specified amount) of and accrued and unpaid interest, if any, on all outstanding Securities shall <font style="font-style: italic;">ipso facto</font> become and be immediately due and payable without any declaration or other act on the part of the Trustee or any Holder.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-weight: normal; font-style: normal;" class="BRPFPageNumber">20</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; text-indent: 72pt; line-height: 1.25;">At any time after such a declaration of acceleration with respect to any Series has been made and before a judgment
        or decree for payment of the money due has been obtained by the Trustee as hereinafter in this Article provided, the Holders of a majority in principal amount of the outstanding Securities of that Series, by written notice to the Company and the
        Trustee, may rescind and annul such declaration and its consequences if all Events of Default with respect to Securities of that Series, other than the non-payment of the principal and interest, if any, of Securities of that Series which have
        become due solely by such declaration of acceleration, have been cured or waived as provided in Section 6.13.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt; line-height: 1.25;">No such rescission shall affect any subsequent Default or impair any right consequent thereon.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-indent: 36pt; line-height: 1.25;">Section 6.3.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Collection of Indebtedness and Suits for Enforcement by Trustee</u>.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt; line-height: 1.25;">The Company covenants that if:</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; line-height: 1.25;">(a)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;default is made in the payment of any interest on any Security when such interest becomes due and payable and such default continues for a period of 30 days, or</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; line-height: 1.25;">(b)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;default is made in the payment of principal of any Security at the Maturity thereof, or</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; line-height: 1.25;">(c)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;default is made in the deposit of any sinking fund payment, if any, when and as due by the terms of a Security,</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; line-height: 1.25;"><font style="font-style: italic;">then,</font> the Company will, upon
        demand of the Trustee, pay to it, for the benefit of the Holders of such Securities, the whole amount then due and payable on such Securities for principal and interest and, to the extent that payment of such interest shall be legally enforceable,
        interest on any overdue principal and any overdue interest at the rate or rates prescribed therefor in such Securities, and, in addition thereto, such further amount as shall be sufficient to cover the costs and expenses of collection, including
        the compensation, reasonable expenses, disbursements and advances of the Trustee, its agents and counsel.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt; line-height: 1.25;">If the Company fails to pay such amounts forthwith upon such demand, the Trustee, in its own name and as trustee of
        an express trust, may institute a judicial proceeding for the collection of the sums so due and unpaid, may prosecute such proceeding to judgment or final decree and may enforce the same against the Company or any other obligor upon such Securities
        and collect the moneys adjudged or deemed to be payable in the manner provided by law out of the property of the Company or any other obligor upon such Securities, wherever situated.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt; line-height: 1.25;">If an Event of Default with respect to any Securities of any Series occurs and is continuing, the Trustee may in
        its discretion proceed to protect and enforce its rights and the rights of the Holders of Securities of such Series by such appropriate judicial proceedings as the Trustee shall deem most effectual to protect and enforce any such rights, whether
        for the specific enforcement of any covenant or agreement in this Indenture or in aid of the exercise of any power granted herein, or to enforce any other proper remedy.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-weight: normal; font-style: normal;" class="BRPFPageNumber">21</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-indent: 36pt; line-height: 1.25;">Section 6.4.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Trustee May File Proofs of Claim</u>.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt; line-height: 1.25;">In case of the pendency of any receivership, insolvency, liquidation, bankruptcy, reorganization, arrangement,
        adjustment, composition or other judicial proceeding relative to the Company or any other obligor upon the Securities or the property of the Company or of such other obligor or their creditors, the Trustee (irrespective of whether the principal of
        the Securities shall then be due and payable as therein expressed or by declaration or otherwise and irrespective of whether the Trustee shall have made any demand on the Company for the payment of overdue principal or interest) shall be entitled
        and empowered, by intervention in such proceeding or otherwise,</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; line-height: 1.25;">(a)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;to file and prove a claim for the whole amount of principal and interest owing and unpaid in respect of the Securities and to file such other papers or documents as may be necessary or advisable in order to have the claims
          of the Trustee (including any claim for the compensation, reasonable expenses, disbursements and advances of the Trustee, its agents and counsel) and of the Holders allowed in such judicial proceeding, and</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; line-height: 1.25;">(b)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;to collect and receive any moneys or other property payable or deliverable on any such claims and to distribute the same,</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; line-height: 1.25;">and any custodian, receiver, assignee, trustee, liquidator, sequestrator or other similar official in any such judicial proceeding is
        hereby authorized by each Holder to make such payments to the Trustee and, in the event that the Trustee shall consent to the making of such payments directly to the Holders, to pay to the Trustee any amount due it for the compensation, reasonable
        expenses, disbursements and advances of the Trustee, its agents and counsel, and any other amounts due the Trustee under Section 7.7.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt; line-height: 1.25;">Nothing herein contained shall be deemed to authorize the Trustee to authorize or consent to or accept or adopt on
        behalf of any Holder any plan of reorganization, arrangement, adjustment or composition affecting the Securities or the rights of any Holder thereof or to authorize the Trustee to vote in respect of the claim of any Holder in any such proceeding.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-indent: 36pt; line-height: 1.25;">Section 6.5.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Trustee May Enforce Claims Without Possession of Securities</u>.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt; line-height: 1.25;">All rights of action and claims under this Indenture or the Securities may be prosecuted and enforced by the
        Trustee without the possession of any of the Securities or the production thereof in any proceeding relating thereto, and any such proceeding instituted by the Trustee shall be brought in its own name as trustee of an express trust, and any
        recovery of judgment shall, after provision for the payment of the compensation, reasonable expenses, disbursements and advances of the Trustee, its agents and counsel, be for the ratable benefit of the Holders of the Securities in respect of which
        such judgment has been recovered.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-indent: 36pt; line-height: 1.25;">Section 6.6.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Application of Money Collected.</u></div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="line-height: 1.25">
        <div style="text-align: justify; text-indent: 72pt; line-height: 1.25;">Any money or property collected by the Trustee pursuant to this Article shall be applied in the following order,
          at the date or dates fixed by the Trustee and, in case of the distribution of such money or property on account of principal or interest, upon presentation of the Securities and the notation thereon of the payment if only partially paid and upon
          surrender thereof if fully paid:</div>
        <div style="text-align: justify; text-indent: 72pt; line-height: 1.25;"> <br>
        </div>
        <div style="text-align: justify; text-indent: 72pt; line-height: 1.25;">
          <div style="text-indent: 72pt; line-height: 1.25;">First:&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;To the payment of all amounts due the Trustee under Section 7.7; and</div>
          <div style="text-indent: 72pt; line-height: 1.25;"> <br>
            </div>
        </div>
      </div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-weight: normal; font-style: normal;" class="BRPFPageNumber">22</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt; line-height: 1.25;">Second: &#160; &#160;&#160; To
          the payment of the amounts then due and unpaid for principal of and interest on the Securities in respect of which or for the benefit of which such money has been collected, ratably, without preference or priority of any kind, according to the
          amounts due and payable on such Securities for principal and interest, respectively; and</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt; line-height: 1.25;">Third:&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;To
          the Company.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-indent: 36pt; line-height: 1.25;">Section 6.7.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Limitation on Suits</u>.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt; line-height: 1.25;">No Holder of any Security of any Series shall have any right to institute any proceeding, judicial or otherwise,
        with respect to this Indenture, or for the appointment of a receiver or trustee, or for any other remedy hereunder, unless</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; line-height: 1.25;">(a)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;such Holder has previously given written notice to the Trustee of a continuing Event of Default with respect to the Securities of that Series;</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; line-height: 1.25;">(b)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;the Holders of not less than 25% in principal amount of the outstanding Securities of that Series shall have made written request to the Trustee to institute proceedings in respect of such Event of Default in its own name
          as Trustee hereunder;</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; line-height: 1.25;">(c)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;such Holder or Holders have offered to the Trustee indemnity or security satisfactory to the Trustee against the costs, expenses and liabilities which might be incurred by the Trustee in compliance with such request;</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; line-height: 1.25;">(d)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;the Trustee for 60 days after its receipt of such notice, request and offer of indemnity has failed to institute any such proceeding; and</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; line-height: 1.25;">(e)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;no direction inconsistent with such written request has been given to the Trustee during such 60-day period by the Holders of a majority in principal amount of the outstanding Securities of that Series;</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; line-height: 1.25;">it being understood, intended and expressly covenanted by the Holder of every Security with every other Holder and the Trustee that no
        one or more of such Holders shall have any right in any manner whatever by virtue of, or by availing of, any provision of this Indenture to affect, disturb or prejudice the rights of any other of such Holders, or to obtain or to seek to obtain
        priority or preference over any other of such Holders or to enforce any right under this Indenture, except in the manner herein provided and for the equal and ratable benefit of all such Holders of the applicable Series.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-weight: normal; font-style: normal;" class="BRPFPageNumber">23</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-indent: 36pt; line-height: 1.25;">Section 6.8.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Unconditional Right of Holders to Receive Principal and Interest</u>.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt; line-height: 1.25;">Notwithstanding any other provision in this Indenture, the Holder of any Security shall have the right, which is
        absolute and unconditional, to receive payment of the principal of and interest, if any, on such Security on the Maturity of such Security, including the Stated Maturity expressed in such Security (or, in the case of redemption, on the redemption
        date) and to institute suit for the enforcement of any such payment, and such rights shall not be impaired without the consent of such Holder.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-indent: 36pt; line-height: 1.25;">Section 6.9.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Restoration of Rights and Remedies</u>.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt; line-height: 1.25;">If the Trustee or any Holder has instituted any proceeding to enforce any right or remedy under this Indenture and
        such proceeding has been discontinued or abandoned for any reason, or has been determined adversely to the Trustee or to such Holder, then and in every such case, subject to any determination in such proceeding, the Company, the Trustee and the
        Holders shall be restored severally and respectively to their former positions hereunder and thereafter all rights and remedies of the Trustee and the Holders shall continue as though no such proceeding had been instituted.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-indent: 36pt; line-height: 1.25;">Section 6.10.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Rights and Remedies Cumulative</u>.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt; line-height: 1.25;">Except as otherwise provided with respect to the replacement or payment of mutilated, destroyed, lost or stolen
        Securities in Section 2.8, no right or remedy herein conferred upon or reserved to the Trustee or to the Holders is intended to be exclusive of any other right or remedy, and every right and remedy shall, to the extent permitted by law, be
        cumulative and in addition to every other right and remedy given hereunder or now or hereafter existing at law or in equity or otherwise.&#160; The assertion or employment of any right or remedy hereunder, or otherwise, shall not, to the extent
        permitted by law, prevent the concurrent assertion or employment of any other appropriate right or remedy.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-indent: 36pt; line-height: 1.25;">Section 6.11.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Delay or Omission Not Waiver</u>.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt; line-height: 1.25;">No delay or omission of the Trustee or of any Holder of any Securities to exercise any right or remedy accruing
        upon any Event of Default shall impair any such right or remedy or constitute a waiver of any such Event of Default or an acquiescence therein.&#160; Every right and remedy given by this Article or by law to the Trustee or to the Holders may be
        exercised from time to time, and as often as may be deemed expedient, by the Trustee or by the Holders, as the case may be.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-indent: 36pt; line-height: 1.25;">Section 6.12.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Control by Holders</u>.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt; line-height: 1.25;">The Holders of a majority in principal amount of the outstanding Securities of any Series shall have the right to
        direct the time, method and place of conducting any proceeding for any remedy available to the Trustee, or exercising any trust or power conferred on the Trustee, with respect to the Securities of such Series, provided that</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; line-height: 1.25;">(a)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;such direction shall not be in conflict with any rule of law or with this Indenture,</div>
      <div style="line-height: 1.25">&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-weight: normal; font-style: normal;" class="BRPFPageNumber">24</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; line-height: 1.25;">(b)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;the Trustee may take any other action deemed proper by the Trustee which is not inconsistent with such direction,</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; line-height: 1.25;">(c)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;subject to the provisions of Section 7.1, the Trustee shall have the right to decline to follow any such direction if the Trustee in good faith shall, by a Responsible Officer of the Trustee, determine that the proceeding
          so directed would involve the Trustee in personal liability, and</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; line-height: 1.25;">(d)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;prior to taking any action as directed under this Section 6.12, the Trustee shall be entitled to indemnity satisfactory to it against the costs, expenses and liabilities which might be incurred by it in compliance with such
          request or direction.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-indent: 36pt; line-height: 1.25;">Section 6.13.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Waiver of Past Defaults</u>.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt; line-height: 1.25;">The Holders of not less than a majority in principal amount of the outstanding Securities of any Series may on
        behalf of the Holders of all the Securities of such Series, by written notice to the Trustee and the Company, waive any past Default hereunder with respect to such Series and its consequences, except a Default in the payment of the principal of or
        interest on any Security of such Series (provided, however, that the Holders of a majority in principal amount of the outstanding Securities of any Series may rescind an acceleration and its consequences, including any related payment default that
        resulted from such acceleration).&#160; Upon any such waiver, such Default shall cease to exist, and any Event of Default arising therefrom shall be deemed to have been cured, for every purpose of this Indenture; but no such waiver shall extend to any
        subsequent or other Default or impair any right consequent thereon.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-indent: 36pt; line-height: 1.25;">Section 6.14.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Undertaking for Costs</u>.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt; line-height: 1.25;">All parties to this Indenture agree, and each Holder of any Security by his acceptance thereof shall be deemed to
        have agreed, that any court may in its discretion require, in any suit for the enforcement of any right or remedy under this Indenture, or in any suit against the Trustee for any action taken, suffered or omitted by it as Trustee, the filing by any
        party litigant in such suit of an undertaking to pay the costs of such suit, and that such court may in its discretion assess reasonable costs, including reasonable attorneys&#8217; fees, against any party litigant in such suit, having due regard to the
        merits and good faith of the claims or defenses made by such party litigant; but the provisions of this Section shall not apply to any suit instituted by the Company, to any suit instituted by the Trustee, to any suit instituted by any Holder, or
        group of Holders, holding in the aggregate more than 10% in principal amount of the outstanding Securities of any Series, or to any suit instituted by any Holder for the enforcement of the payment of the principal of or interest on any Security on
        or after the Maturity of such Security, including the Stated Maturity expressed in such Security (or, in the case of redemption, on the redemption date).</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: center; line-height: 1.25;">ARTICLE VII.<a name="ARTICLEVII."><!--Anchor--></a><br>
        TRUSTEE</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-indent: 36pt; line-height: 1.25;">Section 7.1.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Duties of Trustee</u>.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; line-height: 1.25;">(a)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;If an Event of Default has occurred and is continuing, the Trustee shall exercise the rights and powers vested in it by this Indenture and use the same degree of care and skill in their exercise as a prudent person would
          exercise or use under the circumstances in the conduct of such person&#8217;s own affairs.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-weight: normal; font-style: normal;" class="BRPFPageNumber">25</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      </div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; line-height: 1.25;">(b)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Except during the continuance of an Event of Default:</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 72pt; line-height: 1.25;">(i)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The Trustee need perform only those duties that are specifically set forth in this Indenture and no others.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 72pt; line-height: 1.25;">(ii)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;In the absence of bad faith on its part, the Trustee may conclusively rely, as to the truth of the statements and the correctness of the opinions expressed therein, upon Officer&#8217;s Certificates or Opinions of Counsel furnished to
          the Trustee and conforming to the requirements of this Indenture; <u>however</u>, in the case of any such Officer&#8217;s Certificates or Opinions of Counsel which by
          any provisions hereof are specifically required to be furnished to the Trustee, the Trustee shall examine such Officer&#8217;s Certificates and Opinions of Counsel to determine whether or not they conform to the form requirements of this Indenture.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; line-height: 1.25;">(c)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The Trustee may not be relieved from liability for its own negligent action, its own negligent failure to act or its own willful misconduct, except that:</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 72pt; line-height: 1.25;">(i)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;This paragraph does not limit the effect of paragraph (b) of this Section.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 72pt; line-height: 1.25;">(ii)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The Trustee shall not be liable for any error of judgment made in good faith by a Responsible Officer, unless it is proved that the Trustee was negligent in ascertaining the pertinent facts.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 72pt; line-height: 1.25;">(iii)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The Trustee shall not be liable with respect to any action taken, suffered or omitted to be taken by it with respect to Securities of any Series in good faith in accordance with the direction of the Holders of a majority in
          principal amount of the outstanding Securities of such Series relating to the time, method and place of conducting any proceeding for any remedy available to the Trustee, or exercising any trust or power conferred upon the Trustee, under this
          Indenture with respect to the Securities of such Series in accordance with Section 6.12.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; line-height: 1.25;">(d)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Every provision of this Indenture that in any way relates to the Trustee is subject to paragraph (a), (b) and (c) of this Section.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; line-height: 1.25;">(e)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The Trustee may refuse to perform any duty or exercise any right or power unless it receives indemnity satisfactory to it against the costs, expenses and liabilities which might be incurred by it in performing such duty or
          exercising such right or power.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; line-height: 1.25;">(f)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The Trustee shall not be liable for interest on any money received by it except as the Trustee may agree in writing with the Company.&#160; Money held in trust by the Trustee need not be segregated from other funds except to the
          extent required by law.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-weight: normal; font-style: normal;" class="BRPFPageNumber">26</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; line-height: 1.25;">(g)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;No provision of this Indenture shall require the Trustee to risk its own funds or otherwise incur any financial liability in the performance of any of its duties, or in the exercise of any of its rights or powers, if
          adequate indemnity against such risk is not assured to the Trustee in its satisfaction.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; line-height: 1.25;">(h)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The Paying Agent, the Registrar and any authenticating agent shall be entitled to the protections and immunities as are set forth in paragraphs (e), (f) and (g) of this Section and in Section 7.2, each with respect to the
          Trustee.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-indent: 36pt; line-height: 1.25;">Section 7.2.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Rights of Trustee</u>.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; line-height: 1.25;">(a)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The Trustee may rely on and shall be protected in acting or refraining from acting upon any document (whether in its original or facsimile form) believed by it to be genuine and to have been signed or presented by the
          proper person.&#160; The Trustee need not investigate any fact or matter stated in the document.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; line-height: 1.25;">(b)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Before the Trustee acts or refrains from acting, it may require an Officer&#8217;s Certificate or an Opinion of Counsel or both.&#160; The Trustee shall not be liable for any action it takes or omits to take in good faith in reliance
          on such Officer&#8217;s Certificate or Opinion of Counsel.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; line-height: 1.25;">(c)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The Trustee may act through agents and shall not be responsible for the misconduct or negligence of any agent appointed with due care.&#160; No Depositary shall be deemed an agent of the Trustee and the Trustee shall not be
          responsible for any act or omission by any Depositary.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; line-height: 1.25;">(d)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The Trustee shall not be liable for any action it takes or omits to take in good faith which it believes to be authorized or within its rights or powers, provided that the Trustee&#8217;s conduct does not constitute willful
          misconduct or negligence.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; line-height: 1.25;">(e)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The Trustee may consult with counsel and the advice of such counsel or any Opinion of Counsel shall be full and complete authorization and protection in respect of any action taken, suffered or omitted by it hereunder
          without willful misconduct or negligence, and in reliance thereon.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; line-height: 1.25;">(f)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The Trustee shall be under no obligation to exercise any of the rights or powers vested in it by this Indenture at the request or direction of any of the Holders of Securities unless such Holders shall have offered to the
          Trustee security or indemnity satisfactory to it against the costs, expenses and liabilities which might be incurred by it in compliance with such request or direction.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; line-height: 1.25;">(g)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The Trustee shall not be bound to make any investigation into the facts or matters stated in any resolution, certificate, statement, instrument, opinion, report, notice, request, direction, consent, order, bond, debenture,
          note, other evidence of indebtedness or other paper or document, but the Trustee, in its discretion, may make such further inquiry or investigation into such facts or matters as it may see fit.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-weight: normal; font-style: normal;" class="BRPFPageNumber">27</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; line-height: 1.25;">(h)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The Trustee shall not be deemed to have notice of any Default or Event of Default unless a Responsible Officer of the Trustee has actual knowledge thereof or unless written notice of any event which is in fact such a
          default is received by the Trustee at the Corporate Trust Office of the Trustee, and such notice references the Securities generally or the Securities of a particular Series and this Indenture.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; line-height: 1.25;">(i)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;In no event shall the Trustee be liable to any person for special, punitive, indirect, consequential or incidental loss or damage of any kind whatsoever (including but not limited to lost profits), even if the Trustee has
          been advised of the likelihood of such loss or damage.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; line-height: 1.25;">(j)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The permissive right of the Trustee to take the actions permitted by this Indenture shall not be construed as an obligation or duty to do so.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-indent: 36pt; line-height: 1.25;">Section 7.3.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Individual Rights of Trustee</u>.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt; line-height: 1.25;">The Trustee in its individual or any other capacity may become the owner or pledgee of Securities and may otherwise
        deal with the Company or an Affiliate of the Company with the same rights it would have if it were not Trustee.&#160; Any Agent may do the same with like rights.&#160; The Trustee is also subject to Sections 7.10 and 7.11.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-indent: 36pt; line-height: 1.25;">Section 7.4.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Trustee&#8217;s Disclaimer</u>.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt; line-height: 1.25;">The Trustee makes no representation as to the validity or adequacy of this Indenture or the Securities, it shall
        not be accountable for the Company&#8217;s use of the proceeds from the Securities, and it shall not be responsible for any statement in the Securities other than its authentication.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-indent: 36pt; line-height: 1.25;">Section 7.5.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Notice of Defaults</u>.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt; line-height: 1.25;">If a Default or Event of Default occurs and is continuing with respect to the Securities of any Series and if it is
        known to a Responsible Officer of the Trustee, the Trustee shall send to each Securityholder of the Securities of that Series notice of a Default or Event of Default within 90 days after it occurs or, if later, after a Responsible Officer of the
        Trustee has knowledge of such Default or Event of Default.&#160; Except in the case of a Default or Event of Default in payment of principal of or interest on any Security of any Series, the Trustee may withhold the notice if and so long as its
        corporate trust committee or a committee of its Responsible Officers in good faith determines that withholding the notice is in the interests of Securityholders of that Series.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-indent: 36pt; line-height: 1.25;">Section 7.6.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Reports by Trustee to Holders</u>.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt; line-height: 1.25;">Within 60 days after each [[&#160;&#160; ] commencing [&#160;&#160; ], [&#160;&#160; ]], the Trustee shall transmit by mail to all
        Securityholders, as their names and addresses appear on the register kept by the Registrar, a brief report dated as of such anniversary date, in accordance with, and to the extent required under, TIA &#167; 313.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt; line-height: 1.25;">A copy of each report at the time of its mailing to Securityholders of any Series shall be filed with the SEC and
        each national securities exchange on which the Securities of that Series are listed.&#160; The Company shall promptly notify the Trustee in writing when Securities of any Series are listed on any national securities exchange.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-weight: normal; font-style: normal;" class="BRPFPageNumber">28</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-indent: 36pt; line-height: 1.25;">Section 7.7.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Compensation and Indemnity</u>.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt; line-height: 1.25;">The Company shall pay to the Trustee from time to time compensation for its services as the Company and the Trustee
        shall from time to time agree upon in writing.&#160; The Trustee&#8217;s compensation shall not be limited by any law on compensation of a trustee of an express trust.&#160; The Company shall reimburse the Trustee upon request for all reasonable out of pocket
        expenses incurred by it.&#160; Such expenses shall include the reasonable compensation and expenses of the Trustee&#8217;s agents and counsel.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt; line-height: 1.25;">The Company shall indemnify each of the Trustee and any predecessor Trustee (including for the cost of defending
        itself) against any cost, expense or liability, including taxes (other than taxes based upon, measured by or determined by the income of the Trustee) incurred by it except as set forth in the next paragraph in the performance of its duties under
        this Indenture as Trustee or Agent.&#160; The Trustee shall notify the Company promptly of any claim for which it may seek indemnity.&#160; Failure by the Trustee to so notify the Company shall not relieve the Company of its obligations hereunder, unless and
        to the extent that the Company is materially prejudiced thereby.&#160; The Company shall defend the claim and the Trustee shall cooperate in the defense.&#160; The Trustee may have one separate counsel and the Company shall pay the reasonable fees and
        expenses of such counsel.&#160; The Company need not pay for any settlement made without its consent, which consent will not be unreasonably withheld.&#160; This indemnification shall apply to officers, directors, employees, shareholders and agents of the
        Trustee.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt; line-height: 1.25;">The Company need not reimburse any expense or indemnify against any loss or liability incurred by the Trustee or by
        any officer, director, employee, shareholder or agent of the Trustee through willful misconduct or negligence.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt; line-height: 1.25;">To secure the Company&#8217;s payment obligations in this Section, the Trustee shall have a lien prior to the Securities
        of any Series on all money or property held or collected by the Trustee, except that held in trust to pay principal of and interest on particular Securities of that Series.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt; line-height: 1.25;">When the Trustee incurs expenses or renders services after an Event of Default specified in Section 6.1(d) or (e)
        occurs, the expenses and the compensation for the services are intended to constitute expenses of administration under any Bankruptcy Law.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt; line-height: 1.25;">The provisions of this Section shall survive the termination of this Indenture.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-indent: 36pt; line-height: 1.25;">Section 7.8.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Replacement of Trustee</u>.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt; line-height: 1.25;">A resignation or removal of the Trustee and appointment of a successor Trustee shall become effective only upon the
        successor Trustee&#8217;s acceptance of appointment as provided in this Section.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt; line-height: 1.25;">The Trustee may resign with respect to the Securities of one or more Series by so notifying the Company at least 30
        days prior to the date of the proposed resignation.&#160; The Holders of a majority in principal amount of the Securities of any Series may remove the Trustee with respect to that Series by so notifying the Trustee and the Company.&#160; The Company may
        remove the Trustee with respect to Securities of one or more Series if:</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="line-height: 1.25">
        <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; line-height: 1.25;">(a)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;the Trustee fails to comply with Section 7.10;</div>
        <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; line-height: 1.25;"> <br>
          </div>
      </div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-weight: normal; font-style: normal;" class="BRPFPageNumber">29</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; line-height: 1.25;"><br>
      </div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; line-height: 1.25;">(b)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;the Trustee is adjudged a bankrupt or an insolvent or an order for relief is entered with respect to the Trustee under any Bankruptcy Law;</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; line-height: 1.25;">(c)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;a Custodian or public officer takes charge of the Trustee or its property; or</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; line-height: 1.25;">(d)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;the Trustee becomes incapable of acting.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt; line-height: 1.25;">If the Trustee resigns or is removed or if a vacancy exists in the office of Trustee for any reason, the Company
        shall promptly appoint a successor Trustee.&#160; Within one year after the successor Trustee takes office, the Holders of a majority in principal amount of the then outstanding Securities may appoint a successor Trustee to replace the successor Trustee
        appointed by the Company.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt; line-height: 1.25;">If a successor Trustee with respect to the Securities of any one or more Series does not take office within 60 days
        after the retiring Trustee resigns or is removed, the retiring Trustee, the Company or the Holders of at least a majority in principal amount of the Securities of the applicable Series may petition any court of competent jurisdiction for the
        appointment of a successor Trustee.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt; line-height: 1.25;">A successor Trustee shall deliver a written acceptance of its appointment to the retiring Trustee and to the
        Company.&#160; Immediately after that, the retiring Trustee shall transfer all property held by it as Trustee to the successor Trustee subject to the lien provided for in Section 7.7, the resignation or removal of the retiring Trustee shall become
        effective, and the successor Trustee shall have all the rights, powers and duties of the Trustee with respect to each Series of Securities for which it is acting as Trustee under this Indenture.&#160; A successor Trustee shall mail a notice of its
        succession to each Securityholder of each such Series.&#160; Notwithstanding replacement of the Trustee pursuant to this Section 7.8, the Company&#8217;s obligations under Section 7.7 hereof shall continue for the benefit of the retiring Trustee with respect
        to expenses and liabilities incurred by it for actions taken or omitted to be taken in accordance with its rights, powers and duties under this Indenture prior to such replacement.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-indent: 36pt; line-height: 1.25;">Section 7.9.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Successor Trustee by Merger, Etc</u>.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt; line-height: 1.25;">If the Trustee consolidates with, merges or converts into, or transfers all or substantially all of its corporate
        trust business to, another corporation, the successor corporation without any further act shall be the successor Trustee, subject to Section 7.10.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-indent: 36pt; line-height: 1.25;">Section 7.10.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Eligibility; Disqualification</u>.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt; line-height: 1.25;">This Indenture shall always have a Trustee who satisfies the requirements of TIA &#167; 310(a)(1), (2) and (5).&#160; The
        Trustee shall always have a combined capital and surplus of at least $25,000,000 as set forth in its most recent published annual report of condition.&#160; The Trustee shall comply with TIA &#167; 310(b).</div>
      <div style="line-height: 1.25">&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-weight: normal; font-style: normal;" class="BRPFPageNumber">30</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-indent: 36pt; line-height: 1.25;">Section 7.11.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Preferential Collection of Claims Against Company</u>.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt; line-height: 1.25;">The Trustee is subject to TIA &#167; 311(a), excluding any creditor relationship listed in TIA &#167; 311(b).&#160; A Trustee who
        has resigned or been removed shall be subject to TIA &#167; 311(a) to the extent indicated.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: center; line-height: 1.25;">ARTICLE VIII.<a name="ARTICLEVIII."><!--Anchor--></a><br>
        SATISFACTION AND DISCHARGE; DEFEASANCE</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-indent: 36pt; line-height: 1.25;">Section 8.1.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Satisfaction and Discharge of Indenture</u>.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt; line-height: 1.25;">This Indenture shall upon Company Order be discharged with respect to the Securities of any Series and cease to be
        of further effect as to all Securities of such Series (except as hereinafter provided in this Section 8.1), and the Trustee, at the expense of the Company, shall execute instruments acknowledging satisfaction and discharge of this Indenture, when</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; line-height: 1.25;">(a)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;either</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 72pt; line-height: 1.25;">(i)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;all Securities of such Series theretofore authenticated and delivered (other than Securities that have been destroyed, lost or stolen and that have been replaced or paid) have been delivered to the Trustee for cancellation; or</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 72pt; line-height: 1.25;">(ii)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;all such Securities of such Series not theretofore delivered to the Trustee for cancellation:</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 108pt; line-height: 1.25;">(1)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;have become due and payable by reason of sending a notice of redemption or otherwise, or</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 108pt; line-height: 1.25;">(2)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;will become due and payable at their Stated Maturity within one year, or</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 108pt; line-height: 1.25;">(3)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;have been called for redemption or are to be called for redemption within one year under arrangements satisfactory to the Trustee for the giving of notice of redemption by the Trustee in the name, and at the expense, of the
          Company, or</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 108pt; line-height: 1.25;">(4)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;are deemed paid and discharged pursuant to Section 8.3, as applicable;</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; line-height: 1.25;">and the Company, in the case of (1), (2) or (3) above, has irrevocably deposited or caused to be deposited with the Trustee as trust
        funds in trust an amount of money or U.S. Government Obligations, which amount shall be sufficient for the purpose of paying and discharging each installment of principal (including mandatory sinking fund or analogous payments) of and interest on
        all the Securities of such Series on the dates such installments of principal or interest are due;</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; line-height: 1.25;">(b)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;the Company has paid or caused to be paid all other sums payable hereunder by the Company; and</div>
      <div style="line-height: 1.25">&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-weight: normal; font-style: normal;" class="BRPFPageNumber">31</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; line-height: 1.25;">(c)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;the Company has delivered to the Trustee an Officer&#8217;s Certificate and an Opinion of Counsel, each stating that all conditions precedent provided for relating to the satisfaction and discharge contemplated by this Section
          have been complied with.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt; line-height: 1.25;">Notwithstanding the satisfaction and discharge of this Indenture, the obligations of the Company to the Trustee
        under Section 7.7, and, if money shall have been deposited with the Trustee pursuant to clause (a) of this Section, the provisions of Sections 2.4, 2.7, 2.8, 8.2 and&#160; 8.5 shall survive.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-indent: 36pt; line-height: 1.25;">Section 8.2.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Application of Trust Funds; Indemnification</u>.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; line-height: 1.25;">(a)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Subject to the provisions of Section 8.5, all money and U.S. Government Obligations or Foreign Government Obligations deposited with the Trustee pursuant to Section 8.1, 8.3 or 8.4 and all money received by the Trustee in
          respect of U.S. Government Obligations or Foreign Government Obligations deposited with the Trustee pursuant to Section 8.1, 8.3 or 8.4, shall be held in trust and applied by it, in accordance with the provisions of the Securities and this
          Indenture, to the payment, either directly or through any Paying Agent (including the Company acting as its own Paying Agent) as the Trustee may determine, to the persons entitled thereto, of the principal and interest for whose payment such
          money has been deposited with or received by the Trustee or to make mandatory sinking fund payments or analogous payments as contemplated by Sections 8.1, 8.3 or 8.4.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; line-height: 1.25;">(b)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The Company shall pay and shall indemnify the Trustee against any tax, fee or other charge imposed on or assessed against U.S. Government Obligations or Foreign Government Obligations deposited pursuant to Sections 8.1, 8.3
          or 8.4 or the interest and principal received in respect of such obligations other than any payable by or on behalf of Holders.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; line-height: 1.25;">(c)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The Trustee shall deliver or pay to the Company from time to time upon Company Order any U.S. Government Obligations or Foreign Government Obligations or money held by it as provided in Sections 8.3 or 8.4 which, in the
          opinion of a nationally recognized firm of independent certified public accountants or investment bank expressed in a written certification thereof delivered to the Trustee, are then in excess of the amount thereof which then would have been
          required to be deposited for the purpose for which such U.S. Government Obligations or Foreign Government Obligations or money were deposited or received.&#160; This provision shall not authorize the sale by the Trustee of any U.S. Government
          Obligations or Foreign Government Obligations held under this Indenture.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-weight: normal; font-style: normal;" class="BRPFPageNumber">32</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      </div>
      <div style="text-indent: 36pt; line-height: 1.25;">Section 8.3.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Legal Defeasance of Securities of any Series</u>.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt; line-height: 1.25;">Unless this Section 8.3 is otherwise specified, pursuant to Section 2.2, to be inapplicable to Securities of any
        Series, the Company shall be deemed to have paid and discharged the entire indebtedness on all the outstanding Securities of any Series on the 91st day after the date of the deposit referred to in subparagraph (d) hereof, and the provisions of this
        Indenture, as it relates to such outstanding Securities of such Series, shall no longer be in effect (and the Trustee, at the expense of the Company, shall, upon receipt of a Company Order, execute instruments acknowledging the same), except as to:</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; line-height: 1.25;">(a)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;the rights of Holders of Securities of such Series to receive, from the trust funds described in subparagraph (d) hereof, (i) payment of the principal of and each installment of principal of and interest on the outstanding
          Securities of such Series on the Maturity of such principal or installment of principal or interest and (ii) the benefit of any mandatory sinking fund payments applicable to the Securities of such Series on the day on which such payments are due
          and payable in accordance with the terms of this Indenture and the Securities of such Series;</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; line-height: 1.25;">(b)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;the provisions of Sections 2.4, 2.5, 2.7, 2.8, 7.7, 8.2, 8.3, 8.5 and 8.6; and</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; line-height: 1.25;">(c)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;the rights, powers, trusts and immunities of the Trustee hereunder and the Company&#8217;s obligations in connection therewith;</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; line-height: 1.25;">provided that, the following conditions shall have been satisfied:</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; line-height: 1.25;">(d)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;the Company shall have irrevocably deposited or caused to be deposited (except as provided in Section 8.2(c)) with the Trustee as trust funds specifically pledged as security for and dedicated solely to the benefit of the
          Holders of such Securities (i) in the case of Securities of such Series denominated in Dollars, cash in Dollars and/or U.S. Government Obligations, or (ii) in the case of Securities of such Series denominated in a Foreign Currency (other than a
          composite currency), money and/or Foreign Government Obligations, which through the payment of interest and principal in respect thereof in accordance with their terms, will provide (and without reinvestment and assuming no tax liability will be
          imposed on such Trustee), not later than one day before the due date of any payment of money, an amount in cash, sufficient, in the opinion of a nationally recognized firm of independent public accountants or investment bank expressed in a
          written certification thereof delivered to the Trustee, to pay and discharge each installment of principal of and interest, on and any mandatory sinking fund payments in respect of all the Securities of such Series on the dates such installments
          of principal or interest and such sinking fund payments are due;</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; line-height: 1.25;">(e)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;such deposit will not result in a breach or violation of, or constitute a default under, this Indenture or any other agreement or instrument to which the Company is a party or by which it is bound;</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; line-height: 1.25;">(f)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;no Default or Event of Default with respect to the Securities of such Series shall have occurred and be continuing on the date of such deposit or during the period ending on the 91st day after such date;</div>
      <div style="line-height: 1.25">&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-weight: normal; font-style: normal;" class="BRPFPageNumber">33</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; line-height: 1.25;">(g)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;the Company shall have delivered to the Trustee an Officer&#8217;s Certificate and an Opinion of Counsel to the effect that (i) the Company has received from, or there has been published by, the United States Internal Revenue
          Service a ruling, or (ii) since the date of execution of this Indenture, there has been a change in the applicable U.S. federal income tax law, in either case to the effect that, and based thereon such Opinion of Counsel shall confirm that, the
          Holders of the Securities of such Series will not recognize income, gain or loss for U.S. federal income tax purposes as a result of such deposit, defeasance and discharge and will be subject to U.S. federal income tax on the same amount and in
          the same manner and at the same times as would have been the case if such deposit, defeasance and discharge had not occurred;</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; line-height: 1.25;">(h)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;the Company shall have delivered to the Trustee an Officer&#8217;s Certificate stating that the deposit was not made by the Company with the intent of defeating, hindering, delaying or defrauding any other creditors of the
          Company; and</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; line-height: 1.25;">(i)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;the Company shall have delivered to the Trustee an Officer&#8217;s Certificate and an Opinion of Counsel, each stating that all conditions precedent provided for relating to the defeasance contemplated by this Section have been
          complied with.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-indent: 36pt; line-height: 1.25;">Section 8.4.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Covenant Defeasance</u>.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt; line-height: 1.25;">Unless this Section 8.4 is otherwise specified pursuant to Section 2.2 to be inapplicable to Securities of any
        Series, the Company may omit to comply with respect to the Securities of any Series with any term, provision or condition set forth under Sections 4.2, 4.3, 4.4 and 5.1 and, unless otherwise specified therein, any additional covenants specified in
        a supplemental indenture for such Series of Securities or a Board Resolution or an Officer&#8217;s Certificate delivered pursuant to Section 2.2 (and the failure to comply with any such covenants shall not constitute a Default or Event of Default with
        respect to such Series under Section 6.1) and the occurrence of any event specified in a supplemental indenture for such Series of Securities or a Board Resolution or an Officer&#8217;s Certificate delivered pursuant to Section 2.2 and designated as an
        Event of Default shall not constitute a Default or Event of Default hereunder, with respect to the Securities of such Series, but, except as specified above, the remainder of this Indenture and such Securities will be unaffected thereby; provided
        that the following conditions shall have been satisfied:</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; line-height: 1.25;">(a)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;with reference to this Section 8.4, the Company has irrevocably deposited or caused to be irrevocably deposited (except as provided in Section 8.2(c)) with the Trustee as trust funds in trust for the purpose of making the
          following payments specifically pledged as security for, and dedicated solely to, the benefit of the Holders of such Securities (i) in the case of Securities of such Series denominated in Dollars, cash in Dollars and/or U.S. Government
          Obligations, or (ii) in the case of Securities of such Series denominated in a Foreign Currency (other than a composite currency), money and/or Foreign Government Obligations, which through the payment of interest and principal in respect thereof
          in accordance with their terms, will provide (and without reinvestment and assuming no tax liability will be imposed on such Trustee), not later than one day before the due date of any payment of money, an amount in cash, sufficient, in the
          opinion of a nationally recognized firm of independent certified public accountants or investment bank expressed in a written certification thereof delivered to the Trustee, to pay and discharge each installment of principal (including mandatory
          sinking fund or analogous payments) of and interest on all the Securities of such Series on the dates such installments of principal or interest are due;</div>
      <div style="line-height: 1.25">&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-weight: normal; font-style: normal;" class="BRPFPageNumber">34</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; line-height: 1.25;">(b)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;such deposit will not result in a breach or violation of, or constitute a default under, this Indenture or any other agreement or instrument to which the Company is a party or by which it is bound;</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; line-height: 1.25;">(c)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;no Default or Event of Default with respect to the Securities of such Series shall have occurred and be continuing on the date of such deposit;</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; line-height: 1.25;">(d)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;the Company shall have delivered to the Trustee an Officers&#8217; Certificate and an Opinion of Counsel to the effect that the Holders of the Securities of such Series will not recognize income, gain or loss for U.S. federal
          income tax purposes as a result of such deposit and covenant defeasance and will be subject to U.S. federal income tax on the same amount and in the same manner and at the same times as would have been the case if such deposit and covenant
          defeasance had not occurred;</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; line-height: 1.25;">(e)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The Company shall have delivered to the Trustee an Officer&#8217;s Certificate stating the deposit was not made by the Company with the intent of defeating, hindering, delaying or defrauding any other creditors of the Company;
          and</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; line-height: 1.25;">(f)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The Company shall have delivered to the Trustee an Officer&#8217;s Certificate and an Opinion of Counsel, each stating that all conditions precedent herein provided for relating to the covenant defeasance contemplated by this
          Section have been complied with.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-indent: 36pt; line-height: 1.25;">Section 8.5.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Repayment to Company</u>.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt; line-height: 1.25;">Subject to applicable abandoned property law, the Trustee and the Paying Agent shall pay to the Company upon
        request any money held by them for the payment of principal and interest that remains unclaimed for two years.&#160; After that, Securityholders entitled to the money must look to the Company for payment as general creditors unless an applicable
        abandoned property law designates another person.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-indent: 36pt; line-height: 1.25;">Section 8.6.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Reinstatement</u>.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt; line-height: 1.25;">If the Trustee or the Paying Agent is unable to apply any money deposited with respect to Securities of any Series
        in accordance with Section 8.1 by reason of any legal proceeding or by reason of any order or judgment of any court or governmental authority enjoining, restraining or otherwise prohibiting such application, the obligations of the Company under
        this Indenture with respect to the Securities of such Series and under the Securities of such Series shall be revived and reinstated as though no deposit had occurred pursuant to Section 8.1 until such time as the Trustee or the Paying Agent is
        permitted to apply all such money in accordance with Section 8.1; <u>provided</u>, <u>however</u>,
        that if the Company has made any payment of principal of or interest on or any Additional Amounts with respect to any Securities because of the reinstatement of its obligations, the Company shall be subrogated to the rights of the Holders of such
        Securities to receive such payment from the money or U.S. Government Obligations held by the Trustee or Paying Agent after payment in full to the Holders.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-weight: normal; font-style: normal;" class="BRPFPageNumber">35</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: center; line-height: 1.25;">ARTICLE IX.<a name="ARTICLEIX."><!--Anchor--></a><br>
        AMENDMENTS AND WAIVERS</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-indent: 36pt; line-height: 1.25;">Section 9.1.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Without Consent of Holders</u>.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt; line-height: 1.25;">The Company and the Trustee may amend or supplement this Indenture or the Securities of one or more Series without
        the consent of any Securityholder:</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; line-height: 1.25;">(a)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;to cure any ambiguity, defect or inconsistency;</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; line-height: 1.25;">(b)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;to comply with Article V;</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; line-height: 1.25;">(c)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;to provide for uncertificated Securities in addition to or in place of certificated Securities;</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; line-height: 1.25;">(d)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;to add guarantees with respect to Securities of any Series or secure Securities of any Series;</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; line-height: 1.25;">(e)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;to surrender any of the Company&#8217;s rights or powers under this Indenture;</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; line-height: 1.25;">(f)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;to add covenants or events of default for the benefit of the holders of Securities of any Series;</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; line-height: 1.25;">(g)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;to comply with the applicable procedures of the applicable depositary;</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; line-height: 1.25;">(h)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;to make any change that does not adversely affect the rights of any Securityholder;</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; line-height: 1.25;">(i)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;to provide for the issuance of and establish the form and terms and conditions of Securities of any Series as permitted by this Indenture;</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; line-height: 1.25;">(j)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;to evidence and provide for the acceptance of appointment hereunder by a successor Trustee with respect to the Securities of one or more Series and to add to or change any of the provisions of this Indenture as shall be
          necessary to provide for or facilitate the administration of the trusts hereunder by more than one Trustee; or</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; line-height: 1.25;">(k)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;to comply with requirements of the SEC in order to effect or maintain the qualification of this Indenture under the TIA.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-indent: 36pt; line-height: 1.25;">Section 9.2.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>With Consent of Holders</u>.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt; line-height: 1.25;">The Company and the Trustee may enter into a supplemental indenture with the written consent of the Holders of at
        least a majority in principal amount of the outstanding Securities of each Series affected by such supplemental indenture (including consents obtained in connection with a tender offer or exchange offer for the Securities of such Series), for the
        purpose of adding any provisions to or changing in any manner or eliminating any of the provisions of this Indenture or of any supplemental indenture or of modifying in any manner the rights of the Securityholders of each such Series.&#160; Except as
        provided in Section 6.13, the Holders of at least a majority in principal amount of the outstanding Securities of any Series by notice to the Trustee (including consents obtained in connection with a tender offer or exchange offer for the
        Securities of such Series) may waive compliance by the Company with any provision of this Indenture or the Securities with respect to such Series.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-weight: normal; font-style: normal;" class="BRPFPageNumber">36</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      </div>
      <div style="text-align: justify; text-indent: 72pt; line-height: 1.25;">It shall not be necessary for the consent of the Holders of Securities under this Section 9.2 to approve the
        particular form of any proposed supplemental indenture or waiver, but it shall be sufficient if such consent approves the substance thereof.&#160; After a supplemental indenture or waiver under this section becomes effective, the Company shall send to
        the Holders of Securities affected thereby, a notice briefly describing the supplemental indenture or waiver.&#160; Any failure by the Company to send such notice, or any defect therein, shall not, however, in any way impair or affect the validity of
        any such supplemental indenture or waiver.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-indent: 36pt; line-height: 1.25;">Section 9.3.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Limitations</u>.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt; line-height: 1.25;">Without the consent of each Securityholder affected, an amendment or waiver may not:</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; line-height: 1.25;">(a)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;reduce the principal amount of Securities whose Holders must consent to an amendment, supplement or waiver;</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; line-height: 1.25;">(b)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;reduce the rate of or extend the time for payment of interest (including default interest) on any Security;</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; line-height: 1.25;">(c)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;reduce the principal or change the Stated Maturity of any Security or reduce the amount of, or postpone the date fixed for, the payment of any sinking fund or analogous obligation;</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; line-height: 1.25;">(d)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;reduce the principal amount of Discount Securities payable upon acceleration of the maturity thereof;</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; line-height: 1.25;">(e)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;waive a Default or Event of Default in the payment of the principal of or interest, if any, on any Security (except a rescission of acceleration of the Securities of any Series by the Holders of at least a majority in
          principal amount of the outstanding Securities of such Series and a waiver of the payment default that resulted from such acceleration);</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; line-height: 1.25;">(f)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;make the principal of or interest, if any, on any Security payable in any currency other than that stated in the Security;</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; line-height: 1.25;">(g)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;make any change in Sections 6.8, 6.13 or 9.3 (this sentence); or</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; line-height: 1.25;">(h)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;waive a redemption payment with respect to any Security, provided that such redemption is made at the Company&#8217;s option.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-indent: 36pt; line-height: 1.25;">Section 9.4.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Compliance with Trust Indenture Act</u>.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt; line-height: 1.25;">Every amendment to this Indenture or the Securities of one or more Series shall be set forth in a supplemental
        indenture hereto that complies with the TIA as then in effect.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-weight: normal; font-style: normal;" class="BRPFPageNumber">37</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-indent: 36pt; line-height: 1.25;">Section 9.5.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Revocation and Effect of Consents</u>.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt; line-height: 1.25;">Until an amendment is set forth in a supplemental indenture or a waiver becomes effective, a consent to it by a
        Holder of a Security is a continuing consent by the Holder and every subsequent Holder of a Security or portion of a Security that evidences the same debt as the consenting Holder&#8217;s Security, even if notation of the consent is not made on any
        Security.&#160; However, any such Holder or subsequent Holder may revoke the consent as to his Security or portion of a Security if the Trustee receives the notice of revocation before the date of the supplemental indenture or the date the waiver
        becomes effective.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt; line-height: 1.25;">Any amendment or waiver once effective shall bind every Securityholder of each Series affected by such amendment or
        waiver unless it is of the type described in any of clauses (a) through (h) of Section 9.3.&#160; In that case, the amendment or waiver shall bind each Holder of a Security who has consented to it and every subsequent Holder of a Security or portion of
        a Security that evidences the same debt as the consenting Holder&#8217;s Security.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt; line-height: 1.25;">The Company may, but shall not be obligated to, fix a record date for the purpose of determining the Holders
        entitled to give their consent or take any other action described above or required or permitted to be taken pursuant to this Indenture. If a record date is fixed, then notwithstanding the second immediately preceding paragraph, those Persons who
        were Holders at such record date (or their duly designated proxies), and only those persons, shall be entitled to give such consent or to revoke any consent previously given or take any such action, whether or not such Persons continue to be
        Holders after such record date. No such consent shall be valid or effective for more than 120 days after such record date.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-indent: 36pt; line-height: 1.25;">Section 9.6.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Notation on or Exchange of Securities</u>.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt; line-height: 1.25;">The Company or the Trustee may place an appropriate notation about an amendment or waiver on any Security of any
        Series thereafter authenticated.&#160; The Company in exchange for Securities of that Series may issue and the Trustee shall authenticate upon receipt of a Company Order in accordance with Section 2.3 new Securities of that Series that reflect the
        amendment or waiver.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-indent: 36pt; line-height: 1.25;">Section 9.7.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Trustee Protected</u>.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt; line-height: 1.25;">In executing, or accepting the additional trusts created by, any supplemental indenture permitted by this Article
        or the modifications thereby of the trusts created by this Indenture, the Trustee shall be entitled to receive, and (subject to Section 7.1) shall be fully protected in relying upon, an Officer&#8217;s Certificate or an Opinion of Counsel or both
        complying with Section 10.4.&#160; The Trustee shall sign all supplemental indentures upon delivery of such an Officer&#8217;s Certificate or Opinion of Counsel or both, except that the Trustee need not sign any supplemental indenture that adversely affects
        its rights, duties, liabilities or immunities under this Indenture.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-weight: normal; font-style: normal;" class="BRPFPageNumber">38</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: center; line-height: 1.25;">ARTICLE X.<a name="ARTICLEX."><!--Anchor--></a><br>
        MISCELLANEOUS</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-indent: 36pt; line-height: 1.25;">Section 10.1.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Trust Indenture Act Controls</u>.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt; line-height: 1.25;">If any provision of this Indenture limits, qualifies, or conflicts with another provision which is required or
        deemed to be included in this Indenture by the TIA, such required or deemed provision shall control.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-indent: 36pt; line-height: 1.25;">Section 10.2.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Notices</u>.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt; line-height: 1.25;">Any notice or communication by the Company or the Trustee to the other, or by a Holder to the Company or the
        Trustee, is duly given if in writing and delivered in person or mailed by first&#8209;class mail (registered or certified, return receipt requested), facsimile transmission, email or overnight air courier guaranteeing next day delivery, to the others&#8217;
        address:</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; line-height: 1.25;">if to the Company:</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="margin-left: 108pt; line-height: 1.25;">Innoviz Technologies Ltd.</div>
      <div style="margin-left: 108pt; line-height: 1.25;">Innoviz Technologies Campus, 5 Uri Ariav St., Bldg. C, Nitzba 300<br>
        Rosh HaAin, Israel<br>
        4809202<br>
        Attention:<br>
        Email:</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; line-height: 1.25;">with a copy to:</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 108pt; line-height: 1.25;">Latham &amp; Watkins LLP</div>
      <div style="text-align: justify; text-indent: 108pt; line-height: 1.25;">811 Main Street, Suite 3700</div>
      <div style="text-align: justify; text-indent: 108pt; line-height: 1.25;">Houston, Texas 77002</div>
      <div style="text-align: justify; text-indent: 108pt; line-height: 1.25;">Attention:&#160;&#160;&#160;&#160;Ryan Maierson, Ryan Lynch</div>
      <div style="text-align: justify; text-indent: 108pt; line-height: 1.25;">E-mail:&#160;&#160; &#160;&#160;&#160;&#160; <u>ryan.maierson@lw.com</u>;
        <u>ryan.lynch@lw.com</u></div>
      <div style="line-height: 1.25;">
        <div style="line-height: 1.25;"><br style="line-height: 1.25;">
        </div>
      </div>
      <div style="text-align: justify; text-indent: 108pt; line-height: 1.25;">Latham&#160;&amp; Watkins LLP</div>
      <div style="text-align: justify; text-indent: 108pt; line-height: 1.25;">99 Bishopsgate</div>
      <div style="text-align: justify; text-indent: 108pt; line-height: 1.25;">London EC2M 3XF</div>
      <div style="text-align: justify; text-indent: 108pt; line-height: 1.25;">United Kingdom</div>
      <div style="text-align: justify; text-indent: 108pt; line-height: 1.25;">Attention:&#160;&#160;&#160;&#160;Joshua Kiernan</div>
      <div style="text-align: justify; text-indent: 108pt; line-height: 1.25;">E-mail:&#160;&#160; &#160; &#160;&#160;&#160; <u>joshua.kiernan@lw.com</u></div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; line-height: 1.25;">if to the Trustee:</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="margin-left: 108pt; line-height: 1.25;">[_____]</div>
      <div style="margin-left: 108pt; line-height: 1.25;">Attention: [____]</div>
      <div style="margin-left: 108pt; line-height: 1.25;">Telephone: [____]</div>
      <div style="line-height: 1.25;"> <br>
      </div>
      <div style="line-height: 1.25;">with a copy to:</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-indent: 108pt; line-height: 1.25;">[_____]</div>
      <div style="text-indent: 108pt; line-height: 1.25;">Attention:&#160; [____]</div>
      <div style="margin-left: 108pt; line-height: 1.25;">Telephone: [____]</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-weight: normal; font-style: normal;" class="BRPFPageNumber">39</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      </div>
      <div style="text-align: justify; text-indent: 72pt; line-height: 1.25;">The Company or the Trustee by notice to the other may designate additional or different addresses for subsequent
        notices or communications.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt; line-height: 1.25;">Any notice or communication to a Securityholder shall be sent electronically or by first-class mail to his, her or
        its address shown on the register kept by the Registrar, in accordance with the procedures of the Depositary.&#160; Failure to send a notice or communication to a Securityholder of any Series or any defect in it shall not affect its sufficiency with
        respect to other Securityholders of that or any other Series.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt; line-height: 1.25;">If a notice or communication is sent or published in the manner provided above, within the time prescribed, it is
        duly given, whether or not the Securityholder receives it.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt; line-height: 1.25;">If the Company sends a notice or communication to Securityholders, it shall send a copy to the Trustee and each
        Agent at the same time.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt; line-height: 1.25;">Notwithstanding any other provision of this Indenture or any Security, where this Indenture or any Security
        provides for notice of any event (including any notice of redemption) to a Holder of a Global Security (whether by mail or otherwise), such notice shall be sufficiently given to the Depositary for such Security (or its designee) pursuant to the
        customary procedures of such Depositary.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-indent: 36pt; line-height: 1.25;">Section 10.3.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Communication by Holders with Other Holders</u>.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt; line-height: 1.25;">Securityholders of any Series may communicate pursuant to TIA &#167; 312(b) with other Securityholders of that Series or
        any other Series with respect to their rights under this Indenture or the Securities of that Series or all Series.&#160; The Company, the Trustee, the Registrar and anyone else shall have the protection of TIA &#167; 312(c).</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-indent: 36pt; line-height: 1.25;">Section 10.4.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Certificate and Opinion as to Conditions Precedent</u>.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt; line-height: 1.25;">Upon any request or application by the Company to the Trustee to take any action under this Indenture, the Company
        shall furnish to the Trustee:</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; line-height: 1.25;">(a)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;an Officer&#8217;s Certificate stating that, in the opinion of the signers, all conditions precedent, if any, provided for in this Indenture relating to the proposed action have been complied with; and</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; line-height: 1.25;">(b)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;an Opinion of Counsel stating that, in the opinion of such counsel, all such conditions precedent have been complied with.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-weight: normal; font-style: normal;" class="BRPFPageNumber">40</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-indent: 36pt; line-height: 1.25;">Section 10.5.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Statements Required in Certificate or Opinion</u>.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt; line-height: 1.25;">Each certificate or opinion with respect to compliance with a condition or covenant provided for in this Indenture
        (other than a certificate provided pursuant to TIA &#167; 314(a)(4)) shall comply with the provisions of TIA &#167; 314(e) and shall include:</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; line-height: 1.25;">(a)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;a statement that the person making such certificate or opinion has read such covenant or condition;</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; line-height: 1.25;">(b)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;a brief statement as to the nature and scope of the examination or investigation upon which the statements or opinions contained in such certificate or opinion are based;</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; line-height: 1.25;">(c)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;a statement that, in the opinion of such person, such person has made such examination or investigation as is necessary to enable such person to express an informed opinion as to whether or not such covenant or condition
          has been complied with; and</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; line-height: 1.25;">(d)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;a statement as to whether or not, in the opinion of such person, such condition or covenant has been complied with.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-indent: 36pt; line-height: 1.25;">Section 10.6.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Rules by Trustee and Agents</u>.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt; line-height: 1.25;">The Trustee may make reasonable rules for action by or a meeting of Securityholders of one or more Series.&#160; Any
        Agent may make reasonable rules and set reasonable requirements for its functions.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-indent: 36pt; line-height: 1.25;">Section 10.7.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Legal Holidays</u>.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt; line-height: 1.25;">A &#8220;<font style="font-style: italic;">Legal Holiday</font>&#8221;
        is any day that is not a Business Day.&#160; If a payment date is a Legal Holiday at a place of payment, payment may be made at that place on the next succeeding day that is not a Legal Holiday, and no interest shall accrue for the intervening period.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-indent: 36pt; line-height: 1.25;">Section 10.8.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>No Recourse Against Others</u>.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt; line-height: 1.25;">A director, officer, employee or stockholder (past or present), as such, of the Company shall not have any
        liability for any obligations of the Company under the Securities or the Indenture or for any claim based on, in respect of or by reason of such obligations or their creation.&#160; Each Securityholder by accepting a Security waives and releases all
        such liability.&#160; The waiver and release are part of the consideration for the issue of the Securities.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-indent: 36pt; line-height: 1.25;">Section 10.9.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Counterparts</u>.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt; line-height: 1.25;">This Indenture may be executed in any number of counterparts and by the parties hereto in separate counterparts,
        each of which when so executed shall be deemed to be an original and all of which taken together shall constitute one and the same agreement. The exchange of copies of this Indenture and of signature pages by facsimile or electronic format (e.g.,
        &#8220;.pdf&#8221; or &#8220;.tif&#8221;) transmission shall constitute effective execution and delivery of this Indenture as to the parties hereto and may be used in lieu of the original Indenture for all purposes. Signatures of the parties hereto transmitted by
        facsimile or electronic format (e.g., &#8220;.pdf&#8221; or &#8220;.tif&#8221;) shall be deemed to be their original signatures for all purposes.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-weight: normal; font-style: normal;" class="BRPFPageNumber">41</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      </div>
      <div style="text-align: justify; text-indent: 72pt; line-height: 1.25;">Unless otherwise provided herein or in any other Securities, the words &#8220;execute&#8221;, &#8220;execution&#8221;, &#8220;signed&#8221;, and
        &#8220;signature&#8221; and words of similar import used in or related to any document to be signed in connection with this Indenture, any Securities or any of the transactions contemplated hereby (including amendments, waivers, consents and other
        modifications) shall be deemed to include electronic signatures and the keeping of records in electronic form, each of which shall be of the same legal effect, validity or enforceability as a manually executed signature in ink or the use of a
        paper-based recordkeeping system, as applicable, to the fullest extent and as provided for in any applicable law, including the Federal Electronic Signatures in Global and National Commerce Act, the New York State Electronic Signatures and Records
        Act, and any other similar state laws based on the Uniform Electronic Transactions Act, provided that, notwithstanding anything herein to the contrary, the Trustee is not under any obligation to agree to accept electronic signatures in any form or
        in any format unless expressly agreed to by such Trustee pursuant to procedures approved by such Trustee.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-indent: 36pt; line-height: 1.25;">Section 10.10.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Governing Law; Waiver of Jury Trial; Consent to Jurisdiction</u>.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt; line-height: 1.25; font-weight: bold;">THIS INDENTURE AND THE SECURITIES, INCLUDING ANY CLAIM OR CONTROVERSY ARISING OUT OF OR RELATING
        TO THE INDENTURE OR THE SECURITIES, SHALL BE GOVERNED BY THE LAWS OF THE STATE OF NEW YORK.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt; line-height: 1.25; font-weight: bold;">THE COMPANY, THE TRUSTEE AND THE HOLDERS (BY THEIR ACCEPTANCE OF THE SECURITIES) EACH HEREBY
        IRREVOCABLY WAIVE, TO THE FULLEST EXTENT PERMITTED BY APPLICABLE LAW, ANY AND ALL RIGHT TO TRIAL BY JURY IN ANY LEGAL PROCEEDING ARISING OUT OF OR RELATING TO THIS INDENTURE, THE NOTES OR THE TRANSACTIONS CONTEMPLATED HEREBY OR THEREBY.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt; line-height: 1.25;">Any legal suit, action or proceeding arising out of or based upon this Indenture or the transactions contemplated
        hereby may be instituted in the federal courts of the United States of America located in the City of New York or the courts of the State of New York in each case located in the City of New York (collectively, the &#8220;<font style="font-style: italic;">Specified Courts</font>&#8221;), and each party irrevocably submits to the non-exclusive jurisdiction of such courts in any such suit, action or proceeding.&#160; Service of any process,
        summons, notice or document by mail (to the extent allowed under any applicable statute or rule of court) to such party&#8217;s address set forth above shall be effective service of process for any suit, action or other proceeding brought in any such
        court.&#160; The Company, the Trustee and the Holders (by their acceptance of the Securities) each hereby irrevocably and unconditionally waive any objection to the laying of venue of any suit, action or other proceeding in the Specified Courts and
        irrevocably and unconditionally waive and agree not to plead or claim any such suit, action or other proceeding has been brought in an inconvenient forum.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-weight: normal; font-style: normal;" class="BRPFPageNumber">42</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-indent: 36pt; line-height: 1.25;">Section 10.11.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>No Adverse Interpretation of Other Agreements</u>.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt; line-height: 1.25;">This Indenture may not be used to interpret another indenture, loan or debt agreement of the Company or a
        Subsidiary of the Company.&#160; Any such indenture, loan or debt agreement may not be used to interpret this Indenture.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-indent: 36pt; line-height: 1.25;">Section 10.12.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Successors</u>.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt; line-height: 1.25;">All agreements of the Company in this Indenture and the Securities shall bind its successor.&#160; All agreements of the
        Trustee in this Indenture shall bind its successor.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-indent: 36pt; line-height: 1.25;">Section 10.13.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Severability</u>.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt; line-height: 1.25;">In case any provision in this Indenture or in the Securities shall be invalid, illegal or unenforceable, the
        validity, legality and enforceability of the remaining provisions shall not in any way be affected or impaired thereby.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-indent: 36pt; line-height: 1.25;">Section 10.14.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Table of Contents, Headings, Etc</u>.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt; line-height: 1.25;">The Table of Contents, Cross Reference Table, and headings of the Articles and Sections of this Indenture have been
        inserted for convenience of reference only, are not to be considered a part hereof, and shall in no way modify or restrict any of the terms or provisions hereof.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-indent: 36pt; line-height: 1.25;">Section 10.15.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Securities in a Foreign Currency</u>.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt; line-height: 1.25;">Unless otherwise specified in a Board Resolution, a supplemental indenture hereto or an Officer&#8217;s Certificate
        delivered pursuant to Section 2.2 of this Indenture with respect to a particular Series of Securities, whenever for purposes of this Indenture any action may be taken by the Holders of a specified percentage in aggregate principal amount of
        Securities of all Series or all Series affected by a particular action at the time outstanding and, at such time, there are outstanding Securities of any Series which are denominated in more than one currency, then the principal amount of
        Securities of such Series which shall be deemed to be outstanding for the purpose of taking such action shall be determined by converting any such other currency into a currency that is designated upon issuance of any particular Series of
        Securities.&#160; Unless otherwise specified in a Board Resolution, a supplemental indenture hereto or an Officer&#8217;s Certificate delivered pursuant to Section 2.2 of this Indenture with respect to a particular Series of Securities, such conversion shall
        be at the spot rate for the purchase of the designated currency as published in The Financial Times in the &#8220;Currency Rates&#8221; section (or, if The Financial Times is no longer published, or if such information is no longer available in The Financial
        Times, such source as may be selected in good faith by the Company) on any date of determination.&#160; The provisions of this paragraph shall apply in determining the equivalent principal amount in respect of Securities of a Series denominated in
        currency other than Dollars in connection with any action taken by Holders of Securities pursuant to the terms of this Indenture.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt; line-height: 1.25;">All decisions and determinations provided for in the preceding paragraph shall, in the absence of manifest error,
        to the extent permitted by law, be conclusive for all purposes and irrevocably binding upon the Trustee and all Holders.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-weight: normal; font-style: normal;" class="BRPFPageNumber">43</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-indent: 36pt; line-height: 1.25;">Section 10.16.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Judgment Currency</u>.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt; line-height: 1.25;">The Company agrees, to the fullest extent that it may effectively do so under applicable law, that (a) if for the
        purpose of obtaining judgment in any court it is necessary to convert the sum due in respect of the principal of or interest or other amount on the Securities of any Series (the &#8220;<font style="font-style: italic;">Required Currency</font>&#8221;) into a currency in which a judgment will be rendered (the &#8220;<font style="font-style: italic;">Judgment Currency</font>&#8221;), the
        rate of exchange used shall be the rate at which in accordance with normal banking procedures the Trustee could purchase in The City of New York the Required Currency with the Judgment Currency on the day on which final unappealable judgment is
        entered, unless such day is not a New York Banking Day, then the rate of exchange used shall be the rate at which in accordance with normal banking procedures the Trustee could purchase in The City of New York the Required Currency with the
        Judgment Currency on the New York Banking Day preceding the day on which final unappealable judgment is entered and (b) its obligations under this Indenture to make payments in the Required Currency (i) shall not be discharged or satisfied by any
        tender, any recovery pursuant to any judgment (whether or not entered in accordance with subsection (a)), in any currency other than the Required Currency, except to the extent that such tender or recovery shall result in the actual receipt, by the
        payee, of the full amount of the Required Currency expressed to be payable in respect of such payments, (ii) shall be enforceable as an alternative or additional cause of action for the purpose of recovering in the Required Currency the amount, if
        any, by which such actual receipt shall fall short of the full amount of the Required Currency so expressed to be payable, and (iii) shall not be affected by judgment being obtained for any other sum due under this Indenture.&#160; For purposes of the
        foregoing, &#8220;<font style="font-style: italic;">New York Banking Day</font>&#8221; means any day except a Saturday, Sunday or a legal holiday in The City of New York on which banking
        institutions are authorized or required by law, regulation or executive order to close.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-indent: 36pt; line-height: 1.25;">Section 10.17.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Force Majeure</u>.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt; line-height: 1.25;">In no event shall the Trustee be responsible or liable for any failure or delay in the performance of its
        obligations hereunder arising out of or caused by, directly or indirectly, forces beyond its control, including, without limitation, strikes, work stoppages, accidents, acts of war or terrorism, civil or military disturbances, nuclear or natural
        catastrophes or acts of God, and interruptions, loss or malfunctions of utilities, communications or computer (software and hardware) services, it being understood that the Trustee shall use reasonable best efforts which are consistent with
        accepted practices in the banking industry to resume performance as soon as practicable under the circumstances.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-indent: 36pt; line-height: 1.25;">Section 10.18.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>U.S.A. Patriot Act</u>.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt; line-height: 1.25;">The parties hereto acknowledge that in accordance with Section 326 of the U.S.A. Patriot Act, the Trustee is
        required to obtain, verify, and record information that identifies each person or legal entity that establishes a relationship or opens an account with the Trustee.&#160; The parties to this Indenture agree that they will provide the Trustee with such
        information as it may request in order for the Trustee to satisfy the requirements of the U.S.A. Patriot Act.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-weight: normal; font-style: normal;" class="BRPFPageNumber">44</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <!--PROfilePageNumberReset%Num%45%%%-->
      <div style="text-align: center; line-height: 1.25;">ARTICLE XI.<a name="ARTICLEXI."><!--Anchor--></a><br>
        SINKING FUNDS</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-indent: 36pt; line-height: 1.25;">Section 11.1.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Applicability of Article</u>.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt; line-height: 1.25;">The provisions of this Article shall be applicable to any sinking fund for the retirement of the Securities of a
        Series if so provided by the terms of such Securities pursuant to&#160; Section 2.2, except as otherwise permitted or required by any form of Security of such Series issued pursuant to this Indenture.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt; line-height: 1.25;">The minimum amount of any sinking fund payment provided for by the terms of the Securities of any Series is herein
        referred to as a &#8220;<font style="font-style: italic;">mandatory sinking fund payment</font>&#8221; and any other amount provided for by the terms of Securities of such Series is herein referred
        to as an &#8220;<font style="font-style: italic;">optional sinking fund payment</font>.&#8221;&#160; If provided for by the terms of Securities of any Series, the cash amount of any sinking fund payment
        may be subject to reduction as provided in Section 11.2.&#160; Each sinking fund payment shall be applied to the redemption of Securities of any Series as provided for by the terms of the Securities of such Series.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-indent: 36pt; line-height: 1.25;">Section 11.2.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Satisfaction of Sinking Fund Payments with Securities</u>.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt; line-height: 1.25;">The Company may, in satisfaction of all or any part of any sinking fund payment with respect to the Securities of
        any Series to be made pursuant to the terms of such Securities (1) deliver outstanding Securities of such Series to which such sinking fund payment is applicable (other than any of such Securities previously called for mandatory sinking fund
        redemption) and (2) apply as credit Securities of such Series to which such sinking fund payment is applicable and which have been repurchased by the Company or redeemed either at the election of the Company pursuant to the terms of such Series of
        Securities (except pursuant to any mandatory sinking fund) or through the application of permitted optional sinking fund payments or other optional redemptions pursuant to the terms of such Securities, provided that such Securities have not been
        previously so credited.&#160; Such Securities shall be received by the Trustee, together with an Officer&#8217;s Certificate with respect thereto, not later than 15 days prior to the date on which the Trustee begins the process of selecting Securities for
        redemption, and shall be credited for such purpose by the Trustee at the price specified in such Securities for redemption through operation of the sinking fund and the amount of such sinking fund payment shall be reduced accordingly.&#160; If as a
        result of the delivery or credit of Securities in lieu of cash payments pursuant to this Section 11.2, the principal amount of Securities of such Series to be redeemed in order to exhaust the aforesaid cash payment shall be less than $100,000, the
        Trustee need not call Securities of such Series for redemption, except upon receipt of a Company Order that such action be taken, and such cash payment shall be held by the Trustee or a Paying Agent and applied to the next succeeding sinking fund
        payment, <u>provided</u>, <u>however</u>, that the Trustee or such Paying
        Agent shall from time to time upon receipt of a Company Order pay over and deliver to the Company any cash payment so being held by the Trustee or such Paying Agent upon delivery by the Company to the Trustee of Securities of that Series purchased
        by the Company having an unpaid principal amount equal to the cash payment required to be released to the Company.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-weight: normal; font-style: normal;" class="BRPFPageNumber">45</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      </div>
      <div style="text-indent: 36pt; line-height: 1.25;">Section 11.3.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Redemption of Securities for Sinking Fund</u>.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt; line-height: 1.25;">Not less than 45 days (unless otherwise indicated in the Board Resolution, supplemental indenture hereto or
        Officer&#8217;s Certificate in respect of a particular Series of Securities) prior to each sinking fund payment date for any Series of Securities, the Company will deliver to the Trustee an Officer&#8217;s Certificate specifying the amount of the next ensuing
        mandatory sinking fund payment for that Series pursuant to the terms of that Series, the portion thereof, if any, which is to be satisfied by payment of cash and the portion thereof, if any, which is to be satisfied by delivering and crediting of
        Securities of that Series pursuant to Section 11.2, and the optional amount, if any, to be added in cash to the next ensuing mandatory sinking fund payment, and the Company shall thereupon be obligated to pay the amount therein specified.&#160; Not less
        than 30 days (unless otherwise indicated in the Board Resolution, Officer&#8217;s Certificate or supplemental indenture in respect of a particular Series of Securities) before each such sinking fund payment date the Securities to be redeemed upon such
        sinking fund payment date will be selected in the manner specified in Section 3.2 and the Company shall send or cause to be sent a notice of the redemption thereof to be given in the name of and at the expense of the Company in the manner provided
        in and in accordance with Section 3.3.&#160; Such notice having been duly given, the redemption of such Securities shall be made upon the terms and in the manner stated in Sections 3.4, 3.5 and 3.6.</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman',Times,serif; font-weight: normal; font-style: normal;" class="BRPFPageNumber">46</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; text-indent: 72pt; line-height: 1.25;">IN WITNESS WHEREOF, the parties hereto have caused this Indenture to be duly executed as of the day and year first
        above written.</div>
      <div style="line-height: 1.25">&#160;
        <table cellspacing="0" cellpadding="0" border="0" style="width: 100%; border-collapse: separate; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">

            <tr>
              <td valign="top" style="width: 50%;">&#160;</td>
              <td valign="top" style="width: 38%;" colspan="2"><font style="font-family: 'Times New Roman',Times,serif;">INNOVIZ TECHNOLOGIES LTD.<br>
                  </font></td>
              <td valign="top" style="width: 12%;">&#160;</td>
            </tr>
            <tr>
              <td valign="top" style="width: 50%;">&#160;</td>
              <td valign="top" style="width: 3%;">&#160;</td>
              <td valign="top" style="width: 35%;">&#160;</td>
              <td valign="top" style="width: 12%;">&#160;</td>
            </tr>
            <tr>
              <td valign="top" align="left" style="width: 50%; padding-bottom: 2px;"><br>
              </td>
              <td valign="top" style="width: 3%; padding-bottom: 2px;">
                <div align="left" style="margin-left: 0pt; text-indent: 0pt; margin-right: 0pt">By: </div>
              </td>
              <td valign="top" nowrap="nowrap" align="left" style="width: 35%; border-bottom: #000000 2px solid"><br>
              </td>
              <td valign="top" style="width: 12%; padding-bottom: 2px;">&#160;</td>
            </tr>
            <tr>
              <td valign="top" style="width: 50%;">&#160;</td>
              <td valign="top" style="width: 3%;">&#160;</td>
              <td valign="bottom" nowrap="nowrap" align="left" style="width: 35%;">Name:</td>
              <td valign="top" style="width: 12%;">&#160;</td>
            </tr>
            <tr>
              <td valign="top" style="width: 50%;">&#160;</td>
              <td valign="top" style="width: 3%;">&#160;</td>
              <td valign="top" style="width: 35%;">Its:<br>
              </td>
              <td valign="top" style="width: 12%;">&#160;</td>
            </tr>
            <tr>
              <td valign="top" style="width: 50%;" rowspan="1">&#160;</td>
              <td valign="top" style="width: 3%;" rowspan="1">&#160;</td>
              <td valign="top" style="width: 35%;" rowspan="1">&#160;</td>
              <td valign="top" style="width: 12%;" rowspan="1">&#160;</td>
            </tr>
            <tr>
              <td valign="top" style="width: 50%;">&#160;</td>
              <td valign="top" style="width: 3%;" rowspan="1" colspan="2"><font style="font-family: 'Times New Roman',Times,serif;">[_____], as Trustee</font></td>
              <td valign="top" style="width: 12%;">&#160;</td>
            </tr>

        </table>
      </div>
      <div style="line-height: 1.25">
        <div style="line-height: 1.25">
          <table cellspacing="0" cellpadding="0" border="0" style="width: 100%; border-collapse: separate; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">

              <tr>
                <td valign="top" style="width: 50%;">&#160;</td>
                <td valign="top" style="width: 3%;">&#160;</td>
                <td valign="top" style="width: 35%;">&#160;</td>
                <td valign="top" style="width: 12%;">&#160;</td>
              </tr>
              <tr>
                <td valign="top" align="left" style="width: 50%; padding-bottom: 2px;"><br>
                </td>
                <td valign="top" style="width: 3%; padding-bottom: 2px;">
                  <div align="left" style="margin-left: 0pt; text-indent: 0pt; margin-right: 0pt">By: </div>
                </td>
                <td valign="top" nowrap="nowrap" align="left" style="width: 35%; border-bottom: #000000 2px solid"><br>
                </td>
                <td valign="top" style="width: 12%; padding-bottom: 2px;">&#160;</td>
              </tr>
              <tr>
                <td valign="top" style="width: 50%;">&#160;</td>
                <td valign="top" style="width: 3%;">&#160;</td>
                <td valign="bottom" nowrap="nowrap" align="left" style="width: 35%;">Name:</td>
                <td valign="top" style="width: 12%;">&#160;</td>
              </tr>
              <tr>
                <td valign="top" style="width: 50%;">&#160;</td>
                <td valign="top" style="width: 3%;">&#160;</td>
                <td valign="top" style="width: 35%;">Its:<br>
                </td>
                <td valign="top" style="width: 12%;">&#160;</td>
              </tr>

          </table>
        </div>
      </div>
      <div style="line-height: 1.25">&#160;</div>
    </div>
  </div>
  <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman',Times,serif; font-weight: normal; font-style: normal;" class="BRPFPageNumber"></font>
    <hr align="center" style="border: none; border-bottom: 4px solid black; border-top: 1px solid black; height: 10px; color: #ffffff; background-color: #ffffff; margin-left: auto; margin-right: auto;"></div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-5.1
<SEQUENCE>4
<FILENAME>exhibit_5-1.htm
<DESCRIPTION>EXHIBIT 5.1
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: zk-global
         Document created using Broadridge PROfile 25.5.1.5318
         Copyright 1995 - 2025 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left; color: #000000;">
  <div>
    <hr align="center" style="border: none; border-bottom: 1px solid black; border-top: 4px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;">
    <div>
      <div class="BRPFPageHeader">
        <div style="text-align: center; line-height: 1.25;">
          <div style="text-align: right;"><u><font style="font-weight: bold;">Exhibit 5.1</font></u></div>
          <div><br>
          </div>
          <img src="image00004.jpg"></div>
        <div style="line-height: 1.25;"><br style="line-height: 1.25;">
        </div>
      </div>
      <div style="text-align: center; line-height: 1.25;">Tel-Aviv, August 13, 2025</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-indent: -10.8pt; margin-left: 10.8pt; line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-indent: -10.8pt; margin-left: 10.8pt; line-height: 1.25;">Innoviz Technologies Ltd.</div>
      <div style="text-indent: -10.8pt; margin-left: 10.8pt; line-height: 1.25;">Innoviz Technologies Campus</div>
      <div style="text-indent: -10.8pt; margin-left: 10.8pt; line-height: 1.25;">5 Uri Ariav St., Bldg. C, Nitzba 300</div>
      <div style="text-indent: -10.8pt; margin-left: 10.8pt; line-height: 1.25;">Rosh HaAin 4809202</div>
      <div style="text-indent: -10.8pt; margin-left: 10.8pt; line-height: 1.25;">Israel</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="line-height: 1.25;">Ladies and Gentlemen:</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: justify; text-indent: 35.45pt; line-height: 1.25;">We have acted as Israeli counsel to Innoviz Technologies Ltd., a company organized under the laws of the State
        of Israel (the &#8220;<font style="font-weight: bold; font-style: italic;">Company</font>&#8221;), in connection with the registration statement on Form F-3 (the &#8220;<font style="font-weight: bold; font-style: italic;">Registration Statement</font>&#8221;) to be filed on the date hereof by the Company with the Securities and Exchange Commission under the Securities Act of 1933, as
        amended (the &#8220;<font style="font-weight: bold; font-style: italic;">Securities Act</font>&#8221;).</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 35.45pt; line-height: 1.25;">The Registration Statement registers up to $200,000,000 aggregate amount of the following securities of the Company:</div>
      <div style="line-height: 1.25">&#160;</div>
      <table cellspacing="0" cellpadding="0" id="z12a0658c03a74ba8b66347705597f19a" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 35.45pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top;">1.</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>ordinary shares (the &#8220;<font style="font-weight: bold; font-style: italic;">Ordinary Shares</font>&#8221;) of the Company, no par value&#160;(the &#8220;<font style="font-weight: bold; font-style: italic;">Primary Shares</font>&#8221;);</div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25">&#160;</div>
      <table cellspacing="0" cellpadding="0" id="z7df46d6fa1054a16b2ce3a03ed6ad8da" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 35.45pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top;">2.</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>new warrants to purchase Ordinary Shares and/or debt securities (the &#8220;<font style="font-weight: bold; font-style: italic;">New Warrants</font>&#8221;);</div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25">&#160;</div>
      <table cellspacing="0" cellpadding="0" id="z99a185b47cd147cb9c59aafd0cdfd094" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 35.45pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top;">3.</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>debt securities (the &#8220;<font style="font-weight: bold; font-style: italic;">Debt Securities</font>&#8221;); and</div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25">&#160;</div>
      <table cellspacing="0" cellpadding="0" id="z99c1b616a9dc4747ac6bf037b9602a12" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 35.45pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top;">4.</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>units comprised of one or more of the Ordinary Shares, New Warrants and Debt Securities
                  and in any combination (the &#8220;<font style="font-weight: bold; font-style: italic;">Units</font>&#8221;, and together with the Primary Shares, the New Warrants and the Debt
                Securities, the &#8220;<font style="font-weight: bold; font-style: italic;">Securities</font>&#8221;).</div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 35.45pt; line-height: 1.25;">As Israeli counsel to the Company in connection with the registering of the securities of the Company pursuant
        to the Registration Statement, we have examined such corporate records, certificates and other documents, and such questions of law, as we have considered necessary or appropriate for the purpose of our opinion.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 35.45pt; margin-right: 29.7pt; line-height: 1.25;">Upon the basis of such examination, we are of the opinion that:</div>
      <div style="line-height: 1.25">&#160;</div>
      <table cellspacing="0" cellpadding="0" id="za44213bc98154539b7b99bf3208bd4a3" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 35.3pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top;">1.</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>With respect to the Primary Shares, assuming the taking of all necessary corporate action to authorize and approve the issuance of any Primary Shares, the terms of
                the offering thereof and related matters, upon payment of the consideration therefor provided for in the applicable definitive purchase, underwriting or similar agreement approved by the Company&#8217;s Board of Directors and otherwise in
                accordance with the provisions of the applicable convertible securities, if any, such Primary Shares will be validly issued, fully paid and non-assessable.</div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25">&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      </div>
      <div>
        <div style="line-height: 1.25;">Innoviz Technologies Ltd.</div>
        <div style="line-height: 1.25;">August 13, 2025</div>
        <div style="line-height: 1.25;">Page 2</div>
        <div style="line-height: 1.25;"><font class="BRPFPageNumber"> <br>
          </font></div>
      </div>
      <table cellspacing="0" cellpadding="0" id="zca027276b8c948eca92d7c24901ba7f8" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 35.3pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top;">2.</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>With respect to the New Warrants, assuming the (a) taking of all necessary corporate action to authorize and approve the issuance of the underlying Primary Shares
                and/or Debt Securities and the issuance and terms of any New Warrants, the related New Warrant Agreement, the terms of the offering thereof and related matters and (b) due execution, authentication, issuance and delivery of such New
                Warrants upon payment of the consideration therefor provided for in the applicable definitive purchase, underwriting or similar agreement approved by the Company&#8217;s Board of Directors and otherwise in accordance with the provisions of the
                applicable New Warrant Agreement, such New Warrants will constitute valid and legally binding obligations of the Company to the extent governed by Israeli law.</div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25">&#160;</div>
      <table cellspacing="0" cellpadding="0" id="z452b2c6784cb4f5b857faa85d19d9c0b" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 35.3pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top;">3.</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>With respect to the Debt Securities, assuming the (a) taking of all necessary corporate action to authorize and approve the issuance and terms of any Debt Securities,
                the terms of the offering thereof and related matters and (b) due execution, authentication, issuance and delivery of such Debt Securities upon payment of the consideration therefor provided for in the applicable definitive purchase,
                underwriting or similar agreement approved by the Company&#8217;s Board of Directors and otherwise in accordance with the provisions of the applicable Indenture duly executed by the Company and a trustee, such Debt Securities will constitute
                valid and legally binding obligations of the Company to the extent governed by Israeli law.</div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25">&#160;</div>
      <table cellspacing="0" cellpadding="0" id="z3bd8353d11bc4ae196e1fba2370b4784" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 35.3pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top;">4.</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>With respect to the Units, assuming the (a) taking of all necessary corporate action to authorize and approve the issuance and the terms of the Units, the related
                Unit Agreement and any Securities which are components of the Units, the terms of the offering thereof and related matters and (b) due execution, countersignature (where applicable), authentication, issuance and delivery of the Units and
                the Securities that are components of such Units in each case upon the payment of the consideration therefor provided for in the applicable definitive purchase, underwriting or similar agreement approved by the Company&#8217;s Board of Directors,
                and otherwise in accordance with the provisions of the applicable (i) Warrant Agreement, in the case of New Warrants, and (ii) Indenture, in case of Debt Securities, such Units will be validly issued and will entitle the holders thereof to
                the rights specified in the Unit Agreements to the extent governed by Israeli law.</div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 35.45pt; line-height: 1.25;">The opinion expressed herein is limited to Israeli law, and we do not express any opinion as to the laws of any
        other jurisdiction.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 35.45pt; line-height: 1.25;">We consent to the filing of this opinion as an exhibit to the Registration Statement and to the references to us
        under the headings &#8220;<font style="font-style: italic;">Legal Matters</font>&#8221; and &#8220;<font style="font-style: italic;">Enforceability
          of Civil Liabilities and Agent for Service of Process in the United States</font>&#8221; in the Prospectus which is a part of the Registration Statement.&#160; In giving such consent, we do not thereby admit that we are in the category of persons whose
        consent is required under Section 7 of the Securities Act.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="line-height: 1.25">
        <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; color: #000000; width: 100%;" id="zf3ab7cc88af642edb6545bd1fb5f1cad">

            <tr>
              <td style="width: 50.00%;">
                <div>&#160;</div>
              </td>
              <td style="width: 50.00%;">
                <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">Very truly yours,</div>
                <div style="line-height: 1.25;"><br style="line-height: 1.25;">
                </div>
                <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">/s/ Naschitz, Brandes, Amir &amp; Co., Advocates</div>
                <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">Naschitz, Brandes, Amir &amp; Co., Advocates</div>
              </td>
            </tr>

        </table>
      </div>
      <div style="line-height: 1.25"> <br>
      </div>
      <hr align="center" style="border: none; border-bottom: 4px solid black; border-top: 1px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;"></div>
  </div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-5.2
<SEQUENCE>5
<FILENAME>exhibit_5-2.htm
<DESCRIPTION>EXHIBIT 5.2
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: zk-global
         Document created using Broadridge PROfile 25.5.1.5318
         Copyright 1995 - 2025 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left; color: #000000;">
  <div>
    <hr align="center" style="border: none; border-bottom: 1px solid black; border-top: 4px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;">
    <div>
      <div class="BRPFPageHeader">
        <div style="text-align: center; line-height: 1.25;">
          <div style="text-align: right;"><u><font style="font-weight: bold;">Exhibit 5.2</font></u></div>
        </div>
      </div>
    </div>
  </div>
  <div>
    <div class="BRPFPageHeader">
      <div style="line-height: 1.25"> <br>
      </div>
      <div style="line-height: 1.25">
        <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" id="za6725acc049342e4aecc1c4c64eaac25">

            <tr>
              <td rowspan="20" colspan="1" style="width: 70%; vertical-align: top;">
                <div style="line-height: 1.25;"><img width="232" height="16" src="image00006.jpg">
                  <div><br>
                  </div>
                  <div>
                    <div style="line-height: 1.25; margin-left: 27pt;">August 13, 2025</div>
                    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
                    </div>
                    <div style="line-height: 1.25; margin-left: 27pt;">Innoviz Technologies Ltd.<br>
                      Innoviz Technologies Campus<br>
                      5 Uri Ariav St., Bldg. C<br>
                      Nitzba 300 Rosh HaAin, Israel 4809202</div>
                  </div>
                </div>
              </td>
              <td colspan="2" rowspan="1" style="vertical-align: bottom;">
                <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">811 Main Street, Suite 3700</div>
              </td>
            </tr>
            <tr>
              <td colspan="2" rowspan="1" style="vertical-align: bottom;">
                <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">Houston, TX&#160; 77002</div>
              </td>
            </tr>
            <tr>
              <td colspan="2" rowspan="1" style="vertical-align: bottom;">
                <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">Tel: +1.713.546.5400&#160; Fax: +1.713.546.5401</div>
              </td>
            </tr>
            <tr>
              <td colspan="2" rowspan="1" style="vertical-align: bottom;">
                <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">www.lw.com</div>
              </td>
            </tr>
            <tr>
              <td colspan="2" rowspan="1" style="vertical-align: bottom;">&#160;</td>
            </tr>
            <tr>
              <td colspan="2" rowspan="1" style="vertical-align: bottom;">
                <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">FIRM / AFFILIATE OFFICES</div>
              </td>
            </tr>
            <tr>
              <td style="width: 15%; vertical-align: top;">
                <div style="line-height: 1.25;">Austin</div>
              </td>
              <td style="width: 15%; vertical-align: top;">
                <div style="line-height: 1.25;">&#160;Milan</div>
              </td>
            </tr>
            <tr>
              <td style="width: 15%; vertical-align: top;">
                <div style="line-height: 1.25;">Beijing</div>
              </td>
              <td style="width: 15%; vertical-align: top;">
                <div style="line-height: 1.25;">&#160;Munich</div>
              </td>
            </tr>
            <tr>
              <td style="width: 15%; vertical-align: top;">
                <div style="line-height: 1.25;">Boston</div>
              </td>
              <td style="width: 15%; vertical-align: top;">
                <div style="line-height: 1.25;">&#160;New York</div>
              </td>
            </tr>
            <tr>
              <td style="width: 15%; vertical-align: top;">
                <div style="line-height: 1.25;">Brussels</div>
              </td>
              <td style="width: 15%; vertical-align: top;">
                <div style="line-height: 1.25;">&#160;Orange County</div>
              </td>
            </tr>
            <tr>
              <td style="width: 15%; vertical-align: top;">
                <div style="line-height: 1.25;">Chicago</div>
              </td>
              <td style="width: 15%; vertical-align: top;">
                <div style="line-height: 1.25;">&#160;Paris</div>
              </td>
            </tr>
            <tr>
              <td style="width: 15%; vertical-align: top;">
                <div style="line-height: 1.25;">Dubai</div>
              </td>
              <td style="width: 15%; vertical-align: top;">
                <div style="line-height: 1.25;">&#160;Riyadh</div>
              </td>
            </tr>
            <tr>
              <td style="width: 15%; vertical-align: top;">
                <div style="line-height: 1.25;">D&#252;sseldorf</div>
              </td>
              <td style="width: 15%; vertical-align: top;">
                <div style="line-height: 1.25;">&#160;San Diego</div>
              </td>
            </tr>
            <tr>
              <td style="width: 15%; vertical-align: top;">
                <div style="line-height: 1.25;">Frankfurt</div>
              </td>
              <td style="width: 15%; vertical-align: top;">
                <div style="line-height: 1.25;">&#160;San Francisco</div>
              </td>
            </tr>
            <tr>
              <td style="width: 15%; vertical-align: top;">
                <div style="line-height: 1.25;">Hamburg</div>
              </td>
              <td style="width: 15%; vertical-align: top;">
                <div style="line-height: 1.25;">&#160;Seoul</div>
              </td>
            </tr>
            <tr>
              <td style="width: 15%; vertical-align: top;">
                <div style="line-height: 1.25;">Hong Kong </div>
              </td>
              <td style="width: 15%; vertical-align: top;">
                <div style="line-height: 1.25;">Silicon Valley</div>
              </td>
            </tr>
            <tr>
              <td style="width: 15%; vertical-align: top;">
                <div style="line-height: 1.25;">Houston</div>
              </td>
              <td style="width: 15%; vertical-align: top;">
                <div style="line-height: 1.25;">&#160;Singapore</div>
              </td>
            </tr>
            <tr>
              <td style="width: 15%; vertical-align: top;">
                <div style="line-height: 1.25;">London</div>
              </td>
              <td style="width: 15%; vertical-align: top;">
                <div style="line-height: 1.25;">&#160;Tel Aviv</div>
              </td>
            </tr>
            <tr>
              <td style="width: 15%; vertical-align: top;">
                <div style="line-height: 1.25;">Los Angeles</div>
              </td>
              <td style="width: 15%; vertical-align: top;">
                <div style="line-height: 1.25;">Tokyo</div>
              </td>
            </tr>
            <tr>
              <td style="width: 15%; vertical-align: top;">
                <div style="line-height: 1.25;">Madrid</div>
              </td>
              <td style="width: 15%; vertical-align: top;">
                <div style="line-height: 1.25;">&#160;Washington, D.C.</div>
              </td>
            </tr>

        </table>
      </div>
      <div style="line-height: 1.25">&#160;</div>
    </div>
    <div style="line-height: 1.25;">Re:&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Innoviz Technologies Ltd. &#8211; Registration Statement on Form F-3</u></div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="line-height: 1.25;">To the addressees set forth above:</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">We have acted as special counsel to Innoviz Technologies Ltd., a company organized under the laws of the State of Israel (the &#8220;<font style="font-weight: bold; font-style: italic;">Company</font>&#8221;),
      in connection with its filing on the date hereof with the Securities and Exchange Commission (the &#8220;<font style="font-weight: bold; font-style: italic;">Commission</font>&#8221;) of a registration statement on Form F-3 (as amended, the &#8220;<font style="font-weight: bold; font-style: italic;">Registration Statement</font>&#8221;), including a base prospectus (the &#8220;<font style="font-weight: bold; font-style: italic;">Base Prospectus</font>&#8221;), which provides that it will be supplemented by one or
      more prospectus supplements (each such prospectus supplement, together with the Base Prospectus, a &#8220;<font style="font-weight: bold; font-style: italic;">Prospectus</font>&#8221;), under the Securities Act of 1933, as amended (the &#8220;<font style="font-weight: bold; font-style: italic;">Act</font>&#8221;), relating to the registration for issue and sale by the Company of up to $200,000,000 aggregate offering amount of (i) one or more series of the Company&#8217;s debt securities (collectively, &#8220;<font style="font-weight: bold; font-style: italic;">Debt Securities</font>&#8221;) to be issued under an indenture to be entered into between the Company, as issuer, and a trustee (a form of which is included as Exhibit 4.1 to the Registration Statement) and
      one or more board resolutions, supplements thereto or officer&#8217;s certificates thereunder (such indenture, together with the applicable board resolution, supplement or officer&#8217;s certificate pertaining to the applicable series of Debt Securities, the &#8220;<font style="font-weight: bold; font-style: italic;">Applicable Indenture</font>&#8221;), (ii) ordinary shares, (iii) warrants to purchase ordinary shares (&#8220;<font style="font-weight: bold; font-style: italic;">Warrants</font>&#8221;) and (iv) units comprised of one
      or more of the Debt Securities, ordinary shares and Warrants and in any combination (the &#8220;<font style="font-weight: bold; font-style: italic;">Units</font>&#8221;). The Debt Securities, Warrants and Units, plus any additional Debt Securities, Warrants and
      Units that may be registered pursuant to any subsequent registration statement that the Company may hereafter file with the Commission pursuant to Rule 462(b) under the Act in connection with the offering by the Company contemplated by the
      Registration Statement, are referred to herein collectively as the &#8220;<font style="font-weight: bold; font-style: italic;">Securities</font>.&#8221;</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">This opinion is being furnished in connection with the requirements of Item 601(b)(5) of Regulation S-K under the Act, and no opinion is expressed herein as to any matter
      pertaining to the contents of the Registration Statement or related applicable Prospectus, other than as expressly stated herein with respect to the issue of the Securities.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">As such counsel, we have examined such matters of fact and questions of law as we have considered appropriate for purposes of this letter. With your consent, we have relied upon
      certificates and other assurances of officers of the Company and others as to factual matters without having independently verified such factual matters. We are opining herein as to the internal laws of the State of New York and we express no opinion
      with respect to the applicability thereto, or the effect thereon, of the laws of any other jurisdiction or as to any matters of municipal law or the laws of any local agencies within any state. Various matters concerning the laws of Israel are
      addressed in the opinion of Naschitz, Brandes, Amir &amp; Co., which has been separately provided to you. We express no opinion with respect to those matters herein, and, to the extent such matters are necessary to the conclusions expressed herein,
      we have, with your consent, assumed such matters.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="line-height: 1.25">
      <div>
        <div class="BRPFPageHeader">
          <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

              <tr>
                <td style="width: 100%; vertical-align: top;">
                  <div style="line-height: 1.25; font-weight: bold;">August 13, 2025</div>
                  <div style="line-height: 1.25; font-weight: bold;">Page 2</div>
                </td>
              </tr>

          </table>
          <div style="line-height: 1.25">&#160;</div>
        </div>
      </div>
    </div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">Subject to the foregoing and the other matters set forth herein, it is our opinion that, as of the date hereof:</div>
    <div style="line-height: 1.25">&#160;</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z680bfdb0c46b41fbbfd895c7e075c3fe">

        <tr>
          <td style="width: 36pt; vertical-align: top;">1.</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>When the Applicable Indenture has been duly authorized, executed and delivered by all necessary corporate action of the Company, and when the specific terms of a particular series of Debt Securities have been duly established in accordance
              with the terms of the Applicable Indenture and authorized by all necessary corporate action of the Company, and such Debt Securities have been duly executed, authenticated, issued and delivered against payment therefor in accordance with the
              terms of the Applicable Indenture and in the manner contemplated by the applicable Prospectus and by such corporate action, such Debt Securities will be the legally valid and binding obligations of the Company, enforceable against the Company
              in accordance with their terms.</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z309ae068f28e48b5b4f0348e6a97ae90">

        <tr>
          <td style="width: 36pt; vertical-align: top;">2.</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>When the applicable warrant agreement has been duly authorized, executed and delivered by all necessary corporate action of the Company, and when the specific terms of a particular issuance of Warrants have been duly established in
              accordance with the terms of the applicable warrant agreement and authorized by all necessary corporate action of the Company, and such Warrants have been duly executed, authenticated, issued and delivered against payment therefor in
              accordance with the terms of the applicable warrant agreement and in the manner contemplated by the applicable Prospectus and by such corporate action (assuming the securities issuable upon exercise of such Warrants have been duly authorized
              and reserved for issuance by all necessary corporate action), such Warrants will be the legally valid and binding obligations of the Company, enforceable against the Company in accordance with their terms.</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z6fb3ae354e344ea9917741fb5b23ed60">

        <tr>
          <td style="width: 36pt; vertical-align: top;">3.</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>When the applicable unit agreement has been duly authorized, executed and delivered by all necessary corporate action of the Company, and when the specific terms of a particular issuance of Units have been duly authorized in accordance
              with the terms of the applicable unit agreement and authorized by all necessary corporate action of the Company, and such Units have been duly executed, authenticated, issued and delivered against payment therefor in accordance with the terms
              of the applicable unit agreement and in the manner contemplated by the applicable Prospectus and by such corporate action (assuming the securities issuable upon exercise of such Units have been duly authorized and reserved for issuance by all
              necessary corporate action), such Units will be the legally valid and binding obligations of the Company, enforceable against the Company in accordance with their terms.</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">Our opinions are subject to: (i) the effect of bankruptcy, insolvency, reorganization, preference, fraudulent transfer, moratorium or other similar laws relating to or affecting
      the rights and remedies of creditors; (ii) (a) the effect of general principles of equity, whether considered in a proceeding in equity or at law (including the possible unavailability of specific performance or injunctive relief), (b) concepts of
      materiality, reasonableness, good faith and fair dealing, and (c) the discretion of the court before which a proceeding is brought; and (iii) the invalidity under certain circumstances under law or court decisions of provisions providing for the
      indemnification of or contribution to a party with respect to a liability where such indemnification or contribution is contrary to public policy.&#160; We express no opinion as to (a) any provision for liquidated damages, default interest, late charges,
      monetary penalties, make-whole premiums or other economic remedies to the extent such provisions are deemed to constitute a penalty, (b) consents to, or restrictions upon, governing law, jurisdiction, venue, arbitration, remedies, or judicial relief,
      (c) waivers of rights or defenses, (d) any provision requiring the payment of attorneys&#8217; fees, where such payment is contrary to law or public policy, (e) any provision permitting, upon acceleration of any Debt Securities, collection of that portion
      of the stated principal amount thereof which might be determined to constitute unearned interest thereon, (f) the creation, validity, attachment, perfection, or priority of any lien or security interest, (g) advance waivers of claims, defenses,
      rights granted by law, or notice, opportunity for hearing, evidentiary requirements, statutes of limitation, trial by jury or at law, or other procedural rights, (h) waivers of broadly or vaguely stated rights, (i) provisions for exclusivity,
      election or cumulation of rights or remedies, (j) provisions authorizing or validating conclusive or discretionary determinations, (k) grants of setoff rights, (l) proxies, powers and trusts, (m) provisions prohibiting, restricting, or requiring
      consent to assignment or transfer of any right or property, (n) any provision to the extent it requires that a claim with respect to a security denominated in other than U.S. dollars (or a judgment in respect of such a claim) be converted into U.S.
      dollars at a rate of exchange at a particular date, to the extent applicable law otherwise provides, and (o) the severability, if invalid, of provisions to the foregoing effect.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="line-height: 1.25">
      <div>
        <div class="BRPFPageHeader">
          <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

              <tr>
                <td style="width: 100%; vertical-align: top;">
                  <div style="line-height: 1.25; font-weight: bold;">August 13, 2025</div>
                  <div style="line-height: 1.25; font-weight: bold;">Page 3</div>
                </td>
              </tr>

          </table>
          <div style="line-height: 1.25">&#160;</div>
        </div>
      </div>
    </div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">With your consent, we have assumed (a) that each of the Debt Securities, Warrants, Units and the Applicable Indenture governing such Debt Securities, the warrant agreements
      governing the Warrants and the unit agreements governing the Units will be governed by the internal laws of the State of New York, (b) that each of (i) the Applicable Indenture, (ii) the warrant agreements governing the Warrants and (iii) the unit
      agreements governing the Units (collectively, the &#8220;<font style="font-weight: bold; font-style: italic;">Documents</font>&#8221;) has been or will be duly authorized, executed and delivered by the parties thereto, (c) that each of the Documents constitutes
      or will constitute legally valid and binding obligations of the parties thereto other than the Company, enforceable against each of them in accordance with their respective terms, and (d) that the status of each of the Documents as legally valid and
      binding obligations of the parties will not be affected by any (i) breaches of, or defaults under, agreements or instruments, (ii) violations of statutes, rules, regulations or court or governmental orders, or (iii) failures to obtain required
      consents, approvals or authorizations from, or to make required registrations, declarations or filings with, governmental authorities.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">This opinion is for your benefit in connection with the Registration Statement and may be relied upon by you and by persons entitled to rely upon it pursuant to the applicable
      provisions of the Act. We consent to your filing this opinion as an exhibit to the Registration Statement and to the reference to our firm contained in the Prospectus under the heading &#8220;Legal Matters.&#8221; We further consent to the incorporation by
      reference of this letter and consent into any registration statement or post-effective amendment to the Registration Statement filed pursuant to Rule 462(b) under the Act with respect to the Securities.&#160; In giving such consent, we do not thereby
      admit that we are in the category of persons whose consent is required under Section 7 of the Act or the rules and regulations of the Commission thereunder.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="line-height: 1.25">
      <table cellspacing="0" cellpadding="0" border="0" id="zaf13668138e84d07b9390f42f73a2205" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; color: #000000; width: 100%;">

          <tr>
            <td style="width: 50.00%;">
              <div>&#160;</div>
            </td>
            <td style="width: 50.00%;">
              <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">Sincerely,</div>
              <div style="line-height: 1.25;"><br style="line-height: 1.25;">
              </div>
              <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">/s/ Latham &amp; Watkins LLP</div>
            </td>
          </tr>

      </table>
    </div>
    <br>
    <div style="line-height: 1.25;">
      <hr align="center" style="border: none; border-bottom: 4px solid black; border-top: 1px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;"></div>
  </div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-5.3
<SEQUENCE>6
<FILENAME>exhibit_5-3.htm
<DESCRIPTION>EXHIBIT 5.3
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: zk-global
         Document created using Broadridge PROfile 25.5.1.5318
         Copyright 1995 - 2025 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left; color: #000000;">
  <div>
    <hr align="center" style="border: none; border-bottom: 1px solid black; border-top: 4px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;"></div>
  <div>
    <div class="BRPFPageHeader">
      <div style="text-align: right; line-height: 1.25; font-weight: bold;"><u>Exhibit 5.3<br>
        </u></div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: center; line-height: 1.25;"><img width="200" height="150" src="image2.jpg"></div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
    </div>
    <div style="text-align: center; line-height: 1.25;">Tel-Aviv, August 13, 2025</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-indent: -10.8pt; margin-left: 10.8pt; line-height: 1.25;">Innoviz Technologies Ltd.</div>
    <div style="text-indent: -10.8pt; margin-left: 10.8pt; line-height: 1.25;">Innoviz Technologies Campus</div>
    <div style="text-indent: -10.8pt; margin-left: 10.8pt; line-height: 1.25;">5 Uri Ariav St., Bldg. C, Nitzba 300</div>
    <div style="text-indent: -10.8pt; margin-left: 10.8pt; line-height: 1.25;">Rosh HaAin 4809202</div>
    <div style="margin-right: 29.7pt; line-height: 1.25;">Israel</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="margin-right: 29.7pt; line-height: 1.25;">Ladies and Gentlemen:</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; text-indent: 35.45pt; margin-right: 29.7pt; line-height: 1.25;">This opinion is furnished to you in connection with the Open Market Sale Agreement<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">SM</sup>,
      dated August 13, 2025 (the &#8220;<font style="font-weight: bold; font-style: italic;">Agreement</font>&#8221;), by and
        between Innoviz Technologies Ltd., a company organized under the laws of the State of Israel (the &#8220;<font style="font-weight: bold; font-style: italic;">Company</font>&#8221;), and Jefferies LLC, as sales agent and/or principal, which provides for the offer and sale of ordinary
        shares, no par value per share (&#8220;<font style="font-weight: bold; font-style: italic;">Ordinary Shares</font>&#8221;), of the Company, having an aggregate offering price of up to $75 million (such Ordinary Shares, the &#8220;<font style="font-weight: bold; font-style: italic;">Placement
        Shares</font>&#8221;), pursuant to the Company&#8217;s Registration Statement on Form F-3 (the &#8220;<font style="font-weight: bold; font-style: italic;">Registration Statement</font>&#8221;) filed by the Company with the Securities and Exchange Commission under the Securities Act of 1933, as amended (the &#8220;<font style="font-weight: bold; font-style: italic;">Securities Act</font>&#8221;), including the accompanying prospectus included therein (the &#8220;<font style="font-weight: bold; font-style: italic;">Prospectus</font>&#8221;), and the prospectus supplement (the &#8220;<font style="font-weight: bold; font-style: italic;">Prospectus Supplement</font>&#8221;) (the &#8220;<font style="font-weight: bold; font-style: italic;">Offering</font>&#8221;).</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; text-indent: 35.45pt; margin-right: 29.7pt; line-height: 1.25;">As Israeli counsel to the Company in connection with the Offering, we have examined such
      corporate records, certificates and other documents, and such questions of law, as we have considered necessary or appropriate for the purpose of our opinion.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; text-indent: 35.45pt; margin-right: 29.7pt; line-height: 1.25;">Upon the basis of such examination, we are of the opinion that the Placement Shares have
      been duly authorized for issuance, and when issued and sold in the manner contemplated by the Prospectus Supplement, the Prospectus, and the Agreement, will be validly issued, fully paid and nonassessable.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; text-indent: 35.45pt; margin-right: 29.7pt; line-height: 1.25;">The opinion expressed herein is limited to Israeli law, and we do not express any opinion as
      to the laws of any other jurisdiction.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; text-indent: 35.45pt; margin-right: 29.7pt; line-height: 1.25;">We consent to the filing of this opinion as an exhibit to the Registration Statement and to
      the references to us under the headings &#8220;<font style="font-style: italic;">Legal Matters</font>&#8221; and &#8220;<font style="font-style: italic;">Enforceability of Civil Liabilities</font>&#8221; in the Prospectus Supplement and Prospectus.&#160; In giving such consent, we do not thereby admit that we are in the category of persons whose consent is required under Section 7 of the
      Securities Act.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="line-height: 1.25"> <br>
    </div>
    <div style="line-height: 1.25">
      <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; color: #000000; width: 100%;" id="zd6c544ab03d54168aa67b302f1467035">

          <tr>
            <td style="width: 50.00%;">
              <div>&#160;</div>
            </td>
            <td style="width: 50%;">
              <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">Very truly yours,</div>
              <div style="line-height: 1.25;"><br style="line-height: 1.25;">
              </div>
              <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">/s/ Naschitz, Brandes, Amir &amp; Co., Advocates</div>
            </td>
          </tr>

      </table>
    </div>
    <br>
  </div>
  <div>
    <hr align="center" style="border: none; border-bottom: 4px solid black; border-top: 1px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;"></div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.1
<SEQUENCE>7
<FILENAME>exhibit_23-1.htm
<DESCRIPTION>EXHIBIT 23.1
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: zk-global
         Document created using Broadridge PROfile 25.5.1.5318
         Copyright 1995 - 2025 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left; color: #000000;">
  <div>
    <hr align="center" style="border: none; border-bottom: 1px solid black; border-top: 4px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;">
    <div>
      <div class="BRPFPageHeader">
        <div style="text-align: right; line-height: 1.25; font-weight: bold;"><u>Exhibit 23.1</u></div>
        <div style="line-height: 1.25;"><br style="line-height: 1.25;">
        </div>
        <div style="line-height: 1.25;"><img width="122" height="59" src="image00007.jpg"></div>
      </div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: center; line-height: 1.25;">CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</div>
      <div style="line-height: 1.25;">&#160;</div>
      <div style="text-align: justify; line-height: 1.25;">We hereby consent to the incorporation by reference in this&#160;Registration Statement on Form F-3&#160;of Innoviz Technologies Ltd.<font style="font-weight: bold;">&#160;</font>of our report dated March 12,
        2025 relating to the financial statements, which appears in Innoviz Technologies Ltd.'s Annual Report on Form 20-F for the year ended December&#160;31, 2024. We also consent to the reference to us under the heading<font style="font-weight: bold;">&#160;</font>&#8220;Experts&#8221;
        in such Registration Statement.</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="line-height: 1.25;">/s/ Kesselman &amp; Kesselman</div>
      <div style="line-height: 1.25;">Certified Public Accountants (Isr.)</div>
      <div style="line-height: 1.25;">A member firm of PricewaterhouseCoopers International Limited</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="line-height: 1.25;">Tel Aviv, Israel</div>
      <div style="line-height: 1.25;">August 13, 2025</div>
      <br>
      <div style="line-height: 1.25;">
        <hr align="center" style="border: none; border-bottom: 4px solid black; border-top: 1px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;"></div>
    </div>
  </div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.2
<SEQUENCE>8
<FILENAME>exhibit_23-2.htm
<DESCRIPTION>EXHIBIT 23.2
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: zk-global
         Document created using Broadridge PROfile 25.5.1.5318
         Copyright 1995 - 2025 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left; color: #000000;">
  <div>
    <hr align="center" style="border: none; border-bottom: 1px solid black; border-top: 4px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;">
    <div>
      <div style="line-height: 1.25;">
        <div style="text-align: right; line-height: 1.25; font-weight: bold;"><u>Exhibit 23.2</u></div>
        <div style="line-height: 1.25;"><br style="line-height: 1.25;">
        </div>
      </div>
      <div style="line-height: 1.25;">
        <div style="line-height: 1.25;">
          <div style="text-align: center; line-height: 1.25; font-weight: bold;">CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</div>
          <div style="text-align: center; line-height: 1.25;">&#160;</div>
        </div>
        <div style="line-height: 1.25;">
          <div style="text-align: justify; line-height: 1.25;">We consent to the reference to our firm under the caption &#8220;Experts&#8221; in the Registration Statement (Form F-3) and related Prospectus of Innoviz Technologies Ltd.&#160;for the registration of ordinary
            shares, warrants, debt securities and units and to the incorporation by reference therein of our report dated March 9, 2023, with respect to the consolidated financial statements of Innoviz Technologies Ltd. included in its Annual Report (Form
            20-F) for the year ended December 31, 2024, filed with the Securities and Exchange Commission.</div>
          <div style="text-align: justify; line-height: 1.25;"> <br>
          </div>
        </div>
      </div>
      <div style="line-height: 1.25;">
        <div style="text-align: justify; line-height: 1.25;">/s/ KOST FORER GABBAY &amp; KASIERER</div>
      </div>
      <div style="line-height: 1.25;">A Member of EY Global&#160;&#160;</div>
      <div style="line-height: 1.25;">
        <div style="line-height: 1.25;"><br style="line-height: 1.25;">
        </div>
        <div style="line-height: 1.25;">
          <div style="line-height: 1.25;">Tel Aviv, Israel</div>
          <div style="line-height: 1.25;">August 13, 2025</div>
        </div>
      </div>
      <br>
      <div style="line-height: 1.25;">
        <div style="line-height: 1.25;">
          <hr align="center" style="border: none; border-bottom: 4px solid black; border-top: 1px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;"></div>
      </div>
    </div>
  </div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-FILING FEES
<SEQUENCE>9
<FILENAME>exfilingfees.htm
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:dei="http://xbrl.sec.gov/dei/2025" xmlns:ffd="http://xbrl.sec.gov/ffd/2025">
  <head>
    <title>EX-FILING FEES</title>
  </head>
  <body>
    <div style="display: none">
      <ix:header>
        <ix:hidden>
          <ix:nonNumeric name="ffd:FormTp" contextRef="rc" id="ixv-468">F-3</ix:nonNumeric>
          <ix:nonNumeric name="ffd:SubmissnTp" contextRef="rc" id="ixv-469">F-3</ix:nonNumeric>
          <ix:nonNumeric name="ffd:FeeExhibitTp" contextRef="rc" id="ixv-470">EX-FILING FEES</ix:nonNumeric>
          <ix:nonNumeric name="dei:EntityCentralIndexKey" contextRef="rc" id="ixv-471">0001835654</ix:nonNumeric>
          <ix:nonNumeric name="dei:EntityRegistrantName" contextRef="rc" id="ixv-472">Innoviz Technologies Ltd.</ix:nonNumeric>
          <ix:nonNumeric name="ffd:OfferingTableNa" contextRef="rc" id="hiddenrcOfferingTableNa" xsi:nil="true"></ix:nonNumeric>
          <ix:nonNumeric name="ffd:OffsetTableNa" contextRef="rc" id="hiddenrcOffsetTableNa">N/A</ix:nonNumeric>
          <ix:nonNumeric name="ffd:CombinedProspectusTableNa" contextRef="rc" id="hiddenrcCombinedProspectusTableNa">N/A</ix:nonNumeric>
          <ix:nonFraction name="ffd:FeeRate" unitRef="pure" decimals="INF" format="ixt:numdotdecimal" contextRef="offrl_1" id="ixv-476">0.0001531</ix:nonFraction>
          <ix:nonFraction name="ffd:FeeRate" unitRef="pure" decimals="INF" format="ixt:numdotdecimal" contextRef="offrl_2" id="ixv-477">0.0001531</ix:nonFraction>
          <ix:nonFraction name="ffd:FeeRate" unitRef="pure" decimals="INF" format="ixt:numdotdecimal" contextRef="offrl_3" id="ixv-478">0.0001531</ix:nonFraction>
          <ix:nonFraction name="ffd:FeeRate" unitRef="pure" decimals="INF" format="ixt:numdotdecimal" contextRef="offrl_4" id="ixv-479">0.0001531</ix:nonFraction>
        </ix:hidden>
        <ix:references>
          <link:schemaRef xlink:href="https://xbrl.sec.gov/ffd/2025/ffd-2025.xsd" xlink:type="simple"/>
        </ix:references>
        <ix:resources>
          <xbrli:context id="rc">
            <xbrli:entity>
              <xbrli:identifier scheme="http://www.sec.gov/CIK">0001835654</xbrli:identifier>
            </xbrli:entity>
            <xbrli:period>
              <xbrli:startDate>2025-08-12</xbrli:startDate>
              <xbrli:endDate>2025-08-12</xbrli:endDate>
            </xbrli:period>
          </xbrli:context>
          <xbrli:context id="offrl_1">
            <xbrli:entity>
              <xbrli:identifier scheme="http://www.sec.gov/CIK">0001835654</xbrli:identifier>
              <xbrli:segment>
                <xbrldi:typedMember dimension="ffd:OfferingAxis">
                  <dei:lineNo>1</dei:lineNo>
                </xbrldi:typedMember>
              </xbrli:segment>
            </xbrli:entity>
            <xbrli:period>
              <xbrli:startDate>2025-08-12</xbrli:startDate>
              <xbrli:endDate>2025-08-12</xbrli:endDate>
            </xbrli:period>
          </xbrli:context>
          <xbrli:context id="offrl_2">
            <xbrli:entity>
              <xbrli:identifier scheme="http://www.sec.gov/CIK">0001835654</xbrli:identifier>
              <xbrli:segment>
                <xbrldi:typedMember dimension="ffd:OfferingAxis">
                  <dei:lineNo>2</dei:lineNo>
                </xbrldi:typedMember>
              </xbrli:segment>
            </xbrli:entity>
            <xbrli:period>
              <xbrli:startDate>2025-08-12</xbrli:startDate>
              <xbrli:endDate>2025-08-12</xbrli:endDate>
            </xbrli:period>
          </xbrli:context>
          <xbrli:context id="offrl_3">
            <xbrli:entity>
              <xbrli:identifier scheme="http://www.sec.gov/CIK">0001835654</xbrli:identifier>
              <xbrli:segment>
                <xbrldi:typedMember dimension="ffd:OfferingAxis">
                  <dei:lineNo>3</dei:lineNo>
                </xbrldi:typedMember>
              </xbrli:segment>
            </xbrli:entity>
            <xbrli:period>
              <xbrli:startDate>2025-08-12</xbrli:startDate>
              <xbrli:endDate>2025-08-12</xbrli:endDate>
            </xbrli:period>
          </xbrli:context>
          <xbrli:context id="offrl_4">
            <xbrli:entity>
              <xbrli:identifier scheme="http://www.sec.gov/CIK">0001835654</xbrli:identifier>
              <xbrli:segment>
                <xbrldi:typedMember dimension="ffd:OfferingAxis">
                  <dei:lineNo>4</dei:lineNo>
                </xbrldi:typedMember>
              </xbrli:segment>
            </xbrli:entity>
            <xbrli:period>
              <xbrli:startDate>2025-08-12</xbrli:startDate>
              <xbrli:endDate>2025-08-12</xbrli:endDate>
            </xbrli:period>
          </xbrli:context>
          <xbrli:context id="offrl_5">
            <xbrli:entity>
              <xbrli:identifier scheme="http://www.sec.gov/CIK">0001835654</xbrli:identifier>
              <xbrli:segment>
                <xbrldi:typedMember dimension="ffd:OfferingAxis">
                  <dei:lineNo>5</dei:lineNo>
                </xbrldi:typedMember>
              </xbrli:segment>
            </xbrli:entity>
            <xbrli:period>
              <xbrli:startDate>2025-08-12</xbrli:startDate>
              <xbrli:endDate>2025-08-12</xbrli:endDate>
            </xbrli:period>
          </xbrli:context>
          <xbrli:context id="offrl_6">
            <xbrli:entity>
              <xbrli:identifier scheme="http://www.sec.gov/CIK">0001835654</xbrli:identifier>
              <xbrli:segment>
                <xbrldi:typedMember dimension="ffd:OfferingAxis">
                  <dei:lineNo>6</dei:lineNo>
                </xbrldi:typedMember>
              </xbrli:segment>
            </xbrli:entity>
            <xbrli:period>
              <xbrli:startDate>2025-08-12</xbrli:startDate>
              <xbrli:endDate>2025-08-12</xbrli:endDate>
            </xbrli:period>
          </xbrli:context>
          <xbrli:context id="offrl_7">
            <xbrli:entity>
              <xbrli:identifier scheme="http://www.sec.gov/CIK">0001835654</xbrli:identifier>
              <xbrli:segment>
                <xbrldi:typedMember dimension="ffd:OfferingAxis">
                  <dei:lineNo>7</dei:lineNo>
                </xbrldi:typedMember>
              </xbrli:segment>
            </xbrli:entity>
            <xbrli:period>
              <xbrli:startDate>2025-08-12</xbrli:startDate>
              <xbrli:endDate>2025-08-12</xbrli:endDate>
            </xbrli:period>
          </xbrli:context>
          <xbrli:context id="offrl_8">
            <xbrli:entity>
              <xbrli:identifier scheme="http://www.sec.gov/CIK">0001835654</xbrli:identifier>
              <xbrli:segment>
                <xbrldi:typedMember dimension="ffd:OfferingAxis">
                  <dei:lineNo>8</dei:lineNo>
                </xbrldi:typedMember>
              </xbrli:segment>
            </xbrli:entity>
            <xbrli:period>
              <xbrli:startDate>2025-08-12</xbrli:startDate>
              <xbrli:endDate>2025-08-12</xbrli:endDate>
            </xbrli:period>
          </xbrli:context>
          <xbrli:context id="offrl_9">
            <xbrli:entity>
              <xbrli:identifier scheme="http://www.sec.gov/CIK">0001835654</xbrli:identifier>
              <xbrli:segment>
                <xbrldi:typedMember dimension="ffd:OfferingAxis">
                  <dei:lineNo>9</dei:lineNo>
                </xbrldi:typedMember>
              </xbrli:segment>
            </xbrli:entity>
            <xbrli:period>
              <xbrli:startDate>2025-08-12</xbrli:startDate>
              <xbrli:endDate>2025-08-12</xbrli:endDate>
            </xbrli:period>
          </xbrli:context>
          <xbrli:context id="offrl_10">
            <xbrli:entity>
              <xbrli:identifier scheme="http://www.sec.gov/CIK">0001835654</xbrli:identifier>
              <xbrli:segment>
                <xbrldi:typedMember dimension="ffd:OfferingAxis">
                  <dei:lineNo>10</dei:lineNo>
                </xbrldi:typedMember>
              </xbrli:segment>
            </xbrli:entity>
            <xbrli:period>
              <xbrli:startDate>2025-08-12</xbrli:startDate>
              <xbrli:endDate>2025-08-12</xbrli:endDate>
            </xbrli:period>
          </xbrli:context>
          <xbrli:unit id="USD">
            <xbrli:measure>iso4217:USD</xbrli:measure>
          </xbrli:unit>
          <xbrli:unit id="pure">
            <xbrli:measure>xbrli:pure</xbrli:measure>
          </xbrli:unit>
          <xbrli:unit id="Shares">
            <xbrli:measure>xbrli:shares</xbrli:measure>
          </xbrli:unit>
        </ix:resources>
      </ix:header>
    </div>
    <div>
      <table style="width: 99%; font-family: Arial, Helvetica, sans-serif; font-size: 20pt; text-align: center;">
        <tr>
          <td colspan="4" style="padding-bottom: .5em">
            <p>
              <b>Calculation of Filing Fee Tables</b>
            </p>
          </td>
        </tr>
        <tr>
          <td style="padding-bottom: .25em">
            <p>
              <b>
                <ix:nonNumeric name="ffd:FormTp" contextRef="rc" id="ixv-585">F-3</ix:nonNumeric>
              </b>
            </p>
          </td>
        </tr>
        <tr>
          <td style="padding-bottom: .25em">
            <p>
              <b>
                <ix:nonNumeric name="dei:EntityRegistrantName" contextRef="rc" id="ixv-586">Innoviz Technologies Ltd.</ix:nonNumeric>
              </b>
            </p>
          </td>
        </tr>
      </table>
    </div>
    <div style="padding-bottom: 20px;">
      <table style="float: center; width: 100%; text-align: left;  ">
        <tr style="font-family: Arial, Helvetica, sans-serif; font-size: 16px">
          <th style="vertical-align: bottom; text-align: left; word-wrap: break-word">
            <b>Table 1: Newly Registered and Carry Forward Securities</b>
          </th>
          <th style="vertical-align: bottom; word-wrap: break-word; text-align: right;">
            <span style="-sec-ix-hidden: hiddenrcOfferingTableNa">&#9744;Not Applicable</span>
          </th>
        </tr>
      </table>
      <table style="font-family: Arial, Helvetica, sans-serif; float: center; width: 100%; text-align: center; border: 1px solid black; font-size: 16px;">
        <tr style="background-color:#9ADAF6">
          <th style="width: 12%;">
            <!-- BLANK -->
          </th>
          <th style="width: 2%;">
            <!-- BLANK -->
          </th>
          <th style="width: 12%;">
            <p style="margin: 0pt; text-align: center;">
              <b>Security Type</b>
            </p>
          </th>
          <th style="width: 14%;">
            <p style="margin: 0pt; text-align: center;">
              <b>Security Class Title </b>
            </p>
          </th>
          <th style="width: 2%;">
            <p style="margin: 0pt; text-align: center;">
              <b>Fee Calculation or Carry Forward Rule</b>
            </p>
          </th>
          <th style="width: 5%;">
            <p style="margin: 0pt; text-align: center;">
              <b>Amount Registered</b>
            </p>
          </th>
          <th style="width: 15%;">
            <p style="margin: 0pt; text-align: center;">
              <b>Proposed Maximum Offering Price Per Unit</b>
            </p>
          </th>
          <th style="width: 10%;">
            <p style="margin: 0pt; text-align: center;">
              <b>Maximum Aggregate Offering Price</b>
            </p>
          </th>
          <th style="width: 5%;">
            <p style="margin: 0pt; text-align: center;">
              <b>Fee Rate</b>
            </p>
          </th>
          <th style="width: 6%;">
            <p style="margin: 0pt; text-align: center;">
              <b>Amount of Registration Fee</b>
            </p>
          </th>
          <th style="width: 1%;">
            <p style="margin: 0pt; text-align: center;">
              <b>Carry Forward Form Type</b>
            </p>
          </th>
          <th style="width: 7%;">
            <p style="margin: 0pt; text-align: center;">
              <b>Carry Forward File Number</b>
            </p>
          </th>
          <th style="width: 6%;">
            <p style="margin: 0pt; text-align: center;">
              <b>Carry Forward Initial Effective Date</b>
            </p>
          </th>
          <th style="width: 7%;">
            <p style="margin: 0pt; text-align: center;">
              <b>Filing Fee Previously Paid in Connection with Unsold Securities to be Carried Forward</b>
            </p>
          </th>
        </tr>
        <tr>
          <td colspan="14" style="text-align: center">
            <b>Newly Registered Securities</b>
          </td>
        </tr>
        <tr style="background-color:#E7E7E2">
          <td style="text-align: left;">

	</td>
          <td style="text-align: center;">

	</td>
          <td style="text-align: left;">
            <span style="text-indent: 0px; display:inline-block; padding-left: 20px;">
              <ix:nonNumeric name="ffd:OfferingSctyTp" contextRef="offrl_1" id="ixv-587">Equity</ix:nonNumeric>
            </span>
          </td>
          <td style="text-align: left;">
            <ix:nonNumeric name="ffd:OfferingSctyTitl" contextRef="offrl_1" id="ixv-588">Ordinary shares, no par value per share</ix:nonNumeric>
          </td>
          <td style="text-align: center;">
            <ix:nonNumeric name="ffd:Rule457oFlg" contextRef="offrl_1" format="ixt:booleantrue" id="ixv-589">457(o)</ix:nonNumeric>
          </td>
          <td style="text-align: right;">

	</td>
          <td style="text-align: right;">

	</td>
          <td style="text-align: right;">

	</td>
          <td style="text-align: right;">

	</td>
          <td style="text-align: right;">

	</td>
          <td style="text-align: center;">

	</td>
          <td style="text-align: center;">

	</td>
          <td style="text-align: center;">

	</td>
          <td style="text-align: right;">

	</td>
        </tr>
        <tr style="background-color:#E7E7E2">
          <td style="text-align: left;">

	</td>
          <td style="text-align: center;">

	</td>
          <td style="text-align: left;">
            <span style="text-indent: 0px; display:inline-block; padding-left: 20px;">
              <ix:nonNumeric name="ffd:OfferingSctyTp" contextRef="offrl_2" id="ixv-590">Debt</ix:nonNumeric>
            </span>
          </td>
          <td style="text-align: left;">
            <ix:nonNumeric name="ffd:OfferingSctyTitl" contextRef="offrl_2" id="ixv-591">Debt Securities</ix:nonNumeric>
          </td>
          <td style="text-align: center;">
            <ix:nonNumeric name="ffd:Rule457oFlg" contextRef="offrl_2" format="ixt:booleantrue" id="ixv-592">457(o)</ix:nonNumeric>
          </td>
          <td style="text-align: right;">

	</td>
          <td style="text-align: right;">

	</td>
          <td style="text-align: right;">

	</td>
          <td style="text-align: right;">

	</td>
          <td style="text-align: right;">

	</td>
          <td style="text-align: center;">

	</td>
          <td style="text-align: center;">

	</td>
          <td style="text-align: center;">

	</td>
          <td style="text-align: right;">

	</td>
        </tr>
        <tr style="background-color:#E7E7E2">
          <td style="text-align: left;">

	</td>
          <td style="text-align: center;">

	</td>
          <td style="text-align: left;">
            <span style="text-indent: 0px; display:inline-block; padding-left: 20px;">
              <ix:nonNumeric name="ffd:OfferingSctyTp" contextRef="offrl_3" id="ixv-593">Other</ix:nonNumeric>
            </span>
          </td>
          <td style="text-align: left;">
            <ix:nonNumeric name="ffd:OfferingSctyTitl" contextRef="offrl_3" id="ixv-594">Warrants</ix:nonNumeric>
          </td>
          <td style="text-align: center;">
            <ix:nonNumeric name="ffd:Rule457oFlg" contextRef="offrl_3" format="ixt:booleantrue" id="ixv-595">457(o)</ix:nonNumeric>
          </td>
          <td style="text-align: right;">

	</td>
          <td style="text-align: right;">

	</td>
          <td style="text-align: right;">

	</td>
          <td style="text-align: right;">

	</td>
          <td style="text-align: right;">

	</td>
          <td style="text-align: center;">

	</td>
          <td style="text-align: center;">

	</td>
          <td style="text-align: center;">

	</td>
          <td style="text-align: right;">

	</td>
        </tr>
        <tr style="background-color:#E7E7E2">
          <td style="text-align: left;">

	</td>
          <td style="text-align: center;">

	</td>
          <td style="text-align: left;">
            <span style="text-indent: 0px; display:inline-block; padding-left: 20px;">
              <ix:nonNumeric name="ffd:OfferingSctyTp" contextRef="offrl_4" id="ixv-596">Other</ix:nonNumeric>
            </span>
          </td>
          <td style="text-align: left;">
            <ix:nonNumeric name="ffd:OfferingSctyTitl" contextRef="offrl_4" id="ixv-597">Units</ix:nonNumeric>
          </td>
          <td style="text-align: center;">
            <ix:nonNumeric name="ffd:Rule457oFlg" contextRef="offrl_4" format="ixt:booleantrue" id="ixv-598">457(o)</ix:nonNumeric>
          </td>
          <td style="text-align: right;">

	</td>
          <td style="text-align: right;">

	</td>
          <td style="text-align: right;">

	</td>
          <td style="text-align: right;">

	</td>
          <td style="text-align: right;">

	</td>
          <td style="text-align: center;">

	</td>
          <td style="text-align: center;">

	</td>
          <td style="text-align: center;">

	</td>
          <td style="text-align: right;">

	</td>
        </tr>
        <tr style="background-color:#E7E7E2">
          <td style="text-align: left;">
            <ix:nonNumeric name="ffd:PrevslyPdFlg" contextRef="offrl_5" format="ixt:booleanfalse" id="ixv-599">Fees to be Paid</ix:nonNumeric>
          </td>
          <td style="text-align: center;">
		1
	</td>
          <td style="text-align: left;">
            <ix:nonNumeric name="ffd:OfferingSctyTp" contextRef="offrl_5" id="ixv-600">Unallocated (Universal) Shelf</ix:nonNumeric>
          </td>
          <td style="text-align: left;">

	</td>
          <td style="text-align: center;">
            <ix:nonNumeric name="ffd:Rule457oFlg" contextRef="offrl_5" format="ixt:booleantrue" id="ixv-601">457(o)</ix:nonNumeric>
          </td>
          <td style="text-align: right;">

	</td>
          <td style="text-align: right;">

	</td>
          <td style="text-align: right;">
            <span>$</span>
            <ix:nonFraction name="ffd:MaxAggtOfferingPric" unitRef="USD" decimals="INF" format="ixt:numdotdecimal" contextRef="offrl_5" id="ixv-602">144,788,668.00</ix:nonFraction>
          </td>
          <td style="text-align: right;">
            <ix:nonFraction name="ffd:FeeRate" unitRef="pure" decimals="INF" format="ixt:numdotdecimal" contextRef="offrl_5" id="ixv-603">0.0001531</ix:nonFraction>
          </td>
          <td style="text-align: right;">
            <span>$</span>
            <ix:nonFraction name="ffd:FeeAmt" unitRef="USD" decimals="INF" format="ixt:numdotdecimal" contextRef="offrl_5" id="ixv-604">22,167.15</ix:nonFraction>
          </td>
          <td style="text-align: center;">

	</td>
          <td style="text-align: center;">

	</td>
          <td style="text-align: center;">

	</td>
          <td style="text-align: right;">

	</td>
        </tr>
        <tr style="background-color:#E7E7E2">
          <td style="text-align: left;">
		Fees Previously Paid
	</td>
          <td style="text-align: center;">

	</td>
          <td style="text-align: left;">

	</td>
          <td style="text-align: left;">

	</td>
          <td style="text-align: center;">

	</td>
          <td style="text-align: right;">

	</td>
          <td style="text-align: right;">

	</td>
          <td style="text-align: right;">

	</td>
          <td style="text-align: right;">

	</td>
          <td style="text-align: right;">

	</td>
          <td style="text-align: center;">

	</td>
          <td style="text-align: center;">

	</td>
          <td style="text-align: center;">

	</td>
          <td style="text-align: right;">

	</td>
        </tr>
        <tr>
          <td colspan="14" style="text-align: center">
            <b>Carry Forward Securities</b>
          </td>
        </tr>
        <tr style="background-color:#E7E7E2">
          <td style="text-align: left;">
		Carry Forward Securities
	</td>
          <td style="text-align: center;">

	</td>
          <td style="text-align: left;">
            <span style="text-indent: 0px; display:inline-block; padding-left: 20px;">
              <ix:nonNumeric name="ffd:OfferingSctyTp" contextRef="offrl_6" id="ixv-605">Equity</ix:nonNumeric>
            </span>
          </td>
          <td style="text-align: left;">
            <ix:nonNumeric name="ffd:OfferingSctyTitl" contextRef="offrl_6" id="ixv-606">Ordinary shares, no par value per share</ix:nonNumeric>
          </td>
          <td style="text-align: center;">
            <ix:nonNumeric name="ffd:Rule415a6Flg" contextRef="offrl_6" format="ixt:booleantrue" id="ixv-607">415(a)(6)</ix:nonNumeric>
          </td>
          <td style="text-align: right;">

	</td>
          <td style="text-align: right;">

	</td>
          <td style="text-align: right;">

	</td>
          <td style="text-align: right;">

	</td>
          <td style="text-align: right;">

	</td>
          <td style="text-align: center;">
            <ix:nonNumeric name="ffd:CfwdFormTp" contextRef="offrl_6" id="ixv-608">F-3</ix:nonNumeric>
          </td>
          <td style="text-align: center;">
            <ix:nonNumeric name="ffd:CfwdPrrFileNb" contextRef="offrl_6" id="ixv-609">333-267646</ix:nonNumeric>
          </td>
          <td style="text-align: center;">
            <ix:nonNumeric name="ffd:CfwdPrrFctvDt" format="ixt:datemonthdayyear" contextRef="offrl_6" id="ixv-610">10/11/2022</ix:nonNumeric>
          </td>
          <td style="text-align: right;">

	</td>
        </tr>
        <tr style="background-color:#E7E7E2">
          <td style="text-align: left;">
		Carry Forward Securities
	</td>
          <td style="text-align: center;">

	</td>
          <td style="text-align: left;">
            <span style="text-indent: 0px; display:inline-block; padding-left: 20px;">
              <ix:nonNumeric name="ffd:OfferingSctyTp" contextRef="offrl_7" id="ixv-611">Debt</ix:nonNumeric>
            </span>
          </td>
          <td style="text-align: left;">
            <ix:nonNumeric name="ffd:OfferingSctyTitl" contextRef="offrl_7" id="ixv-612">Debt Securities</ix:nonNumeric>
          </td>
          <td style="text-align: center;">
            <ix:nonNumeric name="ffd:Rule415a6Flg" contextRef="offrl_7" format="ixt:booleantrue" id="ixv-613">415(a)(6)</ix:nonNumeric>
          </td>
          <td style="text-align: right;">

	</td>
          <td style="text-align: right;">

	</td>
          <td style="text-align: right;">

	</td>
          <td style="text-align: right;">

	</td>
          <td style="text-align: right;">

	</td>
          <td style="text-align: center;">
            <ix:nonNumeric name="ffd:CfwdFormTp" contextRef="offrl_7" id="ixv-614">F-3</ix:nonNumeric>
          </td>
          <td style="text-align: center;">
            <ix:nonNumeric name="ffd:CfwdPrrFileNb" contextRef="offrl_7" id="ixv-615">333-267646</ix:nonNumeric>
          </td>
          <td style="text-align: center;">
            <ix:nonNumeric name="ffd:CfwdPrrFctvDt" format="ixt:datemonthdayyear" contextRef="offrl_7" id="ixv-616">10/11/2022</ix:nonNumeric>
          </td>
          <td style="text-align: right;">

	</td>
        </tr>
        <tr style="background-color:#E7E7E2">
          <td style="text-align: left;">
		Carry Forward Securities
	</td>
          <td style="text-align: center;">

	</td>
          <td style="text-align: left;">
            <span style="text-indent: 0px; display:inline-block; padding-left: 20px;">
              <ix:nonNumeric name="ffd:OfferingSctyTp" contextRef="offrl_8" id="ixv-617">Other</ix:nonNumeric>
            </span>
          </td>
          <td style="text-align: left;">
            <ix:nonNumeric name="ffd:OfferingSctyTitl" contextRef="offrl_8" id="ixv-618">Warrants</ix:nonNumeric>
          </td>
          <td style="text-align: center;">
            <ix:nonNumeric name="ffd:Rule415a6Flg" contextRef="offrl_8" format="ixt:booleantrue" id="ixv-619">415(a)(6)</ix:nonNumeric>
          </td>
          <td style="text-align: right;">

	</td>
          <td style="text-align: right;">

	</td>
          <td style="text-align: right;">

	</td>
          <td style="text-align: right;">

	</td>
          <td style="text-align: right;">

	</td>
          <td style="text-align: center;">
            <ix:nonNumeric name="ffd:CfwdFormTp" contextRef="offrl_8" id="ixv-620">F-3</ix:nonNumeric>
          </td>
          <td style="text-align: center;">
            <ix:nonNumeric name="ffd:CfwdPrrFileNb" contextRef="offrl_8" id="ixv-621">333-267646</ix:nonNumeric>
          </td>
          <td style="text-align: center;">
            <ix:nonNumeric name="ffd:CfwdPrrFctvDt" format="ixt:datemonthdayyear" contextRef="offrl_8" id="ixv-622">10/11/2022</ix:nonNumeric>
          </td>
          <td style="text-align: right;">

	</td>
        </tr>
        <tr style="background-color:#E7E7E2">
          <td style="text-align: left;">
		Carry Forward Securities
	</td>
          <td style="text-align: center;">

	</td>
          <td style="text-align: left;">
            <span style="text-indent: 0px; display:inline-block; padding-left: 20px;">
              <ix:nonNumeric name="ffd:OfferingSctyTp" contextRef="offrl_9" id="ixv-623">Other</ix:nonNumeric>
            </span>
          </td>
          <td style="text-align: left;">
            <ix:nonNumeric name="ffd:OfferingSctyTitl" contextRef="offrl_9" id="ixv-624">Units</ix:nonNumeric>
          </td>
          <td style="text-align: center;">
            <ix:nonNumeric name="ffd:Rule415a6Flg" contextRef="offrl_9" format="ixt:booleantrue" id="ixv-625">415(a)(6)</ix:nonNumeric>
          </td>
          <td style="text-align: right;">

	</td>
          <td style="text-align: right;">

	</td>
          <td style="text-align: right;">

	</td>
          <td style="text-align: right;">

	</td>
          <td style="text-align: right;">

	</td>
          <td style="text-align: center;">
            <ix:nonNumeric name="ffd:CfwdFormTp" contextRef="offrl_9" id="ixv-626">F-3</ix:nonNumeric>
          </td>
          <td style="text-align: center;">
            <ix:nonNumeric name="ffd:CfwdPrrFileNb" contextRef="offrl_9" id="ixv-627">333-267646</ix:nonNumeric>
          </td>
          <td style="text-align: center;">
            <ix:nonNumeric name="ffd:CfwdPrrFctvDt" format="ixt:datemonthdayyear" contextRef="offrl_9" id="ixv-628">10/11/2022</ix:nonNumeric>
          </td>
          <td style="text-align: right;">

	</td>
        </tr>
        <tr style="background-color:#E7E7E2">
          <td style="text-align: left;">
		Carry Forward Securities
	</td>
          <td style="text-align: center;">
		2
	</td>
          <td style="text-align: left;">
            <ix:nonNumeric name="ffd:OfferingSctyTp" contextRef="offrl_10" id="ixv-629">Unallocated (Universal) Shelf</ix:nonNumeric>
          </td>
          <td style="text-align: left;">

	</td>
          <td style="text-align: center;">
            <ix:nonNumeric name="ffd:Rule415a6Flg" contextRef="offrl_10" format="ixt:booleantrue" id="ixv-630">415(a)(6)</ix:nonNumeric>
          </td>
          <td style="text-align: right;">

	</td>
          <td style="text-align: right;">

	</td>
          <td style="text-align: right;">
            <span>$</span>
            <ix:nonFraction name="ffd:MaxAggtOfferingPric" unitRef="USD" decimals="INF" format="ixt:numdotdecimal" contextRef="offrl_10" id="ixv-631">55,211,332.00</ix:nonFraction>
          </td>
          <td style="text-align: right;">

	</td>
          <td style="text-align: right;">

	</td>
          <td style="text-align: center;">
            <ix:nonNumeric name="ffd:CfwdFormTp" contextRef="offrl_10" id="ixv-632">F-3</ix:nonNumeric>
          </td>
          <td style="text-align: center;">
            <ix:nonNumeric name="ffd:CfwdPrrFileNb" contextRef="offrl_10" id="ixv-633">333-267646</ix:nonNumeric>
          </td>
          <td style="text-align: center;">
            <ix:nonNumeric name="ffd:CfwdPrrFctvDt" format="ixt:datemonthdayyear" contextRef="offrl_10" id="ixv-634">10/11/2022</ix:nonNumeric>
          </td>
          <td style="text-align: right;">
            <span>$</span>
            <ix:nonFraction name="ffd:CfwdPrevslyPdFee" unitRef="USD" decimals="INF" format="ixt:numdotdecimal" contextRef="offrl_10" id="ixv-635">5,118.09</ix:nonFraction>
          </td>
        </tr>
        <tr>
          <td>
            <!-- BLANK -->
          </td>
          <td>
            <!-- BLANK -->
          </td>
          <td>
            <!-- BLANK -->
          </td>
          <td colspan="3" style="vertical-align: top">
            <p style="margin: 0pt; text-align: right">Total Offering Amounts:</p>
          </td>
          <td>
            <!-- BLANK -->
          </td>
          <td style="vertical-align: top; width: 16%;">
            <p id="MaxAggtOfferingPrice" style="margin: 0pt; text-align: right">
              <span>$</span>
              <ix:nonFraction name="ffd:TtlOfferingAmt" contextRef="rc" decimals="INF" format="ixt:numdotdecimal" unitRef="USD" id="ixv-636">200,000,000.00</ix:nonFraction>
            </p>
          </td>
          <td>
            <!-- BLANK -->
          </td>
          <td style="vertical-align: top; border-bottom: 1px black; width: 16%;">
            <p id="TotalFeeAmt" style="margin: 0pt; text-align: right">
              <span>$</span>
              <ix:nonFraction name="ffd:TtlFeeAmt" contextRef="rc" decimals="INF" format="ixt:numdotdecimal" unitRef="USD" id="ixv-637">22,167.15</ix:nonFraction>
            </p>
          </td>
          <td>
            <!-- BLANK -->
          </td>
          <td>
            <!-- BLANK -->
          </td>
          <td>
            <!-- BLANK -->
          </td>
          <td>
            <!-- BLANK -->
          </td>
        </tr>
        <tr>
          <td>
            <!-- BLANK -->
          </td>
          <td>
            <!-- BLANK -->
          </td>
          <td>
            <!-- BLANK -->
          </td>
          <td colspan="3" style="vertical-align: top">
            <p style="margin: 0pt; text-align: right">
					Total Fees Previously Paid:
				</p>
          </td>
          <td>
            <!-- BLANK -->
          </td>
          <td>
            <!-- BLANK -->
          </td>
          <td>
            <!-- BLANK -->
          </td>
          <td style="vertical-align: top">
            <p id="TotalPreviouslyPaidAmt" style="margin: 0pt; text-align: right">
              <span>$</span>
              <ix:nonFraction name="ffd:TtlPrevslyPdAmt" contextRef="rc" decimals="INF" format="ixt:numdotdecimal" unitRef="USD" id="ixv-638">0.00</ix:nonFraction>
            </p>
          </td>
          <td>
            <!-- BLANK -->
          </td>
          <td>
            <!-- BLANK -->
          </td>
          <td>
            <!-- BLANK -->
          </td>
          <td>
            <!-- BLANK -->
          </td>
        </tr>
        <tr>
          <td>
            <!-- BLANK -->
          </td>
          <td>
            <!-- BLANK -->
          </td>
          <td>
            <!-- BLANK -->
          </td>
          <td colspan="3" style="vertical-align: top">
            <p style="margin: 0pt; text-align: right">
					Total Fee Offsets:
				</p>
          </td>
          <td>
            <!-- BLANK -->
          </td>
          <td>
            <!-- BLANK -->
          </td>
          <td>
            <!-- BLANK -->
          </td>
          <td style="vertical-align: top">
            <p id="TotalOffsetAmt" style="margin: 0pt; text-align: right">
              <span>$</span>
              <ix:nonFraction name="ffd:TtlOffsetAmt" contextRef="rc" decimals="INF" format="ixt:numdotdecimal" unitRef="USD" id="ixv-639">0.00</ix:nonFraction>
            </p>
          </td>
          <td>
            <!-- BLANK -->
          </td>
          <td>
            <!-- BLANK -->
          </td>
          <td>
            <!-- BLANK -->
          </td>
          <td>
            <!-- BLANK -->
          </td>
        </tr>
        <tr>
          <td>
            <!-- BLANK -->
          </td>
          <td>
            <!-- BLANK -->
          </td>
          <td>
            <!-- BLANK -->
          </td>
          <td colspan="3" style="vertical-align: top">
            <p style="margin: 0pt; text-align: right">
					Net Fee Due:
				</p>
          </td>
          <td>
            <!-- BLANK -->
          </td>
          <td>
            <!-- BLANK -->
          </td>
          <td>
            <!-- BLANK -->
          </td>
          <td style="vertical-align: top">
            <p id="NetFeeAmt" style="margin: 0pt; text-align: right">
              <span>$</span>
              <ix:nonFraction name="ffd:NetFeeAmt" contextRef="rc" decimals="INF" format="ixt:numdotdecimal" unitRef="USD" id="ixv-640">22,167.15</ix:nonFraction>
            </p>
          </td>
          <td>
            <!-- BLANK -->
          </td>
          <td>
            <!-- BLANK -->
          </td>
          <td>
            <!-- BLANK -->
          </td>
          <td>
            <!-- BLANK -->
          </td>
        </tr>
      </table>
    </div>
    <div>
      <table style="width: 100%; text-indent: 0px;">
        <tbody>
          <tr style="font-family: Arial, Helvetica, sans-serif; font-size: 16px; vertical-align: top;">
            <td>
              <p style="margin:0pt;text-align:left; margin-bottom: 5px;">
                <b>Offering Note</b>
              </p>
            </td>
            <td/>
          </tr>
        </tbody>
      </table>
    </div>
    <div style="padding-bottom: 20px;">
      <table style="width: 100%; text-indent: 0px;">
        <tr style="font-family: Arial, Helvetica, sans-serif; font-size: 16px; vertical-align: top;">
          <td style="width:10pt;">
            <p style="margin:0pt;text-align:left;">
              <sup style="vertical-align:top;line-height:120%;font-size:10px">1</sup>
            </p>
          </td>
          <td colspan="7" style="white-space: pre-line;">
            <ix:nonNumeric name="ffd:OfferingNote" escape="1" contextRef="offrl_5" id="ixv-641">(1)	The securities registered hereunder include such indeterminate number of (a) ordinary shares, (b) debt securities, (c) warrants to purchase ordinary shares and (d) units consisting of some or all of these securities in any combination, as may be sold from time to time by the registrant. There are also being registered hereunder an indeterminate number of ordinary shares as shall be issuable upon conversion, exchange or exercise of any securities that provide for such issuance.
(2)	Pursuant to Rule 416 under the Securities Act of 1933, as amended, or the Securities Act, this registration statement shall also cover any additional shares of the registrant's securities that become issuable by reason of any stock splits, stock dividend or similar transaction.
(3)	The proposed maximum per security and aggregate offering prices per class of securities will be determined from time to time by the registrant in connection with the issuance by the registrant of the securities registered hereunder and is not specified as to each class of security. Separate consideration may or may not be received for securities that are issuable on exercise, conversion or exchange of other securities, or that are issued in units.</ix:nonNumeric>
          </td>
        </tr>
        <tr>
          <td colspan="7">
            <hr style="width:100%;text-align:left;margin-left:0"/>
          </td>
        </tr>
        <tr style="font-family: Arial, Helvetica, sans-serif; font-size: 16px; vertical-align: top;">
          <td style="width:10pt;">
            <p style="margin:0pt;text-align:left;">
              <sup style="vertical-align:top;line-height:120%;font-size:10px">2</sup>
            </p>
          </td>
          <td colspan="7" style="white-space: pre-line;">
            <ix:nonNumeric name="ffd:OfferingNote" escape="1" contextRef="offrl_10" id="ixv-642">The registrant previously paid registration fees in the aggregate of $18,540 with respect to a Registration Statement on Form F-3 (File No. 333-267646) (the "Prior Registration Statement"). Pursuant to Rule 415(a)(6) ("Rule 415(a)(6)") promulgated under the Securities Act of 1933, as amended (the "Securities Act"), the securities registered pursuant to this Registration Statement on Form F-3 (this "Registration Statement") include $55,211,332 of securities previously registered on the Prior Registration Statement which remain unsold (the "Unsold Securities"). Pursuant to Rule 415(a)(6), the registration fee of $5,118.09 associated with the offering of the Unsold Securities (based on the filing fee rate in effect at the time of the filing of the Prior Registration Statement) is hereby carried forward to be applied to the Unsold Securities registered hereunder, and no additional filing fee is due with respect to the Unsold Securities in connection with the filing of this Registration Statement. The registrant is also registering new securities on this Registration Statement with an aggregate maximum offering price of $144,788,668 (the "New Securities"), which aggregate offering price is not specified as to each class of securities in reliance upon Rule 457(o) promulgated under the Securities Act. A filing fee of $22,167.15 with respect to the New Securities is being paid in connection with the filing of this Registration Statement. Pursuant to Rule 415(a)(6), the offering of the Unsold Securities under the Prior Registration Statement will be deemed terminated as of the date of effectiveness of this Registration Statement.</ix:nonNumeric>
          </td>
        </tr>
        <tr>
          <td colspan="7">
            <hr style="width:100%;text-align:left;margin-left:0"/>
          </td>
        </tr>
      </table>
    </div>
    <div style="padding-bottom: 20px;">
      <table style="float: center; width: 100%; text-align: left;  ">
        <tr style="font-family: Arial, Helvetica, sans-serif; font-size: 16px">
          <th style="vertical-align: bottom; text-align: left; word-wrap: break-word">
            <b>Table 2: Fee Offset Claims and Sources</b>
          </th>
          <th style="vertical-align: bottom; word-wrap: break-word; text-align: right;">
            <span style="-sec-ix-hidden: hiddenrcOffsetTableNa">&#9745;Not Applicable</span>
          </th>
        </tr>
      </table>
      <table style="font-family: Arial, Helvetica, sans-serif; font-size: 16px; float: center; width: 100%; text-align: center;  border: 1px solid black;">
        <tr style="background-color:#9ADAF6">
          <th style="width: 10%; text-align: left;">
            <!-- BLANK -->
          </th>
          <th style="width: 8%; text-align: left;">
            <!-- BLANK -->
          </th>
          <th style="width: 16%;">
				Registrant or Filer Name
			</th>
          <th style="width: 6%;">
				Form or Filing Type
			</th>
          <th style="width: 7%;">
				File Number
			</th>
          <th style="width: 6%;">
				Initial Filing Date
			</th>
          <th style="width: 6%;">
				Filing Date
			</th>
          <th style="width: 6%;">
				Fee Offset Claimed
			</th>
          <th style="width: 6%;">
				Security Type Associated with Fee Offset Claimed
			</th>
          <th style="width: 8%;">
				Security Title Associated with Fee Offset Claimed
			</th>
          <th style="width: 6%;">
				Unsold Securities Associated with Fee Offset Claimed
			</th>
          <th style="width: 9%;">
				Unsold Aggregate Offering Amount Associated with Fee Offset Claimed
			</th>
          <th style="width: 6%;">
				Fee Paid with Fee Offset Source
			</th>
        </tr>
        <tr>
          <td colspan="14" style="text-align: center">
            <b>Rules 457(b) and 0-11(a)(2)</b>
          </td>
        </tr>
        <tr style="background-color:#E7E7E2">
          <td style="text-align: left;">
		Fee Offset Claims
	</td>
          <td>
		N/A
	</td>
          <td style="text-align: left;">
		N/A
	</td>
          <td>
		N/A
	</td>
          <td>
		N/A
	</td>
          <td>
		N/A
	</td>
          <td>
		N/A
	</td>
          <td style="text-align: right;">
		N/A
	</td>
          <td style="text-align: left;">
		N/A
	</td>
          <td style="text-align: left;">
		N/A
	</td>
          <td style="text-align: right;">
		N/A
	</td>
          <td style="text-align: right;">
		N/A
	</td>
          <td style="text-align: right;">
		N/A
	</td>
        </tr>
        <tr style="background-color:#E7E7E2">
          <td style="text-align: left;">
		Fee Offset Sources
	</td>
          <td>
		N/A
	</td>
          <td style="text-align: left;">
		N/A
	</td>
          <td>
		N/A
	</td>
          <td>
		N/A
	</td>
          <td>
		N/A
	</td>
          <td>
		N/A
	</td>
          <td style="text-align: right;">
		N/A
	</td>
          <td style="text-align: left;">
		N/A
	</td>
          <td style="text-align: left;">
		N/A
	</td>
          <td style="text-align: right;">
		N/A
	</td>
          <td style="text-align: right;">
		N/A
	</td>
          <td style="text-align: right;">
		N/A
	</td>
        </tr>
        <tr>
          <td colspan="14" style="text-align: center">
            <b>Rule 457(p)</b>
          </td>
        </tr>
        <tr style="background-color:#E7E7E2">
          <td style="text-align: left;">
		Fee Offset Claims
	</td>
          <td>
		N/A
	</td>
          <td style="text-align: left;">
		N/A
	</td>
          <td>
		N/A
	</td>
          <td>
		N/A
	</td>
          <td>
		N/A
	</td>
          <td>
		N/A
	</td>
          <td style="text-align: right;">
		N/A
	</td>
          <td style="text-align: left;">
		N/A
	</td>
          <td style="text-align: left;">
		N/A
	</td>
          <td style="text-align: right;">
		N/A
	</td>
          <td style="text-align: right;">
		N/A
	</td>
          <td style="text-align: right;">
		N/A
	</td>
        </tr>
        <tr style="background-color:#E7E7E2">
          <td style="text-align: left;">
		Fee Offset Sources
	</td>
          <td>
		N/A
	</td>
          <td style="text-align: left;">
		N/A
	</td>
          <td>
		N/A
	</td>
          <td>
		N/A
	</td>
          <td>
		N/A
	</td>
          <td>
		N/A
	</td>
          <td style="text-align: right;">
		N/A
	</td>
          <td style="text-align: left;">
		N/A
	</td>
          <td style="text-align: left;">
		N/A
	</td>
          <td style="text-align: right;">
		N/A
	</td>
          <td style="text-align: right;">
		N/A
	</td>
          <td style="text-align: right;">
		N/A
	</td>
        </tr>
      </table>
    </div>
    <div style="padding-bottom: 20px;">
      <table style="float: center; width: 100%; text-align: left;  ">
        <tr style="font-family: Arial, Helvetica, sans-serif; font-size: 16px">
          <th style="vertical-align: bottom; text-align: left; word-wrap: break-word">
            <b>Table 3: Combined Prospectuses</b>
          </th>
          <th style="vertical-align: bottom; word-wrap: break-word; text-align: right;">
            <span style="-sec-ix-hidden: hiddenrcCombinedProspectusTableNa">&#9745;Not Applicable</span>
          </th>
        </tr>
      </table>
      <table style="font-family: Arial, Helvetica, sans-serif; font-size: 16px; float: center; width: 100%; border: 1px solid black;">
        <tr style="background-color:#9ADAF6">
          <th style="width: 4%">
            <!-- Note column -->
          </th>
          <th style="width: 14%">
            <p style="margin: 0pt; text-align: center;">
              <b>Security Type</b>
            </p>
          </th>
          <th style="width: 25%">
            <p style="margin: 0pt; text-align: center;">
              <b>Security Class Title</b>
            </p>
          </th>
          <th style="width: 14%">
            <p style="margin: 0pt; text-align: center;">
              <b>Amount of Securities Previously Registered</b>
            </p>
          </th>
          <th style="width: 18%">
            <p style="margin: 0pt; text-align: center;">
              <b>Maximum Aggregate Offering Price of Securities Previously Registered</b>
            </p>
          </th>
          <th style="width: 6%">
            <p style="margin: 0pt; text-align: center;">
              <b>Form Type</b>
            </p>
          </th>
          <th style="width: 10%">
            <p style="margin: 0pt; text-align: center;">
              <b>File Number</b>
            </p>
          </th>
          <th style="width: 8%">
            <p style="margin: 0pt; text-align: center;">
              <b>Initial Effective Date</b>
            </p>
          </th>
        </tr>
        <tr style="background-color:#E7E7E2;">
          <td style="text-align: center;">
		N/A
	</td>
          <td>
		N/A
	</td>
          <td>
		N/A
	</td>
          <td style="text-align: right;">
		N/A
	</td>
          <td style="text-align: right;">
		N/A
	</td>
          <td style="text-align: center;">
		N/A
	</td>
          <td style="text-align: center;">
		N/A
	</td>
          <td style="text-align: center;">
		N/A
	</td>
        </tr>
      </table>
    </div>
  </body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>10
<FILENAME>image00001.jpg
<TEXT>
begin 644 image00001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  8$!08%! 8&!08'!P8("A *"@D)
M"A0.#PP0%Q08&!<4%A8:'24?&ALC'!86("P@(R8G*2HI&1\M,"TH,"4H*2C_
MVP!# 0<'!PH("A,*"A,H&A8:*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H
M*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"C_P  1" !F ,<# 2(  A$! Q$!_\0
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M5]$(6BBBI&?GKX9(/[0-B1_T'Q_Z.KZ+_;0_Y)IIO_833_T7)7K</@SPU#J
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MQ1X4=$9DCN9M[ 9"_N7Z^E=/0!Q.D:EXHUBUDO+&'1H[?SY8HUF:3>0CE,G
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,0 4444 %%%% '__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>11
<FILENAME>image00002.jpg
<TEXT>
begin 644 image00002.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  8$!08%! 8&!08'!P8("A *"@D)
M"A0.#PP0%Q08&!<4%A8:'24?&ALC'!86("P@(R8G*2HI&1\M,"TH,"4H*2C_
MVP!# 0<'!PH("A,*"A,H&A8:*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H
M*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"C_P  1" !H ,<# 2(  A$! Q$!_\0
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MFCHLH0-@^F0<CZ'TK[0_9G^(O_":>$%TS4IMVN:4!'(6/,T/1)/<]C[@'O7
M?LY>%+'QK\$?$NB:@,1W&H-Y<@7<T4@B0JX]P?S&1WKQ7PYJFL_"3XG>;-$R
M7NFSF&Z@SQ-&>J^X88(/T-#][0#L_P!L#_DKY_[!\'\WKZD7_DA0_P"Q;_\
M;6ODS]IW5K37OB!9:MIC>997NE6\T3^H.[KZ$=".Q%?6:_\ )"A_V+?_ +:U
M+V0'P#HNBWNM->IIT+3/:6KWDB#KY:8W$>N <_0&O<_V3OB-_8NO'PEJLS+I
M^HONM&8\17']WV#]/J!ZFL#]DA5D^+L:. 5:QG!!&01@<5G?'[P!+\._'1?3
M@T>D7Q-S8R#CRB#DQY]5.,>Q%6W?1@>Z_MI?\DUTG_L*I_Z*EH_8P('PYU4G
M@#4V_P#1:5YM\5/'Z^/_ ( :'<7,B'6+'5H[>^0'DMY,N),>C#GZY':N\_9*
M26;X0>)(X,^>UW,L>/4PIC]:5K*P'B_CW6M6^,7Q=%GIS%XI;@V6GQD_)%""
M<N?J 7)_P%?26D_##X?_  R\)RW^L6EK=_9XU-SJ-_;^>=Q(&0N"%&2, #ZD
M]:^>OV5)[>U^,UC'=8622WGBBW<8DVYQ]<!A7??M>7WBVPO88(;NX3PEJ%NJ
M21QC]V9E<DJQQD$_*<9P<>U#W20I+F1RUWX;\,^+--DFTL6T<G1)K9-NT^C+
MQ^HKS[PCJ-WX2\7&RO"5C\S[/<+G@C. ?PZ@^E=;\"/#NN7D>J:K:V5P^DQH
M(GD"\.^<C [X&<XZ9]ZY#XENDWCRZ6U^9U*1OC^\  ?\*[I2@XJJM'<^:P]"
MI"O5P55N5-JZ;Z?,^N?@_J1AU2ZTYS^[F7S4'HR\'\P?TKYL_:6\)GPK\3KN
M>WCV6>J_Z= 5& K$_O /HX)^C"O>_A3'(?%MGGDI"WF?]\X_G4O[67A/^W_A
MY_:UNF;S17\[(')A; D'X?*W_ #48Q)5KKJC?ARI*6$L^C:1W?P>\4CQE\.]
M&U@N&N7A$5S[3)\K_F1GZ$5\L_M8>*3X@^)0T>V;?:Z.GV<*O.Z9\&3\?NK_
M ,!J_P#LS?$J#P?HOBRQU)U\B.T;4[5"<;I4 4H/=LI_WR:YW]GWP]/X]^+\
M5_J0,L-I(VIWCL,AWW94'ZN1^ -<B5FV>^?7'P;\)CP7\/-(TEP%N1%YUR?6
M9_F;\L[?HHKXM^'7_)?-&_[#R_\ HZOT+K\]/AU_R7S1O^P\O_HZIAU!GW#X
MX\#^'_&]K;6_B6R-Y#;.9(E$KQX8C!/RD9XKA=6^"'PKTG3;F_U+1A;V=O&9
M)I7O9PJ*.I^_7K\CK&I9V 0#)). !7Q7^T;\6'\;:M_PCWA^5CX?M9<%HR?]
M-E!QGW0'H._7TPE=Z(9YQKT%AXK\<?8O >B26UI<RBWLK02O)))_ML6)P3U/
M8#Z$U]Q?!KP1'\/_  ':Z09C/<LQN+J3L96 R%]A@ >N,]ZXO]G'X2IX+TL:
MYKL(/B.\3A6&39Q'^ ?[9[G\/7/N-$Y7T0A:***D9^>OA?\ Y.$L/^QC'_I1
M7T5^VC_R3+2_^PM'_P"BI:[>S^#/@>T\11ZY!HS+J4=Q]L67[5*<2[]V<;L=
M>V,5TGC7P?HGC72XM.\269NK2*83J@E:/#@$ Y4@]":TYE=,1X]^Q;_R3W5_
M^PFW_HI*I_M:?#K^UM)'C'28?]-L(]E\JCF2'L_U3O['VKVWP1X-T+P3IT]A
MX:LC:VTTOGNAE:3+X SEB3T K<N(8[B&2&=1)%("C(1D,",$$>E1S>]=#/R^
M>1I%16)81C8H)S@9S@?B3^=?H:O_ "0L?]BW_P"VM8C_ +/WPW<D_P!@,,G/
M%Y,/_9Z]#_L:R&@?V/Y)_L_[+]D\K>?]5LV;<]>G&>M5*28D?%W[(?\ R6*'
M_KQG_D*^K/B]X'M_'_@N[TB7:EXH\VRF(_U<P!Q^!Y!]C47@WX4>#O!^KC5?
M#^EM:WPC:(2?:9'^4]1AF([5W]2W=W0S\O-0MKK3;NZT^\22WGAE,<\+<%74
MD8(]1S7V!^Q=_P DWU7_ +";_P#HN.N^\4?"#P3XHUJ?5M:T43W\^/-D6XDC
MWD# )",!G '-=!X(\&Z)X*TV:P\-69M;664SLAE:3+D 9RQ)Z 5;DFK"L?(7
MQZ\"ZC\.?B!_PDFB"6'2[JZ^U6=S$/\ CVFSO,9],')'J..QKU#P9^TIX<U3
M24M?'-E+:W@4++)'#Y]O*?7;U'TP?K7T)JVG66K:?-8ZG:Q7=G,NV2&90RL/
M<&O#?$G[,'A34;HSZ/>ZAI*DY,*D31CZ;N1^9J;IJS R_'7[2>AZ?H[6?@:U
MEN;TH5BN)H?*MX?<*>6(], ?RKR[X$_#?4_B%XBN->U)Y4TV&1II+J5<_:9R
M<A1Z\\L?P[U[1X9_9D\(Z9<+/J]W?ZO@@B*0B*,_4+R?SKV_3;&TTNQAL]/M
MXK6TA4)%#$H5$'H *I22V(G!2BT]F<9\/?"=SH>H7MS?E&<@11.IR"O4GV[5
MVNH6D&H6%S97:"2WGC:&5#T*L,$?D:M=>E+2JU)5'S/<QPF$IX6FJ=/8_,_Q
MWX>G\)^,-7T*YW;K.X:-6/\ &G5&_%2#^-?7_P"R;X2_L#X=_P!KW$9%[K3^
M=DCD0KD1C\?F;_@8KLO%WPF\'>+M7.J:]I/VF^,8C:43R1Y Z9"L 3[UVMC:
MPV-G!:6R+%;PHL448Z*JC  _ 4.=U8Z;%NOSS^'7_)?-&_[#R_\ HZOT,KS;
M3_@SX'TW7X=:LM'D34H;C[5'+]JE.),YS@MCKVJ4[#//OVO/&&IZ%X<TW0].
MD,,.L>:+F53AC&FSY!Z [N?88[FOG+X5^*-'\&^)(];UC17U>6W&;2+SQ&L4
MG]\Y4Y([>AY]*^Y_'7P^\->.FLSXGL#>&T#B'$SQXW8S]TC/05R__#/OPW_Z
M +_^!DW_ ,75)I*S$>;?\-96O_0IS_\ @</_ (BO6O@U\2D^)FB7^HQZ:^G"
MTN! 8VF$F_Y <YP,=:SO^&?/AO\ ] %__ R;_P"+KL/!/@K0?!%C<6?AFS-G
M;SR^;(IE>3+8 SEB>PI.UM!G44445(''ZAXKO;'4;6TD\-:BTEW*T5N1/!B3
M:I8G_6<# )YKI+">:YLXY;BUELY6!S#(RL5^I4D?D:PO$W_(V^#O^OJX_P#2
M:2NII@<A9^*;Z^CDFT_PYJ-S;+-)"LJSP('*,4) :0'&0>M=)9RS7%K')-;R
M6LC)N:&0AF0^A*D@_@:X#P7I^IS:)(]MXEDM(FO;S9 +>%_+_P!)DXRPR?QK
MT&W5A @,GF/C!DP!DXZX'%# YV;Q-+->3PZ'I-YJJ6TAAFGCDCBB$@ZHA<C>
M1T.. >,YR*U=&U(:I9_:!;7EJZL8VANHC'(C#J".A'H02#V-8/PSN(8O"]OI
MCL(K_3,V][ 6^>.0$Y8CT;[X/0ALUTNFZC9ZE TMA<Q7$4;F)VB;< PZC/M0
MP(M'U:+5#?>0D@^R73VK[AU9<9(]N:73=3AO[O4;>-'#V,X@D+#@DQJ^1[8<
M5Q?A;3M6N[OQ')8ZY)8Q?VO<#R5M8Y #A.<L,UI> HKB#4_%4=Y=-=SC4DS,
MT:QEO]&@[+QQ18#37Q'8_P#"6R>'9!+'>B!)XV*XCESO^0'^^ A./3D=#B^V
MIQ)KL.F8;SIH)+D-CY0J,BD?7+C]:Y.ZTF'6O%7B6UE+Q,L%C+#-&</;RCSB
M)$/8@_GR#P34&AZK<7GQ"L[+5$$6LV.F7"72J,+(#+#LE3_8< GV(*GD46 Z
M[7-9M]&M(Y;I99&E<10PPINDFD/1$7N>"?0 $D@#-97_  E,MI<6ZZ[HU]ID
M,\@BCN9)(Y8@['"JY1CL)) !/&3C-1>+IH].\5>&M5O<+IT1N+9YF^[#+*$\
MMB>P.UDSZN!WIWQ*NK?_ (1*_L#MFN]2B:TL[=3EY96&%P/8\D]@">U '1ZG
M>)8:==7<@)CMXGE<+U(4$G'OQ3K"YCO;&WNH@0DT:RJ#U (R,_G6;XH1D\&Z
MN)&W,-/F#'U/EG)J7PS-'_PCFE#S5S]DA[C^X* )=:U&WTG39[Z^D,=O$!N(
MR223@  <DDD  <DD"L&?Q?/8Q"[U;0=2L=,QEKES&YB']Z1$<LBCN<''?%+\
M0CY%GH^H3*38Z?J<5U=[1G;$%==Y'HK,CGT"D]JU-<UG3;#09;^]GBDL6C.W
M:P?S\CA4 ^\3T '7- &NDBR1AT8,A&00>"*YAO$UQ<75PFB:3>:I% YBDGCD
MCBBWCAE0NPWD'(.. 1C.<U<\%65SI_@S1["[^2ZALHXG!.=C!0,?AT_"L'P(
M\LW@2UTNPO([#5M/46MWYD8D:&53\Y*$C[_+ ]PP- '5Z3>MJ-BMPUM=6K,3
MF&XCV2(0<$$<C\02#U%)8ZM#>ZGJ5C&K"6P>-)"1P2R!QC\#6/X#U*\U&TU)
M;Z]AOFM;Y[:.XAB$:R*%0] 2,@EAP>U.\,_\CEXP_P"OBV_])THL!)JGB*>U
MUPZ99:1=:A,MLES(T4L2!%9F4#YV&3E#TK1T>]O+U9#>Z7<Z<4.%$TL;[_<;
M&/ZURNI6MY<_$B[%CJ[Z85TBWW$0QR>9^^F_O#C'MZUU>BP75O:E;W4CJ$N<
M^:8TC('IA>* ,[4M?D@U.73=-TVZU.]A02S"%TC6%&SLW,Y R<' &>F3BM+1
M[]]1LQ-)9W5BX<HT-RH1U(..Q((]""0:P=2TZVOO$5Q+H^N-IFO)"J7$<6V0
M21\F,R1,.<9.&&#R1FK?@[5;K4H=0AOY+:>>PNVM3<VH(BGP%;(!)P1NVD9.
M"IYH Z:BBBD!5E@BEFAEEC1I(6+1LP!*$C!(/;@D?C5JBB@#G9O!_AV::26;
M0],DED8N[-;(Q8DY)/'4UL6=K!9VL=M:0QPV\0V)'&H54'H .E6J* ,?5/#N
MCZO*LVIZ7974P& \T"NP'IDC./:K]K!#:VZ0VT,<$48VK'&H55'H .!5FB@"
MK;V\4/F&&*./S',C;% RQZD^I]Z(8(H))9(HUC:9]\A4 %VP!D^IP /PJU10
M!6C@CCN))EC432!0[A0"P&< GOC)_.FM;0&\6Z\E&N50QB7:-P4D$KGKC(!Q
M[5;HH K7$$=Q"T-Q&LL4@*NCJ&5@>H(/45G:5X=T;2;AI],TNQM9R-ADA@5#
MM],@<#VK:HH @FB2:-DD4-&P*E2,@@]016)'X/\ #D+QM#H.EQO&0R,MJ@*D
M="..U=%10 UE!4@C(/45AV7A;0K"]%W9Z/80W*DLLL<"A@3U(XX_"MZB@ K%
MU3PYHVJS"?4]+LKJ=1@22P*S[?3.,X]JVJ* *UM;Q6T$<-K"D$48VK'&@4(/
M0 <"D2"&*:62.-%EF8&1@H#.0,#)[\#%6J* ,?4_#^CZK.L^J:797DZKL$D\
M*N0,YQDCIFI=)T73=)67^S+"UM!*06\B()G'3..M:=% &5JVA:7K/E_VKIUK
M>>7]TSQ!ROT)Y%6[&UM[*UC@LH(K>W082*)0B*/8#BK5% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
# ?_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>12
<FILENAME>image2.jpg
<TEXT>
begin 644 image2.jpg
M_]C_X  02D9)1@ ! 0$!+ $L  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" '7 G@# 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#^LK_@L'_R
MCH_:(_[I)_ZO3X95_#K7]Q7_  6#_P"4='[1'_=)/_5Z?#*OX=:_S8^F-_R<
MW(O^R$RS_P!:#B<_WO\ V6?_ "C]QA_V>/B#_P!8GP]"BBBOY./]*0HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** /[BO^"P?_*.C]HC_ +I)_P"KT^&5?PZU_<5_P6#_ .4=
M'[1'_=)/_5Z?#*OX=:_K'Z8W_)S<B_[(3+/_ %H.)S_-;]EG_P H_<8?]GCX
M@_\ 6)\/0HHHK^3C_2D**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M;^I0E+'X7$+FS##VJ*=3&J5+&_XF>%/T\<3PEC_&_@3Q6K9[A\+GG$'B;G'
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MG9R3Q+<W^F1ZUIUYINHW-G;&:>#2;J72XM2G6*UDUK2HY'O(_!?^"]EW%?\
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MPFBFU?PSXE\2:;JFGWVF7.Q8K5/".HVE]:W%M*]P^H64T$]N+2>.YK?LN_\
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M]HQ^%MW<6HGGAU6]\'1MHR:%*J,MO?R^'M5TO3#9V\=RVDM?+<W5W\A>$?\
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MI7C*TTZ'$NIR^'K_ $_R[VRB\VZET#5-<.G6E[JRZ?:R_P!2NH?\%6_^"?\
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MC\4_#;X"_&CXA>&);JYLHO$?@?X6^./%F@R7EFRI=VD>KZ#H5_I[W5J[*MS
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M)+YHHKZ7_P"&+OVQ?^C3?VE__#$?%+_YE:^>]:T76?#>LZMX=\1:3J>@>(-
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MY5GC(1>&J4\0I2HI>PG"K?V<HR?!45Z9\._@M\8_B_\ VQ_PJ;X3?$SXH?\
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M; 8+&8BG6JSH4:E##8G$4J]6%6O3J4:<J<)1G5ISIQ;G&27SW17M'@?]F_\
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MX9XGC4P>89"\KAA\HC3CE\,7B9X^I@Y8NEC(86.%PU*+HXCVM115;NX,X/\
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M_P#4D^#O[+_LO_A#O^HC]N_M'_ES^Q_Z5]G_ +/O_!;+1_V=?V?/@I\&]&^
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M#?Q#/BR^L?#6MSW& ^DZ07:ST/Q%?WLD>D16>NV>M7UQ96GA>\G/\]_[#/\
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M^-/^0#_;?AS[=]N_X1S^S?\ D,V?V7[9]L_TC[/]EG_#K_B'<_ZO _\ -?\
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M_$_WT2/^CL_^:'XF?_0:?S1T5_2Y_P 0[G_5X'_FO_\ ^.VC_B'<_P"KP/\
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M*_\ -CX2_P#G\'_$_P!]$C_H[/\ YH?B9_\ 0:?S1T5_2Y_Q#N?]7@?^:_\
M_P".VC_B'<_ZO _\U_\ _P =M'_$M'C;_P!$5_YL?"7_ ,_@_P")_OHD?]'9
M_P#-#\3/_H-/YHZ*_I<_XAW/^KP/_-?_ /\ ';1_Q#N?]7@?^:__ /X[:/\
MB6CQM_Z(K_S8^$O_ )_!_P 3_?1(_P"CL_\ FA^)G_T&G\T=%?TN?\0[G_5X
M'_FO_P#^.VC_ (AW/^KP/_-?_P#\=M'_ !+1XV_]$5_YL?"7_P _@_XG^^B1
M_P!'9_\ -#\3/_H-/YHZ*_I<_P"(=S_J\#_S7_\ _';1_P 0[G_5X'_FO_\
M^.VC_B6CQM_Z(K_S8^$O_G\'_$_WT2/^CL_^:'XF?_0:?S1T5_2Y_P 0[G_5
MX'_FO_\ ^.VC_B'<_P"KP/\ S7__ /';1_Q+1XV_]$5_YL?"7_S^#_B?[Z)'
M_1V?_-#\3/\ Z#3^:.BOZ7/^(=S_ *O _P#-?_\ \=M'_$.Y_P!7@?\ FO\
M_P#CMH_XEH\;?^B*_P#-CX2_^?P?\3_?1(_Z.S_YH?B9_P#0:?S1T5_2Y_Q#
MN?\ 5X'_ )K_ /\ X[:/^(=S_J\#_P U_P#_ ,=M'_$M'C;_ -$5_P";'PE_
M\_@_XG^^B1_T=G_S0_$S_P"@T_FCHK^ES_B'<_ZO _\ -?\ _P#';1_Q#N?]
M7@?^:_\ _P".VC_B6CQM_P"B*_\ -CX2_P#G\'_$_P!]$C_H[/\ YH?B9_\
M0:?S1T5_2Y_Q#N?]7@?^:_\ _P".VC_B'<_ZO _\U_\ _P =M'_$M'C;_P!$
M5_YL?"7_ ,_@_P")_OHD?]'9_P#-#\3/_H-/YHZ*_I<_XAW/^KP/_-?_ /\
M';1_Q#N?]7@?^:__ /X[:/\ B6CQM_Z(K_S8^$O_ )_!_P 3_?1(_P"CL_\
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M_B'<_P"KP/\ S7__ /';1_Q+1XV_]$5_YL?"7_S^#_B?[Z)'_1V?_-#\3/\
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M -$5_P";'PE_\_@_XG^^B1_T=G_S0_$S_P"@T_FCHK^ES_B'<_ZO _\ -?\
M_P#';1_Q#N?]7@?^:_\ _P".VC_B6CQM_P"B*_\ -CX2_P#G\'_$_P!]$C_H
M[/\ YH?B9_\ 0:?S1T5_2Y_Q#N?]7@?^:_\ _P".VBC_ (EH\;?^B*_\V/A+
M_P"?P?\ $_WT2/\ H[/_ )H?B9_]!I_2Y1117^L1_P UH4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!R-_\0/
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MI([*W9_D$]RT41?Y0V>*_F@_X+0?M_\ [!O[1_\ P2@_;4^ NG6/[3;2ZO\
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M/5=4^+-IX>N/A/XX\3>-?!EI\,O&7BV_\)>+!H7XV?\ !33]I77-+_X+X_\
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MMY?"POM1CL+/3M%LK^]GNKBVTZ[^SH(5229$@\P2S1(_\7?_  :__M*^#?\
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M_ /AW2_B]^R-/>?M._M[_M&:I:>-?AAKGA;Q!=Z7\/?ASXZ^.'Q"\/Z=XO\
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MFJ>&OC!I-QJ6AIK'PZT^WO+BZL@#]!:*_+WQO_P5T_98\&?''XK?L[6'@O\
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MT]\ M-_:/^#UOXYUGP'JTWQ+T^RTC7_ /B?P1\1/[?\ A'X[\8?#/QSX5O\
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MH4]QH]O_ ,)%X9-MXCT!=3TC4=+NKX ^D**^"?V5O^"B_P #_P!LO3?'.M_
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MO^":'P]^%>D?\$_/VUO@W\>?C!\7VNO$OA'PY;^%?B%X9^*?AOQ9^S5\%I?
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M61\6/^%I_P#"K/B7_P *+_X5_P#\+M_X5_XR_P"%._\ "V/^$C_X59_PM/\
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MFA/VK_VFWOM9^&<FGOK9DU3XSS_L(S64WB#_ (6S]E\8_:H?@W!I+>#M/L_
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M_![_ (*9>+O^"A?PB_:W^+?P5_8@TOX7_#7X$^*OV>M"\ ^#/VV_CWXK\1^
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M\4>#M=NK:RU#]A_P'JVHV.K0:/XCTW5K3X\?$'1K&]EL=.T7P3:R3@']$_\
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M1U!M+T^YU*73/"'ABWTKPQI3PZ)H=C''Z%_PM[X3?]%0^'?_ (6OAK_Y9U\
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MG\3/%/BCQ9\'/",VI:W*U]=:9HWP>\1>$M)T:PACM=(\-^'4TSPAX=CE\/\
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M\?#OC_\ X+5?#[]LG]N+XP?M/_MK_"7X;?%7X\_&7X#_ + 6A_LP?M4_%_\
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M^YN+:_\ #7A^RTO6-0T+Q?\ M@?&J#5[71OV@/BMX/L7B;38-#^ ?PTOM8\
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MZY^RE8^!/!_CCQ#\/8=#\0P>//"OBB]^'5IX]U2QM/A1XYT_XJ:AI<^I^!/
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MG64NG:?_ ,)1XRT/0+'Q'K_V#3[B>PL_[6U*[^RV4TMK!L@D=&]NHH ****
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M2_"Z[^)6BZGX<\5VC^)M"U234=?U#P[X?TM/H_\ X+'_ +9O_!-;XD?\$O\
M]I#PG^SQ_P %*OV:O#OQL^&'PJU/QC^SU<?LZ_MP_#2+XRKXR\':AI/BNT\&
M>$?^$-^*4_BWQ'%\0DT$^"]<T"*/5+O5-(UFY_L^&+6+?3+ZS /Z=**_(G_@
MAM\#;?X3?\$S_P!DOQSJWQ!^+7Q:^)_[2/P#^#_[1'Q6^)'QE^*GCKXJ>*=;
M\3?%OP+I7Q MM%TZZ\9ZSJ5IX6\*>"],\4P>$_#GAKPK8Z-I:V6E_P!M:S'K
MGC'6/$GBK7?SP^+/_!1'XX_"3_@KK^S1\>-7\00C_@E_^TQ\3_BS_P $H=,G
M:&]ATS1?VH/A'XVN=-L?BUKGG^#[37(=0\5_M*:5\6_V>/#JVM[K'P[M?A]\
M+/$/Q6O_ !M8V'B)=-T0 _J%HK\<O^"\WPW'B?\ X);_ +8GQ$\.^-?B%\*_
MBE\%O@GXD^*7PZ^)_P *?&OB/P'XVT#5?A_?:3XXETB/6/#>IZ=+<Z)XMM_#
MDWA/7[.]%T%T'7M7?3#8ZG)#?1?!-G^SGX=MO^#:*^^,DGCCXR3?'B__ ."5
M(_;!E^.I^.?QP;XMQ_&*#]F]_P!HRSU6T\?W?Q*O/%FGZ>GBSRM,OO#NG:U9
M^#]2T!)=!F\,IX8F'AZ, _J#HK^.?_@F]X<_X)1?M,?LT_\ !.WX7^.?VP?C
M3\3?V\/VI?AIH=EX\\+_  J_X*K?MBZU\5_#OQ)\+?!'QC\:OB9K'Q!^%_@W
M]J/4M$^%EI!IGPZUW2-0MM=\$>'=-M-;U73]#TRSM=4N;2.+]9_V^/!G[0_A
M+_@GE\/?^":W[*7Q U?Q-^US\9OV8]?^!7A+XH>/O&B:MXV@\!? _P"!]CIO
MQ>^-OC3Q(E_X2\7ZIJ_BR_?P-\(KKXG^&]!NK[PS\8/VAOA]XPU/PVMH\E@X
M!^V-%?G'_P $EOVR=2_;Q_X)_?L\?M"^+-+U#P_\5K[PS>_#SX\>&-8TY-$U
MCP]\>OA'K%_\-OBW;WOAX7M_=^'+?6/&/AG4O%?A_0]6G77+#PIXAT%-:M[3
M4VNK6'PC_@NG_P %2+K_ (),?L+ZI\?_  OX(3Q_\6OB)X[TWX%?!/2M0GMH
MO"FA_$GQ9X0\;^*[+QSX^B:[M]4U#P9X.T3P-K>J76BZ%%+J/B?7_P#A'/",
MM]X8TWQ!?^,?#H!^R=%?DOX1_P""1GP5\0^'M-\0?M._%[]LO]H+X\ZW;Q:E
M\2_BMJ'[;W[5'P9'B#7[B-,V>F?#']ESXM? SX&>$=!\.6:VOAKP_I_@CX8^
M'HY-'TFRO-:DUCQ!<ZKK>H?*?[*W[4/BK]GS_@H]\4O^"''[47BS7/B_X-\3
M?!+_ (:#_86^-_Q8\:RZK\7?B%\%-3BO(?%7P%^)6MZP]EKWQ)\??#35?#WQ
M0?P1\0=,O=8\7:Q\-OAEJNN>-;_^WM(NK^W /Z%**_@H_9QA_87_ &9?V[O^
M"W?PB_X*:_MW_'!OA%^REX^^#OB+]DKPIXW_ ."AG[7_ ,*/'P^'WC[P_P#&
M+XF>+/AQ\+O!_@G]I_1?B/\ M ^)/!/A^\^$_@.ZN ?'/B?5;W2]%UTV/AZ\
M\;W=A/[O_P %Q/V,)/V+?^"3WQ>_:4_9L_:B_;/\)7Y^,G[,_P 6?A[=:_\
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MUWPGJ&OZ?+;1Q:=JEI:7FI07@!_2/17G?PA_Y)-\+_\ LG?@K_U&M,K^9_\
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M--=7,\\MSJ%_=7$CR,7E/  !U%%>=_\ "WOA-_T5#X=_^%KX:_\ EG7XY_\
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MOP:^*\BZQ<2^(M3\-_$'P9IUQHVB^.-:M[(_$'6_ /B[Q-I]O]@N(7;\>/\
M@K#K7QK_ .";?_!5WPC^W]\#?BG\3]._9-_9NTS]@'Q)^U[^SI=>./BMXG^$
M,?PZ_;.\>_MP_LX_$/XH:=\/I/'ESX:T(^&/#_[/_A?2_#V@^&?!>H0GXN?$
M#PMX^@\/SZCH^O'7P#^V2BOS[_X*+?'7Q]\/_P!D/Q?;?LU^(-,MOVE?V@]
MU;X4_LI:E-?:1;1VGQ'\6^!?$GB=OB?$NLB:&]T3X(?#+P]XX_:!\416VC^)
MM2;P?\,]:_LKP?XPU5K+PMK'YI?\&O\ X3OO$?\ P2G^ ?[3WQ#\=_$WXJ_&
MWXZ:C\=)_&'COXH?%'XF_$75AI/A/X^>._AMHN@:?%X[\9^)=*T;3K72OAIH
MMSY/AG3/#]M-<R3W-W:7.IW&I:IJ8!_1C17)^/?'/A/X8>!?&GQ+\>Z]IGA;
MP+\//"?B/QSXT\3ZW?6FEZ-X<\)^$M'O-?\ $>O:OJ>H3VUAIVF:1H^GWFH7
M]]>W-O:6EI;RW%S/%#&\B_S,_P#!.?\ :D_:)\7_ /!3C]O?]A#_ (*#>#];
M\/6W[:?PC^$W_!1;]EOPAJFHVNCOX-^%>K^"? OPM\5?!N2[T'XAZYJNE^-_
MA_%X:\)>%+@^$9M.M[GXA_ SXY?$NSGT^S\3^')+H _J2HK^/G_@G]X(U3_@
MG_\ \'$/[0/[#7QK^,WQL^+G@OX[?LV/^T%_P3WU;XU_M0_&3XCW'@_PTVLZ
MW_PG'PJMO ?BWQ!>^&?%/BB33/#OQ6AL?&NOQZQXST#P-\"S<V>J3R_$+QE-
M'^P7Q(_99^'7[7'_  4CC\2R^*_B/I7PW_8Z^'NF-\8?!WPU^,OQ2\!^#OB]
M^TQ\9;KPIXV^'_A+XGZ;\-?BQX<M;NZ^ ?P>\"^'OB#XC\ >*?!G]A^/_#W[
M5G@&\UN[\4:(VM:& #]A**_AL_9YM?V#_AM_P4V_X+9?!S_@HW^W3\3O!?PF
M^!/Q7^!&O_LJ>%OBO_P4E_:3_9\N=#\/?%?PY\5_B7\4?!7PM\-_#S]H7X::
MU\2M(\$?VE\._"^GZ7!IWC+6O#^AV'A6#,6H^(+RXUG^E?\ X)7?!CX>> _@
M!IGQL^"GC[]H?Q7\#?VR/ WP+_:B^&/A/]ISXM>+/C'\2_A-IGQ'^#7A*]F\
M"?\ "3^+_$7C/4X=(DM!I/BJ[TW_ (33Q-;V7C;Q'XTMM,OAX?AT1* /T\HH
MHH **CEBBGBE@GBCF@FC>*:&5%DBEBD4I)%+&X9)(Y$)5T8%64E6!!(K^-KQ
M8?V?OV8_^#EOQ]X4_:0_;.USX(_LD0?L,>'/VF? GPR^/'[7_B_X5?L^Z/\
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M,?@=\,O'/P\TKP'\)? WBV.U)_9T\*>$]#TSQ[HO@/X?:1KN@/KWA?P6OA@
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M=OA7?7MYK?A+PU\1/&4?@1M?U87VHZ]XOU2ST5[/0]+71 #^TVBOQ _X)E_
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MW/Q&T'5[3X!^%)]+@_:"\8^)=6UWPII]S\%;&[=M7T+Q/?6VBP^8_P#!4/\
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MNZ)XP^"7QZUOP5\4_!I6_BFN=$_X2/P_!'KGAZXTKQ#HM[JVAZKIVJWGYF?
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MO"/BGPBHU/\ MXHH _E)_P""Q/BWX3?ME_L6?LT_\%K/^"=/Q,\/_&7XH?\
M!,;XK>#_ -HW3M3^%GC>U76+SX,ZMI_@+QC^T5^S[\5X=)U])?AWXDT_P!?^
M"O&OQ,\%>/\ 0-9\8>%?!NE^,/ NI^ T@^(VN07'] /[.^GZA\"_V;KWXD_M
M)^(]&\#^,=;M_''[2'[2GB;QEXVT*3PE\,M7\4?;?'?B[0M1^(=SX?\ A]H
M^&OP \'QZ?\ "_P]XOUC0?#GE?#3X::'J_BF234UU?5[KZQEBBGBE@GBCF@F
MC>*:&5%DBEBD4I)%+&X9)(Y$)5T8%64E6!!(J2@#^"']B?\ X*4?\$B?'/\
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MI;1--<W5U<S,D-O;V\*/+//*Z111(TDC*JDC^+KX>_\ !0K]@OXM_P#!T_\
M$[7V^,/P0\8?"+5/^"=WA3]D[P1\5-8\;_##Q#\&_B+\=-8^*OPA^+6C:1\+
MO&D'B'7/#7BV]NK/6[KX?6D5M<66MS^/=*\4^'K*PN+>R@O-4_M-HH _C/\
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MG>-]:\5^&M(/[47[.USKGBZ_\(O\)XM3^(WBO5O'VK>";GPQXQU'^P/"1O-
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MCOPSKVO^"/\ A2OQR^)^K?\ !0+XJ>!=>L_$OAT:O??#[X1^.O#WA?\ 9,\
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MHOB7PAXEBT?4M8TJW\4^"O%6E:WX0\46FG:MJ5G9^(-$U*UM[ZZCA69_I:@
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MGAC6YX$TZX .DHK^?K]E;_@L;^U+\8_^"H?B;_@E_P#M%?\ !.[PS^R5X_\
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M/0O#/P9T[_AE7X4>,5\8Z[XA^/7QJ\:> /A9H'P9\%^.[?PA#=^+[>U^*'Q
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M_#NC6.BZ-X*TG4_@U\&?@U%K>D6<=D;S^U/'%GXL\87%[=W/VOQ//9BTL[4
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MBK^V-?MO^$>\*?&:\^'>H?$K2O[#L]5M_#FK?\))=_"?P!-]NUS1]3U+1_[
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M>%]3\=ZS#H$OB#3])U'QC?0VD^N2?RI>!_\ @GG^W]^SS^P5H'QU^$VB:/\
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MH/\ @LK9?M3^"/C3XT^ ^D^(K/P;^R7X[^%6D^%_V?M!_8.'C'P-K/BGX/>
M?%R:UJ_Q/\ ?M1^*8?#H\;^,OV@-/U[6O#'Q=\8Z+X)^'NN_!&/PCX6^'?\
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ME:EX:O?"F_0M1TF\M9;*_P!.FGM;J&6*:1&_*+]K;QH_[,7[/?PJ_P""2O\
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MGX,> O'_ ,'O@O<3644]CXI^)VA6%YH]O\2M>AN[:WTSP)X OM1DU'XE>(=
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M'O$VBQ:H+'4].U?2=)UK2=0BNK*_L+"\BGMH_P ,/^"GGPD_:U_9YUGXP?\
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M$44$$4<,$,:10PQ(L<444:A(XHHT"I''&@"HB@*J@*H  %% $E%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M CX57OPW_9]AFU#3M"F_LCX4Z7$GA;PC;10>%M'_ $BH ^5_VO\ ]M/]G/\
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M,\?[??PQBCF**98XIOV=_P!J1YHDD(WK'*\$#2HI"R-#$S F-"H!_0Y\$_\
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M>FWVGWS>3^HW[!/QNU[]K7]@W]DGX_\ Q*TC3$\5_'W]F3X/_$+XBZ1%HO\
M9_ARZ\4>.?AWH>I^-(]*T*\O=8,7A+4M:OM4ET&RO;Z_DD\.W-BMW++(\HH
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M;.RMX+>+S'=]D:[G9LDZ] !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 ?SY:1_P2IM;'_@X;\5?\%$H/[&3X5:A^RCX
M<\?W7AB#Q3XIL=2D_;(%OXD_9OTKQY/X%M&7PAJVDZ;^S9/XVTZ'6M4N#)8^
M*_&NJ:C8>'&UV^O_ !4+=E_P2T@3_@X:\0?\%$DCT6/X7S_LC>%_&=[H$'B[
MQI;ZQ??MC6\7BC]FW0?']_X&6[E\&ZGI>A_LP7'BWPW8ZI/);0Z;KOB>YO\
M3_";>);[5O&<Y10!_0%7\\/[?_\ P21\/_M4?\%H?^"6O[;LNE^%;CPM\$M)
M^(6H_'BRU+6_$&C:[KMU\ IX/B1^RU>^'M-T=#8>(KW1OC+XVFN_%,6K76C6
M]UX3T>UTK69?%6D1VGAJ,HH W/V]_P#@EI!^TY_P6-_X)@_MC6\>BP^"_A+X
M:^(UO^TCI\_B[QIX?UGQQI7P$\0:#\;?V4M*M-!T2[/A_P 76'AC]HS6[?QC
MKVEZPFBVES9Z%IY\0S^,K/3=!\.Z;_0%110!_/G_ ,%K?^"4NG_\%$_V@_\
M@D[X_?2+37M-^!7[8<6G?&WP_KD?A74/!_B']FG6/#LWQ?\ B/I_BCPYXD>U
MG\3MJFK? 3PU\.-)T[2KK4/LMK\5?$6I:MX2\2Z7:S/H_,?\%XO^"5>H_P#!
M1/XJ_P#!,'Q5X=:]CC^'?[55U\*/C[%#XVF\"Z=J/['_ ,9O"USKGQ^M;S4=
M%-IXUU'6M5T+X5P_#/PMI/A#5[.6\?XLZW;Z_##X=GU#Q3X2** /Z+XHHH(H
MH((HX8(8TBAAB18XHHHU"1Q11H%2..- %1% 55 50  *_*S5?CG_ ,%+K/\
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M@SX^\7Z-:R6.J7-XFB>(?"GC*/4]/O\ 3[?6-)N;*>&PNR44 ?G9_P $6/\
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ME;^'-+\.Z&LNE>(]4DFUV&(/&WZ6?%GP9\=?V8_^"<7_  HS]FCP!X]_:_\
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M\&:KHUQX3L['Q):W_P#PLZ>ZU*QT[PY;^*)=2YG_ (*P?\$LU_:[_P""E_\
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2444 %%%% !1110 4444 ?__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>13
<FILENAME>image00004.jpg
<TEXT>
begin 644 image00004.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  8$!08%! 8&!08'!P8("A *"@D)
M"A0.#PP0%Q08&!<4%A8:'24?&ALC'!86("P@(R8G*2HI&1\M,"TH,"4H*2C_
MVP!# 0<'!PH("A,*"A,H&A8:*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H
M*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"C_P  1" "J .0# 2(  A$! Q$!_\0
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M3?\  /CS%&*^P_LMO_SPB_[X%'V6W_YX1?\ ? H_L%_\_/P_X(?ZYQ_Y\_\
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M_ )J***^C/A HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M=,@CDB),;+D&//)"\\ ^@XH IZKK][_;^H:7ID=HCV%BE[)+>,523>7 4$=
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MNBV\(*B+;_ 2P)(9?F!!S5"YM=6M_"%U<6,FKQ2WEY&88[B::5K>!3C,G)D
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MRW,+31R*PDD,1_=<CJ$R2 >^/2NKHH R+K0H9K:[CCN+M#<#YSYS-WS@!L@
M]#@=*R_"/A-M(\*Z;I6H7LUQ+:# DA=HEQV  (X QQ75T4 </-X+N)O%E[J;
M721Q70D5VC+!MC0B,+M^Z&!&?,'S$<'BJDO@;4[SP9J&A7NJKY<D"06R#+QI
MMBV9;=R03AMG0$=:]#HH R-/T406U@+JZN9KFVC"F3SF <CDDJ.#SZCIBN?T
M_P $36NI^(9GU2=K?5!'A5P'R!ABYQ\V>G3@9%=O10!P%KX+U"U\"66A+=VT
M]S"NW[0VZ,1$?<:,+V4@':>"1S6Y+HEX_BFQU%9H4AMT97=2WF3*4P59?N_>
MPVX<_*!71T4 <SXE\-R:WXBT*]:<1VFG^:TD:LRO(6*%<$'&,IR#D$&J5OX9
MU6SUZ;6+2\LC=W4$L5U')&WEN=V8,8YP@RO/4,>E=G10!Q_A/PYJGAFSN;*S
MNK.:U>X2:+S8V#(&QYR\'IG=L'\(('0"MSQ+H\>NZ/<6$LLL2RKC?&Q4C\B,
M_2M2B@#D=<\'QZAJ-C+ [0I&\#7$AF<O*L,OF(A'0_-GDG(R:M2:%=2'6993
M8S2SA8[*&6(F&"-.5# <DE\L<>BCM7244 <UH/AQ[?18[;5) ;OSI)YI;.5X
MQ+(YRSGD')/;H.U0MX5G_P"$\37UU&3[/]D:WD@/WCE@0 V.$&.G7)SFNKHH
M Y3Q-X4&I:,MC:RN4^TQSR+//(2X7/"R [HSG!W+Z>]9EKX-U>SOM)N+?58A
M);V=O9SNJ%/EBD+G:@^4AE)4@^@/6N^HH Y'1?",NG^(]>OYM1FFMM36,>6#
MM<, 069AC)[#&,"F^,/!SZUI-I:V-_-;O;7$=PC3,90"LBONYR=V%P#GC)KL
M** .*7PA=+XW_ML74+)NPVX$L\?D^7L9?N[MV3YGWL';TJ2T\-7T5OK0E%BX
MU"57^R[Y/+7Y=KL&^\I8>G   %=C10!F^&K"?2]!L+&ZG^T36\2QM(!@''I[
M#I^%%:5% !1110 4444 %%%% !1110!SGC'Q!-X<_LVY>*%M.FN1;W,C,0T6
MY3L*CH=S )SCEA7/KX\O;GPQ)XAM+*V738/)%PLSL)(26 G#8&,Q9.?7:>F*
MZSQ3!%<:2([B))8_M$!VNH89$JD'!]" :S?LMN/!NNPB"+RI3>F1-@VN69RQ
M([YSSZT 8MMX\U#5M-U:[T+3(9&TV&5Y;>>0AV=6)C48'22,!P>V0.]6?"WC
MQ?$^L"RTR&,I&%FDE8G$ENT:LDT?LSEE&?[AK<\.V\,-QK!AACC+RQ;MJ@;L
M6\0&?PXK.\(V=K;7"-;VT,3#2K:,&.,*0H,A"\=@2>/>@"QXO\33>'+S3V>R
M,^FR+(]Y.C?-:QKM'F;?XE!<;L<@9/.*P/$'C^]T33=%O9;&TN4OX[F1A;R.
M^1$A==A"G.Y1UQ@$^E9O@QVF'P^$S-('TZY#ACG<#MSGUZ"LKQTHLM-\+)9@
M6Z0V]RD:Q#8$4KMP,=!CCCMQ0!Z5I7B";4?$GV..&#[ VFPZ@DPDW,?,9@%X
MXQ\A.0>]9UYXUWZMXATG2;:*XU/3;0W,$;2\7)7.]..5(.T<_P!X5YUXP=K'
MQ5Y-DQMXAI-O $A.Q1&#PF!_#R>.G-=3I_S:[X#D;F3R[SYCU^;[W/O@9^E
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' HHHH __V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>14
<FILENAME>image00006.jpg
<TEXT>
begin 644 image00006.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" 0G!WX# 2(  A$! Q$!_\0
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MM']HT=-5K;JNO+_>_O?@'^I69_\ /F?3I+^[Y>?]6U^\O[5A_P">@_U?H/\
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M?[!M?G4_\3B#N!UQ[^G^/>OUQ^",JR_#CPVZ\AK",^O8<\5_-#XM^/$!T*T
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MT_V//C)#K?[1MCIJW0<WC6\6 _7IV!/^//X5_197W61UXXC QE!W2E).W?\
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M*H0BN[E5BDOO/R!M=5B_M;Q.-Z\7DGIQ\YXZ^PYK4M=5A^R#YU&%D].V1_\
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MRAG&5.ZBE\=647Z+3Y^>A_2A1117]#'^0H4444 %%%% !1110 4444 %%%%
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M^MS_ %_7Z>E?E#)XQN_W7^D2#&H!OOGI^/\ CQZ^D;>,;KYO](D_Y"(;[_\
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MEBL+50.H!5B/Q/\ AZU^-T;$RRYYPG!Y]N_K]/0U_(?&%=RS[-'?1XNM:_\
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M?PR)_P">K?GY\7_UQTQ7^HQI/_(*TS_L'V7_ *31U^Q>$EWDN)EWKQ_](7_
M/\V_VA:Y/$_)*5M*>4U8I^7MH_G<T****_6#_/P**** "BBB@ HHHH \0_:.
MO?L'P6^(%UG;Y?AW5>?KI]T/S]*_R>?C?J!N_C;\1+K=G=XLUSGU_P")C<C
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MB^?/^N\0:P<^O^GSD?7/2O\ 45_X*CZE_9?[%/QANMVS;H[+GC^."Z4=??\
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MX5R^^K;]#_87]FIA;\,\9UFOXF>4X7\J>"H-='_S\?XF),I\U&^@_*NT\&7
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M1]':A]8\;?#6E:ZEQ7E5_18F#/\ .D==SRM@8,DA/O\ .?Y?YYJ.-,J#CO\
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M]X>4FKJ?%.5I^GMT?YK"IFXO3W-Y<GV.9W.?SY],5+MR0".A'_ZZ6 9DG/\
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MA;'->UX-K_:L>[;49=.]1?\ R/Y'YK^THDH\.\(4_P";'T7O_)@K[+SJ:_\
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M_P -U/\ =_Z <.;P*RV;_P"AGG4'OM'%T9+\/Z1W7PRCW_%;X;>H\6Z(,?\
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M4 %%%% !1110 4444 %8WB-MGA_6VZ;=(U(Y]-MG,?Z5LUS7C*40^%/$<I.
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M\9,QCWR"3_\  <0F?D,J9CD8?PL!SU['!_#T[_2B)<I(_4)M'';/7/O^-31
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M_P !5_\ !>)3_IG]CU%%%?U:?\_84444 %%%% !1110 4444 %%%% !1110
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M/<O(3^!X/^>/2JL^:?I%?<HZF3DW3PR_FJ5+]=YVU_\  GV170G</?C\A_\
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M=MP'T&!_G]:_DKC^I[?B7$.]_P#:ZL>CTC*,$WYVBK?=N?\ 1/\ 0^R_^S_
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MGN\68'S<OQC^OZG\W?3=@Y_1_P"*>U.%%]?LUJ;[^I_;#1117]8G_/D%%%%
M!1110 4444 %%%% !1110 4444 %%%% !7\*7_!TE8>7\8/A5= 'YM%8\_\
M70'_ !].G>O[K:_B&_X.GK#;X[^%%WMY&C8SCIF08Y_GGCCZU\)XBQYN&\0[
M7Y:E-_>[']3?0WK.EXZ\-J]O:87,HO6W_,.W\S^2V4[MOIA3^07'_P!>KOAI
M]GC;P6Q/(\4: <_[NK6I[>X%9RC<(_0QC\\?TJUHF5\6>#7/\'B/1B3]-3MO
MSK^4\%IB*7E)?A9_H?\ 01Q++VF3YC)_;H+_ ,F]E';TJ_C\S_6H_8ZO1?\
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M3 _IZ>]?QY.+<JCO\51?C*+/^D/#R:H8*"^QA8_?&BXK_P!)[_<?4'[%%_\
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MU/#6^=2O_E;Y'\Q_M+<3S8O@+#_WLSJ6\_JN6/\ ]O['JU%%%?NY_E0%%%%
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MVNH_U"BBBO1/APHHHH Q/$H)\/ZUC_H%W_\ Z2RU_E0_\%#S_P 9<_%L=O\
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M /YC?^#G+Y/V2O"K'@/XXM$_$QP'''J,<?Y'\%&G/MM_0>25]N_]/QK^]?\
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MZ5_7/7]=>'ZMPMER_NS^?O'_ #N?3%E?Z0/&_E6P:^[#Q04445]F?S %%%%
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MD&;:>^[;^ZQ_T986/-%:_#&G3[?'[OWZ[?+O?U+X R&#XT_#M^A7Q)I7.?\
MJ(6O^<5_K-_ 2X^T_!WX<29S_P 4?X?'Y:;;_P"1^E?Y+'P7D\CXO^ GZ8\1
M:4?_ "?M:_UC/V9;C[3\#OAO+G.?">ACKG[NG6X_R*_=O!FI=YO3_P"G>%GU
MUO*JOT9_DS^TKP_+6\/Z]OAJYQ1OY\F"E;\NK/>:***_=C_*@**** /XLO\
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M8_\ @A?J/V_]B?PU\V[[/-;0]<XVP2\>YK]G*_M+AN7/D.4R[X&A_P"DV/\
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M#8;GP5XN/_3*?!_X$_\ ]:OZZ*_D7_X-@N? OBX_[-Q_Z%)_];]*_KHK^N>
M'?A;+O2:]-3_ )VOI@_\G^XU?>I@W]^'C^H4445]F?S&%%%% !1110 4444
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M3[4.7[F_Z_JQ_P WOTIL/]7\=./%:WM<S57UYJ--7_#?4****^L/Y["BBB@
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M_77A]_R2N6^<9O\ \F/^=GZ87_)_^-5_+4P<?NP\?NMM8****^T/YB"BBB@
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M:DKV\_\ @/<^1Q&+BI*2FO>\UTY8WZ]5WZ'!FT;YOE!_> ].O3\L9Z5T?A"
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M +>GP6AVY"ZK(3^#VY[?Y'6O]37PZGEZ#HZ?W--LU_*!!7^7_P#\$;K#[?\
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M?V5A?]VP_P#UXI?^FXG_ #69Z[YUF[[YECON^LU+!1116YY1YO\ %W)^&_C
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M_P"#8;_D2_&'_7.;_P!FK^NBOZ[\/?\ DD\L_P $_P#TH_YT_IA?\I \<_\
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M_P#PMTI_^"Z=2?\ [:?Y_=B,6T?N,G\:GC^Z?]X_SJ. !+:,>D8_4?YYIZG
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M_P"?PZ5_""W7JOS/^L1I\C6CM"V_907_ +C?IW/[:O\ @V&_Y$OQA_USF_\
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M?LO&SCQ?S9LZO_@VE"?_ +<%%%%?4'X4%?YTO_!Q/>?;/VQ=-BSD6]C=)CT
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M ]NV.GY]:_7O"*I_PN5HO>6%JJWI*B_S[?,_SL_:(85U/"G+:]G:AGV6._\
MCHXS_-=?D?NU1117])'^* 4A. ?I2U',<12'T4G\J!QUE%=VE][/\T#_ (+L
MW?VK]NKQG&#GR-0NE_'#?I^77IWK\=4SB/Z'_/\ .OUA_P""V%Y]L_;V^)B$
MD_9]8N4^F=QX^G _SS^4*K@+[9X^O^%?QKQ?.^?YCW^LUU;_ +B3_P"&^5S_
M *6/HX89T_"+@M6=O[&RQM7[8/!/]+?YG[9?\&_-E]I_X* >")\9%O<3Y)Z#
M,<'![^F*_P!)<< #T%?YS/\ P;MV/VC]N'2;O;G[).3GTW16_P#.O]&>OW_P
MKC;AJ_\ -BI/_P I4C_(?Z?=5U/&V,?^?60T(_?C<;+_ -N_4****_2S^'@H
MHHH *J7[[+*[?ILMIFS_ +L;'^E6ZRM=D\K1=6DSC9IUX^>GW;>0]?PI2=HR
M?9/\C6@N:M1C_-5IK[YI'^8/_P %H]1.I?\ !2'XT.#N6.]LP.<XPDX./USW
M)]:_+JX4^9N]SC'?_/\ GM7Z'_\ !6.__M/_ (*#?&J[SNW:E",@Y^ZUPOZ8
M-?GVZ;H8WQR6./P/T^O3T]J_C#B>=\[QU3^;&8B*?DZDI6;UW_#<_P"F7P1H
M>P\*N"L+UCDV4)Q7_3K*\'%W_7TWO8I2_>'^ZO\ *G3=4/;8!^7^-/V[N< _
MY]Z>%W '/(X_GC^E>/3E^[J;748V^37S]3]8E2;DUK[[5NFUF]>W]:G]97_!
MKIJ!3XH^/]/W'!T'4)-I/??<#@>O?CUK^X*OX2O^#8"],7Q\\=6F[[WA>^..
M?^>EQ[^O/3WK^[6OZN\.)\_"> :U495H?^ R7^9_S\_3@P_U?Q^X@=K>VR[*
MZOS=*:;_  "BBBONC^0PHHHH BG&8)AC.8I!^:&ORG^(OPPM;_QYJEV;96,U
MQ*Q8KG.7R<_7(P?SZ#'ZMN,JP]5(_,&OFK7O"HN=<N+@QYWNQZ=<GUQ[CKWK
MR,UPJQ/U6ZO[.M*7_DC76_5_CWL?HGA]GD\DQ.95(S</;X:--M2Y;VD_OW/B
M$_">TV_\>B?>_N]>_P!>_P"5,_X5-:?\^J_]\_\ UZ^VSX24C_5'KG[HS_+]
M:3_A$5_YY-_WR/\ XFO-J99%\GN+2G!;=E_6Y^A1X[KZKZS+>_QOKR[7?GOY
MKU/D3PU\*+-=40FT4X4\[.G4?Y/(/ZU_#M_P6@T6/0OVN?$MK'&(U-Y/M XX
MPW.*_P!%;2O"RPW8?RNV.5P>_'0#O7^?=_P7AL/L?[96L*%V^;<73'CTW<_7
M!Y_&OSSQ%P2H9#SJ-K8J&MNGLY+??K?[S^LOH6<35LU\9L30G6<XU<@Y4FVT
MW'%47I=_/SM;N?B7$-R,O7)'\\]J_4W_ ()":.NM_MB>"["1/,5[W&TCCI#[
M?7_]5?EW;IF94(^]D\=\=_TK]@?^"(%B+[]NGP) 1NS>OQ_NK$>_'UK\;X67
MMN(LMIO[6(I77K4@O/L_/7M8_P!*_'G$RP/A)QQ6B^66'R+&235U:V&Q,FT^
MFZT].B/[;->^%%D;T8M%XM8 /E_V%'7UY'^>F%_PJ:T_Y]5_[Y_^O7W7J7A<
M2W(8PY'DQ+T] !CI[?H.U9W_  B*_P#/)O\ OD?_ !-?U14RV,E#W%HI+;^\
M]=._Y'^#U#CFO&G!/$RTC%:S?DN_]:=#XAE^$UIY;_Z*OW3_  __ %ZQ)_A3
M;1?$CP7=+: ?9ULWR$Z$2 ]AQCU]OR^]W\(*48>4>0>JC'Z+67<^# WB71KK
MRA^XCB&=OHV?K[$$?7K6,\KC[-+D5_:TI?\ @,E^/G]^YT8?CNLL5-O$2Y99
M?C:3]ZZ?M:+C;\7\OF?4&BQ^5I5E&!@)!&N/3"BM2JUFFRVA7T11^0Q_2K-?
M6QTBEV27X'\\5)<U2<OYIRE]\FPHHHID'G7Q:./AQXQS_P!"_JO_ *0W%?Y,
M'[2P(_:&^+![?\)OXA_].=Q7^L[\7?\ DF_C'_L :I_Z0W%?Y-7[3Z;/VA?B
MR.G_ !6FOM^>I3_A7XAXR/\ V?+/\5?\?8H_U+_9J.^;<>+M#*I>?Q5W_P"V
MGA+?ZO\ [:'^M?V+_P#!K-_QZ_$;_K_U'^=S7\=C#]T?Q/\ 0?TK^Q3_ (-:
M#_HWQ$&!C[;J)_\ 2CK7P7A@_P#C*<(E_?O]W_ /ZU^G-#E\"<^?3EHOYN4%
MKU^UV/[.J***_JP_Y_R"YD\JWGE/ CBD<_15)/\ *O\ -*_X+T>)6\1_M]^-
M8UDWQ65U&B+NRJY2?/YGK]1UK_2B\23_ &;P_K5QG'D:7?2Y]-EO(V?TK_+C
M_P""KOB$^*OVX_BA>[S((]4=,YS]Q[A>O_ZO>ORSQ8K>SX?I0_GQ#?JE3FO3
M=^?W7/[\_9[Y0\=XKYAC.6ZPF5TJ5[;.MC</4M?_  T7I_P3\Z'!VR>X&*IZ
MF<6L:C.Z26)>.O+JHX_'OU/Y5IR+^ZC/.68@>G!/_P!?\<U0O5\RYT>'&3/J
M-K'CUS-%V_'_ "*_FW!T_:8O#Q_OTY;=N5^O2WWG^VF=U7#(\YJ+3_9:U*_G
M4FX:/_M]6/\ 1U_X-_/"8\/?L6:)</%LEO;YIMQ7!*O$3QQWSS_6OW@K\MO^
M"0GA3_A%/V-?AW;>7Y9NM+L+S&W!;SK4$DC\>O?%?J37]F\/TO8Y+EU/MA:?
MWN-W?S/^9GQBQO\ :'B=QKBN;F4\^QJ3\H3Y%;1::!1117L'YJ%%%% !7\$7
M_!S=_P G">&O]^/_ -%U_>[7\$/_  <W'/[0GAK_ 'X__02/Z5\!XD_\DS7_
M .OM/_VX_KWZ$7_)]<G_ .P#$?\ J3@S^9!NL7U_I7TE^Q&#_P -C? ;_LH&
MBG\/.>OF_'S*.P'\L_\ UJ^G/V'HPW[8GP*/IX[T1O\ R*WUY_PK^8LCTS/!
MQZ^VI/OM5I]_P_X!_NAXHJ_ _$<NG]G8Y7UZ9?67EY_>?ZPG@;_D4M _[!T'
M_H-=77)^!CGPCH!_ZAMO_P"@UUE?VQ1_A4O^O</_ $E'_+_F7_(PQW_87B/_
M $[,****T.(**** /Y^O^#A[_DSRY^MW_P"@5_G76O\ QY1_]<Q_(5_HH?\
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M]('CCSK81_?AX_\ #!1117VI_,(4444 %%%% !1110 4444 %%%% !7\>?\
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M/L ?\_C7\U>+SMGU-_\ 3FA_Z;B?[?\ [.M7\),=_P!C?,+?^#X;>=KE]/\
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M^5]#_##]H7A_8^,>#JVLJV4<JT_Y\U5%KOIS?UJ2T445^H'\#A1110 4444
M%%%% !7\,'_!S;.3\4?AY$3_ ,NUYQ^+Y./PZ\>_O_<_7\)?_!S9,!\8?AY%
MGK:7W'T+X_R:_/\ Q,=N%L5_U\I+[Y(_LOZ"+7_$?\DO_P!"S-K>KPE1(_EC
M?_EL/^N>!^56!T%5P<],\X_'TJ4'A1ZY_2OY.DG*VMK7T^5OTU^9_P! -&2Y
MF_YK6_\ !CDO_2_\Q]?U2?\ !K7J?D_&WXI6+-@-X8D(&>YDD'KV'/TK^5G=
MT]R?Z_\ UJ_I<_X-C-7^Q_M,_$&TWX\_PT%Q]9'/K7W/AS)T^*<M=[WK*_\
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M]0EZ9^Y9R'^G_P"NO*SR/-E&91[X2LO_ "5GWWA95]AXC<%U;VY.(LL=]O\
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M?6JB=N:6C[]FO\OZOISIT>'!^4?H?T[U&VBQ&XAEVC]V!@D#C'/I^G_ZJZ;
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M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 ?XUR<B$'OO)_
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M7_!(Z_\ M_[#_P %I-V['A6R'O\ ='/3IZ?_ %J_36O[4R6?/E.72_Z@\/\
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M;'TG1117[J?Y0A1110!\\_M8WIT_]G'XQ78.#!X'U>0'.,;8U_Q_#K7^3O\
M%F[-]\5?']X3N^T:_?2;O7<X).>]?ZKW[<5Y]B_93^-\^=NWP%K?.<?\LEK_
M "A_&,QN?&WB>8G/G:Q<'/KN;_\ 57X)XRU'[?*::T_<5'_Y6BKG^M_[-'#_
M /"7X@8JVO\ :V!I7\E@'.WW^1RLF?D'J.GX\5^I'_!&7PK_ ,)1^W)X%@>(
M21P2/(WR[@"DD;#/H>QQSG\J_+V1"9=I[-@#V_Q[\\U^[?\ P;]>$CK'[8^G
MZIY6\:>9%+8SM)\L_A^?I7YGPG2]OG> @U=_6**:MI_%A^GX]#^XOI"YC_9?
MA;Q5BK\JCDN.<6^_U*<5KY-_EU/]%;PY:+8Z'IEJHP(;*V3'TAC%;=0VR[+>
M!0/NPQC\D%35_8L%:,4ME%+[DD?\V=>;J5JM1[SJ3D_64FV%%%%49!1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 ?XV2_P"L
M<>@'Z\_UIK]9/90?Q-.7[Y/][^G3]/Y4QSC>?48_(\?_ %Z_@Z-^=7[1^^_I
MW3^\_P"LF;7LEI;WZCVZ6>OW-']M'_!L+_R)7B__ *YW'_H4E?UT5_(K_P &
MPN?^$,\8_P#7.?\ G)_]:OZZJ_KSP]_Y)/+/\$__ $H_YT_IAN_T@>./*OA5
M_P"6\0HHHK[4_F(**** "BBB@ HHHH **** "BBB@ )QS7^>O_P<HZE]K_:]
M@L0V?LGDMCGY2Z2^O3/3U[U_H3.<(Q]%8_H:_P Y?_@XEU/[=^W+K-MNW?9T
MM./3*3<\'_/<5^=>)]3V?#517MSUXK_R2;L?V=]!7"?6?&_"3LW[#*J]1Z;?
M[9@8_P#MUON/P='^L;_=%=5IVDR7.EWMVJ,5BA8E@,@8QG/OQGG^=<H&^8MS
MR,?E7UK\*_!3ZY\)/%^N"$N+*SN6+[<XV#UQ@?XU_+V"HNKB%&-_X<E;T5]?
M5_UU/]V^)\SHY7EBKUI)*6,HPBV[:SJ1BOS/DMN#CL(L\CG@#_&J=XVVU60\
M;75L],=<U;E.&<>@*>O3K5&^YL'[X'Z@'^5*2<<5%K[-:*TOTY?\T=^):K9;
MBNU3 59+S4E%K]#_ $[O^"+.HB__ &%OA =V3%X;LT/.>WMTZ=#_ /J_6VOQ
M/_X(1:M_:/[$7@&'=N^Q:3:1'G.#@?ET_'@U^V%?V9PW+GR/+)=\)2_"*7Z'
M_,OXTT/JWBIQU1M;EX@QSM:WQU.?;_MZX4445[9^7A1110 4444 %%%% !7\
M-_\ P<ZKGXF> #_TTO!_X[-^O-?W(5_#9_P<[OM^)WP_7^])>8^H2?\ ^MZU
M^>>)_P#R2F*_Z^T/_3B/[%^@M_RD#P__ -B[-?\ U&9_**OWS_N+7V=_P3[_
M .3OO@N>X\66'Z./\:^,4/S9]0!^72OLO_@GV_\ QF!\%AZ^+; ?^1!_]:OY
MBREO^U,%V^L8?_P+VL/U^X_W4\06EP)Q4WM_8>;N_DL#6?Y-KY]C_56\"'_B
MC?#?_8)M/_1==97)^!>/!WAP>FDVO_H%=97]N47>C2?>G3_])1_RY9B[YACF
MMGC,3;_P=,****T.,**** "BBB@#\$O^#A/_ ),NOO\ KYNO_125_G)VI_T.
M#W*_U-?Z-G_!PG_R9=??]?-U_P"BDK_.2M.;6$>@!_'_ ":_FKQ=_P"1]3NK
M_N*/_IM'^WW[.QV\),;YYQF"_P#+B'Y;^AI1C-YI@]=0@_\ 0A7^HE_P22&/
MV*?@\/\ J6+3^0K_ "[%.+K33V^WPG]17^HC_P $D&W?L3_!UO7PQ:?R%=?@
M[_R,,5_UYJ?^G*1\U^TE=^#>'FMO[7PMO_"6J?IQ1117]%'^,P4444 %%%%
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MIV"BBB@ HHHH *^8_P!L6T^V?LX?%F+&?^**U\_^4^;^76OIRO OVHK?[3\
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M+/3;XZT0C_OXW\Z^6OX\C^)>?PS7U!^PW(%_;#^!?(Y\=:(/_(K"OYBR2_\
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M4UMU;J(_MJ0850.@4#\@!3J**_K4_P">(**** "BBB@ HHHH **** "BBB@
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M-Z-5_M#]CK3X-V[[&MK"!_P'_/\ D9K]_*_F\_X-M]4^V_LIZM#NW?9KZUC
M[#Y<'\>O?M7](=?V%PC/GX<RI_\ 4,E]TI(_YO/I$T/J_C/Q]32LO[:G)?\
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MO<CFJ\0_TK3!_>U.Q'XM>1?XXK^*\5:IF<NM\133?_;\;?G_ , _Z<LC@Z'
MU%;>QRBM->35*#3T]/G8_;O]N#P*N@_L1? _7!#L-_-:Y<*!D&T1AR>^/<_3
MBOPZ!_<(QXR<'\>G^-?TT?\ !33PXNF_\$XOV;;H1@&4:?)N(Z[K&,\\'(S]
M.*_F7QFT3Z _D,5[_%^%^K8^A"VGU;"M_P#;U&#[+^O1GY5]'7-YYSPCFU>4
MG)PSW/::;U_A9C.*5_EO?8]7^!EQ]E^.OP?NLX$7C71FS[+,#7^LC^SA=?;?
M@C\.KG.?.\.6+YZYS&.<C_.:_P E/X9S_9/B=\-;OIY'BK2Y,^FV0$?3D?XU
M_K#?L?WGV_\ 9L^$EWG/G>$M/?/UC]J_2?!N;C+,J/:E%V]*L=?Q\C^&?VE5
M#_:^"\59VE.I"_=RPO,_R_#[_I2BBBOW<_RH"BBB@ HHHH **** "O\ /!_X
M.+;GS?VL;6')/EM= <^TG0?Y[5_H?5_G0_\ !PU<>=^V%=1YSY,UP#[962OS
M+Q6E;AI+^;%4U]VJ^ZQ_<OT *;GXW2FE_"R'%R^4JE*#_"7_  #\#E!_='L0
M<_AT_P BI'?<8SW)QS[=\4L2[D!_N _F1Z?B*@'WXQZ$X'H">*_E[I;OK]W,
M?[P1^R_.,';NUAV[_>_6Y,S%C&??!]L8K].?^"05_P#8?V[/@[\VW[1XFTR,
M]LY9O\\^I]:_,>)"V<_PDG]1_+M]/R_03_@EM?\ V#]N/X'R[MH/B_3 3_P,
M_P!?3GFO:X;DX9]E<_\ J*HO[ZU-?U^A^7^-5%XGPFX[H6O?A[,$EYQRZL_E
MM_5S_5$0Y52.X%.JEILOGV%I,.DD*-^8J[7]IIW2?=)_@?\ ,9)<LI1_EDU]
MSL%%%%,D"<<U_G%?\'#&J&X_;^\;VH;(M$LBH],PS^^.GXU_HXRMMBE8]%C=
MOR4FO\U+_@O??&__ ."A?Q-8,6VBP &01PDPZ^WU_7-?E_BS/DX;I+^?'TE]
MU.J?WA^SVPOM_&K'U+-^QX5QK]'+'Y=%6TWLVOG8_%U,D/Z]?Q/%2Q29A=>O
M7OW.?;N>,TZ"/.X=R.W\NGXFHHE(9E'<E>?Q/M7\QRM:3]-?*T7^I_N<G*+H
MIZ)1F_N32V^7IY"1'A_92:_4?_@D'-Y7[:GPW;INO]-7_OJXD_6ORX"E=ZXQ
MD8Y_6OTQ_P""34WV?]L[X7G) ;6-+C_.X?'\Z]?AZ26>98UHOKF'>W]^!^=^
M+T)5/"GCF#OKPUFGXT)RT_3\]#_48LCFSM3ZP1?^@+5FJMB<V5H?^G>'_P!%
MK5JO[46R]%^1_P Q$])S7:<OS84444R HHHH *0G )]*6JUY)Y5K/)_<C9OT
MH;MJ5"/-.,?YI1C][2/A+]M+QQ%X?\'[A.$82@?> / ';J/I^@K\ZOV>/B^E
M_P"/K2![K(:\B7&_/!E ]>GZ=.*Y+_@I1\>X]-%[HHO0K0W+ IY@XP%[9Z<]
MN_8]*_*/]GG]H!;'X@6$K7H4&^A/^L _Y:+WW<]0<'/'K7YSF.=0CFO(IZ)N
M+3:6JE#S7XVZG]W>'OAG6K^&.)KU*#=6O@J]6DW#5\R7(]M.GX;-G]O^C7BW
MNGVDR'<'@B;/U13U'!Z_SK5KP/\ 9U\6KXQ^'>C:LLOFB6SA.\'(/R)T/U.?
MQKWROT##U%5HTYQVE%?UU/X@S;!5,NS'%X*JK5,/6E"2M:S7D%%%%;'G!111
M0 5XU^T+!]H^"/Q0C_O>"]>&/7-C*/Y9KV6O+?C;%Y_PB^(T6/O^$-;7\[*6
ML<0KX>NN]&I_Z0ST\EFZ><95-:..98*7W8FD?Y*/QOM_LWQG^(L&,;?$.I<$
M8P3=SD<5Y@F28VQU# _4=_QQVKV_]I6U^Q?M!?$^WQC9XBO^,8ZW4YKQ6),I
MG^YN_7_]8K^)\UAR9CBX[?O9O[K_ .1_U#< UO:\'\.UGO/ X5IO7?V#_)O2
M_7?4_HP_X-IM3-M^U!XOL\X^U_8UVYZA1#^?^>:_T&J_SMO^#<*Y,/[7^HPY
MQYKVHQZD"+^OMT)]Z_T2:_IGPQ=^&J:_EK27WQB_U/\ #/Z=%)T_&S%3_P"?
MN64'_P" 5JU/\HA1117Z*?QD><?%^7R?AAXYESCR_#FHOGI]V+-?Y/?[6MR;
MK]J#XSW&<EO%NH<_]M&__5_6O]7'X\3>1\&_B3-_SS\)ZJ_Y0FO\G3]I&?[5
M^T'\6[GKYGBC4#GKG]ZW]<^I]37XGXQR:PN71\Y27_@<4]/ZW/\ 4']FO0YN
M(N,:]M(PPM-O_N%.:_%'B$8,DB(/XGX'X\^GTK8U*%K=1&P(PHZ^X_3G\*9X
M>M/MNM:?;8R9;B- .QW.H/O^5>C?%K0&T'5+>VV;/-BC;&,9^0-^0_'FOP1T
M_P!TYVTC.-_O3_KR]#_6Z.+A#,:>'D_?JX>MR+KM"_KI+]?,\CBR8)!CM_//
M^%?U^_\ !K-J0.N_%FPW8V:=:X7ZR+_G/N1S7\A5O'D2*1U4\?0'GCZFOZM_
M^#7/4?(^)GQ8LRV/,TZT&#_OKQC.?_UG'/7[GPWJ*'%&":>DJCCVWIROT[G\
ML_36PLJ_@/Q,K/\ <X.E4;2U7+CL+K_7XG]RU%%%?U<?\^P5Y1\=)/*^#OQ(
MD)QL\(ZPV?I:N:]7KQ;]HJ;R/@?\49.FWP9K9Y]K1ZY\6[83$O:V'K?^FY'J
M9)#VF=91#^?,\!'[\521_E'?M+W7VCX__%2;.?,\27QY.>D\H_.O!96PF1SE
M6_3(KU_X]2?:?C;\1Y\YW^(+_GZW,HS[_P#ZJ\@GYC/LK#\P?_K5_$^,=\;7
M>MG75_646O+S1_U!<%4I4>#,@I[<F5T%VM:%%?DFK=//8_M9_P"#5^SV>"_C
M-=E?]<-*&<=<-;C/_P!?IGI7]?=?R6?\&MEKY7PL^*<^/]<NG\X[A[?\!_.O
MZTZ_K'@2/)PMEB[PJ2^^K)G_ #[_ $LJKJ^/7'+>KCB<#"_^'+<)']-/*P44
M45]>?SB%%%% !7Y[_P#!4#4CI?['/Q4NMVS_ (DUY'GI]^SN%Q^O3O7Z$5^8
M7_!7V]^P_L.?%:?.W_063.2/O6\XQ^)KS,ZERY3F,NV#KO\ \D9]SX9TU6\0
MN"Z3VJ<293'[\921_EVN^=7\12@G]YK>JL/^!7\QY^N>U7M.&[7?#J=I=:TY
M/KNO(%_.LQ/FN-6<_P#+35=0;WYO)3P?QR/>MK1U#^*/"4>/O>(-' 'UU"W'
M/^?K7\8S7-FDEWKZ_+E_!+]3_IBPM\/P3"ILX9+1MTLVW)-=-;KR^]G[$?\
M!4[P6/"?P_\ @3=K#Y9O_#NARD[=N3)I\+9&._([_C7XNNQW*>>5!QZCIS7]
M&7_!;O0!IOP7_9@NE39]H\,>'1N QG_B5V[5_.=(/N'T0 _Y]Z]_BZBJ&;\J
MT7LZ;MV;IP:TZ='Y?<?D_P!'7,ZF;^'RQDI.4OK^-IWO?2GC*L6_PM^9]??L
M!7YT[]LKX&S[MN_QKH29SC.9GR/?_P"O^7^KGX3F\_PYI$W_ #TLH6_\=]J_
MR8?V.+HV/[5_P,N@<;?'6AY/.>)7_P ]>37^L1\-I_M/@3PO/U\W2K=^N>H/
M>OUSP>G_ +!CX/=RH5+;Z<KC?^O*_G_G?^TBPW)Q9P;B+?%@LQIW]:U*:_*^
M_GW.XHHHK]F/\S HHHH **** "BBB@ K_-8_X+UN3^VSXO'_ %$IA_Z%GM^%
M?Z4]?YK'_!>Q,?MN>+!_>U&8_A\WMW_G7Y?XKIOA^AY8R+^Z$C^\?V?3MXPY
MEY\.54K]WBZ!^*Y'#=<J5]NN"1^OZ5^Q_P#P0N_Y/Y^&_P#U^2_^@05^.@7<
M[*.K%3^0%?LA_P $*DW_ +?WPW3'_+[+C_OB"OP#A5WXARRV_P!8I+?^_32_
M)6['^MGTB)<O@UXA+^7AW,G]V%Q?Z<O0_P!+2V_X]X/^N2?^@BIZB@XAB'HB
MC]*EK^S8_#'_  K\C_FDE\4O\3_,****HD**** "BBB@#SOXL_\ )./&/_8O
MZK_Z0SU_DP?M,/N_:&^+(/?QOXA_].5P*_UG?BV2/AOXQ(_Z &J_^D-Q7^3'
M^TRNS]H7XL$YS_PFWB _GJ5P>.!7XAXR?[OEGKB/_<)_J9^S5?\ PJ\>+LLJ
M;].:M^B9X<V=F?\ :*_S_P _A7]C/_!K,?\ 1?B,/2_U'_VY_P *_CH8'RO^
M!D_SK^Q?_@UG&+7XBGUO]1_+_2:^#\,?^2HPG_;]ON7Z7/ZR^G*FO K/_-4F
M_P#P*'_ /[.J***_JL_P!/Y$?^#H7Q3]E\$?#_P^LF!?0RNR9Z[)&_A]L_6O
MXFI#M>->VU<?B >?ZU_6M_P<^^*/MWC+X;Z&LN1;P78*9Z?,Y[]#_B.U?R7L
MFZ8<<87] .>/QK^6O$BM[3B/&2O?V<Z<5OIRPIIVOV;?>WW'^_OT(\MEE_@/
MP\^7EEB5/$3TW=3%XJ::_P"W8PUN-F8HDY_Z9@_F#_\ 6_'O7]>__!K_ .%/
M-OO'&O-%_P NPP^W/23UQ]._3D&OY!K_ .6VD;IG:N!ZY(QU['./;ITK^Y;_
M (-D_"/]G_"+7]>:+;]M61-^W[V&S][\?_UYKI\+Z?M>)'*VD.>7_@,8_CK9
M_.YY/T[LT6$\&\RH\UG74:45W=3&4^^EW&%MO\E_5W1117].'^# 4444 %%%
M% !7\$7_  <W?\G">&O]^/\ ]%U_>[7\$7_!S=_R<)X:_P!^/_T77P'B3_R3
M-?\ Z^T__;C^O?H1?\GUR?\ [ ,1_P"I.#/YCSUB^H_E7TI^Q$^/VQO@/VS\
M0-$'_D5Q7S6>3'[8/X8KZ5_8A0G]L;X$'^[X_P!$;_R*V?\ #_\ 57\Q9$_^
M%+!]_;4?_3M/]-_T/]T/%*_^I'$G\O\ 9N-O_P"&ZM?\?U/]8WP-_P BEH'_
M &#H/_0:ZNN4\#?\BEH'_8.@_P#0:ZNO[8H_PJ7_ %[A_P"DH_Y?\R_Y&&._
M["\1_P"G9A1116AQ!1110!_/W_P</''['MR?1KO_ -!K_.NM3_H<9_V ?T%?
MZ*/_  </?\F>W ]6NQ_X[7^==:_\><8_V0/Y5_,WBVK\0TUWI4%]\8'^X_[.
M[_DT&)?19GF7_@7M_P#AOZN/FS]F/^[G/X9/XX-20'$$9]%S_.IQ%YEJXQDC
M('Y#'K_AQSSS4*?+$!Z#'XGU_.OREW]FO*LT_E;_ (&Q_?D)7Q<T]E@8JS[W
MB_Q'!LR(?49_7G-?>_\ P2RUP^'OVYOA9=;O+\S45BSG&=]Q;KUXSUZ9-? L
M?WX\]OE/U)KZC_8GU8>'OVM_A1J&\Q@:_IT>[/\ STO[5?PX]:]WAJK[/.L#
M-[1J07S4TT_Z[:'Y9XV8+Z]X8<2X6W-S8*JM5TGA_9O\VO7TT_UE/#\OG:#H
MLHY\S2=.?/\ O6<+9_'.:UZY'P#<?:O!/A2XSGS?#VC/GKG=IUL>O'K775_9
M]-WA!]X1?WI'_,OBX>RQ6(I_R5ZL?G&<DPHHHJSG/Y?O^#GQMO[)WA+W\<6@
M^O[N"OX)[3_CTA/< #\\?TK^]G_@Y[4O^R=X3'IXWM3^4<%?P46@_P!#AX_N
MFOY>\5?^2DKW_DP__IIG^[_T DWX)9=;IC,V?7IC*5OUTWM?O8[KX7\?%CX=
M#M_PF&B#Z#[=":_UC/V1AC]GKX9CT\.V'_I+#7^3G\+^?BO\.CC_ )F_1&^H
M^W0__7K_ %B_V16W?L\_#,^OAVP/_DK#7UG@Y_S,O\%/\S^??VD_-_QA/;ZU
MC?O=*/Z'TE1117[J?Y1!1110!^</_!5FZ^R_L4?&QLXW^"M:7/UAC]?6O\LN
M-]TLC]RQ;],_UXK_ %#O^"OMW]E_8D^+G./.\+:O%Z9S#%7^77;'Y2?J/S&/
MYU_.?C%)_P!L8!=(X-_>ZD7_ %T/]H?V;E)1\..*ZEM:W$D->K4,)RO\/\NI
M<+X?=ZHQ/^17]F?_  :WZ3YF@?%W5"F=FK60#X]5C'7]>W4]J_C&;.P^HC8'
M\0:_N$_X-==*\CX3_%:\*\S:K8MG'4@1]^?Y]J^?\,(<_%6"TNHJLWIVI2?Z
M?\-N?KWTY\0\/X <2).SG5RVDNCM4S#!PDON;7<_K.HHHK^K#_  **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH _P ;
M \;\?P8/Y]/TIK#AAZ*&_/\ PIS?\M?]H#'X<?\ UZ1OXO= /Q'6OX0C]GO=
M7_#_ (/X'_6-)[VV]Z_WSMOY<I_;-_P;"_\ (E^,?^N<_P#Z%)7]=5?R+_\
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M-9;Y4YQ^ZI(_YT/I14/J_CAQQ&UN?'4*G_@6"PU_Q3[^K"BBBOJC^?@HHHH
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MX5+_ *]P_P#24?\ +_C],=C%VQ>(7W5IA1116AR!1110 4444 ?@E_P<)_\
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M'$5N5!X!F/\ /M_+_&K5FV)HQWR?PK7U"R-L;:7&-\H;IV/?I7\Y2UI5&O\
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MMOQ'ZO>7!].!NY_^O_D?Z35?YM'_  7S?=^VUXA_V;RY'_H7^?PK\O\ %?\
MY)VG_P!A2_\ 2)']W_L^KOQDQJ[Y"_\ U-P_Z7Z_\#\4K<;KF-<?>!Z?2OV3
M_P""$*[O^"@WPV7UO;C]$@/]*_&RV;;=PGV:OV4_X(/G'_!0?X:G_I]N/_1<
M-?S_ ,'+_C)\I3U3Q.%T_P"XT4U_7F?ZU?2-?_&F_$E+[/#>9)?^$&(?YL_T
MKD^XO^ZO\A3J:IRJG_9'\J=7]GK9>B/^:=WN[]PHHHIB"BBB@ HHHH \W^+I
M_P"+;^,?^P#JGZV-P*_R;_VHU\O]H;XL_P#8Y:^?_*C.>>/>O]9#XN_\DV\8
M_P#8!U/_ -(IZ_R<_P!J@Y_:'^+('_0X:[_Z<9N/S%?A_C*_]GROSG7_ /<+
M/]2/V:C_ .%KCY7WH979:[WQ6_X?B>#D?NS_ +I/]?\ ZU?V)?\ !K1_Q[_$
M3WO-1/ZW']*_CM)Q&<?W<?IC^=?V*?\ !K5_Q[_$+_KZU#^=S7P'A??_ %JP
MOK+_ -)T/Z^^G0E_Q 3/VND</^-6E^EC^SBD)P":6H+I_+MIY/[D;M^0S7]7
MG_/W%<THQ_FDE][L?Y_?_!R!XH_M3]I'0]'$FX6(NEV9R ,R=NGO_P#K.?YR
MH4#2Q^I4_H ?Y?E]:_:S_@O7XF_MW]LS5K<2[UL+JXC(SG&0_7D\XS_2OQ5M
MFQ(I]%8?R K^0N.J_M<XS22=W[:NEZQJ4XJW]?J?]('T7<NCEW@IPE0Y;7R?
M!U+)6]Z>%C4?XS;Z[W\S/U0?\2^-AGYYU7'KF0 ?7ICZ]>E?Z&O_  ;M^$O[
M'_8^TG6#$4:^N)QN(^]P#UQGO7^>=> R0Z9!DDRZA @ ']^Y08^O-?Z9O_!$
MOPK_ ,(O^P_X!@,?EM<*+@_+@GS858''X\'TKZWP=IN>:XFJ_LTJ[6BZR@E^
M&GK?H?RY^T2S*6&\/,IP7,D\9FN#@XWWC&.(JR5NMFX_@^A^OM%%%?T@?XP!
M1110 4444 %?P0?\'-O_ "<)X;_WX_\ T%J_O?K^"#_@YM_Y.$\-_P"_'_Z"
MU? >)/\ R3-?_K[3_P#;C^O?H1?\GUR?_L Q'_J3@S^9/.9,?W5!_/-?4/[#
M2[OVP_@9[>.M$(^OFM7R]TD)]5'Z9KZD_87/_&8WP*7^]XZT1?SD:OYBR2_]
MK8/M[6G_ .G8?\ _W2\4/^2"XD[_ -GYA;?;ZE73_ _U>_ O_(HZ!_V#;?\
M]!KK*Y;P2-OA30EQC&G0>O\ =KJ:_MBC_"I?]>X?^DH_Y?<Q_P"1ACO^PO$?
M^G9!1116AQ!1110!_/Q_P</'_C$&0>KW7\E_^O7^=E:_\>\(Z\@?H:_T3/\
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MSZBOQGQCDO[.RZ'5U:TK=[>R_*Y_I;^S=PKJ<9\88JWNTL+E<&^GO2Q<K?\
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M8?ZOXZ<5)*WM?JM2W_<)0O\ ^2_@%%%%?9'\P!1110 4444 %%%% !7\+_\
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MWGB'\J_U#])_Y!6F?]@^R_\ 2:.O\NW_ ()!''[>7PQ_Z[,/_(T=?ZB6D_\
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M01TSA(_Y=:_TKAT'T%?YD?\ P0YO?L'_  4*^%0SM\_4Y!UP.4BZC_/OBO\
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MXBW6?.ZVH81_=A:#_,_F[Z&%1/PDH*+5EF^?)^O]LXV+^[I;R[G5^ KHV7Q
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M2#_A7\U^+S?]O45_U!TK+YH_VW_9TQMX2YE/OQ%CK_="/Y?GY()S^Z]F7/\
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M.,\)QZ=Q7SO!TN7/LLEVQ.&_&M31^R_2.HJMX0\<4]V\BS9K_MW+*TW9>O\
MGL?Z<-%,C;=&C#H5!I]?V6?\TSTT[!7YP?\ !52\^Q_L=?$Y\X\S0M3B/;A[
M0_\ Z_YU^C]?EW_P5ZN3;?L8_$-LXW:?>I]=UL:\S.I..4YC);K"5O\ TAGW
MGA=#VGB+P5#^;B/*U_Y<P9_E]W@_T[43S_R$;SMZW,F#_*J<PRN/22,'V)8?
MY_&KMT1]HOB/XKZYYY[7#\?Y_.J_5P/[US"OYNH_E7\75/XU)]7)-W[^T/\
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MQ8_Y)UXP_P"P!JG_ *13U_DV_M3J%_:)^+7I_P )CKI_'^T)P?K7^LE\6/\
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MO\[*#_CWA/HRFOYE\7/^2B@O^H:D_FHK_@'^X_[.W_DSN+?7^V<>EZ>WC?\
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M[_[/^-O!3+O/,,R?_@6-H_E_5SO/A@,_%CX=Y''_  E>BG\KV+^1Q7^L%^R
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ML/\ KQ1_]-Q1_MY^SM?_ !J7%>>=9@O_ "LG^:5B[NQ/IS>E]"?U&:_U$O\
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M_P#2:*O\N3_@D9_R??\ ##_KX/\ Z/BK_4;T?_D$Z7_V#K+_ -)HJ_9_"/\
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M"=K_ /<)=CZ^HHHK]O/\NPHHHH *9(,HP]1C\Z?0>01ZT#3LT^S3_$_S1/\
M@NU8_8_VZ_'<F,"XU*5B?7 <YQ@=_P#/2OQNC<F5>>01].#_ #S_ #K]OO\
M@O\ 6@MOVVO$$NW'GW4YSZX#C^9__57X<Q$B0'_/^<XK^-N+(VSS-8V:OC*[
MUOTJU/QM8_Z3/HU8IU?![@&>NN1Y9!O7:.&H1_)_=UW/O;_@FE=_9OV\/@=/
MG'_$[ STZM .W?.*_P!3_P *OYGAO0W_ +^EV;?G"AK_ "G/^">MU]F_;5^"
M-QG&W7HP3T)!E@'KUR?RK_5:\$/YG@_PT_7=HNG-^=M'7[+X.6648N*Z58.W
MRM^A_FM^T?I\O'_#,NV6UZ?_ )/&;\K+F.HHHHK]D/\ -L_(S_@M7J?]F?L2
M>.WSM-Q:WUOUQG?;IQ^-?YD_F;H1S_RTE^N3*Q_KQ^E?Z37_  7FOS9?L0>(
MMIQYU[+$?^!6Z?S_ ,>*_P UN$Y@_P"VS_\ HPFOYU\8I?\ "G@HWVPZT^:?
MY?/<_P!I/V<&'Y/#O/<1;^)G&+5]/L^RBET_F[]SZV_88&?VJ_A,.<CQ+I(_
M/4;<_P!*_7;_ (.-%V_''X3OTSH-J#_X+5['VZ5^2'[",9F_:S^%" 9QXBTD
M_P#D_;8_SVZU^OG_  <>0E?C3\(F_O:%;_CC35_#_/<U\_E7_)$9SU7UK!_^
M3*M_F?I/'DE_Q-AX?IOX.',Z:M_<J9=9>7P_E;:Q_.:Y^8^P'X#U_.OTW_X(
MV:@;/]O?X3G."^N1 ]O[G\_YX]Z_,<YQ(/\ 80?SK]!_^"3%V;+]O'X/MG&_
M7X?K_P L_P"O7^745\SPL^3.,OEVQ.%_"O1?Z_@S][\=J?M_#3BRETJ9'G47
M_P"&W&12?W+TV['^I[8/YEE:O_>@C;ICJH-6ZR=!?S-&TQ^NZSA;/U05K5_9
MT7>,7_=7Y'_,W67+5JQ_EJ3C]TF@K\GO^"S,_P!G_8I\>-G&;>Z7//>W]O\
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M/Q%?1/['-I]M_:>^%5OC.?$-D<?]O$!.?3D=O4U\XG($A]1'C\AG _&OK?\
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M'ZG[LT445_2!_B@%%%% !1110 4444 %?YL7_!>U]_[;/BE>NR_N5_1O\_\
MU\U_I.U_FM?\%Y2W_#;OBW/_ $$;C'Y'K_GUK\M\6?\ DG:/_89'_P!(D?WI
M^SU_Y/-C_P#LGJB^;Q=&WXGXN2/^ZA&?ND_J>/>OV,_X(5_\G\?#H^EW)_Z+
MAK\;7R1(.X*X_,'CWP:_97_@A0,_M\?#H?\ 3W)_Z+A%?@O"=_\ 6/*'_P!1
MF'7S]K1N?ZV?2!27@UX@P>RX<S>7_ECC>W7W5^!_I9V_^HA_ZYI_(5-4-O\
MZB'_ *YI_(5-7]EK9>B_(_YH9_'+_%+\V%%%%,D**** "BBB@#SOXL''PY\8
MG_J7]5_](9Z_R9OVGG+_ +0WQ;/7/C;Q O?MJ,_Z\5_K,_%D_P#%N/&/_8OZ
MK_Z0SU_DO_M+$_\ #0WQ9Z_\COXA_P#3G/7XAXR?[OEGKB/_ '"?ZF?LU?\
MD:<>+NLK7WNJCQ%CP?R_S_GUK^Q;_@UFYB^(Q_Z>]1'Y&Y_P_6OXZ6_U>>_F
M$?SK^Q?_ (-9?]1\1O\ K]U/_P!N:^#\,/\ DJ,)Z2_0_K'Z<[;\"<^3[T9?
M?.'3Y?<?V=U^8'_!7/Q9_P (C^QI\1;[S/*,^GW5GG.W(FM77'ORWK7Z?U^$
MO_!P#XM'A_\ 8D\2VR2[)KN\A0#)&5=&4CWSG]*_I/B"K['),TJ;<N"KVUMJ
MXM+\S_$WP<P']I^*/ V#Y>95>(LMYE_=C7C)OY6/\XLRF6^UBX[SZE>OGO\
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M_F7Q<_Y*"%MW1HK_ ,EC_F?[C_L[E;P@Q*_ZF>8S?RKZ?@CZ^_8(F\O]L_\
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MK_2U_P""+>EB#]A3P_ 1@3Q,Q!'!W6C\C\?\Y%<OA#3]IF^/;Z8":]>>UO\
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M^&?^P1:?^@5U]?VQ1_A4O^O</_24?\O^/_W[&_\ 87B?_3TPHHHK0Y HHHH
M**** /P2_P"#A/\ Y,NOO^OFZ_\ 125_G-V"?\2]&QU 4'']?Q]:_P!&3_@X
M3_Y,NOO^OFZ_]%)7^='I_P#R"(SWW@?RK^9_&&7+GM%]Z>'3^<(G^WO[.M7\
M*,0O^IYC_P#T\K_@,VYGTY?6^A'ZC-?ZB7_!(Q=G[$?P;3T\,6G\E']*_P O
M*/F\TSM_Q,(.?^!"O]1+_@DF,?L4_!X#_H6+3^0KN\'7?,,4^]&I_P"G*1\W
M^TETX,X=7;-\*O\ RTJ]3]-:***_HH_QF"BBB@ HHHH _P [K_@Y"7/[9&@@
M]/\ A'\_^1H\?US[U_/] F^5EQVW<>P_^O7] G_!R#_R>3H'_8N$X^DT>/RK
M\ K,9N<=1Y3_ ,B<?Y].U?QYQJ[\49FNV+K?ARV_X)_T??1;BH>!G!$EURC+
MUIZ2^_?>[OJ?HS_P2'7?^WG\,AZ7#_\ HZ(\5_J*Z1QI.ECTTZR_])HJ_P O
M/_@C\N?V^/AJ.PN)/TFAK_4-TG_D%:9_V#[/_P!)HZ_:?"*5\CQ,>V(BU\X*
M_P"1_FA^T5=_$S(/^Q5B?_3\#0HHHK]:/\\ HHHH **** "OY /^#IK4?+\#
M?#&Q#8^T177![D23'I_G ^M?U_U_&'_P=1ZCBW^#=@&/[R*_RH/H\O;OQ_G/
M3X[CR?)PUCNSE0C]]>FOU_7H?TI]$K#?6O'+A.+5_9QS*K_X!E^(DOQ2_0_C
MJ1=L,(_NHOYE0?\ /Z5]$?L@6?V[]J#X1VN,[_$EH<<_\_$1Q^'OQZU\^2C$
M*#TCB_D/\:^K/V#[7[?^V'\&;7&=_B.WX]?WL9Z?Y]:_EC*%?.</'?\ VN,?
M7]['MZG^^GB>U0X!XADM/99+5DO+DPSW_P#!:V_X)_?Y_P %.])-Q_P3,\1I
MLS]C^&5L<8Z8M(P?\C'X5_FE6J^6LJ=Q,Q_(D?Y_6O\ 4!_X*/:7]H_X)N?$
M>#;DV_PR08QT*VR?_7_SS7^80Z>7<7T9X*2R#\0>/QR*_3?%N#CC,NE9WE@:
M*Z_9=MO7\S^&OV=^*]MPQQM3<K^RXKQLE?M6I1J?IJ_Z;E *S+W,9./7_P#7
MBO[C?^#835?-^"WCVQ+Y*>)&^7/HD@Z?XU_#K",EL_Q6_P!><=?TK^T3_@UY
MU/=X*^(=ANS_ ,5!,P&3GA7.?ICGMUQ[U\]X75.3BS#1_GA-=?Y%Y>?];GZW
M].[!K$?1^SFJE=X?&8*:^6*IO[M=.U[.[T/[!J***_JP_P  0HHHH **** "
MBBB@#'\0'&AZJ?2QN#^49K_+E_X*R2^?^W'\8.^W7)!@\XY?IW&>G-?ZB_B5
MMOA_66]-.NC^435_EJ?\%2YO/_;C^-#9R!K\F/SD(Z?RK\<\8I6RG+U>U\5+
MOTA_P3_23]FY157Q"XLDU\.2T%?KKC*+_3_@=3\]9?E@QCHR'\ 3_C7]-]YI
MOVC_ ((<^&KP+GR5U0\@<9G_ ,X_SG^9&X_U1^J_SK^JC3[);C_@@O87&,^3
M%J1!QG'^D#G/M^O\ORO@I<]'B'^[E.*E\E[*W]?\$_OOZ359X?-/!^U[3\0\
MCH/7I4CB8VOK>_\ PQ_*S8C?$/\ 8&35RQ'^D ]-LL3>G D'Z5#I@!CGSV4?
M^A5:L>))3Z",_DPKX>#_ '\E_+*'X\CM_P"3G]--_P"PU)>2A_Y3C\_ZL?Z?
M?_!(>\^V?L7_  U;.?*T;3(_7&+=^#Z'V[<5^H5?DC_P1;OA??L4^!B#GR;6
MRBZYQMMW^N.E?K=7]J\.RY\BRF7? T/_ $A(_P"9'QDH_5_%3CZC:W)Q/FG2
MWQ8B4OU"BBBO:/S0^./V][O[%^RS\5)\[<>'M0&?]ZPNQ_6O\H[Q.<^,/%K#
MG?XDUMOKG4[DC^=?ZI/_  4GO/L/['_Q8N,XVZ+<+GI]^TNEQ^.<?2O\K'Q
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MK6O[#.,I=^MYXSD?=K:UGT^\_I>HHHK^EC_#@**** "BBB@ HHHH *_S8_\
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MV_>S-=J=/\T?@'[2F"]CP1/J\5B_QP]-_K_6M_IFBBBOW<_R<"BBB@#\-_\
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MW'_[]C?^PO$_^GIA1116AR!1110 4444 ?@E_P '"?\ R9=??]?-U_Z*2O\
M.?T]_P#B61KV!!_D:_T8/^#A/_DRZ^_Z^;K_ -%)7^<K8,?LJ+_TS!_G[5_-
M/B_'FSVEY4:#^Z$3_;S]G:[>$^(?;/,>_NK)EU6Q<Z:W3_3X3^HK_42_X)'M
MO_8F^#C=<^&+3W[#_P"M7^7020]@3U%Y%T]B*_U$?^"0YS^P_P#!D_\ 4L6O
M\DKL\'?^1CB_^O-3_P!.4CYO]I&[\%\./OFV$?WX2J?I]1117]%'^,X4444
M%%%% '^=Y_P<A$?\-D:#[>'L9_[;19_6OY_[9MLY.?X&'7'49_Q__57[^?\
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M#S_^#?#5G/(BM=1(&/\ IXK\OX*NJ?$:7_0EQE_NI/\  _N+Z4\K8CP<K?\
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ML:^,PR_VJA+MB:<OOG![G]09Y)SR/,]_WV4XN#T[4)+KZ_Y[Z?ZQ/[+$GF_
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ME\<>"%Q][Q1H:GOUU2V']2*_CW#W>)I+_IZOS7^1_P!'N;2_X1\9+J\N</\
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M$VH_9?V(_$]J&P;J*$;>YVRW'3OWY_#@U_G86Z;(8LY&')Y[[CGK]*_T$_\
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MAN_X.=DW?$WP ?22\'3IE9^?\XK\\\3_ /DE,5_U]H?^G$?V+]!;_E('(/\
ML79K^&';_-'\H"#[@]#N_'%?8/[ <>?VO?@OQPOC"P/M_K#^O3O7R"OWR/10
M?Q/6OLK_ ()_IG]KKX-=O^*LT\_G)S^/]*_F+*7_ ,*F 7_45AG_ .5Z9_NC
MXB0MP%Q6^JR#.%KVCEU9?+X;>NA_JJ^ O^1,\-?]@FU_] KKJY#P!_R)?AG_
M +!%I_Z!77U_;E'^%2_Z]P_])1_RZ8__ '[&_P#87B?_ $],****T.0****
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M7_G_ .O7W$>01Z\5\C?L)6WV3]DWX)P8P$\%:8,8Z?N^G_UJ^N:_5LK7+EN
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M4O\ KW#_ -)1_P NN/\ ]^QO_87B?_3TPHHHK0Y HHHH **** /P2_X.$_\
MDRZ^_P"OFZ_]%)7^<QII'E6G7*LK?E_G-?Z,_P#P<)_\F77W_7S=?^BDK_.4
MT\XAB]D#?X_TK^:_%S_D?TO*C0_]-Q7ZG^WG[.[_ )-'C5;XLWS&/_E5/]#5
MF<?VG8'UU"$C\')K_4-_X))'=^Q1\'3Z^&+3^0K_ "Y9'/VW3V_Z?(F_\>&/
M3^E?ZBG_  2*;=^Q#\&CZ^&+3_T%*Z_!]6S'%>=";_\ *E,^8_:0._!/#OEG
M&%7_ ):57^I^GE%%%?T2?XU!1110 4444 ?YWW_!R"?^,QM!Q_T+I'_D:+_
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M>$:OI'Q4X'^5Z^)EL_3^NO\ $3=C;<72CM<RKZ\B0@_R-,NWS*,?\\%_,?\
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M?]1IUX,^GR./4^G\O2OQ_P#^""]@;W]N_P '';D1PW)Z9Y!0]/\ /Y5^V?\
MP=+6&_P!\&KK;_Q[V=RN[!R/]8H]AT__ %]*^FR&/_&N<\_OXC#67I5P\O\
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MM:&,<\738_' /Z5^B>,L+QRV5MXSCM_>[_\ ;Q_&7[-*OIQS1_Y]XK"5;?\
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M'_KFG\A4U?V8MEZ+\C_F@G\<O\4OS84444R0HHHH **** ///BQ_R3KQA_V
M-4_](IZ_R:OVI&+_ +0_Q<_['/7Q_P"5&8?TK_64^+/_ "3CQC_V+^J_^D,]
M?Y,7[33[_P!H;XM?]COXAY]O[2G%?A_C)KA\L_Q5_P '19_J;^S5_P"1IQYY
MQRQ??[9?J>($_>/JFW\A7]BW_!K2/W/Q#/\ T]:@/UN*_CG8G;GU)7\O\:_L
M<_X-;/\ CW^(?_7YJ/\ .XK\_P##6/-Q3@'VG?\ \!3_ ,[']:_3DE_QH7B)
M6^U0?WU:;_3[S^NCXRZB-)^&'C742VT6OA_492W3 2$MU_"O\HG]K?6CXB_:
ML^,FL%C(L_B:^8-G.?WC]#G![]OQK_4P_:\U?^Q/V=/BOJ._R_L_@S6Y V<8
M*VK&O\GCXB:J=>^*'Q$UDOO-UX@O7W]<_OY!G/\ GOBOTCQDK<N6X*C_ #SD
M[;;RA#]?ZV?\@?LV<N]IQ-Q%F'+_  I4X\UO^?>'G5T].7^MCD"VYUYS@']<
MFO;/V6]!/BK]J'X/Z*J>:3XDT]]F">(]1M'QC_/XUXA 23GW _45]Q?\$O?#
MA\6_M\_!_2S'YJIJOF%<9&8Y;5^1^']?6OQCAZ'MLYH4[7YE2C\Y2I0[+OVO
MJ?Z:^,F8+ >&V?8MNR=*K5^6&HRQ-VUV]AY)6]#_ %+_ (7V:V'PZ\$VBKM\
MCPMH,9&,8*:7:J1^&*[RL/PS!]F\.:#;XQY&D:=%CTV6D2_TK<K^S*:M3IKM
M"*^Z*1_S(8V;J8S%5'KSXBM*_?FJ2=_F%%%%6<P4444 %%%% !7\$'_!S;_R
M<)X;_P!^/_T%J_O?K^"+_@YN_P"3A/#7^_'_ .BZ^ \2?^29K_\ 7VG_ .W'
M]>_0B_Y/KD__ & 8C_U)P9_,CTDS_>4?IFOJ']AI]O[8?P,]_'.B@?7S&KY<
M/!C]\#],U]*_L0N1^V-\"!_>\?Z(O_D5L_X__KK^8LCUS3!R_P"GM+\:M.WY
MV/\ ='Q1=N!>)(=\NQS];X"O)?G^#['^L9X%_P"11T#_ +!MO_Z#765RG@;_
M )%+0/\ L'0?^@UU=?VQ1_A4O^O</_24?\OV9?\ (PQW_87B/_3LPHHHK0X@
MHHHH _GX_P"#AX?\8@R-Z/=?R7_Z]?YV-OS;0GI@AA^5?Z*/_!P]_P F>W!]
M&NS_ ..U_G76I_T.,_[ (_(5_,OBY_R4,'O^XHQ7SBO\S_<?]G;_ ,F?Q2[Y
MMF$]NBKI7^Z/]:'I_P &C_Q>GX5CM_PF6DG_ ,CU_?\ ?\%(]"_MS_@E+HL8
M3>;?PW;W&,9QY=H#G'/IUQQCUQ7^?]\%SGXU_"KKC_A+=)_]&Y_K7^C-^UWH
M8US_ ()=/ 4W_9_AU-<8QG'EV!.?PQ7;X=TE5X?XEANY8!Z>O*[_ )GRGTTL
M4\-XJ^">)3M[+B>B[KT@M?OU/\TRPX6X7_GG<SK^4SC'X5K6[?N+D9^\>/?
MS65;@I<:M'WCO[M<>F+F3I5N)L+@\;\\<]AT_.OR.NN7$XE?WY?DI?U^I_HQ
MDT_:Y+DL^V&P\K_X7"F>O? +4?[+^-?PVO@VWR?$FE_-R,9U&U[_ )'^=?ZP
MW[/NIC5O@[\/KT-N$GA70QGZ:;;<?A7^2#X O3I_CWP3> [?*\1:0V?3_B96
MW^?IFO\ 5W_8IU7^V?V</AI>[M^[PWI*YSG[NGVP_I7[EX,U+?VI2[PI2MVY
M9S_S1_E=^TMPG.^!,PM\-7'4&_\ KYAL#)+_ ,D^],^K:***_=S_ "</YA_^
M#F]MO[*7AGW\9VH_\AP?X5_!#;']Q ?2(C\\U_>M_P '/;%?V3O"9]?&]J/S
MC@K^">T_X](#[!?Y8_*OY=\5?^2EK/\ Z=T/QI?\ _W?^@&_^-)9;_V&YI_Y
M+C*3?Z,[[X5L1\5?ARO_ %-.C#_R>B)_E7^L%^Q\"O[.OPR!ZCP]9?\ I-#7
M^3U\+^/BO\.AG_F;]$7/_;]#G^M?ZQ?[(HV_L\_#-?3P[8#_ ,E8:^L\&UKF
M;[PI_FK?DS\!_:45+T^"(=L7B_72A"/Z6_K7Z2HHHK]V/\G@HHHH _'W_@MK
M:?:OV)_'7&?)L+^7IG@0Q<_R_P#UU_F6QG*$?]-"?R/-?Z?O_!8VR^V?L4?$
MX;<^3H.JR],XQ#%7^8&F<LO/RYS^'^-?S?XPJV>8-]\"G?TJ)?UZG^UO[-ZI
MS>%G$T/^??%#A_X,PL9V:[.Q8B/SL?5@?PZ'-?MA_P $'O%X\+_MFZ#F7RUN
MW>+[V =[1J.X]_\ ]5?B6IY4^JDG\/Y^M?H9_P $M_%I\)_M>?#RX$GEBXU:
MTC+9VY$EW"N,^_3WKXC@^NJ&>8">S6)I/[FMW^OD?U7](K ?VKX1<6X+EO[7
M*L;%*W6=#EVZWY['^IU9R>;9VDO7S+:!\^N^)6S^M6:P_#-T+OP_HEPIW>;I
M.G29X.=UG"V>/<\UN5_8T7>,7W2?X'_-75BX5:D'O&<H_=)H****9F%%%% !
M1110 4444 ?Q!?\ !T*?^*R^&P]+VX)]LI)_A7TA_P &PKY\(^,ES_R[R\>V
M3C^7Z^]?,O\ P="-GQM\/03]V]FX^JO_ )_"OI'_ (-@GSX7\9KZ6DGYY.?Y
M?YS7X5AY7\59N^\ZD;:Z?N8Z?B?ZN9W3Y?H X-?]0N$J>M\P4?S[']>U%%%?
MNI_E&%?-W[6__)OGQ0_[%#7?_3?/7TC7S9^UT<?L\_%(^GA#7/\ TWS5Q9C_
M +AC/^P:M_Z0SZ;@S7BWAI=\\RS_ -2Z1_F"?")MW[:>A>_Q,M3_ .7%'_C7
M^K%X#;=X(\'G_J6-!''_ &"K2O\ *4^#CY_;5\/@\D_$J _EX@2O]6?X?'_B
MA?!__8LZ%_Z;+6OROPE7[C.9?S8FE^"GUZ[G^@'[0I?[;X9K?V>69G#YM9:_
MPU75'84445^PG^;(AZ'Z'^5?Y^__  <T?\G7Z W7'@FU7Z9DM_\ ]7M_+_0(
M/0_0_P J_P _C_@YF!'[4F@.?^A1M5_#S+?_ .OCZC\/SGQ2E;A6:_FS# K_
M ,J29_:/T#I<OCMA^_\ JSGK_P#*--?J?LY_P;+6<5S^R'XQ9ER1XQP>.?\
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M;"Y_X0SQC_USG_G)_P#6K^NJOZZ\/?\ DD\L_P $_P#TH_YU_IA?\I \<_\
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M444 %%%% !7\,?\ P<^KGXI_#@XSB6^S]-D_^/\ .O[G*_AL_P"#G9-WQ/\
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MQQ=MEAI?^G:?^?X'RW[2*/+P5PYYYYAUY?[E6_+E_4_4.BBBOZ)/\:0HHHH
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M%OFPV+EO;"5)?=32?X;?(_U0?^"9DGF?L9_!0^GA#3OUCK[ZK\]_^"8$F_\
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M_B[]FGBO^,BXZP-]9X7+:]K]IUX?T_D?,T8X1O3"^W'^<U^__P#P;=ZB=/\
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MFW_3"49_X$P_H/\ .:_",-&WBM47:<Y?^4DOT?X'^K6=UE+Z V$CVR_!1_\
M,E?]//KL?UVT445^[G^4H5\U_M=<_L\_%(>O@_7/_3?-7TI7S=^UN,_L^?%
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MB^%\>>6;0_ZE6+C\FX]_\^]S]<^GMB/98/PQJW_A\=</U7M]B>)E^OW/S/\
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M\5UR<35':SG1HO\ !*_GM]Y_O#^S_K?6/!#"4K_P<QS.G;M:49?^Y5?\RRA
MDLSW6]L6Z>EQ&37^G9_P1FOA?_L/?#J4'.V)(\]?NV\8Z]Z_S#$;YHR/X;FW
M;\ID.?;I7^E[_P $+=0_M#]@KP!-NW;;B>/U^XB+^E>EX.2Y<XQM/;FPU227
MI['OO>_<^#_:24E4\..&<5;X<]PM._K#&?G;I^5C]DJ***_H\_Q:/X,?^#F[
M4_._:/\  UH&SY?A2WR.>TD/^1R?YU_,7:OBX.?^>+<?A_\ J/L:_HQ_X.4]
M4^T?M9^%K;<#Y7AA 1G.")( ?IZ=<?2OYPUDVSD_[)'7'89_S^-?R)QY+GXL
MS-K[-64?N4%_P3_HL^B7A_JO@!P+!JSJ97A:MO\ '4K2O\_\V?T7_P#!MO9^
M=^V!%<XR(K>\&<="57%?MC_P<PZ=Y_[*\%WC(M0@SZ;I9A_2OQV_X-I[3S/V
MGKVZQ_JH[A<_5%XSW[?A7[B_\'(NG?:?V+-<O-I/V5K3G'3=-./Y?_KYK]*X
M?C;PQS+3>=66W_7E+^F?PYXQXJWTX>!G>RA1R?#^GM*N,BU]T[67_ /\]VS(
M,%K_ +.<_EBI=1;"Z>W]V_MC_P"3"-U_"JMF3]GC]OT)Y_I3]5;$%L?[MQ;M
M^(E0Y_*OQ*G/_::*U_B16N^KI?Y/\>Q_K)CFGPUFB[Y3)K_MVE!?BZ;/].K_
M ((N:C_:/[$G@&3=N$<%O']-MLHQ]*_6NOQ;_P""$>H?;_V%_!S[MVRY\LG_
M '8.GU]?\FOVDK^P^&W?(<J_[ J/_I)_S,^+]+V'B=QQ2M;EXBS#3M>K?]0K
M^(7_ (.A-2#?%;X8V>[.W08B5^DD0SSS_GZU_;U7\'__  <YZH9OV@/AW9[N
M(_#9...,21\X^OM[FOF?$VIR<*XE?S8C"K_RJC]]^@OAOK/T@,C>_L<HSNK]
MV$L?R\W1_>S>[H>!WZC\,=:^U/\ @G39?VA^U]\++?&[.M6C =<[+RT.?PQ7
MQ-*=SD^H!_(?T'^%?H1_P2KL?[3_ &WOA):[=V[4-XX/\%Q;G\.F<U_-F3/G
MSC*[+;$4&_\ P=%_UY'^X'B=B/J?AUQ=6;M['(,QD_\ MW"57?7SFNG^1_J2
M^%E\OPQX=0#&S0M(7\M/MQ6]65H*[-#T9/[FE:<O_?-G"/Z5JU_:4/@C_AC^
M2/\ F!Q#YL17?>M5?WSDPHHHJC$**** /*_C?<?9?A)\0YNFSPEK;9],6,M?
MY0/[45[]O^/WQ(NR<[]?U'GKTNYQU_#C\J_U7_VE+G[+\#?B;-G&SP=KISTZ
M6$QK_)V^.%W]N^+?CZZ+9W>(=2Y)SG_39QU^N/:OPOQGG[F3P[_6)?=*FC_5
MG]F?0_VGQ%Q5OAEE%*^NG[O%5/\ VS;R/, <6^?0'K_NU_;A_P &ONF"/X>>
M/]0* &XAA&XCKMDCXZ>A_I7\1,K%8)NV!G^G^?K7]V7_  ;'Z=Y/P'\07VW'
MVE<;O7;)&/K_ )Q7Q?AE'FXKPD^G++\,/;\&_P"M3^F_IY8SV'@)G%!.SK5L
M#1Z?]!]!M=?^?+M\S^HC7XQ+H>KH1D-IE\/_ "5EK_*4_P""@5C_ &=^U[\9
M8=NT/XOUN0=OO7K_ (=ST_\ KU_JYZJ,Z7J0];"\'YV\@K_*\_X*?V']F?MG
M_%6+&T2ZYJDWI]Z[;_\ 5_\ 7Y/Z-XQ0Y\HP#_EKU?\ TFGUM]W0_B_]FYB/
M8^(7%T+V53*<!IWY:]=]^FG_  -SX.1MMG%T_P"/W/\ 3\,?7FOV _X(<ZG_
M &;^W5X=;=M%Q9)#Z9WS-VXSG(S7X[.^(8U_Z:[S^'']/7\*_4'_ ((^:I_9
MG[<'P_DW;?M$UE#GIG?<D>V>O?M7XMPFW'B/)Y]L33]?BBS_ $^\>:'UGP;\
M0L);F=3)L8TM-;X=^G;T^9_J"6IS;6Y]8(C^<:U/5:R.;.T/K;0'\XDJS7]E
M+9>B/^9Z6DI+LW^84444Q!1110 4444 %?YMO_!?-]W[:WB(>E[<?UZ_I^M?
MZ25?YL/_  7JDW_MM^*1G.S4+@?^A?Y_R*_+?%G_ ))VC_V&1_\ 2)']Z?L]
M%?QGQW_9/5/_ %+H/]#\4O\ ELGT/\Z_9K_@@\<?\%!OAIG_ )_;@?\ D*&O
MQC;.XGKM(_#O^%?LK_P0E<I_P4 ^&K=Q>3<].L< _K7X1P>_^%_)5VQU*_HZ
ME'_@G^M/TC=?!?Q%BMWP[F?I_N->#^>GX??_ *6ZG*J?8?RI:CA.8HSZHI_2
MI*_LA.Z3\C_FC>C:[-H****8@HHHH **** /-_B[_P DV\8_]@'4_P#TBGK_
M "<_VJ3_ ,9#_%H?]3AKO_IPF_PK_6.^+?/PX\8?]@'5,_\ @#<5_DV?M1L3
M^T1\6>?^9SUX?EJ$Y_0U^'>,K?L,J2_GQ#^[V']?(_U(_9JZ9UQYVE1RR+^3
MQ/\ \EJ>&DXC/^[CU[8__77]B7_!K3_Q[_$/_K[O_P#VXK^.EC^Z/UQ_C^M?
MV,_\&M8 MOB&0/\ E]U ?^E/^%?!>&"MQ3A'WYW^!_7WTYI<W@+Q"E]F.&_]
M.4W^C_R1^D7_  <4^*_[(_8VO-,638]YJL8(SR5>- <C/_Z^.G?_ #PK,;=.
M@.,;@Y^N6;'8?G7]TG_!S5XL-A\%-"T 2X^UWEK(8\XSGRAG&1Z]?Z8K^%\#
M986Z_P"S].N>WXU[/BSB/:9TJ-]H4HI=G!7_ %O;R\CX#]GCE?U/PLQF.:L\
M16Q%:]M_;5Z26_E2>OR)(GV0L>F(W_\ 02/\\>]?U8?\&O\ X1$OCWXA>(GB
MR/-LBDA'0'[/G!QU/M_(5_*#/)LLYFST4\_48&/?_/-?VP_\&P_A 0> ?%OB
M-H\&[:U(<K@L \ X/I]/?M7E>'.&=?B2A-*ZA*C+;;V<$]K_ ''V'TY<Z^H^
M">88=3Y7B*,:-D[7]MB,-!VV_D???5G]>PX 'I1117]5'^! 4444 %%%% !1
M110 5_!!_P '-O\ R<)X;_WX_P#T%J_O?K^"+_@YN&/VA/#7^_'_ .@$_P!3
M7P'B3_R3-?\ Z^T__;C^O?H1?\GUR?\ [ ,1_P"I.#/YD1Q(3ZJ,?@:^I?V%
M_P#D\7X%C^]XZT0?G(W\J^62>4/K@?Y_.OIW]AA_^,S/@&N?O?$'0UQZ_OF_
M_5_3BOYBR-7S7!R_Z>TO_3L/\^A_NCXHNW ?$D?^I=CI/_PAKR_77]-;?ZPW
M@@;?">@CTTZ#_P!!KJ:YSP@NWPSH@]+"#^7^%='7]L4?X5+_ *]P_P#24?\
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MQ4YZY_3_ .M7XWF]/ES7$O\ EJU5UW52W7_"C_2;P]K^VX,X?J*S53*<,_\
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M#C.[P!K8_.)/Q[=OK7^45XO0VWBOQ5;=/*U>X&,=,$<?F?\ /%?S_P",L/\
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M5/\ TJWZ'_.U],9W^D#QMY5,$ONPT0HHHK[8_E\**** "BBB@ HHHH ****
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M_@BIXB77?V(_A>H?>UEX?T^W<YS@JC<8SQCO7Z[N<*Q/0 U_/_\ \&]'BO\
MM_\ 8[TVU\S>=,:UM,9SMV(^1UX_D*_?J[;9;3M_=B<_D#7W_"U3VF099/\
MZAH)O_#=?I_PQ_'7C7E[R[Q7XUPC5K9_B9I?]?IJK_[>?YNW_!P3JW]H?MJ>
M(( VX6=W,N.XR)!T^GZU_3Q_P;E6AA_8HT&X*X%Q')C\)8._>OY//^"Y.K?V
MG^W1\1HMVX6VINHY/&1*#Q^?;K7]>W_!O-I_V7]@;P!=;<&ZCN^?[VV:#^73
MBORSA;]]XAYI46JIO&7_ / ^7]=KG]Z_2%I_V?\ 0]\-L(]/:U.'G;O?+I5+
M^K_#\OWFHHHK]S/\M HHHH **** /YV_^#C.P^T?L;:S<  F&YL^<<CYG[^_
MU_GQ_GJVP_=J/]HC]<5_HQ_\'".G?:_V'/%LVW/DW%ESCD9:3 ^G<U_G/P##
M%.?EF9?_ !\CBOYD\75R\14^\L+0E]TIH_W,_9U5N?P@KTV[\F?YK!+?:G@)
M?E+].A H*;\YXDB(_P"_@/&?_P!5?Z1/_!OSJ!O/V _!BELF/4[X'Z#:!_GK
M_7_-^O4,8E&,?ZLC_OH'/Z]_2O\ 1+_X-V-0-Q^PMX;MRV?*U._XSZD?Y'T^
ME;>$4E_K%B(_]05;\)4+_G;_ (!P_M$\*ZO@SE5>VN'XCRR3?95(9@O\O/O8
M_?\ HHHK^E3_ !!/\Z__ (.,[\W?[9VDP[LB'P^5(^DL&>Y]^]?S]/D2DCMG
M^E?NK_P<$7AO?VW70D,(-(E3Z8FB_H#Z5^%L@^=O]W)_+_\ 57\=\93OQ/FK
M[XFIONM8)(_Z2?HTX7V/@7X?0U7+DF"BUV?+*7_MZ?\ PY_4+_P;+V7F?'C7
M[S;_ *IG7=[[ ,?Y]<5^[7_!Q%IOVW]@GQW,%R8#8<XZ9FGY_P ]*_%/_@V'
MLO,^)GC.]VY\JZ"Y],J,_P"?ZU^]O_!>_3/M_P#P3]^*#;2WE+8'&,]'F/<'
M_&OU_A^DY>&6.CU=/%3_ / (P?E_+<_S:\:L9[/Z;O"4[V]GFO#%"_;VN)V?
MRJ;:(_S6;4?Z,^.QQ_WR?_K4S5>;,'/*O#S]) ?Z58M5Q%(/^FTP]_E<@?CQ
M46H#-BQQT9>?HPQ_GTS7\_4[_6T[_P .M'IO:4$U;OT]#_8W$0Y^'JZ7_+_*
M*C[O6E)_^W_)>2/]'W_@WPO_ +;^PCX<^;)CU2=.N>D>/TQBOW;K^?'_ (-Q
MK[[7^PMI:[L^7KUXOY ^_;W_ /U?T'5_8W"T^?A_*I+_ *!*2^Z*/^:OQZP[
MPWC!Q_1M;EXAQKM;:\DPK^ #_@Y=OVN/VH?!D(;/E>')5VY[B5.W;_(%?W_U
M_GJ_\''EU]J_:PT)<Y,&C3H/QD7_ #_DU\IXK2MPM-?S8O#+_P G7^?W7/Z#
M_9_T?:^/6&DU?V?#V</_ ,"H<I_.UDDJ?6-J_3[_ ((WV']H?M[_  CB*Y"S
MW!Z>CV[?S_3K7Y@?T.#]?3ZU^NO_  0]L/MW_!0+X7 KGRWO#@^WD'_(_E7\
M[\-Q=3.\MAJ[XJ@K?]Q(I?F?[%>.U5X?PCX\J+3EX:S75-[_ %*7_P K;/\
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MO[&B_NC'_(_W'_9W:^#^)?\ U-,QA]]?\]?R.U^&1*?%3X=-TQXCTT_E(/\
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MRSC2&<QI\L,32P^$;M:\\/AZ49+S=_ZWO[/1117Z6?PF%%%% !1110 4444
M?PY?\'0)*^// 9];J3KW_=O7TC_P;  _\(YXV/;[))_A_GZU\Z?\'0Z;/&OP
M\D_OWLP_\<D_SSTKZ4_X-@DQX5\9O_>M9!^I_P _A]*_"\/_ ,G7J/O*?X4(
MJWR5C_57.G_QP%@%U6'PR]4\SD_R;_JY_7G1117[H?Y5!7S5^UY_R;O\4_\
ML3M>_P#3?/7TK7S9^UR,_L]?%(>O@_7?_3?/7'F'^XXO_L'J_P#I#/I.#O\
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MDK3]EXW>("2LI9W6J?\ @=F%?YUW_!PW=FX_:Z@3=GRK.X3'_;1?KW_SBO\
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M(6[ZVI+_ -L9_;7_ ,&PW_(E^,/^N<W_ +-7]=%?R+_\&PQ_XHOQA_USF_\
M9_\  U_717]=>'O_ "2>6?X)_P#I1_SK_3"_Y2!XY_[",+_ZCQ"BBBOM3^8P
MHHHH **** "BBB@ HHHH *R=>?R]$U>3ILTV]?/^[;R-_2M:N>\6OY?A?Q$_
M]S1=3;\K.8U,W:$GVC)_<F;X5<V)P\?YJ])??4BC_+A_X*TZF=4_;\^+LQ._
M9J:*#UY5IQCCZ?C7Y[2MND0_7IT^Z:^U/^"D][_:/[</QANBQ8#6&&<],3W
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MPK]!*_M3*9<V69?+O@\/_P"FHG_,+XAT7AN.^,*#5G3XDSB-K6VQU<****]
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M[?\ @BWIQTW]@SX5P%=N8)7Q_OQP-T_/)K_,9L5\S4=+3J9=7TQ?^^KR%?\
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MHHHIDA1110 4444 >>?%@X^'/C$_]0#5/_2&>O\ )H_:@)_X:*^+'_8ZZ_\
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M#75URG@;_D4M _[!T'_H-=77]L4?X5+_ *]P_P#24?\ +_F7_(PQW_87B/\
MT[,****T.(**** /Y^O^#A[_ ),\N?K=_P#H%?YUUK_QY1_]<Q_(5_HH_P#!
MP\?^,/IQZM=#_P =%?YU]M_QZ1CU4#]*_F7Q<_Y*"'7]S1T\N6)_N1^SNU\(
M,2]E_:>8Q]).OH_75>?X':_#/)^*GPZ_[&33/_1@S_C7^L/^QR,?LT_"(>GA
M'3O_ $4*_P GWX8KGXK?#GCKXETT8Z?\M#G/X5_K"_L>@K^S9\) ?^A2T_\
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MR\_\&O\ Q^ROX['<^-&]?^><O].:_J&KV^"O^28RBW_0/_[?*_XGY=]*"_\
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M_K5_,^5O_A2P7_8;AO\ T[3/]QO$#_DA^)[[?ZM9U_Z@XA_CI_PY_JG^ /\
MD2_#/_8(M/\ T"NOKD/ /_(E^&?^P1:?^@5U]?VO1_A4O^O</_24?\O^/_W[
M&_\ 87B?_3TPHHHK0Y HHHH **** /P2_P"#A/\ Y,NOO^OFZ_\ 125_G*6H
MS96Y]Q_G/X_I7^C7_P '"?\ R9=??]?-U_Z*2O\ .6M3_H$'^\#^6*_F_P 6
M'_POQ_[!:=O7V<?O]#_;S]G=_P FCQO_ &.,?_ZD0-B)5-K*3_#.OIVR>G^>
MWX_2OA?XNW.A^%+;35N'1;?8@4-P ".GM^?<8Z5\SQ-_HLHX^9P?T/\ ];\J
MR[B^D2!XPQP)!QGL,?D>, ?3-?E^7UY4:\G%M?NE>SMVT^_\S^W.+<KP^99=
M1IUX*?+CI3BFK[)=+=G;]>_V+_PO.[X_TF7C_;/^/\L?2@_'.[X_TF7C_;/^
M)_I7Q?\ ;Y?5OSH^WR>K?G_]>N[Z]5_FEO=Z[[>?E_77Y+_5;*_^?$.BV72W
ME]WR[:_:'_"\[S_GYD_[[-'_  O.\_Y^)/\ OMO\:^+_ +?)ZM^?_P!>C[?)
MZM^?_P!>FL?66O-+I?Y<OGY?B+_57*_^?,/N7E_=\G]_D?:/_"\[O'_'S+]-
MYQ_/^E6M+^.UXFHQO]IDS&-_WSGC/O\ C^GO7Q)]OD]6_/\ ^O4MKJ,JW!;<
M?]60,G./;V/<=:TI9A64E[[TN]=NG^7Z$SX4RN7(O8PWL]%LXR7;1:].A[)\
M6/%$GB[7CJ<CF0F(\DD\\'J>>V?TKS:R :=/00MT^C?TJ$7#7,;.QW'81US@
M8/Y=/TIUB^V0'TB8?C@X_P ^M>9.?M/:R?Q.<FWWYI0?S>A^EY?A:6#RS+\-
M0BHTX8:C&*6R4)127R5S])O^"/Z[OV]_AJOI<2=?::+_ #_]:O\ 4.TG_D%:
M9_V#[/\ ])HZ_P O/_@CX<?M[_#0GO/)R?\ KK%_45_J&:3_ ,@K3/\ L'V7
M_I-'7]"^$5_[%Q7;V\/OY#_%K]HH_P#C9N0+JLIQ'XUX_P"1H4445^MG^>(4
M444 %%%% 'Y+?\%I=3_LW]AOXAR;MI=1'G./OPR#U]_?_#_,<N3NN-1?N;ZY
M.?\ >G;/YYK_ $E_^"\^L#3/V&O&B[@IFG@'4CJL@^G3I7^;'G>;AL\27$S9
M_P"VA/\ /%?SAXP3OG6%ANHX.D[?XISO]_*?[6?LX\)[+PPSS$\K3Q.?YA9V
MW]G0P4%OO9S^\LQ+F[TU.N[4+-?SN(Q^%?Z=O_!&C3!IG[#WPUBV[2\'FXQC
M[\,1S[YR>:_S%K$;]6T-!U?5M/7ZYNX!W]Z_U)O^"5-A_9O[&GPQM]N,Z7:R
M=,9WVL)]!5^#E.^;8R;U<<')/RO.FOS7Y'+^TEQ/)X><.89-_ON(L).WE2P5
M=_\ MZO;R/T>K^0W_@Z$TO/PX\"ZCM_YCUO'N^BPG\/\\U_7E7\J7_!SYI@D
M^ /@B_V=/%,2%L=/W<0_7_/K7ZYQ['GX3SC3;#QDO55(?Y_H?Y[?1 Q/U;Z0
M' EW95L7B:/_ ('A:C7Y'\,]R/\ CU([V2G^?Z\]*=:MY=Q8S#C9/&__ (]G
M\_3FHYGW):D=K5$_GGO]*CWE5C/]UP?_ ![^G:OY)I.TW_CHO[IJY_T0Q2G@
M)Q=[2PE3?^]&.OW;^9_J'?\ !(;4?[0_8=^#+;@Q3PW;@X/3A.H_^O\ 3K7Z
M>U^0/_!$[5/[0_8@^&$>[=]ET2W0\YP<+_G'Y^_Z_5_9W#\^?)<MEWPE'\*<
M5^A_S)>,V'^J^*O'U"UN3BC-[+LI8NI)?G_P6%%%%>P?F04444 %%%% 'YS?
M\%3KC[/^Q[\3'SC.C:BF>GWK.0?R_#UK_+0FYU?6O^PIJ'_I5,?_ -=?ZC7_
M  5ED\K]C7XDG./^)9>CZ_Z)(/RYYK_+BD_Y">KGUU&^/YW4HK^>/&&5\SP,
M?Y<-%OR3JI_HS_9/]FS%+@WB:36^>SOYI89)?.\B]8)NU_PT/7Q%HG'UU*V'
M\\?K7^JM^P%;B']C_P"'$0'WO"5O_P"/:3!]?6O\JO226\1^%QV_X231,@=@
M-2ML5_JR?L$C/[)GPT7U\*V0Z>NE6PQ^'2M_!]7QV:/_ *=2_&:_X!P_M)ZE
MLCX+BMI9LI?.%"7_ ,G^)_GV_P#!9C3O[._;L^(\6-H:))!P>=\LA[_B?QK\
MI8!N6[]H<_J/YU^Q?_!=*T^P?MZ^.0!@2V-L>F,[F<Y]_P _SK\<X&Q]H]X]
MOO\ Y_\ U5^8<3P=/B;-XVT^MUDM/[R_R9_;/@+6>)\'.")[N60Y2WK=ZX.E
M^::ZZZZ'V=_P3FNQ9?MF? Z7.W_BM=#7/_;5OU/_ -?%?ZKOAZ7SM%TZ4<B2
MUB;\U%?Y.?[#5_\ V?\ M;_ ^XSMV^.=$'Y2M^/:O]7;P#<?:O!WAZX!SYNF
M6[Y^JU^S>#;?U#-%_P!/Z+W_ .G>FGI]VQ_FU^THIK_6O@:LE_S+<RIM^?UF
MG+TZ/S.OJAJK^7IE^_\ <M+AO^^8V/\ 2K]8GB63R?#VM2]/+TR]?_OFW<U^
MSR=HR?:+?X'^9F'7-B*$?YJU)??.*/\ +Y_X+%:B=1_X*&_&,[MP34XE]<8$
MH_3^E?FTO1_^N;_^@FON[_@J5?\ ]I?M\?&>ZSN!U<*#U^ZTX_+J.*^#BV _
MLK9_[Y)Q7\7\13]IG^+D]4\75?R^LM_UY:'_ $X^!U!83PLX2I6MR9)E<?1Q
MRG")Z?)O\3^K/_@UDTSSOB1\8+XK]W3K7!QZ2#O_ )'K7[\_\%RH/._8I\>'
M&=FE7K?^.C_Z_P#D5^)7_!K%INS5?BU?[3^\T^ !L8Z2#O\ T_KBOW._X+:P
M>=^Q)\2CC/EZ%?-_XZ,'\.>U?T!D$%_Q#O%O7WL/CWKV4I6]5;^KG^0GC!B'
M/Z9N0:Z4<ZX1I[K?V>%YO35ZG^9;$/W,1]7 _P /ZU-=#,?X@?G38A^Y48Z,
M3TZ8)HNC^[X^O^%?S%JZD4NDW^+7_ /]QXVC@IMZ\V'IOH].5;?UT/\ 19_X
M-Z[CSOV/HU_YY3VJ=<X^1L#Z?_KK]^:_GN_X-UYO-_9$N><A+^W&,]/D?_/-
M?T(U_97![OPUD[_Z@X+[FU^A_P U'TC8>S\;_$>%MN(\2_\ P*G2E^H4445]
M*?B84444 <%\3-232_!.OW;L%$6GSMDD#!"^I_&O\PC_ (*F>*/^$I_:K\4W
MGF>8MO=W5NK9R,++'P#ST QP?>O](G]LCQ4OA#X'>+]6:3RO+TJ\.[..B+ZD
M>O\ ^JO\O#]KWQ+_ ,)3\9O%>M>;Y@FU2[8.3G[SJ<\'N!_@,U^+>+^)_P!B
MPF%3^*HFUUUVT_'[['^G7[.7)6^)>(L\E"\:6"G3C.VW(X2FK]7MY;;;G:?L
M%^+6\(_M2?#BX60QK<Z[ID3-D@8DN0#]..OX@\8K^^[_ (*->/HK#_@G_K%_
M'.-]UX?B0$.,L)-/QZCKWK_.;^ 6L'1?C5\/=7#[!;:_ICL^<;=DZL3G^?/4
M]J_LU_X*'?&A-1_X)]Z7;+=@F_T2T'#<G_10O3/.<D<C'IFO"X!S!8?A[.Z+
MDDXX163?5IQ:VOU7Y6/U_P"E3PA_:WC=X2YC3I<U.MQ''VK4='!5<-62;2?N
M^Y+='\87PY@?7_C_ .!80"[7?Q TMF&-QP=?A.<#GO7^M-\!M*71/@_\/[!5
MV"'PKH3;<=-VE69/':O\J']B_0&\6_M6_#+3!'YA;Q;8W)4#.?+U:WDSWZ>N
M,5_K&^!X!9^!_"UN!CR/#.C)W_Y9Z7;*?U'YU[WA+2?+F5?^=Q7_ )/*7ZKS
M_3\3_:'8Y/,N ,KB]*&&Q]24?*-'+:,7;O>-3OU/QW_X*C_$Q?"UWX.M$N-C
MMJ]LK*'VGYKI1R ?J#VSTYS7ZN? O45U3X4^"+U6W>?X>TN0G.>6M8S7\L__
M  6B^,BV'Q?TCPX+K:UAJ^G$Q^9TWWB]@>^/;Z'J?Z2OV,-;_M[]GGX=7^_?
MN\.Z4N[.>EG']>V/\XK[K*,9[?/LVI)W4%!)7_DT?3HS^9O$;AO^RO!CPWQK
MARU,3B\95G*UKPQ&'PTZ;]-';5]?(^J:***^N/YK"BBB@#\]O^"G]I]M_8^^
M)\&,_P#$INWQ_N6=P:_RSM44KK>OK_=UG5!_WS?3?X5_JM?\%$;3[;^RE\4(
M<;B- U)P/]VQN#7^53K?R^(O$B]"->U@<=L:A.*_G_QAC;'Y;-_:P>(BOE9V
M_'M\S_8K]FA4OPOQQ3?V,ZP4E_V_0E^L3/C'[F]SSA4(]N_]?\XX_M@_X-@=
M0\SP+XTLMW^J@+;?JP]_S_QK^)^,XBNAG[ZXY]L\C\*_LJ_X->-0W6'Q#L\_
M<LE./3+8SUZ]/Z<5\IX52<>*J2?VX377_GU']4_F?N'TY:'MO CBC2_)6PM5
M>D,7AEIIVG9]#^QRL_5G\O3;Q^FV!SGTQBM"L#Q3+Y/A[5Y3QY=E*V?H!7]4
MS=H3?:,G^#/\#,*N;%8:/\U>C'[ZD4?Y:O\ P4MO/MW[:OQODSGR_&.M)GV$
MJ=,?7Z^M? L !ED!_P">$GY@?YQ],5]E?\% ;[[9^V+\=)=V<^.-94<CO(#Q
M_D8[5\8+)M:0_P#3&1?S7^>3^F*_BS.I<V;XR7?&XG_TZTM?O_0_Z@?#>FL/
MX6<'44K.EP]EM_1X+#O\OZU/[PO^#96P$'P!\?7&,&;4+,YYYP5X^N!_CZU^
MX'[>]E_:'[+'Q5M]N[/AW4GQ_N:=>G^=?C3_ ,&U5L(?V:O%,N#^^NK0\^VW
MG_Z]?MY^V5;?:_V<?BA#C.[POK)Q]-*O?K7].<-P_P",&PT;?%EU?_R;VGRZ
MG^$/C5B6OI4YS7=_W7&F3-7Z<BP'Y6_#0_R6M9&SQ7XI3^[XDUQ#_P !U2Y_
MPJ-N5<>JD=/Y_@*M^(U\OQMXT0_P>*O$ (],:O=?X52W AO8'K]#7\H8Z_UN
MM;1>U_6-O0_Z!>%6GD.7J6K>%IKY>RC%W[N][G]H_P#P:[WN[PSXXLMW^JBN
M7VY[%V_KU]_I7]@E?QD_\&N%_NN?B+8Y'[O3I)",] 7;M^/7TK^S:OZS\/I<
MW"N7OM[1?=(_YZ_I?TO8^//&"2LIO!5/_ \.G^O^6@C' )]!7^8E_P %G[LW
M7[;_ ,3N<^5X@U!.N?XUK_3EO'\NUG?ILC9L_09K_+P_X*\WHN_VW/BTV<[?
M$^H GZ.,_P __P!72OF/&"5LDP$?YL<_PIG[M^SCIW\4^**C7P\-4HK3J\=3
M_&US\S8OOM[-Q^6<5_2U_P &U=EYW[3^KW07FW?&?0&.(_YQZ\]J_FCC.&)]
M?F/X8_2OZ@_^#9BV\[X]>++K&?*EC&>N,I".OU/X_P _R'P_CS<39:N^+IO_
M ,!5_P T?Z1?2ZK^Q\ >.GLWEF(A?_K[^[M\^=?EU/[R:***_KH_YS HHHH
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M110 5_FV_P#!?--O[:WB(^M[<?UZ_I^M?Z25?YM/_!?!]W[;'B0?W;ZX!_\
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MZ6-P:_R;_P!J4[OVA_BR"?\ F<=='_E0FS^/%?A_C+;ZOE5U]NO_ .X?TO\
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M/TK_ #N_^#=;PE_;/[8^EZZ8]Z:4MRC/C(7>L>.>-N?UXK_1,C&V-!Z(H_(
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MC^MM#7TG@U>^9=O94K?>C\1_:62BZ?!:6_UW&?\ IB'ZW_JY]+T445^\'^3
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MMZNG16GG]Q^O_P#P; _\FL^./^QR;_T5+7]0U?R[_P#!K^V?V6?'(]/&;?\
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MZ84445H<@4444 %%%% 'X)?\'"?_ "9=??\ 7S=?^BDK_.2MS_H,'X?J#_\
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MS.IVH4X^EYRT^=KGY;^TJQ3AP[P/A&]:V:8BKR^5+!89)^EYM?F?5U?S*_\
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M>5%_-@<9+_P+F?XH_P 5/%/%*K],C!U$]*7%7#5)/M[+ZM']#_+Z7(A;V)_
MU!=']UG_ *9YJVZ[!<(.,3,HS[9JO<+FW)]%"?\ ZO?C_/?^7;<M:S_Y^+?L
M[)=M?^ ?[O.;>7TFG\>%I>EWK?[FO\K'^A=_P;C3>;^R-J8_N:I;#\1&V:_H
MEK^<+_@VUN/-_9.\0)G/EZU F/3$;_KQ7]'M?V)P6[\+Y,_^H1?^ER/^;SZ3
M</9^.WB1'_J?2?WX7#M_C<****^H/P<**** /RV_X*X^+_\ A$?V2?'5]YGE
M-_9-^%.['.R/Z?0?C7^8QXWUQO$-]J6J,Y=[B^D.[.<[N>_X]^N<\U_H>_\
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MB@#Y%_;EM?MG[,WQ1BV[O^*7UEL?[NFW1K_*$\2 IXM\3ITQXBUP8^FI7/\
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M?S'GK%]1_*OIO]AEC_PV=\ 1_>^(FA+_ .1F%?,AY,?M@_ABOIS]AE<_MF_
M$_W?B'H3?^1F_K_^NOYCR+_D98/_ *^TO_3E,_W/\4[_ .H_$EMO[,QWW_V=
M6^6_ZG^LAX3&/#>BC'2PA_D:Z&N=\)'/AK12.<V$/\C715_:]'^%2_Z]P_\
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MDTKC[OC2%ORBAK_/6L%S;1#GY5W?@,X/_P"KZU_./BVE_K"EWH8;_P!-W/\
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MSN/_ $*3_"OZZ*_D5_X-A3_Q1?C$?],Y_P#T*3_"OZZJ_KSP]_Y)/+/\$_\
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M>%2W^/!X:5_FV_SZA1117U9_/P4444 %%%% 'Y%_\%K[C[/^P[X[;.-Q*?\
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ME5-*[GF."C;O?$TU8_R?_P!H^]_M'X^_$N[W;M_B351G.>E_=KU''^%>.W8
MTH/Z[^WH,?S&*[KXN77VOXL_$"YR6W>)=9Y]1_:5V<_4Y _+Z5PM\<:*N.H#
M\>F3U_SQT%?Q/CGS9A6?652.GG)Q9_U!<)T_JW".606D:.!KM^7)245T[1[V
M/[MO^#8[3O*_9KO]1"_\?-S=)N/?;(/S_/C\J_63_@K+!]H_8K^,*8S_ ,4M
M?G_QS\?\C'>OS7_X-I=/\C]CJSNRN//O[\9/&?W@[?X^_M7ZA?\ !4V#SOV+
MOC.<?<\)WYS_ , Z?_JYK^H<I@H\!V6B>65I/YP<C_!_Q Q;G]+&5:3UI\;Y
M53;_ .O>)HP2^6Q_EGWHVW5ZG]V^D3]2,_K4$JYL9&_NSA.GI_D_G5K4\?VE
MJ0[#493],-^><9_.JTK8L9%SUN-P^A _Q_0U_*>+TKQM_/"]O\7^1_OWA)<^
M4X*3ZX?#[]O91W/[\?\ @VBN/-_99\81Y_U?B&(?3]VV1^AK^EFOY@?^#9:\
MS^S=XWMMV/\ BHXSMR>T;]OR[?UK^GZOZ^X'ES<*Y/Y85+_R:6A_SH_2HINE
MX^^)*?7/')>CPN'L^VP4445]6?SZ%%%% '\KW_!S%XQ.C? G0-)67:=0U40L
MF[&Y72+C&>?RQ7\+OA*S:[\4^$=/52WVB^L\KCKN8C_ZW/\ /BOZ_/\ @Z0\
M6_Z-X"\+K+R=3M;DQ9YPPCYQGH?6OY4?V>O#S>*?C9X$TA(S(1>6!V8W<>81
MT''3MC\>E?S3Q])XKC"%%7?*TOG&,%VZ-W_ _P!P?HB4X9#]'&IF=3]W[>G[
M2^R:JXB<F[[.\(]S*^*FD/I'CJYLF4J%21PI&W! 7GO_ /6[>E:WBGQ2^J>$
M=!T8R;A:6VS;NSM /IV_ =^>:]Q_;D\$/X"^+ZV[Q&'[38R. 4V_>"\@8^N.
M>H_+XTCG:6:VC).W(4 ^YZ^O?Z_K7P6/C4PF,Q=';GI1@U?KS7:MKU2[]?E_
M4_!U;#\095E.9)J<<)BZ5>$OBM'V2A??31R^=[=3^G#_ (-O? _]I?&O6]?:
M#=]AGCVR%>!N$6>?_P!?Z"O[UF7;:E.F+<K],1XK^0K_ (-P?AP=(M]>\1O
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MZ''7?TU&:O\ 61^+'_).O&'_ & -4_\ 2*>O\FS]J9M_[1'Q<Q_T.>OCZ_\
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MO,.?_P!5?ZO?[)7_ ";K\*?^Q5L/_1=?Y/\ \,)?)^)/P[D)X3Q=IK?E(?\
M'_"O]7C]C^;S_P!FWX22CD/X2TXC\8A7O^"W_,U?7DBOESP?YL_&/VE,;+@V
M71YCBTO3ZHFOZW/G7_@JIH@U[]CKXF6A3?Y>DWUQC&?]5:2-T_"O\MF[39=Z
MNIX\K5M03WXO)AC]/Y5_J]?M\:6-7_9=^*=J5W8\+:S)C&?NZ?.?\_Y(_P I
M7Q#!]FU[Q5;8P8=>U0;<?]1"X%<WC+1MB\OK)?%!)NW\LDM_G]_0^F_9IX_F
MX=XSRYRUIXR=:,?.=!.]G_U[\MBC;+^ZN\]4"8Z]^:GT]_)U'2;K_GWU;36S
MZ?Z;"<_E^'KVJ*U;]S>=1N"8]\?Y-1%]D DX_=WMB_K]VYB/Z;?K^N?Q["/E
MQF$E_?@K^LDO\S_2;B*FZO#G$%-+?#8B4='M3IPFO_25KKLS_5(_X)GZU_;G
M[(WPNNM^_;X>TJ+KG&RQB&/\^M??M?D[_P $:/$ U_\ 8G^'<X??Y5G;P=<X
M\JV1<=3Z"OUBK^T<EG[3*<OG>]\+2U_[=1_S&>)F&>#\0.+\,UR^RS[,$E:V
MGMY/;YG\\'_!R.N[]B6P![>+XS^4,/\ G_.:_P ]+2US$O\ U[,WKT/_ -;U
MK_0M_P"#D9MO[$VGY[^+D'X^3!7^>GI1Q$O_ %ZN/S/3'KS7\^>+7_)20_[!
MJ'_II'^Q7[/7_DR^(MO_ &UFEO\ PJHW_ [+X6*3\5?AT?\ J:M'/Y7T0_K7
M^L#^Q\2?V=?AD3U_X1ZQ_P#2:&O\G_X6-CXJ_#H?]33HX_.^B_I_6O\ 5_\
MV/1C]G7X9#'_ #+UE_Z30U[_ (-WYLS_ .O=/\U_P#\A_:46^K\#]_K6*_\
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M9OXIQXYXVPM_CR3 58J^\ECE';=NWZ'P1&V(_HP_7D?K7[)?\$,=5.F_MY^
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M-K_Z!775_;5'^%2_Z]P_])1_R\X__?L;_P!A>)_]/3"BBBM#D"BBB@ HHHH
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MO5\&H^]FDO\ IU17H_:5OTM]Y\%^TLJ/ZOP%![O&YG+U2P.5?K)]/F?QV_\
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M\_3'Y5\.?\&].G?8/V!O!9(P9+Z];IZF,\^_\NGU^]_^"E$7F_L5_'E<<_\
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ME'_ M-N![^M?Y.7[5=E]@_:'^)=J1@Q^(]5."""-U_='O[&OPWQGA^YR>?\
M>Q"?S]E_E_5C_5/]F=7_ .%'Q%PU_BCD=1+T^NQ=O_ NB['SV3E$]#N_KU_6
MOZ1/^#:F^^S_ +3?C6(-CS[&S0\]<,./R]NH]J_F^C3('HF[MV(S_P#6K^A7
M_@W$O/L_[5FN1%B#<16B$9QGYAGV_G^'!K\TX$;AQ/EB>EL3%Z=_>B]^M_S/
M[D^E?3>(\"N.H[\V35/_ "G]5J?H_P 7U/\ 0WKY\_:NG^S?LX_&.?./*\#Z
MN^<XZ1K_ %KZ#KY=_;3NOL?[+'QQGSC9\/\ 6R#R/^62'K^%?UGCI<N"QDNV
M%KO_ ,I2/^>?A2FZW%'#E)*_M,]RB-K7WQ^'1_E/_%RY\[XG^/)]V3-XAO#]
M=S_7M[$_SKSB!=\]NG4M=Q*??)&>O?%=3\09S<>-O%$XY\W6;A\^Q(Y_7CVK
MF]/4OJ=@G.&U"W'YL!G_ !K^(ZFN-J/^?$W^^:/^HK Q]APYA8K_ )=Y-AH:
M/^3")6/]._\ X(W6/V+]A?X/#&/,T"(_^@'I^/'TX]3^EWC<;O!GBU?[WAK7
M5_/2[H5^?G_!):U%K^PW\%5 QGP["3Z\A#_GW_3]"?%R[_"GB9?[V@:POYZ?
M<#^M?V9D4>7(<MC_ -2[#_C0B?\ -+XIUG6\6^-*M[WXSS77_#FE1?H?Y-?[
M:=N;/]J'XKP8P$\2:FV!Q][4KT].F3_+&*^;,DH@Y^7GVY%?6_[?UD;/]K[X
MN6V"/^)[=O@C.=U]='_#\*^1E!WOQP%_7&.GM^E?Q]G,>3,L9%+_ )?S@E_V
M]'_@_P!:G_1YX7U/;\$\,2>K>6X*?=:T$T_FK6]?)'[[_P#!N1??9/VO];C)
MQ]HL+5,9(S^]/;^OI7^BG7^;[_P;ZW_V']LZ*,D+]J6UCP>,_O#_ "]/YBO]
M(*OZ/\*Y<W#C7\N)E^,4[?+Y'^*OT^:/LO&:E*UO:Y+1?F^6K*-]#S/XRS_9
MOA7X\N,X\GPWJ#Y]-L>:_P H+]KF[-]^TS\7;C.?,\5ZB_\ Y$/]!_GBO]6C
M]H*7R/@G\39<X\OPCJK9^D-?Y.W[1DQNOV@/B=-][S/$E^W_ )$;//%?-^,C
MO1RN/;VTOQC']3]K_9JT6\SXZKVTYLLHM^34IM=NESQ56XE]?+<_CC/]<U_;
M9_P:SV.SX>?&2[Q_K+S3.>G3R3_D=*_B1/R&;/\ =DZ?[N*_NA_X-=K#R/@M
M\4;HK@W%SIS X]##_P#7'TKXOPNA?BG#O^2%1_=1GO\ H?T]]/#%>R\!,WA?
M^-BL#!*_?,\ _F[-G]6M%%%?U(?X*A1110 4444 ?PW?\'1.J;OB9\,K('_F
M$RY ]G'T_P _K_*$.",=B@_$@8_SZU_3Y_P<[ZC]I^._PYM-V?*TNXR!ST?_
M ".GTYYK^85UV[?=HC^6 :_DGQ!GS<59C*_PU_P5.BOSOT[G_1!]#F@\-X"\
M$0M;FRN$O^WIXG'U.OR?]:_;/_!.*Q_M+]N3X)6>-V=8!Q_NS6[9Q^OX5_JI
M^%$\OPQX>CQC9HNFIC_=LX1_2O\ +A_X)0:?_:?_  4(^"4 &[&I2L1C(X-N
M>?R_QK_4IT)/+T728_[FG6:?]\V\8_I7ZSX00MD>(G;>M%?^2*7YM_C<_P ]
M/VCF)]IXI9/0O?V675Y;W24JRIK_ --?@S5K\"/^#A73S>_L>[\9^S7MS+TZ
M8C3FOWWK\1/^"\>F'4/V,O$C[-WV2"]F^F(T_$<9K] XF@JG#^;P:T>!K/;M
M&_Z'\G?1\K_5O&CPZK7MR<2X)7_QN5/\>:Q_FP*3L'^\/YX_E5J4Y7!_YYD_
MD/\ ]555'RCKUS^1_2K3C]RSX^[&5Z>GO7\8M7E&V]]?FXI?H?\ 2Q2E:C*^
MEZ<%UU27]?>?Z"G_  ;=ZE]M_96UR'=DVNH6T0')Q@'CGV%?T>5_,%_P;)ZF
M;G]F_P =6I;)AUVW7KG'#9_R!7]/M?V!P1+GX7RA_P#4.UUTM.2/^</Z4E#Z
MOX\^(D+64LXA47_;^"PLW^+84445]6?S^%%%% !1110 5_FO_P#!>I]_[;7B
MM<_=U"X ^F&_QK_2@K_-;_X+S(5_;=\6GUU&X_\ 9NGZ_I7Y;XL_\D[1_P"P
MR/\ Z1(_O3]GK=^,V/7?AZK_ .I5$_%,Y&3_ '2 ?QQS7[*_\$*O^3]_AWC.
M?M<G3_<A_P *_&QA_K!_>*D?H3_+^5?LO_P0F&[]OGX=#_I[D_\ 1<(K\$X2
M_P"2BRB7?&T%_P"5J/\ F?ZW?2#?_&G/$)/IPWFS?JL#C5;\(_>?Z6-O_J(?
M^N:?R%35#;_ZB+_KFO\ (5-7]F+9>B_(_P"9^?Q2_P 3_-A1113)"BBB@ HH
MHH \[^+/_)./&/\ V+^J_P#I#/7^3'^TV^_]H;XM<\GQOXA'_E2G'\_\:_UF
M_BT<?#CQC_V -5'_ )(W%?Y,'[2ZD?M"_%@GI_PF_B _GJ5P?Y5^(>,G^[Y9
MZXC_ -PG^IG[-7_D:<>+RRJ_HW6U^ZYXGZ>[%1]1_GBMZZO"-'CM-V 9P<<]
M=OO^GZ5ALN"@[;]W\C_/\Z9=2-YD,6?XE8C)(/O]?\\U^!T9-3MWC*_IIT/]
M;<;257#1D]>2OA^5[ZR:32]>O^99D?Y(QDX0@?YY]:U?"J?:/%_ARW_Y[ZS8
MP?7?.@]/>L-\\CG[X/Z\UU/@=/\ BO\ P3D</XGTD'WS=1Y!K;"1YL70OUJ4
MOQ</ZT_4X>(JCHY!F;C_ ,N\%B7'UA2J/;H]OP/]/[_@EEX57PQ^RMX#B6/8
M+G2+63IC.8H3SQG//^&1BOTHKX]_80M([7]F#X7>6H4/X?LR<#&?]'A/&.P_
M.OL*O[4RBFJ65X""V6%H/[Z<7_P3_F(\1L7/'<=\68F;;E4S[,KM[^YB:D%^
M$0HHHKT3XL**** "BBB@ HHHH *_@B_X.;O^3A/#7^_'_P"@5_>[7\$7_!S=
M_P G">&O]^/_ -%U\!XD_P#),U_^OM/_ -N/Z]^A%_R?7)_^P#$?^I.#/YD"
M>8SW.!^G_P"NOI;]B"0K^V+\"!D_-X^T11_W];/X_P">E?-#?\LOK_2OI/\
M8C4G]L;X#>WQ T4G&>GFOWK^8LC_ .1E@WU]M1\]ZM/^G^I_NAXHW_U(XC5M
M/[-QO_JNK/UZ]._D?ZQ_@;_D4M _[!T'_H-=77*>!O\ D4M _P"P=!_Z#75U
M_;%'^%2_Z]P_])1_R_YE_P C#'?]A>(_].S"BBBM#B"BBB@#^?K_ (.'L?\
M#'MP3V:[/_CHK_.OM3_H<9]%!'Y"O]%#_@X>Y_8]N1ZF[_\ 0:_SKK7BR0>D
M8_D*_F7Q<_Y*"'3]S1_])B?[D?L[O^308FW_ $,\Q?\ V][?;\%]YV?@28P^
M._!$@/$?B&PD_ /U_/\ K7^KQ^Q%,;C]E?X+S'GS/!NFM_Y#%?Y/'A4E?%_A
M#MC6K+GWW>OI7^KQ^P<2W[)/P/)Y)\$Z9GZ^4,U]#X,*TLT2_P"?47]]6/\
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M?_J_>![P7_A+0+I3N$VFVSYSG.Y,]:ZNOG[]F;Q3'XL^$?A748Y!(/[,M$+
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MNE:E66FODOD?WYQPH\&?1$RW"Q_=5*D,OE;9\TLPRV<M+=Y2/X^#QN_V>O\
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M7,FGH/XM0L%'_ KJ$?R)J*TR-/!_O2.?S;_Z^?\ .:N0IYE_HL7>35],4?\
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M[<UT$=-;N4X!XPY'].E<[?IAV '1]N>?8_XFNOUM?+\1^)$(P4\270^F&/\
MGGTKE+_F67_KIG^8_K7\AXCW<7;3^.EY;1_R/^C/(_?R+!WUOET&M%?XE8_M
M=_X-@KC?\.O'\6?N:Z1C_@+G_/\ DU_757\?'_!KU<Y\&_$6'/77W..>,))_
MC_A7]@]?UCX?N_"V7]E[1+Y2/^?7Z8T.3Q_XUM]JOA9;?]0U-+\MN@4445]H
M?RZ%0W+;;>X;IMAE.?I&QJ:J.IOY>G7SYQMM+@Y^D+G^E!=-.4X)=9Q7WM(_
MS//^"[>N_P#"0?M[Z])O\P6&E>1G.=IBG48]NGX"OL'_ (-O_!']O_'/6O$#
M0%OL-Q< .5SCRY)SU^N.O\\U^;G_  5QUO\ MS]N/XF7&[>+6XO[8<YP4N@,
M>@(]L_X_O%_P:_>"LGQKX@EAW9O;X*Y7'_/RW!//3\/PZ?SWD]-8SCV<WJOK
M%23_ /!K=_R_$_V3\3:[X=^B!E.'7N.>44Z:2T_YA:-);6^S-Z['N7_!RM\/
MOMWPVTKQ6(<M9^1!Y@7.!B,GDCKGGJ/UK^)'0_F;1<]1J-K^&)AGU''']>]?
MZ)/_  <"> QXF_9.U*ZC@#S6MTK[@NX[4B!../3G]>U?YWFFQFUO[.W8'=;:
MG&".?X9^<^_KC],5R^)V&=/./:VLG4H5+^KBGTUV^>G30]OZ"&<_VAX89A@)
M3YI4,#C<-RWO;V<X.*2UO\4C_4;_ ."2)7_AA7X*8QDZ$N?7.V/]./:OTLK\
MCO\ @C=XNMM8_8T^%.DQR!I+#1U1P&SM^6(C/Y<?6OUQK]WR&2EDV66Z8'#+
MYJC"Y_DGXMT*E#Q,XYC534I<4YW-)_R/,*_*_FO\^I_%Q_P=/V6(_@_=!1\]
M_?C..X63_/7K]*^RO^#9R[W_ +,-Q;9^Y>7;8^I_IS[^OM\O?\'4%KGPW\'+
M@ _+?ZESC_KIW_SQ^GOG_!L?=>9^S_JMOG/ES7+8],M_A_D5^881\OB?C--Y
M)+YX.A*_WG]RYP_K'T$LKN[NCB:<M>GL\UQ,%;[_ ,3^J*BBBOV8_P U0HHH
MH X_X@Q^;X&\7Q8SYGAS6$QZ[K&<?UK_ "EOVYK :;^U9\6K/;M\K7KIL>F^
M[N3].Y_SS7^KKXQ3S/"GB.,C(?1=17\[66O\KS_@H_9C3_VS_C- %P%ULL!C
M PT]RWZY_P XK\6\98_\)V63M\-><;^4N2_Y7/\ 3G]FEB.7C3C7#7_BY9@Z
MK6O_ "ZJ54O+1S/B6W3*W'^R,_GU%?O%_P &\EX;7]KYHB0/M#6BX]<$<8_^
ML>:_"*V^[>>ZKC\"<_GG]*_;'_@@1?BT_;1T6(G'VF[M4QD#."#WK\EX3E[/
MB?++=<527WU%Z=_OL?Z*_2/H+$>"_'T&K\N2YFTO^O>%4U\_<^_R/](NOC/_
M (*!WOV']D'X\3;MN/AYKN/KY2?_ %J^S*^ O^"F]_\ 8/V,/CH^<>9X"UR,
M>Y\E,?Y_0C-?UEF\N3*LQE_+@\0_NI2/^>;PXH_6./N#J%K^TXER:-K7WS##
MG^6)XBG-SXAUF;.[S+V63/MQFF:#'YFNZ,F/OZA;?^C5'^-4+ER]]>R$YW.Y
M_P#0?YUL^$T\WQ1X;BQG?J=FN/K.G'Y&OXIC[V*CUO5B_P#R9-'_ $\U/W.1
MSB_=]G@&M]/<IQC\E:]S_4F_X):V_P!F_8D^":8QGPY%Z]EC]>>_^>@^\?$:
M[_#VO)_>T;5%_.RG%?%G_!-:V^R_L9?!:(]5\.0<>GR1FOMK6EW:/JR_WM,O
MU_.UE%?VGE,>7)\OAM;+\,O_ "A$_P"8SQ!J^T\2.+ZN_-Q=G$K_ /=4K'^5
MK_P4IT_[%^VY\6K;;C.K3OC&,YN;ILX/'^<U\+(/GDSZL"/H?_KU^CO_  5=
ML1IW[?'Q8AV[1]NR1Q_$UT?Y_F>]?G$#B20_]-'_ )U_'V>1?]L8R/58ZI%Z
M+;VS3T\DK'_2)X/U%4X"X2J[J?#N4U$[[N>!PTD_OEYG[&_\$*=0^P?MN>%(
M]V/MFH6D1'K\^>1W'7KP/:O]+FO\P_\ X(O:C]@_;F^&29QY^OV4>,]?F[__
M %_Y9-?Z=R'**?4"OZ#\)I7R#$+?EQK^YTXL_P >OVAE#V/B_E4[:5>'T]%U
M6)DCQ#]I:3R?@'\69?[G@K6&_*'WK_)X^-LAN/C;\09.OF>(;WGKQYC5_JY_
MM7W'V;]G'XQS'C9X$ULCZB#_  S7^3W\4)Q/\6/&<_\ STU^[.?]Z5O\X_"O
MFO&:6N51_P"G59^G[V"_&Y^T_LTJ'[GC_$=LPRV"T[82I+\SSB[7RVNN.!N'
M_CIK^]+_ (-E-/\ LW[.OC&ZVX^U2V3 ],X:+GWX[FOX,=4.#=D<\G^1_IBO
M] 3_ (-M+#[-^RK>76,?:EMSG'!PT/0_K_A7S?A1'FXD<OY:-3Y?N[?^W'[9
M^T#K.CX)1I7M[?,L$K:J]L71GMW]S\.Q_211117]-G^& 4444 %%%% '^?C_
M ,'*FH?:_P!IWP?:[O\ 4:?=+MSR,/GGW_GG K^<NY&T6_\ M#/?L>!^6:_?
M7_@XJU3[=^U]I=N&W?9;>[3'I\S$<?R__57X&W?(M/9&)'UR/\_6OX_XXGS\
M29F]_P!]+SVE%?H?]'OT6*"P_@GP)36G_"=@UMTG!SVTO?VKW_(_3K_@B[IW
M]I_\%'/@Q$5W;;R[8\9QM2W/8?CTK_3YT]?+L;-/[EM OY1J*_S0_P#@@]IO
M]H_\%'?A9,5)6UN+TMQD#=#!W_3TQ^(K_3$A&V*)?2-!^2BOVSPEAR\.S?\
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M4#\1",R*/7!_*OV:_P""$"AO^"@7PW3UNYQCV$<)_I7XS?\ +9/H?YU^S?\
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M?\*43_F!X[I2H<9\4TYIQE'/LTNGYXNJU]Z84445WGR84444 %%%% !1110
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M_P FPHHHH *I:E'YUA=Q$9WPNN/J*NTUQN5E]1@_3O073ER5(2_EG&7W-/\
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M +C'@KP^>F.NG05]+5_:65JV6X%=L+1_](1_S <7UOK'%/$5;?VF<YC*_?\
MVJJOT"O\UK_@O/IW]F_MOZO)MV_:XKN;IR0TL=?Z4M?YS7_!Q%I1T_\ ;.LI
M]NW[3H\DN<$ YFC'MGK@CGG/K7Y]XKPYN'(.WPXF/XQM;YG]E_L^\3[#QHQ%
M.]O;9)4T[NE6C/\ #<_!<GY\^AP?TS7U/^Q5J7]E?M.?"V[W;=OB;1H\]/\
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MK^E>OXG/^#:GXE'^VO&GAVYN" EU:I#&6[;8AP.GX^W!K^V%&W(C#HRJ1]"
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MNW^F/YUJ7FCS3Z:FHHF428*6 XR!GGJ/KZ=^U?A6$3G5;6Z@[_\ @._X7/\
M6?-:T<+EK<FH\N(PW*]%[SJ177KT]-#-F((!']W'^?SK4TZY,%SHMQG'V74K
M20=ON2AL\<\8S^%94O,"D=< 9]^O]?\ .*C+LEDS#AHI$<?\!)/''\_6LJ4[
M5*4^U>E?_MV45^:_R-\RI>VPV/I:M5<LQ?3K4P_ZZ'^F)_P17\9_\)9^RIX;
M_>^8;+3[6,C=NQ\D0Q7['5_.+_P;H^+CKO[,US922[Y+-+6/;G=MXB]>1Z=
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M-UA;#TB _7_ZY]^*_P!!/_@Y@;_C"70%]?'5N?\ R%!S7^?#;DM81 ^G\_\
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M/E'EM^?WG_/%]*[*'E?BIC*G)R_VA@L/BY.V\YN:D_734?1117UY_,P4444
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MO[RL1_Z%WKY]UW59M/F:.-RH=B.OJ<>G_P"OFN=.MSNGE&0X;@C)YXQ_]?\
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M-2K_ *U_H/UY_F::_63_ '!7\_Q=YI?X7^*_S7I8_P!=9Q_=>LJD=+[))?\
MMB/[:O\ @V';/@?Q</\ 8N/YL/YYK^N6OY%_^#84_P#%%>,/:.X_]"D-?UT5
M_7?AYIPGEG^&;^^1_P ZOTQ'?Z0/&_E6PB^[#Q5@HHHK[8_F$**** "BBB@
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M_P#24?\ +IC_ /?L;_V%XG_T],****T.0**** "BBB@#\$O^#A/_ ),NOO\
MKYNO_125_G,Z?S;6X]<#FO\ 1F_X.$_^3+K[_KYNO_125_G,Z;_J;/G&9$!/
MMS7\U^+NN?TO^O5#\(19_M[^SM=O"+,'VS7,K?\ @Z/Z%N="LN._W1[#IZ?T
MK/>7#%3[\=_3H:UKSB=O^NF/_'B!7/7!(N6'7+ X_7@_Y%?EE&GSTY.VT[?<
MOZ^6Y_?N.K?5XTI?S<D7Y\T(NW_DI9\["D>QZC_Z]-2;"8YXS_GV]?UJG(Q#
M$>H'7I_G^1J/<W'(_'/Z_P!,52I75^]GMY+_ #7W^9Y<\P<9_$_<3A\DU_\
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MOK_5E\OTL_X) \_MY_#$#_GN?_1T1K_43TG_ )!6F?\ 8/LO_2:.O\NS_@D
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M1^R%KT.<^5XH*8],1R\8S]/7\\U_G^W@_P!$F_ZXD8_+)_6O[S/^#8O41/\
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MQ-NP=IA\-WS9Z?\ +%Q6&*GR8:O/;DHU)?=!L]GAVE[?/\EH_P#/W-<OI_\
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M=/GX5H=U7J)_^ 4_ZN?X+_3EI.GXY8R37\;(\MJ>KY\3%_/17N%%%%?HI_'
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MIR"8)$/\4?3\/_K'VY%(1]_CJBG\>!_G\ZD!RV/]A<_C_AR*C7V4Y?RRI/\
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M+,OE_-@\._OI19_R_P#B+3=+CWC*G_)Q-G4?NQ]=(****[SXP**** "BBB@
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MK_.6TX_NK;_9VG^?./Q_2O\ 1I_X.$_^3+K[_KYNO_125_G)V!Q#&?[L8/\
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M1BI>U\;N!]/X>8RK?^":<I_?H?PM6C!;"T&>@/'U(/'\J]6^$=M]O^+/PRM
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MPC\Q_P#7JC;JT)NXCP8KR1,<\8=A5HGES_M@?F*^+KPY*]56^W+O_=?7MO\
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M"3=<^"M-/_D.O\H#PD?^*S\''_J-67_H8K_5Z_81)/[)7P./KX(TS_T77O\
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M]\,#CXL?#O/3_A*]%'YWL7\SBO\ 6"_9 7;^SM\,A_U+MB?SMH:_R>?A@?\
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MY!X\7Z>Q].7'^17R->*%FQZ1Q_AT_IVK[*_8)3/[7GP7[?\ %4Z:?S89^O\
M]>OYFRI6S/!/_J-PWXUH,_W'\0)<W W$Z_ZIK.'_ . Y?6C^*C_6Q_JF> O^
M1,\-?]@FU_\ 0*ZZN0\ ?\B7X9_[!%I_Z!77U_;%'^%2_P"O</\ TE'_ "_8
M_P#W[&_]A>)_]/3"BBBM#D"BBB@ HHHH _!+_@X3_P"3+K[_ *^;K_T4E?YS
M-@G^@K)C^ +G'7GZ?UK_ $9O^#A/_DRZ^_Z^;K_T4E?YTFG+_P 2='Q_&HS^
M7^-?S7XN_P#(]A_V#T?_ $B)_M[^SLU\)\0N^>8Y??62*LH^:W'JR*/?H,?D
M:_7OX/?L_3>)OA?HFMBQ:436L9W>63G()ZXZ?GU ]17Y#R#,UF/6ZB7\S_\
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M_ _BP_; \#/X$^*EQI+0^29(I90I7;_$!T]>>OKZX%?+EO'DE>O<]NF?\/\
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MB/G\AUK\PYEVX&",DL>.^>/\^F,5^P7_  70TO\ LS]N_P 1';M^U6MU/P,
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MOAA7]OX=<"XF_P 61Y;&_P#W)X>_Y_Y'ZP_\$0=2_LK]N_P;-G;OMFA_[[E
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M?]; /Q_PK_0.K_/X_P"#G9=G[6WA;'0^![)N<?WX.3BOSKQ1UX6J1[XW"?\
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MX-5_9O\ <_!_U_PWK>EQK4LOWTOL_:\J/_R/G^9\GM\/XB9?W YM5'W>/?\
MR?3WK?\ "7@2&#Q+8R^0 %MX@3M]_P!?Y<9]*^D3X7'S?NS_ *L#[O;WSWX/
MZU<TSPXL%_#,(\%44=!V_P#K?YQP5_9JUO'K%VL^DHO]##$\8U*F'G!57K&2
M^+I*'+MZ/]?7_/\ ?^#AO2UTC]L30E"A!/X8=Q@8&#+%^?4#'85^#EJVVY8^
MB./Q.<?SS^%?T+?\'+-K]B_;$\%D<>=X.1\XQUFB_P ?ISVZ5_._&Y5V/3!
M^O;^?_ZZ_F#C6E['B?,DO^@B:M_X#]V__#'^[OT7,4\=X)\&8B3YI5,GP+N_
M^G?M$_\ TG^K'Z6_\$?#_P 9\?#7WGD_]&Q&O]0S2?\ D%:9_P!@^R_])HZ_
MR\/^"0!Q^WI\,S_TV?\ 6>*O]0_2?^05IG_8/LO_ $FCK]H\(E_PBXI_]/X+
M_P DN?YG?M%'_P ;/R*'\N4U_P#U(C^?Z&A1117ZV?YY!1110 5Y9\;YOL_P
MA^(T_3RO"6L/GTVVKFO4Z\4_:.G^S? GXKSYQY7@C7G_ "LI*QQ+MAZ[_P"G
M-7_TB1ZF1QY\ZRB%K\V:8"/WXNDC_*2_:8OO[0_:&^+-UG=YOB6\(.<Y_P!(
ME!]/Y=:\-<X1R/[C?^@FO0?C#??;_C%\1[HG=YGB+4#GK]V[F'^>?YUYR[8M
MY#S_ *MS[]#7\19JN;,L5+^:NG]]O3NON/\ J"\.8?5>"\JIVMRX-RZ_8A"'
M9?A^-M/[:O\ @UFTWROAQ\5[_;C[2NG_ #>NV2'OW].!G^O]<M?RJ?\ !KYI
MWD? 3QA?8Q]K$/..NV6 <GU_/IVK^JNOZSX#A[/A?+8_W:TMM^:M.7ZG_/;]
M*:LZ_CGQQ4O?_:\(E_V[@<,OT"D/0_0_RI:*^P/Y\3LT^S/\WG_@X.T[^SOV
MY=^-OVK06ESTSOGBY[?XX]J_$2];+0]>(MOTXXK]]O\ @Y+T[^S_ -M3P],%
MQ]I\*0/['=/!SP.>I[_7G K\ )VW8/\ =(7\\8_Q]\]J_CGC*E[+B#,X_P#4
M15_"<?\ ->1_TA?1AQ'UKP6X%=[\F38&?G[U"2_]M_JR/HC]D"^_L[]I?X27
M&[;M\6Z(N?KJ,/\ A7^L?\.[G[7X'\*3@[M^@:2<^O\ H%O_ /JXXK_(]_9\
MO3I_QY^%EQG&SQGX?&?;^TH,]Q]:_P!9[X'W?V[X4^![G.[S/#NE'.<Y_P!
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MOX+C\GPIH,6,>7IL"XY[ U_E/_\ !.J'[3^V[\%DQD'XF::,8SQYK>O3FO\
M5PT"/RM%TR/^Y:1+^0K\S\)%^XSN7_4707_E%,_N/]H=6<\X\,*5](\/9E)+
MM?')?IY^IKU\S_M<:$OB#X$?$"P,8D,WAS5D"D9R6LY5&.OK[=.M?3%>??%+
M2O[:\#>(M.*[A<Z7>1E>N=\#KTP<]<8_+FOUG%P]IAJ]/^>E./WQ9_GOP_BG
M@L[RG%I\OU?,,+6OM;V=:$OT/\D[]HWPXWA+XJ>.-%:/RC#K5_\ (1MZW4[#
M@\\?4\]>]?U1?\&SWQ ^QKK_ (4DFP;MK8+#N&3M:W/W>N./Y]Z_GN_X*<>$
MF\'?M7_$32Q&8D_MB<A=N!\\LQ/'09_'GZBOTS_X-X_'IT7]I;3/#1GV)?RJ
MICS@-M$!Z$_J,\_6OYIX7E_9W&4*3O%/&RIKI>\O8]NE_P#/<_V^\>**XT^C
M36QZ7M94^&J.+NO>=Z>'IX^]^_[N_7RZGWK_ ,'3UWG3?@W #TOK_CZI*>1Z
M_P P<>]?5?\ P;+0;/V<+^;'W[FY'_CP/^?P]:^)O^#I74%EN/A! #PMU=D#
MV9)#]#7WK_P;06Q3]EJ6?&-][>#./]KI_G\*^^PROXGXA?RT7/\ \MZ']>7W
M7_E'B!_5OH)9*G:];'8>GZ^TS/&2_P#;;_BO/^G*BBBOV _S7"BBB@ K^ ?_
M (.7[3R?VD?"%QC'VB2^.?[P"3_RZ?C7]_%?P8_\'.EIY/QW^&UQC_7MJ1SC
MJ )?Y8/^<U^=^*"OPKB7VK47_P"36_4_LKZ"=3D\?,FC>WM<MS"'K[D9?^V_
MKT/Y@1_K&/J!^G_UJ]F_9SN?LWQX^&\V<;?$%B/3_EYB_P#UUXR3AT]P1^7_
M .NO1_@E<FV^,?@";.-OB&QY_P"WF(=^.GUK^7\L_P!^PTNOM*;OZ2B_T/\
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M\6?^QPU[_P!.$U?ZQ_Q:!/PY\8 ?] '5/_2&XK_)O_:H_P"3B_BL/7QCKO\
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M'^1KHJ_MBC_"I?\ 7N'_ *2C_E]S!WQ^-_["\1^%6:"BBBM#C"BBB@#^??\
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M(\W%7#D>^=9:O_+ND?Y@GPD?/[:FA'U^)5J?Q'B&//\ *O\ 5C\!'/@?P?\
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MO?\ F@KOKOS_ *=3_0;_ .#;^^^T_LH/;[L_9HXAC/3=)!Z<?I7]'5?S+?\
M!M'>^?\ LU^(+8'BW%J,>Y>#/'Y_C7]--?V)P5+FX8RAK7_9DO\ P%M?H?\
M-U])VE['QU\18VM?/)U-K?Q*%&?_ +=N%%%%?4GX*%%%% !1110 5_#%_P '
M/J[OBG\.#Z27PZ=,QS\_K_.O[G:_AL_X.=TW?$[X?-C[LEYCIU*3U^>>)_\
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M7'?ZC)(&VX4_--WP!_/K]*\T_P""+7BX^%/VT/ ]P9?*26[522VT$DVX _\
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M<_R>"BBB@ HHHH **** .;\2Z;'?Z5J,;J&WV-VO//6WD&.1[\#_ "/X"?\
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MNOKD? /_ ")GAK_L$VO_ *!775_;E'^%2_Z]P_\ 24?\NF/_ -^QO_87B?\
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M_MW>&OF""?3HX.N,[IVXQ[]/Q]\5^/2GY5_W\?S&/YU^G?\ P1XU7^SOVZ?
M3;L>?/9P9)QG?<'C\\]/J*_&>%%R\09=/MB(/T]^/EZ_@C_2SZ05+ZSX4\3T
MK-\V48^+TNKO!2;[_P I_J&6YS;P'UAB/YHM?YT?_!Q#J'VO]LJ"WSDVK7BX
MSG'#G\..WUK_ $6;,YL[0^MM ?\ R$M?YMG_  7YU'[9^W)K\&[=]DN[E.O3
M(8?KS^?'8U_0?BI4Y>'*<?\ GY7Y?6U*4OTN?X_?0)H^T\;7-+2AECGZ7QM"
M'Z_YGXG-_K$/8*Q/Y&OW-_X-^M.%Y^W#X4N2NX6MTQSZ9CCQ_DU^&+GEO]D#
M\,C(_P __6K^@?\ X-TM/^U?M@1W6P-]DEA;.,D;DA''I7X-P5'GXCRE6_YB
M\.__  &K!M?D?ZW_ $FL1[#P6\0:E[7X=S:-]M:F"J4?SNE]WD?Z(PX 'H *
MH:LN[2]14C@V5R/_ ""]:%4M2&=/OACK:7'_ **>O[&EL_1_D?\ -G2=JM-]
MJD'_ .3(_P I?_@HG%Y/[97QL7 !/C+7#^=UV_#G\?3%?%,!^9C@\N<?CG%?
M<?\ P4LC^S_MH_&91QN\6:V_O\UUG_/^-?#2<$@_W=WX>O\ .OXIX@AR9WF"
M6G^US[]*K?\ 7R/^H'PBJ\WAUP;;>&1Y>N]G+!8=?UIKYV/WI_X-YKGROVV;
M>/)&[2+KIW^9O\]Z_P!&&(YBC/JB?^@BO\WO_@WTNC%^W+IJ;L;]&N2>V?WC
M<#]*_P!(*#_4P_\ 7*/_ - %?T3X5ROP_4CVQ=1_?&%OZ_I?XP_M 5_QNVG*
MV_#V!2TZ>UQ#_4EHHHK]./X8"OS-_P""MPW?L0?&@8_YE:\_]!-?IE7YJ_\
M!61-_P"Q)\:1C)_X16]]?[I]*\[-_P#D5YC_ -@6*_\ 3,S] \*7;Q(X)?\
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MNQ$?7_EW^!_I:V_^HA_ZYI_(5-4-O_J(?^N:?R%35_9BV7HOR/\ F@G\<O\
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MWZ_@B_X.;AC]H3PU_OQ_^@$_U-? >)/_ "3-?_K[3_\ ;C^O?H1?\GUR?_L
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M_P#3B/[%^@M_RD#D'_8NS3_U'O\ \'_@G\HP&T1#WR>_45]>_L#(1^U[\%0
M>?&%A_Z&/T_K7R3.NQU&.B(>G&/7\:^Q?V"(<?M>_!;V\6:<W?\ O^O]*_F7
M*DUF>"[?7,/^-:#_ "/]R?$*5^!>)UWX<S>7W9;4B_Q3T1_JJ^ O^1,\-?\
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MK2[]'U1< YTZ]Z_]>TE?Y6'_  4OL/[._;.^*L17;YOB#59<<_Q7KGICW/\
M]?K7^JKJ0SIVH#ULKH?G!(*_RX_^"M^G?V9^V_\ $&+;M\Z]O)N./O7/7WS^
M%9>+M+GR;"5+:PKS7_@48V7X';^SFQ7LO$?B2A>WM\MP#MW]GB*OW_%_5V?F
MQSG'I,6_ 'M7W]_P2QOFL/VX?A:^[;YNNZ7#[G==8_S[U\"@9<CT^;^M?:'_
M  3CNS8_MK?!Q\[?-\4Z*F<X^]=>WZ__ %Z_">''RYOE\OYJT&K^56FOP/\
M5WQIHNIX;<4*UU'+L9&VK6N#K*W_  6C_5LLI,:7:2'M8P-^'DH?Y5_F<?\
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M_P#D9X-=?:T7]U6G_P ,?[H^*/\ R0_$<E_T+<<OFLOK)Z>J?X?+_6%\#?\
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M[>=,9W1.N/7<I']:GIKC*L/4&OW@_P EX.TXOM*+_%'^9%_P75T$Z+_P4?\
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M_P *^@\77;B"/_8/AO\ TE_I<_(?V=4?^-1XOSSK-MO*M1.Z^%_/Q9^'6/\
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MKC.^X<8_'_/-?E$O+#\_Z_K7Z5_\$B+S[!^W7\-VW;1<7^FQ>F=URP_'W_Q
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M!7^K3\.01X#\'@_]"UH?_IKM:_RKO@9:A_VVO#\>>GQ)C.,>GB%/P[U_JK^
M4\OP1X27T\-Z'_Z:[6OROPF_AYS_ -?J7YU#_0+]H._]J\,X]\LS*7_DF5Q_
M1G74445^Q'^;8AZ'Z'^5?Y^7_!RX"O[3^AYX+>&+8\CMOMZ_T#CR"/6O\_G_
M (.:U\G]J?PY'TW>$+1_8_/;_P#Z_P#Z]?GOB:[<+S\\?@?PJ,_M#Z"&OCE3
M77_5?/6O^W:5)GZY_P#!KF"/V6OB*?7QTV./^F<M?U)U_+E_P:]+L_99\?C^
M_P"-F/?M'+_.OZC:];@>3EPQE?E2DONG(_,/I2_\GX\0_P#L<1^[ZGA;?@%%
M%%?6'\_'^-@W6;Z+_+/\Z1OX_P#KFM!YS[]?<4USA2?;'^?PZ5_"$?LKS6NO
ME_7S9_UBR=TV[+23[[N;_P#;U_3/[:?^#87_ )$KQA[I<?\ H3U_737\C/\
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M:]OX>(AK_P"3'XM)_KF_W?Z&OJK]A.[^P_MD?!&7=MSXRT)2>>?]+&?IU_\
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MQTH5+[*U2"?KK;7J?[=_L^ZTI^#%2C*7\+-,;!=URXB,=.UNW_ -53Y:64O
M*:A;-D]/ED'/Y9_SFO\ 4*_X)#:D-1_8+^!KAMS)X?56]>D8Y]>GZU_EU3N%
MM(V/:XB?\CG^E?Z9/_!$76!J?["/PFCW;C:Z,J$9SC)C_P#U>_6O7\&&XYEF
M4&[WP\__ $NA_E^2Z'Y]^TDP;J<#\.8E)VHY_AJC=NDL%B:>OSG9>?0_8"BB
MBOZ,/\9@HHHH **** "O\V[_ (+Z8_X;6\18Z_;;C/\ X]_G\*_TD:_S9?\
M@O;)O_;9\3K_ '+^X7^?^?\ ZV*_+?%G_DG:7_89'_TB1_>G[/7_ )//CO\
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M/\97_L^5*U_WE9[=O9;^7_!/]2?V:B_X6./GT='*XW\[XG_/_/H>"2_ZEO\
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M_N/_ .#7G4_.^$7Q+LMW^INM/&W/3F+M_GUSGBM_"N?_ !DM)?S0KK_RB_\
M),R^GOA'5\$L?.U_95<LJ)VL_=S&AS-?*2U[']8]%%%?T^?X1!1110 4444
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MX+PS@Y<5Y;I=0=:;TZO"U%?[W^)_5GT[<0Z/@%Q'RNWMZV!IZ.UU_:V&=O\
MP&/0_K5J"Z_X]KC_ *X2_P#HMJGJ&X_X]Y_^N,O_ * U?U:?X$0^./\ BC^:
M/\QK_@MK;_9OV[?%XQCS+2X?Z[KA#_+WYK\G0,X;_IE^IK]@/^"Z5K]G_;M\
M0G&#)ITAY_VIT]NE?D'@^1O_ -K9G\/RZ5_&?%<.7/<P5MJ]1_\ D_\ D?\
M2K]'2;_X@]P.V_BRG!:ZMZTXOKUT\^Y^FW_!'RY^S?ML> &)P'GM$^N;D?\
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M)^T@OR/Z:^B)C:F%\=.#:4).,<5BZM*=G:Z^KU6OQ7^1_%-\#Y1#\9?AS,W
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MBBBM#D"BBB@#^?K_ (.'O^3/+GZW?_H%?YUUK_QY1_\ 7,?R%?Z*/_!P\?\
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M;7O\$V_U8RFW_0/KZ\\C\J^E"FO'3Q!OUSB^W?"X<****^J/P$_QLE_UCCT
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M4_\ 3E(^:_:2N_!O#S6W]KX6W_A+5/TWHHHK^BC_ !F"BBB@ HHHH _SP/\
M@Y!_Y/&T$?\ 4ND_E-":_GZ<< ]^,_E7] 7_  <@G_C,?0<?]"[C_P C1YK^
M?HMD =AC\^E?R!QNFN(<X2T_VB5MUO*FW^&GJ?\ 2-]%24?^()<#?]B;!Z=O
M<G;_ #^74_27_@D <?MZ?#(^EPW_ *-BK_42TG_D%:9_V#[+_P!)HZ_RZ?\
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M68*EX,<$1V_X2<)IMO0;[?WNW8_?#_@WEAS^WSH+X_U;R<YZ9MX:_P!%BO\
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MQ_XQ#<?[=U_)?\*_SLH/^/>$#C+*/PK_ $3O^#AX?\8@R-Z/=?R7^F?\BO\
M.QM^;:(_0CZXK^9?%S_DHH=OJU)/UY5^A_N/^SM_Y,[B^_\ ;./>VR]M'_AS
MK/!G_(^^"_\ L/V7_HRO]7K]ASC]E/X*CT\&:;_Z+K_*$\&''CSP6?\ J/67
M_HP5_J\_L-G/[*7P4(YSX+TW_P!%U[G@S_O&8_\ 8''_ -2('Y+^TN_W/@EV
MT_M7$_C@6U^!]8T445^_'^21_/!_P<;>'1JO[&6KZELW-ID:D';DCS)9^AQG
M\OQK_/7TQ<V$GJN!@]L'C_/^!K_26_X+R:%_;/["GQ%;R]YM[2%NF<8><GL3
MCUQ7^;38GRX[N(X 6:5,?[CL/Z=?\:_F7Q@I..>0FK^_1P\ON=G_ .DV/]P/
MV>&-5?PEQ&%;N\/G.-I6[)UL-62^^KS;?>0G[TGLF[^7ZD]:^OOV ]3.D_MA
M_ ^XW[=WC#203G'&\GD_YZU\@$\M^7ZC^E?07[)5_P#V9^TW\&[X-M\CQ?IA
M)/&,/DG/X^U?"91/DQ> ELUB,.W\J\&]O)?UH?V=XC4%B>"^*:+2:J9-F<5?
MO+!UXKYW9_>M_P %S+@7/_!/"TN,Y\YD<'N<VT)K_.=L5_T0>X8?EG']/RK_
M $.O^"T]^+K_ ()F>%KS=G[5:VC[NN=]M#SW_P#U"O\ /&L3_HB_5OU.*^\\
M6G?-\++^?!81M_\ ;B?]>I_&W[/:DJ/ASG\'O3XFS^G\XXI0_3\3OOA4N?BG
M\.C_ -31HQ_*^AK_ %@/V/3G]G3X9?\ 8O67_I-#7^3]\+#CXJ_#H=!_PE6C
M#_R>B/X^E?ZP?['XV_LZ_#(?]2]8_K;0U]%X-WYLS[>SIV^]'X_^TI:]AP.N
MOUK%?^H]-/\ %,^EZ***_=S_ ":"BBB@ HHHH **** "BBB@#R;XY:2NM_"G
MQKIKC<MQH6H#!&0<6DYYK_)X_:2TPZ-^T3\6=/*[!%XPUP*N,<"^D_S[U_K<
M>-8!<^$_$,!&1)I&H+CZVLH_K_DU_E-?M\:(?#_[7'Q5M"OEB7Q)JTX7&.'O
MI""?\^GUK\5\8J3E@<#4M]JK&_I[-K7YO3OJ?Z<_LV\?[+BKBS!N7QT\!5C&
M_5^W@]/DOPMMI\GZB-JQX[Q _P J]\_92E\G]I[X%R9QCQGH!X/<S@=1TKP+
M4&W+$/\ ID!^/'_U_P#]=>V_LRS>7^TG\#B.,>-="'_D8>_MFOP7+.;^U,#;
M?ZQ#7I:]-+TV/]7^/$O]4L[YOACD^/YNMG]6K.[^32[]/7_6/^%4GF_#WPK)
MUW:1:'/K^Z6O0J\S^#C;_AGX/;UT:T/_ )"6O3*_M[#_ .[T/^O-+_TB)_R\
MYS_R-\TMM_:&,MZ?6*E@HHHK8\T_B!_X.AU_XK#X:^]]<'_QUQ].G_UZ_%C]
MB/XF2^"=/NH$G,7F;LA6(ZG)Z'KT_.OVI_X.A>?&'PV]KZY^G*O^O]*_F?\
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MCTK^0..6GQ)F2[XF:?WTW^:^_4_Z.OHJ.4?!'@B6ULEP6K\X5+)>K?0_1_\
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MLKG]>]?Y/WQ+A\GXD?$"#IL\5:V"/IJ,X[^P_"OP/QFA^]RN7>G47_@,XO\
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M5_HE5_FY?\'!VH_VA^V\D>[/V2TGB/?!$D?'7_ZX^AQ7YQXH3Y>&YKO7B_\
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M%].(\_3']3P<U_%ECY2/2)E/XU_83_P:SZF8T^+>G;_OZI:';D=E3C'YY_\
MK8/W7AA-QXFPM]O>C]].<?Z_ _E'Z=6%]OX%YV[7<)86;\O9XS"3_P#;6?VC
MT445_5!_@2%%%% !1110 5_FN?\ !>=]_P"VYXM7TU&X'TX;_']*_P!*.O\
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M5%0EOYM[^9_>I_P5^OC>_P#!*#X97F2?M.DZ4Y/KNM(B3_2O\_RS_P"/2/\
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M\O\ C_\ ?L;_ -A>)_\ 3TPHHHK0Y HHHH **** /P2_X.$_^3+K[_KYNO\
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MC?TC5KVV\I^119=\H7^]<1@^^9E'\J_TI_\ @A!I?V#_ ()_?"V3;M,POL\
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M;5X/,8-]_?H/]%_2.WHHHK]H/\R ID@W1NOJC#\U(I]!YX]:!IV:?F?YW?\
MP<;^%/[!_:RL;\1;%O=/MG)"XR7>,]?QX['ZU^?G_!-/Q^W@;X^:25F, O)X
M8SABN=\CY]SU'?GKQ7[0?\'/?A P?%GPCXF$6%DMK&WWXZD>6<9_$]ST/6OY
MN?V<=?;0/B_X6OU?8JWUIELXX\PY/M@_RSGI7\P<4<V#XVKU/A_VEU.VCE"4
M;?B_Z9_NOX)4Z?%7T7LJPU5>TYLFHTI+?WJ="<)IK79Q6FFY_JR_LZ>)HM8^
M&7ARZ\P,TNGV[9SG.5_$\]:][:\11DE0._\ ];KFOR _8J^.<.I?##PO:_:U
M9DLK2-@7Y^[WY)_SVXK[RUGXCQVE@\YG5=HSG<>.,_YZU_0N69A3K8&C4YD^
M6E!R?1:+SZ^?WG^._&O!V-R_BK,\(Z,ESX^NJ?N[Q]I9-:>:TZ>C/GK_ (*"
M>/$\,_"O5[E)Q&R:;>L"' .1;S$=QUQ_];K7^;-^U?XX?QQ\5]<U!YO./]IW
M2Y)W?\O$P'.3W./\\?VO_P#!4#X\Q3_#36]/CO 6.GWR;0_K!-VS_CTZ>G\#
M_B2^?5O&MZ[L7-QK$JC//,EXP&?P;U-?B/B3F'UG,*="$KQMM?3F_=Z_I?I^
M7^I7T'N#GDO"U;-<52Y,1+$02;C9^SE*M>S:V]W\/0]J\>^&Y+'X)?#_ %?R
MROVNYO@SX(R >F<<C\O?I7U=_P $C?&9\(?M:^!HA-Y2ZGJUI W.-V7''^>O
M7VKK/CS\(Y-+_8T^&FOFV*B#[7.SE>!YBJV2<8[]<?6OCW]B'Q$WAK]I_P"%
MNIAR@AU^S9FW8&-XR3_D<_K\1@XSR_-<OG+W;_5I_)3IKKN[7^[YG]*YM7P_
M&/AYQMAZ;56,,5Q)AK+6SYL=)+KUY;?>?ZR7@^[6]\-:-<*0PDT^W?([Y0'-
M=+7@/[./BE?%7PS\-WZR"3=IEH,@YS^ZS_G_ .M7OU?UQAJJJT*51;2A%_\
MDJ^\_P">/.<)+ YKF&$FFI4,77@TU:W+5DOZ^X****W/,"O@7_@IO9_;_P!C
M#XP6^W=NT65L?[MK=FOOJOC#_@H'9F^_9.^+-OC.[P_>-C&?NV5V:\_-5S99
MCX]\)B%]]*1]?X?S]GQSPA4_DXCR>7W8^@S_ "A[Y/+\0>(H\']WKFK#Z?Z?
M,/Z&H6'R3C_9S_7_ .M6CK:[/%GBY/[GB36E_P"^=2NA_2LW))G_ -S 'TQ7
M\5UE_P *&(712E]^C7XL_P"G[A_7AS*>[PD%\G1L_71*_D?V>?\ !MCJ'E?
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MCC^?Z&HY/]7_ ,">OX06Z]5^9_UB2_AMW?P=^O+2NO\ R:7]7/[</^#8<?\
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M,'I,/7J"*?;G%O$?]I<_3V]ZBO01;R'_ *:D_GZ_E7\>+2K&/555_P"E1/\
MI#K+FRZK+_GY@TWW?[E:W_'_ #/[J/A+K/F?\$73\W^I\&O#UZ$V3C\L9_/M
M7\-DLFV_U5O74+_I[W,ON*_M+^#>H'_ARWJ)W<)X?\OD]C:OQ_\ 6Z?6OXKK
MG)GU$^M_>?\ I3)G]#7Z/Q[+FPW#3[950O\ /E7_ +;OU9_&'T2,/[+/?&VR
M2YN/,TLUUM:7_MR'6!WZGIB8Y;5+!?SNXA^>3]*_U%?^"1-G]@_87^$4&,8L
M7;'^]%;G_)K_ "Z]'7=K6AK_ 'M;TE?SO[<?UK_5"_X)?V1T_P#8R^$MOC&-
M(A;'INM;4_KU_&O;\'J5LVQ\UTP<EZ<U2B^W6R^X_*?VD6(OP!PA0;OS<10F
MM]H8/%)Z?]OKR/T%I#T/T-+17]$'^-B=M3_/N_X.9(O(_;$\,,!C=X4L&'XO
M#D]N?U]??^<F1\W&[_@9]AGW^OK7]*/_  <]6AC_ &L?"=T!P?"NGKG_ ('#
M_/O^E?S5E>-_JF.GU[_TK^2/$*/)Q/F%K:5Y2^_D_5[:'_19]$:JZW@3P-.]
M^;(\!!O_  ^TC;\GYZ['OO[*LYB_:6^$DF>OC+0SR<8_TV,>OU[_ (U_K"_"
M.7SOASX2D_O:+89^OV6$5_DS?LS.8OVA_A')G'_%8Z",]/\ E]C]^V<U_K&?
M!%_,^%G@MLYSH=AG\+6(5^D^#<O]GS./_7IVU[O^OGYG\,_M)()9OP5/2]LP
MA_Y+A6_Q/5:***_;C_+D**** /X__P#@Z"\'>9X%\%>*EARPUFVMC+M/14B.
M,D?UQS7\7W@C4FTOQ%H^HAMK074)#9_NG\AZYK^_K_@X_P# Q\3?LOZ'?1P[
MI-/UXSE@N2%2.,=1R.AK_/?=FM'"J2K0SX]_E]^WY>E?S;XF4?J_%/MDK*=+
M#3OYRIIOMU6O;N?[??0IS".;> U# -\TL-/,<-*-]N3$)4U9O^5M_P##Z_V(
M_P#!/+]H62[\/Z-8-?$B*6VBV^:>!D]L^P QG@?C7[(_$3XNBT\+74XNL;50
M@[QQ^[SQSS^'KQZ5_';^P#\4)M&DLXY;IE"WT. SG& Q[9_#CWZ]_P!J?BG\
M<EE\'7D:W8W%%Z2<_P"KSS@Y]_;/Y^[P[GK_ +'Q*G/WH0BDK]$XK3JO\]C\
MG\7O":#\0,#+#X;]W7JQG4:AI>=6FW>RZ^G3NT? W_!0C]H*754U?2OMQ8,D
M\>T29X99!C&2>_\ /\?YW=+1K_QCIH4$FYUVS4XZ_O=0C!_$AL9_E7V'^UQX
M\N=9\47_ /I#LCRMQN)')8>N#V'TY^OSI\#/#TGBKXF>$].1#(\NOZ6V "20
MNH6QZ8^F>G6OS7-<7/'YES-W_?**L[Z2Y/\ )?FS^T^ <APW!G!48PBJ48Y<
M\3/2VL%4E)OSU_X<_J%_;"^"BZ;_ ,$RO#.M+:8>ST""Y#A.AEM8F)R1P>WO
MUZ\5_+?\&=8?P]\3_"6K!O+:RU6UDW9QC#J.I]R?U-?WS?MG_"I;_P#X)<1:
M1'; S0^#K X"?,"MA%STSGCW_F*_S^=3MI/#OC 6^#')9Z@%[@C9* >1W&/H
M*^CXWP+R_'Y5.$;)X'#RNEHY*2D^VJ2[]C\2^BQQ-_K;PGQYA:]3GFN+,\BD
MY<S=*M=+372\WY._F?ZC7_!,OQ@?&'[//A>_,OFG[%;C=G/2$C&?UK](J_#[
M_@AMXI/B+]ES0PTOF-;QI&>2W"Q,.3GK]1].M?N#7[]PU6=?)<%5>\J2_)'^
M/_C%ERRGQ+XOP$8\L:&<XN*6MDG4D]%I9=D%%%%>\?F85\M?MH69O_V:_BG;
MXW;O#.JMC&?NZ=>'I[=:^I:\!_:BM?MOP'^)4&,[O"NMG'KC2KVN/,%S8'%Q
M[X>LO_)&?1\(5/9<5<.5'HH9WED[_P"'&4F?Y)7B=/+\;^-T_N>*M>7\M5NZ
MY\-_KB>P(/\ D>QKK_'D1M_B/\0(",;/%WB'K_V%[S_Z]<BJ\3<=5;G\./Z?
MYS7\38G3&8E]?:*+^=E_2/\ J'X=?-D&26NT\(G]U**_7<_KE_X-R+LK\+/C
M6A/^K\/:J^/JLQ/\N/?WK^9S]J6X,G[3GQM?/W_'>N#C_:N,_P#ZNM?T?_\
M!NK<F+X;?'E,X\OPKJK#J/X)OZ_YYS7\U'[3$A?]I+XS29X?QYK9S_VW//MQ
M^0XK]$XD?_&'<.+^]BG\N:/G]Y_&?@E2?_$QWC-4:U5#AU/RO%R_S7GHSPZ_
MSY#GU;'Y5_I2_P#!"&S^R_L5>"VQ@3:;9OTZ_*>?\\CBO\UZ\0F(+_><$?CT
M]?\ Z]?Z:7_!$K3_ +#^Q'\-#MQY^A6,F<$9RI_/Z_Y/I^$2OG&)D]U1E^,:
M?^?X'QW[1FLH^&.30O\ QL]PZ2MORJ<OPLGWW/V#HHHK^CC_ !2/.?BW&9OA
MMXSCX^;PYK Y_P"P==5_DT_M-P?9OV@OBO$> OBS7#],ZG<8K_6F^(\?F^ _
M%L?][P]K QC.?^)?<\5_D[?M>VAM?VE?BO"1@'Q1K)(QQ_R$KC'IWQ^&,BOQ
M;QBAS8' 2[59I?-TVS_4+]FQ7Y,^XYIWU=+*Y]-E#'KK_2/G,-\X89^49_0U
M_2A_P:_W1/[7/Q&@+<?\(/<OCZRS_P#U_3K[U_-;C#/C^Y@?@./YU_1O_P &
MP4A7]LOXAJ20&\ 3G_R++_C_ )/%?EG '[OBG*Y;6Q%/[G&=OS7Z']U?2YBY
M^!?'DUUR'%IOTK86WX;+<_.7_@KG<^?^WA\7AG/E>(]73OVFB'Z?K7YNQD9E
M_P!TG^O]17Z$_P#!5V0S?MX?&O!SL\6:VF/3$T9Y[?Y K\\EX$A_V6_5?Z$=
M*\_B63EG>8]?]JJ.WI4:O^'R/N? _FI^&7!M]EDF 7_F.PS_ "]+G]='_!KU
M9[_$7Q#O-OW=149([%1T/^?Y5_;=7\8W_!KCII:S^)=_C(758QNZ<%1QVYK^
MSFOZ6\//^23RV762K-^OM9+]/\C_ !&^FA557Q]XL47=4Z>7P^?U6$VO_)PH
MHHK[8_E,**** *MZVRTN&_NQ,?3M7^5__P %5M3_ +3_ &[?C2=VX6WC#58O
M7I(O'7/O7^IGK\P@T74ICP([25L_05_E*?\ !1J\.H?MP?'J?=N \=ZM@Y)
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M^QX%J\G$F6+OB\/_ .G8K7RUW/YN^E7A_K7@?QQ"UW#(<UJ)=;QP3E?\]?\
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M\_[.K/;?=_B?ZR/A$;?#.BCTL(/Y5T5<]X3.?#>C'UL(3^AKH:_M>C_"I?\
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MKC_QX_R-?U__  -E;Q%_P0\\=\F3^S;O45/?:(K$^N>@_K[U_'[:_P#'JO\
MUT/_ *%7WW&SY\'P[5DW>KE6'N_\$I1\K]%^"/XZ^B9%X;-_&3 K_F&X\S6\
M=K>VE2J_CS7.[^%Q(^*_PZ'?_A+M$7\[Z'/\S7^L5^R(-O[//PS'IX=L/S^R
MPU_DZ_"_GXL?#KT_X3#1/R^W0C^M?ZQG[(YS^SU\-#_U+MA_Z2PU]SX.?\S+
M_!3_ #/YD_:3N7_&$KI]:QO_ *:C;\-3Z1HHHK]U/\H@HHHH **** "BBB@
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M==34%A>'LRC![>_'"MP2UT=]M?,_N+^/WPV77/V-KSPH;?>J>$D01[?^>>G
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M^VJG\>/Y5^U7_! [4_[._P""@7A"/=M$L%X.N/O+'P<_AV/IWK\5H_\ 6?\
M;9*_6?\ X(F:D-,_X*$^ 6W;5D%POL=QA7_)]^^:^@X1J.'$F6.]K8BC+[J]
M+OU1^"?2+H?6?";C2BU=3X=S:/SE@JZ7Y+[[=3_3?MSN@@;UAC/YHIJ:JMBV
MZQLV_O6MNWYPH:M5_9BV7HOR/^:V>DY+M*2^YL****9(4444 %?YLW_!?"/9
M^VOXG;&-][<G]&_+O_G-?Z3-?YMO_!?4@_MJ^(\#_E\N?Q^]_G\<=J_+?%G_
M ))VE_V&1_\ 2)']Y_L]?^3S8_\ [)VK_P"I='_AC\01R5S_ !8./;O7[)?\
M$+/^3^_AM_U^2_\ HN"OQM7K%_NG^H'ZFOV3_P""%?\ R?W\-O:\E_\ 1<%?
M@G"/_)293_V%T?\ T]3/];/I#7_X@MQ^]4_]7LQ?G_R+ZLOS;7?<_P!+>W_U
M$/\ US3^0J:H;?\ U$/_ %S3^0J:O[,6R]%^1_S13^.7^*7YL****9(4444
M%%%% 'GGQ8_Y)UXP_P"P!JG_ *13U_DV_M3J$_:)^+7I_P )EKI_'^T)\_6O
M]9+XL?\ ).O&'_8 U3_TBGK_ ";?VJ&S^T1\6\?]#EK_ /Z<)OZYK\.\95>A
ME3O:TJ_XN@?ZF?LU5?->.WVAENGRK?J>!G.&&.BY_ BO[%/^#6<D1_$4=/\
M2M0/UR;@?Y^M?QV_W_\ KD/Y5_8E_P &M/*?$3':XOP?KNN*^$\,/^2IPO\
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M/\I?HC^S/H+2<?'+ 6ZY3CO_ $[A3^=6[78D9QCY=QZ>W_UZ]I_9MCS^T?\
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M/F[_ ()R_#Q?AW\*M2TQ8/)$^I++M"[<X5SG'U/KZ\8K]%:\C^#_ (?A\/\
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M,+_^DJ^W^?["4445_1)_C$%%%% !1110 5_#1_P<]/M^*'P\7^_)>C\DG_\
MU5_<O7\,/_!S]G_A:GPX _YZ7_Y^7/C\?\]J_//$_P#Y)3%?]?:'_IQ']B_0
M6_Y2!R#_ +%V:_\ J/8_E/0\@]C_ )Q^=?8?[ 4F/VO/@P.>?%]@/_(G3'IQ
M7QT!M$6?[V?ID5]>_L# K^U[\%<?]#C8<]/X^?Y_K7\QY3IF>!\L7AU_Y7IG
M^YOB'/\ XP/BE7^+A[-Y??EM1Z_?ZG^K+X!X\%^&AZ:3:_\ H%==7(^ O^1,
M\-?]@FU_] KKJ_MNC_"I?]>X?^DH_P"7C'_[]C?^PO$_^GIA1116AR!1110
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M_G-?R#QQIQ'FB7V\1-->:=-_U]Y_T=_15G)^"/ ]]5')L$_NA4?YV\C])?\
M@D0VS]O#X9'UN#_Z/A7^7-?ZC.D'.DZ8?73[+_TFBK_+C_X)&9_X;N^&./\
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M,9X_M>R.>_\ G-?ZTOP9MA:?"OP# !C;X2\/=L=='LJ^\\&8\RSBMY8:-_\
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M^>EW0_K45%>G47>$E_Y*SKP$N7'8.7\N*P[^ZK!G^2?^T] ;7]HKXJQ8P/\
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M3X9RN*6]*4O_  *I)G^ GTF:GM?''Q G>_\ PK4X_P#@."PT?R04445]6?A
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MY_SZU_8M_P &LXS#\16_Z>]1'Y?:3_G_ .M7\=+?ZO/?S"/YU_8Q_P &LO\
MQ[_$8_\ 3]J?Z_:O\*^#\,/^2HPGFI+\O^"?UE].9M^!.?)[7I2_\F@_TTZ;
M']G5?/W[46F?VO\  OXCV.W=YOA761C&?^7*4<?Y_.OH&O.OBW8C4?AMXTLR
M-PF\.ZHF/4M:R#%?U%C(>UPN(I_ST:B_\E9_@OD-=X;.\HK[>QS+!5+[6Y<1
M3>Y_DC_'+33HOQL^(NED;?L^OW_RXQ]Z[G.<?Y]^17F4#;)@>I4_U_K7TO\
MMIZ,?#_[5OQ8L&38%\079"XQP9YCT_+UX[U\RD;/,?GDKS]3V_K7\5YM2]CF
MF*ALE4;Z]))?K^!_T]>'F+_M'@;(,3>[J8.-G>]U[&-5?DK6TZ;'>?#'43I?
MQ/\ !NHYV_9M=L&W>F;V#OV_K7^JS^P_KG_"0?LW_#C4 ^_=X=TI,YS]VRAX
MS[?_ %J_R=M+N3::YI%VIPT.IZ<X;.,8NXCZCGCUK_4;_P""57B-?$7[(GPZ
MN _F-'I-C$3G.-EI$".I'45^P^#M9?6,QIWWH4EZN+O;Y<W^9_G7^TBROGR/
MAC,U&[HYC.FY6^S6@UO;K[-=O\_TFHHHK]\/\@PHHHH **** "OX(?\ @YN&
M/VA/#7N\?_H!/]:_O>K^"+_@YN_Y.$\-?[\?_HNO@/$G_DF:_P#U]I_^W']>
M_0B_Y/KD_P#V 8C_ -2<&?S($_,A]1C_ #^=?3?[#\NW]L3X$C'7QYHB_P#D
M5OZ=:^8VZQ?7^E?27[$>?^&QO@-_V4'1?_1SU_,61_\ (SP;_P"GU+RWJT[_
M / MN?[H>*+_ .,'XCC;3^S<<]N^7UF_S[=C_60\#<>$= 'IIUO_ .@UU=<I
MX&_Y%+0/^P=!_P"@UU=?VQ1_A4O^O</_ $E'_+_F7_(PQW_87B/_ $[,****
MT.(**** /Y^O^#AX9_8_F/\ =>Z/3_9!_I7^=?;?\>D9/90?T_\ KU_HH?\
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MGX=8_P"AQT3_ -+H:_UC/V1_^3>_AIC_ *%ZQ_\ 26&OT/P;7_(R?]RG^?\
MP$?QQ^THFVN"8]%BL9;3M1BOT1](T445^['^4(4444 %%%% !1110 4444 (
M>A^A_E7^>]_P<IR[OVP=/'4_V58_R'^?Y5_H0GH?H?Y5_GF?\')DP?\ ;,L8
M@?NZ59'Z9 _7V^OX_GWB:TN%:_=XFBOERU/\F?V=]!6#EXX8)VORY3BV_1XC
M!I_@V?SUW,FYD7T0#Z\?ETY'UKWC]F!M_P"TQ\#4SU\<: O_ ),8[?YX^E?/
MC$M<8[;@0/09Z?E7T3^RG$9?VH_@8N.3X^\/].>/M!'H*_E_+(WS3+VM?WU)
M_?."_3\3_<7CMK_4KB63_P"7>68^"\O]EK/]-]S_ %@OA$NSX;^$4_NZ-9CO
M_P \4KTBN"^%Z>7X!\+IC&W2;4?^0EKO:_MS#Z4**[4J:_\ )(G_ "^YN[YK
MF3[X_%O[Z]0****U/..?UNU%P]H2 =C-_*JSV0^S(-O20]ORSCT__7[=%-&'
M*D]CQQW_ ,]/I2>7\H&WC/3Z>H_S^'%8NE>I.?\ -%+UM^AWPQ,HTZ$$]*;N
MEZR;?SU,&&T BA&!@3Y/';KT]O\ />FW%D&MIUQPTS'I]>W&?;TXZ5T CP
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MG?#X&EWA5DEY\T4G<_U5_9I8;FS/C'$M:4ZN%5[=J$W;;^OQ/.4!+X[@'_\
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MN_M,!@_FIX>A+_+;_A_Z2O\ @@-/Y?AO]J*(G&WX:ZH^!TY67\NF.G_U_P
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M^D4]?Y.7[4ZA?VAOBUC_ *'#7OQ_XF$W^-?A_C)?ZOE?G*NO_3!_J3^S4?\
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M^P>#;][,UVIT_P T?YR_M*8+V/!$^KQ6+_'#TW^O]:W^F:***_=S_)P****
M"BBB@ HHHH **** $;H?H?Y5_G8_\'(5SO\ VY([?^YH>G-W[XY_I7^B:_W'
M_P!UOY&O\X__ (.,+L7'[?=S&,$1>']/Z9X(P/;^7OFOS+Q5K.'#D8+_ )>8
MJ-UM\,)M?FS^X?H"4/;>-DG;2EP_C)_/ZW@;'X0;3]H)_'\._P#GVKZC_8\M
M3<?M8_ F+K_Q7'A]_7_EX'/X?S[U\PG_ %[>P/\ /_)_"OL']AZW%S^V%\"(
MP,[?%_A]N!_T\_3KZ5_.611]IFV7QM?]]AEITO4A?\4?[4>*518;@'BFIM?
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MTW[:.L_YN_L7_P"W6_'M;Y*NO#3%X_W9Z ?=ZX 'I^'UHNO#3;H_D[ 8QV
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M^%E&*J6U_P"7E6E'_P!Q6^1LT445^PG^:Q_&K_P=)P?\2'X>3@8_XG=D,_A
M?Z>]?QN9^6/OPI_08Y_.O[//^#I2V/\ P@_P]N /^9ALU!]_+@X_'VK^,",Y
M"?\ 7'/]!^F:_E+Q+7+Q5B7I_P NY>GNQ?\ 7S/^@3Z#4[^ G#R[^WCK;[-=
MK[_+[SI?"$FSQQX.ESC;X@TYL_2=?\_SK_5B_8 G^T?LE_!Z7.=WAJTY_P"V
M,5?Y2'AN0KXI\*R=-NLV)_*85_JK_P#!..?[1^QO\%9<D[O#-MR>^(HA7V'@
MY*^*S+?7#N7WUH:G\Z?M*8WR3@VK;7^UU'[\OJR_S]3[AHHHK]]/\A@HHHH
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M"OYSO^#C_P /'5?V0Y=2";O[+CGD+8SMW-)S[=O\YK^C&OQ"_P""^&@?VO\
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MEF9E*_V<W;_EEGH1Z#)_R:C_ .&6)B7']G-RH'^J[C'^ST]/TK^D9/V;K=F
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M3_Z]26@W3L/2%S^'/]:YGJZ7DFU_Y+<]FFN18R6W/5H+K?97U?>_W7ZG2_#
M8^+/P[XY'B[1&[]KZ'/]:_UB/V1&W?L\_#,^OAVP_/[+#7^3[\,%S\6/AX?^
MIJT<_E?1#^1K_5\_8].?V=?AE_V+UE_Z30U^[>#4K_VDO^G=)_>U_P $_P H
MOVE5+ECP5+_J,QJMZT(/]?ZZ?3-%%%?NY_DX%%%% !1110 4444 %%%% %#5
M&VZ9J+?W;"[;\K>0U_ES_P#!7#5?[9_;B^(<P;?]GN+F$<\#9<,,<>F/_K=!
M7^H?XAE\G0M9E/ 32[\Y^EK*:_RIO^"BVJ_VU^V7\6KC=O6'7M4A!SG[MZXQ
M]!_4=<U^2>+<O^$K!1O\52N__ 84_P ==#_1G]G-AG5\1>(ZUM*>"RZ%^SG5
MQ+?1_P B_I'Q%_$!V$F[\<U^AO\ P2DLC??MS_"M<9\G6M+EZ= MR>?S_EC-
M?GF,F4CVS_3^HK]//^".EE]N_;M\ KMSY,UA*#Z;;E^?S/Y<=\U^$\+>]GF7
MQMJZM-V_[B4[=/Z1_JIX[R]CX5<7U-?=R[&1W7_0+5CZ7N_O/]0FTXM+4>EO
M"/\ R&M6*@MN+:W'I!%_Z+6IZ_M!;+T7Y'_,I+XI?XG^84444R0HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** /\ &_M6^2Y_V@O_ (Z1C]!^IH1\
M6ET/[P _'G/\JJPMA/\ ?!_3_P"N/\\TQI,6TB^I(_G_ )[U_"/6'HE^-OT/
M^L*;_<5[?;?/M;=47^-S^V/_ (-A#GP7XQ]/+G_]"DK^NJOY$_\ @V!.?!/C
M'_=N1^3/7]=E?UUX?:<*98O[L_\ TH_YV/I@/F\?N-Y?S5L*_P#R@O\ A_F%
M%%%?:'\R!1110 4444 %%%% !7"?$^?[-\/?&,^<>5H&H/GTVPDUW=>6?&^?
M[-\(OB)/G'E>%=6<'Z6[&LJ[M0K/M2J/[H-GHY1#VF;973M?GS'!0MWYL32C
M^I_E6?MNWGV_]K'XS76[<)?%-Z0>O_+5_P!:^5T/SRX^OY9KW_\ :IO/MW[1
MOQ3NL[O-\1WQSZXFD']/\FOGJ-N7Q_=;\P,U_$F:/GS+'R_FKS?W5+G_ %$<
M P^K<&\*T=O9Y7A(/RY,)0CT]3^K3_@V$\.KJ/Q(^*FIN@86[:9\^W[N1;@]
M>_\ +TYK^W6;0[<O+^[4\+V'//T[?YQ7\>/_  :Q:*)D^-NJ[ 3&^C@/V!)M
MQZ>GZ=Z_LR9<EOPS^>0/U_G7]0>'-!?ZI8&Z^*I7:WVC7E'[M-_7H?X-?3(S
M2>)\?>*^6H[4*66T='M_L>&J_C[1_I8Y670K?</W0/RKV]N>W8\42:%;[A^[
M!^4=O\]/Z\\UU!4$\CL/7Z_UH*#C([#'7IVK[ITE?1+K^F^G];G\O+&55R^_
M+1?>_=UW\O\ @',OH5O\OR+_ *OIP<^HZ#\_TJ%M!@(_U8^[CIT_3_/Y5UA0
M<9]!CZ?XTA0=AS^--4URI62T_P#;D_Z^X4<7522YY??\_P#@[_>?F7_P5*\,
MPWG[&WQ'B2,,8]'OI, #C9:2'@ =NO)_*O\ +^O_ )+O4(O^>6H7Z'ZBYE'Z
MU_JN_P#!0S2_[4_90^*=N5W;/"VL2?\ ?-E*<_I7^5'K8\O7_$4'_/+6;]0,
M=/\ 39A_A7X#XRTDL3EDDMJ<OPE%-O[_ "/]<?V;^82JY!Q/AI2;='-)U+-W
M_BX9N_3K#I^I33_5X[A7S_WS7]7G_!K3JHA\>_&.PW8\V+30!G!X,7I^?OBO
MY0DX\U<]%/KW!/\ *OZ=/^#835?L_P <_B=8%MOGII_&>N/*_P#UXP<_E7Q_
MAW4MQ5@GWE37_E'E_-_\.?TK]-"C[;P&XFBNF&E>W3V>)PLO_<?R7H?WKT44
M5_69_P \X4444 %%%% !7\-O_!SL^WXF_#\>LEX1]0L__P!:O[DJ_AC_ .#G
MU]OQ2^'(]9+[/T"3U^>>)_\ R2F*_P"OM#_TXC^Q?H+?\I Y!Y9=FO\ ZCV_
M4_E.3[^?50/Q%?9/[ #X_:[^#6/^ALT\<^HDZ5\9H<;#ZG;^G6OL#]@1\?M>
M_!;W\8:>#]/,X_,8K^8\I7_"I@7U^MX=?^5Z9_NAXB2_XP'BM;-Y!F[MY/+J
MK_7\+G^K#X _Y$OPS_V"+3_T"NOKD? 7_(F>&O\ L$VO_H%==7]MT?X5+_KW
M#_TE'_+KC_\ ?L;_ -A>)_\ 3TPHHHK0Y HHHH **** /P2_X.$_^3+K[_KY
MNO\ T4E?YR5IS:P#T /\_P#$5_HV_P#!PG_R9=??]?-U_P"BDK_.1LO^/=/:
M+=^7^-?S5XN_\CVGY4*/_IN*_4_V]_9VO_C4N+7?.<P7_E9/]#30XN]-/IJ$
M!S^(K_41_P""2+;OV)_@ZWKX8M/Y"O\ +HW?O-/;TO83^1%?ZB/_  2(;=^Q
M!\&F]?#%K_Z"E=?@[_R,,7_UYJ?^G*1\W^TD?-P9PZ^^;X1_?A*K/T]HHHK^
MBC_&8**** "BBB@#_.^_X.03_P 9C:#C_H72/_(T7^!%?S],W 'IC\^E?T ?
M\'(9(_;'T+'_ $ /_:T=?S\%CS[./\_IDU_(''"MQ'FVE^?$2_"5-O[KW_X)
M_P!(/T5*W_&DN![Z6R7!_P#I$W^-M=C])_\ @D(VW]O'X9GI_I!&?K+%7^HM
MI/\ R"M,_P"P?9?^DT=?Y<G_  2,./V[_AC_ -?!]L?Z1#7^HUH__()TO_L'
M67_I-%7[/X1K_A!Q#[XE?A31_F3^T437BED3[Y175^]L0O\ ,T:***_6#_/0
M**** /QH_P""Y>H_V?\ L2>+CN*^<;F'Z[H$^GKT^E?YHD0_<#T,KM]?G<C_
M #Z5_H__ /!P!J/V']B/6 "5,VJ-%]=T,7^0/ZXK_."C'[F'/='.?7YF.?Z5
M_./B[4MGF'7;"1^=U?\ KT/]L/V<F&MX7YY7Y?XF=8A7[VJTH?K9;?D07/S*
MB?\ /2YA _%P.GTK_2*_X(9>&8X?V&O ,SQC-S8AN1P<-#^>./PZ@U_F[$;[
MK3H_^>MW ,>NYPN/K7^G=_P1ATC^SOV#?A"VW;]HTIF/'H8OKQTZUIX2T_:9
MI6E_)@JB^^I2C=O^F<O[1+,)8?P_R>A&3BZ_$. C;J^3#8RMLNU_F?IPNA6_
MEO\ NQVXXY_,9_S^-(FA6^V3]V.@XP.?_P!7'OSZ5U 08/''&>OX4!!@\<<9
MZ_A_C7]!>QWT6K7?RV\N_P T?XU_6ZOO>_)7E%O7MRZ;];'+IH5OA_W0'R^G
M7V_&B+0K?YOW8'R'GCG]#^E=0$'.!VYZ]* @YQZ'/7D=Z/8K71:M?IY?>]]P
M>,JM2]^6K77HN73?R.6CT*WWI^[ ^8<X[>O2OY(/^#G70TM]!\%WZ( $AMHB
M0/5HCC(]?\^M?V$!1D8'/3//TK^4'_@YUT[?\)_#&H[?]7=V<6['O&<9_P#U
M>V3T^,\0J"EPGF6FL72J:)OX)I_+^NY_2WT1<=4C](#@5RF[5,1B:+OU4Z-K
M=?Z_'^'E6'E@=\8_S_6K4CE1IA&?W=S"2/3]ZI_#/Z?K68C$!1VX_P _Y]/K
M5B9L+%_TSEB.?^!Y_#I^OO7\GT[PFM/M1?K[R6_S_(_Z$,:_;X.:WY</4B]/
M^G5_E\/HGV/]-'_@A_JG]H?L _"*/=N,%G=@^V7@]S_GKS7Z^U^''_! G5?M
M_P"PG\/H=Q;[-!<C&>F6@&/K_GC-?N/7]E\*2YN',E?_ %+<(ONHP7Z'_,]X
MYX7ZGXP>(^'M;EXNSN5K6^/'5I?K]P4445] ?E 5X?\ M+-L^ /Q<?IM\"ZZ
M<^F+5J]PKP7]J-_+_9W^,;GC;X"UX_\ DHU88K_=<3_UXK?^FY'K\/\ _(^R
M3_L;Y;_ZFT3_ "<OC++YWQA\?R==VO7Q_P#)B45YQ.?W9KM_BE+YOQ3\<R]=
MVN7Y/U^T2\?I7!7#?N<_[+'],#_"OXDQ\;YC7[^V_P ORW/^HGA"7)P=E<=O
M^$Z"7_@%./;SZG]S7_!KO#L^$/Q3FQ_K3I7/;@P9K^KJOY7/^#8& I\#/B#,
M?^6IT_G'HT'^'K^%?U1U_6W T/9\+93'_IS)_?4F_P!3_GI^E?5]KX]\>S[X
MS K_ ,!RS!Q_"U@KD_'4'VGPEKT&,^9IMTOYQ-765DZ[%Y^CZE#C/F6=PN/K
M$]?5O9^A_/N$G[/%8:I_S[Q%&?\ X!4C+]#_ ":_VX;/[!^UG\<8=N,^.-=X
MZ8S<>P_S[5\OHW[M/]U1^(R/ZU]E_P#!1:R_L_\ ;'^-D0&T-XTUQL=O^/D>
MOU_SUKXO0_NU/7YP/H/_ *PYK^)\YC[/,<RA;_F+JK[JS?X7;_JY_P!0_AGC
M/K'!?"M>]_:9!EL[][X+"OU=]M_4)#FY1O1"/H3_ )_*E8_O4Q]#^--;[^[N
MK ?T'^/YU&[_ +X#OD#\O\]*\R7OS3MM32^?+'TZ_D?:\W)&>OQXF-3YWC]^
ML>_GT9^W7_! ;3_MG_!0/X?S$$BW:]Z#IF.#'\NO7^=?Z2\0Q%&/1$'Y**_S
MG_\ @W?L/M?[=7AZXQG[,;CJ#@9BAXR/7&>:_P!&)?NCZ#^5?T[X40<>')2_
MFQ+_ /3% _PH_:#8KV_C7AZ=[^PX?HP\E?,,>_\ +^D+1117Z>?PD?RN_P#!
MSY#G]G+P3-_=\7P_I'#GZX'^%?PEP<VT0^C?E_\ KXK^\K_@YYAS^S%X-EQ]
MWQ?#^D</]/\ /K_!M;\P0#_IB#^7_P"NOY>\5HVXDJ2_FI4OP@O^!]Y_O)]
M.7-X&Y:M^7'9HN__ #%Q7RVZ^:1H1/MN]-/]V_@.?HX.?S-?ZD/_  2:N?M/
M[#'P/;.<>&8!QR.B_P"?\*_RT]_[ZR/I/$WY,/\ "O\ 4*_X(]77VG]A/X*G
M.=OAR$?EM'\L?7/K7N^#\K8_%I;+"<OWU(/]&?F/[26G[3@CABMOR\04;O\
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MC#X)Q8QCPQ;Y'U2/_P"O_P#KS7WE7]J9)ID^6?\ 8#A?QHP9_P P7B14=7Q
MXTJ;\_$^=/\ \OZX4445Z9\4%%%% '\]'_!QOJ_]G_L86D.['VCQ1''C/7=%
M .1_G_#_ #QX&QY9Z_*V?Q)/_P!>O[Y/^#FO6#8_LG>&;4.!Y_C.T4KG^]%
M,XXZ?C^%?P*VY_=(W8$#Z]Z_F/Q6J7XIW^##4(^EX>1_NI^SVP_L/!&G5M;Z
MSGN:U?7V>(HJ]_32W:Z-[1T\[6](AZF74K5, 9Y:51T]\FO]/K_@E9X8ALOV
M*O@]"\2JW]AH2".>4B.>1C//_P!;-?YB'@U//\;>%8,?ZW7]-C[_ ,5S&O\
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M&,EX<^V1Z"O[O]@W>^?PS_\ KYK^(G_@Z3T[;\0_AUJ03/\ Q)[2/=]7@/\
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MZ_LVE+FITY?S0A+[XIG_ #08ZDZ&-Q=#_GSB:]+_ , JRC^@44459RA1110
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MOP#XJOB=HAT;4&+=,?Z)-7^4#^U_JO\ ;'[47Q@OPV[=XIUH;LY_Y?7[]O\
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MX5RQ=XUI?^!UZDOQ3N?\[_TJZSK^._'DKWY<9@H>G)EN$A;\!, ]0/RHP#U
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M_KC+_P"@-7TY^"P^./\ BC^:/\KK_@J;IYT_]M;XOKM(\[Q/K$W3&0URO/\
M6OS[@7*8[ [OK@8_ITK]0O\ @L+IO]G_ +;OQ'7;M^T7NI3XQC.ZX4Y[=:_,
M:S7._P#ZXLV/IU_S^=?Q?Q)'DS[,Z?;&U7^-_F?]./@[/G\,."Z_\W#F6*]^
MV&P\?32UOP*IYW>[J?P[TB)ON ?J>F>!W^N:=Z>X)_ =:MV$?F7*]"#%(?R!
M(/\ 4^U>#%V?R?Y?\"Q^H3CS1BK:\T.G=Q^_XD[>9_0Y_P &WFF_:/VQ'O\
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MKT_SU]*_DF+^!]%*S^;_ $/^AZO[WUA?ST*<_GR1>WS_  7J5RI3:OI$5/\
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M5WYJIB86=OE_2.V^&L'G_$OP'%C_ %OBG1EQZYO8AQQSSGZU_JY?L760T_\
M9M^&%L!C9X>L>, =;6W/&/\ /%?Y5?P=MC/\6OA?'C/F^+="&,YSF^A]/K_*
MO]7[]F&T^P_ SX>6V,;/#^G<8Z9L[<__ %Z^L\&H^_FTNT*,?OL]_D?SE^TJ
MJOZIX?T[W]IBLRJ6_P"O<816G_;_ /GT/?,>WZ4F!UP,_2EHK]Y/\F;B8'7
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M'PX\8G_J7]5_](;BO\F']I==O[0OQ8)_Z'?Q#VZ?\3*X-?ZSGQ=./AOXQ_[
M.J?K8W K_)M_:B3R_P!H7XL\?\SEKY_\J,_Y5^(>,CMA\L_Q5_Q=%'^I?[-1
MWS?CV/:GE4DO^WL0_P#VU'@[ ^5]')_G_CFO[%_^#68?Z+\1CZW^H_\ MS_C
M7\=C#]T?H3_7^5?V)_\ !K1_Q[_$3K_Q^ZB<?C<"O@?#"5^*<(ETY[_=_P
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MYQBOYE\7/^2A@MG["B_NC']4?[C_ +.Z[\'\4WM_:V8P^3KK_/U^XZ?P</\
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M^M?UL5_7? ,^?A3*GVA5C_X!7J1_0_YT/I8T?8>/O'].UKX[!S_\&9=A9_\
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M>)\?;_GX_P 8PE^OX;G_ $*_0PK>U\"^$4]?]ABEW]RM5I>OE_P=VR@%E)[
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M$YBC/JBG]*DK^R$[I/R/^:-Z-KLV@HHHIB"BBB@ HHHH \W^+O\ R3;QC_V
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M4NG_ &X_TW/[<_\ @VLUJ'3_ (/>(D<@-Y]T>3CC+_\ ZOH>:_J*/C.W&?G
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M+_+FW/@9O^6ONR ?7-?IK_P1WO\ ^S_^"@?P>D+;1)JI4]OX81ZU^9?4C/\
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M<52VMP_F\;>F65%\MMK'^JYX"_Y$SPU_V";7_P! KKJY'P"<^"_#1]=)M?\
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M1H_ZU_J):3_R"M,_[!]E_P"DT=?Y=O\ P2!^;]O/X8CI_I!_]'1&O]1+2?\
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MHK]J/\T HHHH *_GK_X.-M,^V_L3RRA<M#XA@8''3$<??M_G'.:_H4K\*_\
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M27<]GJEZP4MDA1OZ#/UY[]*_J@K^,?\ X-</%>^P\;>%C)C[.EU<^66'&YW
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M3OZC(^GK7P+>K\WV7?\ K^KG]70TC%/2RBEO_+%=_.WXG9_"_/\ PMGX=?\
M8XZ)_P"ET(K_ %C/V1S_ ,8]?#3'_0O6/_I-#7^3I\+1GXK?#K_L;-%;\KZ+
M'\A7^L/^R"V_]G;X9'_J7;'_ -)H?\_SK]Y\&W_R,E_<I_G_ ,$_R:_:40:C
MP3/I]:QGXT8O]?ZZ?2M%%%?NQ_E %%%% %'4CBPNST_<O_*OQ(^ /Q=@T_\
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MWQB\97N/NZ7?19QTP9N_UZ#\:_N<K^K_  S5N%<*^]>N_P#TC^OZN?\ /O\
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M-3^"O_8F:;_Z+K_*"\&G_BNO!AZ?\3ZR/X>8,U_J]?L,G=^RC\$SZ^"]-_\
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MPF^'4P.?,\'Z"_\ WUIT!_GG\/:O3J\4_9SN?M7P1^&4V<[O!N@<]>FFV_\
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MY<]H/?HM?Y]]XO[AN.?+(Q^'^-?W\?\ !M+/YO[,?BB/.?*O;0=>F=O:O/\
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M,V/7?AZI_P"I=$_$UAQ+QR&4C],?SK]E_P#@A2,_M\?#L=?]+DXY_P"></\
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M5XSEM'%8+%QO:R?+B>9?^2O3RL='1117ZR?Y^A1110 5_!%_P<W?\G">&O\
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M%)0<;->TMOI_IT'^<BOYCPKM/"M;JL_OM3/]U\]C&IE&;4W9\]!NU^D81O\
M<T]3_6@_9*N_MO[/OPOF!#9\(:$,@YZ:;;_US_@*^CZ^/?V$=1&I?LQ_#"X#
M;O\ BF='0G_=L(!]?SK["K^V<M=\OP3[X:C_ .FXG_+GQO2]CQAQ-2M;V>>9
ME&W9+%5+(****[3Y<**** "OX</^#G09^)O@ ]_-NQUQ_#/_ (U_<?7\-O\
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MO[0_;F\//MW>7!=,,?5#VZ]AUK_1\MQMMX!Z0Q#\D45^^>$,''AVI)_:Q/\
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MTV_MK>(CZWMQ_7K^GZU_I)5_FT_\%\'W?ML>)!_=OK@'_P >_P \5^6^+/\
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M>:1_ZA*K7JHW7Y'Z9X-XW^S_ !0X(Q3?*H<09?&3V]VI7A"2OYJ1_F Z2/\
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M(/\ @YM_Y.$\-_[\?_H+5_>_7\$'_!S;_P G">&O]^/_ -!:O@/$G_DF:_\
MU]I_^W']>_0B_P"3ZY/_ -@&(_\ 4G!G\R8.9#[*,?G7U'^PPN[]L3X&#_J>
M=%Q_W\;_  KY<Z/D?Q#^6>E?4?["[8_;'^!"_P!_QYH:^_\ K6_K^M?S%DE_
M[6P?_7VG\_WL/\[G^Z7BA_R07$BZ_P!GX]K3I]2Q#_%:7/\ 5]\#<>$= 'II
MUO\ ^@UU=<QX,7;X6T-?33X!_P".UT]?VQ1_A4O^O</_ $E'_+YF+OC\:_\
MJ+Q'_IV04445H<84444 ?S[_ /!P\?\ C$-Q_MW7\E_PK_.R@_X]X0.,LH_"
MO]$[_@X>'_&(,C>CW7\E_IG_ "*_SL;?FUA/3E3^E?S+XN?\E%#M]6I)^O*O
MT/\ <?\ 9VM?\0=Q??\ MG'OT7MH]?74ZSP7_P C[X*_[#]E_P"C*_U>_P!A
MX8_94^"H]/!FF_\ HL5_E!^#"!X\\%GM_;]E_P"C!7^KW^PXV[]E/X*'U\%Z
M;_Z+KW_!CX\R_P"P:'_IY?UY_(_)?VEW^Y\$OI_:N)_]06?5]%%%?O9_DD%%
M%% 'Y@_\%=] &N?L1_&(E-[6OAJ[D48SSM/M_+\:_P O&YC\F\U&+H8[F5?I
MM;'YU_JS_P#!1W2AK/['?QILBNXR>%;L >OR,3U^G\J_RK_%5N;3Q7XFM",>
M1J]W#C&,!)".E?SYXQ4[8[ U.^&2];57IZV\F?[$?LV<9S\*<88.^M'.HSCK
MLJF"H].W,5;P8BA/', ;\< _Y_\ K4MR,00>\*GU_O8_'_(J.Z8-'$!_SS"^
M_8?RS[4MP^880,?+&%_4_P LU^*?\_?\<?S1_IY#_F&T_P"8>HGIUMH=3\*U
MS\4_AT>__"4:.3[XOHJ_U?\ ]CTY_9T^&7_8O67_ *30U_D_?"PD?%7X<CM_
MPE6C+_Y/1?GFO]8/]C\;?V=?AD/^I>L?UMH:_=_!N_-F?;V=.WWH_P G_P!I
M0U[#@==?K6*_]1Z:?XI_U<^EZ***_=S_ ";"BBB@#.U8XTV])_Y]Y/Y5_E/_
M /!2)=_[9/Q]? _Y*'K0'T\U/Z?YYK_5:U]]FC:D_3;:R'/3'%?Y4'_!19]_
M[8OQ[/\ >^(&LO\ AYB_X'\>*_'/&*5LLRU=\34^Y05_Z^X_TQ_9L4U/B[Q"
MOTR3*DO7^T/\CXJTJZ-D))5)&'(_,D]?\^]>K^&?B#/IB_+,ZG<HZGN1SV]_
M\17C6"+>0>K@XXYQW.?\\BJD<LB*<$CYP?4]??MC/\\5^"X6NZ7/9[SCK?LH
M:_A]Z\C_ %6S+*88J<U5A=2ISCJNB6GEU^\^KK_XM7+V31>>YPN/O>HQQSW_
M  ZUX-XEUM]7N2S.6^88SDXR?QQG_P#6*Y:6[E:-OF/.!P?3'\^W//.:BB+/
M,Q/)^7'^?Y#FKKXF=6FU*7=OSUAO]WJ3E&18; XI5*--1<W3U5NM.HNG?3SV
MUZFS(NW;C&"HZ?3]*KC_ %C>P!_.K$C!MGTQ^G_ZZKQ_-,X/IC\A_DUXD>90
M;?\ *OONE^%V]#]#P]EA\%!:?!'_ ,E3_P CV?\ 9AT<^(OVH?@YI03>LWC#
M258;<\,Y&3P>/_K=":_UD/@CI8T7X5>!],"A1::!90X P!L5AC\/ZU_EP_\
M!-;PP?%O[9WPNA$1E%CXCTRX(QNV[)7&<>HQR>W3I7^J=X.MA:>%]#M@,"'3
MX4P/8&OZ2\(:')E^+JM:R5*'IHI/TN_P/\8/VBV;?6>+N'\!&5XPECZ[C_V]
M"G'SV3_ Z6BBBOV,_P U@HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@#_&S=]YB/<D_C_GBD8[BA]3@_@*C''E_[&?UY/\ ]:E'\/LQ/X'I
M7\(-WOYNY_UBQ6D+](PCL^BH7_!2^7IK%-_J\_[6/RQ0B_NTSWDQW[_Y-/;[
MF/1B?S-.3[J ]FW?X?SS^57S?:Z\U_N5C+D3JN_6E%;:O6-_N?R5KC O _ZZ
MA?\ ]=+C&[VD&/Q-/R.>/XP_^?R_G0>=W7E@WY?Y%3S>7;_VW_Y'\37D25E^
M.O1K]?P0QEP'Q_? _.AA_K?8J/P_SBGGG=UY8-^7^10<?-_M$'\N?\/UHYO+
MM^'+_P#(B<%KIT>R_NSTT]4BQ#S=:<G==3TW' _Y^XOYU_J$_P#!(9=G[$WP
MQ'_3C&?SM[>O\O6UYO\ 3SCKJFFY_P# N(?RK_40_P""1O\ R93\,/\ L'Q?
M^DT%?M'@V[YEF/\ V#?E*BC_ #0_:2I+@CA5KKG<?_2<6U^#1^G%%%%?T,?X
MU!7\7'_!TAJ^-7^'NE!OOZ;:S%<^CQ<X]?UY_&O[1Z_AH_X.C-7\SXM?#K3@
MV<:! VWZ21]OIQ[U\/XB34.%L;?[4Z,?OF?U1]#/#O$>/7##2O[##YA6>E_@
MHQ/Y1QT0=MA/^%>K_ *U^W?'7X56^"=_BS0SC&?NZK:=17E.,;"?^>>W\<5]
M ?LEV)U']I7X2VH&0/$^D-C&<;=3M#SZ^O\ ]?%?ROED7+&4+)_&E]Z9_O7X
MB5OJ_!F?3>G+@)-W[)47]UE+_AW<_P!7_P"#%M]C^%O@6W"[=GAC0^/^X7:5
MZ?7%?#B'R/ 7@^(# 3PWH@_+3+4?TKM:_MN@N6A1CVI4U]T$C_E\S:I[7,\P
MJ?SXW$S_ / JTV%%%%:GGA1110 5_!A_P<SZ;Y/QO\"7F#B6WO3G'7YI/\]N
MN<>O]Y]?P\_\'/&C^7X\^'.H[<9M;SYL=]SX/3_]7N!7Y[XFP<^%\1_=K4'_
M .5(G]B?0:Q*P_CSDR;M[?+LSI+S?U:<DOP/Y-F/^L/]W9C\:MZ'*8]=T*;/
M^KUC3"/_  -@/6J757_V@N/^ @8_&I-/^2^TR3H4U*P/_?-U"?T-?RUAM:E/
M^[5@_OE%?H?[X9LG/!XI+:6$Q,MWT4VK_)Q_R/\ 5-_X)F:E_:G[(WPSN=V[
M_B36$><Y^Y90#U-?H!7Y@_\ !(C4O[3_ &*_AQ/NW;;2&/.<_<MXQ_2OT^K^
MU\JES99@)+9X2@UZ>SB?\POB=1>'\0^,Z+_Y=\1YI'[L54"BBBO0/A0HHHH
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MG^>E?QI?_:WTYJUO_ K'_2])6R"E;:.5QD_*\*;_ !7]61_IJ?\ !#^+R_\
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M'&?]@'Z<"O\ 11_X.'O^3/;@>K78_P#':_SK[0?Z)&.VS'Z5_,OBY_R4$/\
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M "6_:3\W_&$]OK6-^]TH_H?25%%%?NI_E$%%%% '/^*FV^'-8;IBQF/Z"O\
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MS_2FG]T)&/\ =)_R16%KIQ[V2^]/]#TX_N_9-WY:34I;VLJ<?7=I]^I^MO\
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M'_C"CX8C_IQC/_DO!7[1X-_\C+,?/"NW_@=._P"6Y_F;^TE=^!>$NZSRG?\
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MCA4^'&IA2,6EQD]CEWP,\\D?CBO[+J_D=_X.@=-$G@'P)?[03!;R+NQTW.X
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M:OB[<YQY7@_4VS](Q_3-<F82<<#C)+=86N_NI2/<X9I^VXCR"E_S\SG+(?\
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M+/\ L-P__I=(_P!:OI!6_P"(*\>/JN&<X?\ X#0FUZ_:^5]C_2UM_P#40_\
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M\5_V_P#LE7-JTF]M/UV2V )SA8XI@!C/'3T_K7^>LOW&'/4G]3_AGWK^Y/\
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MK\.F_P"IIT9OROH@?YU_K!?L?$G]G7X9$]?^$>L?_2:&O\G[X5L1\5/AT/\
MJ:-&'YWT7\O\:_U@/V/1C]G7X9<?\R]9?^DT-?O7@W?FS/\ Z]T_S7_ /\F?
MVE%OJ_ [Z_6L5Z_[O3O^)],T445^\'^304444 87B<9\/ZN,=;*7^0K_ "H?
M^"@JX_;"^/!]/'VLKT_Z:C_/^>/]5WQ2VWP]K#>EE*?T%?Y3_P#P4"?=^V!\
M>3V;Q_K#?^1%K\4\:;_V9E5K_P"]U/\ TA'^FO[-)O\ UVX[7?)LL^=L>CXQ
MDZ ^X'YTV51MX&.0/S-.DZ ?[0/Y'FB3E1]0?RYK^>:;:E27>6MUV>A_LO5L
M_;KM"%O*Z7_ &RIM3Z8_(X_^M]*9C#2=]H4_I5B?YE^H'X<D_P!,5"V/WF/X
M@/S'^?TK6<KSJ><Y?==?CH93C&+NND(6\G[.I^&JW77S'M]P'I@ _P"?SS4.
MHGR[5SW,8(_'OZ_E4S?<^H JMJOS)!".3*$3!XZD#^O^-104IXBC&V]3\$X^
M6NYEF56-#+,RKMV]E@XM/^\XR2]':Q_7I_P;,^ C<)KOB=X"Q2YN%$A7G"^:
M0 <8R/I^M?VPU_+S_P &X/P^/ASX+7VI/!L:]EEE#%<9#I*P.>,]^F?\?ZAJ
M_KS@+#O#\.85-6<YU)/3NU8_YROI4YM_:WC-Q/.,^>&&J4L/!]%RP3DE_P!O
M-A1117V9_.04444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!_
MC7CD+_M=/KWHZX]R0/J*5!Q#[!NON/\ &@ _)_OLU?P>?]8\4VHWO=J-_G['
M_P"28G7'N2!]12 Y_%MOXTX _)[.3^?_ .NE"X 'I-G_  _I0)*6F^R_*#_5
MKYC,]?9MOXTO3/L0#]33L'_R-NI"#\WO(/TH*L[=7_PW>WE^?:PG3/L0#]32
M9QG_ &2 ?QIQ!^?_ 'P?R_\ U4,O^M_VBO\ //\ C03RM7WT3U]%-K\DO5+L
M.MB1J6E@]M4TX'\;N+_ZWY5_J*?\$C/^3*?AC_UX1_\ I/!7^7;"I.I::?74
M]-_]*X1^6*_U$O\ @D7_ ,F4_#'WL(__ $G@K]I\'&GF..M_T#/OWIO]3_,O
M]I(I+@OAE.]O[<IVO_UYQ"_0_3FBBBOZ'/\ &T*_SC/^#B34_MW[:-G"&S]E
MTR>,C.<;98_\^M?Z.=?YIG_!>W4O[1_;AUB,-G[(+R'V&V1../\ (K\Q\5)6
MX?IQ_FQ/_I,+_P!?U;^YOH"T/:>,&+JV?[G)K:=JN)C!_P!=3\8%8MQCH,_E
M7Z2_\$A=..J?M[?"JWV[@+F1\8S]R6 _TS_GG\W88S\Q([8K]9O^"(6D?VE_
MP4!^&;;=WD"[)X)&?W)!';MCD?\ U_P+A:/-GN I]\12MI=_%&[_ !/]>_';
M$?5_"?B^O)VY,ES%_=AI6_-['^FQI"[-)TM/[FG62_\ ?-M$/Z5HU5L5V65F
MO]VUMU_*)!_2K5?V5'2,5V2_(_YHJKO5J/O4F_ODPHHHIF84444 %?RM?\'-
M^G>=\#?#]]MS]G\L9]-TC_CV_P#K=Z_JEK^9/_@Y6T_[3^S+!<;>89+< \]W
MD_G^!KY/CB/-POFJ_P"G%_NDF?T%]%JLZ'CMP!-:7S90[?Q(2A^-[?U<_@7C
M/[O/9<?AG&/UJ1R1$_L4;_QY33(US&X_W1^1HN>(Y??:3^&*_D&.D[K^:/WJ
M5-_FT?\ 1W._U236M\--?*5*LM/_  &/K\M/]$?_ (-VM5^V_L5Z#;;@?(OK
MS@'..G/]/R/?G^@ROYK?^#;34C<_LFP6F[/D7=X<9S@%A^73^7'>OZ4J_L+@
MR?/PSE+_ .H6"Z]%8_YM_I+X987QP\0J25D\]Q-3_P &/F_4****^H/PH***
M* "OX9?^#GMMOQ2^'(]9;[_T";'^?:O[FJ_AB_X.?5S\4_AP?^FM\#^*35^>
M>)__ "2F*_Z^T/\ TXC^QOH*_P#*0.0?]BW-?_4<_E724X)S]Y<=?3C_ ":^
MMOV G/\ PU[\%NV[QA8#';_6']:^0!D"(>_/T_S^?6OKW]@-2?VO_@HOIXQL
M#Z?\M#7\QY1_R,L ETQ6'7_E>!_N5XA1<. ^*T_^B>S6_D_[,J?YL_U8O '_
M ")?AG_L$6G_ *!77UR/@+CP9X:_[!-I_P"@5UU?VW1_A4O^O</_ $E'_+UC
M_P#?L;_V%XG_ -/3"BBBM#D"BBB@ HHHH _!'_@X4_Y,NOO^OJY_]%QU_G*:
M<2(8,]HU8^V.M?Z-G_!PD,_L7WP/_/U=?^BHZ_SD[$$6Z'_IEC\^>?\ /K7\
MU^+K2SZG?I0H6_\  (_\$_V[_9VQ<O"7&=GG.87^55O^NYHRR$S6!YR;Z(_A
MO^O6O]0S_@D2V[]B'X--Z^&+7_T%*_R[=K,]@,'/VR+IP>HQC^E?ZA__  2&
M!'[$'P:![>&;7_T%#79X//FS'%V^SAYW_P#!E/\ #^F?-_M([K@KAFZMS9KA
M+?+"5;_UZGZ?T445_1!_C0%%%% !1110!_G>_P#!Q\V/VR=#..?^$>*_^18O
M\_6OY_;IL^2?[J@?CD8_SV)-?T ?\'(2D?MC:".F= )SSG'FPX]_;_//\_$I
M)4#T(_3G_P"M7\?\=-OB?,>\L34C\X\O^9_T>?123?@?P8WKR9+E[CZ\M3;T
M_&Y^E'_!( D?MZ_#+&?]>_'_ &V@K_43TG_D%:9_V#[+_P!)HZ_R[_\ @C^A
M;]O7X8#_ *;,?P\^(^_I7^HCI7&EZ:/2PL__ $GCK]F\(O\ D1XK_L(C_P"F
MT?YF_M%+KQ2R.+Z9/5?WUUK^&GS+]%%%?K1_GJ%>(_M(W9L?@5\4+P';]G\)
M:E)G.,;8QWKVZOF_]KVX-K^S3\9IP<&/P-J[ \Y!$:],?C6&)=L-B&]E1J_^
MD2/:X;@ZO$60T_\ GYG.5P_\"QM!?J?Y2GQTO#?_ !O^*MX6W&?Q=JDF[_>D
M4Y_K^->2JPV3'_8;/]?RS7=?$F4W'Q+\?SGDR^(;YL]^6 Y/X5PFTB.?@_ZM
ML_4\_P!*_BC'NV/QLOYL1.*^<_UT/^H7A6,X\,</0V]GE=)/_MVA&/IT_+L?
MV0_\&M^G;K#XG7Y7E-4A&['JJ^W\L]:_LUK^0?\ X-;]+\OX?_%"\*_>U6UP
M>O\ "IZ__7Z<8ZY_KXK^JN 8<G#6"5K7YFOG;8_Y^?I>8EXGQYXR;;?LZF"I
M^EL%0DU]\G<****^T/YF"BBB@ ID@RC#U&/SI]!YX]:!IV:?9I_<?YIG_!<J
MS-E^V[XTDV[?M&HW;#C!/7//^?Y5^,Z-L<MT ./IDXK]RO\ @OUIQLOVS=4F
M V_:KBZ<9'4<G/09Q_GN3^&9!'F>[*?P.,U_&W&*Y>(\W6W-B:J:\E.Z^Y?U
MK8_Z5?HZ3>*\&.!*N_-P_@(W\X8.$?G[T3T/X-WQT_XT?#>Z#;2GBG1!G_>U
M2T%?ZV/P+N/M/PA^',P.=_@WPX?7_F$VO\^M?Y%?@B4V_P 2? 4X.TIXIT(@
MYQQ_:EK^O7_"O];']F"]%_\  CX8W .[=X.\/+G.?NZ39CKS_.OU7P;E:.9T
M_P#IUAI+_P #J:V_K7[S^ _VE.'?M.!\1;_F.SF%_P#%A\M:^]19[Y1117[H
M?Y2A7\]7_!QG=^1^Q9+%D_O/$%OQ_P!LT]>GY_GS7]"M?SC_ /!R//Y?[',2
M9^]XBM1C/7*1=OQ[]^E?/<5RY>'<V?\ U"5/T/V3Z/E+VWC-X>PM>_$.$?\
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MMMHHHK^KS_GT"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ^!/\
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M5;PAQ+6RS/,I/U=5_I:S^1TW@LX\;^#3ZZ]9-],MC/\ *O\ 5Z_88;=^R?\
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MIGITQ^OY5[/^SKIXO_VA?@_;!<[_ !9H;8]<:I;'_)]O6O'[9QOZ]8S^@/\
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M*_?_  :O?,EVI4OS1_DK^TJBO9\%R7_0=C4O3V%-_JSZ:HHHK]X/\F@HHHH
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M^P:$%3HTH+:-.,5\DC_G!S7$O&9ECL5+5XC%5JK?=SFY-_>PHHHK4X HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#_ !K=XYY/;\?_ -7O
M^%&\<\GM^/\ ^KW_  I?(/\ >'Y4>0?[P_*OX4]GZ_=Z?U\U\_\ JX^N^?\
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MKQ0?_&,55WQ-'\.9O\C^P/H.2Y?'[()=L!F/RO22O^)_*AYH;!R?P[>_]?\
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MZG".O.8HN!CZUX?$M1T\AS6>UL'5UMW27ZGZ/X0X?ZUXG<#4&KJ?$N5O_P
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M^1\;?A[? ??TRY&<8ZGM_AG'X]?Y;Q)_M$>W-?UF_P#!T'I9C\=?#F_"D?\
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M_P#2$?\ -GXU5%5\5..*B=T\^QB3W^&2C^@4445[9^7!1110 4444 ?YV/\
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M3M(H8RY:[B& .@\U>G7G'],8XQ_H,?\ !#_X71Z#\(=-OY[<1S_9XSN9<?\
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MAJ_YUOIY[K]/-'@IL",?+V!Z&@V!&/E[ ]#7O7_"O[P_\NSC\,?S[_3BC_A
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M"/CMP9*;2C&OB'=Z+^%;KZG\3<%BPL+<[3R!VYYQQD?6M;0K0Q^.?!";?O\
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M\ 7IL-1(M7.+5B/EZG!Z>OZ]*_J2_P"#8G1+C29O'PFB9 9-0'(]6N#S^/\
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M3S\_Q51]OP]FM.U[X2;_ / ;/]#]B\ ,Q_LOQBX QO-RJGQ!@XM]E5G[-_\
MI1_F[Z;:&6U#[>^.G/<'T&>F/_K5?%@W]WMW'_U^M>N^'? -Z^FY-L_W_3V.
M!C_ #UK;_P"$ O./]%;[F.A_SCIS],]Z_D.>'FJD$XR][D;^<X[[;WV_$_Z%
MWQ!ADY?OH+5_;7E^2[=O,\J\&VK6WQ5^%X*X\SQ3HK=.O^G1]L5_JW?L>_\
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M44 %%%% !1110 4444 ?YXT'[.LK0J_V(]&/"=<#U(/3K1!^SK*Z%OL1ZO\
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M9!D83VZ?+_+TQ[T6WP6M3=7J_9DPI3@JO<]N.W'8>E-\-0_>>Y\,8/Y-T_\
M/T?GJQKQGK6C_M$OB_F]/\GY[>1^$6O?LYRB.V;["?DO[-O]7_T\J3ZXX^G3
M)YK^W/\ X)YZ&WAW]F'P)I;)L\FSCXQCK!$/Z"OQ7U[X*6OV1C]FC^2[LSR%
MX_?J>#_A^?:OZ"/V9=)71?A%X:L%4*([6+  P.8HZ^HX+RM8#,,9)1M>C!7]
M8PE_7_#G\W_25X^J<6\)9'AIU'-8?.*\K-W^",EM_P!O/;S\SZ HHHK]+/XG
M/*OCC";CX0_$. #/F^%]13\XQ7\"VN?L_P NH_$KQ_??8B?/UV\EW;/5SCMW
M_#CGFO[_ /XJ1>?\.O&,)&1)H5ZI![@H,C\J_FET?X.6MYKWB>[-NC&;4;AS
MD+SGUX'/X]17Y]QMEZQ]7+XM7Y5/_P!+BS^Q/HN\6SX6R_BZM"?(ZE;"2O>V
MU)Q/Q1U/]G.4V%R!8D_N9#_JSZ-TX]J_H,_X(*?#1O OAKXDR-!Y)N[ZU8';
MMW;63/\ +_\ 77G]Y\%+4V5R/LR?\>LK=%/13S^7TXYK]-/^":?@>+PEX1\1
M&*)8_M-PI.T#YL.!V&.,_A^->)PWDJP>>X2JHVY85'M_<:_S?]7/T_QH\3ZO
M$?A9Q!ETJSE[3$9?%KFZ.M0GWM;W4WO_ )?J/1117ZX?YV!1110 4444 %?-
M/[6^C_V[\#/&NG;-YGTN\4+CKFUF'^>#7TM7FWQ:TY=5\!Z]9,NX2V-P,8R.
M89!_6N3'4O;X/$T6KJI1J0_\"BT>UPYBW@,_R?&IV>%S'"5T^WLZT97_  /X
M'=7_ &=I6UC7/]!/_(3O6_U?]^ZF/H!WZ^O>J0_9SE$)'V(_<?CR^Y!SVQ^>
M:_<W4/@M:G5=;_T>/_C]E/0?Q3.>N/7UZ^M1R?!2U$3C[-']WKA>I!__ %#C
M\.]?BG^K\8N*LE[2K*#T[:_^V['^H[\9JT5#]_+]W@J$OB_FIP???2[7H?.W
M_!%_X3R>"OC]XDN6MC$)(X.=H7^/.>@_#U[Y-?U\5^%G["/P[@\*_&#6)XX4
M3=##G  )Y]L>GUK]TZ_2^#\*L'E4J*5K8BK+:WQ/0_B#Z2.?RXDX]I9C*7,W
MD^!IWW^"FD%%%%?5G\^A1110 5_+Y_P6U^%+^-_'GA.Y2V\[;+<$_+N_AD/H
M?7CMG\:_J#K\F/V_OA[!XJ\0>&YY(5<JUR<L ?X']<XZYYX^E?-\587ZYE%:
MBU>\Z4MK[3BOU/VOP X@EPUXC9=F49.#CA<;2O>WQT);Z^1_(_9_LZRF1#]B
M/S */DZXXQG&/T]?K7MW[,GP!ETO]I3X=W_V,J+?6K-]WEXQM9<= /\ #U/!
MK]6;'X*VN+<_9H\F9E^ZHY!';'?&>/YUZ-\)/@];6'QC\)WBVZ*8=0@8$*!C
M!X[#@?K7YI3R"-&>#K\OPXBATT]RM2].WE\]C^[L\\8:V(R;,J+KMJOE.-H_
M$]I8>I#>^_EI;75;']#'A&+R/#.APXQY6G6Z8],+TKHJS]*C\G3;*+&/+@1<
M?0>U:%?ML?AC_A7Y'^5F(ESXBO+^:M5E]\Y/]0HHHJC$**** "BBB@#\F?\
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M?C7Y9V7P3M19VO\ HL?$:_PC/W5]!7Y3Q1DRQ>;5Z_+=N-)7]8/\_/\ S/\
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M\^=H_B;)Z<^OJ<>U?!\<8%8VGEMU?EQ+C]Z7];,_JWZ,'%T^%L7Q;*$W!XC
M839VNXXA+]?R/PETW]G>7S91]B/!8?<Z].^.V.?QS[?:O_!*OX(OX=_;4TC6
M#:;!:QW0+>6 !G:?3J?Y'M7W5I_P6M/.NA]FCXF8?=4]>?0_X=NV:^@/V'OA
M5;Z)^T'<ZFD"*UN9%#!1QD+[?ECTSVY^/P&01P^<9=/EL_K=&3T7V(<_6VWS
M/Z/XV\6*N.X'XNPKK-_6,@Q5"W-O[2/L[;O^;\K]+_OA"-L,0](XQ^2@5)2+
M]T?0?RI:_;%HDNQ_F(W=M]V%%%% CD/'UO\ :_!OB*WQGS=,G3'KD#^M?P-?
M%W]GZ6Y^/WQ<NOL61<>*=6GR(^Q<'/3'/0?IT-?W_P"N0_:-(U"#&1+;.A'L
M<9K^:CQ]\'+:X^+GC^X-O'F?4=0F)P"22W7'X?A^E?!\;9>L='+TU\-2?Y)_
MA_5^G]:?1=XPGPK6XNE&?)[?"8.3ULG:KRGX9P?L[281OL1Y7/\ J_<]RO3\
M/TK]3O\ @BY\+7\&_M,:K>-;^4&%QSMP>4_#'4_A7N=I\%;4P1'[-&,P$GY1
MZ]QV_3\:^G?V ?A_#X9^-]]<QPJA/G\A0.-I[C'/'^17S&3Y''"9IE=91M^_
M4MOY7!]=;G[YXD>)U7/?#SC' RJN7M,LQ%*W->_/24>]GOYW^]'[M4445^QG
M^9X4444 %%%% !1110 4444 %%%% !1110 4444 %%%% &9K2>9HVK1_W],O
MTZ?WK64?UK^#+]JCX!2:C^TOX_NQ9[EN=6O9-VS)(>ZD/I^N?ZU_>M>KOLKM
M/[UK<+_WU$X_K7\XOQM^#]K>_&[Q'=&W0^?<R/DJN?FE<Y]>_P#GFOAN-\M6
M8X7"0:3Y:E1+_MZ,5Z]/Z9_4WT8.,9\(YOQ+5C-P^M9?AD]6OX=6:\O^?A^!
M,W[.LJ&,?8B=SXP8SQ^A_7T]:N^'?V=)8_'W@F4V1^37[(G]WTPQ]0.G'TK]
MM+WX+6H>V'V9!FX()PIXX]/\]OKKZ5\%+5/%7A206R977K8YP,\,?;@^O3 ]
MQ7YQ3X<BYX=\OQ**M9;)Q=_E<_KZMXSUOJ^+C]8=IX:O3?O?ST;?)-G] OP%
MT_\ LKX/?#[3]NW[)X<L8<>FQ2,>V.F/Y]:]=KE? ]H+#PEH-F!@6VG01 >@
M5:ZJOWK#1Y,/AX?R4:4?_ :<5^A_E7FU5U\TS*N]76QV+JM]W4KSG?YW"BBB
MMCSPJ.49BE'K&X_-2*DI#T/T/\J!IZKU7YG\7/\ P5M^##^)/VN'U1;4R>9;
M6X+^7D<.3UY]?Y]NOP?+^SK((V?[$P^3./+_ ,%[>^:_I _;T^&,&N?'BUOW
MA5BT5N-VT8[>Q_SQ7@=Q\%;063M]EC_U!.=@_+&.?3K[&OQ3-<AC6S7'S:?O
M5W+9?::;OW_$_P!/?#[Q7K9;P!PEAE7<51RNE1M=Z>R25OP^[SU/PFN/V=I?
ML%[_ *#]ZU=^$R>@]ORS[5_5'_P1/\#'P/\  #6;-H3$;C54DP5QD!#STY_S
MVKXAG^"UK]@G_P!&CRVFNWW1^N/ZC\:_9?\ 8%\)Q^%?A2UM'&J"::.3  '.
MWVQD<\5Z_"&2K YE&NHV48U87_Q1V_/]3\\^D+XB5.(O#B>62JN:GF. JN-V
M_@DY;-^?;_@_>%%%%?JA_ @4444 %?SS_P#!>[P0_C7X4^!K)(C+L\30L1MW
M?P1=O\.:_H8K\H/^"GWA./Q5X1\(6TD:N$\01-@@'^!/4>F/\BO#XDP_UK)\
M90:TG&/3M),_7/ O-'DWB?PUF$7RNC6Q&O\ BPU5?CL?R1M^SQ)_96B#[$?^
M/*WC_P!7_P#6]O4YK&\3?L\2#6_!Q-ETU2P3/E_]-%]O7MCGFOW3?X+VHTS1
M_P#1DZ1)]Q?H/_K<G'KQSD^*?@O:_P!J^$R+>/Y==T]?NJ/^6@^GXU^/2X>C
M"4:JC:RBD[?WHOI\_N/]$J'B]6Q$IX;V[?-3JPMS/94=OO7Y'[^?L=:-_P (
M_P#LY?#'2=FPVGA^VC*XQC"*<8[=:^FZ\T^$&FKI'PZ\+Z>HVBVTV!, 8 _=
MKTQV]*]+K]UPD?9X7#0_EH4H_="*/\JN(Z[Q6?YUB6[NOFN/K7_Z^8FI+]0H
MHHKH/&"BBB@ HHHH _FI_P""Z7PS;QOJ/@:=;?S3!!"A.T-C]X.IP<=?Y^E?
M@RO[.\F^W'V)OGB7C9QT'JN?SYK^M[_@H]X&A\51>'Y9(UD,)B'(!P-X/4\C
MBOS=B^"]J9].'V>/YH?[BGIQCIQT[_TK\?XBR..)SO&UG'^+.,_GRTX_DM/Q
MTN?Z+^"OB95R+PTX>R^-5Q6&5:G92M:]><]%\_QZW1^$WBG]G>6.PB_T(_\
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MA=I8\H.@_P G.,5^BU?/?[3GAU/$OPB\5V,B!P=+N>",]5]^.W?VKBS*E[;
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M4445]P?RJ%%%% %6^YM+@>L;5^*'C&QB/Q-\:<#_ %UZ3D?[7^>U%%?/9_\
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MSA'Y1J*ZFBBOT&C_  J7_7N'_I*/X[S)_P#"ACO^PO$?^G9!1116AQ!1110
M4444 ?!'[:,"36.D[@,B2+!(]Q7QE#81?:=+P%_U'<?3O^/; ]J**^,S-?\
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M$5E$+OPY\J_\?5MT&.=PZ>G].U?M5\,5V^!/#2CH-.A_E117;D:LZC[TU?\
M\"1X?BS)O+,FN[_[;C_SB_U.\HHHKZ,_"PHHHH *\Y^+42R_#SQ2K#(_LNXZ
M^ZT45CB/X%;_ *]S_)GHY0VLURUK1_7L)_Z?@?D+H]A#Y$V57_C[/0?7_/XU
M:-C%\W YN1CCW[_Y-%%?GLXKVDU;=0^5X+;L?U+BISM#WGO4_.*.9OK*+_A(
M]#.!D:O8_I,GL>Y[YR*_;GPD OAW2@!@?8[?_P!$I117U64*U:O9?\N:/Y'P
M7C#)O <.7=_W=;_VTZ.BBBO>/P8****  \C%?EQ^W[91?V%>,54YTZ8GCV'Z
M]>OYT45X'$2O@*EU_P NJW_I,3]-\(&UQ_P^DVO]LI_^E+^ODC^+[]K6%4O[
MX#H+:X(X'O7XD>)?^0G<_P#75_\ T)J**_EOB+_>I><$_P :9_T">"K;X8J7
M\O\ T[$9I7_'[I_^]_05^_/_  3Y@60>#2PR3=(/_(D7U]/2BBCA!)YE3O\
MW?\ TLY/I"MK@G%6_P"?2_\ 4:D?W??LS6D:?"W06  /D)R!S_JT_P \?CFO
MHNBBOZYP/^Z8;_KS3_\ 24?\ZO$K;S_-[N_^WXG\:C"BBBNH\,**** "BBB@
C HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** /_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>15
<FILENAME>image00007.jpg
<TEXT>
begin 644 image00007.jpg
M_]C_X  02D9)1@ ! 0$!+ $L  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" +)!;X# 2(  A$! Q$!_\0
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M^2^X/[&RC_H59;_X0X7_ .5':_\ "ROB+_T/WC7_ ,*G7?\ Y/H_X65\1?\
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MU&$*V&Q6=X^@\/1JTYJ4<#@LRA)1>(H3.IHHHK^SS_'T**** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M)_P^-_8W_P"?KXG?^$,O_P N:/\ A\;^QO\ \_7Q._\ "&7_ .7-?R=T4?\
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MU_)W11_Q,?X@?] _#G_ANQ?_ ,\@_P"*?_@/_P!!''?_ (D.!_\ G&?UB?\
M#XW]C?\ Y^OB=_X0R_\ RYH_X?&_L;_\_7Q._P#"&7_Y<U_)W11_Q,?X@?\
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M_P"7//\ PYQ_^90_XG]\>NW!/_B.XC_Y['\H7_#FW]L3_JE7_A;W?_S/4?\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M,JN*J+V-"K*/[<_L'_LQ6O[+/P \.^#KV"W/CWQ'L\6_$F_B^<R^)]2MH?\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MHYEQA.FZ.*B[-QG#A_#SJ993NHRIYA6SB#YX*C,****_H8_@<**** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M (EMX^_Z#N&/_#AF/_SG_JWH?VU_Q4(\#?\ H4^(O_AAR3_Z)S^1NBOZY/\
MAT7^Q-_T)/B[_P .%XH_^3:/^'1?[$W_ $)/B[_PX7BC_P"3:/\ B6WC[_H.
MX8_\.&8__.?^K>@?\5"/ W_H4^(O_AAR3_Z)S^1NBOZY/^'1?[$W_0D^+O\
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M8_\ #AF/_P Y_P"K>@?\5"/ W_H4^(O_ (8<D_\ HG/Y&Z*_KD_X=%_L3?\
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MYOF-6>.QE!++H)TJ4:6'QF)Q,*\,10H*7IE%%%?U>?Y=A1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M;3WE]<V]G9VT;37-U=S1V]M;Q(,O+//,R111J.6>1E51R2*^!?B;_P %7?\
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M[+F-XA] 1313Q13P21S031I+#-$ZR12Q2*'CEBD0E)(Y$(9'4E64AE)!!K_
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MKCQC_8+O<KINDZQ\0OB5>>.M7?4K:UEMCJ&O>#K/P(^H:C:FZM-/TBPG;24
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4R21(HWEE=(XHT:2221@D<<: L[N[$*B(H+,S$*H!)(
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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ME9G/N=% !1110!_-[_P=A_\ *$W]H?\ [*)^SQ_ZNKP;7^237^MM_P '8?\
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M (*!_P#)^G[;G_9W?[2?_JY?&E?(E?[%/Q!_X-K?^"*?Q3\>^-_B=X\_8O\
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M;L;2#7]%DGC/V/7M$FU#1=1A:*ZL+^YMIH9G /%**** "BBB@ HHHH ****
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M?65W;O):ZEHNO:)J&F>(/#VL6<DMCK.@ZIINJV,LMI>0R-XI0 4444 %%%%
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MHHH **** "BBB@ HHHH *_R!?^#H[_E.O^W-_P!VS?\ K'G[/M?Z_5?Y O\
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M6[!9'U;X]VC$J&!@O_V6?CC8W*X8$ O;7$J*WWD+!U(901^"]?T@_P#!I_\
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MQL+*""UM+6!$A@MXHXHT5$4#4HHH *^5/VYOVE](_8X_8[_:5_:CUJ(75O\
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MO OB3PWIMS!?A1)<W%W<?"/58KJS9V2QBLK.9%5M0D+_ -R5 !1110 4444
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MH **** /\P3_ (/5O^4IOP#_ .S /A9_ZT5^U57\@5?U^_\ !ZM_RE-^ ?\
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MFP-'J-G-:.LT?_+2(K,1(G\:;E[U_@/4 %%%% !1110 4444 %%%% !1110
M4444 ?WQ_P#!C5<3+XA_X*8VJR,+>;1OV1+B6(?=>:VOOVE8X)#WW1)=W"KS
MC$SYSQC_ $%:_P ]7_@QO-__ ,)Y_P %(1&L?]EGPC^RX;QCM\T7XUGX\#35
M3)W^6UN=5,FU2NY8MY4[ W^A50 4444 %%%% !1110 5_D"_\'1W_*=?]N;_
M +MF_P#6//V?:_U^J_R!?^#H[_E.O^W-_P!VS?\ K'G[/M 'X T444 %%%%
M!1110 4444 %%%% ']0W_!H/_P ICO"W_9N_QT_]-V@U_JY5_E&_\&@__*8[
MPM_V;O\ '3_TW:#7^KE0 4444 %?SX?\''7_  5:3_@F7^PWJNF_#?7H[+]J
MC]ID:W\+O@7%:3Z:^K>"[!M.'_"P?C/)87EPLQL_ &CWUK8:#=PV6I1I\1/$
M_@I+VQFTD:M+;?N_\0OB!X+^%'@/QG\3_B1XFTCP9\/OAYX7UWQKXV\7>(+R
M'3M#\,^%?#.F7.LZ]KNK7T[+#:Z?I>F6=S>74TC )#"QY. ?\8'_ (+%?\%)
M/&?_  5'_;D^)_[1>JW&IV/PQL+EOA_^SYX)OWC">"/@SX9N[I/#L+V\=O;F
M/7O%MW/J/CSQ:URUY<P^(O$U]I,%_+HFD:+;6@!^6M%%% !1110 5[%^SY\!
M_B=^U#\;_A9^SS\&?#EUXK^*'QB\;:%X#\&Z-;0W<L;ZKKMY';'4=4EL[:\E
MTWP[H5H;G7?%&NRV[67A[PYINJZ[J3PZ?IUU-'X[7^BW_P &?W_!)L_#OP#K
M'_!43XV^'HU\8_%72M5\#?LKZ-J^EWEOJ'A3X;)?7>F>//BN@O9DC^V_$N]M
M%\,^$KJ/2X;BT\#Z/K.J:?J^HZ+\2/)M0#^K[_@G-^PS\,?^"<G['GP=_9,^
M%J"ZT[X>:$;CQ=XHD67[?X_^)6OR?VMX_P#'>HF=Y9TD\1>([B[FTZP:1H-!
MT&+2/#FGB+3-(LH(O\^/_@]6_P"4IOP#_P"S /A9_P"M%?M55_I]U_F"?\'J
MW_*4WX!_]F ?"S_UHK]JJ@#^0*BBB@ HHHH **** "BBB@ HHHH ^_\ _@D[
M_P I3?\ @FG_ -G_ /[&_P#ZT5\.:_V^:_Q!O^"3O_*4W_@FG_V?_P#L;_\
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M/35O^"B'[!6E2R/%'J?[:'[+FGR2H 7B2]^./@:V>1 WRET60LH;@D 'BO\
M<HK_  Y_^"9'_*27_@GQ_P!GP?LG_P#J^? -?[C% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110!_E&_\'?'_ "F.\4_]F[_ O_TW:]7\O-?U
M#?\ !WQ_RF.\4_\ 9N_P+_\ 3=KU?R\T %%%% !1110 4444 %%%% !1110
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M\D4BM%*C!XG>-P=R.RD$@&C1110 4444 %%%% !1110 4444 %%%% !1110
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M&+_2-6L"RHYL;ZW,D<3EHU_W#*_R0_\ @ZV^"-Q\'_\ @L_\>?$!E#:7\?/
M7P:^-VAP?9VA:SM[SP'I_P ,M;B:8R,MX;CQC\+_ !/J2W"1P+''?)8M')+9
MR7-P ?SAT444 %%%% !1110 4444 %%%% !1110 5_?E_P &1/[3:1W?[;/[
M'&KZGI41N8_ ?[2?P_T@N8M:NY(=_P ,OBS>A7N&6]T^TB/P;C06]K$^GSW%
MPUS-<IJ%LEG_  &U^SG_  ;\?M>-^QA_P5G_ &2OB)J6J:AIW@/XB>-A^SY\
M38K+[ +>\\(_'&,>!=/NM;DU":V2#0/"/C[4/!/Q"U>>VN8[V&U\',]O%J#
MZ7? '^RY1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!_E&_P#!
MWQ_RF.\4_P#9N_P+_P#3=KU?R\U_4-_P=\?\ICO%/_9N_P "_P#TW:]7\O-
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MBGA'X</<W,]Y<"S\&6=O]I,%O!%$ ?LK1110 4444 %%%% !1110 5_D"_\
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M7;_3M&TJUN=0OK:"3V)W6-6=V5$12[NY"JBJ"69F) 55 )))  !).*_RV?\
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M\T"Z1\//!T$UW-;Q&^\9>.]2\.^%[&(2>;-=ZM%'"DDA6-OKRO\ /Z_X//\
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MU'PC\.M3@N(2GV'Q?/)G=&H;_9J15C54151$4(B(H5450 JJH "JH
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M *T5^U57^GW7^8)_P>K?\I3?@'_V8!\+/_6BOVJJ /Y J*** "BBB@ HHHH
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MH>EVD>9+K4=6U6]M+"QMT^>>YN(HEY84 ?2G[#/[%GQN_P""@G[3WPP_99^
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MN+:78X2>TNX"SVNHZ;>107^EZA!=:=J%O;WMM/!'Z?0 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !117Y2?\%#O^"TW_!/G_@F9I-_!^T1\:=.
MU+XJIIS7VB_L^?##[)XY^->NM);7\^G+/X5LKV"T\&:=JLFFW5I8^)?B+JWA
M#PQ-=I]F36&N"D+ 'ZMT5X'^RM\?='_:J_9I^ G[3'AW0-3\+>'_ (_?"+X?
M_&#0O#>M7%K=ZSH6C?$/PQIOBG3-*U:XL<V4NIV5EJ<%O?M9O+:BZ25;>::$
M)*_OE !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M?]F+]G!_#?Q6_:&N&6SDM?$=L=5N'\ _""2&[CN/.'Q5UG0M3L]:46P"^ M
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MPJ^%=A<N^E:+$EL!:W'B379VE\2^.-:S<3:IXDU&Y@M[E= TSP_INF_F510
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% '^4;_P '?'_*8[Q3_P!F[_ O_P!-VO5_+S7]0W_!WQ_R
MF.\4_P#9N_P+_P#3=KU?R\T %%%% !1110 4444 %%%% !1110 5_O\ %?X
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MX;V2?:M,^"-I=6\5Z)+@6^J_$>[2WFO[73O"UHECXB^ /^"RG_!P_P#M1_\
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MDHL]9\=>--/O/C UI875VMQI4>E_$G2VTZ*RL=(MG3P_ VD2 '^Q?17^:_\
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MVP?^#B/_ ())_L9PZM8>,/VJ?"OQ?\?:9#XA6/X7_LU>5\</%=SK/AK9%?\
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M_&FC7<[7'QYUS0+JT\IO#'@S4;>TC^$LEU/*^M>,+74?&2Z?9V'A?PAJWB(
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MO5_+S7]0W_!WQ_RF.\4_]F[_  +_ /3=KU?R\T %%%% !1110 4444 %%%%
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M]BOX7_LP>"DTO4O%%A:?\)=\:/'UCIR:?<_$SXR>(;2S/C'Q9>?/-<R6=O\
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MRNHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MKUH%EN[Z:7+GZDHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M")KW0/$=AINJVJR%'"&>TC#E&VYVG'%4 %%%% !1110 4444 %%%% !1110
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M>3;E+2X^TR"T_P!&NB@#_+5UC_@S._X*SZ8^RR\=_L7^(5WW"^;H_P 8/B;
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 ?Y1O_!WQ
M_P ICO%/_9N_P+_]-VO5_+S7]0W_  =\?\ICO%/_ &;O\"__ $W:]7\O- !1
M110 4444 %%%% !1110 4444 %?[_%?X ]?[_% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110!_E&_P#!WQ_RF.\4_P#9N_P+_P#3=KU?R\U_4-_P=\?\ICO%
M/_9N_P "_P#TW:]7\O- !1110 4444 %%%% !1110 4444 %?[_%?X ]?[_%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110!_E&_\'?'_ "F.\4_]F[_ O_TW
M:]7\O-?U#?\ !WQ_RF.\4_\ 9N_P+_\ 3=KU?R\T %%%% !1110 4444 %%%
M% !1110 5_O\5_@#U_O\4 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% '^4;_
M ,'?'_*8[Q3_ -F[_ O_ --VO5_+S7]0W_!WQ_RF.\4_]F[_  +_ /3=KU?R
M\T %%%% !1110 4444 %%%% !1110 5_O\5_@#U_O\4 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MZ7I>GZ3IEP^EZ7:V>G;;5?FJ@#_2%_:1_P"#V?\ 99\*?;M,_93_ &1/C/\
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M *NKP;7^230 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !7^NW_ ,&K/_*#G]D3_L/_ +2/_K3?Q>K_ ")*_P!=O_@U9_Y0
M<_LB?]A_]I'_ -:;^+U ']#M%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% '\WO_!V'_P H3?VA_P#LHG[/'_JZO!M?Y)-?
M[;7_  57_P"3/?%/_8X>!?\ T^1U_++0!_G?T5_H@44 ?YW]%?Z(%% '^=_1
M7^B!10!_G?T5_H@44 ?YW]%?Z(%% '^=_17^B!10!_G?T5_H@44 ?YW]%?Z(
M%% '^=_17^B!10!_G?T5_H@44 ?YW]%?Z(%% '^=_7^NW_P:L_\ *#G]D3_L
M/_M(_P#K3?Q>K\9*_JT_X)>_\F7_  R_["WQ!_\ 4^\1T ?H)1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
H0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Submission<br></strong></div></th>
<th class="th"><div>Aug. 12, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_SubmissionLineItems', window );"><strong>Submission [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Central Index Key</a></td>
<td class="text">0001835654<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Registrant Name</a></td>
<td class="text">Innoviz Technologies Ltd.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FormTp', window );">Form Type</a></td>
<td class="text">F-3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_SubmissnTp', window );">Submission Type</a></td>
<td class="text">F-3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeeExhibitTp', window );">Fee Exhibit Type</a></td>
<td class="text">EX-FILING FEES<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingTableNa', window );">Offering Table N/A</a></td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OffsetTableNa', window );">Offset Table N/A</a></td>
<td class="text">N/A<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_CombinedProspectusTableNa', window );">Combined Prospectus Table N/A</a></td>
<td class="text">N/A<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_CombinedProspectusTableNa">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_CombinedProspectusTableNa</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:naItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FeeExhibitTp">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FeeExhibitTp</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:feeExhibitTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FormTp">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FormTp</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingTableNa">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingTableNa</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:naItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OffsetTableNa">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OffsetTableNa</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:naItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_SubmissionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_SubmissionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_SubmissnTp">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_SubmissnTp</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Offerings<br></strong></div></th>
<th class="th">
<div>Aug. 12, 2025 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingAxis=1', window );">Offering: 1</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingTable', window );"><strong>Offering:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_Rule457oFlg', window );">Rule 457(o)</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingSctyTp', window );">Security Type</a></td>
<td class="text">Equity<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingSctyTitl', window );">Security Class Title</a></td>
<td class="text">Ordinary shares, no par value per share<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeeRate', window );">Fee Rate</a></td>
<td class="nump">0.01531%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingAxis=2', window );">Offering: 2</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingTable', window );"><strong>Offering:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_Rule457oFlg', window );">Rule 457(o)</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingSctyTp', window );">Security Type</a></td>
<td class="text">Debt<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingSctyTitl', window );">Security Class Title</a></td>
<td class="text">Debt Securities<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeeRate', window );">Fee Rate</a></td>
<td class="nump">0.01531%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingAxis=3', window );">Offering: 3</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingTable', window );"><strong>Offering:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_Rule457oFlg', window );">Rule 457(o)</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingSctyTp', window );">Security Type</a></td>
<td class="text">Other<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingSctyTitl', window );">Security Class Title</a></td>
<td class="text">Warrants<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeeRate', window );">Fee Rate</a></td>
<td class="nump">0.01531%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingAxis=4', window );">Offering: 4</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingTable', window );"><strong>Offering:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_Rule457oFlg', window );">Rule 457(o)</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingSctyTp', window );">Security Type</a></td>
<td class="text">Other<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingSctyTitl', window );">Security Class Title</a></td>
<td class="text">Units<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeeRate', window );">Fee Rate</a></td>
<td class="nump">0.01531%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingAxis=5', window );">Offering: 5</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingTable', window );"><strong>Offering:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_PrevslyPdFlg', window );">Fee Previously Paid</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_Rule457oFlg', window );">Rule 457(o)</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingSctyTp', window );">Security Type</a></td>
<td class="text">Unallocated (Universal) Shelf<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_MaxAggtOfferingPric', window );">Maximum Aggregate Offering Price</a></td>
<td class="nump">$ 144,788,668.00<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeeRate', window );">Fee Rate</a></td>
<td class="nump">0.01531%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeeAmt', window );">Amount of Registration Fee</a></td>
<td class="nump">$ 22,167.15<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingNote', window );">Offering Note</a></td>
<td class="text">(1)	The securities registered hereunder include such indeterminate number of (a) ordinary shares, (b) debt securities, (c) warrants to purchase ordinary shares and (d) units consisting of some or all of these securities in any combination, as may be sold from time to time by the registrant. There are also being registered hereunder an indeterminate number of ordinary shares as shall be issuable upon conversion, exchange or exercise of any securities that provide for such issuance.
(2)	Pursuant to Rule 416 under the Securities Act of 1933, as amended, or the Securities Act, this registration statement shall also cover any additional shares of the registrant's securities that become issuable by reason of any stock splits, stock dividend or similar transaction.
(3)	The proposed maximum per security and aggregate offering prices per class of securities will be determined from time to time by the registrant in connection with the issuance by the registrant of the securities registered hereunder and is not specified as to each class of security. Separate consideration may or may not be received for securities that are issuable on exercise, conversion or exchange of other securities, or that are issued in units.<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingAxis=6', window );">Offering: 6</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingTable', window );"><strong>Offering:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_Rule415a6Flg', window );">Rule 415(a)(6)</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingSctyTp', window );">Security Type</a></td>
<td class="text">Equity<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingSctyTitl', window );">Security Class Title</a></td>
<td class="text">Ordinary shares, no par value per share<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_CfwdFormTp', window );">Carry Forward Form Type</a></td>
<td class="text">F-3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_CfwdPrrFileNb', window );">Carry Forward File Number</a></td>
<td class="text">333-267646<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_CfwdPrrFctvDt', window );">Carry Forward Initial Effective Date</a></td>
<td class="text">Oct. 11,  2022<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingAxis=7', window );">Offering: 7</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingTable', window );"><strong>Offering:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_Rule415a6Flg', window );">Rule 415(a)(6)</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingSctyTp', window );">Security Type</a></td>
<td class="text">Debt<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingSctyTitl', window );">Security Class Title</a></td>
<td class="text">Debt Securities<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_CfwdFormTp', window );">Carry Forward Form Type</a></td>
<td class="text">F-3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_CfwdPrrFileNb', window );">Carry Forward File Number</a></td>
<td class="text">333-267646<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_CfwdPrrFctvDt', window );">Carry Forward Initial Effective Date</a></td>
<td class="text">Oct. 11,  2022<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingAxis=8', window );">Offering: 8</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingTable', window );"><strong>Offering:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_Rule415a6Flg', window );">Rule 415(a)(6)</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingSctyTp', window );">Security Type</a></td>
<td class="text">Other<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingSctyTitl', window );">Security Class Title</a></td>
<td class="text">Warrants<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_CfwdFormTp', window );">Carry Forward Form Type</a></td>
<td class="text">F-3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_CfwdPrrFileNb', window );">Carry Forward File Number</a></td>
<td class="text">333-267646<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_CfwdPrrFctvDt', window );">Carry Forward Initial Effective Date</a></td>
<td class="text">Oct. 11,  2022<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingAxis=9', window );">Offering: 9</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingTable', window );"><strong>Offering:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_Rule415a6Flg', window );">Rule 415(a)(6)</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingSctyTp', window );">Security Type</a></td>
<td class="text">Other<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingSctyTitl', window );">Security Class Title</a></td>
<td class="text">Units<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_CfwdFormTp', window );">Carry Forward Form Type</a></td>
<td class="text">F-3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_CfwdPrrFileNb', window );">Carry Forward File Number</a></td>
<td class="text">333-267646<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_CfwdPrrFctvDt', window );">Carry Forward Initial Effective Date</a></td>
<td class="text">Oct. 11,  2022<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingAxis=10', window );">Offering: 10</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingTable', window );"><strong>Offering:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_Rule415a6Flg', window );">Rule 415(a)(6)</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingSctyTp', window );">Security Type</a></td>
<td class="text">Unallocated (Universal) Shelf<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_MaxAggtOfferingPric', window );">Maximum Aggregate Offering Price</a></td>
<td class="nump">$ 55,211,332.00<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_CfwdFormTp', window );">Carry Forward Form Type</a></td>
<td class="text">F-3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_CfwdPrrFileNb', window );">Carry Forward File Number</a></td>
<td class="text">333-267646<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_CfwdPrrFctvDt', window );">Carry Forward Initial Effective Date</a></td>
<td class="text">Oct. 11,  2022<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_CfwdPrevslyPdFee', window );">Filing Fee Previously Paid in Connection with Unsold Securities to be Carried Forward</a></td>
<td class="nump">$ 5,118.09<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingNote', window );">Offering Note</a></td>
<td class="text">The registrant previously paid registration fees in the aggregate of $18,540 with respect to a Registration Statement on Form F-3 (File No. 333-267646) (the "Prior Registration Statement"). Pursuant to Rule 415(a)(6) ("Rule 415(a)(6)") promulgated under the Securities Act of 1933, as amended (the "Securities Act"), the securities registered pursuant to this Registration Statement on Form F-3 (this "Registration Statement") include $55,211,332 of securities previously registered on the Prior Registration Statement which remain unsold (the "Unsold Securities"). Pursuant to Rule 415(a)(6), the registration fee of $5,118.09 associated with the offering of the Unsold Securities (based on the filing fee rate in effect at the time of the filing of the Prior Registration Statement) is hereby carried forward to be applied to the Unsold Securities registered hereunder, and no additional filing fee is due with respect to the Unsold Securities in connection with the filing of this Registration Statement. The registrant is also registering new securities on this Registration Statement with an aggregate maximum offering price of $144,788,668 (the "New Securities"), which aggregate offering price is not specified as to each class of securities in reliance upon Rule 457(o) promulgated under the Securities Act. A filing fee of $22,167.15 with respect to the New Securities is being paid in connection with the filing of this Registration Statement. Pursuant to Rule 415(a)(6), the offering of the Unsold Securities under the Prior Registration Statement will be deemed terminated as of the date of effectiveness of this Registration Statement.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_CfwdFormTp">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Form Type of the prior shelf registration statement from which unsold securities are carried forward under 415(a)(6). This should be an EDGAR submission type (S-3, S-3/A, S-3ASR, etc.), which means there is a fixed set of possible responses. Note that while the XBRL response should be an EDGAR submission type, the human-readable Ex. 107 could include a simpler label (e.g., "Form S-3" in the human-readable and "S-3ASR" in the XBRL).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 415<br> -Subsection a<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_CfwdFormTp</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:formTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_CfwdPrevslyPdFee">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The fee previously paid in connection with the securities being brought forward from the prior shelf registration statement on which unsold securities are carried forward under 415(a)(6).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 415<br> -Subsection a<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_CfwdPrevslyPdFee</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegative1TMonetary2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_CfwdPrrFctvDt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The initial effective date of the prior shelf registration statement from which unsold securities are carried forward under 415(a)(6).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 415<br> -Subsection a<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_CfwdPrrFctvDt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_CfwdPrrFileNb">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The EDGAR File Number of the prior shelf registration statement from which unsold securities are carried forward under 415(a)(6). If the prior registration statement has a Securities Act File Number and an Investment Company Act File Number, the Securities Act File Number should be used.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 415<br> -Subsection a<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_CfwdPrrFileNb</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FeeAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total amount of registration fee (amount due after offsets).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FeeAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegative1TMonetary2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FeeRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The rate per dollar of fees that public companies and other issuers pay to register their securities with the Commission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FeeRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_MaxAggtOfferingPric">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum aggregate offering price for the offering that is being registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_MaxAggtOfferingPric</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegative100TMonetary2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingNote">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingNote</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingSctyTitl">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The title of the class of securities being registered (for each class being registered).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingSctyTitl</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingSctyTp">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Type of securities: "Asset-backed Securities", "ADRs/ADSs", "Debt", "Debt Convertible into Equity", "Equity", "Face Amount Certificates", "Limited Partnership Interests", "Mortgage Backed Securities", "Non-Convertible Debt", "Unallocated (Universal) Shelf", "Exchange Traded Vehicle Securities", "Other"</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingSctyTp</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:securityTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingTable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingTable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_PrevslyPdFlg">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_PrevslyPdFlg</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_Rule415a6Flg">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Checkbox indicating whether filer is claiming a 415(a)(6) carryforward.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 415<br> -Subsection a<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_Rule415a6Flg</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_Rule457oFlg">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Checkbox indicating whether filer is using Rule 457(o) to calculate the registration fee due.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 457<br> -Subsection o<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_Rule457oFlg</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingAxis=1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingAxis=1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingAxis=2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingAxis=2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingAxis=3">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingAxis=3</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingAxis=4">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingAxis=4</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingAxis=5">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingAxis=5</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingAxis=6">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingAxis=6</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingAxis=7">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingAxis=7</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingAxis=8">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingAxis=8</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingAxis=9">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingAxis=9</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingAxis=10">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingAxis=10</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>19
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Fees Summary<br></strong></div></th>
<th class="th">
<div>Aug. 12, 2025 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeesSummaryLineItems', window );"><strong>Fees Summary [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_TtlOfferingAmt', window );">Total Offering</a></td>
<td class="nump">$ 200,000,000.00<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_TtlPrevslyPdAmt', window );">Previously Paid Amount</a></td>
<td class="nump">0.00<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_TtlFeeAmt', window );">Total Fee Amount</a></td>
<td class="nump">22,167.15<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_TtlOffsetAmt', window );">Total Offset Amount</a></td>
<td class="nump">0.00<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_NetFeeAmt', window );">Net Fee</a></td>
<td class="nump">$ 22,167.15<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FeesSummaryLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FeesSummaryLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_NetFeeAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_NetFeeAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_TtlFeeAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_TtlFeeAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegative1TMonetary2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_TtlOfferingAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_TtlOfferingAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegative1TMonetary2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_TtlOffsetAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_TtlOffsetAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegative1TMonetary2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_TtlPrevslyPdAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_TtlPrevslyPdAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegative1TMonetary2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>20
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>21
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
.report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

.report table.authRefData a {
	display: block;
	font-weight: bold;
}

.report table.authRefData p {
	margin-top: 0px;
}

.report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

.report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

.report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

.report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
.pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
.report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

.report hr {
	border: 1px solid #acf;
}

/* Top labels */
.report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

.report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

.report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

.report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

.report td.pl div.a {
	width: 200px;
}

.report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
.report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
.report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
.report .re, .report .reu {
	background-color: #def;
}

.report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
.report .ro, .report .rou {
	background-color: white;
}

.report .rou td {
	border-bottom: 1px solid black;
}

.report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
.report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
.report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

.report .nump {
	padding-left: 2em;
}

.report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
.report .text {
	text-align: left;
	white-space: normal;
}

.report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

.report .text .more {
	display: none;
}

.report .text .note {
	font-style: italic;
	font-weight: bold;
}

.report .text .small {
	width: 10em;
}

.report sup {
	font-style: italic;
}

.report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>23
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.25.2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>11</ContextCount>
  <ElementCount>26</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>1</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>3</UnitCount>
  <MyReports>
    <Report instance="exfilingfees.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>995210 - Document - Submission</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ffd/role/document/submissionTable</Role>
      <ShortName>Submission</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="exfilingfees.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>995211 - Document - Offerings</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ffd/role/document/feesOfferingTable</Role>
      <ShortName>Offerings</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="exfilingfees.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>995215 - Document - Fees Summary</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ffd/role/document/feesSummaryTable</Role>
      <ShortName>Fees Summary</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="EX-FILING FEES" original="exfilingfees.htm">exfilingfees.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="3">http://xbrl.sec.gov/dei/2025</BaseTaxonomy>
    <BaseTaxonomy items="67">http://xbrl.sec.gov/ffd/2025</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>false</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>25
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "exfilingfees.htm": {
   "dts": {
    "inline": {
     "local": [
      "exfilingfees.htm"
     ]
    },
    "schema": {
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/lrr/arcrole/deprecated-2009-12-16.xsd",
      "https://www.xbrl.org/dtr/type/2024-01-31/types.xsd",
      "https://xbrl.sec.gov/dei/2025/dei-2025.xsd",
      "https://xbrl.sec.gov/ffd/2025/ffd-2025.xsd"
     ]
    }
   },
   "keyStandard": 26,
   "keyCustom": 0,
   "axisStandard": 1,
   "axisCustom": 0,
   "memberStandard": 1,
   "memberCustom": 0,
   "hidden": {
    "total": 12,
    "http://xbrl.sec.gov/ffd/2025": 10,
    "http://xbrl.sec.gov/dei/2025": 2
   },
   "contextCount": 11,
   "entityCount": 1,
   "segmentCount": 1,
   "elementCount": 107,
   "unitCount": 3,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/ffd/2025": 67,
    "http://xbrl.sec.gov/dei/2025": 3
   },
   "report": {
    "R1": {
     "role": "http://xbrl.sec.gov/ffd/role/document/submissionTable",
     "longName": "995210 - Document - Submission",
     "shortName": "Submission",
     "isDefault": "true",
     "groupType": "Fee_Exhibit",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": null,
     "uniqueAnchor": null
    },
    "R2": {
     "role": "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable",
     "longName": "995211 - Document - Offerings",
     "shortName": "Offerings",
     "isDefault": "false",
     "groupType": "Fee_Exhibit",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "2",
     "firstAnchor": {
      "contextRef": "offrl_1",
      "name": "ffd:Rule457oFlg",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "exfilingfees.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "offrl_1",
      "name": "ffd:Rule457oFlg",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "exfilingfees.htm",
      "first": true,
      "unique": true
     }
    },
    "R3": {
     "role": "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable",
     "longName": "995215 - Document - Fees Summary",
     "shortName": "Fees Summary",
     "isDefault": "false",
     "groupType": "Fee_Exhibit",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "3",
     "firstAnchor": {
      "contextRef": "rc",
      "name": "ffd:TtlOfferingAmt",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "exfilingfees.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "rc",
      "name": "ffd:TtlOfferingAmt",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "exfilingfees.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "ffd_AggtRedRpPricFsclYr": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "AggtRedRpPricFsclYr",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Redeemed or Repurchased Price, Fiscal Year",
        "terseLabel": "Aggregate Redeemed or Repurchased, FY"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_AggtRedRpPricPrrFsclYr": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "AggtRedRpPricPrrFsclYr",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Redeemed or Repurchased Price, Prior Fiscal Year",
        "terseLabel": "Aggregate Redeemed or Repurchased, Prior FY"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_AggtSalesPricFsclYr": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "AggtSalesPricFsclYr",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Sales Price, Fiscal Year",
        "terseLabel": "Aggregate Sales Price"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_AmtRedCdts": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "AmtRedCdts",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amount of Redemption Credits",
        "terseLabel": "Redemption Credits"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_AmtSctiesRcvd": {
     "xbrltype": "nonNegativeDecimal2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "AmtSctiesRcvd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amount of Securities Received",
        "terseLabel": "Amount of Securities Received",
        "documentation": "Amount of securities to be received by the registrant (or cancelled upon issuance of securities to be registered on the form)"
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "ffd_AmtSctiesRegd": {
     "xbrltype": "nonNegativeDecimal2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "AmtSctiesRegd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amount of Securities Registered",
        "terseLabel": "Amount Registered",
        "documentation": "The amount of securities being registered."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_CeasedOprsDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CeasedOprsDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Ceased Operations Date",
        "terseLabel": "Ceased Operations Date"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_CfwdFormTp": {
     "xbrltype": "formTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CfwdFormTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Carry Forward Form Type",
        "terseLabel": "Carry Forward Form Type",
        "documentation": "The Form Type of the prior shelf registration statement from which unsold securities are carried forward under 415(a)(6). This should be an EDGAR submission type (S-3, S-3/A, S-3ASR, etc.), which means there is a fixed set of possible responses. Note that while the XBRL response should be an EDGAR submission type, the human-readable Ex. 107 could include a simpler label (e.g., \"Form S-3\" in the human-readable and \"S-3ASR\" in the XBRL)."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "ffd_CfwdPrevslyPdFee": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CfwdPrevslyPdFee",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Carry Forward Previously Paid Fee",
        "terseLabel": "Filing Fee Previously Paid in Connection with Unsold Securities to be Carried Forward",
        "documentation": "The fee previously paid in connection with the securities being brought forward from the prior shelf registration statement on which unsold securities are carried forward under 415(a)(6)."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "ffd_CfwdPrrFctvDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CfwdPrrFctvDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Carry Forward Prior Effective Date",
        "terseLabel": "Carry Forward Initial Effective Date",
        "documentation": "The initial effective date of the prior shelf registration statement from which unsold securities are carried forward under 415(a)(6)."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "ffd_CfwdPrrFileNb": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CfwdPrrFileNb",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Carry Forward File Number",
        "terseLabel": "Carry Forward File Number",
        "documentation": "The EDGAR File Number of the prior shelf registration statement from which unsold securities are carried forward under 415(a)(6). If the prior registration statement has a Securities Act File Number and an Investment Company Act File Number, the Securities Act File Number should be used."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "ffd_CmbndPrspctsItemAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CmbndPrspctsItemAxis",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Combined Prospectus Item [Axis]",
        "terseLabel": "Combined Prospectus",
        "documentation": "A sequence number (1, 2, 3...) used to distinguish different references to earlier prospectuses on a single fee bearing submission."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_CmbndPrspctsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CmbndPrspctsLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Combined Prospectus [Line Items]",
        "terseLabel": "Combined Prospectus:"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_CmbndPrspctsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CmbndPrspctsTable",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Combined Prospectus [Table]",
        "terseLabel": "Combined Prospectus Table"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_CombinedProspectusTableNa": {
     "xbrltype": "naItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CombinedProspectusTableNa",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Combined Prospectus Table [N/A]",
        "terseLabel": "Combined Prospectus Table N/A"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_CshPdByRegistrantInTx": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CshPdByRegistrantInTx",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash Paid by Registrant in Transaction",
        "terseLabel": "Cash Consideration Paid",
        "documentation": "Amount of cash consideration paid by registrant in connection with the exchange or other transaction being registered (in a 457(f) calculation)."
       }
      }
     },
     "auth_ref": [
      "r12"
     ]
    },
    "ffd_CshRcvdByRegistrantInTx": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CshRcvdByRegistrantInTx",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash Received by Registrant in Transaction",
        "terseLabel": "Cash Consideration Received",
        "documentation": "Amount of cash consideration received by registrant in connection with the exchange or other transaction being registered (in a 457(f) calculation)."
       }
      }
     },
     "auth_ref": [
      "r12"
     ]
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "terseLabel": "Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "terseLabel": "Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "ffd_FeeAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FeeAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable",
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Amount",
        "terseLabel": "Amount of Registration Fee",
        "documentation": "Total amount of registration fee (amount due after offsets)."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeeExhibitTp": {
     "xbrltype": "feeExhibitTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FeeExhibitTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Exhibit Type",
        "terseLabel": "Fee Exhibit Type"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_FeeIntrstAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FeeIntrstAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Interest Amount",
        "terseLabel": "Interest Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeeNote": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FeeNote",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Note",
        "terseLabel": "Fee Note"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeeNoteMaxAggtOfferingPric": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FeeNoteMaxAggtOfferingPric",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Note Maximum Aggregate Offering Price",
        "terseLabel": "Fee Note MAOP"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeeRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FeeRate",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable",
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Rate",
        "terseLabel": "Fee Rate",
        "documentation": "The rate per dollar of fees that public companies and other issuers pay to register their securities with the Commission."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeesOthrRuleFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FeesOthrRuleFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fees, Other Rule [Flag]",
        "terseLabel": "Other Rule",
        "documentation": "Checkbox indicating whether filer is using a rule other than 457(a), 457(o), or 457(f) to calculate the registration fee due."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeesSummaryLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FeesSummaryLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Fees Summary [Line Items]",
        "terseLabel": "Fees Summary:"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FnlPrspctsFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FnlPrspctsFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Final Prospectus [Flag]",
        "terseLabel": "Final Prospectus"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FormTp": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FormTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Form Type",
        "terseLabel": "Form Type"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_GnlInstrIIhiFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "GnlInstrIIhiFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "General Instruction II.H,I [Flag]",
        "terseLabel": "General Instruction II.H,I"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrBizAdrCity": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "IssrBizAdrCity",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Business Address, City",
        "terseLabel": "City"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrBizAdrStatOrCtryCd": {
     "xbrltype": "stateOrCountryCodeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "IssrBizAdrStatOrCtryCd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Business Address, State or Country Code",
        "terseLabel": "State or Country Code"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrBizAdrStrt1": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "IssrBizAdrStrt1",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Business Address, Street 1",
        "terseLabel": "Street 1"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrBizAdrStrt2": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "IssrBizAdrStrt2",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Business Address, Street 2",
        "terseLabel": "Street 2"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrBizAdrZipCd": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "IssrBizAdrZipCd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Business Address, Zip Code",
        "terseLabel": "Zip Code"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrNm": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "IssrNm",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Name",
        "terseLabel": "Issuer Name"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_MaxAggtOfferingPric": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "MaxAggtOfferingPric",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maximum Aggregate Offering Price",
        "terseLabel": "Maximum Aggregate Offering Price",
        "documentation": "The maximum aggregate offering price for the offering that is being registered."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_MaxOfferingPricPerScty": {
     "xbrltype": "nonNegativeDecimal4lItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "MaxOfferingPricPerScty",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maximum Offering Price per Security",
        "terseLabel": "Proposed Maximum Offering Price per Unit",
        "documentation": "The maximum offering price per share/unit being registered."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_NetFeeAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "NetFeeAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Fee Amount",
        "terseLabel": "Net Fee"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_NetSalesAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "NetSalesAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Sales Amount",
        "terseLabel": "Net Sales"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_NrrtvDsclsr": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "NrrtvDsclsr",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Narrative Disclosure",
        "terseLabel": "Narrative Disclosure"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_NrrtvMaxAggtAmt": {
     "xbrltype": "nonNegativeDecimal2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "NrrtvMaxAggtAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Narrative Disclosure, Maximum Aggregate Offering Amount",
        "terseLabel": "Narrative - Max Aggregate Offering Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_NrrtvMaxAggtOfferingPric": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "NrrtvMaxAggtOfferingPric",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Narrative Disclosure, Maximum Aggregate Offering Price",
        "terseLabel": "Narrative - Max Aggregate Offering Price"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OfferingAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OfferingAxis",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering [Axis]",
        "terseLabel": "Offering",
        "documentation": "A sequence number (1, 2, 3...) used to distinguish different security offerings on a single fee bearing submission."
       }
      }
     },
     "auth_ref": []
    },
    "ffd_OfferingLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OfferingLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering [Line Items]",
        "terseLabel": "Offering:"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_OfferingNote": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OfferingNote",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering Note",
        "terseLabel": "Offering Note"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OfferingSctyTitl": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OfferingSctyTitl",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable",
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering Security Title",
        "terseLabel": "Security Class Title",
        "documentation": "The title of the class of securities being registered (for each class being registered)."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OfferingSctyTp": {
     "xbrltype": "securityTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OfferingSctyTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering Security Type",
        "terseLabel": "Security Type",
        "documentation": "Type of securities: \"Asset-backed Securities\", \"ADRs/ADSs\", \"Debt\", \"Debt Convertible into Equity\", \"Equity\", \"Face Amount Certificates\", \"Limited Partnership Interests\", \"Mortgage Backed Securities\", \"Non-Convertible Debt\", \"Unallocated (Universal) Shelf\", \"Exchange Traded Vehicle Securities\", \"Other\""
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OfferingTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OfferingTable",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering [Table]",
        "terseLabel": "Offering:"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_OfferingTableNa": {
     "xbrltype": "naItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OfferingTableNa",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering Table [N/A]",
        "terseLabel": "Offering Table N/A"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_OffsetAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetAxis",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset [Axis]",
        "terseLabel": "Offset",
        "documentation": "A sequence number (1, 2, 3...) used to distinguish different offsets as applied to a fee bearing submission."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetClmInitlFilgDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetClmInitlFilgDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Claim Initial Filing Date",
        "terseLabel": "Initial Filing Date",
        "documentation": "The initial filing date of the earlier registration statement with which the earlier (offsetting) fee was paid for a claimed offset. If the offset fee was paid with an amendment, do not provide the amendment date under this element; instead, provide the date of the initial filing (i.e. the \"parent\" filing) ."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetClmdAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetClmdAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Claimed Amount",
        "terseLabel": "Fee Offset Claimed",
        "documentation": "The amount of offsetting fees being claimed."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetClmdInd": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetClmdInd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Claimed Indicator",
        "terseLabel": "Offset Claimed"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetExpltnForClmdAmt": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetExpltnForClmdAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Explanation for Claimed Amount",
        "terseLabel": "Explanation for Claimed Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetLineItems",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Offset:",
        "label": "Offset [Line Items]"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetNote": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetNote",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Note",
        "terseLabel": "Offset Note"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetPrrFeeAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetPrrFeeAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Fee Amount",
        "terseLabel": "Fee Paid with Fee Offset Source",
        "documentation": "The fee previously paid from which an offset is being derived."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrFileNb": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetPrrFileNb",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior File Number",
        "terseLabel": "File Number",
        "documentation": "The EDGAR File Number of the earlier registration statement with which the earlier (offsetting) fee was paid. If the offset filing for the offset has a Securities Act File Number and an Investment Company Act File Number, the Securities Act File Number should be used."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrFilerNm": {
     "xbrltype": "filerNameItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetPrrFilerNm",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Filer Name",
        "terseLabel": "Registrant or Filer Name",
        "documentation": "The name of the registrant that filed the earlier registration statement with which the earlier (offsetting) fee was paid."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrFormTp": {
     "xbrltype": "formTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetPrrFormTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Form Type",
        "terseLabel": "Form or Filing Type",
        "documentation": "The Form Type of the offset filing."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrNbOfUnsoldScties": {
     "xbrltype": "nonNegativeIntegerItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetPrrNbOfUnsoldScties",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Unsold Number of Securities",
        "terseLabel": "Unsold Securities Associated with Fee Offset Claimed",
        "documentation": "The number of unsold securities registered on the prior registration statement that are associated with the claimed offset."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrSctyTitl": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetPrrSctyTitl",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Security Title",
        "terseLabel": "Security Title Associated with Fee Offset Claimed",
        "documentation": "The title of the class of securities from which offset fees were derived."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrSctyTp": {
     "xbrltype": "securityTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetPrrSctyTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Security Type",
        "terseLabel": "Security Type Associated with Fee Offset Claimed",
        "documentation": "Type of securities: \"Asset-backed Securities\", \"ADRs/ADSs\", \"Debt\", \"Debt Convertible into Equity\", \"Equity\", \"Face Amount Certificates\", \"Limited Partnership Interests\", \"Mortgage Backed Securities\", \"Non-Convertible Debt\", \"Unallocated (Universal) Shelf\", \"Exchange Traded Vehicle Securities\", \"Other\""
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrUnsoldOfferingAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetPrrUnsoldOfferingAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Unsold Offering Amount",
        "terseLabel": "Unsold Aggregate Offering Amount Associated with Fee Offset Claimed",
        "documentation": "The aggregate offering amount of unsold securities registered on the prior registration statement that are associated with the claimed offset."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetSrcFilgDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetSrcFilgDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Source Filing Date",
        "terseLabel": "Filing Date",
        "documentation": "The filing date of the earlier registration statement with which the earlier (offsetting) fee was paid in an offset."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetTable",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Offset Payment:",
        "label": "Offset [Table]"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetTableNa": {
     "xbrltype": "naItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetTableNa",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Table [N/A]",
        "terseLabel": "Offset Table N/A"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_PrevslyPdFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "PrevslyPdFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable",
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Previously Paid [Flag]",
        "terseLabel": "Fee Previously Paid"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_RegnFileNb": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "RegnFileNb",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Registration File Number",
        "terseLabel": "Registration File Number"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_RptgFsclYrEndDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "RptgFsclYrEndDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Reporting Fiscal Year End Date",
        "terseLabel": "Reporting FY End Date"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_Rule011Flg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule011Flg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 0-11 [Flag]",
        "terseLabel": "Rule 0-11"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_Rule011a2OffsetFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule011a2OffsetFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Rule 0-11(a)(2) Offset",
        "label": "Rule 0-11(a)(2) Offset [Flag]"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_Rule415a6Flg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule415a6Flg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 415(a)(6) [Flag]",
        "terseLabel": "Rule 415(a)(6)",
        "documentation": "Checkbox indicating whether filer is claiming a 415(a)(6) carryforward."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "ffd_Rule429AggtOfferingAmt": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule429AggtOfferingAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Aggregate Offering Amount",
        "terseLabel": "Maximum Aggregate Offering Price of Securities Previously Registered",
        "documentation": "The maximum aggregate offering amount of unsold securities registered on the prior registration statement that are carried forward under Rule 429. Only applicable if 457(o) was used in the fee calculation for the prior registration statement."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429CmbndPrspctsFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule429CmbndPrspctsFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Combined Prospectus [Flag]",
        "terseLabel": "Rule 429",
        "documentation": "Checkbox indicating whether filer is using a combined prospectus under Rule 429."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429EarlierFileNb": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule429EarlierFileNb",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Earlier File Number",
        "terseLabel": "File Number",
        "documentation": "The Securities Act File Number of the earlier effective registration statement(s) from which securities may be offered and sold using the combined prospectus pursuant to Rule 429."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429EarlierFormTp": {
     "xbrltype": "formTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule429EarlierFormTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Earlier Form Type",
        "terseLabel": "Form Type",
        "documentation": "The Form Type of the earlier registration statement from which unsold securities are carried forward under Rule 429. This should be an EDGAR submission type (S-3, S-3/A, S-3ASR, etc.), which means there is a fixed set of possible responses. Note that while the XBRL response should be an EDGAR submission type, the human-readable Ex. 107 could include a simpler label (e.g., \"Form S-3\" in the human-readable and \"S-3ASR\" in the XBRL)."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429InitlFctvDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule429InitlFctvDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Initial Effective Date",
        "terseLabel": "Initial Effective Date",
        "documentation": "The filing date of the earlier registration statement from which unsold securities are carried forward under Rule 429."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429NbOfUnsoldScties": {
     "xbrltype": "nonNegativeDecimal2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule429NbOfUnsoldScties",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Number Of Unsold Securities",
        "terseLabel": "Amount of Securities Previously Registered",
        "documentation": "The number of securities registered on the prior registration statement that are carried forward under Rule 429."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429PrspctsNote": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule429PrspctsNote",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Prospectus Note",
        "terseLabel": "Combined Prospectus Note"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Rule429SctyTitl": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule429SctyTitl",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Security Title",
        "terseLabel": "Security Class Title"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Rule429SctyTp": {
     "xbrltype": "securityTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule429SctyTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Security Type",
        "terseLabel": "Security Type"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Rule457aFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule457aFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(a) [Flag]",
        "terseLabel": "Rule 457(a)",
        "documentation": "Checkbox indicating whether filer is using Rule 457(a) to calculate the registration fee due."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "ffd_Rule457bOffsetFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule457bOffsetFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(b) Offset [Flag]",
        "terseLabel": "Rule 457(b) Offset",
        "documentation": "Checkbox indicating whether filer is claiming an offset under Rule 457(b) or 0-11(a)(2)."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "ffd_Rule457fFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule457fFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(f) [Flag]",
        "terseLabel": "Rule 457(f)",
        "documentation": "Checkbox indicating whether filer is using Rule 457(f) to calculate the registration fee due."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "ffd_Rule457oFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule457oFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(o) [Flag]",
        "terseLabel": "Rule 457(o)",
        "documentation": "Checkbox indicating whether filer is using Rule 457(o) to calculate the registration fee due."
       }
      }
     },
     "auth_ref": [
      "r7"
     ]
    },
    "ffd_Rule457pOffsetFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule457pOffsetFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(p) Offset [Flag]",
        "terseLabel": "Rule 457(p) Offset",
        "documentation": "Checkbox indicating whether filer is claiming an offset under Rule 457(p)."
       }
      }
     },
     "auth_ref": [
      "r8"
     ]
    },
    "ffd_Rule457rFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule457rFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(r) [Flag]",
        "terseLabel": "Rule 457(r)"
       }
      }
     },
     "auth_ref": [
      "r9"
     ]
    },
    "ffd_Rule457sFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule457sFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(s) Flag",
        "terseLabel": "Rule 457(s)"
       }
      }
     },
     "auth_ref": [
      "r10"
     ]
    },
    "ffd_Rule457uFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule457uFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(u) [Flag]",
        "terseLabel": "Rule 457(u)",
        "documentation": "Checkbox indicating whether filer is using Rule 457(u) to calculate the registration fee due."
       }
      }
     },
     "auth_ref": [
      "r11"
     ]
    },
    "ffd_Scties424iAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Scties424iAxis",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Securities, 424I [Axis]",
        "terseLabel": "Securities, 424I"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Scties424iLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Scties424iLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Securities, 424I [Line Items]",
        "terseLabel": "Securities, 424I:"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Scties424iTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Scties424iTable",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Securities, 424I [Table]",
        "terseLabel": "Securities, 424I Table"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Securities424iTableNa": {
     "xbrltype": "naItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Securities424iNa",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Securities 424I [N/A]",
        "terseLabel": "Securities 424I N/A"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_SubmissionLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "SubmissionLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Submission [Line Items]",
        "terseLabel": "Items"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_SubmissnTp": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "SubmissnTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Submission Type",
        "terseLabel": "Submission Type"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_TermntnCmpltnWdrwl": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "TermntnCmpltnWdrwl",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Termination / Completion / Withdrawal Statement",
        "terseLabel": "Termination / Withdrawal Statement"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_TtlFeeAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "TtlFeeAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Fee Amount",
        "terseLabel": "Total Fee Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TtlFeeAndIntrstAmt": {
     "xbrltype": "nonNegativeDecimal2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "TtlFeeAndIntrstAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Fee and Interest Amount",
        "terseLabel": "Total Fee and Interest Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TtlOfferingAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "TtlOfferingAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Offering Amount",
        "terseLabel": "Total Offering"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TtlOffsetAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "TtlOffsetAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Offset Amount",
        "terseLabel": "Total Offset Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TtlPrevslyPdAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "TtlPrevslyPdAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Previously Paid Amount",
        "terseLabel": "Previously Paid Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TtlTxValtn": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "TtlTxValtn",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Transaction Valuation",
        "terseLabel": "Total Transaction Valuation"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TxValtn": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "TxValtn",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Transaction Valuation",
        "terseLabel": "Transaction Valuation"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_ValSctiesRcvd": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "ValSctiesRcvd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Value of Securities Received",
        "terseLabel": "Value of Securities Received",
        "documentation": "Value of securities to be received by the registrant (or cancelled upon issuance of securities to be registered on the form)"
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "ffd_ValSctiesRcvdPerShr": {
     "xbrltype": "nonNegativeDecimal4lItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "ValSctiesRcvdPerShr",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Value of Securities Received, Per Share",
        "terseLabel": "Value of Securities Received, Per Share",
        "documentation": "Value per share of securities to be received by the registrant (or cancelled upon issuance of securities to be registered on the form). This is included in the explanation of 457(f) fee calculation."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "415",
   "Subsection": "a"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "429"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "b"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "f"
  },
  "r7": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "o"
  },
  "r8": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "p"
  },
  "r9": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "r"
  },
  "r10": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "s"
  },
  "r11": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "u"
  },
  "r12": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Subsection": "f",
   "Section": "457"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>26
<FILENAME>0001178913-25-002838-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001178913-25-002838-xbrl.zip
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M2)+K14C*N4ZN(4D 7>-(0Y) 9/.40Y+ 2:L(26\A)'7B.F^?UE*H0'OGM;>
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MUIY-MR]+J]F(3@U+/6$$D9$2"JB4E=ODX'8U_-<9P*-G+$YWQ:V4R>,"LQN
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M#-:=E7)4[!+2EK7'B:PFM.0(6HK+;YVB0L:VN9-A"S6^C-)BWLRG348%;0H
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M[$V,_O\!4$L! A0#%     @  T0-6\)B[]C&$0  EK8  !
M ( !     &5X9FEL:6YG9F5E<RYH=&U02P4&      $  0 ^    ]!$

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>exfilingfees_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2025"
  xmlns:ffd="http://xbrl.sec.gov/ffd/2025"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <link:schemaRef
      xlink:href="https://xbrl.sec.gov/ffd/2025/ffd-2025.xsd"
      xlink:type="simple"/>
    <context id="rc">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001835654</identifier>
        </entity>
        <period>
            <startDate>2025-08-12</startDate>
            <endDate>2025-08-12</endDate>
        </period>
    </context>
    <context id="offrl_1">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001835654</identifier>
            <segment>
                <xbrldi:typedMember dimension="ffd:OfferingAxis">
                    <dei:lineNo>1</dei:lineNo>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-08-12</startDate>
            <endDate>2025-08-12</endDate>
        </period>
    </context>
    <context id="offrl_2">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001835654</identifier>
            <segment>
                <xbrldi:typedMember dimension="ffd:OfferingAxis">
                    <dei:lineNo>2</dei:lineNo>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-08-12</startDate>
            <endDate>2025-08-12</endDate>
        </period>
    </context>
    <context id="offrl_3">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001835654</identifier>
            <segment>
                <xbrldi:typedMember dimension="ffd:OfferingAxis">
                    <dei:lineNo>3</dei:lineNo>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-08-12</startDate>
            <endDate>2025-08-12</endDate>
        </period>
    </context>
    <context id="offrl_4">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001835654</identifier>
            <segment>
                <xbrldi:typedMember dimension="ffd:OfferingAxis">
                    <dei:lineNo>4</dei:lineNo>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-08-12</startDate>
            <endDate>2025-08-12</endDate>
        </period>
    </context>
    <context id="offrl_5">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001835654</identifier>
            <segment>
                <xbrldi:typedMember dimension="ffd:OfferingAxis">
                    <dei:lineNo>5</dei:lineNo>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-08-12</startDate>
            <endDate>2025-08-12</endDate>
        </period>
    </context>
    <context id="offrl_6">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001835654</identifier>
            <segment>
                <xbrldi:typedMember dimension="ffd:OfferingAxis">
                    <dei:lineNo>6</dei:lineNo>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-08-12</startDate>
            <endDate>2025-08-12</endDate>
        </period>
    </context>
    <context id="offrl_7">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001835654</identifier>
            <segment>
                <xbrldi:typedMember dimension="ffd:OfferingAxis">
                    <dei:lineNo>7</dei:lineNo>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-08-12</startDate>
            <endDate>2025-08-12</endDate>
        </period>
    </context>
    <context id="offrl_8">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001835654</identifier>
            <segment>
                <xbrldi:typedMember dimension="ffd:OfferingAxis">
                    <dei:lineNo>8</dei:lineNo>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-08-12</startDate>
            <endDate>2025-08-12</endDate>
        </period>
    </context>
    <context id="offrl_9">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001835654</identifier>
            <segment>
                <xbrldi:typedMember dimension="ffd:OfferingAxis">
                    <dei:lineNo>9</dei:lineNo>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-08-12</startDate>
            <endDate>2025-08-12</endDate>
        </period>
    </context>
    <context id="offrl_10">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001835654</identifier>
            <segment>
                <xbrldi:typedMember dimension="ffd:OfferingAxis">
                    <dei:lineNo>10</dei:lineNo>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-08-12</startDate>
            <endDate>2025-08-12</endDate>
        </period>
    </context>
    <unit id="USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="pure">
        <measure>pure</measure>
    </unit>
    <unit id="Shares">
        <measure>shares</measure>
    </unit>
    <ffd:FormTp contextRef="rc" id="ixv-468">F-3</ffd:FormTp>
    <ffd:SubmissnTp contextRef="rc" id="ixv-469">F-3</ffd:SubmissnTp>
    <ffd:FeeExhibitTp contextRef="rc" id="ixv-470">EX-FILING FEES</ffd:FeeExhibitTp>
    <dei:EntityCentralIndexKey contextRef="rc" id="ixv-471">0001835654</dei:EntityCentralIndexKey>
    <dei:EntityRegistrantName contextRef="rc" id="ixv-472">Innoviz Technologies Ltd.</dei:EntityRegistrantName>
    <ffd:OfferingTableNa contextRef="rc" id="hiddenrcOfferingTableNa" xsi:nil="true"/>
    <ffd:OffsetTableNa contextRef="rc" id="hiddenrcOffsetTableNa">N/A</ffd:OffsetTableNa>
    <ffd:CombinedProspectusTableNa contextRef="rc" id="hiddenrcCombinedProspectusTableNa">N/A</ffd:CombinedProspectusTableNa>
    <ffd:FeeRate
      contextRef="offrl_1"
      decimals="INF"
      id="ixv-476"
      unitRef="pure">0.0001531</ffd:FeeRate>
    <ffd:FeeRate
      contextRef="offrl_2"
      decimals="INF"
      id="ixv-477"
      unitRef="pure">0.0001531</ffd:FeeRate>
    <ffd:FeeRate
      contextRef="offrl_3"
      decimals="INF"
      id="ixv-478"
      unitRef="pure">0.0001531</ffd:FeeRate>
    <ffd:FeeRate
      contextRef="offrl_4"
      decimals="INF"
      id="ixv-479"
      unitRef="pure">0.0001531</ffd:FeeRate>
    <ffd:FormTp contextRef="rc" id="ixv-585">F-3</ffd:FormTp>
    <dei:EntityRegistrantName contextRef="rc" id="ixv-586">Innoviz Technologies Ltd.</dei:EntityRegistrantName>
    <ffd:OfferingSctyTp contextRef="offrl_1" id="ixv-587">Equity</ffd:OfferingSctyTp>
    <ffd:OfferingSctyTitl contextRef="offrl_1" id="ixv-588">Ordinary shares, no par value per share</ffd:OfferingSctyTitl>
    <ffd:Rule457oFlg contextRef="offrl_1" id="ixv-589">true</ffd:Rule457oFlg>
    <ffd:OfferingSctyTp contextRef="offrl_2" id="ixv-590">Debt</ffd:OfferingSctyTp>
    <ffd:OfferingSctyTitl contextRef="offrl_2" id="ixv-591">Debt Securities</ffd:OfferingSctyTitl>
    <ffd:Rule457oFlg contextRef="offrl_2" id="ixv-592">true</ffd:Rule457oFlg>
    <ffd:OfferingSctyTp contextRef="offrl_3" id="ixv-593">Other</ffd:OfferingSctyTp>
    <ffd:OfferingSctyTitl contextRef="offrl_3" id="ixv-594">Warrants</ffd:OfferingSctyTitl>
    <ffd:Rule457oFlg contextRef="offrl_3" id="ixv-595">true</ffd:Rule457oFlg>
    <ffd:OfferingSctyTp contextRef="offrl_4" id="ixv-596">Other</ffd:OfferingSctyTp>
    <ffd:OfferingSctyTitl contextRef="offrl_4" id="ixv-597">Units</ffd:OfferingSctyTitl>
    <ffd:Rule457oFlg contextRef="offrl_4" id="ixv-598">true</ffd:Rule457oFlg>
    <ffd:PrevslyPdFlg contextRef="offrl_5" id="ixv-599">false</ffd:PrevslyPdFlg>
    <ffd:OfferingSctyTp contextRef="offrl_5" id="ixv-600">Unallocated (Universal) Shelf</ffd:OfferingSctyTp>
    <ffd:Rule457oFlg contextRef="offrl_5" id="ixv-601">true</ffd:Rule457oFlg>
    <ffd:MaxAggtOfferingPric
      contextRef="offrl_5"
      decimals="INF"
      id="ixv-602"
      unitRef="USD">144788668.00</ffd:MaxAggtOfferingPric>
    <ffd:FeeRate
      contextRef="offrl_5"
      decimals="INF"
      id="ixv-603"
      unitRef="pure">0.0001531</ffd:FeeRate>
    <ffd:FeeAmt
      contextRef="offrl_5"
      decimals="INF"
      id="ixv-604"
      unitRef="USD">22167.15</ffd:FeeAmt>
    <ffd:OfferingSctyTp contextRef="offrl_6" id="ixv-605">Equity</ffd:OfferingSctyTp>
    <ffd:OfferingSctyTitl contextRef="offrl_6" id="ixv-606">Ordinary shares, no par value per share</ffd:OfferingSctyTitl>
    <ffd:Rule415a6Flg contextRef="offrl_6" id="ixv-607">true</ffd:Rule415a6Flg>
    <ffd:CfwdFormTp contextRef="offrl_6" id="ixv-608">F-3</ffd:CfwdFormTp>
    <ffd:CfwdPrrFileNb contextRef="offrl_6" id="ixv-609">333-267646</ffd:CfwdPrrFileNb>
    <ffd:CfwdPrrFctvDt contextRef="offrl_6" id="ixv-610">2022-10-11</ffd:CfwdPrrFctvDt>
    <ffd:OfferingSctyTp contextRef="offrl_7" id="ixv-611">Debt</ffd:OfferingSctyTp>
    <ffd:OfferingSctyTitl contextRef="offrl_7" id="ixv-612">Debt Securities</ffd:OfferingSctyTitl>
    <ffd:Rule415a6Flg contextRef="offrl_7" id="ixv-613">true</ffd:Rule415a6Flg>
    <ffd:CfwdFormTp contextRef="offrl_7" id="ixv-614">F-3</ffd:CfwdFormTp>
    <ffd:CfwdPrrFileNb contextRef="offrl_7" id="ixv-615">333-267646</ffd:CfwdPrrFileNb>
    <ffd:CfwdPrrFctvDt contextRef="offrl_7" id="ixv-616">2022-10-11</ffd:CfwdPrrFctvDt>
    <ffd:OfferingSctyTp contextRef="offrl_8" id="ixv-617">Other</ffd:OfferingSctyTp>
    <ffd:OfferingSctyTitl contextRef="offrl_8" id="ixv-618">Warrants</ffd:OfferingSctyTitl>
    <ffd:Rule415a6Flg contextRef="offrl_8" id="ixv-619">true</ffd:Rule415a6Flg>
    <ffd:CfwdFormTp contextRef="offrl_8" id="ixv-620">F-3</ffd:CfwdFormTp>
    <ffd:CfwdPrrFileNb contextRef="offrl_8" id="ixv-621">333-267646</ffd:CfwdPrrFileNb>
    <ffd:CfwdPrrFctvDt contextRef="offrl_8" id="ixv-622">2022-10-11</ffd:CfwdPrrFctvDt>
    <ffd:OfferingSctyTp contextRef="offrl_9" id="ixv-623">Other</ffd:OfferingSctyTp>
    <ffd:OfferingSctyTitl contextRef="offrl_9" id="ixv-624">Units</ffd:OfferingSctyTitl>
    <ffd:Rule415a6Flg contextRef="offrl_9" id="ixv-625">true</ffd:Rule415a6Flg>
    <ffd:CfwdFormTp contextRef="offrl_9" id="ixv-626">F-3</ffd:CfwdFormTp>
    <ffd:CfwdPrrFileNb contextRef="offrl_9" id="ixv-627">333-267646</ffd:CfwdPrrFileNb>
    <ffd:CfwdPrrFctvDt contextRef="offrl_9" id="ixv-628">2022-10-11</ffd:CfwdPrrFctvDt>
    <ffd:OfferingSctyTp contextRef="offrl_10" id="ixv-629">Unallocated (Universal) Shelf</ffd:OfferingSctyTp>
    <ffd:Rule415a6Flg contextRef="offrl_10" id="ixv-630">true</ffd:Rule415a6Flg>
    <ffd:MaxAggtOfferingPric
      contextRef="offrl_10"
      decimals="INF"
      id="ixv-631"
      unitRef="USD">55211332.00</ffd:MaxAggtOfferingPric>
    <ffd:CfwdFormTp contextRef="offrl_10" id="ixv-632">F-3</ffd:CfwdFormTp>
    <ffd:CfwdPrrFileNb contextRef="offrl_10" id="ixv-633">333-267646</ffd:CfwdPrrFileNb>
    <ffd:CfwdPrrFctvDt contextRef="offrl_10" id="ixv-634">2022-10-11</ffd:CfwdPrrFctvDt>
    <ffd:CfwdPrevslyPdFee
      contextRef="offrl_10"
      decimals="INF"
      id="ixv-635"
      unitRef="USD">5118.09</ffd:CfwdPrevslyPdFee>
    <ffd:TtlOfferingAmt contextRef="rc" decimals="INF" id="ixv-636" unitRef="USD">200000000.00</ffd:TtlOfferingAmt>
    <ffd:TtlFeeAmt contextRef="rc" decimals="INF" id="ixv-637" unitRef="USD">22167.15</ffd:TtlFeeAmt>
    <ffd:TtlPrevslyPdAmt contextRef="rc" decimals="INF" id="ixv-638" unitRef="USD">0.00</ffd:TtlPrevslyPdAmt>
    <ffd:TtlOffsetAmt contextRef="rc" decimals="INF" id="ixv-639" unitRef="USD">0.00</ffd:TtlOffsetAmt>
    <ffd:NetFeeAmt contextRef="rc" decimals="INF" id="ixv-640" unitRef="USD">22167.15</ffd:NetFeeAmt>
    <ffd:OfferingNote contextRef="offrl_5" id="ixv-641">(1)	The securities registered hereunder include such indeterminate number of (a) ordinary shares, (b) debt securities, (c) warrants to purchase ordinary shares and (d) units consisting of some or all of these securities in any combination, as may be sold from time to time by the registrant. There are also being registered hereunder an indeterminate number of ordinary shares as shall be issuable upon conversion, exchange or exercise of any securities that provide for such issuance.
(2)	Pursuant to Rule 416 under the Securities Act of 1933, as amended, or the Securities Act, this registration statement shall also cover any additional shares of the registrant's securities that become issuable by reason of any stock splits, stock dividend or similar transaction.
(3)	The proposed maximum per security and aggregate offering prices per class of securities will be determined from time to time by the registrant in connection with the issuance by the registrant of the securities registered hereunder and is not specified as to each class of security. Separate consideration may or may not be received for securities that are issuable on exercise, conversion or exchange of other securities, or that are issued in units.</ffd:OfferingNote>
    <ffd:OfferingNote contextRef="offrl_10" id="ixv-642">The registrant previously paid registration fees in the aggregate of $18,540 with respect to a Registration Statement on Form F-3 (File No. 333-267646) (the "Prior Registration Statement"). Pursuant to Rule 415(a)(6) ("Rule 415(a)(6)") promulgated under the Securities Act of 1933, as amended (the "Securities Act"), the securities registered pursuant to this Registration Statement on Form F-3 (this "Registration Statement") include $55,211,332 of securities previously registered on the Prior Registration Statement which remain unsold (the "Unsold Securities"). Pursuant to Rule 415(a)(6), the registration fee of $5,118.09 associated with the offering of the Unsold Securities (based on the filing fee rate in effect at the time of the filing of the Prior Registration Statement) is hereby carried forward to be applied to the Unsold Securities registered hereunder, and no additional filing fee is due with respect to the Unsold Securities in connection with the filing of this Registration Statement. The registrant is also registering new securities on this Registration Statement with an aggregate maximum offering price of $144,788,668 (the "New Securities"), which aggregate offering price is not specified as to each class of securities in reliance upon Rule 457(o) promulgated under the Securities Act. A filing fee of $22,167.15 with respect to the New Securities is being paid in connection with the filing of this Registration Statement. Pursuant to Rule 415(a)(6), the offering of the Unsold Securities under the Prior Registration Statement will be deemed terminated as of the date of effectiveness of this Registration Statement.</ffd:OfferingNote>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
